1	Annu	NNP	PERSON	Annu	_	0	SENT_1	[p1l268t1680r291b1760],
2	.	.	O	.	_	0	SENT_1	[p1l268t1680r291b1760],

1	Rev.	NNP	O	Rev.	nn	2	SENT_2	[p1l268t1609r291b1669],
2	Med	NNP	O	Med	_	0	SENT_2	[p1l268t1531r291b1599],
3	.	.	O	.	_	0	SENT_2	[p1l268t1531r291b1599],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_3	[p1l268t1406r291b1520],
2	:	:	O	:	_	0	SENT_3	[p1l268t1406r291b1520],
3	1	CD	NUMBER	1	number	4	SENT_3	[p1l268t1390r291b1400],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_3	[p1l268t1286r292b1383],
5	.	.	O	.	_	0	SENT_3	[p1l268t1286r292b1383],

1	Downloaded	VBN	O	download	_	0	SENT_4	[p1l268t1105r291b1275],
2	from	IN	O	from	_	0	SENT_4	[p1l268t1032r291b1096],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_4	[p1l268t699r298b1022],
4	by	IN	O	by	_	0	SENT_4	[p1l301t1694r332b1726],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_4	[p1l301t1544r332b1684],
6	of	IN	ORGANIZATION	of	_	0	SENT_4	[p1l301t1505r325b1534],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_4	[p1l301t1358r325b1499],
8	-	:	O	-	_	0	SENT_4	[p1l315t1340r318b1349],
9	Madison	NNP	O	Madison	prep_by	1	SENT_4	[p1l301t1214r325b1330],
10	on	IN	O	on	_	0	SENT_4	[p1l309t1172r325b1204],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_4	[p1l301t1038r325b1163],
12	.	.	O	.	_	0	SENT_4	[p1l301t1038r325b1163],

1	For	IN	O	for	_	0	SENT_5	[p1l302t981r325b1028],
2	personal	JJ	O	personal	amod	3	SENT_5	[p1l301t862r332b974],
3	use	NN	O	use	pobj	1	SENT_5	[p1l309t809r325b852],
4	only	RB	O	only	advmod	3	SENT_5	[p1l301t734r332b799],
5	.	.	O	.	_	0	SENT_5	[p1l301t734r332b799],

1	Annu	NNP	PERSON	Annu	_	0	SENT_6	[p1l1488t81r1557b102],
2	.	.	O	.	_	0	SENT_6	[p1l1488t81r1557b102],

1	Rev.	NNP	O	Rev.	nn	2	SENT_7	[p1l1567t82r1616b102],
2	Med	NNP	O	Med	_	0	SENT_7	[p1l1625t81r1684b102],
3	.	.	O	.	_	0	SENT_7	[p1l1625t81r1684b102],

1	2006	CD	DATE	2006	_	0	SENT_8	[p1l1694t81r1757b102],
2	.	.	O	.	_	0	SENT_8	[p1l1694t81r1757b102],

1	572119-37	CD	NUMBER	572119-37	_	0	SENT_9	[p1l1766t81r1889b102],
2	doi	FW	O	doi	dep	1	SENT_9	[p1l1362t115r1404b136],
3	:	:	O	:	_	0	SENT_9	[p1l1362t115r1404b136],
4	10.1146	CD	NUMBER	10.1146	dep	2	SENT_9	[p1l1417t115r1889b136],
5	/	:	O	/	punct	1	SENT_9	[p1l1417t115r1889b136],
6	annurev	NN	O	annurev	dep	1	SENT_9	[p1l1417t115r1889b136],
7	.	.	O	.	_	0	SENT_9	[p1l1417t115r1889b136],

1	med	VBN	O	med	_	0	SENT_10	[p1l1417t115r1889b136],
2	.56.082103.104724	CD	NUMBER	.56.082103.104724	num	3	SENT_10	[p1l1417t115r1889b136],
3	Copyright	NN	O	copyright	dobj	1	SENT_10	[p1l1202t149r1319b175],
4	©	CD	NUMBER	©	num	5	SENT_10	[p1l1328t148r1357b175],
5	2006	CD	DATE	2006	npadvmod	1	SENT_10	[p1l1367t149r1424b169],
6	by	IN	O	by	_	0	SENT_10	[p1l1432t149r1460b175],
7	Annual	JJ	SET	annual	amod	8	SENT_10	[p1l1468t149r1553b169],
8	Reviews	NNS	O	review	prep_by	1	SENT_10	[p1l1561t149r1665b169],
9	.	.	O	.	_	0	SENT_10	[p1l1561t149r1665b169],

1	All	DT	O	all	det	2	SENT_11	[p1l1674t149r1711b169],
2	rights	NNS	O	rights	nsubj	3	SENT_11	[p1l1719t149r1784b175],
3	reserved	VBD	O	reserve	_	0	SENT_11	[p1l1792t149r1890b169],
4	First	JJ	ORDINAL	first	advmod	5	SENT_11	[p1l1154t182r1207b203],
5	published	VBN	O	publish	dep	3	SENT_11	[p1l1214t182r1327b209],
6	online	NN	O	online	dep	5	SENT_11	[p1l1335t182r1406b203],
7	as	IN	O	as	_	0	SENT_11	[p1l1415t188r1437b203],
8	a	DT	O	a	det	9	SENT_11	[p1l1447t188r1459b203],
9	Review	NN	O	review	prep_as	5	SENT_11	[p1l1467t182r1552b203],
10	in	IN	O	in	_	0	SENT_11	[p1l1561t182r1582b203],
11	Advance	NNP	O	Advance	prep_in	9	SENT_11	[p1l1591t182r1692b203],
12	on	IN	O	on	_	0	SENT_11	[p1l1701t188r1729b203],
13	Sept.	NNP	DATE	Sept.	prep_on	5	SENT_11	[p1l1738t182r1794b209],
14	1	CD	DATE	1	num	13	SENT_11	[p1l1806t182r1823b206],
15	,	,	DATE	,	_	0	SENT_11	[p1l1806t182r1823b206],
16	2005	CD	DATE	2005	num	13	SENT_11	[p1l1833t182r1888b203],

1	PHARMACOGENOMICS	NNS	O	pharmacogenomic	_	0	SENT_12	[p1l448t284r1080b339],
2	AND	CC	O	and	_	0	SENT_12	[p1l1100t299r1222b339],
3	INDIVIDUALIZED	NNS	O	individualized	conj_and	1	SENT_12	[p1l1245t284r1721b339],

1	DRUG	NN	O	drug	nn	2	SENT_13	[p1l447t375r626b431],
2	THERAPY	NN	O	therapy	_	0	SENT_13	[p1l647t373r918b431],

1	Michel	NNP	PERSON	Michel	nn	5	SENT_14	[p1l546t541r705b584],
2	Eichelbaum	NNP	PERSON	Eichelbaum	nn	5	SENT_14	[p1l720t536r1024b590],
3	}	NNP	O	}	nn	5	SENT_14	[p1l720t536r1024b590],
4	Magnus	NNP	PERSON	Magnus	nn	5	SENT_14	[p1l1044t545r1228b597],
5	Ingelman	NNP	PERSON	Ingelman	_	0	SENT_14	[p1l1245t536r1740b597],
6	.	.	O	.	_	0	SENT_14	[p1l1245t536r1740b597],

1	—	NN	O	—	_	0	SENT_15	[p1l1245t536r1740b597],
2	.	.	O	.	_	0	SENT_15	[p1l1245t536r1740b597],

1	Sundberg	NNP	PERSON	Sundberg	_	0	SENT_16	[p1l1245t536r1740b597],
2	,2	CD	NUMBER	,2	num	1	SENT_16	[p1l1245t536r1740b597],
3	and	CC	O	and	_	0	SENT_16	[p1l547t604r632b647],
4	William	NNP	PERSON	William	nn	5	SENT_16	[p1l645t604r831b647],
5	E.	NNP	PERSON	E.	conj_and	1	SENT_16	[p1l847t608r889b647],
6	Evans3	NN	O	evans3	dep	1	SENT_16	[p1l906t599r1056b647],
7	1	CD	NUMBER	1	num	6	SENT_16	[p1l546t661r555b678],
8	Dr.	NNP	O	Dr.	nn	10	SENT_16	[p1l559t667r602b692],
9	Margarete	NNP	PERSON	Margarete	nn	10	SENT_16	[p1l615t667r771b699],
10	Fischer	NNP	PERSON	Fischer	dep	6	SENT_16	[p1l782t666r1130b692],
11	.	.	O	.	_	0	SENT_16	[p1l782t666r1130b692],

1	—	NN	O	—	_	0	SENT_17	[p1l782t666r1130b692],
2	.	.	O	.	_	0	SENT_17	[p1l782t666r1130b692],

1	Bosch	NNP	PERSON	Bosch	_	0	SENT_18	[p1l782t666r1130b692],
2	.	.	O	.	_	0	SENT_18	[p1l782t666r1130b692],

1	—	NN	O	—	_	0	SENT_19	[p1l782t666r1130b692],
2	.	.	O	.	_	0	SENT_19	[p1l782t666r1130b692],

1	Institute	NNP	O	Institute	_	0	SENT_20	[p1l782t666r1130b692],
2	of	IN	O	of	_	0	SENT_20	[p1l1141t666r1175b699],
3	Clinical	JJ	O	clinical	amod	4	SENT_20	[p1l1181t666r1299b692],
4	Pharmacology	NN	O	pharmacology	prep_of	1	SENT_20	[p1l1309t666r1531b699],
5	,	,	O	,	_	0	SENT_20	[p1l1309t666r1531b699],
6	Auerbachstr	NN	O	auerbachstr	appos	1	SENT_20	[p1l1543t666r1729b692],
7	112	CD	NUMBER	112	num	6	SENT_20	[p1l1745t666r1804b696],
8	,	,	O	,	_	0	SENT_20	[p1l1745t666r1804b696],
9	D-70376	NNP	O	D-70376	nn	10	SENT_20	[p1l544t703r678b730],
10	Stuttgart	NNP	LOCATION	Stuttgart	appos	1	SENT_20	[p1l687t704r823b737],
11	,	,	O	,	_	0	SENT_20	[p1l687t704r823b737],
12	Germany	NNP	LOCATION	Germany	appos	1	SENT_20	[p1l838t704r985b737],
13	;	:	O	;	_	0	SENT_20	[p1l838t704r985b737],
14	email	NN	O	email	dep	12	SENT_20	[p1l998t703r1090b730],
15	:	:	O	:	_	0	SENT_20	[p1l998t703r1090b730],
16	michel.eichelbaum@ikp-stuttgartde	JJ	O	michel.eichelbaum@ikp-stuttgartde	amod	17	SENT_20	[p1l1102t703r1645b737],
17	2Karolinska	NN	O	2karolinska	dep	1	SENT_20	[p1l545t744r723b775],
18	Institntet	NNP	O	Institntet	dep	17	SENT_20	[p1l732t750r871b779],
19	,	,	O	,	_	0	SENT_20	[p1l732t750r871b779],
20	Division	NNP	O	Division	appos	1	SENT_20	[p1l884t750r1010b775],
21	of	IN	O	of	_	0	SENT_20	[p1l1021t749r1055b783],
22	Molecular	JJ	O	molecular	amod	23	SENT_20	[p1l1058t749r1216b775],
23	Toxicology	NN	O	toxicology	prep_of	20	SENT_20	[p1l1226t749r1389b783],
24	,	,	O	,	_	0	SENT_20	[p1l1226t749r1389b783],
25	IMM	NNP	O	IMM	nn	26	SENT_20	[p1l1402t750r1479b775],
26	SE	NN	O	se	appos	1	SENT_20	[p1l1487t750r1529b776],
27	[	CD	NUMBER	[	number	28	SENT_20	[p1l1539t749r1633b775],
28	7177	CD	NUMBER	7177	num	29	SENT_20	[p1l1539t749r1633b775],
29	Stockholm	NNP	LOCATION	Stockholm	dep	26	SENT_20	[p1l1641t749r1801b780],
30	,	,	O	,	_	0	SENT_20	[p1l1641t749r1801b780],
31	Sweden	NNP	LOCATION	Sweden	appos	1	SENT_20	[p1l545t795r669b825],
32	;	:	O	;	_	0	SENT_20	[p1l545t795r669b825],
33	email	NN	O	email	dep	1	SENT_20	[p1l682t795r774b821],
34	:	:	O	:	_	0	SENT_20	[p1l682t795r774b821],
35	magnus	NN	O	magnus	dep	33	SENT_20	[p1l786t804r907b828],
36	.	.	O	.	_	0	SENT_20	[p1l786t804r907b828],

1	ingelman	NN	O	ingelman	_	0	SENT_21	[p1l912t795r1199b828],
2	—	CD	NUMBER	—	num	3	SENT_21	[p1l912t795r1199b828],
3	sundberg	NN	O	sundberg	dep	1	SENT_21	[p1l912t795r1199b828],
4	@	IN	O	@	_	0	SENT_21	[p1l1204t795r1230b821],
5	imm	NN	O	imm	prep_@	3	SENT_21	[p1l1236t795r1374b821],
6	.	.	O	.	_	0	SENT_21	[p1l1236t795r1374b821],

1	ki	NN	O	kus	_	0	SENT_22	[p1l1236t795r1374b821],
2	.	.	O	.	_	0	SENT_22	[p1l1236t795r1374b821],

1	se	FW	O	se	nn	2	SENT_23	[p1l1236t795r1374b821],
2	3St	FW	O	3st	_	0	SENT_23	[p1l545t835r594b867],
3	.	.	O	.	_	0	SENT_23	[p1l545t835r594b867],

1	Jude	NNP	ORGANIZATION	Jude	nn	2	SENT_24	[p1l607t840r675b867],
2	Children	NNP	ORGANIZATION	Children	poss	5	SENT_24	[p1l688t840r816b867],
3	’s	POS	ORGANIZATION	’s	_	0	SENT_24	[p1l823t841r842b867],
4	Research	NNP	ORGANIZATION	Research	nn	5	SENT_24	[p1l851t840r988b867],
5	Hospital	NNP	ORGANIZATION	Hospital	nn	12	SENT_24	[p1l998t840r1132b874],
6	,	,	O	,	_	0	SENT_24	[p1l998t840r1132b874],
7	Memphis	NNP	LOCATION	Memphis	appos	5	SENT_24	[p1l1145t840r1288b874],
8	,	,	O	,	_	0	SENT_24	[p1l1145t840r1288b874],
9	Tennessee	NNP	LOCATION	Tennessee	appos	5	SENT_24	[p1l1304t841r1451b867],
10	38105	CD	NUMBER	38105	num	9	SENT_24	[p1l1461t841r1564b871],
11	;	:	O	;	_	0	SENT_24	[p1l1461t841r1564b871],
12	email	NN	O	email	_	0	SENT_24	[p1l546t886r638b912],
13	:	:	O	:	_	0	SENT_24	[p1l546t886r638b912],
14	William.Evans@stjude.org	NN	O	william.evans@stjude.org	dep	12	SENT_24	[p1l652t886r1049b920],

1	Key	NN	O	key	nn	2	SENT_25	[p1l546t1020r615b1057],
2	Words	NNS	O	word	_	0	SENT_25	[p1l626t1020r741b1049],
3	pharmacogenetics	NNS	O	pharmacogenetic	dep	2	SENT_25	[p1l784t1021r1077b1057],
4	,	,	O	,	_	0	SENT_25	[p1l784t1021r1077b1057],
5	drugs	NNS	O	drug	appos	3	SENT_25	[p1l1089t1021r1184b1057],
6	,	,	O	,	_	0	SENT_25	[p1l1089t1021r1184b1057],
7	metabolism	NN	O	metabolism	appos	3	SENT_25	[p1l1196t1021r1388b1054],
8	,	,	O	,	_	0	SENT_25	[p1l1196t1021r1388b1054],
9	transport	NN	O	transport	appos	3	SENT_25	[p1l1400t1025r1548b1057],
10	,	,	O	,	_	0	SENT_25	[p1l1400t1025r1548b1057],
11	receptor	NN	O	receptor	appos	3	SENT_25	[p1l1560t1025r1689b1057],

1	I	PRP	O	I	nsubj	4	SENT_26	[p1l546t1090r575b1119],
2	Abstract	JJ	O	abstract	amod	4	SENT_26	[p1l596t1091r743b1120],
3	Pharmacogenetics	NNS	O	pharmacogenetic	nn	4	SENT_26	[p1l783t1092r1068b1128],
4	deals	NNS	O	deal	_	0	SENT_26	[p1l1084t1092r1162b1119],
5	with	IN	O	with	_	0	SENT_26	[p1l1178t1092r1247b1119],
6	inherited	VBN	O	inherit	amod	7	SENT_26	[p1l1261t1092r1401b1119],
7	differences	NNS	O	difference	prep_with	4	SENT_26	[p1l1415t1092r1587b1119],
8	in	IN	O	in	_	0	SENT_26	[p1l1603t1092r1632b1119],
9	the	DT	O	the	det	10	SENT_26	[p1l1647t1092r1694b1119],
10	response	NN	O	response	prep_in	7	SENT_26	[p1l1708t1100r1845b1128],
11	to	TO	O	to	_	0	SENT_26	[p1l1860t1096r1889b1119],
12	drugs	NNS	O	drug	prep_to	10	SENT_26	[p1l546t1137r640b1173],
13	.	.	O	.	_	0	SENT_26	[p1l546t1137r640b1173],

1	The	DT	O	the	det	3	SENT_27	[p1l650t1137r710b1165],
2	best-recognized	JJ	O	best-recognized	amod	3	SENT_27	[p1l717t1137r967b1173],
3	examples	NNS	O	example	nsubj	6	SENT_27	[p1l975t1137r1121b1173],
4	are	VBP	O	be	cop	6	SENT_27	[p1l1131t1146r1177b1165],
5	genetic	JJ	O	genetic	amod	6	SENT_27	[p1l1186t1137r1298b1173],
6	polymorphisms	NNS	O	polymorphism	_	0	SENT_27	[p1l1306t1137r1550b1173],
7	of	IN	O	of	_	0	SENT_27	[p1l1560t1137r1594b1165],
8	drug-metabolizing	JJ	O	drug-metabolizing	amod	9	SENT_27	[p1l1599t1137r1889b1173],
9	enzymes	NNS	O	enzyme	prep_of	6	SENT_27	[p1l545t1192r691b1219],
10	,	,	O	,	_	0	SENT_27	[p1l545t1192r691b1219],
11	which	WDT	O	which	nsubj	12	SENT_27	[p1l710t1183r805b1211],
12	affect	VBP	O	affect	rcmod	9	SENT_27	[p1l823t1183r911b1211],
13	about	IN	O	about	_	0	SENT_27	[p1l928t1183r1015b1211],
14	30	CD	PERCENT	30	num	15	SENT_27	[p1l1033t1183r1101b1211],
15	%	NN	PERCENT	%	prep_about	12	SENT_27	[p1l1033t1183r1101b1211],
16	of	IN	O	of	_	0	SENT_27	[p1l1121t1183r1155b1211],
17	all	DT	O	all	det	18	SENT_27	[p1l1170t1183r1208b1211],
18	drugs	NNS	O	drug	prep_of	15	SENT_27	[p1l1226t1183r1320b1219],
19	.	.	O	.	_	0	SENT_27	[p1l1226t1183r1320b1219],

1	Loss	NN	O	loss	nsubj	10	SENT_28	[p1l1339t1184r1412b1211],
2	of	IN	O	of	_	0	SENT_28	[p1l1431t1183r1465b1211],
3	function	NN	O	function	prep_of	1	SENT_28	[p1l1480t1183r1610b1211],
4	of	IN	O	of	_	0	SENT_28	[p1l1628t1183r1662b1211],
5	thiopurine	NN	O	thiopurine	nn	6	SENT_28	[p1l1677t1183r1838b1219],
6	Smethyltransferase	NN	O	smethyltransferase	prep_of	3	SENT_28	[p1l1857t1183r1888b1211, p1l545t1229r824b1265],
7	(	CD	NUMBER	(	num	9	SENT_28	[p1l834t1229r962b1263],
8	TPMT	NN	O	tpmt	nn	9	SENT_28	[p1l834t1229r962b1263],
9	)	NN	O	)	dep	6	SENT_28	[p1l834t1229r962b1263],
10	results	VBZ	O	result	_	0	SENT_28	[p1l971t1229r1072b1257],
11	in	IN	O	in	_	0	SENT_28	[p1l1081t1229r1111b1256],
12	severe	JJ	O	severe	amod	16	SENT_28	[p1l1120t1238r1217b1257],
13	and	CC	O	and	_	0	SENT_28	[p1l1226t1229r1281b1256],
14	life-threatening	JJ	O	life-threatening	amod	16	SENT_28	[p1l1289t1229r1531b1265],
15	hematopoietic	JJ	O	hematopoietic	amod	16	SENT_28	[p1l1539t1229r1761b1265],
16	toxicity	NN	O	toxicity	prep_in	10	SENT_28	[p1l1770t1229r1889b1265],
17	if	IN	O	if	mark	19	SENT_28	[p1l545t1275r571b1302],
18	patients	NNS	O	patient	nsubj	19	SENT_28	[p1l580t1275r701b1311],
19	receive	VBP	O	receive	advcl	10	SENT_28	[p1l714t1275r825b1302],
20	standard	JJ	O	standard	amod	21	SENT_28	[p1l839t1275r970b1302],
21	doses	NNS	O	dose	dobj	19	SENT_28	[p1l982t1275r1068b1302],
22	of	IN	O	of	_	0	SENT_28	[p1l1081t1275r1115b1302],
23	mercaptopurine	NN	O	mercaptopurine	prep_of	21	SENT_28	[p1l1125t1275r1371b1311],
24	and	CC	O	and	_	0	SENT_28	[p1l1384t1275r1439b1302],
25	azathioprine	NN	O	azathioprine	prep_of	21	SENT_28	[p1l1452t1275r1653b1311],
26	.	.	O	.	_	0	SENT_28	[p1l1452t1275r1653b1311],

1	Gene	NNP	PERSON	Gene	nn	2	SENT_29	[p1l1668t1275r1749b1302],
2	duplication	NN	O	duplication	nsubjpass	17	SENT_29	[p1l1762t1275r1888b1311, p1l545t1320r606b1348],
3	of	IN	O	of	_	0	SENT_29	[p1l621t1320r655b1348],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_29	[p1l668t1320r852b1356],
5	P4502D6	NN	O	p4502d6	prep_of	2	SENT_29	[p1l867t1320r1015b1348],
6	(	CD	NUMBER	(	num	8	SENT_29	[p1l1032t1320r1209b1355],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_29	[p1l1032t1320r1209b1355],
8	)	NN	O	)	dep	5	SENT_29	[p1l1032t1320r1209b1355],
9	,	,	O	,	_	0	SENT_29	[p1l1032t1320r1209b1355],
10	which	WDT	O	which	nsubj	11	SENT_29	[p1l1226t1320r1321b1348],
11	metabolizes	VBZ	O	metabolize	rcmod	2	SENT_29	[p1l1336t1320r1522b1348],
12	many	JJ	O	many	amod	13	SENT_29	[p1l1539t1329r1624b1356],
13	antidepressants	NNS	O	antidepressant	dobj	11	SENT_29	[p1l1640t1320r1888b1356],
14	,	,	O	,	_	0	SENT_29	[p1l1640t1320r1888b1356],
15	has	VBZ	O	have	aux	17	SENT_29	[p1l545t1366r596b1394],
16	been	VBN	O	be	auxpass	17	SENT_29	[p1l609t1366r683b1394],
17	identiﬁed	VBN	O	identiﬁed	_	0	SENT_29	[p1l696t1366r845b1394],
18	as	IN	O	as	_	0	SENT_29	[p1l858t1375r888b1394],
19	a	DT	O	a	det	20	SENT_29	[p1l903t1375r919b1394],
20	mechanism	NN	O	mechanism	prep_as	17	SENT_29	[p1l932t1366r1111b1394],
21	of	IN	O	of	_	0	SENT_29	[p1l1124t1366r1158b1394],
22	poor	JJ	O	poor	amod	23	SENT_29	[p1l1168t1375r1241b1402],
23	response	NN	O	response	prep_of	20	SENT_29	[p1l1252t1375r1390b1402],
24	in	IN	O	in	_	0	SENT_29	[p1l1403t1366r1433b1393],
25	the	DT	O	the	det	26	SENT_29	[p1l1446t1366r1493b1394],
26	treatment	NN	O	treatment	prep_in	17	SENT_29	[p1l1506t1370r1655b1394],
27	of	IN	O	of	_	0	SENT_29	[p1l1667t1366r1702b1394],
28	depression	NN	O	depression	prep_of	26	SENT_29	[p1l1712t1366r1888b1402],
29	.	.	O	.	_	0	SENT_29	[p1l1712t1366r1888b1402],

1	There	EX	O	there	expl	2	SENT_30	[p1l545t1412r636b1439],
2	is	VBZ	O	be	_	0	SENT_30	[p1l649t1412r673b1439],
3	also	RB	O	also	advmod	2	SENT_30	[p1l687t1412r748b1439],
4	a	DT	O	a	det	6	SENT_30	[p1l762t1421r779b1439],
5	growing	VBG	O	grow	amod	6	SENT_30	[p1l791t1412r920b1448],
6	list	NN	O	list	nsubj	2	SENT_30	[p1l933t1412r980b1439],
7	of	IN	O	of	_	0	SENT_30	[p1l993t1412r1027b1439],
8	genetic	JJ	O	genetic	amod	9	SENT_30	[p1l1037t1412r1149b1448],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_30	[p1l1162t1412r1405b1448],
10	in	IN	O	in	_	0	SENT_30	[p1l1419t1412r1449b1439],
11	drug	NN	O	drug	nn	12	SENT_30	[p1l1461t1412r1532b1448],
12	targets	NNS	O	target	prep_in	9	SENT_30	[p1l1545t1416r1647b1448],
13	that	WDT	O	that	nsubjpass	16	SENT_30	[p1l1661t1412r1720b1439],
14	have	VBP	O	have	aux	16	SENT_30	[p1l1731t1412r1803b1440],
15	been	VBN	O	be	auxpass	16	SENT_30	[p1l1816t1412r1890b1439],
16	shown	VBN	O	show	rcmod	6	SENT_30	[p1l546t1458r646b1485],
17	to	TO	O	to	_	0	SENT_30	[p1l659t1462r689b1485],
18	inﬂuence	NN	O	inﬂuence	nn	20	SENT_30	[p1l702t1457r846b1485],
19	drug	NN	O	drug	nn	20	SENT_30	[p1l859t1458r930b1493],
20	response	NN	O	response	prep_to	16	SENT_30	[p1l943t1466r1088b1493],
21	.	.	O	.	_	0	SENT_30	[p1l943t1466r1088b1493],

1	A	DT	O	a	det	3	SENT_31	[p1l1103t1458r1131b1485],
2	major	JJ	O	major	amod	3	SENT_31	[p1l1144t1458r1236b1493],
3	limitation	NN	O	limitation	nsubj	19	SENT_31	[p1l1248t1458r1401b1485],
4	that	WDT	O	that	nsubj	7	SENT_31	[p1l1414t1458r1472b1485],
5	has	VBZ	O	have	aux	7	SENT_31	[p1l1485t1458r1536b1485],
6	heretofore	RB	O	heretofore	advmod	7	SENT_31	[p1l1549t1457r1711b1485],
7	moderated	VBN	O	moderate	rcmod	3	SENT_31	[p1l1724t1457r1890b1485],
8	the	DT	O	the	det	9	SENT_31	[p1l545t1503r592b1531],
9	use	NN	O	use	dobj	7	SENT_31	[p1l607t1512r659b1531],
10	of	IN	O	of	_	0	SENT_31	[p1l675t1503r709b1531],
11	pharmacogenetic	JJ	O	pharmacogenetic	amod	12	SENT_31	[p1l721t1503r989b1539],
12	testing	NN	O	testing	prep_of	9	SENT_31	[p1l1005t1503r1108b1539],
13	in	IN	O	in	_	0	SENT_31	[p1l1124t1503r1154b1530],
14	the	DT	O	the	det	16	SENT_31	[p1l1169t1503r1216b1531],
15	clinical	JJ	O	clinical	amod	16	SENT_31	[p1l1231t1503r1346b1531],
16	setting	NN	O	setting	prep_in	7	SENT_31	[p1l1363t1503r1465b1539],
17	is	VBZ	O	be	cop	19	SENT_31	[p1l1481t1503r1505b1531],
18	the	DT	O	the	det	19	SENT_31	[p1l1521t1503r1568b1531],
19	lack	NN	O	lack	_	0	SENT_31	[p1l1583t1503r1649b1531],
20	of	IN	O	of	_	0	SENT_31	[p1l1664t1503r1698b1531],
21	prospective	JJ	O	prospective	amod	23	SENT_31	[p1l1710t1503r1889b1539],
22	clinical	JJ	O	clinical	amod	23	SENT_31	[p1l545t1549r660b1576],
23	trials	NNS	O	trial	prep_of	19	SENT_31	[p1l670t1549r747b1576],
24	demonstrating	VBG	O	demonstrate	partmod	23	SENT_31	[p1l757t1549r981b1585],
25	that	IN	O	that	complm	29	SENT_31	[p1l991t1549r1050b1576],
26	such	JJ	O	such	amod	27	SENT_31	[p1l1060t1549r1130b1576],
27	testing	NN	O	testing	nsubj	29	SENT_31	[p1l1139t1549r1243b1585],
28	can	MD	O	can	aux	29	SENT_31	[p1l1253t1558r1306b1576],
29	improve	VB	O	improve	ccomp	24	SENT_31	[p1l1315t1549r1444b1585],
30	the	DT	O	the	det	31	SENT_31	[p1l1454t1549r1501b1576],
31	beneﬁt	NN	O	beneﬁt	dobj	29	SENT_31	[p1l1510t1549r1688b1577],
32	/	:	O	/	punct	34	SENT_31	[p1l1510t1549r1688b1577],
33	risk	NN	O	risk	nn	34	SENT_31	[p1l1510t1549r1688b1577],
34	ratio	NN	O	ratio	dep	29	SENT_31	[p1l1696t1549r1767b1576],
35	of	IN	O	of	_	0	SENT_31	[p1l1778t1549r1812b1576],
36	drug	NN	O	drug	nn	37	SENT_31	[p1l1819t1549r1889b1585],
37	therapy	NN	O	therapy	prep_of	34	SENT_31	[p1l545t1594r667b1630],
38	.	.	O	.	_	0	SENT_31	[p1l545t1594r667b1630],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_32	[p1l446t1711r825b1746],

1	Most	JJS	O	most	amod	3	SENT_33	[p1l545t1817r630b1846],
2	patient	NN	O	patient	nn	3	SENT_33	[p1l643t1816r756b1854],
3	populations	NNS	O	population	nsubj	4	SENT_33	[p1l769t1816r961b1854],
4	show	VBP	O	show	_	0	SENT_33	[p1l978t1816r1062b1846],
5	large	JJ	O	large	amod	7	SENT_33	[p1l1076t1816r1157b1854],
6	interindividual	JJ	O	interindividual	amod	7	SENT_33	[p1l1171t1816r1414b1846],
7	variability	NN	O	variability	dobj	4	SENT_33	[p1l1428t1816r1596b1854],
8	in	IN	O	in	_	0	SENT_33	[p1l1611t1816r1642b1845],
9	drug	NN	O	drug	nn	10	SENT_33	[p1l1656t1816r1731b1854],
10	response	NN	O	response	prep_in	7	SENT_33	[p1l1745t1825r1889b1854],
11	and	CC	O	and	_	0	SENT_33	[p1l546t1866r604b1895],
12	toxicity	NN	O	toxicity	conj_and	10	SENT_33	[p1l615t1866r746b1904],
13	.	.	O	.	_	0	SENT_33	[p1l615t1866r746b1904],

1	For	IN	O	for	_	0	SENT_34	[p1l759t1867r816b1895],
2	all	DT	O	all	det	4	SENT_34	[p1l826t1866r866b1895],
3	major	JJ	O	major	amod	4	SENT_34	[p1l876t1866r973b1904],
4	classes	NNS	O	class	prep_for	43	SENT_34	[p1l983t1866r1096b1895],
5	of	IN	O	of	_	0	SENT_34	[p1l1108t1866r1144b1895],
6	drugs	NNS	O	drug	prep_of	4	SENT_34	[p1l1152t1866r1242b1904],
7	(	CD	NUMBER	(	num	9	SENT_34	[p1l1255t1866r1348b1902],
8	ACE	NN	O	ace	nn	9	SENT_34	[p1l1255t1866r1348b1902],
9	inhibitors	NNS	O	inhibitor	dep	29	SENT_34	[p1l1358t1866r1526b1901],
10	,	,	O	,	_	0	SENT_34	[p1l1358t1866r1526b1901],
11	[	CD	NUMBER	[	num	13	SENT_34	[p1l1542t1865r1828b1904],
12	5-adrenoreceptor	NN	O	5-adrenoreceptor	nn	13	SENT_34	[p1l1542t1865r1828b1904],
13	antagonists	NNS	O	antagonist	dep	29	SENT_34	[p1l1838t1875r1888b1895, p1l545t1916r701b1954],
14	,	,	O	,	_	0	SENT_34	[p1l1838t1875r1888b1895, p1l545t1916r701b1954],
15	selective	JJ	O	selective	amod	18	SENT_34	[p1l713t1916r854b1945],
16	serotonin	NN	O	serotonin	nn	18	SENT_34	[p1l866t1916r1018b1945],
17	reuptake	NN	O	reuptake	nn	18	SENT_34	[p1l1027t1916r1169b1954],
18	inhibitors	NNS	O	inhibitor	dep	29	SENT_34	[p1l1179t1916r1346b1950],
19	,	,	O	,	_	0	SENT_34	[p1l1179t1916r1346b1950],
20	tricyclic	JJ	O	tricyclic	amod	21	SENT_34	[p1l1357t1916r1491b1954],
21	antidepressants	NNS	O	antidepressant	dep	29	SENT_34	[p1l1502t1916r1763b1954],
22	,	,	O	,	_	0	SENT_34	[p1l1502t1916r1763b1954],
23	statins	NNS	O	statin	dep	29	SENT_34	[p1l1775t1916r1888b1950],
24	,	,	O	,	_	0	SENT_34	[p1l1775t1916r1888b1950],
25	and	CC	O	and	_	0	SENT_34	[p1l546t1966r604b1995],
26	[	NN	O	[	dep	29	SENT_34	[p1l617t1965r802b2003],
27	5	CD	NUMBER	5	num	28	SENT_34	[p1l617t1965r802b2003],
28	—	NN	O	—	dep	29	SENT_34	[p1l617t1965r802b2003],
29	agonists	NNS	O	agonist	dep	4	SENT_34	[p1l617t1965r802b2003],
30	)	CD	NUMBER	)	dep	29	SENT_34	[p1l617t1965r802b2003],
31	given	VBN	O	give	prep	4	SENT_34	[p1l814t1965r903b2003],
32	at	IN	O	at	pcomp	31	SENT_34	[p1l913t1970r942b1995],
33	standard	JJ	O	standard	amod	34	SENT_34	[p1l952t1966r1090b1995],
34	doses	NNS	O	dose	pobj	32	SENT_34	[p1l1100t1965r1200b2000],
35	,	,	O	,	_	0	SENT_34	[p1l1100t1965r1200b2000],
36	a	DT	O	a	det	38	SENT_34	[p1l1211t1975r1229b1994],
37	substantial	JJ	O	substantial	amod	38	SENT_34	[p1l1239t1965r1414b1995],
38	proportion	NN	O	proportion	nsubj	43	SENT_34	[p1l1423t1965r1598b2003],
39	of	IN	O	of	_	0	SENT_34	[p1l1608t1965r1643b1994],
40	patients	NNS	O	patient	prep_of	38	SENT_34	[p1l1649t1965r1777b2003],
41	do	VBP	O	do	aux	43	SENT_34	[p1l1788t1965r1828b1995],
42	not	RB	O	not	neg	43	SENT_34	[p1l1838t1970r1890b1995],
43	respond	VB	O	respond	_	0	SENT_34	[p1l545t2014r684b2052],
44	,	,	O	,	_	0	SENT_34	[p1l545t2014r684b2052],
45	respond	VB	O	respond	parataxis	43	SENT_34	[p1l692t2014r824b2052],
46	only	RB	O	only	advmod	47	SENT_34	[p1l831t2014r903b2052],
47	partially	RB	O	partially	advmod	45	SENT_34	[p1l909t2014r1053b2052],
48	,	,	O	,	_	0	SENT_34	[p1l909t2014r1053b2052],
49	or	CC	O	or	_	0	SENT_34	[p1l1062t2023r1096b2043],
50	experience	NN	O	experience	conj_or	43	SENT_34	[p1l1103t2014r1280b2052],
51	adverse	JJ	O	adverse	amod	53	SENT_34	[p1l1288t2014r1413b2043],
52	drug	NN	O	drug	nn	53	SENT_34	[p1l1420t2014r1494b2052],
53	reactions	NNS	O	reaction	nsubj	54	SENT_34	[p1l1501t2014r1650b2043],
54	(	VBP	O	(	rcmod	50	SENT_34	[p1l1659t2014r1796b2050],
55	ADRS	NNS	O	adr	dobj	54	SENT_34	[p1l1659t2014r1796b2050],
56	)	CD	NUMBER	)	tmod	54	SENT_34	[p1l1659t2014r1796b2050],
57	.	.	O	.	_	0	SENT_34	[p1l1659t2014r1796b2050],

1	Drug	NN	O	drug	nn	2	SENT_35	[p1l1805t2015r1889b2052],
2	concentrations	NNS	O	concentration	nsubj	6	SENT_35	[p1l546t2064r785b2094],
3	in	IN	O	in	_	0	SENT_35	[p1l797t2064r828b2093],
4	plasma	NN	O	plasma	prep_in	2	SENT_35	[p1l838t2064r956b2102],
5	can	MD	O	can	aux	6	SENT_35	[p1l966t2073r1023b2094],
6	vary	VB	O	vary	_	0	SENT_35	[p1l1033t2073r1104b2102],
7	more	JJR	O	more	mwe	8	SENT_35	[p1l1115t2073r1199b2094],
8	than	IN	O	than	quantmod	10	SENT_35	[p1l1210t2064r1281b2094],
9	600	CD	NUMBER	600	number	10	SENT_35	[p1l1292t2064r1433b2094],
10	—	CD	NUMBER	—	num	11	SENT_35	[p1l1292t2064r1433b2094],
11	fold	NN	O	fold	dobj	6	SENT_35	[p1l1292t2064r1433b2094],
12	between	IN	O	between	_	0	SENT_35	[p1l1443t2064r1581b2094],
13	two	CD	NUMBER	two	num	14	SENT_35	[p1l1592t2069r1652b2094],
14	individuals	NNS	O	individual	prep_between	11	SENT_35	[p1l1663t2064r1844b2094],
15	of	IN	O	of	_	0	SENT_35	[p1l1856t2064r1892b2094],
16	the	DT	O	the	det	18	SENT_35	[p1l545t2114r595b2143],
17	same	JJ	O	same	amod	18	SENT_35	[p1l607t2123r690b2143],
18	weight	NN	O	weight	prep_of	14	SENT_35	[p1l702t2114r814b2152],
19	on	IN	O	on	_	0	SENT_35	[p1l825t2123r865b2143],
20	the	DT	O	the	det	23	SENT_35	[p1l876t2114r926b2143],
21	same	JJ	O	same	amod	23	SENT_35	[p1l939t2123r1022b2143],
22	drug	NN	O	drug	nn	23	SENT_35	[p1l1033t2114r1108b2152],
23	dosage	NN	O	dosage	prep_on	6	SENT_35	[p1l1120t2114r1242b2152],
24	.	.	O	.	_	0	SENT_35	[p1l1120t2114r1242b2152],

1	This	DT	O	this	det	2	SENT_36	[p1l1255t2114r1327b2143],
2	variation	NN	O	variation	nsubj	4	SENT_36	[p1l1339t2114r1485b2143],
3	can	MD	O	can	aux	4	SENT_36	[p1l1496t2123r1552b2143],
4	be	VB	O	be	_	0	SENT_36	[p1l1563t2114r1602b2143],
5	of	IN	O	of	_	0	SENT_36	[p1l1614t2114r1649b2143],
6	genetic	JJ	O	genetic	prep_of	4	SENT_36	[p1l1658t2114r1785b2152],
7	,	,	O	,	_	0	SENT_36	[p1l1658t2114r1785b2152],
8	physiological	JJ	O	physiological	amod	6	SENT_36	[p1l1798t2114r1888b2152, p1l545t2164r698b2202],
9	,	,	O	,	_	0	SENT_36	[p1l1798t2114r1888b2152, p1l545t2164r698b2202],
10	pathophysiological	JJ	O	pathophysiological	amod	6	SENT_36	[p1l715t2164r1040b2202],
11	,	,	O	,	_	0	SENT_36	[p1l715t2164r1040b2202],
12	or	CC	O	or	_	0	SENT_36	[p1l1058t2173r1092b2193],
13	environmental	JJ	O	environmental	amod	14	SENT_36	[p1l1107t2164r1344b2193],
14	origin	NN	O	origin	prep_of	4	SENT_36	[p1l1361t2164r1467b2202],
15	,	,	O	,	_	0	SENT_36	[p1l1361t2164r1467b2202],
16	but	CC	O	but	_	0	SENT_36	[p1l1484t2164r1537b2193],
17	a	DT	O	a	det	18	SENT_36	[p1l1553t2173r1571b2193],
18	drug	NN	O	drug	poss	20	SENT_36	[p1l1586t2164r1688b2202],
19	’s	POS	O	’s	_	0	SENT_36	[p1l1586t2164r1688b2202],
20	absorption	NN	O	absorption	nsubjpass	33	SENT_36	[p1l1706t2164r1888b2202],
21	,	,	O	,	_	0	SENT_36	[p1l1706t2164r1888b2202],
22	distribution	NN	O	distribution	appos	20	SENT_36	[p1l546t2213r735b2243],
23	and	CC	O	and	_	0	SENT_36	[p1l751t2213r810b2243],
24	metabolism	NN	O	metabolism	appos	20	SENT_36	[p1l825t2213r1027b2248],
25	,	,	O	,	_	0	SENT_36	[p1l825t2213r1027b2248],
26	and	CC	O	and	_	0	SENT_36	[p1l1045t2213r1103b2243],
27	interactions	NNS	O	interaction	conj_and	20	SENT_36	[p1l1118t2213r1310b2243],
28	with	IN	O	with	_	0	SENT_36	[p1l1327t2213r1400b2243],
29	its	PRP$	O	its	poss	30	SENT_36	[p1l1415t2213r1453b2243],
30	target	NN	O	target	prep_with	27	SENT_36	[p1l1469t2218r1563b2251],
31	can	MD	O	can	aux	33	SENT_36	[p1l1578t2222r1634b2243],
32	be	VB	O	be	auxpass	33	SENT_36	[p1l1649t2213r1688b2243],
33	determined	VBN	O	determine	conj_but	4	SENT_36	[p1l1704t2213r1890b2243],
34	by	IN	O	by	_	0	SENT_36	[p1l545t2263r585b2301],
35	genetic	JJ	O	genetic	amod	36	SENT_36	[p1l603t2263r720b2301],
36	differences	NNS	O	difference	agent	33	SENT_36	[p1l738t2263r928b2292],
37	.	.	O	.	_	0	SENT_36	[p1l738t2263r928b2292],

1	In	IN	O	in	_	0	SENT_37	[p1l947t2264r981b2292],
2	general	JJ	O	general	prep_in	7	SENT_37	[p1l997t2263r1127b2301],
3	,	,	O	,	_	0	SENT_37	[p1l997t2263r1127b2301],
4	genetic	JJ	O	genetic	amod	5	SENT_37	[p1l1146t2263r1263b2301],
5	factors	NNS	O	factor	nsubjpass	7	SENT_37	[p1l1281t2263r1391b2292],
6	are	VBP	O	be	auxpass	7	SENT_37	[p1l1410t2272r1458b2292],
7	estimated	VBN	O	estimate	_	0	SENT_37	[p1l1475t2263r1633b2292],
8	to	TO	O	to	aux	9	SENT_37	[p1l1650t2267r1680b2292],
9	account	VB	O	account	xcomp	7	SENT_37	[p1l1698t2267r1826b2292],
10	for	IN	O	for	_	0	SENT_37	[p1l1842t2263r1890b2292],
11	l5	CD	PERCENT	l5	num	12	SENT_37	[p1l549t2313r715b2342],
12	%	NN	PERCENT	%	prep_for	9	SENT_37	[p1l549t2313r715b2342],
13	.	.	O	.	_	0	SENT_37	[p1l549t2313r715b2342],

1	—	NN	O	—	_	0	SENT_38	[p1l549t2313r715b2342],
2	.	.	O	.	_	0	SENT_38	[p1l549t2313r715b2342],

1	30	CD	PERCENT	30	num	2	SENT_39	[p1l549t2313r715b2342],
2	%	NN	PERCENT	%	_	0	SENT_39	[p1l549t2313r715b2342],
3	of	IN	O	of	_	0	SENT_39	[p1l728t2313r764b2342],
4	interindividual	JJ	O	interindividual	amod	5	SENT_39	[p1l771t2313r1013b2342],
5	differences	NNS	O	difference	prep_of	2	SENT_39	[p1l1024t2313r1205b2342],
6	in	IN	O	in	_	0	SENT_39	[p1l1217t2313r1248b2342],
7	drug	NN	O	drug	nn	8	SENT_39	[p1l1259t2313r1333b2351],
8	metabolism	NN	O	metabolism	prep_in	5	SENT_39	[p1l1344t2313r1537b2342],
9	and	CC	O	and	_	0	SENT_39	[p1l1547t2313r1606b2342],
10	response	NN	O	response	conj_and	8	SENT_39	[p1l1615t2322r1769b2351],
11	,	,	O	,	_	0	SENT_39	[p1l1615t2322r1769b2351],
12	but	CC	O	but	_	0	SENT_39	[p1l1780t2313r1832b2342],
13	for	IN	O	for	conj_but	2	SENT_39	[p1l1842t2313r1890b2342],

1	0066-4219	CD	DURATION	0066-4219	_	0	SENT_40	[p1l446t2393r786b2420],
2	/	:	O	/	punct	3	SENT_40	[p1l446t2393r786b2420],
3	O6/0218-Ol	NN	O	o6/0218-ol	dep	1	SENT_40	[p1l446t2393r786b2420],
4	19552000	CD	NUMBER	19552000	number	5	SENT_40	[p1l794t2391r929b2422],
5	119	CD	NUMBER	119	dep	3	SENT_40	[p1l1830t2390r1889b2420],
6	120	CD	NUMBER	120	dep	5	SENT_40	[p1l438t2445r497b2475],

1	EICHELBAUM	NNP	O	EICHELBAUM	nsubj	5	SENT_41	[p1l585t2448r826b2475],
2	I	PRP	O	I	dep	1	SENT_41	[p1l844t2451r861b2469],
3	INGELMAN-SUNDBERG	NN	O	ingelman-sundberg	dep	1	SENT_41	[p1l880t2448r1292b2475],
4	I	PRP	O	I	dep	3	SENT_41	[p1l1310t2451r1327b2469],
5	EVANS	VBP	O	evan	_	0	SENT_41	[p1l1346t2448r1463b2475],

1	certain	JJ	O	certain	amod	2	SENT_42	[p1l536t2571r648b2601],
2	drugs	NNS	O	drug	nsubj	10	SENT_42	[p1l658t2571r748b2609],
3	or	CC	O	or	_	0	SENT_42	[p1l759t2580r793b2601],
4	classes	NNS	O	class	nsubj	10	SENT_42	[p1l803t2571r916b2601],
5	of	IN	O	of	_	0	SENT_42	[p1l927t2571r963b2601],
6	drugs	NNS	O	drug	prep_of	2	SENT_42	[p1l971t2571r1070b2609],
7	,	,	O	,	_	0	SENT_42	[p1l971t2571r1070b2609],
8	genetic	JJ	O	genetic	amod	9	SENT_42	[p1l1083t2571r1200b2609],
9	factors	NNS	O	factor	appos	6	SENT_42	[p1l1211t2571r1322b2601],
10	are	VBP	O	be	_	0	SENT_42	[p1l1333t2580r1382b2601],
11	of	IN	O	of	_	0	SENT_42	[p1l1393t2571r1429b2601],
12	utmost	JJ	O	utmost	amod	13	SENT_42	[p1l1436t2576r1548b2601],
13	importance	NN	O	importance	prep_of	10	SENT_42	[p1l1558t2571r1744b2609],
14	and	CC	O	and	_	0	SENT_42	[p1l1755t2571r1813b2601],
15	can	MD	O	can	aux	16	SENT_42	[p1l1823t2580r1880b2601],
16	account	VB	O	account	conj_and	10	SENT_42	[p1l536t2625r664b2650],
17	for	IN	O	for	_	0	SENT_42	[p1l674t2621r722b2650],
18	up	RB	O	up	quantmod	20	SENT_42	[p1l731t2630r771b2659],
19	to	TO	O	to	dep	20	SENT_42	[p1l782t2625r813b2650],
20	95	CD	PERCENT	95	num	21	SENT_42	[p1l824t2621r897b2651],
21	%	NN	PERCENT	%	prep_for	16	SENT_42	[p1l824t2621r897b2651],
22	of	IN	O	of	_	0	SENT_42	[p1l909t2621r945b2650],
23	interindividual	JJ	O	interindividual	amod	24	SENT_42	[p1l952t2621r1195b2650],
24	variability	NN	O	variability	prep_of	21	SENT_42	[p1l1205t2621r1373b2659],
25	in	IN	O	in	_	0	SENT_42	[p1l1384t2621r1415b2650],
26	drug	NN	O	drug	nn	27	SENT_42	[p1l1426t2621r1500b2659],
27	disposition	NN	O	disposition	prep_in	16	SENT_42	[p1l1511t2621r1692b2659],
28	and	CC	O	and	_	0	SENT_42	[p1l1703t2621r1761b2650],
29	effects	NNS	O	effect	nsubj	30	SENT_42	[p1l1771t2621r1878b2650],
30	(	VBP	O	(	conj_and	10	SENT_42	[p1l537t2671r633b2707],
31	1-3	CD	NUMBER	1-3	num	32	SENT_42	[p1l537t2671r633b2707],
32	)	CD	NUMBER	)	dobj	30	SENT_42	[p1l537t2671r633b2707],
33	.	.	O	.	_	0	SENT_42	[p1l537t2671r633b2707],

1	The	DT	O	the	det	2	SENT_43	[p1l585t2720r649b2750],
2	idea	NN	O	idea	nsubj	19	SENT_43	[p1l659t2720r728b2750],
3	that	IN	O	that	complm	7	SENT_43	[p1l737t2720r799b2750],
4	drug	NN	O	drug	nn	5	SENT_43	[p1l808t2720r883b2758],
5	response	NN	O	response	nsubjpass	7	SENT_43	[p1l893t2729r1037b2758],
6	is	VBZ	O	be	auxpass	7	SENT_43	[p1l1047t2720r1073b2750],
7	determined	VBN	O	determine	dep	2	SENT_43	[p1l1084t2720r1270b2750],
8	by	IN	O	by	_	0	SENT_43	[p1l1279t2720r1320b2758],
9	genetic	JJ	O	genetic	amod	10	SENT_43	[p1l1330t2720r1448b2758],
10	factors	NNS	O	factor	agent	7	SENT_43	[p1l1459t2720r1569b2750],
11	that	WDT	O	that	nsubj	12	SENT_43	[p1l1580t2720r1642b2750],
12	alter	VBP	O	alter	rcmod	10	SENT_43	[p1l1652t2720r1725b2750],
13	the	DT	O	the	det	14	SENT_43	[p1l1734t2720r1783b2750],
14	pharmacokinetics	NNS	O	pharmacokinetic	dobj	12	SENT_43	[p1l1793t2720r1878b2758, p1l535t2769r753b2798],
15	and	CC	O	and	_	0	SENT_43	[p1l769t2769r828b2798],
16	pharmacodynamics	NNS	O	pharmacodynamic	dobj	12	SENT_43	[p1l842t2769r1163b2807],
17	of	IN	O	of	_	0	SENT_43	[p1l1180t2769r1216b2798],
18	medications	NNS	O	medication	prep_of	14	SENT_43	[p1l1228t2769r1427b2798],
19	evolved	VBD	O	evolve	_	0	SENT_43	[p1l1443t2769r1571b2798],
20	in	IN	O	in	_	0	SENT_43	[p1l1586t2769r1617b2798],
21	the	DT	O	the	det	23	SENT_43	[p1l1632t2769r1682b2798],
22	late	JJ	O	late	amod	23	SENT_43	[p1l1697t2769r1756b2798],
23	1950s	NNS	DATE	1950	prep_in	19	SENT_43	[p1l1775t2769r1878b2804],
24	,	,	O	,	_	0	SENT_43	[p1l1775t2769r1878b2804],
25	when	WRB	O	when	advmod	37	SENT_43	[p1l536t2818r624b2847],
26	an	DT	O	a	det	28	SENT_43	[p1l639t2827r676b2847],
27	inherited	VBN	O	inherit	amod	28	SENT_43	[p1l690t2818r836b2847],
28	deﬁciency	NN	O	deﬁciency	nsubjpass	37	SENT_43	[p1l850t2818r1018b2856],
29	of	IN	O	of	_	0	SENT_43	[p1l1033t2818r1068b2847],
30	glucose	NN	O	glucose	prep_of	28	SENT_43	[p1l1080t2818r1421b2856],
31	—	CD	NUMBER	—	num	30	SENT_43	[p1l1080t2818r1421b2856],
32	6	CD	NUMBER	6	num	35	SENT_43	[p1l1080t2818r1421b2856],
33	—	NN	O	—	nn	35	SENT_43	[p1l1080t2818r1421b2856],
34	phosphate	NN	O	phosphate	nn	35	SENT_43	[p1l1080t2818r1421b2856],
35	dehydrogenase	NN	O	dehydrogenase	dep	30	SENT_43	[p1l1436t2818r1683b2856],
36	was	VBD	O	be	auxpass	37	SENT_43	[p1l1697t2827r1759b2847],
37	shown	VBN	O	show	dep	23	SENT_43	[p1l1775t2818r1880b2847],
38	to	TO	O	to	aux	39	SENT_43	[p1l536t2872r566b2896],
39	cause	VB	O	cause	xcomp	37	SENT_43	[p1l585t2876r676b2896],
40	the	DT	O	the	det	42	SENT_43	[p1l694t2867r743b2896],
41	severe	JJ	O	severe	amod	42	SENT_43	[p1l763t2876r865b2897],
42	hemolysis	NN	O	hemolysis	dobj	39	SENT_43	[p1l883t2867r1050b2905],
43	observed	VBN	O	observe	partmod	42	SENT_43	[p1l1069t2867r1217b2897],
44	in	IN	O	in	_	0	SENT_43	[p1l1235t2867r1266b2896],
45	some	DT	O	some	det	46	SENT_43	[p1l1285t2876r1370b2896],
46	patients	NNS	O	patient	prep_in	43	SENT_43	[p1l1388t2867r1516b2905],
47	exposed	VBN	O	expose	partmod	46	SENT_43	[p1l1535t2867r1670b2905],
48	to	TO	O	to	_	0	SENT_43	[p1l1687t2872r1718b2896],
49	the	DT	O	the	det	54	SENT_43	[p1l1737t2867r1786b2896],
50	antimalarial	JJ	O	antimalarial	amod	54	SENT_43	[p1l1805t2867r1878b2896, p1l535t2916r670b2945],
51	primaquine	NN	O	primaquine	nn	54	SENT_43	[p1l684t2916r872b2954],
52	(	NN	O	(	nn	54	SENT_43	[p1l887t2916r941b2952],
53	4	CD	NUMBER	4	num	54	SENT_43	[p1l887t2916r941b2952],
54	)	NN	O	)	prep_to	47	SENT_43	[p1l887t2916r941b2952],
55	.	.	O	.	_	0	SENT_43	[p1l887t2916r941b2952],

1	This	DT	O	this	det	2	SENT_44	[p1l957t2916r1029b2945],
2	discovery	NN	O	discovery	nsubj	3	SENT_44	[p1l1044t2916r1202b2954],
3	explained	VBD	O	explain	_	0	SENT_44	[p1l1217t2916r1376b2954],
4	why	WRB	O	why	advmod	7	SENT_44	[p1l1390t2916r1460b2954],
5	hemolysis	NN	O	hemolysis	nsubjpass	7	SENT_44	[p1l1473t2916r1640b2954],
6	was	VBD	O	be	auxpass	7	SENT_44	[p1l1655t2925r1717b2945],
7	observed	VBN	O	observe	advcl	3	SENT_44	[p1l1732t2916r1880b2945],
8	mainly	RB	O	mainly	advmod	7	SENT_44	[p1l535t2965r649b3003],
9	in	IN	O	in	_	0	SENT_44	[p1l663t2965r695b2994],
10	African	NNP	MISC	African	prep_in	7	SENT_44	[p1l708t2965r1036b3000],
11	.	.	O	.	_	0	SENT_44	[p1l708t2965r1036b3000],

1	—	NN	O	—	_	0	SENT_45	[p1l708t2965r1036b3000],
2	.	.	O	.	_	0	SENT_45	[p1l708t2965r1036b3000],

1	Americans	NNPS	MISC	Americans	nsubj	12	SENT_46	[p1l708t2965r1036b3000],
2	,	,	O	,	_	0	SENT_46	[p1l708t2965r1036b3000],
3	in	IN	O	in	_	0	SENT_46	[p1l1051t2965r1083b2994],
4	whom	WP	O	whom	rel	8	SENT_46	[p1l1096t2965r1199b2995],
5	the	DT	O	the	det	6	SENT_46	[p1l1212t2965r1262b2995],
6	deﬁciency	NN	O	deﬁciency	nsubj	8	SENT_46	[p1l1276t2965r1444b3003],
7	is	VBZ	O	be	cop	8	SENT_46	[p1l1458t2965r1484b2995],
8	common	JJ	O	common	rcmod	1	SENT_46	[p1l1499t2974r1651b3000],
9	,	,	O	,	_	0	SENT_46	[p1l1499t2974r1651b3000],
10	and	CC	O	and	dep	12	SENT_46	[p1l1667t2965r1726b2995],
11	rarely	RB	O	rarely	advmod	12	SENT_46	[p1l1738t2965r1834b3003],
12	in	IN	O	in	_	0	SENT_46	[p1l1848t2965r1880b2994],
13	Caucasians	NNPS	MISC	Caucasians	pobj	12	SENT_46	[p1l536t3015r720b3045],
14	of	IN	MISC	of	_	0	SENT_46	[p1l734t3015r770b3044],
15	Northern	NNP	MISC	Northern	prep_of	12	SENT_46	[p1l780t3015r938b3050],
16	,	,	O	,	_	0	SENT_46	[p1l780t3015r938b3050],
17	Western	NNP	MISC	Western	prep_of	12	SENT_46	[p1l951t3016r1094b3050],
18	,	,	O	,	_	0	SENT_46	[p1l951t3016r1094b3050],
19	and	CC	O	and	_	0	SENT_46	[p1l1110t3015r1168b3044],
20	Eastern	JJ	MISC	eastern	amod	22	SENT_46	[p1l1180t3016r1304b3044],
21	European	JJ	MISC	european	amod	22	SENT_46	[p1l1316t3016r1474b3053],
22	descent	NN	O	descent	prep_of	12	SENT_46	[p1l1487t3015r1618b3044],
23	.	.	O	.	_	0	SENT_46	[p1l1487t3015r1618b3044],

1	In	IN	O	in	_	0	SENT_47	[p1l1633t3016r1667b3044],
2	1959	CD	DATE	1959	prep_in	5	SENT_47	[p1l1683t3015r1770b3050],
3	,	,	O	,	_	0	SENT_47	[p1l1683t3015r1770b3050],
4	Vogel	NNP	PERSON	Vogel	nsubj	5	SENT_47	[p1l1784t3015r1879b3053],
5	coined	VBD	O	coin	_	0	SENT_47	[p1l536t3064r646b3093],
6	the	DT	O	the	det	8	SENT_47	[p1l661t3064r711b3093],
7	term	NN	O	term	nn	8	SENT_47	[p1l727t3069r803b3093],
8	pharmacogenetics	NNS	O	pharmacogenetic	dobj	5	SENT_47	[p1l818t3064r1116b3102],
9	to	TO	O	to	aux	10	SENT_47	[p1l1134t3069r1164b3093],
10	describe	VB	O	describe	xcomp	5	SENT_47	[p1l1181t3064r1318b3093],
11	inherited	VBN	O	inherit	amod	12	SENT_47	[p1l1334t3064r1481b3093],
12	differences	NNS	O	difference	dobj	10	SENT_47	[p1l1498t3064r1678b3093],
13	in	IN	O	in	_	0	SENT_47	[p1l1696t3064r1727b3093],
14	drug	NN	O	drug	nn	15	SENT_47	[p1l1744t3064r1818b3102],
15	reAnnu	NNP	O	reAnnu	prep_in	12	SENT_47	[p1l1834t3073r1878b3093, p2l268t3302r291b3382],
16	.	.	O	.	_	0	SENT_47	[p1l1834t3073r1878b3093, p2l268t3302r291b3382],

1	Rev.	NNP	O	Rev.	nn	2	SENT_48	[p2l268t3231r291b3291],
2	Med	NNP	O	Med	_	0	SENT_48	[p2l268t3154r291b3221],
3	.	.	O	.	_	0	SENT_48	[p2l268t3154r291b3221],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_49	[p2l268t3029r291b3143],
2	:	:	O	:	_	0	SENT_49	[p2l268t3029r291b3143],
3	1	CD	NUMBER	1	number	4	SENT_49	[p2l268t3013r291b3023],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_49	[p2l268t2909r292b3006],
5	.	.	O	.	_	0	SENT_49	[p2l268t2909r292b3006],

1	Downloaded	VBN	O	download	_	0	SENT_50	[p2l268t2729r291b2898],
2	from	IN	O	from	_	0	SENT_50	[p2l268t2655r291b2720],
3	www.annualreviews.org	NN	O	www.annualreviews.org	nn	4	SENT_50	[p2l268t2322r298b2646],
4	Annu	NN	PERSON	annu	prep_from	1	SENT_50	[p2l278t991r301b1071],
5	.	.	O	.	_	0	SENT_50	[p2l278t991r301b1071],

1	Rev.	NNP	O	Rev.	nn	2	SENT_51	[p2l278t920r301b980],
2	Med	NNP	O	Med	_	0	SENT_51	[p2l278t843r301b910],
3	.	.	O	.	_	0	SENT_51	[p2l278t843r301b910],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_52	[p2l278t718r301b832],
2	:	:	O	:	_	0	SENT_52	[p2l278t718r301b832],
3	1	CD	NUMBER	1	number	4	SENT_52	[p2l278t702r301b712],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_52	[p2l278t598r302b695],
5	.	.	O	.	_	0	SENT_52	[p2l278t598r302b695],

1	Downloaded	VBN	O	download	_	0	SENT_53	[p2l278t418r301b587],
2	from	IN	O	from	_	0	SENT_53	[p2l278t344r301b409],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_53	[p2l278t11r308b335],
4	by	IN	O	by	_	0	SENT_53	[p2l311t1004r342b1037],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_53	[p2l311t855r342b995],
6	of	IN	ORGANIZATION	of	_	0	SENT_53	[p2l311t817r335b846],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_53	[p2l311t671r335b810],
8	-	:	O	-	_	0	SENT_53	[p2l325t652r328b661],
9	Madison	NNP	O	Madison	prep_by	1	SENT_53	[p2l311t526r335b642],
10	on	IN	O	on	_	0	SENT_53	[p2l319t484r335b517],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_53	[p2l311t351r335b475],
12	.	.	O	.	_	0	SENT_53	[p2l311t351r335b475],

1	For	IN	O	for	_	0	SENT_54	[p2l312t294r335b340],
2	personal	JJ	O	personal	amod	3	SENT_54	[p2l311t174r342b286],
3	use	NN	O	use	pobj	1	SENT_54	[p2l319t121r335b165],
4	only	RB	O	only	advmod	3	SENT_54	[p2l311t46r342b111],
5	.	.	O	.	_	0	SENT_54	[p2l311t46r342b111],

1	by	IN	O	by	dep	6	SENT_55	[p2l301t3315r332b3348],
2	University	NNP	ORGANIZATION	University	pobj	1	SENT_55	[p2l301t3166r332b3306],
3	of	IN	ORGANIZATION	of	_	0	SENT_55	[p2l301t3128r325b3157],
4	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	2	SENT_55	[p2l301t2982r325b3121],
5	-	:	O	-	_	0	SENT_55	[p2l315t2963r318b2972],
6	Madison	NNP	O	Madison	_	0	SENT_55	[p2l301t2837r325b2953],
7	on	IN	O	on	_	0	SENT_55	[p2l309t2795r325b2828],
8	01/05/14	CD	DATE	01/05/14	prep_on	6	SENT_55	[p2l301t2662r325b2786],
9	.	.	O	.	_	0	SENT_55	[p2l301t2662r325b2786],

1	For	IN	O	for	_	0	SENT_56	[p2l302t2605r325b2651],
2	personal	JJ	O	personal	amod	3	SENT_56	[p2l301t2485r332b2597],
3	use	NN	O	use	pobj	1	SENT_56	[p2l309t2432r325b2476],
4	only	RB	O	only	advmod	3	SENT_56	[p2l301t2357r332b2422],
5	.	.	O	.	_	0	SENT_56	[p2l301t2357r332b2422],

1	sponses	NNS	O	sponse	_	0	SENT_57	[p2l537t23r663b52],
2	(	CD	NUMBER	(	number	3	SENT_57	[p2l682t14r737b50],
3	5	CD	NUMBER	5	dep	1	SENT_57	[p2l682t14r737b50],
4	)	NN	O	)	dep	3	SENT_57	[p2l682t14r737b50],
5	.	.	O	.	_	0	SENT_57	[p2l682t14r737b50],

1	The	DT	O	the	det	3	SENT_58	[p2l756t14r819b43],
2	term	NN	O	term	nn	3	SENT_58	[p2l837t18r913b43],
3	pharmacogenomics	NNS	O	pharmacogenomic	nsubjpass	5	SENT_58	[p2l929t14r1250b52],
4	was	VBD	O	be	auxpass	5	SENT_58	[p2l1269t23r1331b43],
5	introduced	VBN	O	introduce	_	0	SENT_58	[p2l1349t14r1526b43],
6	to	TO	O	to	aux	7	SENT_58	[p2l1543t18r1574b43],
7	reﬂect	VB	O	reﬂect	xcomp	5	SENT_58	[p2l1591t14r1695b43],
8	the	DT	O	the	det	10	SENT_58	[p2l1712t14r1761b43],
9	recent	JJ	O	recent	amod	10	SENT_58	[p2l1779t18r1880b43],
10	transition	NN	O	transition	dobj	7	SENT_58	[p2l535t64r691b93],
11	from	IN	O	from	_	0	SENT_58	[p2l705t64r784b93],
12	genetics	NNS	O	genetics	prep_from	7	SENT_58	[p2l798t64r931b102],
13	to	TO	O	to	_	0	SENT_58	[p2l946t68r976b93],
14	genomics	NNS	O	genomic	prep_to	7	SENT_58	[p2l991t64r1147b102],
15	and	CC	O	and	_	0	SENT_58	[p2l1162t64r1221b93],
16	the	DT	O	the	det	17	SENT_58	[p2l1234t64r1283b93],
17	use	NN	O	use	prep_to	7	SENT_58	[p2l1297t73r1351b93],
18	of	IN	O	of	_	0	SENT_58	[p2l1365t64r1401b93],
19	genome-wide	JJ	O	genome-wide	amod	20	SENT_58	[p2l1411t64r1636b102],
20	approaches	NNS	O	approach	prep_of	17	SENT_58	[p2l1650t64r1834b102],
21	to	TO	O	to	aux	22	SENT_58	[p2l1848t68r1879b93],
22	identify	VB	O	identify	xcomp	7	SENT_58	[p2l536t114r663b152],
23	genes	NNS	O	gene	dobj	22	SENT_58	[p2l672t123r764b152],
24	that	WDT	O	that	nsubj	25	SENT_58	[p2l773t114r835b143],
25	contribute	VBP	O	contribute	rcmod	23	SENT_58	[p2l842t114r1008b143],
26	to	TO	O	to	_	0	SENT_58	[p2l1016t118r1047b143],
27	a	DT	O	a	det	29	SENT_58	[p2l1056t123r1073b143],
28	speciﬁc	NN	O	speciﬁc	nn	29	SENT_58	[p2l1082t114r1205b152],
29	disease	NN	O	disease	prep_to	25	SENT_58	[p2l1214t114r1332b143],
30	or	CC	O	or	_	0	SENT_58	[p2l1341t123r1375b143],
31	drug	NN	O	drug	nn	32	SENT_58	[p2l1382t114r1456b152],
32	response	NN	O	response	prep_to	25	SENT_58	[p2l1464t123r1617b152],
33	.	.	O	.	_	0	SENT_58	[p2l1464t123r1617b152],

1	A	DT	O	a	det	5	SENT_59	[p2l1627t114r1656b143],
2	pharmacoge	JJ	O	pharmacoge	amod	5	SENT_59	[p2l1663t114r1878b152],
3	—	NN	O	—	nn	5	SENT_59	[p2l1663t114r1878b152],
4	nomics	NNS	O	nomic	nn	5	SENT_59	[p2l536t164r653b193],
5	approach	NN	O	approach	nsubj	23	SENT_59	[p2l668t164r819b202],
6	may	MD	O	may	aux	7	SENT_59	[p2l832t173r902b202],
7	allow	VB	O	allow	_	0	SENT_59	[p2l916t164r1005b193],
8	a	DT	O	a	det	11	SENT_59	[p2l1020t173r1037b193],
9	speciﬁc	NN	O	speciﬁc	nn	11	SENT_59	[p2l1051t164r1174b202],
10	drug	NN	O	drug	nn	11	SENT_59	[p2l1189t164r1263b202],
11	therapy	NN	O	therapy	dobj	7	SENT_59	[p2l1277t164r1399b202],
12	to	TO	O	to	aux	14	SENT_59	[p2l1413t168r1444b193],
13	be	VB	O	be	auxpass	14	SENT_59	[p2l1457t164r1495b193],
14	targeted	VBN	O	target	xcomp	7	SENT_59	[p2l1509t164r1641b202],
15	to	TO	O	to	_	0	SENT_59	[p2l1654t168r1685b193],
16	genetically	RB	O	genetically	amod	18	SENT_59	[p2l1699t164r1879b202],
17	deﬁned	VBN	O	deﬁned	dep	16	SENT_59	[p2l536t214r657b243],
18	subsets	NNS	O	subset	prep_to	14	SENT_59	[p2l675t214r791b243],
19	of	IN	O	of	_	0	SENT_59	[p2l810t214r845b243],
20	patients	NNS	O	patient	prep_of	18	SENT_59	[p2l859t214r987b251],
21	and	CC	O	and	_	0	SENT_59	[p2l1005t214r1063b243],
22	may	MD	O	may	aux	23	SENT_59	[p2l1080t223r1150b251],
23	lead	VB	O	lead	conj_and	7	SENT_59	[p2l1167t214r1236b243],
24	to	TO	O	to	_	0	SENT_59	[p2l1252t218r1283b243],
25	a	DT	O	a	det	27	SENT_59	[p2l1301t223r1318b243],
26	new	JJ	O	new	amod	27	SENT_59	[p2l1334t223r1401b243],
27	disease	NN	O	disease	prep_to	23	SENT_59	[p2l1419t214r1537b243],
28	and	CC	O	and	_	0	SENT_59	[p2l1555t214r1613b243],
29	treatment	NN	O	treatment	nn	30	SENT_59	[p2l1629t218r1786b243],
30	classiﬁcation	NN	O	classiﬁcation	prep_to	23	SENT_59	[p2l1802t214r1878b243, p2l537t263r687b292],
31	at	IN	O	at	_	0	SENT_59	[p2l703t267r732b292],
32	the	DT	O	the	det	34	SENT_59	[p2l747t263r797b292],
33	molecular	JJ	O	molecular	amod	34	SENT_59	[p2l813t263r979b292],
34	level	NN	O	level	prep_at	27	SENT_59	[p2l994t263r1080b292],
35	.	.	O	.	_	0	SENT_59	[p2l994t263r1080b292],

1	Moreover	RB	O	moreover	advmod	9	SENT_60	[p2l1098t264r1267b297],
2	,	,	O	,	_	0	SENT_60	[p2l1098t264r1267b297],
3	identiﬁcation	NN	O	identiﬁcation	nsubj	9	SENT_60	[p2l1285t263r1503b292],
4	of	IN	O	of	_	0	SENT_60	[p2l1519t263r1555b292],
5	new	JJ	O	new	amod	7	SENT_60	[p2l1568t272r1635b292],
6	disease	NN	O	disease	nn	7	SENT_60	[p2l1652t263r1770b292],
7	genes	NNS	O	gene	prep_of	3	SENT_60	[p2l1786t272r1878b301],
8	may	MD	O	may	aux	9	SENT_60	[p2l536t322r605b351],
9	provide	VB	O	provide	_	0	SENT_60	[p2l619t313r744b351],
10	new	JJ	O	new	amod	12	SENT_60	[p2l758t322r825b342],
11	drug	NN	O	drug	nn	12	SENT_60	[p2l839t313r914b351],
12	targets	NNS	O	target	dobj	9	SENT_60	[p2l928t317r1045b351],
13	.	.	O	.	_	0	SENT_60	[p2l928t317r1045b351],

1	For	IN	O	for	_	0	SENT_61	[p2l1060t314r1117b342],
2	the	DT	O	the	det	5	SENT_61	[p2l1130t313r1180b342],
3	30,000	CD	NUMBER	30,000	num	5	SENT_61	[p2l1195t313r1306b347],
4	known	JJ	O	known	amod	5	SENT_61	[p2l1320t313r1431b342],
5	diseases	NNS	O	disease	prep_for	18	SENT_61	[p2l1445t313r1589b347],
6	,	,	O	,	_	0	SENT_61	[p2l1445t313r1589b347],
7	including	VBG	O	include	_	0	SENT_61	[p2l1604t313r1759b351],
8	100	CD	NUMBER	100	number	10	SENT_61	[p2l1777t313r1834b342],
9	to	TO	O	to	dep	10	SENT_61	[p2l1848t317r1879b342],
10	150	CD	NUMBER	150	num	13	SENT_61	[p2l540t363r596b392],
11	major	JJ	O	major	amod	13	SENT_61	[p2l604t363r700b400],
12	common	JJ	O	common	amod	13	SENT_61	[p2l707t372r851b392],
13	diseases	NNS	O	disease	prep_including	18	SENT_61	[p2l859t363r1002b397],
14	,	,	O	,	_	0	SENT_61	[p2l859t363r1002b397],
15	no	DT	O	no	det	17	SENT_61	[p2l1011t372r1050b392],
16	drug	NN	O	drug	nn	17	SENT_61	[p2l1059t363r1133b400],
17	treatment	NN	O	treatment	nsubj	18	SENT_61	[p2l1140t367r1297b392],
18	exists	VBZ	O	exist	_	0	SENT_61	[p2l1304t363r1395b392],
19	or	CC	O	or	_	0	SENT_61	[p2l1404t372r1438b392],
20	improved	VBN	O	improve	amod	22	SENT_61	[p2l1444t363r1601b400],
21	drug	NN	O	drug	nn	22	SENT_61	[p2l1608t363r1682b400],
22	treatment	NN	O	treatment	nsubjpass	24	SENT_61	[p2l1690t367r1846b392],
23	is	VBZ	O	be	auxpass	24	SENT_61	[p2l1853t363r1878b392],
24	needed	VBN	O	need	conj_or	18	SENT_61	[p2l536t413r652b442],
25	(	NN	O	(	nn	27	SENT_61	[p2l665t412r719b448],
26	6	CD	NUMBER	6	num	27	SENT_61	[p2l665t412r719b448],
27	)	NN	O	)	dobj	24	SENT_61	[p2l665t412r719b448],
28	.	.	O	.	_	0	SENT_61	[p2l665t412r719b448],

1	Severe	JJ	O	severe	amod	2	SENT_62	[p2l586t463r695b492],
2	ADRs	NNS	MISC	adr	nsubj	9	SENT_62	[p2l708t463r810b491],
3	such	JJ	O	such	_	0	SENT_62	[p2l825t462r898b491],
4	as	IN	O	as	_	0	SENT_62	[p2l911t471r943b491],
5	hepatotoxicity	NN	O	hepatotoxicity	prep_such_as	2	SENT_62	[p2l956t462r1193b500],
6	or	CC	O	or	_	0	SENT_62	[p2l1206t472r1240b491],
7	drug-induced	JJ	O	drug-induced	amod	8	SENT_62	[p2l1252t462r1472b500],
8	arrhythmias	NNS	O	arrhythmia	prep_such_as	2	SENT_62	[p2l1485t462r1680b500],
9	continue	VBP	O	continue	_	0	SENT_62	[p2l1694t462r1836b491],
10	to	TO	O	to	aux	13	SENT_62	[p2l1848t467r1879b491],
11	be	VB	O	be	cop	13	SENT_62	[p2l535t512r573b541],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_62	[p2l591t512r762b550],
13	problems	NNS	O	problem	xcomp	9	SENT_62	[p2l777t512r930b550],
14	for	IN	O	for	_	0	SENT_62	[p2l947t512r995b541],
15	many	JJ	O	many	amod	17	SENT_62	[p2l1010t521r1100b550],
16	new	JJ	O	new	amod	17	SENT_62	[p2l1116t521r1183b541],
17	drugs	NNS	O	drug	prep_for	13	SENT_62	[p2l1200t512r1289b550],
18	during	IN	O	during	_	0	SENT_62	[p2l1307t512r1413b550],
19	the	DT	O	the	det	20	SENT_62	[p2l1430t512r1479b541],
20	development	NN	O	development	prep_during	13	SENT_62	[p2l1495t512r1707b550],
21	and	CC	O	and	_	0	SENT_62	[p2l1724t512r1782b541],
22	postmarketing	VBG	O	postmarket	amod	23	SENT_62	[p2l1797t517r1878b550, p2l536t562r702b600],
23	phases	NNS	O	phase	prep_during	13	SENT_62	[p2l712t562r830b600],
24	.	.	O	.	_	0	SENT_62	[p2l712t562r830b600],

1	ADRs	NNPS	MISC	ADRs	nsubj	2	SENT_63	[p2l842t562r943b591],
2	increase	VBP	O	increase	_	0	SENT_63	[p2l954t562r1088b591],
3	morbidity	NN	O	morbidity	dobj	2	SENT_63	[p2l1098t562r1260b600],
4	and	CC	O	and	_	0	SENT_63	[p2l1271t562r1330b591],
5	mortality	NN	O	mortality	conj_and	3	SENT_63	[p2l1339t562r1490b600],
6	and	CC	O	and	_	0	SENT_63	[p2l1501t562r1559b591],
7	are	VBP	O	be	auxpass	8	SENT_63	[p2l1569t571r1618b591],
8	associated	VBN	O	associate	conj_and	2	SENT_63	[p2l1628t562r1798b591],
9	with	IN	O	with	_	0	SENT_63	[p2l1807t562r1879b591],
10	considerable	JJ	O	considerable	amod	11	SENT_63	[p2l536t612r744b641],
11	cost	NN	O	cost	prep_with	8	SENT_63	[p2l753t616r819b641],
12	to	TO	O	to	_	0	SENT_63	[p2l827t616r858b641],
13	the	DT	O	the	det	16	SENT_63	[p2l867t612r916b641],
14	health	NN	O	health	nn	16	SENT_63	[p2l925t612r1025b641],
15	care	NN	O	care	nn	16	SENT_63	[p2l1034t621r1101b641],
16	system	NN	O	system	prep_to	8	SENT_63	[p2l1112t616r1233b649],
17	.	.	O	.	_	0	SENT_63	[p2l1112t616r1233b649],

1	They	PRP	O	they	nsubj	4	SENT_64	[p2l1243t612r1327b649],
2	may	MD	O	may	aux	4	SENT_64	[p2l1335t621r1405b649],
3	be	VB	O	be	cop	4	SENT_64	[p2l1414t612r1452b641],
4	responsible	JJ	O	responsible	_	0	SENT_64	[p2l1460t612r1649b649],
5	for	IN	O	for	_	0	SENT_64	[p2l1657t612r1705b641],
6	>	JJR	O	>	prep_for	4	SENT_64	[p2l1716t621r1741b640],
7	100,000	CD	NUMBER	100,000	num	8	SENT_64	[p2l1750t612r1879b646],
8	deaths	NNS	O	death	nsubj	24	SENT_64	[p2l536t662r640b691],
9	yearly	JJ	SET	yearly	amod	8	SENT_64	[p2l651t662r753b699],
10	in	IN	O	in	_	0	SENT_64	[p2l764t662r795b690],
11	the	DT	O	the	det	13	SENT_64	[p2l806t662r855b691],
12	United	NNP	LOCATION	United	nn	13	SENT_64	[p2l866t662r978b691],
13	States	NNPS	LOCATION	States	prep_in	8	SENT_64	[p2l990t662r1086b691],
14	and	CC	O	and	_	0	SENT_64	[p2l1098t662r1156b691],
15	account	NN	O	account	nsubj	24	SENT_64	[p2l1167t666r1295b691],
16	for	IN	O	for	_	0	SENT_64	[p2l1305t662r1353b691],
17	~	NN	O	~	prep_for	15	SENT_64	[p2l1364t662r1448b691],
18	5	CD	PERCENT	5	number	19	SENT_64	[p2l1364t662r1448b691],
19	%	NN	PERCENT	%	amod	17	SENT_64	[p2l1364t662r1448b691],
20	of	IN	O	of	_	0	SENT_64	[p2l1461t662r1496b691],
21	all	DT	O	all	det	23	SENT_64	[p2l1505t662r1544b691],
22	hospital	NN	O	hospital	nn	23	SENT_64	[p2l1555t662r1685b699],
23	admissions	NNS	O	admission	prep_of	17	SENT_64	[p2l1697t662r1878b691],
24	(	VBP	O	(	rcmod	6	SENT_64	[p2l537t712r591b747],
25	7	CD	NUMBER	7	number	26	SENT_64	[p2l537t712r591b747],
26	)	CD	NUMBER	)	dobj	24	SENT_64	[p2l537t712r591b747],
27	.	.	O	.	_	0	SENT_64	[p2l537t712r591b747],

1	Genetic	JJ	O	genetic	amod	2	SENT_65	[p2l605t711r732b741],
2	factors	NNS	O	factor	nsubj	3	SENT_65	[p2l744t711r854b741],
3	play	VBP	O	play	_	0	SENT_65	[p2l865t711r936b749],
4	a	DT	O	a	det	5	SENT_65	[p2l948t721r966b741],
5	role	NN	O	role	dobj	3	SENT_65	[p2l975t712r1039b741],
6	in	IN	O	in	_	0	SENT_65	[p2l1050t711r1082b740],
7	the	DT	O	the	det	8	SENT_65	[p2l1093t712r1142b741],
8	pathogenesis	NN	O	pathogenesis	prep_in	5	SENT_65	[p2l1153t711r1366b749],
9	of	IN	O	of	_	0	SENT_65	[p2l1379t711r1414b740],
10	predictable	JJ	O	predictable	amod	11	SENT_65	[p2l1422t711r1606b749],
11	ADRs	NNS	MISC	adr	prep_of	8	SENT_65	[p2l1617t712r1729b746],
12	,	,	O	,	_	0	SENT_65	[p2l1617t712r1729b746],
13	and	CC	O	and	_	0	SENT_65	[p2l1742t711r1800b741],
14	basing	VBG	O	base	csubj	26	SENT_65	[p2l1811t711r1878b741, p2l536t761r587b798],
15	drug	NN	O	drug	nn	16	SENT_65	[p2l602t761r676b798],
16	therapy	NN	O	therapy	dobj	14	SENT_65	[p2l690t761r813b798],
17	on	IN	O	on	_	0	SENT_65	[p2l827t770r867b790],
18	patients	NNS	O	patient	prep_on	14	SENT_65	[p2l881t761r1019b798],
19	’	CD	NUMBER	’	num	22	SENT_65	[p2l881t761r1019b798],
20	individual	JJ	O	individual	amod	22	SENT_65	[p2l1037t761r1203b790],
21	genetic	JJ	O	genetic	amod	22	SENT_65	[p2l1217t761r1335b798],
22	make	NN	O	make	dep	18	SENT_65	[p2l1349t761r1492b798],
23	—	CD	NUMBER	—	dep	24	SENT_65	[p2l1349t761r1492b798],
24	up	RP	O	up	advmod	14	SENT_65	[p2l1349t761r1492b798],
25	may	MD	O	may	aux	26	SENT_65	[p2l1507t770r1577b798],
26	result	VB	O	result	conj_and	3	SENT_65	[p2l1591t761r1683b790],
27	not	RB	O	not	neg	28	SENT_65	[p2l1696t765r1749b790],
28	only	RB	O	only	preconj	26	SENT_65	[p2l1762t761r1834b798],
29	in	IN	O	in	_	0	SENT_65	[p2l1848t761r1879b789],
30	an	DT	O	a	det	32	SENT_65	[p2l536t820r574b840],
31	improved	JJ	O	improved	amod	32	SENT_65	[p2l588t810r745b848],
32	response	NN	O	response	prep_in	26	SENT_65	[p2l758t820r903b848],
33	but	CC	O	but	_	0	SENT_65	[p2l916t811r969b840],
34	also	RB	O	also	advmod	26	SENT_65	[p2l983t811r1048b840],
35	in	IN	O	in	_	0	SENT_65	[p2l1062t810r1094b839],
36	a	DT	O	a	det	39	SENT_65	[p2l1108t820r1126b840],
37	clinically	RB	O	clinically	advmod	38	SENT_65	[p2l1139t810r1292b848],
38	important	JJ	O	important	amod	39	SENT_65	[p2l1306t810r1468b848],
39	reduction	NN	O	reduction	prep_in	26	SENT_65	[p2l1481t810r1637b840],
40	in	IN	O	in	_	0	SENT_65	[p2l1651t810r1682b839],
41	ADRs	NNS	MISC	adr	prep_in	39	SENT_65	[p2l1696t811r1807b840],
42	.	.	O	.	_	0	SENT_65	[p2l1696t811r1807b840],

1	For	IN	O	for	_	0	SENT_66	[p2l1823t811r1880b840],
2	example	NN	O	example	prep_for	16	SENT_66	[p2l536t860r683b898],
3	,	,	O	,	_	0	SENT_66	[p2l536t860r683b898],
4	of	IN	O	of	_	0	SENT_66	[p2l696t860r732b889],
5	27	CD	NUMBER	27	num	6	SENT_66	[p2l741t860r779b889],
6	drugs	NNS	O	drug	prep_of	2	SENT_66	[p2l792t860r882b898],
7	frequently	RB	O	frequently	advmod	8	SENT_66	[p2l894t860r1063b898],
8	cited	VBN	O	cite	partmod	6	SENT_66	[p2l1074t860r1154b889],
9	in	IN	O	in	_	0	SENT_66	[p2l1165t860r1196b889],
10	ADR	NN	O	adr	nn	11	SENT_66	[p2l1207t860r1294b889],
11	studies	NNS	O	study	prep_in	8	SENT_66	[p2l1306t860r1427b894],
12	,	,	O	,	_	0	SENT_66	[p2l1306t860r1427b894],
13	59	CD	PERCENT	59	num	14	SENT_66	[p2l1441t860r1513b889],
14	%	NN	PERCENT	%	nsubjpass	16	SENT_66	[p2l1441t860r1513b889],
15	are	VBP	O	be	auxpass	16	SENT_66	[p2l1527t869r1575b889],
16	metabolized	VBN	O	metabolize	_	0	SENT_66	[p2l1586t860r1789b889],
17	by	IN	O	by	_	0	SENT_66	[p2l1799t860r1839b898],
18	at	IN	O	at	quantmod	20	SENT_66	[p2l1851t864r1880b889],
19	least	JJS	O	least	mwe	18	SENT_66	[p2l536t910r611b939],
20	one	CD	NUMBER	one	num	21	SENT_66	[p2l622t919r680b939],
21	enzyme	NN	O	enzyme	agent	16	SENT_66	[p2l691t919r819b947],
22	with	IN	O	with	_	0	SENT_66	[p2l830t910r902b939],
23	a	DT	O	a	det	25	SENT_66	[p2l914t919r931b939],
24	variant	JJ	O	variant	amod	25	SENT_66	[p2l941t910r1055b939],
25	allele	NN	O	allele	prep_with	16	SENT_66	[p2l1066t910r1153b939],
26	associated	VBN	O	associate	partmod	25	SENT_66	[p2l1165t910r1334b939],
27	with	IN	O	with	_	0	SENT_66	[p2l1345t910r1417b939],
28	decreased	VBN	O	decrease	amod	30	SENT_66	[p2l1428t910r1591b939],
29	drug	NN	O	drug	nn	30	SENT_66	[p2l1601t910r1676b947],
30	metabolism	NN	O	metabolism	prep_with	26	SENT_66	[p2l1687t910r1880b939],
31	(	CD	NUMBER	(	num	33	SENT_66	[p2l537t960r591b995],
32	8	CD	NUMBER	8	num	33	SENT_66	[p2l537t960r591b995],
33	)	NN	O	)	dep	30	SENT_66	[p2l537t960r591b995],
34	.	.	O	.	_	0	SENT_66	[p2l537t960r591b995],

1	Conversely	RB	O	conversely	_	0	SENT_67	[p2l610t959r801b997],
2	,	,	O	,	_	0	SENT_67	[p2l610t959r801b997],
3	only	RB	O	only	dep	1	SENT_67	[p2l819t960r891b997],
4	7	CD	PERCENT	7	num	5	SENT_67	[p2l908t960r1057b989],
5	%	NN	PERCENT	%	pobj	3	SENT_67	[p2l908t960r1057b989],
6	.	.	O	.	_	0	SENT_67	[p2l908t960r1057b989],

1	—	NN	O	—	_	0	SENT_68	[p2l908t960r1057b989],
2	.	.	O	.	_	0	SENT_68	[p2l908t960r1057b989],

1	20	CD	PERCENT	20	num	2	SENT_69	[p2l908t960r1057b989],
2	%	NN	PERCENT	%	nsubjpass	8	SENT_69	[p2l908t960r1057b989],
3	of	IN	O	of	_	0	SENT_69	[p2l1076t959r1111b989],
4	randomly	RB	O	randomly	advmod	6	SENT_69	[p2l1124t959r1283b997],
5	selected	VBN	O	select	amod	6	SENT_69	[p2l1300t959r1432b989],
6	drugs	NNS	O	drug	prep_of	2	SENT_69	[p2l1448t959r1538b997],
7	are	VBP	O	be	auxpass	8	SENT_69	[p2l1556t969r1605b989],
8	metabolized	VBN	O	metabolize	_	0	SENT_69	[p2l1621t959r1823b989],
9	by	IN	O	by	_	0	SENT_69	[p2l1838t959r1879b997],
10	enzymes	NNS	O	enzyme	agent	8	SENT_69	[p2l536t1019r679b1047],
11	known	VBN	O	know	partmod	10	SENT_69	[p2l695t1009r806b1039],
12	to	TO	O	to	aux	13	SENT_69	[p2l822t1014r852b1039],
13	exhibit	VB	O	exhibit	xcomp	11	SENT_69	[p2l869t1009r982b1039],
14	functional	JJ	O	functional	amod	16	SENT_69	[p2l997t1009r1164b1039],
15	genetic	JJ	O	genetic	amod	16	SENT_69	[p2l1180t1009r1298b1047],
16	polymorphisms	NNS	O	polymorphism	dobj	13	SENT_69	[p2l1314t1009r1580b1047],
17	.	.	O	.	_	0	SENT_69	[p2l1314t1009r1580b1047],

1	Genetic	JJ	O	genetic	amod	2	SENT_70	[p2l1598t1009r1725b1039],
2	variability	NN	O	variability	nsubj	13	SENT_70	[p2l1741t1009r1878b1039, p2l536t1060r578b1098],
3	in	IN	O	in	_	0	SENT_70	[p2l593t1060r625b1089],
4	drug	NN	O	drug	prep_in	2	SENT_70	[p2l640t1060r945b1098],
5	—	CD	NUMBER	—	num	4	SENT_70	[p2l640t1060r945b1098],
6	metabolizing	VBG	O	metabolize	partmod	4	SENT_70	[p2l640t1060r945b1098],
7	enzymes	NNS	O	enzyme	dobj	6	SENT_70	[p2l961t1069r1104b1098],
8	may	MD	O	may	aux	13	SENT_70	[p2l1120t1069r1189b1098],
9	therefore	RB	O	therefore	advmod	13	SENT_70	[p2l1205t1060r1353b1089],
10	be	VB	O	be	cop	13	SENT_70	[p2l1368t1060r1407b1089],
11	an	DT	O	a	det	13	SENT_70	[p2l1423t1069r1460b1089],
12	important	JJ	O	important	amod	13	SENT_70	[p2l1475t1060r1636b1098],
13	contributor	NN	O	contributor	_	0	SENT_70	[p2l1651t1060r1834b1089],
14	to	TO	O	to	_	0	SENT_70	[p2l1848t1064r1879b1089],
15	the	DT	O	the	det	16	SENT_70	[p2l536t1109r585b1138],
16	incidence	NN	O	incidence	prep_to	13	SENT_70	[p2l603t1109r761b1138],
17	of	IN	O	of	_	0	SENT_70	[p2l779t1109r815b1138],
18	ADRs	NNPS	MISC	ADRs	prep_of	16	SENT_70	[p2l829t1109r940b1138],
19	.	.	O	.	_	0	SENT_70	[p2l829t1109r940b1138],

1	Indeed	RB	O	indeed	advmod	6	SENT_71	[p2l960t1109r1081b1144],
2	,	,	O	,	_	0	SENT_71	[p2l960t1109r1081b1144],
3	genetic	JJ	O	genetic	amod	4	SENT_71	[p2l1100t1109r1218b1147],
4	susceptibility	NN	O	susceptibility	nsubjpass	6	SENT_71	[p2l1238t1109r1456b1147],
5	is	VBZ	O	be	auxpass	6	SENT_71	[p2l1474t1109r1500b1138],
6	implicated	VBN	O	implicate	_	0	SENT_71	[p2l1519t1109r1693b1147],
7	in	IN	O	in	_	0	SENT_71	[p2l1710t1109r1742b1138],
8	various	JJ	O	various	amod	10	SENT_71	[p2l1760t1109r1878b1139],
9	idiosyncratic	JJ	O	idiosyncratic	amod	10	SENT_71	[p2l535t1158r748b1196],
10	ADRs	NNS	MISC	adr	prep_in	6	SENT_71	[p2l762t1159r874b1193],
11	,	,	O	,	_	0	SENT_71	[p2l762t1159r874b1193],
12	including	VBG	O	include	_	0	SENT_71	[p2l889t1158r1044b1196],
13	hypersensitivity	NN	O	hypersensitivity	prep_including	6	SENT_71	[p2l1058t1158r1321b1196],
14	to	TO	O	to	_	0	SENT_71	[p2l1335t1163r1366b1187],
15	abacavir	NN	O	abacavir	prep_to	13	SENT_71	[p2l1380t1158r1519b1187],
16	(	CD	NUMBER	(	number	17	SENT_71	[p2l1533t1158r1588b1194],
17	9	CD	NUMBER	9	num	18	SENT_71	[p2l1533t1158r1588b1194],
18	)	NN	O	)	dep	15	SENT_71	[p2l1533t1158r1588b1194],
19	,	,	O	,	_	0	SENT_71	[p2l1533t1158r1588b1194],
20	Stevens-Johnson	NN	O	stevens-johnson	nn	21	SENT_71	[p2l1604t1158r1879b1187],
21	syndrome	NN	O	syndrome	prep_to	13	SENT_71	[p2l537t1207r698b1245],
22	induced	VBN	O	induce	partmod	21	SENT_71	[p2l708t1207r839b1237],
23	by	IN	O	by	_	0	SENT_71	[p2l848t1207r889b1245],
24	carbamazepine	NN	O	carbamazepine	agent	22	SENT_71	[p2l900t1207r1147b1245],
25	(	CD	NUMBER	(	number	26	SENT_71	[p2l1159t1207r1235b1243],
26	10	CD	NUMBER	10	num	27	SENT_71	[p2l1159t1207r1235b1243],
27	)	NN	O	)	dep	22	SENT_71	[p2l1159t1207r1235b1243],
28	,	,	O	,	_	0	SENT_71	[p2l1159t1207r1235b1243],
29	and	CC	O	and	_	0	SENT_71	[p2l1247t1207r1305b1237],
30	severe	JJ	O	severe	amod	32	SENT_71	[p2l1317t1216r1418b1237],
31	cutaneous	JJ	O	cutaneous	amod	32	SENT_71	[p2l1429t1211r1593b1237],
32	ADRs	NNS	MISC	adr	conj_and	15	SENT_71	[p2l1604t1207r1706b1237],
33	caused	VBN	O	cause	partmod	32	SENT_71	[p2l1717t1207r1829b1237],
34	by	IN	O	by	_	0	SENT_71	[p2l1838t1207r1879b1245],
35	allopurinol	NN	O	allopurinol	nn	36	SENT_71	[p2l536t1257r716b1295],
36	(	NN	O	(	agent	33	SENT_71	[p2l729t1257r758b1293],
37	1	CD	NUMBER	1	number	38	SENT_71	[p2l729t1257r758b1293],
38	1	CD	NUMBER	1	num	39	SENT_71	[p2l767t1257r804b1293],
39	)	NN	O	)	dep	33	SENT_71	[p2l767t1257r804b1293],
40	.	.	O	.	_	0	SENT_71	[p2l767t1257r804b1293],

1	With	IN	O	with	mark	9	SENT_72	[p2l585t1306r666b1335],
2	the	DT	O	the	det	4	SENT_72	[p2l682t1306r731b1335],
3	complete	JJ	O	complete	amod	4	SENT_72	[p2l748t1306r898b1344],
4	sequence	NN	O	sequence	dep	9	SENT_72	[p2l916t1315r1065b1344],
5	of	IN	O	of	_	0	SENT_72	[p2l1082t1306r1118b1335],
6	the	DT	O	the	det	8	SENT_72	[p2l1131t1306r1180b1335],
7	human	JJ	O	human	amod	8	SENT_72	[p2l1196t1306r1308b1335],
8	genome	NN	O	genome	prep_of	4	SENT_72	[p2l1325t1315r1454b1344],
9	available	JJ	O	available	advcl	16	SENT_72	[p2l1472t1306r1626b1340],
10	,	,	O	,	_	0	SENT_72	[p2l1472t1306r1626b1340],
11	individualized	JJ	O	individualized	amod	12	SENT_72	[p2l1644t1306r1880b1335],
12	medicine	NN	O	medicine	nsubj	16	SENT_72	[p2l535t1355r686b1384],
13	may	MD	O	may	aux	16	SENT_72	[p2l694t1364r764b1393],
14	soon	RB	O	soon	advmod	16	SENT_72	[p2l774t1364r850b1384],
15	become	VB	O	become	cop	16	SENT_72	[p2l857t1355r985b1384],
16	reality	NN	O	reality	_	0	SENT_72	[p2l992t1355r1103b1393],
17	.	.	O	.	_	0	SENT_72	[p2l992t1355r1103b1393],

1	Genomic	JJ	MISC	genomic	amod	2	SENT_73	[p2l1114t1355r1264b1385],
2	information	NN	O	information	nsubj	4	SENT_73	[p2l1272t1355r1467b1384],
3	may	MD	O	may	aux	4	SENT_73	[p2l1474t1364r1544b1393],
4	allow	VB	O	allow	_	0	SENT_73	[p2l1553t1355r1642b1385],
5	more	JJR	O	more	dep	6	SENT_73	[p2l1650t1364r1734b1384],
6	accurate	JJ	O	accurate	amod	7	SENT_73	[p2l1743t1360r1879b1384],
7	prediction	NN	O	prediction	dobj	4	SENT_73	[p2l535t1404r703b1442],
8	of	IN	O	of	_	0	SENT_73	[p2l716t1404r752b1433],
9	an	DT	O	a	det	10	SENT_73	[p2l763t1413r800b1433],
10	individual	JJ	O	individual	poss	13	SENT_73	[p2l813t1404r1006b1433],
11	’s	POS	O	’s	_	0	SENT_73	[p2l813t1404r1006b1433],
12	drug	NN	O	drug	nn	13	SENT_73	[p2l1020t1404r1094b1442],
13	response	NN	O	response	prep_of	7	SENT_73	[p2l1107t1413r1251b1442],
14	and	CC	O	and	_	0	SENT_73	[p2l1265t1404r1323b1433],
15	selection	NN	O	selection	prep_of	7	SENT_73	[p2l1337t1404r1482b1433],
16	of	IN	O	of	_	0	SENT_73	[p2l1495t1404r1531b1433],
17	the	DT	O	the	det	20	SENT_73	[p2l1541t1404r1591b1433],
18	appropriate	JJ	O	appropriate	amod	20	SENT_73	[p2l1604t1404r1791b1442],
19	drug	NN	O	drug	nn	20	SENT_73	[p2l1805t1404r1879b1442],
20	dosage	NN	O	dosage	prep_of	13	SENT_73	[p2l536t1453r649b1491],
21	to	TO	O	to	aux	22	SENT_73	[p2l661t1458r692b1482],
22	achieve	VB	O	achieve	xcomp	4	SENT_73	[p2l704t1453r827b1482],
23	the	DT	O	the	det	26	SENT_73	[p2l839t1453r888b1482],
24	optimal	JJ	O	optimal	amod	26	SENT_73	[p2l900t1453r1025b1491],
25	therapeutic	JJ	O	therapeutic	amod	26	SENT_73	[p2l1036t1453r1219b1491],
26	response	NN	O	response	dobj	22	SENT_73	[p2l1231t1462r1384b1491],
27	,	,	O	,	_	0	SENT_73	[p2l1231t1462r1384b1491],
28	avoid	VB	O	avoid	conj_and	22	SENT_73	[p2l1398t1453r1487b1482],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_73	[p2l1498t1453r1680b1491],
30	failure	NN	O	failure	dobj	28	SENT_73	[p2l1692t1453r1808b1487],
31	,	,	O	,	_	0	SENT_73	[p2l1692t1453r1808b1487],
32	and	CC	O	and	_	0	SENT_73	[p2l1821t1453r1880b1482],
33	minimize	VB	O	minimize	conj_and	22	SENT_73	[p2l535t1502r691b1531],
34	side	JJ	O	side	amod	35	SENT_73	[p2l700t1502r764b1531],
35	effects	NNS	O	effect	dobj	33	SENT_73	[p2l772t1502r879b1531],
36	and	CC	O	and	_	0	SENT_73	[p2l888t1502r946b1531],
37	toxicity	NN	O	toxicity	conj_and	35	SENT_73	[p2l953t1502r1085b1540],
38	.	.	O	.	_	0	SENT_73	[p2l953t1502r1085b1540],

1	Such	JJ	O	such	amod	2	SENT_74	[p2l1095t1502r1176b1532],
2	information	NN	O	information	nsubj	3	SENT_74	[p2l1183t1502r1378b1531],
3	is	VBZ	O	be	_	0	SENT_74	[p2l1385t1502r1411b1531],
4	of	IN	O	of	_	0	SENT_74	[p2l1420t1502r1456b1531],
5	utmost	JJ	O	utmost	amod	6	SENT_74	[p2l1460t1506r1572b1531],
6	importance	NN	O	importance	prep_of	3	SENT_74	[p2l1579t1502r1765b1540],
7	during	IN	O	during	_	0	SENT_74	[p2l1772t1502r1879b1540],
8	drug	NN	O	drug	nn	9	SENT_74	[p2l536t1551r610b1589],
9	development	NN	O	development	prep_during	3	SENT_74	[p2l626t1551r845b1589],
10	.	.	O	.	_	0	SENT_74	[p2l626t1551r845b1589],

1	About	RB	O	about	quantmod	2	SENT_75	[p2l862t1551r965b1580],
2	4	CD	PERCENT	4	num	3	SENT_75	[p2l979t1551r1031b1580],
3	%	NN	PERCENT	%	nsubjpass	9	SENT_75	[p2l979t1551r1031b1580],
4	of	IN	O	of	_	0	SENT_75	[p2l1048t1551r1084b1580],
5	all	DT	O	all	det	7	SENT_75	[p2l1097t1551r1136b1580],
6	new	JJ	O	new	amod	7	SENT_75	[p2l1151t1560r1217b1580],
7	medications	NNS	O	medication	prep_of	3	SENT_75	[p2l1232t1551r1431b1580],
8	are	VBP	O	be	auxpass	9	SENT_75	[p2l1447t1560r1496b1580],
9	withdrawn	VBN	O	withdraw	_	0	SENT_75	[p2l1511t1551r1687b1580],
10	because	IN	O	because	_	0	SENT_75	[p2l1700t1551r1831b1580],
11	of	IN	O	of	_	0	SENT_75	[p2l1846t1551r1882b1580],
12	ADRs	NNPS	MISC	ADRs	prep_of	14	SENT_75	[p2l535t1600r637b1630],
13	(	CD	NUMBER	(	number	14	SENT_75	[p2l649t1600r725b1636],
14	12	CD	NUMBER	12	prep_because	9	SENT_75	[p2l649t1600r725b1636],
15	)	NN	O	)	dep	14	SENT_75	[p2l649t1600r725b1636],
16	,	,	O	,	_	0	SENT_75	[p2l649t1600r725b1636],
17	and	CC	O	and	_	0	SENT_75	[p2l737t1600r795b1630],
18	failure	NN	O	failure	nsubj	25	SENT_75	[p2l805t1600r912b1630],
19	of	IN	O	of	_	0	SENT_75	[p2l922t1600r958b1630],
20	a	DT	O	a	det	23	SENT_75	[p2l966t1609r983b1630],
21	newly	RB	O	newly	advmod	22	SENT_75	[p2l992t1600r1091b1638],
22	released	VBN	O	release	amod	23	SENT_75	[p2l1101t1600r1237b1630],
23	drug	NN	O	drug	prep_of	18	SENT_75	[p2l1247t1600r1321b1638],
24	is	VBZ	O	be	cop	25	SENT_75	[p2l1331t1600r1357b1630],
25	disastrous	JJ	O	disastrous	conj_and	9	SENT_75	[p2l1368t1600r1532b1630],
26	for	IN	O	for	_	0	SENT_75	[p2l1543t1600r1591b1630],
27	a	DT	O	a	det	29	SENT_75	[p2l1600t1609r1618b1630],
28	pharmaceutical	JJ	O	pharmaceutical	amod	29	SENT_75	[p2l1626t1600r1879b1638],
29	PHARMACOGENOMICS	NN	O	pharmacogenomic	prep_for	25	SENT_75	[p2l1336t1660r1738b1687],
30	121	CD	NUMBER	121	tmod	25	SENT_75	[p2l1830t1657r1888b1687],

1	company	NN	O	company	_	0	SENT_76	[p2l546t1792r702b1821],
2	,	,	O	,	_	0	SENT_76	[p2l546t1792r702b1821],
3	which	WDT	O	which	nsubj	6	SENT_76	[p2l715t1783r815b1813],
4	may	MD	O	may	aux	6	SENT_76	[p2l826t1792r896b1821],
5	have	VB	O	have	aux	6	SENT_76	[p2l907t1783r983b1813],
6	spent	VBN	O	spend	dep	1	SENT_76	[p2l995t1788r1081b1821],
7	more	JJR	O	more	mwe	8	SENT_76	[p2l1091t1792r1175b1813],
8	than	IN	O	than	quantmod	11	SENT_76	[p2l1186t1783r1257b1813],
9	a	DT	MONEY	a	quantmod	11	SENT_76	[p2l1269t1792r1286b1813],
10	billion	CD	MONEY	billion	number	11	SENT_76	[p2l1296t1783r1404b1813],
11	dollars	NNS	MONEY	dollar	dobj	6	SENT_76	[p2l1415t1783r1526b1813],
12	to	TO	O	to	aux	13	SENT_76	[p2l1537t1788r1568b1813],
13	develop	VB	O	develop	xcomp	6	SENT_76	[p2l1580t1783r1708b1821],
14	that	DT	O	that	det	16	SENT_76	[p2l1719t1783r1781b1813],
15	single	JJ	O	single	amod	16	SENT_76	[p2l1793t1783r1889b1821],
16	product	NN	O	product	dobj	13	SENT_76	[p2l545t1833r679b1871],
17	.	.	O	.	_	0	SENT_76	[p2l545t1833r679b1871],

1	Although	IN	O	although	mark	20	SENT_77	[p2l595t1882r751b1920],
2	many	JJ	O	many	amod	3	SENT_77	[p2l768t1891r858b1920],
3	genes	NNS	O	gene	nsubjpass	20	SENT_77	[p2l876t1891r968b1920],
4	encoding	VBG	O	encode	partmod	3	SENT_77	[p2l986t1882r1136b1920],
5	proteins	NNS	O	protein	dobj	4	SENT_77	[p2l1153t1882r1285b1920],
6	involved	VBN	O	involve	partmod	5	SENT_77	[p2l1303t1882r1445b1911],
7	in	IN	O	in	_	0	SENT_77	[p2l1461t1882r1493b1911],
8	the	DT	O	the	det	9	SENT_77	[p2l1509t1882r1559b1911],
9	metabolism	NN	O	metabolism	prep_in	6	SENT_77	[p2l1576t1882r1778b1916],
10	,	,	O	,	_	0	SENT_77	[p2l1576t1882r1778b1916],
11	transport	NN	O	transport	conj_and	9	SENT_77	[p2l1796t1887r1888b1911, p2l545t1936r620b1969],
12	,	,	O	,	_	0	SENT_77	[p2l1796t1887r1888b1911, p2l545t1936r620b1969],
13	and	CC	O	and	_	0	SENT_77	[p2l632t1931r690b1961],
14	mechanism	NN	O	mechanism	conj_and	9	SENT_77	[p2l700t1931r888b1961],
15	of	IN	O	of	_	0	SENT_77	[p2l898t1931r934b1961],
16	action	NN	O	action	prep_of	9	SENT_77	[p2l942t1931r1041b1961],
17	of	IN	O	of	_	0	SENT_77	[p2l1052t1931r1087b1961],
18	medications	NNS	O	medication	prep_of	16	SENT_77	[p2l1094t1931r1293b1961],
19	are	VBP	O	be	auxpass	20	SENT_77	[p2l1305t1940r1353b1961],
20	known	VBN	O	know	advcl	36	SENT_77	[p2l1363t1931r1474b1961],
21	to	TO	O	to	aux	22	SENT_77	[p2l1484t1936r1515b1961],
22	exhibit	VB	O	exhibit	xcomp	20	SENT_77	[p2l1525t1931r1639b1961],
23	polymorphism	NN	O	polymorphism	dobj	22	SENT_77	[p2l1648t1931r1890b1969],
24	in	IN	O	in	_	0	SENT_77	[p2l545t1981r576b2010],
25	humans	NNS	O	human	prep_in	22	SENT_77	[p2l590t1981r727b2016],
26	,	,	O	,	_	0	SENT_77	[p2l590t1981r727b2016],
27	use	NN	O	use	nsubjpass	36	SENT_77	[p2l743t1990r797b2010],
28	of	IN	O	of	_	0	SENT_77	[p2l811t1981r847b2010],
29	this	DT	O	this	det	30	SENT_77	[p2l858t1981r916b2010],
30	knowledge	NN	O	knowledge	prep_of	27	SENT_77	[p2l931t1981r1111b2019],
31	in	IN	O	in	_	0	SENT_77	[p2l1125t1981r1156b2010],
32	routine	JJ	O	routine	amod	34	SENT_77	[p2l1170t1981r1287b2010],
33	clinical	JJ	O	clinical	amod	34	SENT_77	[p2l1301t1981r1422b2010],
34	practice	NN	O	practice	prep_in	30	SENT_77	[p2l1435t1981r1566b2019],
35	is	VBZ	O	be	auxpass	36	SENT_77	[p2l1580t1981r1606b2010],
36	limited	VBN	O	limit	_	0	SENT_77	[p2l1621t1981r1745b2010],
37	.	.	O	.	_	0	SENT_77	[p2l1621t1981r1745b2010],

1	Excepting	VBG	O	except	partmod	27	SENT_78	[p2l1761t1982r1888b2019, p2l545t2030r597b2068],
2	a	DT	O	a	det	4	SENT_78	[p2l614t2039r632b2059],
3	few	JJ	O	few	amod	4	SENT_78	[p2l647t2030r707b2059],
4	examples	NNS	O	example	dobj	1	SENT_78	[p2l724t2030r878b2068],
5	of	IN	O	of	_	0	SENT_78	[p2l895t2030r931b2059],
6	drug	NN	O	drug	prep_of	4	SENT_78	[p2l945t2030r1250b2068],
7	—	CD	NUMBER	—	num	6	SENT_78	[p2l945t2030r1250b2068],
8	metabolizing	VBG	O	metabolize	partmod	6	SENT_78	[p2l945t2030r1250b2068],
9	enzymes	NNS	O	enzyme	dobj	8	SENT_78	[p2l1267t2039r1420b2068],
10	,	,	O	,	_	0	SENT_78	[p2l1267t2039r1420b2068],
11	the	DT	O	the	det	12	SENT_78	[p2l1437t2030r1487b2059],
12	contribution	NN	O	contribution	nsubjpass	27	SENT_78	[p2l1504t2030r1705b2059],
13	of	IN	O	of	_	0	SENT_78	[p2l1721t2030r1757b2059],
14	genetic	JJ	O	genetic	amod	15	SENT_78	[p2l1771t2030r1889b2068],
15	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_78	[p2l545t2079r802b2117],
16	to	TO	O	to	_	0	SENT_78	[p2l817t2083r848b2108],
17	individual	JJ	O	individual	amod	18	SENT_78	[p2l863t2079r1029b2108],
18	differences	NNS	O	difference	prep_to	15	SENT_78	[p2l1044t2079r1225b2108],
19	in	IN	O	in	_	0	SENT_78	[p2l1240t2079r1271b2108],
20	drug	NN	O	drug	nn	21	SENT_78	[p2l1286t2079r1360b2117],
21	effects	NNS	O	effect	prep_in	18	SENT_78	[p2l1375t2079r1483b2108],
22	and	CC	O	and	_	0	SENT_78	[p2l1499t2079r1557b2108],
23	toxicity	NN	O	toxicity	conj_and	21	SENT_78	[p2l1571t2079r1697b2117],
24	is	VBZ	O	be	auxpass	27	SENT_78	[p2l1712t2079r1737b2108],
25	not	RB	O	not	neg	27	SENT_78	[p2l1753t2083r1805b2108],
26	well	RB	O	well	advmod	27	SENT_78	[p2l1819t2079r1889b2108],
27	understood	VBN	O	understand	_	0	SENT_78	[p2l545t2128r737b2157],
28	.	.	O	.	_	0	SENT_78	[p2l545t2128r737b2157],

1	Moreover	RB	O	moreover	advmod	6	SENT_79	[p2l752t2129r921b2163],
2	,	,	O	,	_	0	SENT_79	[p2l752t2129r921b2163],
3	most	RBS	O	most	advmod	4	SENT_79	[p2l936t2133r1017b2157],
4	studies	NNS	O	study	nsubj	6	SENT_79	[p2l1031t2128r1143b2157],
5	have	VBP	O	have	aux	6	SENT_79	[p2l1158t2128r1234b2157],
6	focused	VBN	O	focus	_	0	SENT_79	[p2l1247t2128r1376b2157],
7	on	IN	O	on	_	0	SENT_79	[p2l1390t2137r1430b2157],
8	the	DT	O	the	det	9	SENT_79	[p2l1443t2128r1493b2157],
9	effect	NN	O	effect	prep_on	6	SENT_79	[p2l1507t2128r1600b2157],
10	of	IN	O	of	_	0	SENT_79	[p2l1613t2128r1649b2157],
11	a	DT	O	a	det	13	SENT_79	[p2l1661t2137r1678b2157],
12	single	JJ	O	single	amod	13	SENT_79	[p2l1692t2128r1789b2166],
13	polymorphism	NN	O	polymorphism	prep_of	9	SENT_79	[p2l1802t2128r1888b2166, p2l545t2177r713b2215],
14	on	IN	O	on	_	0	SENT_79	[p2l727t2186r767b2207],
15	drug	NN	O	drug	nn	16	SENT_79	[p2l782t2177r856b2215],
16	response	NN	O	response	prep_on	13	SENT_79	[p2l870t2186r1023b2215],
17	.	.	O	.	_	0	SENT_79	[p2l870t2186r1023b2215],

1	This	DT	O	this	det	2	SENT_80	[p2l1040t2177r1111b2207],
2	approach	NN	O	approach	nsubj	3	SENT_80	[p2l1128t2177r1278b2215],
3	neglects	VBZ	O	neglect	dep	27	SENT_80	[p2l1292t2177r1426b2215],
4	the	DT	O	the	det	5	SENT_80	[p2l1441t2177r1490b2207],
5	fact	NN	O	fact	dobj	3	SENT_80	[p2l1505t2177r1566b2207],
6	that	IN	O	that	complm	21	SENT_80	[p2l1580t2177r1642b2207],
7	drug	NN	O	drug	nn	10	SENT_80	[p2l1656t2177r1889b2215],
8	—	NN	O	—	nn	10	SENT_80	[p2l1656t2177r1889b2215],
9	response	NN	O	response	nn	10	SENT_80	[p2l1656t2177r1889b2215],
10	phenotype	NN	O	phenotype	nsubj	21	SENT_80	[p2l545t2227r726b2265],
11	,	,	O	,	_	0	SENT_80	[p2l545t2227r726b2265],
12	like	IN	O	like	_	0	SENT_80	[p2l739t2227r800b2256],
13	most	JJS	O	most	amod	15	SENT_80	[p2l812t2231r892b2256],
14	disease	NN	O	disease	nn	15	SENT_80	[p2l904t2227r1022b2256],
15	phenotypes	NNS	O	phenotype	prep_like	10	SENT_80	[p2l1033t2227r1231b2265],
16	,	,	O	,	_	0	SENT_80	[p2l1033t2227r1231b2265],
17	is	VBZ	O	be	cop	21	SENT_80	[p2l1244t2227r1270b2256],
18	a	DT	O	a	det	21	SENT_80	[p2l1283t2236r1301b2256],
19	complex	JJ	O	complex	amod	21	SENT_80	[p2l1312t2227r1453b2265],
20	polygenic	JJ	O	polygenic	amod	21	SENT_80	[p2l1464t2227r1627b2265],
21	trait	NN	O	trait	ccomp	3	SENT_80	[p2l1639t2227r1706b2256],
22	also	RB	O	also	advmod	23	SENT_80	[p2l1718t2227r1782b2256],
23	determined	VBN	O	determine	partmod	21	SENT_80	[p2l1795t2227r1888b2256, p2l545t2276r648b2305],
24	by	IN	O	by	_	0	SENT_80	[p2l661t2276r702b2314],
25	nongenetic	JJ	O	nongenetic	amod	26	SENT_80	[p2l717t2276r897b2314],
26	factors	NNS	O	factor	agent	23	SENT_80	[p2l912t2276r1023b2305],
27	(	VBP	O	(	_	0	SENT_80	[p2l1039t2276r1084b2312],
28	3	CD	NUMBER	3	num	29	SENT_80	[p2l1039t2276r1084b2312],
29	)	CD	NUMBER	)	dobj	27	SENT_80	[p2l1039t2276r1084b2312],
30	(	CD	NUMBER	(	num	33	SENT_80	[p2l1101t2276r1221b2314],
31	Figure	NN	O	figure	nn	33	SENT_80	[p2l1101t2276r1221b2314],
32	1	CD	NUMBER	1	num	33	SENT_80	[p2l1239t2277r1277b2312],
33	)	NN	O	)	nsubj	27	SENT_80	[p2l1239t2277r1277b2312],
34	.	.	O	.	_	0	SENT_80	[p2l1239t2277r1277b2312],

1	The	DT	O	the	det	2	SENT_81	[p2l1293t2276r1356b2305],
2	extent	NN	O	extent	nsubj	14	SENT_81	[p2l1371t2281r1471b2305],
3	to	TO	O	to	_	0	SENT_81	[p2l1485t2281r1516b2305],
4	which	WDT	O	which	rel	7	SENT_81	[p2l1530t2276r1631b2305],
5	genetic	JJ	O	genetic	amod	6	SENT_81	[p2l1645t2276r1763b2314],
6	factors	NNS	O	factor	nsubj	7	SENT_81	[p2l1778t2276r1889b2305],
7	contribute	VBP	O	contribute	rcmod	2	SENT_81	[p2l545t2325r711b2354],
8	to	TO	O	to	_	0	SENT_81	[p2l726t2330r757b2354],
9	the	DT	O	the	det	13	SENT_81	[p2l772t2325r821b2354],
10	drug	NN	O	drug	nn	13	SENT_81	[p2l836t2325r1208b2363],
11	—	NN	O	—	nn	13	SENT_81	[p2l836t2325r1208b2363],
12	response/toxicity	NN	O	response/toxicity	nn	13	SENT_81	[p2l836t2325r1208b2363],
13	phenotype	NN	O	phenotype	prep_to	7	SENT_81	[p2l1223t2325r1395b2363],
14	depends	VBZ	O	depend	_	0	SENT_81	[p2l1410t2325r1543b2363],
15	on	IN	O	on	_	0	SENT_81	[p2l1559t2334r1599b2354],
16	the	DT	O	the	det	17	SENT_81	[p2l1613t2325r1663b2354],
17	extent	NN	O	extent	prep_on	14	SENT_81	[p2l1678t2329r1778b2354],
18	of	IN	O	of	_	0	SENT_81	[p2l1792t2325r1828b2354],
19	the	DT	O	the	det	21	SENT_81	[p2l1840t2325r1889b2354],
20	candidate	NN	O	candidate	nn	21	SENT_81	[p2l545t2375r703b2404],
21	gene	NN	O	gene	poss	23	SENT_81	[p2l718t2375r822b2413],
22	’s	POS	O	’s	_	0	SENT_81	[p2l718t2375r822b2413],
23	inﬂuence	NN	O	inﬂuence	prep_of	17	SENT_81	[p2l837t2375r988b2404],
24	on	IN	O	on	_	0	SENT_81	[p2l1003t2384r1042b2404],
25	drug	NN	O	drug	nn	26	SENT_81	[p2l1057t2375r1131b2413],
26	disposition	NN	O	disposition	prep_on	14	SENT_81	[p2l1146t2375r1327b2413],
27	and	CC	O	and	_	0	SENT_81	[p2l1342t2375r1401b2404],
28	effects	NNS	O	effect	conj_and	26	SENT_81	[p2l1415t2375r1531b2404],
29	.	.	O	.	_	0	SENT_81	[p2l1415t2375r1531b2404],

1	Misconceptions	NNS	MISC	misconception	nsubj	3	SENT_82	[p2l1547t2375r1809b2413],
2	also	RB	O	also	advmod	3	SENT_82	[p2l1824t2375r1889b2404],
3	exist	VBP	O	exist	_	0	SENT_82	[p2l545t2425r622b2454],
4	about	IN	O	about	_	0	SENT_82	[p2l632t2425r723b2454],
5	the	DT	O	the	det	6	SENT_82	[p2l732t2425r781b2454],
6	information	NN	O	information	prep_about	3	SENT_82	[p2l791t2425r986b2454],
7	provided	VBN	O	provide	partmod	6	SENT_82	[p2l995t2425r1141b2463],
8	by	IN	O	by	_	0	SENT_82	[p2l1150t2425r1190b2463],
9	a	DT	O	a	det	11	SENT_82	[p2l1201t2434r1218b2454],
10	pharmacogenetic	JJ	O	pharmacogenetic	amod	11	SENT_82	[p2l1227t2425r1509b2463],
11	test	NN	O	test	agent	7	SENT_82	[p2l1519t2429r1584b2454],
12	.	.	O	.	_	0	SENT_82	[p2l1519t2429r1584b2454],

1	Even	RB	O	even	advmod	5	SENT_83	[p2l1595t2425r1679b2454],
2	if	IN	O	if	dep	5	SENT_83	[p2l1688t2425r1715b2454],
3	a	DT	O	a	det	4	SENT_83	[p2l1723t2434r1740b2454],
4	gene	NN	O	gene	nsubj	5	SENT_83	[p2l1749t2434r1826b2463],
5	has	VBZ	O	have	advcl	33	SENT_83	[p2l1835t2425r1889b2454],
6	a	DT	O	a	det	8	SENT_83	[p2l546t2484r563b2504],
7	large	JJ	O	large	amod	8	SENT_83	[p2l573t2475r653b2513],
8	effect	NN	O	effect	dobj	5	SENT_83	[p2l664t2475r756b2504],
9	on	IN	O	on	_	0	SENT_83	[p2l766t2484r806b2504],
10	a	DT	O	a	det	11	SENT_83	[p2l817t2484r834b2504],
11	drug	NN	O	drug	poss	13	SENT_83	[p2l843t2475r945b2513],
12	’s	POS	O	’s	_	0	SENT_83	[p2l843t2475r945b2513],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	8	SENT_83	[p2l955t2475r1246b2513],
14	or	CC	O	or	_	0	SENT_83	[p2l1258t2484r1292b2504],
15	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	8	SENT_83	[p2l1300t2475r1631b2513],
16	,	,	O	,	_	0	SENT_83	[p2l1300t2475r1631b2513],
17	the	DT	O	the	det	18	SENT_83	[p2l1642t2475r1692b2504],
18	presence	NN	O	presence	nsubj	33	SENT_83	[p2l1702t2484r1846b2513],
19	of	IN	O	of	_	0	SENT_83	[p2l1856t2475r1892b2504],
20	a	DT	O	a	det	27	SENT_83	[p2l546t2534r563b2554],
21	single	JJ	O	single	amod	27	SENT_83	[p2l573t2525r857b2562],
22	—	NN	O	—	nn	27	SENT_83	[p2l573t2525r857b2562],
23	nucleotide	NN	O	nucleotide	nn	27	SENT_83	[p2l573t2525r857b2562],
24	polymorphism	NN	O	polymorphism	nn	27	SENT_83	[p2l866t2525r1108b2562],
25	(	CD	NUMBER	(	num	27	SENT_83	[p2l1118t2525r1219b2561],
26	SNP	NN	ORGANIZATION	snp	nn	27	SENT_83	[p2l1118t2525r1219b2561],
27	)	NN	O	)	prep_of	18	SENT_83	[p2l1118t2525r1219b2561],
28	in	IN	O	in	_	0	SENT_83	[p2l1229t2525r1260b2553],
29	that	DT	O	that	det	30	SENT_83	[p2l1270t2525r1332b2554],
30	gene	NN	O	gene	prep_in	27	SENT_83	[p2l1341t2534r1418b2562],
31	will	MD	O	will	aux	33	SENT_83	[p2l1428t2525r1491b2554],
32	not	RB	O	not	neg	33	SENT_83	[p2l1500t2529r1553b2554],
33	provide	VB	O	provide	_	0	SENT_83	[p2l1561t2525r1687b2562],
34	an	DT	O	a	det	36	SENT_83	[p2l1697t2534r1735b2554],
35	unequivocal	JJ	O	unequivocal	amod	36	SENT_83	[p2l1744t2525r1888b2562, p2l546t2574r613b2603],
36	answer	NN	O	answer	dobj	33	SENT_83	[p2l626t2583r742b2603],
37	but	CC	O	but	_	0	SENT_83	[p2l753t2574r813b2608],
38	,	,	O	,	_	0	SENT_83	[p2l753t2574r813b2608],
39	rather	RB	O	rather	dep	33	SENT_83	[p2l826t2574r930b2608],
40	,	,	O	,	_	0	SENT_83	[p2l826t2574r930b2608],
41	will	MD	O	will	aux	42	SENT_83	[p2l943t2574r1006b2603],
42	indicate	VB	O	indicate	conj_but	33	SENT_83	[p2l1019t2574r1149b2603],
43	the	DT	O	the	det	44	SENT_83	[p2l1161t2574r1210b2603],
44	likelihood	NN	O	likelihood	dobj	42	SENT_83	[p2l1222t2574r1390b2603],
45	that	IN	O	that	complm	50	SENT_83	[p2l1401t2574r1463b2603],
46	an	DT	O	a	det	48	SENT_83	[p2l1475t2583r1512b2603],
47	individual	JJ	O	individual	amod	48	SENT_83	[p2l1524t2574r1690b2603],
48	patient	NN	O	patient	nsubj	50	SENT_83	[p2l1702t2574r1815b2612],
49	will	MD	O	will	aux	50	SENT_83	[p2l1826t2574r1889b2603],
50	show	VB	O	show	ccomp	42	SENT_83	[p2l547t2624r630b2653],
51	an	DT	O	a	det	54	SENT_83	[p2l644t2633r681b2653],
52	altered	JJ	O	altered	amod	54	SENT_83	[p2l694t2624r806b2653],
53	drug	NN	O	drug	nn	54	SENT_83	[p2l818t2624r892b2662],
54	response	NN	O	response	dobj	50	SENT_83	[p2l904t2633r1057b2662],
55	.	.	O	.	_	0	SENT_83	[p2l904t2633r1057b2662],

1	The	DT	O	the	det	5	SENT_84	[p2l1072t2624r1135b2653],
2	highest	JJS	O	highest	amod	5	SENT_84	[p2l1147t2624r1267b2662],
3	positive	JJ	O	positive	amod	5	SENT_84	[p2l1278t2624r1407b2662],
4	predictive	JJ	O	predictive	amod	5	SENT_84	[p2l1419t2624r1583b2662],
5	value	NN	O	value	nsubjpass	12	SENT_84	[p2l1595t2624r1683b2653],
6	of	IN	O	of	_	0	SENT_84	[p2l1696t2624r1732b2653],
7	a	DT	O	a	det	9	SENT_84	[p2l1742t2633r1759b2653],
8	genetic	JJ	O	genetic	amod	9	SENT_84	[p2l1771t2624r1889b2662],
9	test	NN	O	test	prep_of	5	SENT_84	[p2l545t2678r602b2703],
10	will	MD	O	will	aux	12	SENT_84	[p2l616t2674r679b2703],
11	be	VB	O	be	auxpass	12	SENT_84	[p2l692t2674r730b2703],
12	observed	VBN	O	observe	_	0	SENT_84	[p2l744t2674r892b2703],
13	for	IN	O	for	_	0	SENT_84	[p2l906t2674r954b2703],
14	genes	NNS	O	gene	prep_for	12	SENT_84	[p2l967t2683r1059b2711],
15	with	IN	O	with	_	0	SENT_84	[p2l1074t2674r1146b2703],
16	a	DT	O	a	det	18	SENT_84	[p2l1160t2683r1178b2703],
17	major	JJ	O	major	amod	18	SENT_84	[p2l1190t2674r1287b2711],
18	effect	NN	O	effect	prep_with	14	SENT_84	[p2l1300t2674r1400b2703],
19	.	.	O	.	_	0	SENT_84	[p2l1300t2674r1400b2703],

1	Genetic	JJ	O	genetic	amod	2	SENT_85	[p2l1416t2674r1543b2703],
2	polymorphisms	NNS	O	polymorphism	nsubj	16	SENT_85	[p2l1557t2674r1814b2711],
3	that	WDT	O	that	nsubj	4	SENT_85	[p2l1828t2674r1890b2703],
4	lead	VBP	O	lead	rcmod	2	SENT_85	[p2l545t2724r613b2753],
5	to	TO	O	to	_	0	SENT_85	[p2l624t2728r655b2753],
6	a	DT	O	a	det	7	SENT_85	[p2l667t2733r685b2753],
7	loss	NN	O	loss	prep_to	4	SENT_85	[p2l695t2724r758b2753],
8	of	IN	O	of	_	0	SENT_85	[p2l770t2723r806b2753],
9	function	NN	O	function	prep_of	7	SENT_85	[p2l814t2723r952b2753],
10	of	IN	O	of	_	0	SENT_85	[p2l963t2723r999b2753],
11	drug	NN	O	drug	prep_of	9	SENT_85	[p2l1008t2723r1313b2761],
12	—	CD	NUMBER	—	num	11	SENT_85	[p2l1008t2723r1313b2761],
13	metabolizing	VBG	O	metabolize	xcomp	4	SENT_85	[p2l1008t2723r1313b2761],
14	enzymes	NNS	O	enzyme	dobj	13	SENT_85	[p2l1324t2733r1467b2761],
15	will	MD	O	will	aux	16	SENT_85	[p2l1479t2724r1543b2753],
16	result	VB	O	result	_	0	SENT_85	[p2l1553t2724r1646b2753],
17	in	IN	O	in	_	0	SENT_85	[p2l1656t2723r1688b2752],
18	higher	JJR	O	higher	amod	20	SENT_85	[p2l1698t2723r1804b2761],
19	drug	NN	O	drug	nn	20	SENT_85	[p2l1815t2724r1889b2761],
20	concentrations	NNS	O	concentration	prep_in	16	SENT_85	[p2l546t2773r795b2802],
21	.	.	O	.	_	0	SENT_85	[p2l546t2773r795b2802],

1	If	IN	O	if	mark	5	SENT_86	[p2l812t2773r841b2802],
2	such	JJ	O	such	amod	3	SENT_86	[p2l855t2773r929b2802],
3	concentrations	NNS	O	concentration	nsubjpass	5	SENT_86	[p2l945t2773r1184b2802],
4	are	VBP	O	be	auxpass	5	SENT_86	[p2l1202t2783r1250b2802],
5	associated	VBN	O	associate	advcl	22	SENT_86	[p2l1266t2773r1436b2802],
6	with	IN	O	with	_	0	SENT_86	[p2l1451t2773r1524b2802],
7	a	DT	O	a	det	9	SENT_86	[p2l1539t2783r1557b2802],
8	high	JJ	O	high	amod	9	SENT_86	[p2l1571t2773r1644b2811],
9	probability	NN	O	probability	prep_with	5	SENT_86	[p2l1659t2773r1840b2811],
10	of	IN	O	of	_	0	SENT_86	[p2l1856t2773r1892b2802],
11	drug	NN	O	drug	nn	12	SENT_86	[p2l546t2823r620b2861],
12	toxicity	NN	O	toxicity	prep_of	9	SENT_86	[p2l630t2823r762b2861],
13	,	,	O	,	_	0	SENT_86	[p2l630t2823r762b2861],
14	a	DT	O	a	det	15	SENT_86	[p2l774t2832r791b2852],
15	patient	NN	O	patient	nsubj	22	SENT_86	[p2l800t2823r913b2861],
16	who	WP	O	who	nsubj	17	SENT_86	[p2l922t2823r992b2852],
17	has	VBZ	O	have	rcmod	15	SENT_86	[p2l1002t2823r1056b2852],
18	this	DT	O	this	det	19	SENT_86	[p2l1066t2823r1124b2852],
19	genotype	NN	O	genotype	dobj	17	SENT_86	[p2l1136t2828r1286b2861],
20	is	VBZ	O	be	cop	22	SENT_86	[p2l1296t2823r1322b2852],
21	highly	RB	O	highly	advmod	22	SENT_86	[p2l1332t2823r1437b2861],
22	likely	JJ	O	likely	_	0	SENT_86	[p2l1447t2823r1540b2861],
23	to	TO	O	to	aux	24	SENT_86	[p2l1550t2828r1581b2852],
24	develop	VB	O	develop	xcomp	22	SENT_86	[p2l1592t2823r1719b2861],
25	toxicity	NN	O	toxicity	dobj	24	SENT_86	[p2l1730t2823r1855b2861],
26	if	IN	O	if	mark	27	SENT_86	[p2l1865t2823r1892b2852],
27	given	VBN	O	give	advcl	22	SENT_86	[p2l546t2873r635b2911],
28	the	DT	O	the	det	30	SENT_86	[p2l642t2873r692b2902],
29	same	JJ	O	same	amod	30	SENT_86	[p2l701t2882r783b2902],
30	dose	NN	O	dose	dobj	27	SENT_86	[p2l791t2873r866b2902],
31	as	IN	O	as	_	0	SENT_86	[p2l874t2882r906b2902],
32	patients	NNS	O	patient	prep_as	27	SENT_86	[p2l914t2873r1042b2911],
33	who	WP	O	who	nsubj	34	SENT_86	[p2l1051t2873r1120b2902],
34	carry	VBP	O	carry	rcmod	32	SENT_86	[p2l1129t2882r1212b2911],
35	the	DT	O	the	det	39	SENT_86	[p2l1220t2873r1269b2902],
36	wild	JJ	O	wild	amod	39	SENT_86	[p2l1277t2873r1435b2911],
37	—	NN	O	—	nn	39	SENT_86	[p2l1277t2873r1435b2911],
38	type	NN	O	type	nn	39	SENT_86	[p2l1277t2873r1435b2911],
39	allele	NN	O	allele	dobj	34	SENT_86	[p2l1443t2873r1531b2902],
40	of	IN	O	of	_	0	SENT_86	[p2l1540t2873r1575b2902],
41	the	DT	O	the	det	42	SENT_86	[p2l1580t2873r1629b2902],
42	gene	NN	O	gene	prep_of	39	SENT_86	[p2l1638t2882r1723b2911],
43	.	.	O	.	_	0	SENT_86	[p2l1638t2882r1723b2911],

1	However	RB	O	however	advmod	22	SENT_87	[p2l1732t2874r1888b2907],
2	,	,	O	,	_	0	SENT_87	[p2l1732t2874r1888b2907],
3	the	DT	O	the	det	8	SENT_87	[p2l545t2923r595b2952],
4	negative	JJ	O	negative	amod	8	SENT_87	[p2l609t2923r746b2960],
5	predictive	JJ	O	predictive	amod	8	SENT_87	[p2l760t2923r923b2960],
6	value	NN	O	value	nn	8	SENT_87	[p2l938t2923r1025b2952],
7	(	NN	O	(	nn	8	SENT_87	[p2l1041t2923r1221b2958],
8	likelihood	NN	O	likelihood	nsubj	22	SENT_87	[p2l1041t2923r1221b2958],
9	that	IN	O	that	complm	17	SENT_87	[p2l1234t2923r1296b2952],
10	a	DT	O	a	det	11	SENT_87	[p2l1310t2932r1328b2952],
11	patient	NN	O	patient	nsubj	17	SENT_87	[p2l1341t2923r1454b2960],
12	without	IN	O	without	_	0	SENT_87	[p2l1467t2923r1594b2952],
13	the	DT	O	the	det	14	SENT_87	[p2l1607t2923r1656b2952],
14	SNP	NN	ORGANIZATION	snp	prep_without	11	SENT_87	[p2l1672t2923r1746b2952],
15	will	MD	O	will	aux	17	SENT_87	[p2l1760t2923r1823b2952],
16	not	RB	O	not	neg	17	SENT_87	[p2l1837t2927r1890b2952],
17	have	VB	O	have	dep	8	SENT_87	[p2l545t2973r621b3002],
18	toxicity	NN	O	toxicity	nn	19	SENT_87	[p2l629t2973r767b3010],
19	)	NN	O	)	dobj	17	SENT_87	[p2l629t2973r767b3010],
20	will	MD	O	will	aux	22	SENT_87	[p2l777t2973r840b3002],
21	be	VB	O	be	cop	22	SENT_87	[p2l847t2973r886b3002],
22	poor	JJ	O	poor	_	0	SENT_87	[p2l893t2982r970b3010],
23	if	IN	O	if	mark	32	SENT_87	[p2l977t2973r1004b3001],
24	nongenetic	JJ	O	nongenetic	amod	25	SENT_87	[p2l1009t2973r1189b3010],
25	factors	NNS	O	factor	nsubjpass	32	SENT_87	[p2l1198t2973r1308b3002],
26	leading	VBG	O	lead	partmod	25	SENT_87	[p2l1317t2973r1438b3010],
27	to	TO	O	to	_	0	SENT_87	[p2l1446t2977r1477b3002],
28	high	JJ	O	high	amod	30	SENT_87	[p2l1485t2973r1558b3010],
29	drug	NN	O	drug	nn	30	SENT_87	[p2l1566t2973r1640b3010],
30	concentrations	NNS	O	concentration	prep_to	26	SENT_87	[p2l1649t2973r1889b3002],
31	are	VBP	O	be	auxpass	32	SENT_87	[p2l546t3032r595b3052],
32	neglected	VBN	O	neglect	advcl	22	SENT_87	[p2l609t3022r767b3060],
33	(	CD	NUMBER	(	dobj	32	SENT_87	[p2l783t3023r863b3060],
34	e.g.	FW	O	e.g.	amod	33	SENT_87	[p2l783t3023r863b3060],
35	,	,	O	,	_	0	SENT_87	[p2l783t3023r863b3060],
36	drug	NN	O	drug	dep	34	SENT_87	[p2l880t3022r1044b3060],
37	—	CD	NUMBER	—	num	39	SENT_87	[p2l880t3022r1044b3060],
38	drug	NN	O	drug	nn	39	SENT_87	[p2l880t3022r1044b3060],
39	interactions	NNS	O	interaction	dep	36	SENT_87	[p2l1059t3022r1274b3058],
40	)	CD	NUMBER	)	dep	39	SENT_87	[p2l1059t3022r1274b3058],
41	.	.	O	.	_	0	SENT_87	[p2l1059t3022r1274b3058],

1	If	IN	O	if	mark	13	SENT_88	[p2l1290t3022r1320b3051],
2	a	DT	O	a	det	3	SENT_88	[p2l1332t3032r1350b3052],
3	patient	NN	O	patient	nsubjpass	13	SENT_88	[p2l1363t3022r1476b3060],
4	who	WP	O	who	nsubj	5	SENT_88	[p2l1490t3022r1560b3052],
5	carries	VBZ	O	carry	rcmod	3	SENT_88	[p2l1576t3022r1684b3052],
6	a	DT	O	a	det	10	SENT_88	[p2l1700t3032r1717b3052],
7	wild	JJ	O	wild	amod	10	SENT_88	[p2l1731t3022r1889b3060],
8	—	NN	O	—	nn	10	SENT_88	[p2l1731t3022r1889b3060],
9	type	NN	O	type	nn	10	SENT_88	[p2l1731t3022r1889b3060],
10	allele	NN	O	allele	dobj	5	SENT_88	[p2l546t3072r634b3101],
11	is	VBZ	O	be	auxpass	13	SENT_88	[p2l649t3072r675b3101],
12	concomitantly	RB	O	concomitantly	advmod	13	SENT_88	[p2l691t3072r927b3109],
13	treated	VBN	O	treat	advcl	25	SENT_88	[p2l942t3072r1055b3101],
14	with	IN	O	with	_	0	SENT_88	[p2l1070t3072r1142b3101],
15	a	DT	O	a	det	16	SENT_88	[p2l1158t3081r1175b3101],
16	drug	NN	O	drug	prep_with	13	SENT_88	[p2l1190t3072r1264b3109],
17	that	WDT	O	that	nsubj	18	SENT_88	[p2l1280t3072r1342b3101],
18	inhibits	VBZ	O	inhibit	rcmod	16	SENT_88	[p2l1356t3072r1479b3101],
19	the	DT	O	the	det	20	SENT_88	[p2l1494t3072r1544b3101],
20	enzyme	NN	O	enzyme	dobj	18	SENT_88	[p2l1560t3081r1696b3109],
21	,	,	O	,	_	0	SENT_88	[p2l1560t3081r1696b3109],
22	the	DT	O	the	det	23	SENT_88	[p2l1713t3072r1762b3101],
23	patient	NN	O	patient	nsubj	25	SENT_88	[p2l1777t3072r1890b3109],
24	will	MD	O	will	aux	25	SENT_88	[p2l545t3121r609b3151],
25	show	VB	O	show	_	0	SENT_88	[p2l626t3122r710b3151],
26	a	DT	O	a	det	30	SENT_88	[p2l726t3131r744b3151],
27	phenotype	NN	O	phenotype	nn	30	SENT_88	[p2l758t3122r930b3159],
28	(	RB	O	(	advmod	29	SENT_88	[p2l948t3121r1033b3159],
29	high	JJ	O	high	amod	30	SENT_88	[p2l948t3121r1033b3159],
30	drug	NN	O	drug	iobj	25	SENT_88	[p2l1049t3122r1123b3159],
31	concentration	NN	O	concentration	dobj	25	SENT_88	[p2l1140t3122r1377b3157],
32	)	CD	NUMBER	)	num	31	SENT_88	[p2l1140t3122r1377b3157],
33	like	IN	O	like	_	0	SENT_88	[p2l1394t3121r1454b3151],
34	that	DT	O	that	prep_like	31	SENT_88	[p2l1470t3122r1532b3151],
35	of	IN	O	of	_	0	SENT_88	[p2l1548t3121r1584b3151],
36	patients	NNS	O	patient	prep_of	34	SENT_88	[p2l1596t3121r1724b3159],
37	with	IN	O	with	_	0	SENT_88	[p2l1740t3121r1813b3151],
38	two	CD	NUMBER	two	num	40	SENT_88	[p2l1829t3126r1889b3151],
39	nonfunctional	JJ	O	nonfunctional	amod	40	SENT_88	[p2l545t3171r774b3200],
40	alleles	NNS	O	allele	prep_with	36	SENT_88	[p2l785t3171r888b3200],
41	of	IN	O	of	_	0	SENT_88	[p2l899t3171r935b3200],
42	the	DT	O	the	det	43	SENT_88	[p2l942t3171r991b3200],
43	gene	NN	O	gene	prep_of	40	SENT_88	[p2l1001t3180r1087b3209],
44	,	,	O	,	_	0	SENT_88	[p2l1001t3180r1087b3209],
45	a	DT	O	a	det	46	SENT_88	[p2l1099t3180r1116b3200],
46	phenomenon	NN	O	phenomenon	appos	43	SENT_88	[p2l1124t3171r1338b3209],
47	called	VBN	O	call	partmod	46	SENT_88	[p2l1348t3171r1446b3200],
48	phenocopying	VBG	O	phenocopy	xcomp	47	SENT_88	[p2l1455t3171r1697b3209],
49	.	.	O	.	_	0	SENT_88	[p2l1455t3171r1697b3209],

1	Neglecting	VBG	O	neglect	_	0	SENT_89	[p2l1709t3171r1889b3209],
2	the	DT	O	the	det	3	SENT_89	[p2l545t3221r595b3250],
3	impact	NN	O	impact	dobj	1	SENT_89	[p2l607t3221r720b3258],
4	of	IN	O	of	_	0	SENT_89	[p2l732t3221r768b3250],
5	nongenetic	JJ	O	nongenetic	amod	6	SENT_89	[p2l778t3221r958b3258],
6	factors	NNS	O	factor	prep_of	3	SENT_89	[p2l972t3221r1082b3250],
7	on	IN	O	on	_	0	SENT_89	[p2l1096t3230r1136b3250],
8	a	DT	O	a	det	12	SENT_89	[p2l1149t3230r1166b3250],
9	drug	NN	O	drug	nn	12	SENT_89	[p2l1179t3221r1412b3258],
10	—	NN	O	—	nn	12	SENT_89	[p2l1179t3221r1412b3258],
11	response	NN	O	response	nn	12	SENT_89	[p2l1179t3221r1412b3258],
12	phenotype	NN	O	phenotype	prep_on	1	SENT_89	[p2l1424t3221r1597b3258],
13	has	VBZ	O	have	aux	14	SENT_89	[p2l1609t3221r1663b3250],
14	led	VBN	O	lead	dep	1	SENT_89	[p2l1676t3221r1726b3250],
15	to	TO	O	to	_	0	SENT_89	[p2l1738t3225r1769b3250],
16	claims	NNS	O	claim	prep_to	14	SENT_89	[p2l1782t3221r1889b3250],
17	that	IN	O	that	complm	32	SENT_89	[p2l545t3270r607b3300],
18	the	DT	O	the	det	19	SENT_89	[p2l615t3271r664b3300],
19	presence	NN	O	presence	nsubj	32	SENT_89	[p2l672t3280r817b3308],
20	of	IN	O	of	_	0	SENT_89	[p2l826t3270r862b3300],
21	deﬁcient	JJ	O	deﬁcient	amod	22	SENT_89	[p2l868t3270r1010b3300],
22	alleles	NNS	O	allele	prep_of	19	SENT_89	[p2l1019t3270r1122b3300],
23	of	IN	O	of	_	0	SENT_89	[p2l1132t3270r1168b3300],
24	thiopurine	JJ	O	thiopurine	amod	25	SENT_89	[p2l1174t3270r1343b3308],
25	S-methyltransferase	NN	O	s-methyltransferase	prep_of	22	SENT_89	[p2l1353t3270r1682b3308],
26	(	CD	NUMBER	(	num	28	SENT_89	[p2l1692t3271r1827b3306],
27	TPMT	NN	O	tpmt	nn	28	SENT_89	[p2l1692t3271r1827b3306],
28	)	NN	O	)	dep	25	SENT_89	[p2l1692t3271r1827b3306],
29	is	VBZ	O	be	cop	32	SENT_89	[p2l1837t3270r1863b3300],
30	a	DT	O	a	det	32	SENT_89	[p2l1873t3280r1890b3300],
31	poor	JJ	O	poor	amod	32	SENT_89	[p2l545t3330r621b3358],
32	predictor	NN	O	predictor	ccomp	14	SENT_89	[p2l630t3320r780b3358],
33	of	IN	O	of	_	0	SENT_89	[p2l790t3320r825b3350],
34	severe	JJ	O	severe	amod	35	SENT_89	[p2l834t3330r936b3350],
35	myelosuppression	NN	O	myelosuppression	prep_of	32	SENT_89	[p2l946t3320r1245b3358],
36	caused	VBN	O	cause	partmod	35	SENT_89	[p2l1255t3320r1367b3350],
37	by	IN	O	by	_	0	SENT_89	[p2l1376t3320r1417b3358],
38	the	DT	O	the	det	39	SENT_89	[p2l1428t3320r1477b3350],
39	use	NN	O	use	agent	36	SENT_89	[p2l1487t3330r1541b3350],
40	of	IN	O	of	_	0	SENT_89	[p2l1552t3320r1588b3350],
41	6	CD	NUMBER	6	num	43	SENT_89	[p2l1596t3320r1889b3358],
42	—	NN	O	—	nn	43	SENT_89	[p2l1596t3320r1889b3358],
43	mercaptopurine	NN	O	mercaptopurine	prep_of	39	SENT_89	[p2l1596t3320r1889b3358],
44	or	CC	O	or	_	0	SENT_89	[p2l546t3380r579b3400],
45	azathioprine	NN	O	azathioprine	prep_of	39	SENT_89	[p2l591t3371r794b3408],
46	(	CD	NUMBER	(	num	45	SENT_89	[p2l807t3371r882b3406],
47	13	CD	NUMBER	13	num	48	SENT_89	[p2l807t3371r882b3406],
48	)	NN	O	)	nsubj	1	SENT_89	[p2l807t3371r882b3406],
49	.	.	O	.	_	0	SENT_89	[p2l807t3371r882b3406],

1	Clinical	JJ	O	clinical	amod	2	SENT_90	[p2l595t3420r725b3450],
2	use	NN	O	use	nsubjpass	9	SENT_90	[p2l737t3429r791b3449],
3	of	IN	O	of	_	0	SENT_90	[p2l804t3420r839b3449],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_90	[p2l848t3420r1130b3458],
5	testing	NN	O	testing	prep_of	2	SENT_90	[p2l1143t3420r1252b3458],
6	has	VBZ	O	have	aux	9	SENT_90	[p2l1264t3420r1317b3449],
7	been	VBN	O	be	auxpass	9	SENT_90	[p2l1330t3420r1408b3449],
8	severely	RB	O	severely	advmod	9	SENT_90	[p2l1421t3420r1554b3458],
9	limited	VBN	O	limit	_	0	SENT_90	[p2l1567t3420r1684b3449],
10	by	IN	O	by	_	0	SENT_90	[p2l1694t3420r1735b3458],
11	a	DT	O	a	det	12	SENT_90	[p2l1748t3429r1765b3449],
12	lack	NN	O	lack	agent	9	SENT_90	[p2l1776t3420r1845b3449],
13	of	IN	O	of	_	0	SENT_90	[p2l1856t3420r1892b3449],
14	prospective	JJ	O	prospective	amod	16	SENT_90	[p2l545t3469r734b3507],
15	clinical	JJ	O	clinical	amod	16	SENT_90	[p2l741t3469r862b3498],
16	trials	NNS	O	trial	prep_of	12	SENT_90	[p2l869t3469r960b3498],
17	.	.	O	.	_	0	SENT_90	[p2l869t3469r960b3498],

1	Such	JJ	O	such	amod	2	SENT_91	[p2l970t3469r1051b3498],
2	trials	NNS	O	trial	nsubjpass	4	SENT_91	[p2l1058t3469r1139b3498],
3	are	VBP	O	be	auxpass	4	SENT_91	[p2l1148t3478r1197b3498],
4	required	VBN	O	require	_	0	SENT_91	[p2l1204t3469r1342b3507],
5	to	TO	O	to	aux	6	SENT_91	[p2l1349t3474r1379b3498],
6	establish	VB	O	establish	xcomp	4	SENT_91	[p2l1387t3469r1532b3498],
7	that	DT	O	that	det	8	SENT_91	[p2l1539t3469r1600b3498],
8	pharmaco	NN	O	pharmaco	dobj	6	SENT_91	[p2l1606t3469r1769b3507],
9	genetic	JJ	O	genetic	amod	10	SENT_91	[p2l1771t3469r1889b3507],
10	testing	NN	O	testing	nsubj	11	SENT_91	[p2l545t3518r654b3556],
11	beneﬁts	VBZ	O	beneﬁts	rcmod	8	SENT_91	[p2l668t3518r796b3548],
12	the	DT	O	the	det	13	SENT_91	[p2l811t3518r860b3548],
13	selection	NN	O	selection	dobj	11	SENT_91	[p2l876t3518r1021b3548],
14	of	IN	O	of	_	0	SENT_91	[p2l1035t3518r1071b3548],
15	the	DT	O	the	det	17	SENT_91	[p2l1082t3518r1132b3548],
16	appropriate	JJ	O	appropriate	amod	17	SENT_91	[p2l1147t3518r1334b3556],
17	drug	NN	O	drug	prep_of	13	SENT_91	[p2l1348t3518r1422b3556],
18	and	CC	O	and	_	0	SENT_91	[p2l1437t3518r1496b3548],
19	dose	NN	O	dose	prep_of	13	SENT_91	[p2l1510t3518r1584b3548],
20	for	IN	O	for	_	0	SENT_91	[p2l1598t3518r1647b3548],
21	the	DT	O	the	det	23	SENT_91	[p2l1660t3518r1709b3548],
22	individual	JJ	O	individual	amod	23	SENT_91	[p2l1723t3518r1889b3548],
23	patient	NN	O	patient	prep_for	11	SENT_91	[p2l545t3568r666b3606],
24	,	,	O	,	_	0	SENT_91	[p2l545t3568r666b3606],
25	thereby	RB	O	thereby	advmod	26	SENT_91	[p2l679t3568r802b3606],
26	improving	VBG	O	improve	partmod	11	SENT_91	[p2l814t3568r985b3606],
27	therapeutic	JJ	O	therapeutic	amod	28	SENT_91	[p2l997t3568r1179b3606],
28	responses	NNS	O	response	nsubj	30	SENT_91	[p2l1191t3577r1351b3606],
29	and/or	JJ	O	and/or	dep	30	SENT_91	[p2l1364t3568r1469b3598],
30	reducing	VBG	O	reduce	xcomp	26	SENT_91	[p2l1479t3568r1624b3606],
31	ADRs	NNS	MISC	adr	dobj	30	SENT_91	[p2l1635t3568r1746b3597],
32	.	.	O	.	_	0	SENT_91	[p2l1635t3568r1746b3597],

1	This	DT	O	this	det	2	SENT_92	[p2l595t3617r667b3647],
2	review	NN	O	review	nsubj	19	SENT_92	[p2l678t3617r788b3647],
3	focuses	VBZ	O	focus	_	0	SENT_92	[p2l799t3617r921b3647],
4	on	IN	O	on	_	0	SENT_92	[p2l933t3626r973b3647],
5	the	DT	O	the	det	8	SENT_92	[p2l983t3617r1033b3647],
6	potential	JJ	O	potential	amod	8	SENT_92	[p2l1043t3617r1188b3655],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_92	[p2l1198t3617r1381b3655],
8	consequences	NNS	O	consequence	prep_on	3	SENT_92	[p2l1392t3626r1618b3655],
9	of	IN	O	of	_	0	SENT_92	[p2l1630t3617r1666b3647],
10	inherited	VBN	O	inherit	amod	11	SENT_92	[p2l1674t3617r1820b3647],
11	differences	NNS	O	difference	prep_of	8	SENT_92	[p2l1831t3617r1888b3647, p2l545t3667r681b3696],
12	in	IN	O	in	_	0	SENT_92	[p2l695t3667r726b3696],
13	drug	NN	O	drug	nn	14	SENT_92	[p2l740t3667r814b3705],
14	disposition	NN	O	disposition	prep_in	11	SENT_92	[p2l827t3667r1008b3705],
15	and	CC	O	and	_	0	SENT_92	[p2l1022t3667r1080b3696],
16	drug	NN	O	drug	nn	17	SENT_92	[p2l1093t3667r1167b3705],
17	action	NN	O	action	conj_and	14	SENT_92	[p2l1181t3667r1281b3696],
18	and	CC	O	and	_	0	SENT_92	[p2l1294t3667r1353b3696],
19	illustrates	VBZ	O	illustrate	conj_and	3	SENT_92	[p2l1365t3667r1524b3696],
20	the	DT	O	the	det	21	SENT_92	[p2l1538t3667r1588b3696],
21	potential	NN	O	potential	dobj	19	SENT_92	[p2l1600t3667r1745b3705],
22	of	IN	O	of	_	0	SENT_92	[p2l1758t3667r1794b3696],
23	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	21	SENT_92	[p2l1803t3667r1888b3705, p2l545t3716r769b3754],
24	to	TO	O	to	aux	25	SENT_92	[p2l779t3721r810b3745],
25	improve	VB	O	improve	xcomp	19	SENT_92	[p2l819t3716r955b3754],
26	the	DT	O	the	det	27	SENT_92	[p2l964t3716r1013b3745],
27	beneﬁt	NN	O	beneﬁt	dobj	25	SENT_92	[p2l1022t3716r1209b3746],
28	/	:	O	/	punct	30	SENT_92	[p2l1022t3716r1209b3746],
29	risk	NN	O	risk	nn	30	SENT_92	[p2l1022t3716r1209b3746],
30	ratio	NN	O	ratio	dep	25	SENT_92	[p2l1216t3716r1292b3745],
31	of	IN	O	of	_	0	SENT_92	[p2l1301t3716r1337b3745],
32	drugs	NNS	O	drug	prep_of	30	SENT_92	[p2l1344t3716r1443b3754],
33	.	.	O	.	_	0	SENT_92	[p2l1344t3716r1443b3754],

1	The	DT	O	the	det	3	SENT_93	[p2l1454t3716r1517b3745],
2	best	JJS	O	best	amod	3	SENT_93	[p2l1525t3716r1726b3745],
3	—	NN	O	—	nsubj	13	SENT_93	[p2l1525t3716r1726b3745],
4	studied	VBN	O	study	partmod	3	SENT_93	[p2l1525t3716r1726b3745],
5	examples	NNS	O	example	dobj	4	SENT_93	[p2l1735t3716r1889b3754],
6	of	IN	O	of	_	0	SENT_93	[p2l546t3765r581b3794],
7	genetic	JJ	O	genetic	amod	8	SENT_93	[p2l591t3765r709b3803],
8	polymorphisms	NNS	O	polymorphism	prep_of	5	SENT_93	[p2l720t3765r977b3803],
9	that	WDT	O	that	nsubj	10	SENT_93	[p2l990t3765r1052b3794],
10	alter	VBP	O	alter	rcmod	5	SENT_93	[p2l1064t3765r1136b3794],
11	drug	NN	O	drug	nn	12	SENT_93	[p2l1148t3765r1222b3803],
12	response	NN	O	response	dobj	10	SENT_93	[p2l1234t3774r1378b3803],
13	are	VBP	O	be	_	0	SENT_93	[p2l1391t3774r1440b3794],
14	in	IN	O	in	_	0	SENT_93	[p2l1451t3765r1483b3794],
15	genes	NNS	O	gene	prep_in	13	SENT_93	[p2l1495t3774r1587b3803],
16	that	WDT	O	that	nsubj	17	SENT_93	[p2l1599t3765r1661b3794],
17	encode	VBP	O	encode	rcmod	15	SENT_93	[p2l1673t3765r1789b3794],
18	drugnloaded	VBN	O	drugnload	dep	17	SENT_93	[p2l1801t3765r1888b3803, p3l269t3536r292b3641],

1	from	IN	O	from	_	0	SENT_94	[p3l269t3462r292b3527],
2	www.annualreviews.org	JJ	O	www.annualreviews.org	amod	4	SENT_94	[p3l269t3128r299b3452],
3	metabolizing	VBG	O	metabolize	amod	4	SENT_94	[p3l545t12r761b50],
4	enzymes	NNS	O	enzyme	pobj	1	SENT_94	[p3l776t21r928b50],
5	.	.	O	.	_	0	SENT_94	[p3l776t21r928b50],

1	Less	RBR	O	less	_	0	SENT_95	[p3l945t13r1019b41],
2	extensively	RB	O	extensively	advmod	3	SENT_95	[p3l1035t12r1220b50],
3	studied	VBN	O	study	csubj	6	SENT_95	[p3l1236t12r1354b41],
4	is	VBZ	O	be	cop	6	SENT_95	[p3l1368t12r1394b41],
5	the	DT	O	the	det	6	SENT_95	[p3l1410t12r1459b41],
6	role	NN	O	role	dep	1	SENT_95	[p3l1473t12r1537b41],
7	of	IN	O	of	_	0	SENT_95	[p3l1553t12r1588b41],
8	polymorphism	NN	O	polymorphism	prep_of	6	SENT_95	[p3l1600t12r1842b50],
9	of	IN	O	of	_	0	SENT_95	[p3l1856t12r1892b41],
10	the	DT	O	the	det	11	SENT_95	[p3l545t61r595b90],
11	genes	NNS	O	gene	prep_of	8	SENT_95	[p3l610t70r702b99],
12	encoding	VBG	O	encode	partmod	11	SENT_95	[p3l718t61r869b99],
13	transporters	NNS	O	transporter	dobj	12	SENT_95	[p3l884t66r1088b99],
14	,	,	O	,	_	0	SENT_95	[p3l884t66r1088b99],
15	receptors	NNS	O	receptor	dobj	12	SENT_95	[p3l1103t66r1264b99],
16	,	,	O	,	_	0	SENT_95	[p3l1103t66r1264b99],
17	and	CC	O	and	_	0	SENT_95	[p3l1281t61r1339b90],
18	signaling	NN	O	signaling	nn	19	SENT_95	[p3l1355t61r1505b99],
19	pathways	NNS	O	pathway	dobj	12	SENT_95	[p3l1519t61r1684b99],
20	,	,	O	,	_	0	SENT_95	[p3l1519t61r1684b99],
21	but	CC	O	but	_	0	SENT_95	[p3l1700t61r1752b90],
22	there	EX	O	there	expl	24	SENT_95	[p3l1766t61r1848b90],
23	is	VBZ	O	be	aux	24	SENT_95	[p3l1863t61r1889b90],
24	growing	VBG	O	grow	conj_but	6	SENT_95	[p3l546t110r681b148],
25	evidence	NN	O	evidence	dobj	24	SENT_95	[p3l693t110r838b140],
26	that	IN	O	that	complm	30	SENT_95	[p3l850t110r912b140],
27	these	DT	O	these	det	28	SENT_95	[p3l923t110r1007b140],
28	genes	NNS	O	gene	nsubj	30	SENT_95	[p3l1019t119r1111b148],
29	also	RB	O	also	advmod	30	SENT_95	[p3l1124t110r1188b140],
30	alter	VBP	O	alter	ccomp	24	SENT_95	[p3l1201t110r1274b140],
31	drug	NN	O	drug	nn	32	SENT_95	[p3l1285t110r1359b148],
32	response	NN	O	response	dobj	30	SENT_95	[p3l1371t119r1524b148],
33	.	.	O	.	_	0	SENT_95	[p3l1371t119r1524b148],

1	122	CD	NUMBER	122	num	2	SENT_96	[p3l438t165r497b195],
2	EICHELBAUM	NN	O	eichelbaum	_	0	SENT_96	[p3l585t168r826b195],
3	I	PRP	O	I	nsubj	4	SENT_96	[p3l844t171r861b189],
4	INGELMAN-SUNDBERG	VBP	O	ingelman-sundberg	rcmod	2	SENT_96	[p3l880t168r1292b195],
5	I	PRP	O	I	nsubj	6	SENT_96	[p3l1310t171r1327b189],
6	EVANS	NNS	O	evan	xcomp	4	SENT_96	[p3l1346t168r1463b195],

1	METABOLISM	NN	O	metabolism	_	0	SENT_97	[p3l436t291r746b326],

1	Much	JJ	O	much	amod	2	SENT_98	[p3l535t396r631b425],
2	phase	NN	O	phase	nsubjpass	7	SENT_98	[p3l645t396r739b434],
3	I	PRP	O	I	dep	2	SENT_98	[p3l753t397r766b425],
4	drug	NN	O	drug	nn	5	SENT_98	[p3l780t396r855b434],
5	metabolism	NN	O	metabolism	dep	2	SENT_98	[p3l869t396r1062b425],
6	is	VBZ	O	be	auxpass	7	SENT_98	[p3l1076t396r1102b425],
7	performed	VBN	O	perform	_	0	SENT_98	[p3l1116t396r1289b434],
8	by	IN	O	by	_	0	SENT_98	[p3l1302t396r1343b434],
9	polymorphic	JJ	O	polymorphic	amod	10	SENT_98	[p3l1357t396r1568b434],
10	enzymes	NNS	O	enzyme	agent	7	SENT_98	[p3l1583t405r1736b434],
11	,	,	O	,	_	0	SENT_98	[p3l1583t405r1736b434],
12	particularly	RB	O	particularly	advmod	10	SENT_98	[p3l1751t396r1878b434, p3l536t445r610b483],
13	various	JJ	O	various	amod	14	SENT_98	[p3l625t445r744b474],
14	forms	NNS	O	form	pobj	12	SENT_98	[p3l760t445r855b474],
15	of	IN	O	of	_	0	SENT_98	[p3l871t445r907b474],
16	cytochrome	NN	O	cytochrome	nn	17	SENT_98	[p3l919t445r1113b483],
17	P450	NN	O	p450	prep_of	12	SENT_98	[p3l1127t445r1212b474],
18	(	CD	NUMBER	(	num	19	SENT_98	[p3l1228t445r1333b481],
19	CYP	NN	O	cyp	dep	10	SENT_98	[p3l1228t445r1333b481],
20	)	CD	NUMBER	)	number	21	SENT_98	[p3l1228t445r1333b481],
21	(	CD	NUMBER	(	dep	19	SENT_98	[p3l1350t445r1425b481],
22	14	CD	NUMBER	14	num	23	SENT_98	[p3l1350t445r1425b481],
23	)	NN	O	)	dep	21	SENT_98	[p3l1350t445r1425b481],
24	.	.	O	.	_	0	SENT_98	[p3l1350t445r1425b481],

1	This	DT	O	this	det	2	SENT_99	[p3l1441t445r1513b474],
2	variability	NN	O	variability	nsubj	3	SENT_99	[p3l1529t445r1697b483],
3	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_99	[p3l1712t445r1878b474],
4	the	DT	O	the	det	5	SENT_99	[p3l535t494r585b523],
5	bioavailability	NN	O	bioavailability	dobj	3	SENT_99	[p3l598t494r835b532],
6	of	IN	O	of	_	0	SENT_99	[p3l850t494r885b523],
7	many	JJ	O	many	prep_of	5	SENT_99	[p3l896t503r986b532],
8	of	IN	O	of	_	0	SENT_99	[p3l1001t494r1036b523],
9	the	DT	O	the	det	10	SENT_99	[p3l1047t494r1096b523],
10	drugs	NNS	O	drug	prep_of	7	SENT_99	[p3l1111t494r1200b532],
11	in	IN	O	in	_	0	SENT_99	[p3l1215t494r1246b523],
12	clinical	JJ	O	clinical	amod	13	SENT_99	[p3l1260t494r1380b523],
13	use	NN	O	use	prep_in	10	SENT_99	[p3l1394t503r1456b523],
14	.	.	O	.	_	0	SENT_99	[p3l1394t503r1456b523],

1	The	DT	O	the	det	2	SENT_100	[p3l1472t494r1535b523],
2	inﬂuence	NN	O	inﬂuence	nsubj	16	SENT_100	[p3l1549t494r1700b523],
3	of	IN	O	of	_	0	SENT_100	[p3l1714t494r1750b523],
4	genetic	JJ	O	genetic	amod	5	SENT_100	[p3l1761t494r1879b532],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_100	[p3l535t543r792b581],
6	of	IN	O	of	_	0	SENT_100	[p3l807t543r843b572],
7	drugs	NNS	O	drug	prep_of	5	SENT_100	[p3l855t543r944b581],
8	metabolized	VBN	O	metabolize	partmod	7	SENT_100	[p3l959t543r1161b572],
9	by	IN	O	by	_	0	SENT_100	[p3l1174t543r1215b581],
10	CYP2C9	NN	O	cyp2c9	agent	8	SENT_100	[p3l1230t543r1387b578],
11	,	,	O	,	_	0	SENT_100	[p3l1230t543r1387b578],
12	CYP2C19	NN	O	cyp2c19	conj_and	10	SENT_100	[p3l1403t543r1581b578],
13	,	,	O	,	_	0	SENT_100	[p3l1403t543r1581b578],
14	and	CC	O	and	_	0	SENT_100	[p3l1597t543r1656b572],
15	CYP2D6	NN	O	cyp2d6	conj_and	10	SENT_100	[p3l1670t543r1820b572],
16	indicates	VBZ	O	indicate	_	0	SENT_100	[p3l1834t543r1878b572, p3l536t592r649b622],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_100	[p3l664t592r835b630],
18	penetrance	NN	O	penetrance	dobj	16	SENT_100	[p3l848t597r1027b630],
19	of	IN	O	of	_	0	SENT_100	[p3l1041t592r1076b622],
20	these	DT	O	these	det	21	SENT_100	[p3l1087t592r1171b622],
21	polymorphisms	NNS	O	polymorphism	prep_of	18	SENT_100	[p3l1184t592r1450b630],
22	,	,	O	,	_	0	SENT_100	[p3l1184t592r1450b630],
23	affecting	VBG	O	affect	partmod	16	SENT_100	[p3l1466t592r1610b630],
24	the	DT	O	the	det	25	SENT_100	[p3l1624t592r1673b622],
25	metabolism	NN	O	metabolism	dobj	23	SENT_100	[p3l1687t592r1880b622],
26	of	IN	O	of	_	0	SENT_100	[p3l536t641r572b670],
27	20	CD	PERCENT	20	num	28	SENT_100	[p3l582t641r752b671],
28	%	NN	PERCENT	%	prep_of	25	SENT_100	[p3l582t641r752b671],
29	.	.	O	.	_	0	SENT_100	[p3l582t641r752b671],

1	—	NN	O	—	_	0	SENT_101	[p3l582t641r752b671],
2	.	.	O	.	_	0	SENT_101	[p3l582t641r752b671],

1	30	CD	PERCENT	30	num	2	SENT_102	[p3l582t641r752b671],
2	%	NN	PERCENT	%	nsubj	7	SENT_102	[p3l582t641r752b671],
3	of	IN	O	of	_	0	SENT_102	[p3l767t641r803b670],
4	clinically	RB	O	clinically	advmod	5	SENT_102	[p3l813t641r966b679],
5	used	VBN	O	use	amod	6	SENT_102	[p3l978t641r1054b670],
6	drugs	NNS	O	drug	prep_of	2	SENT_102	[p3l1067t641r1157b679],
7	(	VBP	O	(	_	0	SENT_102	[p3l1172t641r1309b677],
8	15-17	CD	NUMBER	15-17	num	9	SENT_102	[p3l1172t641r1309b677],
9	)	CD	NUMBER	)	dobj	7	SENT_102	[p3l1172t641r1309b677],
10	.	.	O	.	_	0	SENT_102	[p3l1172t641r1309b677],

1	Genetic	JJ	O	genetic	amod	2	SENT_103	[p3l1324t641r1451b671],
2	polymorphism	NN	O	polymorphism	nsubj	18	SENT_103	[p3l1464t641r1706b679],
3	of	IN	O	of	_	0	SENT_103	[p3l1719t641r1755b670],
4	several	JJ	O	several	amod	5	SENT_103	[p3l1766t641r1879b670],
5	phase	NN	O	phase	prep_of	2	SENT_103	[p3l535t690r629b728],
6	II	CD	NUMBER	ii	num	7	SENT_103	[p3l639t691r666b719],
7	enzymes	NNS	O	enzyme	dep	5	SENT_103	[p3l676t699r829b728],
8	,	,	O	,	_	0	SENT_103	[p3l676t699r829b728],
9	including	VBG	O	include	_	0	SENT_103	[p3l841t690r996b728],
10	some	DT	O	some	det	14	SENT_103	[p3l1008t699r1093b719],
11	relevant	JJ	O	relevant	amod	14	SENT_103	[p3l1103t690r1235b719],
12	to	TO	O	to	_	0	SENT_103	[p3l1245t695r1275b719],
13	cancer	NN	O	cancer	prep_to	11	SENT_103	[p3l1286t699r1394b719],
14	chemotherapy	NN	O	chemotherapy	prep_including	2	SENT_103	[p3l1404t690r1643b728],
15	,	,	O	,	_	0	SENT_103	[p3l1404t690r1643b728],
16	is	VBZ	O	be	cop	18	SENT_103	[p3l1655t690r1681b719],
17	also	RB	O	also	advmod	18	SENT_103	[p3l1693t690r1757b719],
18	important	JJ	O	important	_	0	SENT_103	[p3l1768t690r1878b728, p3l536t744r605b769],
19	.	.	O	.	_	0	SENT_103	[p3l1768t690r1878b728, p3l536t744r605b769],

1	Below	IN	O	below	prep	4	SENT_104	[p3l617t739r729b774],
2	,	,	O	,	_	0	SENT_104	[p3l617t739r729b774],
3	we	PRP	O	we	nsubj	4	SENT_104	[p3l741t748r787b769],
4	provide	VBP	O	provide	_	0	SENT_104	[p3l797t739r922b777],
5	several	JJ	O	several	amod	8	SENT_104	[p3l933t739r1047b769],
6	clinically	RB	O	clinically	advmod	7	SENT_104	[p3l1057t739r1210b777],
7	important	JJ	O	important	amod	8	SENT_104	[p3l1219t739r1380b777],
8	examples	NNS	O	example	dobj	4	SENT_104	[p3l1390t739r1544b777],
9	of	IN	O	of	_	0	SENT_104	[p3l1555t739r1591b769],
10	polymorphism	NN	O	polymorphism	prep_of	8	SENT_104	[p3l1597t739r1839b777],
11	in	IN	O	in	_	0	SENT_104	[p3l1848t739r1880b768],
12	metabolizing	VBG	O	metabolize	amod	13	SENT_104	[p3l536t789r751b827],
13	enzymes	NNS	O	enzyme	prep_in	4	SENT_104	[p3l763t798r915b827],
14	.	.	O	.	_	0	SENT_104	[p3l763t798r915b827],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_105	[p3l437t932r607b966],
2	and	CC	O	and	_	0	SENT_105	[p3l621t930r696b966],
3	Warfarin	NNP	O	Warfarin	nn	4	SENT_105	[p3l706t930r889b966],
4	Treatment	NN	O	treatment	conj_and	1	SENT_105	[p3l901t931r1110b966],

1	Warfarin	NNP	MISC	Warfarin	nsubjpass	4	SENT_106	[p3l535t1011r681b1040],
2	is	VBZ	O	be	auxpass	4	SENT_106	[p3l693t1011r719b1040],
3	widely	RB	O	widely	advmod	4	SENT_106	[p3l732t1011r844b1049],
4	used	VBN	O	use	_	0	SENT_106	[p3l856t1011r932b1040],
5	as	IN	O	as	_	0	SENT_106	[p3l945t1020r977b1040],
6	an	DT	O	a	det	8	SENT_106	[p3l991t1020r1029b1040],
7	oral	JJ	O	oral	amod	8	SENT_106	[p3l1042t1011r1105b1040],
8	anticoagulant	NN	O	anticoagulant	prep_as	4	SENT_106	[p3l1118t1011r1348b1049],
9	.	.	O	.	_	0	SENT_106	[p3l1118t1011r1348b1049],

1	Major	JJ	O	major	amod	3	SENT_107	[p3l1363t1011r1464b1049],
2	side	JJ	O	side	amod	3	SENT_107	[p3l1477t1011r1541b1040],
3	effects	NNS	O	effect	nsubj	5	SENT_107	[p3l1555t1011r1662b1040],
4	are	VBP	O	be	aux	5	SENT_107	[p3l1676t1020r1725b1040],
5	bleeding	VBG	O	bleed	_	0	SENT_107	[p3l1737t1011r1879b1049],
6	complications	NNS	O	complication	dobj	5	SENT_107	[p3l536t1061r776b1099],
7	,	,	O	,	_	0	SENT_107	[p3l536t1061r776b1099],
8	whose	WP$	O	whose	dep	15	SENT_107	[p3l787t1061r892b1090],
9	estimated	VBN	O	estimate	csubj	15	SENT_107	[p3l901t1061r1059b1090],
10	average	JJ	O	average	amod	12	SENT_107	[p3l1069t1070r1194b1099],
11	annual	JJ	SET	annual	amod	12	SENT_107	[p3l1204t1061r1313b1090],
12	frequencies	NNS	O	frequency	dobj	9	SENT_107	[p3l1322t1061r1511b1099],
13	are	VBP	O	be	cop	15	SENT_107	[p3l1522t1070r1571b1090],
14	0.6	CD	PERCENT	0.6	num	15	SENT_107	[p3l1580t1061r1664b1090],
15	%	NN	PERCENT	%	dep	6	SENT_107	[p3l1580t1061r1664b1090],
16	(	CD	NUMBER	(	num	18	SENT_107	[p3l1676t1061r1783b1097],
17	fatal	JJ	O	fatal	amod	18	SENT_107	[p3l1676t1061r1783b1097],
18	)	NN	O	)	dep	15	SENT_107	[p3l1676t1061r1783b1097],
19	,	,	O	,	_	0	SENT_107	[p3l1676t1061r1783b1097],
20	3.0	CD	PERCENT	3.0	num	21	SENT_107	[p3l1795t1061r1878b1090],
21	%	NN	PERCENT	%	dep	6	SENT_107	[p3l1795t1061r1878b1090],
22	(	CD	NUMBER	(	num	24	SENT_107	[p3l537t1111r668b1149],
23	major	JJ	O	major	amod	24	SENT_107	[p3l537t1111r668b1149],
24	)	NN	O	)	dep	21	SENT_107	[p3l537t1111r668b1149],
25	,	,	O	,	_	0	SENT_107	[p3l537t1111r668b1149],
26	and	CC	O	and	_	0	SENT_107	[p3l685t1111r743b1140],
27	9.6	CD	PERCENT	9.6	num	28	SENT_107	[p3l758t1111r841b1140],
28	%	NN	PERCENT	%	dep	6	SENT_107	[p3l758t1111r841b1140],
29	(	CD	NUMBER	(	num	31	SENT_107	[p3l859t1111r982b1147],
30	minor	JJ	O	minor	amod	31	SENT_107	[p3l859t1111r982b1147],
31	)	NN	O	)	dep	28	SENT_107	[p3l859t1111r982b1147],
32	(	CD	NUMBER	(	number	33	SENT_107	[p3l999t1111r1074b1147],
33	18	CD	NUMBER	18	num	34	SENT_107	[p3l999t1111r1074b1147],
34	)	NN	O	)	dep	31	SENT_107	[p3l999t1111r1074b1147],
35	.	.	O	.	_	0	SENT_107	[p3l999t1111r1074b1147],

1	In	IN	O	in	_	0	SENT_108	[p3l1091t1112r1124b1140],
2	a	DT	O	a	det	4	SENT_108	[p3l1140t1120r1157b1140],
3	prospective	JJ	O	prospective	amod	4	SENT_108	[p3l1170t1111r1359b1149],
4	study	NN	O	study	prep_in	17	SENT_108	[p3l1375t1111r1469b1149],
5	,	,	O	,	_	0	SENT_108	[p3l1375t1111r1469b1149],
6	the	DT	O	the	det	7	SENT_108	[p3l1485t1111r1534b1140],
7	frequency	NN	O	frequency	nsubj	17	SENT_108	[p3l1549t1111r1713b1149],
8	of	IN	O	of	_	0	SENT_108	[p3l1729t1111r1764b1140],
9	severe	JJ	O	severe	amod	10	SENT_108	[p3l1777t1120r1879b1140],
10	bleeding	NN	O	bleeding	prep_of	7	SENT_108	[p3l535t1161r677b1198],
11	after	IN	O	after	_	0	SENT_108	[p3l688t1161r763b1190],
12	starting	VBG	O	start	prepc_after	10	SENT_108	[p3l774t1161r895b1198],
13	warfarin	NN	O	warfarin	nn	14	SENT_108	[p3l906t1161r1045b1190],
14	therapy	NN	O	therapy	dobj	12	SENT_108	[p3l1055t1161r1177b1198],
15	was	VBD	O	be	cop	17	SENT_108	[p3l1188t1170r1250b1190],
16	3.0	CD	PERCENT	3.0	num	17	SENT_108	[p3l1262t1161r1344b1190],
17	%	NN	PERCENT	%	_	0	SENT_108	[p3l1262t1161r1344b1190],
18	during	IN	O	during	_	0	SENT_108	[p3l1357t1161r1463b1198],
19	the	DT	DATE	the	det	21	SENT_108	[p3l1473t1161r1523b1190],
20	ﬁrst	JJ	DATE	ﬁrst	amod	21	SENT_108	[p3l1534t1161r1597b1190],
21	month	NN	DATE	month	prep_during	17	SENT_108	[p3l1607t1161r1720b1195],
22	,	,	O	,	_	0	SENT_108	[p3l1607t1161r1720b1195],
23	0.8	CD	PERCENT	0.8	num	24	SENT_108	[p3l1732t1161r1816b1190],
24	%	NN	PERCENT	%	conj_and	17	SENT_108	[p3l1732t1161r1816b1190],
25	per	IN	O	per	_	0	SENT_108	[p3l1827t1170r1880b1198],
26	month	NN	DURATION	month	prep_per	24	SENT_108	[p3l536t1211r641b1240],
27	during	IN	O	during	_	0	SENT_108	[p3l655t1211r762b1249],
28	the	DT	O	the	det	29	SENT_108	[p3l776t1211r826b1240],
29	remainder	NN	O	remainder	prep_during	26	SENT_108	[p3l840t1211r1008b1240],
30	of	IN	O	of	_	0	SENT_108	[p3l1022t1211r1058b1240],
31	the	DT	O	the	det	33	SENT_108	[p3l1069t1211r1119b1240],
32	ﬁrst	NN	O	ﬁrst	nn	33	SENT_108	[p3l1134t1211r1198b1240],
33	year	NN	DURATION	year	prep_of	29	SENT_108	[p3l1211t1220r1289b1249],
34	,	,	O	,	_	0	SENT_108	[p3l1211t1220r1289b1249],
35	and	CC	O	and	_	0	SENT_108	[p3l1305t1211r1364b1240],
36	0.3	CD	PERCENT	0.3	num	37	SENT_108	[p3l1378t1211r1461b1240],
37	%	NN	PERCENT	%	conj_and	17	SENT_108	[p3l1378t1211r1461b1240],
38	per	IN	O	per	_	0	SENT_108	[p3l1477t1220r1530b1249],
39	month	NN	DURATION	month	prep_per	37	SENT_108	[p3l1543t1211r1649b1240],
40	after	IN	O	after	_	0	SENT_108	[p3l1664t1211r1738b1240],
41	the	DT	O	the	det	43	SENT_108	[p3l1752t1211r1801b1240],
42	ﬁrst	NN	O	ﬁrst	nn	43	SENT_108	[p3l1816t1211r1880b1240],
43	year	NN	DURATION	year	prep_after	17	SENT_108	[p3l535t1270r607b1298],
44	(	CD	NUMBER	(	number	45	SENT_108	[p3l617t1261r692b1297],
45	19	CD	NUMBER	19	num	46	SENT_108	[p3l617t1261r692b1297],
46	)	NN	O	)	dep	17	SENT_108	[p3l617t1261r692b1297],
47	.	.	O	.	_	0	SENT_108	[p3l617t1261r692b1297],

1	However	RB	O	however	advmod	7	SENT_109	[p3l705t1261r860b1295],
2	,	,	O	,	_	0	SENT_109	[p3l705t1261r860b1295],
3	some	DT	O	some	det	4	SENT_109	[p3l873t1270r958b1290],
4	patients	NNS	O	patient	nsubj	7	SENT_109	[p3l968t1261r1095b1298],
5	are	VBP	O	be	cop	7	SENT_109	[p3l1107t1270r1156b1290],
6	very	RB	O	very	advmod	7	SENT_109	[p3l1166t1270r1238b1298],
7	sensitive	JJ	O	sensitive	_	0	SENT_109	[p3l1250t1261r1390b1290],
8	to	TO	O	to	_	0	SENT_109	[p3l1401t1265r1432b1290],
9	anticoagulant	JJ	O	anticoagulant	amod	10	SENT_109	[p3l1443t1261r1665b1298],
10	effects	NNS	O	effect	prep_to	7	SENT_109	[p3l1675t1261r1792b1295],
11	,	,	O	,	_	0	SENT_109	[p3l1675t1261r1792b1295],
12	even	RB	O	even	advmod	7	SENT_109	[p3l1804t1270r1879b1290],
13	at	IN	O	at	_	0	SENT_109	[p3l536t1315r565b1340],
14	a	DT	O	a	det	17	SENT_109	[p3l577t1320r594b1340],
15	very	RB	O	very	advmod	16	SENT_109	[p3l605t1320r676b1348],
16	low	JJ	O	low	amod	17	SENT_109	[p3l688t1311r748b1340],
17	dose	NN	O	dose	prep_at	7	SENT_109	[p3l760t1311r835b1340],
18	of	IN	O	of	_	0	SENT_109	[p3l847t1311r883b1340],
19	warfarin	NN	O	warfarin	prep_of	17	SENT_109	[p3l891t1311r1038b1340],
20	.	.	O	.	_	0	SENT_109	[p3l891t1311r1038b1340],

1	Because	IN	O	because	mark	6	SENT_110	[p3l585t1361r722b1390],
2	required	VBN	O	require	amod	3	SENT_110	[p3l731t1360r869b1398],
3	dosages	NNS	O	dosage	nsubj	6	SENT_110	[p3l879t1361r1008b1398],
4	of	IN	O	of	_	0	SENT_110	[p3l1018t1360r1054b1390],
5	warfarin	NN	O	warfarin	prep_of	3	SENT_110	[p3l1061t1360r1199b1390],
6	vary	VBP	O	vary	advcl	26	SENT_110	[p3l1208t1370r1280b1398],
7	markedly	RB	O	markedly	advmod	6	SENT_110	[p3l1289t1360r1444b1398],
8	(	VBN	O	(	dep	7	SENT_110	[p3l1455t1361r1508b1398],
9	up	RP	O	up	prt	8	SENT_110	[p3l1455t1361r1508b1398],
10	to	TO	O	to	_	0	SENT_110	[p3l1517t1365r1548b1390],
11	tenfold	RB	O	tenfold	advmod	12	SENT_110	[p3l1558t1360r1687b1396],
12	)	CD	NUMBER	)	prep_to	8	SENT_110	[p3l1558t1360r1687b1396],
13	and	CC	O	and	_	0	SENT_110	[p3l1698t1361r1756b1390],
14	anticoagulative	JJ	O	anticoagulative	amod	15	SENT_110	[p3l1766t1360r1878b1390, p3l536t1410r685b1448],
15	responses	NNS	O	response	nsubj	18	SENT_110	[p3l695t1420r855b1448],
16	to	TO	O	to	_	0	SENT_110	[p3l867t1415r897b1440],
17	warfarin	NN	O	warfarin	prep_to	15	SENT_110	[p3l909t1410r1047b1440],
18	vary	VBP	O	vary	conj_and	6	SENT_110	[p3l1058t1420r1129b1448],
19	unpredictably	RB	O	unpredictably	advmod	18	SENT_110	[p3l1140t1410r1367b1448],
20	among	IN	O	among	_	0	SENT_110	[p3l1379t1420r1490b1448],
21	individuals	NNS	O	individual	prep_among	18	SENT_110	[p3l1501t1410r1692b1445],
22	,	,	O	,	_	0	SENT_110	[p3l1501t1410r1692b1445],
23	it	PRP	O	it	nsubjpass	26	SENT_110	[p3l1704t1410r1727b1440],
24	has	VBZ	O	have	aux	26	SENT_110	[p3l1737t1410r1790b1440],
25	been	VBN	O	be	auxpass	26	SENT_110	[p3l1802t1410r1880b1440],
26	suggested	VBN	O	suggest	_	0	SENT_110	[p3l537t1460r698b1498],
27	that	IN	O	that	complm	45	SENT_110	[p3l707t1460r769b1489],
28	patients	NNS	O	patient	nsubj	45	SENT_110	[p3l776t1460r904b1498],
29	who	WP	O	who	nsubj	30	SENT_110	[p3l913t1460r983b1490],
30	carry	VBP	O	carry	rcmod	28	SENT_110	[p3l992t1470r1076b1498],
31	the	DT	O	the	det	32	SENT_110	[p3l1085t1460r1134b1489],
32	*	NN	O	*	dobj	30	SENT_110	[p3l1144t1460r1180b1489],
33	2	CD	NUMBER	2	dep	32	SENT_110	[p3l1144t1460r1180b1489],
34	and	CC	O	and	_	0	SENT_110	[p3l1189t1460r1248b1489],
35	*	CD	NUMBER	*	number	36	SENT_110	[p3l1257t1460r1291b1490],
36	3	CD	NUMBER	3	num	37	SENT_110	[p3l1257t1460r1291b1490],
37	alleles	NNS	O	allele	conj_and	32	SENT_110	[p3l1302t1460r1406b1489],
38	of	IN	O	of	_	0	SENT_110	[p3l1416t1460r1451b1489],
39	polymorphic	JJ	O	polymorphic	amod	42	SENT_110	[p3l1457t1460r1668b1498],
40	C	NN	O	c	nn	42	SENT_110	[p3l1679t1461r1705b1490],
41	YP2	NN	O	yp2	nn	42	SENT_110	[p3l1707t1461r1772b1489],
42	C9	NN	O	c9	prep_of	37	SENT_110	[p3l1776t1461r1822b1490],
43	are	VBP	O	be	cop	45	SENT_110	[p3l1831t1469r1879b1489],
44	more	RBR	O	more	advmod	45	SENT_110	[p3l535t1519r620b1539],
45	susceptible	JJ	O	susceptible	ccomp	26	SENT_110	[p3l632t1510r813b1548],
46	to	TO	O	to	_	0	SENT_110	[p3l824t1515r855b1539],
47	bleeding	VBG	O	bleed	amod	48	SENT_110	[p3l865t1510r1007b1548],
48	complications	NNS	O	complication	prep_to	45	SENT_110	[p3l1019t1510r1249b1548],
49	with	IN	O	with	_	0	SENT_110	[p3l1261t1510r1333b1539],
50	warfarin	NN	O	warfarin	nn	51	SENT_110	[p3l1344t1510r1483b1539],
51	treatment	NN	O	treatment	prep_with	48	SENT_110	[p3l1493t1515r1657b1539],
52	.	.	O	.	_	0	SENT_110	[p3l1493t1515r1657b1539],

1	Warfarin	NNP	O	Warfarin	nsubj	4	SENT_111	[p3l1669t1510r1815b1539],
2	is	VBZ	O	be	cop	4	SENT_111	[p3l1825t1510r1851b1539],
3	a	DT	O	a	det	4	SENT_111	[p3l1863t1519r1880b1539],
4	racemate	NN	O	racemate	_	0	SENT_111	[p3l535t1565r693b1594],
5	,	,	O	,	_	0	SENT_111	[p3l535t1565r693b1594],
6	and	CC	O	and	_	0	SENT_111	[p3l703t1560r762b1589],
7	its	PRP$	O	its	poss	10	SENT_111	[p3l769t1560r807b1589],
8	S	NN	O	s	nn	10	SENT_111	[p3l816t1560r1039b1589],
9	—	CD	NUMBER	—	num	10	SENT_111	[p3l816t1560r1039b1589],
10	enantiomer	NN	O	enantiomer	nsubj	15	SENT_111	[p3l816t1560r1039b1589],
11	is	VBZ	O	be	cop	15	SENT_111	[p3l1046t1560r1072b1589],
12	ﬁve	JJ	O	ﬁve	amod	13	SENT_111	[p3l1081t1560r1141b1589],
13	times	NNS	O	time	dep	15	SENT_111	[p3l1149t1560r1237b1589],
14	more	RBR	O	more	advmod	15	SENT_111	[p3l1246t1569r1330b1589],
15	potent	JJ	O	potent	conj_and	4	SENT_111	[p3l1337t1565r1441b1598],
16	than	IN	O	than	_	0	SENT_111	[p3l1448t1560r1519b1589],
17	its	PRP$	O	its	poss	20	SENT_111	[p3l1527t1560r1564b1589],
18	R	NN	O	r	nn	20	SENT_111	[p3l1573t1560r1806b1589],
19	—	CD	NUMBER	—	num	20	SENT_111	[p3l1573t1560r1806b1589],
20	enantiomer	NN	O	enantiomer	prep_than	15	SENT_111	[p3l1573t1560r1806b1589],
21	.	.	O	.	_	0	SENT_111	[p3l1573t1560r1806b1589],

1	The	DT	O	the	det	4	SENT_112	[p3l1816t1560r1879b1589],
2	S	NN	O	s	nn	4	SENT_112	[p3l537t1610r759b1639],
3	—	NN	O	—	nn	4	SENT_112	[p3l537t1610r759b1639],
4	enantiomer	NN	O	enantiomer	nsubjpass	7	SENT_112	[p3l537t1610r759b1639],
5	is	VBZ	O	be	auxpass	7	SENT_112	[p3l766t1610r792b1639],
6	mostly	RB	O	mostly	advmod	7	SENT_112	[p3l800t1610r912b1648],
7	metabolized	VBN	O	metabolize	_	0	SENT_112	[p3l920t1610r1122b1639],
8	by	IN	O	by	_	0	SENT_112	[p3l1129t1610r1170b1648],
9	CYP2C9	NN	O	cyp2c9	agent	7	SENT_112	[p3l1178t1610r1326b1640],
10	to	TO	O	to	_	0	SENT_112	[p3l1335t1614r1365b1639],
11	the	DT	O	the	det	16	SENT_112	[p3l1374t1610r1423b1639],
12	inactive	JJ	O	inactive	amod	16	SENT_112	[p3l1431t1610r1560b1639],
13	7-hydroxywarfarin	JJ	O	7-hydroxywarfarin	amod	16	SENT_112	[p3l1568t1610r1879b1648],
14	(	NN	O	(	nn	16	SENT_112	[p3l537t1660r613b1696],
15	20	CD	NUMBER	20	num	16	SENT_112	[p3l537t1660r613b1696],
16	)	NN	O	)	prep_to	7	SENT_112	[p3l537t1660r613b1696],
17	;	:	O	;	_	0	SENT_112	[p3l537t1660r613b1696],
18	any	DT	O	any	det	19	SENT_112	[p3l626t1669r683b1698],
19	change	NN	O	change	nsubj	26	SENT_112	[p3l693t1660r809b1698],
20	in	IN	O	in	_	0	SENT_112	[p3l819t1660r850b1689],
21	the	DT	O	the	det	22	SENT_112	[p3l860t1660r909b1689],
22	activity	NN	O	activity	prep_in	19	SENT_112	[p3l920t1660r1041b1698],
23	of	IN	O	of	_	0	SENT_112	[p3l1052t1660r1088b1689],
24	CYP2C9	NN	O	cyp2c9	prep_of	22	SENT_112	[p3l1095t1660r1243b1689],
25	is	VBZ	O	be	cop	26	SENT_112	[p3l1254t1660r1279b1689],
26	likely	JJ	O	likely	parataxis	7	SENT_112	[p3l1290t1660r1383b1698],
27	to	TO	O	to	aux	28	SENT_112	[p3l1393t1664r1424b1689],
28	have	VB	O	have	xcomp	26	SENT_112	[p3l1434t1660r1509b1689],
29	a	DT	O	a	det	31	SENT_112	[p3l1520t1669r1538b1689],
30	signiﬁcant	JJ	O	signiﬁcant	amod	31	SENT_112	[p3l1548t1660r1719b1698],
31	inﬂuence	NN	O	inﬂuence	dobj	28	SENT_112	[p3l1728t1660r1879b1689],
32	on	IN	O	on	_	0	SENT_112	[p3l536t1718r576b1739],
33	the	DT	O	the	det	35	SENT_112	[p3l588t1709r637b1739],
34	anticoagulative	JJ	O	anticoagulative	amod	35	SENT_112	[p3l649t1709r899b1747],
35	response	NN	O	response	prep_on	31	SENT_112	[p3l910t1718r1063b1747],
36	.	.	O	.	_	0	SENT_112	[p3l910t1718r1063b1747],

1	Several	JJ	O	several	amod	3	SENT_113	[p3l586t1759r707b1789],
2	clinical	JJ	O	clinical	amod	3	SENT_113	[p3l722t1759r842b1789],
3	studies	NNS	O	study	nsubj	5	SENT_113	[p3l858t1759r970b1789],
4	have	VBP	O	have	aux	5	SENT_113	[p3l985t1759r1061b1789],
5	investigated	VBN	O	investigate	_	0	SENT_113	[p3l1075t1759r1273b1797],
6	the	DT	O	the	det	7	SENT_113	[p3l1287t1759r1336b1789],
7	inﬂuence	NN	O	inﬂuence	dobj	5	SENT_113	[p3l1351t1759r1501b1789],
8	of	IN	O	of	_	0	SENT_113	[p3l1517t1759r1552b1789],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_113	[p3l1564t1760r1712b1789],
10	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_113	[p3l1726t1760r1878b1797, p3l535t1809r651b1847],
11	on	IN	O	on	_	0	SENT_113	[p3l667t1819r707b1839],
12	warfarin	NN	O	warfarin	nn	15	SENT_113	[p3l721t1809r860b1839],
13	sensitivity	NN	O	sensitivity	nn	15	SENT_113	[p3l875t1809r1042b1847],
14	and/or	NN	O	and/or	nn	15	SENT_113	[p3l1058t1809r1163b1839],
15	risk	NN	O	risk	prep_on	5	SENT_113	[p3l1176t1809r1238b1839],
16	of	IN	O	of	_	0	SENT_113	[p3l1252t1809r1288b1839],
17	overanticoagulation	NN	O	overanticoagulation	prep_of	15	SENT_113	[p3l1300t1809r1627b1847],
18	after	IN	O	after	_	0	SENT_113	[p3l1642t1809r1717b1839],
19	initiation	NN	O	initiation	prep_after	5	SENT_113	[p3l1731t1809r1879b1839],
20	of	IN	O	of	_	0	SENT_113	[p3l536t1860r572b1890],
21	therapy	NN	O	therapy	nn	25	SENT_113	[p3l583t1860r705b1898],
22	or	CC	O	or	_	0	SENT_113	[p3l720t1869r754b1890],
23	long	JJ	O	long	nn	25	SENT_113	[p3l767t1860r930b1898],
24	—	NN	O	—	nn	25	SENT_113	[p3l767t1860r930b1898],
25	term	NN	O	term	prep_of	19	SENT_113	[p3l767t1860r930b1898],
26	treatment	NN	O	treatment	dep	19	SENT_113	[p3l943t1865r1099b1890],
27	(	CD	NUMBER	(	num	26	SENT_113	[p3l1113t1860r1194b1898],
28	e.g.	FW	O	e.g.	dep	26	SENT_113	[p3l1113t1860r1194b1898],
29	,	,	O	,	_	0	SENT_113	[p3l1113t1860r1194b1898],
30	21-26	CD	NUMBER	21-26	num	31	SENT_113	[p3l1209t1860r1333b1896],
31	)	NN	O	)	appos	19	SENT_113	[p3l1209t1860r1333b1896],
32	.	.	O	.	_	0	SENT_113	[p3l1209t1860r1333b1896],

1	Despite	IN	O	despite	_	0	SENT_114	[p3l1349t1860r1475b1898],
2	different	JJ	O	different	amod	4	SENT_114	[p3l1489t1860r1630b1890],
3	study	NN	O	study	nn	4	SENT_114	[p3l1644t1860r1732b1898],
4	designs	NNS	O	design	prep_despite	9	SENT_114	[p3l1746t1860r1878b1898],
5	,	,	O	,	_	0	SENT_114	[p3l1746t1860r1878b1898],
6	the	DT	O	the	det	7	SENT_114	[p3l535t1910r585b1939],
7	data	NNS	O	datum	nsubj	9	SENT_114	[p3l598t1910r666b1939],
8	clearly	RB	O	clearly	advmod	9	SENT_114	[p3l678t1910r789b1948],
9	indicate	VBP	O	indicate	_	0	SENT_114	[p3l802t1910r932b1939],
10	that	IN	O	that	complm	20	SENT_114	[p3l945t1910r1007b1939],
11	patients	NNS	O	patient	nsubj	20	SENT_114	[p3l1018t1910r1146b1948],
12	carrying	VBG	O	carry	partmod	11	SENT_114	[p3l1159t1910r1296b1948],
13	at	IN	O	at	quantmod	15	SENT_114	[p3l1309t1914r1338b1939],
14	least	JJS	O	least	mwe	13	SENT_114	[p3l1350t1910r1425b1939],
15	one	CD	NUMBER	one	num	16	SENT_114	[p3l1438t1919r1496b1939],
16	variant	NN	O	variant	dobj	12	SENT_114	[p3l1509t1910r1622b1939],
17	C	NN	O	c	prep	16	SENT_114	[p3l1636t1910r1662b1940],
18	YPZC9	NN	O	ypzc9	nn	19	SENT_114	[p3l1664t1910r1779b1940],
19	allele	NN	O	allele	dep	17	SENT_114	[p3l1791t1910r1879b1939],
20	require	VBP	O	require	ccomp	9	SENT_114	[p3l535t1959r652b1997],
21	lower	JJR	O	lower	amod	23	SENT_114	[p3l664t1959r757b1988],
22	maintenance	NN	O	maintenance	nn	23	SENT_114	[p3l767t1959r976b1988],
23	doses	NNS	O	dose	dobj	20	SENT_114	[p3l988t1959r1078b1988],
24	and	CC	O	and	_	0	SENT_114	[p3l1091t1959r1150b1988],
25	have	VBP	O	have	ccomp	9	SENT_114	[p3l1160t1959r1236b1988],
26	a	DT	O	a	det	29	SENT_114	[p3l1249t1968r1266b1988],
27	signiﬁcantly	RB	O	signiﬁcantly	advmod	28	SENT_114	[p3l1279t1959r1481b1997],
28	higher	JJR	O	higher	amod	29	SENT_114	[p3l1492t1959r1599b1997],
29	risk	NN	O	risk	dobj	25	SENT_114	[p3l1609t1959r1671b1988],
30	of	IN	O	of	_	0	SENT_114	[p3l1683t1959r1718b1988],
31	bleeding	NN	O	bleeding	prep_of	29	SENT_114	[p3l1726t1959r1877b1997],
32	.	.	O	.	_	0	SENT_114	[p3l1726t1959r1877b1997],

1	A	DT	O	a	det	6	SENT_115	[p3l535t2008r565b2037],
2	landmark	NN	O	landmark	nn	6	SENT_115	[p3l575t2008r731b2037],
3	study	NN	O	study	nn	6	SENT_115	[p3l742t2008r829b2046],
4	(	CD	NUMBER	(	number	5	SENT_115	[p3l841t2008r906b2044],
5	22	CD	NUMBER	22	num	6	SENT_115	[p3l841t2008r906b2044],
6	)	NN	O	)	_	0	SENT_115	[p3l841t2008r906b2044],
7	compared	VBN	O	compare	prep	6	SENT_115	[p3l918t2008r1081b2046],
8	frequencies	NNS	O	frequency	dep	7	SENT_115	[p3l1090t2008r1280b2046],
9	of	IN	O	of	_	0	SENT_115	[p3l1291t2008r1327b2037],
10	C	NN	O	c	prep_of	8	SENT_115	[p3l1336t2009r1363b2038],
11	YP2C9	NN	O	yp2c9	nn	12	SENT_115	[p3l1365t2008r1479b2038],
12	polymorphisms	NNS	O	polymorphism	dep	6	SENT_115	[p3l1488t2008r1745b2046],
13	in	IN	O	in	_	0	SENT_115	[p3l1756t2008r1787b2037],
14	three	CD	NUMBER	three	num	15	SENT_115	[p3l1797t2008r1879b2037],
15	groups	NNS	O	group	prep_in	12	SENT_115	[p3l536t2067r646b2096],
16	on	IN	O	on	_	0	SENT_115	[p3l657t2067r697b2087],
17	warfarin	NN	O	warfarin	prep_on	15	SENT_115	[p3l707t2058r854b2087],
18	:	:	O	:	_	0	SENT_115	[p3l707t2058r854b2087],
19	an	DT	O	a	det	22	SENT_115	[p3l866t2067r904b2087],
20	anticoagulation	JJ	O	anticoagulation	amod	22	SENT_115	[p3l914t2058r1168b2096],
21	clinic	NN	O	clinic	nn	22	SENT_115	[p3l1177t2058r1377b2087],
22	—	NN	O	—	dep	6	SENT_115	[p3l1177t2058r1377b2087],
23	based	VBN	O	base	partmod	22	SENT_115	[p3l1177t2058r1377b2087],
24	group	NN	O	group	dobj	23	SENT_115	[p3l1386t2067r1481b2096],
25	requiring	VBG	O	require	xcomp	23	SENT_115	[p3l1490t2058r1641b2096],
26	low	JJ	O	low	amod	27	SENT_115	[p3l1651t2058r1710b2087],
27	doses	NNS	O	dose	dobj	25	SENT_115	[p3l1721t2058r1810b2087],
28	and	CC	O	and	_	0	SENT_115	[p3l1821t2058r1880b2087],
29	two	CD	NUMBER	two	num	31	SENT_115	[p3l536t2112r596b2136],
30	control	NN	O	control	nn	31	SENT_115	[p3l608t2107r724b2136],
31	groups	NNS	O	group	conj_and	12	SENT_115	[p3l735t2116r846b2145],
32	receiving	VBG	O	receive	partmod	31	SENT_115	[p3l857t2107r1010b2145],
33	a	DT	O	a	det	35	SENT_115	[p3l1022t2116r1039b2136],
34	wide	JJ	O	wide	amod	35	SENT_115	[p3l1050t2107r1129b2136],
35	range	NN	O	range	dobj	32	SENT_115	[p3l1140t2116r1231b2145],
36	of	IN	O	of	_	0	SENT_115	[p3l1243t2107r1279b2136],
37	dosages	NNS	O	dosage	prep_of	35	SENT_115	[p3l1287t2107r1425b2145],
38	.	.	O	.	_	0	SENT_115	[p3l1287t2107r1425b2145],

1	The	DT	O	the	det	2	SENT_116	[p3l1439t2107r1502b2136],
2	frequency	NN	O	frequency	nsubj	7	SENT_116	[p3l1513t2107r1677b2145],
3	of	IN	O	of	_	0	SENT_116	[p3l1689t2107r1725b2136],
4	homozygotes	NNS	O	homozygote	nn	6	SENT_116	[p3l1733t2107r1878b2145, p3l536t2161r621b2194],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_116	[p3l632t2156r868b2186],
6	*	NN	O	*	prep_of	2	SENT_116	[p3l632t2156r868b2186],
7	2	CD	NUMBER	2	_	0	SENT_116	[p3l632t2156r868b2186],
8	/	:	O	/	punct	13	SENT_116	[p3l632t2156r868b2186],
9	*	CD	NUMBER	*	number	13	SENT_116	[p3l632t2156r868b2186],
10	2	CD	NUMBER	2	number	13	SENT_116	[p3l632t2156r868b2186],
11	and	CC	O	and	_	0	SENT_116	[p3l879t2157r937b2186],
12	*	CD	NUMBER	*	dep	7	SENT_116	[p3l948t2156r1031b2186],
13	3	CD	NUMBER	3	dep	7	SENT_116	[p3l948t2156r1031b2186],
14	/	:	O	/	punct	13	SENT_116	[p3l948t2156r1031b2186],
15	*	CD	NUMBER	*	number	16	SENT_116	[p3l948t2156r1031b2186],
16	3	CD	NUMBER	3	nsubj	19	SENT_116	[p3l948t2156r1031b2186],
17	was	VBD	O	be	cop	19	SENT_116	[p3l1043t2166r1105b2186],
18	0.7	CD	PERCENT	0.7	num	19	SENT_116	[p3l1116t2157r1200b2186],
19	%	NN	PERCENT	%	rcmod	7	SENT_116	[p3l1116t2157r1200b2186],
20	in	IN	O	in	_	0	SENT_116	[p3l1211t2156r1243b2185],
21	the	DT	O	the	det	24	SENT_116	[p3l1253t2156r1302b2186],
22	combined	JJ	O	combined	amod	24	SENT_116	[p3l1313t2156r1475b2186],
23	control	NN	O	control	nn	24	SENT_116	[p3l1485t2156r1601b2186],
24	groups	NNS	O	group	prep_in	19	SENT_116	[p3l1612t2166r1722b2194],
25	but	CC	O	but	_	0	SENT_116	[p3l1732t2156r1785b2186],
26	5.6	CD	PERCENT	5.6	num	27	SENT_116	[p3l1795t2156r1878b2186],
27	%	NN	PERCENT	%	rcmod	7	SENT_116	[p3l1795t2156r1878b2186],
28	(	CD	NUMBER	(	npadvmod	29	SENT_116	[p3l537t2205r622b2243],
29	only	RB	O	only	advmod	30	SENT_116	[p3l537t2205r622b2243],
30	*	NN	O	*	rcmod	27	SENT_116	[p3l639t2205r737b2241],
31	2	CD	NUMBER	2	num	30	SENT_116	[p3l639t2205r737b2241],
32	/	:	O	/	punct	35	SENT_116	[p3l639t2205r737b2241],
33	*	CD	NUMBER	*	number	34	SENT_116	[p3l639t2205r737b2241],
34	2	CD	NUMBER	2	num	35	SENT_116	[p3l639t2205r737b2241],
35	)	NN	O	)	dep	7	SENT_116	[p3l639t2205r737b2241],
36	in	IN	O	in	_	0	SENT_116	[p3l755t2205r786b2234],
37	the	DT	O	the	det	39	SENT_116	[p3l803t2205r852b2234],
38	low-dose	JJ	O	low-dose	amod	39	SENT_116	[p3l869t2205r1019b2234],
39	group	NN	O	group	prep_in	35	SENT_116	[p3l1036t2214r1139b2243],
40	.	.	O	.	_	0	SENT_116	[p3l1036t2214r1139b2243],

1	Compared	VBN	O	compare	_	0	SENT_117	[p3l1158t2205r1330b2243],
2	with	IN	O	with	prepc_compared_with	21	SENT_117	[p3l1346t2205r1419b2234],
3	controls	NNS	O	control	pobj	21	SENT_117	[p3l1436t2205r1577b2239],
4	,	,	O	,	_	0	SENT_117	[p3l1436t2205r1577b2239],
5	the	DT	O	the	det	7	SENT_117	[p3l1595t2205r1644b2234],
6	odds	NNS	O	odds	nn	7	SENT_117	[p3l1661t2205r1737b2234],
7	ratio	NN	O	ratio	nsubj	21	SENT_117	[p3l1754t2205r1829b2234],
8	of	IN	O	of	_	0	SENT_117	[p3l1846t2205r1882b2234],
9	heterozygosity	NN	O	heterozygosity	prep_of	7	SENT_117	[p3l535t2254r779b2292],
10	for	IN	O	for	_	0	SENT_117	[p3l789t2254r837b2284],
11	*	NN	O	*	prep_for	9	SENT_117	[p3l846t2254r882b2283],
12	2	CD	NUMBER	2	number	15	SENT_117	[p3l846t2254r882b2283],
13	or	CC	O	or	_	0	SENT_117	[p3l892t2264r926b2284],
14	*	CD	NUMBER	*	conj_or	15	SENT_117	[p3l936t2254r970b2284],
15	3	CD	NUMBER	3	num	11	SENT_117	[p3l936t2254r970b2284],
16	was	VBD	O	be	cop	21	SENT_117	[p3l982t2264r1044b2284],
17	2.68	CD	PERCENT	2.68	num	21	SENT_117	[p3l1055t2254r1124b2284],
18	(	CD	PERCENT	(	number	19	SENT_117	[p3l1137t2254r1222b2290],
19	95	CD	PERCENT	95	dep	20	SENT_117	[p3l1137t2254r1222b2290],
20	%	NN	PERCENT	%	dep	21	SENT_117	[p3l1137t2254r1222b2290],
21	CI	NN	O	ci	_	0	SENT_117	[p3l1234t2255r1283b2289],
22	,	,	O	,	_	0	SENT_117	[p3l1234t2255r1283b2289],
23	1.22-5	CD	NUMBER	1.22-5	number	24	SENT_117	[p3l1298t2254r1472b2290],
24	.86	CD	NUMBER	.86	num	25	SENT_117	[p3l1298t2254r1472b2290],
25	)	NN	O	)	conj_and	21	SENT_117	[p3l1298t2254r1472b2290],
26	and	CC	O	and	_	0	SENT_117	[p3l1484t2254r1542b2284],
27	the	DT	O	the	det	29	SENT_117	[p3l1551t2255r1601b2284],
28	odds	NNS	O	odds	nn	29	SENT_117	[p3l1611t2254r1687b2284],
29	ratio	NN	O	ratio	conj_and	21	SENT_117	[p3l1697t2254r1772b2284],
30	of	IN	O	of	_	0	SENT_117	[p3l1783t2254r1818b2284],
31	homozygosity	NN	O	homozygosity	prep_of	29	SENT_117	[p3l1825t2255r1878b2284, p3l535t2303r728b2341],
32	for	IN	O	for	_	0	SENT_117	[p3l739t2303r787b2332],
33	*	NN	O	*	prep_for	31	SENT_117	[p3l798t2303r834b2332],
34	2	CD	NUMBER	2	num	33	SENT_117	[p3l798t2303r834b2332],
35	or	CC	O	or	_	0	SENT_117	[p3l845t2313r879b2332],
36	*	CD	NUMBER	*	number	37	SENT_117	[p3l890t2303r924b2333],
37	3	CD	NUMBER	3	conj_or	21	SENT_117	[p3l890t2303r924b2333],
38	was	VBD	O	be	cop	43	SENT_117	[p3l937t2313r999b2332],
39	7.8	CD	PERCENT	7.8	num	43	SENT_117	[p3l1011t2304r1060b2333],
40	(	CD	PERCENT	(	number	41	SENT_117	[p3l1074t2303r1125b2339],
41	95	CD	PERCENT	95	dep	42	SENT_117	[p3l1074t2303r1125b2339],
42	%	NN	PERCENT	%	dep	43	SENT_117	[p3l1130t2303r1160b2333],
43	CI	NN	O	ci	rcmod	37	SENT_117	[p3l1173t2303r1221b2338],
44	,	,	O	,	_	0	SENT_117	[p3l1173t2303r1221b2338],
45	l.	NN	O	l.	appos	43	SENT_117	[p3l1238t2304r1421b2339],
46	90	CD	NUMBER	90	num	45	SENT_117	[p3l1238t2304r1421b2339],
47	—	CD	NUMBER	—	number	48	SENT_117	[p3l1238t2304r1421b2339],
48	32	CD	NUMBER	32	dep	45	SENT_117	[p3l1238t2304r1421b2339],
49	.	.	O	.	_	0	SENT_117	[p3l1238t2304r1421b2339],

1	l	NN	O	l	_	0	SENT_118	[p3l1238t2304r1421b2339],
2	)	NN	O	)	dep	1	SENT_118	[p3l1238t2304r1421b2339],
3	.	.	O	.	_	0	SENT_118	[p3l1238t2304r1421b2339],

1	The	DT	O	the	det	2	SENT_119	[p3l1434t2303r1497b2332],
2	rate	NN	O	rate	nsubj	12	SENT_119	[p3l1508t2308r1569b2332],
3	of	IN	O	of	_	0	SENT_119	[p3l1581t2303r1616b2332],
4	life-threatening	JJ	O	life-threatening	amod	5	SENT_119	[p3l1625t2303r1879b2341],
5	bleeding	NN	O	bleeding	prep_of	2	SENT_119	[p3l535t2352r677b2390],
6	in	IN	O	in	_	0	SENT_119	[p3l689t2352r721b2381],
7	the	DT	O	the	det	9	SENT_119	[p3l733t2352r782b2381],
8	low-dose	JJ	O	low-dose	amod	9	SENT_119	[p3l795t2352r945b2381],
9	group	NN	O	group	prep_in	5	SENT_119	[p3l957t2361r1052b2390],
10	was	VBD	O	be	cop	12	SENT_119	[p3l1065t2361r1127b2381],
11	3.7	CD	NUMBER	3.7	num	12	SENT_119	[p3l1141t2352r1189b2381],
12	times	NNS	O	time	_	0	SENT_119	[p3l1203t2352r1291b2381],
13	that	IN	O	that	complm	16	SENT_119	[p3l1304t2352r1366b2381],
14	of	IN	O	of	_	0	SENT_119	[p3l1378t2352r1414b2381],
15	controls	NNS	O	control	prep_of	16	SENT_119	[p3l1423t2352r1555b2381],
16	(	VBP	O	(	dep	12	SENT_119	[p3l1569t2352r1655b2388],
17	95	CD	PERCENT	95	num	18	SENT_119	[p3l1569t2352r1655b2388],
18	%	NN	PERCENT	%	dobj	16	SENT_119	[p3l1569t2352r1655b2388],
19	CI	NN	O	ci	nsubj	16	SENT_119	[p3l1669t2352r1718b2387],
20	,	,	O	,	_	0	SENT_119	[p3l1669t2352r1718b2387],
21	1.4-9	CD	NUMBER	1.4-9	number	22	SENT_119	[p3l1736t2352r1877b2388],
22	.5	CD	NUMBER	.5	num	23	SENT_119	[p3l1736t2352r1877b2388],
23	)	NN	O	)	appos	19	SENT_119	[p3l1736t2352r1877b2388],
24	.	.	O	.	_	0	SENT_119	[p3l1736t2352r1877b2388],

1	Genotyping	VBG	O	genotype	_	0	SENT_120	[p3l536t2401r730b2439],
2	for	IN	O	for	_	0	SENT_120	[p3l744t2401r792b2431],
3	CYP2C9	NN	O	cyp2c9	prep_for	1	SENT_120	[p3l807t2401r950b2431],
4	before	IN	O	before	_	0	SENT_120	[p3l963t2401r1068b2431],
5	giving	VBG	O	give	prepc_before	1	SENT_120	[p3l1083t2401r1186b2439],
6	warfarin	NN	O	warfarin	iobj	5	SENT_120	[p3l1200t2401r1339b2431],
7	therapy	NN	O	therapy	dobj	5	SENT_120	[p3l1353t2401r1475b2439],
8	and	CC	O	and	_	0	SENT_120	[p3l1490t2401r1549b2431],
9	adjustment	NN	O	adjustment	dobj	5	SENT_120	[p3l1563t2401r1744b2439],
10	of	IN	O	of	_	0	SENT_120	[p3l1758t2401r1793b2431],
11	dose	NN	O	dose	prep_of	7	SENT_120	[p3l1805t2401r1879b2431],
12	for	IN	O	for	mark	21	SENT_120	[p3l536t2451r584b2480],
13	patients	NNS	O	patient	nsubj	21	SENT_120	[p3l596t2451r724b2489],
14	with	IN	O	with	_	0	SENT_120	[p3l739t2451r812b2480],
15	variant	JJ	O	variant	amod	18	SENT_120	[p3l826t2451r939b2480],
16	C	NN	O	c	nn	18	SENT_120	[p3l954t2451r981b2481],
17	YP2C9	NN	O	yp2c9	nn	18	SENT_120	[p3l983t2451r1097b2481],
18	alleles	NNS	O	allele	prep_with	13	SENT_120	[p3l1111t2451r1214b2480],
19	could	MD	O	could	aux	21	SENT_120	[p3l1230t2451r1321b2480],
20	therefore	RB	O	therefore	advmod	21	SENT_120	[p3l1334t2451r1483b2480],
21	reduce	VB	O	reduce	advcl	5	SENT_120	[p3l1496t2451r1606b2480],
22	severe	JJ	O	severe	amod	24	SENT_120	[p3l1622t2460r1723b2480],
23	bleeding	NN	O	bleeding	nn	24	SENT_120	[p3l1737t2451r1879b2489],
24	PHARMACOGENOMICS	NN	O	pharmacogenomic	iobj	21	SENT_120	[p3l1336t2512r1739b2539],
25	123	CD	NUMBER	123	dobj	21	SENT_120	[p3l1831t2509r1890b2539],

1	Annu	NNP	PERSON	Annu	_	0	SENT_121	[p3l278t1820r301b1901],
2	.	.	O	.	_	0	SENT_121	[p3l278t1820r301b1901],

1	Rev.	NNP	O	Rev.	nn	2	SENT_122	[p3l278t1749r301b1809],
2	Med	NNP	O	Med	_	0	SENT_122	[p3l278t1671r301b1738],
3	.	.	O	.	_	0	SENT_122	[p3l278t1671r301b1738],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_123	[p3l278t1546r301b1660],
2	:	:	O	:	_	0	SENT_123	[p3l278t1546r301b1660],
3	1	CD	NUMBER	1	number	4	SENT_123	[p3l278t1530r301b1540],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_123	[p3l278t1426r302b1523],
5	.	.	O	.	_	0	SENT_123	[p3l278t1426r302b1523],

1	Downloaded	VBN	O	download	_	0	SENT_124	[p3l278t1245r301b1415],
2	from	IN	O	from	_	0	SENT_124	[p3l278t1171r301b1236],
3	www.annua]reviews.org	NN	O	www.annua]reviews.org	prep_from	1	SENT_124	[p3l278t837r308b1162],
4	by	IN	O	by	_	0	SENT_124	[p3l311t1833r342b1867],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_124	[p3l312t1684r342b1824],
6	of	IN	ORGANIZATION	of	_	0	SENT_124	[p3l311t1645r335b1674],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_124	[p3l312t1498r335b1639],
8	-	:	O	-	_	0	SENT_124	[p3l325t1480r328b1489],
9	Madison	NNP	O	Madison	prep_by	1	SENT_124	[p3l311t1354r335b1470],
10	on	IN	O	on	_	0	SENT_124	[p3l319t1312r335b1344],
11	01/05/14	NN	DATE	01/05/14	prep_on	1	SENT_124	[p3l311t1185r335b1303],
12	For	IN	O	for	dep	16	SENT_124	[p3l312t1121r335b1167],
13	personal	JJ	O	personal	amod	14	SENT_124	[p3l311t1001r342b1113],
14	use	NN	O	use	pobj	12	SENT_124	[p3l319t948r335b992],
15	only	RB	O	only	advmod	16	SENT_124	[p3l311t880r342b938],
16	complications	NNS	O	complication	rcmod	11	SENT_124	[p3l547t2635r786b2673],
17	.	.	O	.	_	0	SENT_124	[p3l547t2635r786b2673],

1	Additional	JJ	O	additional	amod	2	SENT_125	[p3l803t2635r980b2665],
2	variability	NN	O	variability	nsubjpass	10	SENT_125	[p3l995t2635r1163b2673],
3	in	IN	O	in	_	0	SENT_125	[p3l1178t2635r1210b2664],
4	warfarin	NN	O	warfarin	poss	7	SENT_125	[p3l1225t2635r1390b2665],
5	’s	POS	O	’s	_	0	SENT_125	[p3l1225t2635r1390b2665],
6	anticoagulant	JJ	O	anticoagulant	amod	7	SENT_125	[p3l1407t2635r1629b2673],
7	effects	NNS	O	effect	prep_in	2	SENT_125	[p3l1644t2635r1751b2665],
8	may	MD	O	may	aux	10	SENT_125	[p3l1767t2644r1837b2673],
9	be	VB	O	be	auxpass	10	SENT_125	[p3l1852t2635r1890b2665],
10	explained	VBN	O	explain	_	0	SENT_125	[p3l547t2685r706b2723],
11	by	IN	O	by	_	0	SENT_125	[p3l720t2685r761b2723],
12	polymorphisms	NNS	O	polymorphism	agent	10	SENT_125	[p3l776t2685r1033b2723],
13	in	IN	O	in	_	0	SENT_125	[p3l1049t2685r1080b2714],
14	genes	NNS	O	gene	prep_in	10	SENT_125	[p3l1095t2694r1187b2723],
15	that	WDT	O	that	nsubj	16	SENT_125	[p3l1203t2685r1265b2714],
16	encode	VBP	O	encode	rcmod	14	SENT_125	[p3l1280t2685r1396b2714],
17	clotting	NN	O	clotting	nn	18	SENT_125	[p3l1411t2685r1536b2723],
18	factors	NNS	O	factor	dobj	16	SENT_125	[p3l1552t2685r1662b2714],
19	and	CC	O	and	_	0	SENT_125	[p3l1679t2685r1737b2714],
20	warfarin	NN	O	warfarin	nn	21	SENT_125	[p3l1752t2685r1891b2715],
21	targets	NNS	O	target	conj_and	18	SENT_125	[p3l546t2739r664b2772],
22	,	,	O	,	_	0	SENT_125	[p3l546t2739r664b2772],
23	including	VBG	O	include	_	0	SENT_125	[p3l680t2734r836b2772],
24	the	DT	O	the	det	27	SENT_125	[p3l851t2734r901b2763],
25	recently	RB	DATE	recently	advmod	26	SENT_125	[p3l915t2734r1048b2772],
26	reported	VBN	O	report	amod	27	SENT_125	[p3l1063t2734r1201b2772],
27	inﬂuence	NN	O	inﬂuence	prep_including	10	SENT_125	[p3l1216t2734r1367b2763],
28	of	IN	O	of	_	0	SENT_125	[p3l1382t2734r1418b2763],
29	polymorphisms	NNS	O	polymorphism	prep_of	27	SENT_125	[p3l1430t2734r1687b2772],
30	in	IN	O	in	_	0	SENT_125	[p3l1702t2734r1734b2763],
31	the	DT	O	the	det	32	SENT_125	[p3l1749t2734r1798b2763],
32	gene	NN	O	gene	prep_in	27	SENT_125	[p3l1814t2743r1890b2772],
33	encoding	VBG	O	encode	partmod	27	SENT_125	[p3l546t2784r697b2822],
34	vitamin	NN	O	vitamin	nn	38	SENT_125	[p3l709t2784r835b2814],
35	K	NN	O	k	nn	38	SENT_125	[p3l847t2785r876b2813],
36	epoxide	NN	O	epoxide	nn	38	SENT_125	[p3l887t2784r1017b2822],
37	reductase	NN	O	reductase	nn	38	SENT_125	[p3l1028t2784r1184b2814],
38	complex	NN	O	complex	dobj	33	SENT_125	[p3l1196t2784r1337b2822],
39	1	CD	NUMBER	1	number	40	SENT_125	[p3l1352t2784r1364b2813],
40	(	CD	NUMBER	(	num	42	SENT_125	[p3l1381t2784r1579b2820],
41	VKORC1	NN	O	vkorc1	nn	42	SENT_125	[p3l1381t2784r1579b2820],
42	)	NN	O	)	dep	38	SENT_125	[p3l1381t2784r1579b2820],
43	.	.	O	.	_	0	SENT_125	[p3l1381t2784r1579b2820],

1	Indeed	RB	O	indeed	advmod	5	SENT_126	[p3l1593t2784r1714b2819],
2	,	,	O	,	_	0	SENT_126	[p3l1593t2784r1714b2819],
3	VKORCI	NNP	O	VKORCI	nn	4	SENT_126	[p3l1727t2784r1887b2814],
4	haplotype	NN	O	haplotype	nsubj	5	SENT_126	[p3l546t2833r709b2871],
5	explained	VBD	O	explain	_	0	SENT_126	[p3l720t2833r880b2871],
6	~	CD	PERCENT	~	number	7	SENT_126	[p3l892t2833r996b2863],
7	25	CD	PERCENT	25	num	8	SENT_126	[p3l892t2833r996b2863],
8	%	NN	PERCENT	%	dobj	5	SENT_126	[p3l892t2833r996b2863],
9	of	IN	O	of	_	0	SENT_126	[p3l1009t2833r1045b2862],
10	the	DT	O	the	det	11	SENT_126	[p3l1053t2833r1103b2862],
11	variance	NN	O	variance	prep_of	8	SENT_126	[p3l1114t2833r1252b2862],
12	in	IN	O	in	_	0	SENT_126	[p3l1263t2833r1295b2862],
13	warfarin	NN	O	warfarin	prep_in	11	SENT_126	[p3l1305t2833r1453b2868],
14	,	,	O	,	_	0	SENT_126	[p3l1305t2833r1453b2868],
15	compared	VBN	O	compare	_	0	SENT_126	[p3l1466t2833r1628b2871],
16	to	TO	O	to	prepc_compared_to	5	SENT_126	[p3l1639t2838r1670b2862],
17	6	CD	PERCENT	6	num	18	SENT_126	[p3l1682t2833r1830b2863],
18	%	NN	PERCENT	%	pobj	5	SENT_126	[p3l1682t2833r1830b2863],
19	.	.	O	.	_	0	SENT_126	[p3l1682t2833r1830b2863],

1	—	NN	O	—	_	0	SENT_127	[p3l1682t2833r1830b2863],
2	.	.	O	.	_	0	SENT_127	[p3l1682t2833r1830b2863],

1	10	CD	PERCENT	10	num	2	SENT_128	[p3l1682t2833r1830b2863],
2	%	NN	PERCENT	%	_	0	SENT_128	[p3l1682t2833r1830b2863],
3	for	IN	O	for	_	0	SENT_128	[p3l1843t2833r1891b2862],
4	CYP2C9	NN	O	cyp2c9	prep_for	2	SENT_128	[p3l547t2883r694b2913],
5	alone	RB	O	alone	advmod	4	SENT_128	[p3l707t2883r795b2912],
6	(	RB	O	(	advmod	4	SENT_128	[p3l808t2883r870b2919],
7	15	CD	NUMBER	15	dep	2	SENT_128	[p3l808t2883r870b2919],
8	,	,	O	,	_	0	SENT_128	[p3l808t2883r870b2919],
9	27-29	CD	NUMBER	27-29	num	10	SENT_128	[p3l884t2883r1008b2919],
10	)	NN	O	)	appos	7	SENT_128	[p3l884t2883r1008b2919],
11	.	.	O	.	_	0	SENT_128	[p3l884t2883r1008b2919],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_129	[p3l448t2996r642b3031],
2	and	CC	O	and	_	0	SENT_129	[p3l656t2994r730b3031],
3	Proton	NNP	ORGANIZATION	Proton	nn	5	SENT_129	[p3l743t2997r882b3031],
4	Pump	NN	O	pump	nn	5	SENT_129	[p3l895t2997r1015b3041],
5	Inhibitor	NNP	O	Inhibitor	conj_and	1	SENT_129	[p3l1028t2994r1212b3031],
6	Therapy	NN	O	therapy	dep	1	SENT_129	[p3l1224t2994r1395b3042],

1	Proton	NNP	ORGANIZATION	Proton	nn	3	SENT_130	[p3l546t3054r656b3082],
2	pump	NN	O	pump	nn	3	SENT_130	[p3l672t3062r766b3091],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_130	[p3l783t3053r940b3082],
4	(	CD	NUMBER	(	num	5	SENT_130	[p3l959t3054r1060b3089],
5	PPIs	NNS	O	ppi	dep	3	SENT_130	[p3l959t3054r1060b3089],
6	)	CD	NUMBER	)	nsubj	9	SENT_130	[p3l959t3054r1060b3089],
7	are	VBP	O	be	cop	9	SENT_130	[p3l1079t3062r1127b3082],
8	the	DT	O	the	det	9	SENT_130	[p3l1144t3053r1194b3082],
9	drugs	NNS	O	drug	dep	3	SENT_130	[p3l1211t3053r1301b3091],
10	of	IN	O	of	_	0	SENT_130	[p3l1320t3053r1355b3082],
11	choice	NN	O	choice	prep_of	9	SENT_130	[p3l1370t3053r1477b3082],
12	for	IN	O	for	_	0	SENT_130	[p3l1494t3053r1542b3082],
13	the	DT	O	the	det	17	SENT_130	[p3l1558t3053r1608b3082],
14	acute	JJ	O	acute	amod	17	SENT_130	[p3l1625t3058r1711b3082],
15	and	CC	O	and	_	0	SENT_130	[p3l1729t3053r1787b3082],
16	longterin	JJ	O	longterin	conj_and	14	SENT_130	[p3l1804t3053r1889b3091, p3l546t3106r622b3131],
17	treatment	NN	O	treatment	prep_for	11	SENT_130	[p3l639t3106r796b3131],
18	of	IN	O	of	_	0	SENT_130	[p3l814t3102r850b3131],
19	gastric	JJ	O	gastric	amod	23	SENT_130	[p3l865t3102r974b3140],
20	acid	NN	O	acid	nn	23	SENT_130	[p3l994t3102r1195b3131],
21	—	NN	O	—	nn	23	SENT_130	[p3l994t3102r1195b3131],
22	related	JJ	O	related	amod	23	SENT_130	[p3l994t3102r1195b3131],
23	disorders	NNS	O	disorder	prep_of	17	SENT_130	[p3l1213t3102r1363b3131],
24	such	JJ	O	such	_	0	SENT_130	[p3l1383t3102r1457b3131],
25	as	IN	O	as	_	0	SENT_130	[p3l1476t3111r1508b3131],
26	peptic	JJ	O	peptic	amod	27	SENT_130	[p3l1527t3102r1627b3140],
27	ulcer	NN	O	ulcer	prep_such_as	9	SENT_130	[p3l1645t3102r1728b3131],
28	and	CC	O	and	_	0	SENT_130	[p3l1746t3102r1805b3131],
29	gastroesophageal	NN	O	gastroesophageal	nn	31	SENT_130	[p3l1823t3111r1889b3140, p3l546t3151r776b3189],
30	reﬂux	NN	O	reﬂux	nn	31	SENT_130	[p3l788t3151r884b3180],
31	disease	NN	O	disease	conj_and	27	SENT_130	[p3l897t3151r1016b3180],
32	and	CC	O	and	_	0	SENT_130	[p3l1029t3151r1096b3186],
33	,	,	O	,	_	0	SENT_130	[p3l1029t3151r1096b3186],
34	combined	VBN	O	combine	conj_and	9	SENT_130	[p3l1111t3151r1274b3180],
35	with	IN	O	with	_	0	SENT_130	[p3l1286t3151r1359b3181],
36	two	CD	NUMBER	two	nn	39	SENT_130	[p3l1371t3156r1432b3180],
37	or	CC	O	or	_	0	SENT_130	[p3l1445t3160r1479b3180],
38	three	CD	NUMBER	three	nn	39	SENT_130	[p3l1491t3151r1573b3180],
39	antibiotics	NNS	O	antibiotic	prep_with	34	SENT_130	[p3l1587t3151r1767b3186],
40	,	,	O	,	_	0	SENT_130	[p3l1587t3151r1767b3186],
41	for	IN	O	for	_	0	SENT_130	[p3l1781t3151r1829b3180],
42	the	DT	O	the	det	43	SENT_130	[p3l1841t3151r1890b3180],
43	eradication	NN	O	eradication	prep_for	3	SENT_130	[p3l547t3201r730b3231],
44	of	IN	O	of	_	0	SENT_130	[p3l744t3201r780b3231],
45	Helicobacter	NNP	PERSON	Helicobacter	nn	49	SENT_130	[p3l790t3201r1008b3231],
46	pylori	NNP	PERSON	pylori	nn	49	SENT_130	[p3l1017t3201r1119b3239],
47	(	NNP	O	(	nn	49	SENT_130	[p3l1134t3202r1219b3239],
48	Hp	NNP	O	Hp	nn	49	SENT_130	[p3l1134t3202r1219b3239],
49	)	NN	O	)	prep_of	43	SENT_130	[p3l1134t3202r1219b3239],
50	.	.	O	.	_	0	SENT_130	[p3l1134t3202r1219b3239],

1	PPIs	NNS	O	ppi	nsubj	6	SENT_131	[p3l1235t3202r1309b3230],
2	in	IN	O	in	_	0	SENT_131	[p3l1324t3201r1355b3230],
3	clinical	JJ	O	clinical	amod	4	SENT_131	[p3l1369t3201r1490b3230],
4	use	NN	O	use	prep_in	1	SENT_131	[p3l1503t3211r1558b3231],
5	are	VBP	O	be	cop	6	SENT_131	[p3l1573t3211r1621b3231],
6	omeprazole	NN	O	omeprazole	_	0	SENT_131	[p3l1636t3201r1837b3239],
7	,	,	O	,	_	0	SENT_131	[p3l1636t3201r1837b3239],
8	its	PRP$	O	its	poss	12	SENT_131	[p3l1852t3201r1890b3231],
9	S	NN	O	s	nn	12	SENT_131	[p3l547t3251r770b3281],
10	—	CD	NUMBER	—	num	12	SENT_131	[p3l547t3251r770b3281],
11	enantiomer	NN	O	enantiomer	nn	12	SENT_131	[p3l547t3251r770b3281],
12	esomeprazole	NN	O	esomeprazole	conj_and	6	SENT_131	[p3l781t3251r1016b3289],
13	,	,	O	,	_	0	SENT_131	[p3l781t3251r1016b3289],
14	lansoprazole	NN	O	lansoprazole	conj_and	6	SENT_131	[p3l1029t3251r1247b3289],
15	,	,	O	,	_	0	SENT_131	[p3l1029t3251r1247b3289],
16	pantoprazole	NN	O	pantoprazole	conj_and	6	SENT_131	[p3l1259t3251r1482b3289],
17	,	,	O	,	_	0	SENT_131	[p3l1259t3251r1482b3289],
18	and	CC	O	and	_	0	SENT_131	[p3l1496t3251r1554b3280],
19	rabeprazole	NN	O	rabeprazole	conj_and	6	SENT_131	[p3l1565t3251r1758b3289],
20	(	CD	NUMBER	(	number	21	SENT_131	[p3l1771t3252r1846b3287],
21	30	CD	NUMBER	30	num	22	SENT_131	[p3l1771t3252r1846b3287],
22	)	NN	O	)	dep	19	SENT_131	[p3l1771t3252r1846b3287],
23	.	.	O	.	_	0	SENT_131	[p3l1771t3252r1846b3287],

1	All	DT	O	all	det	4	SENT_132	[p3l596t3301r648b3330],
2	PPIs	NNS	O	ppi	nn	4	SENT_132	[p3l661t3302r735b3330],
3	dose	NN	O	dose	nn	4	SENT_132	[p3l750t3301r1041b3339],
4	—	NN	O	—	nsubj	6	SENT_132	[p3l750t3301r1041b3339],
5	dependently	RB	O	dependently	advmod	6	SENT_132	[p3l750t3301r1041b3339],
6	inhibit	VBP	O	inhibit	_	0	SENT_132	[p3l1055t3301r1163b3330],
7	gastric	JJ	O	gastric	amod	9	SENT_132	[p3l1176t3301r1284b3339],
8	acid	NN	O	acid	nn	9	SENT_132	[p3l1299t3301r1367b3330],
9	secretion	NN	O	secretion	dobj	6	SENT_132	[p3l1381t3301r1529b3330],
10	and	CC	O	and	_	0	SENT_132	[p3l1543t3301r1601b3330],
11	raise	VB	O	raise	conj_and	6	SENT_132	[p3l1614t3301r1691b3330],
12	intragastric	JJ	O	intragastric	amod	13	SENT_132	[p3l1705t3301r1890b3339],
13	pH	NN	O	ph	dobj	11	SENT_132	[p3l546t3352r596b3389],
14	for	IN	O	for	mark	21	SENT_132	[p3l604t3351r652b3380],
15	24-48	CD	DATE	24-48	num	18	SENT_132	[p3l660t3351r761b3380],
16	h.	NN	O	h.	nn	18	SENT_132	[p3l771t3351r799b3380],
17	Intragastric	JJ	O	intragastric	amod	18	SENT_132	[p3l809t3351r996b3389],
18	pH	NN	O	ph	nsubjpass	21	SENT_132	[p3l1005t3352r1055b3389],
19	should	MD	O	should	aux	21	SENT_132	[p3l1065t3351r1174b3380],
20	be	VB	O	be	auxpass	21	SENT_132	[p3l1181t3351r1219b3380],
21	maintained	VBN	O	maintain	advcl	11	SENT_132	[p3l1228t3351r1412b3380],
22	above	IN	O	above	_	0	SENT_132	[p3l1420t3351r1516b3380],
23	3	CD	NUMBER	3	num	24	SENT_132	[p3l1526t3351r1542b3380],
24	.5	NN	NUMBER	.5	prep_above	21	SENT_132	[p3l1548t3351r1574b3380],
25	to	TO	O	to	aux	26	SENT_132	[p3l1584t3356r1615b3380],
26	heal	VB	O	heal	ccomp	21	SENT_132	[p3l1623t3351r1691b3380],
27	peptic	JJ	O	peptic	amod	28	SENT_132	[p3l1699t3351r1800b3389],
28	ulcer	NN	O	ulcer	dobj	26	SENT_132	[p3l1808t3351r1891b3380],
29	and	CC	O	and	_	0	SENT_132	[p3l547t3401r605b3430],
30	above	IN	O	above	advmod	26	SENT_132	[p3l619t3401r715b3430],
31	4	CD	NUMBER	4	pobj	30	SENT_132	[p3l727t3401r747b3430],
32	to	TO	O	to	aux	33	SENT_132	[p3l760t3406r791b3430],
33	heal	VB	O	heal	ccomp	21	SENT_132	[p3l804t3401r872b3430],
34	gastroesophageal	NN	O	gastroesophageal	nn	36	SENT_132	[p3l886t3401r1170b3439],
35	reﬂux	NN	O	reﬂux	nn	36	SENT_132	[p3l1183t3401r1279b3430],
36	disease	NN	O	disease	dobj	33	SENT_132	[p3l1292t3401r1419b3430],
37	.	.	O	.	_	0	SENT_132	[p3l1292t3401r1419b3430],

1	The	DT	O	the	det	2	SENT_133	[p3l1434t3401r1497b3430],
2	area	NN	O	area	nsubj	8	SENT_133	[p3l1511t3410r1579b3430],
3	under	IN	O	under	_	0	SENT_133	[p3l1591t3401r1685b3430],
4	the	DT	O	the	det	7	SENT_133	[p3l1698t3401r1747b3430],
5	plasmaconcentration-versus	JJ	O	plasmaconcentration-versus	amod	7	SENT_133	[p3l1760t3401r1889b3439, p3l547t3451r978b3480],
6	—	NN	O	—	nn	7	SENT_133	[p3l1760t3401r1889b3439, p3l547t3451r978b3480],
7	time	NN	O	time	prep_under	2	SENT_133	[p3l1760t3401r1889b3439, p3l547t3451r978b3480],
8	curve	NN	O	curve	_	0	SENT_133	[p3l985t3460r1075b3480],
9	(	CD	NUMBER	(	num	11	SENT_133	[p3l1084t3451r1193b3487],
10	AUC	NN	O	auc	nn	11	SENT_133	[p3l1084t3451r1193b3487],
11	)	NN	O	)	nsubj	14	SENT_133	[p3l1084t3451r1193b3487],
12	is	VBZ	O	be	cop	14	SENT_133	[p3l1202t3451r1227b3480],
13	closely	RB	O	closely	advmod	14	SENT_133	[p3l1236t3451r1351b3489],
14	related	JJ	O	related	ccomp	8	SENT_133	[p3l1358t3451r1471b3480],
15	to	TO	O	to	_	0	SENT_133	[p3l1478t3455r1508b3480],
16	the	DT	O	the	det	17	SENT_133	[p3l1516t3451r1566b3480],
17	inhibition	NN	O	inhibition	prep_to	14	SENT_133	[p3l1573t3451r1733b3480],
18	of	IN	O	of	_	0	SENT_133	[p3l1741t3451r1777b3480],
19	gastric	JJ	O	gastric	amod	20	SENT_133	[p3l1781t3451r1890b3489],
20	secretion	NN	O	secretion	prep_of	17	SENT_133	[p3l548t3501r703b3531],
21	.	.	O	.	_	0	SENT_133	[p3l548t3501r703b3531],

1	Above	IN	O	above	_	0	SENT_134	[p3l718t3502r827b3531],
2	an	DT	O	a	det	4	SENT_134	[p3l841t3511r878b3531],
3	AUC	NN	O	auc	nn	4	SENT_134	[p3l891t3502r975b3531],
4	value	NN	O	value	prep_above	19	SENT_134	[p3l989t3501r1076b3531],
5	of	IN	O	of	_	0	SENT_134	[p3l1090t3501r1126b3531],
6	~	NN	O	~	nn	9	SENT_134	[p3l1138t3502r1186b3531],
7	3	CD	NUMBER	3	num	9	SENT_134	[p3l1138t3502r1186b3531],
8	umol	NN	O	umol	nn	9	SENT_134	[p3l1205t3502r1291b3538],
9	h/1	NN	O	h/1	prep_of	4	SENT_134	[p3l1304t3501r1356b3536],
10	,	,	O	,	_	0	SENT_134	[p3l1304t3501r1356b3536],
11	almost	RB	O	almost	quantmod	12	SENT_134	[p3l1371t3501r1481b3531],
12	100	CD	PERCENT	100	dep	13	SENT_134	[p3l1497t3502r1587b3531],
13	%	NN	PERCENT	%	dep	14	SENT_134	[p3l1497t3502r1587b3531],
14	inhibition	NN	O	inhibition	nsubjpass	19	SENT_134	[p3l1602t3501r1763b3531],
15	of	IN	O	of	_	0	SENT_134	[p3l1776t3501r1812b3531],
16	acid	NN	O	acid	nn	17	SENT_134	[p3l1823t3501r1891b3531],
17	secretion	NN	O	secretion	prep_of	14	SENT_134	[p3l548t3551r695b3581],
18	is	VBZ	O	be	auxpass	19	SENT_134	[p3l712t3551r737b3581],
19	achieved	VBN	O	achieve	_	0	SENT_134	[p3l756t3551r900b3581],
20	(	CD	NUMBER	(	num	21	SENT_134	[p3l918t3552r980b3587],
21	31	CD	NUMBER	31	dobj	19	SENT_134	[p3l918t3552r980b3587],
22	,	,	O	,	_	0	SENT_134	[p3l918t3552r980b3587],
23	32	CD	NUMBER	32	num	24	SENT_134	[p3l999t3552r1060b3587],
24	)	NN	O	)	appos	21	SENT_134	[p3l999t3552r1060b3587],
25	.	.	O	.	_	0	SENT_134	[p3l999t3552r1060b3587],

1	These	DT	O	these	det	2	SENT_135	[p3l1079t3551r1177b3581],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_135	[p3l1195t3551r1326b3589],
3	suggest	VBP	O	suggest	_	0	SENT_135	[p3l1345t3556r1468b3589],
4	that	IN	O	that	complm	7	SENT_135	[p3l1484t3551r1546b3581],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_135	[p3l1562t3551r1744b3589],
6	efﬁcacy	NN	O	efﬁcacy	nsubj	7	SENT_135	[p3l1762t3551r1890b3589],
7	depends	VBZ	O	depend	ccomp	3	SENT_135	[p3l547t3602r680b3639],
8	on	IN	O	on	_	0	SENT_135	[p3l698t3611r738b3631],
9	drug	NN	O	drug	nn	10	SENT_135	[p3l754t3601r828b3639],
10	dose	NN	O	dose	prep_on	7	SENT_135	[p3l845t3602r920b3631],
11	and	CC	O	and	_	0	SENT_135	[p3l937t3602r995b3631],
12	dosing	NN	O	dosing	nn	13	SENT_135	[p3l1011t3601r1120b3639],
13	interval	NN	O	interval	conj_and	10	SENT_135	[p3l1136t3601r1270b3636],
14	,	,	O	,	_	0	SENT_135	[p3l1136t3601r1270b3636],
15	but	CC	O	but	_	0	SENT_135	[p3l1287t3602r1340b3631],
16	all	DT	O	all	det	17	SENT_135	[p3l1356t3601r1395b3631],
17	regimens	NNS	O	regimen	conj_but	10	SENT_135	[p3l1411t3601r1561b3639],
18	for	IN	O	for	_	0	SENT_135	[p3l1578t3601r1626b3631],
19	Hp	NN	O	hp	nn	20	SENT_135	[p3l1641t3602r1691b3639],
20	eradication	NN	O	eradication	prep_for	17	SENT_135	[p3l1707t3601r1891b3631],
21	on	IN	O	on	_	0	SENT_135	[p3l310t3603r326b3635],
22	01/05/14	CD	DATE	01/05/14	prep_on	7	SENT_135	[p3l302t3468r326b3593],
23	.	.	O	.	_	0	SENT_135	[p3l302t3468r326b3593],

1	For	IN	O	for	_	0	SENT_136	[p3l303t3411r326b3458],
2	personal	JJ	O	personal	amod	3	SENT_136	[p3l302t3291r333b3403],
3	use	NN	O	use	pobj	1	SENT_136	[p3l310t3238r326b3281],
4	only	RB	O	only	advmod	3	SENT_136	[p3l302t3163r333b3228],
5	.	.	O	.	_	0	SENT_136	[p3l302t3163r333b3228],

1	Annu	NNP	PERSON	Annu	_	0	SENT_137	[p4l269t476r292b557],
2	.	.	O	.	_	0	SENT_137	[p4l269t476r292b557],

1	Rev.	NNP	O	Rev.	nn	2	SENT_138	[p4l269t405r292b465],
2	Med	NNP	O	Med	_	0	SENT_138	[p4l269t327r292b394],
3	.	.	O	.	_	0	SENT_138	[p4l269t327r292b394],

1	2006.57:119	CD	NUMBER	2006.57:119	num	2	SENT_139	[p4l269t82r293b316],
2	-137	CD	NUMBER	-137	_	0	SENT_139	[p4l269t82r293b316],
3	.	.	O	.	_	0	SENT_139	[p4l269t82r293b316],

1	Dow	NNP	MISC	Dow	_	0	SENT_140	[p4l269t7r292b71],
2	by	IN	O	by	_	0	SENT_140	[p4l302t489r333b523],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_140	[p4l303t340r333b480],
4	of	IN	ORGANIZATION	of	_	0	SENT_140	[p4l302t301r326b330],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	1	SENT_140	[p4l303t154r326b295],
6	-	:	O	-	_	0	SENT_140	[p4l316t136r319b145],
7	Madison	NNP	PERSON	Madison	dep	1	SENT_140	[p4l302t10r326b126],

1	Annu	NNP	PERSON	Annu	_	0	SENT_141	[p4l278t2813r301b2893],
2	.	.	O	.	_	0	SENT_141	[p4l278t2813r301b2893],

1	Rev.	NNP	O	Rev.	nn	2	SENT_142	[p4l278t2742r301b2802],
2	Med	NNP	O	Med	_	0	SENT_142	[p4l278t2664r301b2731],
3	.	.	O	.	_	0	SENT_142	[p4l278t2664r301b2731],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_143	[p4l278t2539r301b2653],
2	:	:	O	:	_	0	SENT_143	[p4l278t2539r301b2653],
3	1	CD	NUMBER	1	number	4	SENT_143	[p4l278t2523r301b2533],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_143	[p4l278t2419r302b2516],
5	.	.	O	.	_	0	SENT_143	[p4l278t2419r302b2516],

1	Downloaded	VBN	O	download	_	0	SENT_144	[p4l278t2238r301b2408],
2	from	IN	O	from	_	0	SENT_144	[p4l278t2164r301b2229],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_144	[p4l278t1831r308b2155],
4	by	IN	O	by	_	0	SENT_144	[p4l311t2826r342b2859],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_144	[p4l311t2677r342b2817],
6	of	IN	ORGANIZATION	of	_	0	SENT_144	[p4l311t2638r335b2667],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_144	[p4l311t2491r335b2632],
8	-	:	O	-	_	0	SENT_144	[p4l325t2473r328b2481],
9	Madison	NNP	O	Madison	prep_by	1	SENT_144	[p4l311t2346r335b2463],
10	on	IN	O	on	_	0	SENT_144	[p4l319t2305r335b2337],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_144	[p4l311t2171r335b2295],
12	.	.	O	.	_	0	SENT_144	[p4l311t2171r335b2295],

1	For	IN	O	for	_	0	SENT_145	[p4l312t2114r335b2160],
2	personal	JJ	O	personal	amod	3	SENT_145	[p4l311t1994r342b2106],
3	use	NN	O	use	pobj	1	SENT_145	[p4l319t1941r335b1985],
4	only	RB	O	only	advmod	3	SENT_145	[p4l311t1866r342b1931],
5	.	.	O	.	_	0	SENT_145	[p4l311t1866r342b1931],

1	are	VBP	O	be	auxpass	2	SENT_146	[p4l547t26r596b46],
2	based	VBN	O	base	csubj	29	SENT_146	[p4l607t16r702b46],
3	on	IN	O	on	_	0	SENT_146	[p4l714t26r754b46],
4	the	DT	O	the	det	6	SENT_146	[p4l767t16r816b46],
5	same	JJ	O	same	amod	6	SENT_146	[p4l830t26r913b46],
6	dose	NN	O	dose	prep_on	2	SENT_146	[p4l926t16r1000b46],
7	of	IN	O	of	_	0	SENT_146	[p4l1013t16r1049b46],
8	PPI	NNP	O	PPI	prep_of	6	SENT_146	[p4l1058t17r1117b45],
9	for	IN	O	for	_	0	SENT_146	[p4l1130t16r1178b46],
10	all	DT	O	all	det	11	SENT_146	[p4l1190t16r1229b46],
11	patients	NNS	O	patient	prep_for	8	SENT_146	[p4l1241t16r1379b54],
12	,	,	O	,	_	0	SENT_146	[p4l1241t16r1379b54],
13	assuming	VBG	O	assume	partmod	6	SENT_146	[p4l1393t16r1548b54],
14	that	IN	O	that	complm	16	SENT_146	[p4l1561t16r1623b46],
15	the	DT	O	the	det	16	SENT_146	[p4l1634t16r1684b46],
16	rate	NN	O	rate	dep	13	SENT_146	[p4l1696t21r1757b46],
17	of	IN	O	of	_	0	SENT_146	[p4l1770t16r1806b46],
18	drug	NN	O	drug	nn	19	SENT_146	[p4l1816t17r1890b54],
19	elimination	NN	O	elimination	prep_of	16	SENT_146	[p4l546t66r734b96],
20	(	CD	NUMBER	(	num	19	SENT_146	[p4l743t66r870b104],
21	mainly	RB	O	mainly	advmod	16	SENT_146	[p4l743t66r870b104],
22	by	IN	O	by	dep	16	SENT_146	[p4l877t66r918b104],
23	hepatic	JJ	O	hepatic	amod	25	SENT_146	[p4l926t66r1044b104],
24	metabolism	NN	O	metabolism	nn	25	SENT_146	[p4l1052t66r1258b102],
25	)	NN	O	)	pobj	22	SENT_146	[p4l1052t66r1258b102],
26	is	VBZ	O	be	cop	29	SENT_146	[p4l1267t66r1292b96],
27	essentially	RB	O	essentially	advmod	29	SENT_146	[p4l1301t66r1475b104],
28	the	DT	O	the	det	29	SENT_146	[p4l1483t66r1532b96],
29	same	JJ	O	same	_	0	SENT_146	[p4l1542t76r1624b96],
30	among	IN	O	among	_	0	SENT_146	[p4l1633t76r1744b104],
31	patients	NNS	O	patient	prep_among	29	SENT_146	[p4l1751t66r1888b104],
32	.	.	O	.	_	0	SENT_146	[p4l1751t66r1888b104],

1	Pronounced	JJ	O	pronounced	amod	2	SENT_147	[p4l596t116r794b145],
2	differences	NNS	O	difference	nsubj	6	SENT_147	[p4l807t116r988b145],
3	in	IN	O	in	_	0	SENT_147	[p4l1001t116r1033b145],
4	PPI	NNP	O	PPI	nn	5	SENT_147	[p4l1045t117r1104b145],
5	pharrnacokinetics	NNS	O	pharrnacokinetic	prep_in	2	SENT_147	[p4l1117t116r1408b154],
6	result	VBP	O	result	_	0	SENT_147	[p4l1421t116r1514b145],
7	in	IN	O	in	advmod	6	SENT_147	[p4l1526t116r1557b145],
8	up	RB	O	up	advmod	7	SENT_147	[p4l1570t126r1610b154],
9	to	TO	O	to	_	0	SENT_147	[p4l1623t121r1654b145],
10	a	DT	O	a	det	12	SENT_147	[p4l1668t126r1685b145],
11	12-fold	JJ	O	12-fold	amod	12	SENT_147	[p4l1702t116r1819b145],
12	difference	NN	O	difference	prep_to	6	SENT_147	[p4l1832t116r1889b145, p4l546t166r667b195],
13	among	IN	O	among	_	0	SENT_147	[p4l683t175r794b204],
14	patients	NNS	O	patient	prep_among	12	SENT_147	[p4l809t166r946b204],
15	.	.	O	.	_	0	SENT_147	[p4l809t166r946b204],

1	Hepatic	JJ	O	hepatic	amod	2	SENT_148	[p4l963t166r1090b204],
2	metabolism	NN	O	metabolism	nsubjpass	6	SENT_148	[p4l1106t166r1300b195],
3	of	IN	O	of	_	0	SENT_148	[p4l1314t166r1350b195],
4	PPIS	NNP	O	PPIS	prep_of	2	SENT_148	[p4l1362t167r1437b195],
5	is	VBZ	O	be	auxpass	6	SENT_148	[p4l1453t166r1478b195],
6	catalyzed	VBN	O	catalyze	_	0	SENT_148	[p4l1495t166r1650b204],
7	by	IN	O	by	_	0	SENT_148	[p4l1665t166r1705b204],
8	CYP2C19	NN	O	cyp2c19	agent	6	SENT_148	[p4l1721t166r1890b196],
9	and	CC	O	and	_	0	SENT_148	[p4l547t216r614b250],
10	,	,	O	,	_	0	SENT_148	[p4l547t216r614b250],
11	to	TO	O	to	dep	8	SENT_148	[p4l626t221r657b245],
12	a	DT	O	a	det	14	SENT_148	[p4l669t225r686b245],
13	smaller	JJR	O	smaller	amod	14	SENT_148	[p4l698t216r818b245],
14	extent	NN	O	extent	pobj	11	SENT_148	[p4l829t221r937b250],
15	,	,	O	,	_	0	SENT_148	[p4l829t221r937b250],
16	CYP3A4	NN	O	cyp3a4	agent	6	SENT_148	[p4l950t216r1109b245],
17	.	.	O	.	_	0	SENT_148	[p4l950t216r1109b245],

1	Genetic	JJ	O	genetic	amod	2	SENT_149	[p4l1122t216r1249b245],
2	polymorphism	NN	O	polymorphism	nsubj	7	SENT_149	[p4l1260t216r1502b254],
3	of	IN	O	of	_	0	SENT_149	[p4l1513t216r1549b245],
4	C	NN	O	c	nn	5	SENT_149	[p4l1559t217r1585b246],
5	YPZCI	NN	O	ypzcus	prep_of	2	SENT_149	[p4l1587t216r1698b246],
6	9	CD	NUMBER	9	num	5	SENT_149	[p4l1702t216r1722b245],
7	manifests	VBZ	O	manifest	_	0	SENT_149	[p4l1732t216r1890b245],
8	in	IN	O	in	_	0	SENT_149	[p4l546t266r577b295],
9	three	CD	NUMBER	three	num	11	SENT_149	[p4l589t266r671b295],
10	distinct	JJ	O	distinct	amod	11	SENT_149	[p4l684t266r805b295],
11	phenotypes	NNS	O	phenotype	prep_in	7	SENT_149	[p4l817t266r1014b304],
12	:	:	O	:	_	0	SENT_149	[p4l817t266r1014b304],
13	the	DT	O	the	det	18	SENT_149	[p4l1029t266r1078b295],
14	poor	JJ	O	poor	amod	18	SENT_149	[p4l1090t275r1166b304],
15	metabolizer	NN	O	metabolizer	nn	18	SENT_149	[p4l1178t266r1374b295],
16	(	NN	O	(	nn	18	SENT_149	[p4l1386t266r1480b302],
17	PM	NN	O	pm	nn	18	SENT_149	[p4l1386t266r1480b302],
18	)	NN	O	)	dobj	7	SENT_149	[p4l1386t266r1480b302],
19	,	,	O	,	_	0	SENT_149	[p4l1386t266r1480b302],
20	the	DT	O	the	det	26	SENT_149	[p4l1494t266r1544b295],
21	heterozygous	JJ	O	heterozygous	amod	26	SENT_149	[p4l1556t266r1775b304],
22	extensive	JJ	O	extensive	amod	26	SENT_149	[p4l1789t270r1889b295, p4l548t316r610b345],
23	metabolizer	NN	O	metabolizer	nn	26	SENT_149	[p4l626t316r822b345],
24	(	NN	O	(	nn	26	SENT_149	[p4l838t316r985b352],
25	hetEM	NN	O	hetem	nn	26	SENT_149	[p4l838t316r985b352],
26	)	NN	O	)	conj_and	18	SENT_149	[p4l838t316r985b352],
27	,	,	O	,	_	0	SENT_149	[p4l838t316r985b352],
28	and	CC	O	and	_	0	SENT_149	[p4l1004t316r1062b345],
29	the	DT	O	the	det	34	SENT_149	[p4l1078t316r1127b345],
30	extensive	JJ	O	extensive	amod	34	SENT_149	[p4l1144t316r1297b345],
31	metabolizer	NN	O	metabolizer	nn	34	SENT_149	[p4l1313t316r1508b345],
32	(	NN	O	(	nn	34	SENT_149	[p4l1525t316r1621b352],
33	EM	NN	O	em	nn	34	SENT_149	[p4l1525t316r1621b352],
34	)	NN	O	)	dobj	7	SENT_149	[p4l1525t316r1621b352],
35	.	.	O	.	_	0	SENT_149	[p4l1525t316r1621b352],

1	PMS	NNS	O	pm	nsubj	2	SENT_150	[p4l1639t316r1713b345],
2	carry	VBP	O	carry	_	0	SENT_150	[p4l1730t325r1813b353],
3	two	CD	NUMBER	two	num	5	SENT_150	[p4l1830t320r1890b345],
4	nonfunctional	JJ	O	nonfunctional	amod	5	SENT_150	[p4l546t365r776b395],
5	alleles	NNS	O	allele	dobj	2	SENT_150	[p4l791t365r904b400],
6	,	,	O	,	_	0	SENT_150	[p4l791t365r904b400],
7	hetEMs	NNS	O	hetem	nsubj	8	SENT_150	[p4l920t365r1048b395],
8	have	VBP	O	have	dep	2	SENT_150	[p4l1063t365r1139b395],
9	one	CD	NUMBER	one	dep	10	SENT_150	[p4l1154t374r1212b395],
10	nonfunctional	JJ	O	nonfunctional	dep	8	SENT_150	[p4l1227t365r1457b395],
11	and	CC	O	and	_	0	SENT_150	[p4l1472t365r1531b395],
12	one	CD	NUMBER	one	num	14	SENT_150	[p4l1545t374r1604b395],
13	wild	JJ	O	wild	amod	14	SENT_150	[p4l1619t365r1776b403],
14	—	NN	O	—	dep	16	SENT_150	[p4l1619t365r1776b403],
15	type	NN	O	type	nn	16	SENT_150	[p4l1619t365r1776b403],
16	allele	NN	O	allele	conj_and	10	SENT_150	[p4l1792t365r1889b400],
17	,	,	O	,	_	0	SENT_150	[p4l1792t365r1889b400],
18	and	CC	O	and	_	0	SENT_150	[p4l547t416r605b445],
19	EMS	NNP	ORGANIZATION	EMS	nsubj	21	SENT_150	[p4l615t416r692b445],
20	are	VBP	O	be	cop	21	SENT_150	[p4l703t425r752b445],
21	homozygous	JJ	O	homozygous	conj_and	2	SENT_150	[p4l762t416r973b453],
22	for	IN	O	for	_	0	SENT_150	[p4l984t415r1032b445],
23	the	DT	O	the	det	27	SENT_150	[p4l1041t415r1091b445],
24	wild	JJ	O	wild	amod	27	SENT_150	[p4l1101t415r1259b453],
25	—	NN	O	—	nn	27	SENT_150	[p4l1101t415r1259b453],
26	type	NN	O	type	nn	27	SENT_150	[p4l1101t415r1259b453],
27	allele	NN	O	allele	prep_for	21	SENT_150	[p4l1270t415r1366b445],
28	.	.	O	.	_	0	SENT_150	[p4l1270t415r1366b445],

1	Thus	RB	O	thus	advmod	2	SENT_151	[p4l1379t415r1460b445],
2	far	RB	O	far	advmod	14	SENT_151	[p4l1471t415r1522b450],
3	,	,	O	,	_	0	SENT_151	[p4l1471t415r1522b450],
4	eight	CD	NUMBER	eight	num	6	SENT_151	[p4l1535t415r1617b453],
5	loss	NN	O	loss	nn	6	SENT_151	[p4l1626t415r1891b445],
6	—	NN	O	—	nsubjpass	17	SENT_151	[p4l1626t415r1891b445],
7	of	IN	O	of	_	0	SENT_151	[p4l1626t415r1891b445],
8	—	CD	NUMBER	—	num	11	SENT_151	[p4l1626t415r1891b445],
9	function	NN	O	function	nn	11	SENT_151	[p4l1626t415r1891b445],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_151	[p4l548t466r712b495],
11	alleles	NNS	O	allele	prep_of	6	SENT_151	[p4l725t465r828b495],
12	have	VBP	O	have	aux	14	SENT_151	[p4l842t466r918b495],
13	been	VBN	O	be	auxpass	14	SENT_151	[p4l930t466r1008b495],
14	reported	VBN	O	report	_	0	SENT_151	[p4l1021t466r1167b503],
15	,	,	O	,	_	0	SENT_151	[p4l1021t466r1167b503],
16	and	CC	O	and	_	0	SENT_151	[p4l1182t466r1241b495],
17	pronounced	VBD	O	pronounce	conj_and	14	SENT_151	[p4l1253t466r1448b503],
18	ethnic	JJ	O	ethnic	amod	19	SENT_151	[p4l1461t465r1561b495],
19	differences	NNS	O	difference	nsubj	20	SENT_151	[p4l1575t465r1756b495],
20	exist	VBP	O	exist	ccomp	17	SENT_151	[p4l1770t465r1847b495],
21	in	IN	O	in	_	0	SENT_151	[p4l1859t465r1891b494],
22	the	DT	O	the	det	23	SENT_151	[p4l546t516r596b546],
23	frequencies	NNS	O	frequency	prep_in	20	SENT_151	[p4l609t516r799b554],
24	of	IN	O	of	_	0	SENT_151	[p4l814t516r849b546],
25	the	DT	O	the	det	27	SENT_151	[p4l860t516r910b546],
26	nonfunctional	JJ	O	nonfunctional	amod	27	SENT_151	[p4l923t516r1153b546],
27	alleles	NNS	O	allele	prep_of	23	SENT_151	[p4l1167t516r1280b546],
28	.	.	O	.	_	0	SENT_151	[p4l1167t516r1280b546],

1	The	DT	O	the	det	2	SENT_152	[p4l1295t516r1359b546],
2	frequency	NN	O	frequency	nsubj	4	SENT_152	[p4l1372t516r1536b554],
3	is	VBZ	O	be	cop	4	SENT_152	[p4l1550t516r1576b546],
4	low	JJ	O	low	_	0	SENT_152	[p4l1590t516r1657b551],
5	,	,	O	,	_	0	SENT_152	[p4l1590t516r1657b551],
6	ranging	VBG	O	range	parataxis	4	SENT_152	[p4l1671t516r1797b554],
7	from	IN	O	from	_	0	SENT_152	[p4l1811t516r1891b546],
8	1.2	CD	PERCENT	1.2	number	12	SENT_152	[p4l550t566r630b596],
9	%	NN	PERCENT	%	dep	12	SENT_152	[p4l550t566r630b596],
10	to	TO	O	to	dep	12	SENT_152	[p4l641t570r672b595],
11	3.8	CD	PERCENT	3.8	number	12	SENT_152	[p4l683t566r776b601],
12	%	NN	PERCENT	%	prep_from	6	SENT_152	[p4l683t566r776b601],
13	,	,	O	,	_	0	SENT_152	[p4l683t566r776b601],
14	in	IN	O	in	_	0	SENT_152	[p4l787t566r818b595],
15	Caucasian	NNP	MISC	Caucasian	nn	16	SENT_152	[p4l828t566r997b595],
16	Europeans	NNPS	MISC	Europeans	prep_in	4	SENT_152	[p4l1006t567r1189b604],
17	,	,	O	,	_	0	SENT_152	[p4l1006t567r1189b604],
18	but	CC	O	but	_	0	SENT_152	[p4l1200t566r1252b595],
19	as	RB	O	as	advmod	20	SENT_152	[p4l1261t575r1293b595],
20	high	JJ	O	high	amod	26	SENT_152	[p4l1303t566r1376b604],
21	as	IN	O	as	_	0	SENT_152	[p4l1386t575r1418b595],
22	23	CD	PERCENT	23	num	23	SENT_152	[p4l1429t566r1502b596],
23	%	NN	PERCENT	%	prep_as	20	SENT_152	[p4l1429t566r1502b596],
24	in	IN	O	in	_	0	SENT_152	[p4l1513t566r1544b595],
25	Oriental	JJ	O	oriental	prep_in	20	SENT_152	[p4l1554t566r1688b595],
26	populations	NNS	O	population	nsubj	27	SENT_152	[p4l1697t566r1890b604],
27	(	VBP	O	(	conj_but	4	SENT_152	[p4l547t615r609b651],
28	33	CD	NUMBER	33	dobj	27	SENT_152	[p4l547t615r609b651],
29	,	,	O	,	_	0	SENT_152	[p4l547t615r609b651],
30	34	CD	NUMBER	34	num	31	SENT_152	[p4l626t615r687b651],
31	)	NN	O	)	appos	28	SENT_152	[p4l626t615r687b651],
32	.	.	O	.	_	0	SENT_152	[p4l626t615r687b651],

1	The	DT	O	the	det	3	SENT_153	[p4l703t615r767b644],
2	Same	JJ	O	same	amod	3	SENT_153	[p4l782t624r865b644],
3	dose	NN	O	dose	nsubj	7	SENT_153	[p4l879t615r954b644],
4	of	IN	O	of	_	0	SENT_153	[p4l968t615r1004b644],
5	a	DT	O	a	det	6	SENT_153	[p4l1016t624r1033b644],
6	PPI	NNP	O	PPI	prep_of	3	SENT_153	[p4l1046t616r1105b644],
7	produces	VBZ	O	produce	_	0	SENT_153	[p4l1119t615r1267b653],
8	3-12	CD	NUMBER	3-12	num	9	SENT_153	[p4l1283t615r1363b644],
9	times	NNS	O	time	npadvmod	10	SENT_153	[p4l1377t615r1465b644],
10	greater	JJR	O	greater	amod	12	SENT_153	[p4l1481t620r1595b653],
11	drug	NN	O	drug	nn	12	SENT_153	[p4l1609t615r1683b653],
12	exposure	NN	O	exposure	dobj	7	SENT_153	[p4l1697t624r1845b653],
13	in	IN	O	in	_	0	SENT_153	[p4l1859t615r1891b644],
14	PMS	NN	O	pm	prep_in	12	SENT_153	[p4l546t665r620b693],
15	than	IN	O	than	prep	7	SENT_153	[p4l634t664r705b693],
16	in	IN	O	in	pcomp	15	SENT_153	[p4l717t664r749b693],
17	EMS	NNP	O	EMS	pobj	16	SENT_153	[p4l761t665r847b693],
18	.	.	O	.	_	0	SENT_153	[p4l761t665r847b693],

1	HetEMs	NNS	O	hetem	nsubj	2	SENT_154	[p4l862t665r998b693],
2	have	VBP	O	have	_	0	SENT_154	[p4l1011t664r1087b693],
3	2-4	CD	NUMBER	2-4	num	4	SENT_154	[p4l1101t664r1161b693],
4	times	NNS	O	time	npadvmod	5	SENT_154	[p4l1174t664r1262b693],
5	higher	JJR	O	higher	amod	7	SENT_154	[p4l1276t664r1382b702],
6	AUC	NN	O	auc	nn	7	SENT_154	[p4l1394t664r1477b694],
7	values	NNS	O	value	dobj	2	SENT_154	[p4l1491t664r1594b693],
8	than	IN	O	than	mark	9	SENT_154	[p4l1607t664r1678b693],
9	do	VBP	O	do	dep	7	SENT_154	[p4l1691t664r1731b693],
10	homozygous	JJ	O	homozygous	amod	11	SENT_154	[p4l1744t664r1889b702, p4l547t723r623b752],
11	EMS	NNP	O	EMS	dobj	9	SENT_154	[p4l634t715r720b743],
12	.	.	O	.	_	0	SENT_154	[p4l634t715r720b743],

1	These	DT	O	these	det	3	SENT_155	[p4l733t714r831b743],
2	genotype	NN	O	genotype	nn	3	SENT_155	[p4l842t714r1101b752],
3	—	NN	O	—	nsubj	8	SENT_155	[p4l842t714r1101b752],
4	based	VBN	O	base	partmod	3	SENT_155	[p4l842t714r1101b752],
5	differences	NNS	O	difference	dobj	4	SENT_155	[p4l1112t714r1293b743],
6	in	IN	O	in	_	0	SENT_155	[p4l1305t714r1336b743],
7	AUC	NN	O	auc	prep_in	5	SENT_155	[p4l1347t714r1430b743],
8	translate	VB	O	translate	_	0	SENT_155	[p4l1442t714r1581b743],
9	into	IN	O	into	_	0	SENT_155	[p4l1592t714r1655b743],
10	differences	NNS	O	difference	prep_into	8	SENT_155	[p4l1667t714r1848b743],
11	in	IN	O	in	_	0	SENT_155	[p4l1859t714r1891b743],
12	the	DT	O	the	det	13	SENT_155	[p4l546t763r596b792],
13	extent	NN	O	extent	prep_in	10	SENT_155	[p4l606t768r706b792],
14	and	CC	O	and	_	0	SENT_155	[p4l716t763r774b792],
15	duration	NN	O	duration	conj_and	13	SENT_155	[p4l784t763r921b792],
16	of	IN	O	of	_	0	SENT_155	[p4l931t763r967b792],
17	inhibition	NN	O	inhibition	prep_of	13	SENT_155	[p4l973t763r1134b792],
18	of	IN	O	of	_	0	SENT_155	[p4l1144t763r1180b792],
19	gastric	JJ	O	gastric	amod	21	SENT_155	[p4l1187t763r1296b801],
20	acid	NN	O	acid	nn	21	SENT_155	[p4l1307t763r1374b792],
21	secretion	NN	O	secretion	prep_of	17	SENT_155	[p4l1385t763r1541b792],
22	.	.	O	.	_	0	SENT_155	[p4l1385t763r1541b792],

1	After	IN	O	after	_	0	SENT_156	[p4l1552t763r1640b792],
2	a	DT	O	a	det	7	SENT_156	[p4l1649t772r1667b792],
3	single	JJ	O	single	amod	7	SENT_156	[p4l1677t763r1773b801],
4	20	CD	NUMBER	20	number	5	SENT_156	[p4l1784t763r1890b801],
5	—	CD	NUMBER	—	num	7	SENT_156	[p4l1784t763r1890b801],
6	mg	NN	O	mg	nn	7	SENT_156	[p4l1784t763r1890b801],
7	dose	NN	O	dose	prep_after	21	SENT_156	[p4l547t812r621b841],
8	of	IN	O	of	_	0	SENT_156	[p4l634t812r670b841],
9	omeprazole	NN	O	omeprazole	prep_of	7	SENT_156	[p4l679t812r880b850],
10	,	,	O	,	_	0	SENT_156	[p4l679t812r880b850],
11	the	DT	O	the	det	15	SENT_156	[p4l894t812r944b841],
12	intragastric	JJ	O	intragastric	amod	15	SENT_156	[p4l956t812r1141b850],
13	pH	NN	O	ph	nn	15	SENT_156	[p4l1153t813r1203b850],
14	(	NN	O	(	nn	15	SENT_156	[p4l1217t812r1351b848],
15	median	NN	O	median	nsubj	21	SENT_156	[p4l1217t812r1351b848],
16	over	IN	O	over	_	0	SENT_156	[p4l1363t821r1435b841],
17	24	CD	NUMBER	24	num	19	SENT_156	[p4l1447t812r1486b841],
18	h	NN	O	h	nn	19	SENT_156	[p4l1498t812r1531b848],
19	)	NN	O	)	prep_over	15	SENT_156	[p4l1498t812r1531b848],
20	was	VBD	O	be	cop	21	SENT_156	[p4l1545t821r1607b841],
21	4.5	CD	NUMBER	4.5	_	0	SENT_156	[p4l1619t812r1669b842],
22	for	IN	O	for	_	0	SENT_156	[p4l1683t812r1731b841],
23	PMS	NNP	O	PMS	prep_for	21	SENT_156	[p4l1742t813r1826b847],
24	,	,	O	,	_	0	SENT_156	[p4l1742t813r1826b847],
25	3.3	CD	NUMBER	3.3	conj_and	21	SENT_156	[p4l1841t812r1888b842],
26	for	IN	O	for	_	0	SENT_156	[p4l546t861r594b890],
27	hetEMs	NNS	O	hetem	prep_for	25	SENT_156	[p4l605t861r732b890],
28	and	CC	O	and	_	0	SENT_156	[p4l746t861r804b890],
29	2.1	CD	NUMBER	2.1	conj_and	21	SENT_156	[p4l816t861r863b890],
30	for	IN	O	for	_	0	SENT_156	[p4l878t861r926b890],
31	EMS	NNP	O	EMS	prep_for	29	SENT_156	[p4l937t862r1023b890],
32	.	.	O	.	_	0	SENT_156	[p4l937t862r1023b890],

1	In	IN	O	in	_	0	SENT_157	[p4l1037t862r1071b890],
2	view	NN	O	view	prep_in	32	SENT_157	[p4l1082t861r1160b890],
3	of	IN	O	of	_	0	SENT_157	[p4l1173t861r1209b890],
4	the	DT	O	the	det	6	SENT_157	[p4l1218t861r1267b890],
5	close	JJ	O	close	amod	6	SENT_157	[p4l1280t861r1363b890],
6	relationship	NN	O	relationship	prep_of	2	SENT_157	[p4l1375t861r1570b899],
7	between	IN	O	between	_	0	SENT_157	[p4l1581t861r1719b890],
8	drug	NN	O	drug	nn	9	SENT_157	[p4l1731t861r1806b899],
9	concentration	NN	O	concentration	prep_between	6	SENT_157	[p4l1818t870r1889b890, p4l547t910r711b940],
10	and	CC	O	and	_	0	SENT_157	[p4l725t910r783b940],
11	inhibition	NN	O	inhibition	conj_and	9	SENT_157	[p4l795t910r956b940],
12	of	IN	O	of	_	0	SENT_157	[p4l969t910r1005b940],
13	acid	NN	O	acid	nn	14	SENT_157	[p4l1015t910r1083b940],
14	secretion	NN	O	secretion	prep_of	6	SENT_157	[p4l1097t910r1253b945],
15	,	,	O	,	_	0	SENT_157	[p4l1097t910r1253b945],
16	the	DT	O	the	det	17	SENT_157	[p4l1267t910r1317b940],
17	outcome	NN	O	outcome	nsubj	32	SENT_157	[p4l1330t915r1471b940],
18	of	IN	O	of	_	0	SENT_157	[p4l1485t910r1520b940],
19	giving	VBG	O	give	prepc_of	17	SENT_157	[p4l1531t910r1634b948],
20	all	DT	O	all	det	21	SENT_157	[p4l1648t910r1687b940],
21	patients	NNS	O	patient	iobj	19	SENT_157	[p4l1700t910r1827b948],
22	the	DT	O	the	det	24	SENT_157	[p4l1841t910r1890b940],
23	same	JJ	O	same	amod	24	SENT_157	[p4l548t969r630b989],
24	dose	NN	O	dose	dobj	19	SENT_157	[p4l644t960r718b989],
25	to	TO	O	to	aux	26	SENT_157	[p4l731t964r762b989],
26	eradicate	VB	O	eradicate	infmod	24	SENT_157	[p4l775t960r923b989],
27	Hp	NNP	O	Hp	dobj	26	SENT_157	[p4l936t961r985b998],
28	and	CC	O	and	_	0	SENT_157	[p4l999t960r1058b989],
29	heal	VB	O	heal	infmod	24	SENT_157	[p4l1070t960r1138b989],
30	ulcers	NNS	O	ulcer	dobj	29	SENT_157	[p4l1151t960r1248b989],
31	is	VBZ	O	be	cop	32	SENT_157	[p4l1262t960r1287b989],
32	likely	JJ	O	likely	_	0	SENT_157	[p4l1301t960r1394b998],
33	to	TO	O	to	aux	36	SENT_157	[p4l1407t964r1438b989],
34	be	VB	O	be	auxpass	36	SENT_157	[p4l1450t960r1489b989],
35	signiﬁcantly	RB	O	signiﬁcantly	advmod	36	SENT_157	[p4l1503t960r1705b998],
36	inﬂuenced	VBN	O	inﬂuenced	xcomp	32	SENT_157	[p4l1719t960r1891b989],
37	by	IN	O	by	_	0	SENT_157	[p4l546t1009r586b1047],
38	CYP2C19	NN	O	cyp2c19	nn	39	SENT_157	[p4l600t1009r764b1039],
39	genotype	NN	O	genotype	agent	36	SENT_157	[p4l775t1014r926b1047],
40	(	CD	NUMBER	(	number	41	SENT_157	[p4l939t1009r1000b1045],
41	35	CD	NUMBER	35	dep	39	SENT_157	[p4l939t1009r1000b1045],
42	,	,	O	,	_	0	SENT_157	[p4l939t1009r1000b1045],
43	36	CD	NUMBER	36	num	44	SENT_157	[p4l1014t1009r1076b1045],
44	)	NN	O	)	appos	39	SENT_157	[p4l1014t1009r1076b1045],
45	.	.	O	.	_	0	SENT_157	[p4l1014t1009r1076b1045],

1	This	DT	O	this	det	2	SENT_158	[p4l596t1058r668b1087],
2	contention	NN	O	contention	nsubjpass	4	SENT_158	[p4l684t1058r858b1087],
3	is	VBZ	O	be	auxpass	4	SENT_158	[p4l874t1058r900b1087],
4	supported	VBN	O	support	_	0	SENT_158	[p4l917t1058r1079b1096],
5	by	IN	O	by	_	0	SENT_158	[p4l1093t1058r1134b1096],
6	several	JJ	O	several	amod	8	SENT_158	[p4l1151t1058r1265b1087],
7	clinical	JJ	O	clinical	amod	8	SENT_158	[p4l1280t1058r1401b1087],
8	studies	NNS	O	study	agent	4	SENT_158	[p4l1418t1058r1530b1087],
9	of	IN	O	of	_	0	SENT_158	[p4l1547t1058r1583b1087],
10	Hp	NN	O	hp	nn	11	SENT_158	[p4l1595t1059r1645b1096],
11	eradication	NN	O	eradication	prep_of	8	SENT_158	[p4l1661t1058r1844b1087],
12	in	IN	O	in	_	0	SENT_158	[p4l1859t1058r1891b1087],
13	which	WDT	O	which	rel	23	SENT_158	[p4l547t1108r647b1137],
14	the	DT	O	the	det	17	SENT_158	[p4l657t1108r707b1137],
15	C	NN	O	c	nn	17	SENT_158	[p4l720t1108r746b1138],
16	YP2	NN	O	yp2	nn	17	SENT_158	[p4l748t1108r813b1137],
17	C	NN	O	c	nsubjpass	23	SENT_158	[p4l817t1108r843b1138],
18	1	CD	NUMBER	1	num	20	SENT_158	[p4l844t1108r859b1137],
19	9	CD	NUMBER	9	num	20	SENT_158	[p4l864t1108r883b1138],
20	genotype	NN	O	genotype	dep	17	SENT_158	[p4l894t1112r1045b1146],
21	was	VBD	O	be	auxpass	23	SENT_158	[p4l1056t1117r1118b1137],
22	retrospectively	RB	O	retrospectively	advmod	23	SENT_158	[p4l1129t1108r1373b1146],
23	analyzed	VBN	O	analyze	rcmod	8	SENT_158	[p4l1386t1108r1540b1146],
24	.	.	O	.	_	0	SENT_158	[p4l1386t1108r1540b1146],

1	The	DT	O	the	det	3	SENT_159	[p4l1553t1108r1616b1137],
2	cure	NN	O	cure	nn	3	SENT_159	[p4l1627t1117r1697b1137],
3	rates	NNS	O	rate	dep	8	SENT_159	[p4l1708t1113r1785b1137],
4	of	IN	O	of	_	0	SENT_159	[p4l1797t1108r1833b1137],
5	Hp	NNP	O	Hp	nn	6	SENT_159	[p4l1841t1109r1890b1146],
6	EICHELBAUM	NNP	O	EICHELBAUM	prep_of	3	SENT_159	[p4l585t1166r826b1193],
7	I	PRP	O	I	dep	8	SENT_159	[p4l844t1169r861b1187],
8	INGELMAN-SUNDBERG	NN	O	ingelman-sundberg	dep	10	SENT_159	[p4l880t1166r1292b1193],
9	I	PRP	O	I	dep	8	SENT_159	[p4l1310t1169r1327b1187],
10	EVANS	VBP	O	evan	_	0	SENT_159	[p4l1346t1166r1463b1193],

1	infection	NN	O	infection	nsubj	4	SENT_160	[p4l535t1289r682b1319],
2	were	VBD	O	be	cop	4	SENT_160	[p4l693t1298r772b1319],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_160	[p4l784t1289r986b1327],
4	lower	JJR	O	lower	_	0	SENT_160	[p4l997t1289r1090b1319],
5	in	IN	O	in	_	0	SENT_160	[p4l1099t1289r1131b1318],
6	EMS	NNP	O	EMS	prep_in	4	SENT_160	[p4l1141t1290r1217b1319],
7	than	IN	O	than	dep	4	SENT_160	[p4l1229t1289r1299b1319],
8	in	IN	O	in	_	0	SENT_160	[p4l1309t1289r1341b1318],
9	hetEMs	NN	O	hetem	prep_in	4	SENT_160	[p4l1351t1289r1478b1319],
10	and	CC	O	and	_	0	SENT_160	[p4l1490t1289r1549b1319],
11	PMS	NN	O	pm	prep_in	4	SENT_160	[p4l1559t1290r1633b1319],
12	(	CD	NUMBER	(	num	11	SENT_160	[p4l1645t1289r1783b1325],
13	35-41	CD	NUMBER	35-41	num	14	SENT_160	[p4l1645t1289r1783b1325],
14	)	NN	O	)	dep	11	SENT_160	[p4l1645t1289r1783b1325],
15	.	.	O	.	_	0	SENT_160	[p4l1645t1289r1783b1325],

1	Most	JJS	O	most	amod	3	SENT_161	[p4l1795t1290r1880b1319],
2	treatment	NN	O	treatment	nn	3	SENT_161	[p4l536t1343r692b1368],
3	failures	NNS	O	failure	nsubjpass	5	SENT_161	[p4l701t1339r822b1368],
4	were	VBD	O	be	auxpass	5	SENT_161	[p4l833t1348r912b1368],
5	observed	VBN	O	observe	_	0	SENT_161	[p4l922t1339r1070b1369],
6	in	IN	O	in	_	0	SENT_161	[p4l1079t1339r1110b1368],
7	EMS	NNP	O	EMS	prep_in	5	SENT_161	[p4l1119t1340r1205b1368],
8	.	.	O	.	_	0	SENT_161	[p4l1119t1340r1205b1368],

1	In	IN	O	in	_	0	SENT_162	[p4l1216t1340r1250b1368],
2	one	CD	NUMBER	one	num	3	SENT_162	[p4l1259t1348r1318b1368],
3	study	NN	O	study	prep_in	14	SENT_162	[p4l1328t1339r1415b1377],
4	(	CD	NUMBER	(	number	5	SENT_162	[p4l1426t1339r1502b1375],
5	41	CD	NUMBER	41	num	6	SENT_162	[p4l1426t1339r1502b1375],
6	)	NN	O	)	dep	3	SENT_162	[p4l1426t1339r1502b1375],
7	,	,	O	,	_	0	SENT_162	[p4l1426t1339r1502b1375],
8	clear	JJ	O	clear	amod	12	SENT_162	[p4l1513t1339r1593b1368],
9	genotype	NN	O	genotype	nn	12	SENT_162	[p4l1602t1339r1880b1377],
10	—	NN	O	—	nn	12	SENT_162	[p4l1602t1339r1880b1377],
11	related	JJ	O	related	amod	12	SENT_162	[p4l1602t1339r1880b1377],
12	differences	NNS	O	difference	nsubjpass	14	SENT_162	[p4l536t1389r717b1419],
13	were	VBD	O	be	auxpass	14	SENT_162	[p4l734t1399r813b1419],
14	observed	VBN	O	observe	_	0	SENT_162	[p4l831t1389r978b1419],
15	in	IN	O	in	_	0	SENT_162	[p4l995t1389r1026b1418],
16	the	DT	O	the	det	18	SENT_162	[p4l1042t1389r1092b1419],
17	PPI	NNP	O	PPI	nn	18	SENT_162	[p4l1108t1390r1167b1418],
18	concentrations	NNS	O	concentration	prep_in	14	SENT_162	[p4l1184t1389r1423b1419],
19	at	IN	O	at	_	0	SENT_162	[p4l1442t1394r1470b1419],
20	the	DT	O	the	det	21	SENT_162	[p4l1486t1389r1535b1419],
21	end	NN	O	end	prep_at	14	SENT_162	[p4l1552t1389r1611b1419],
22	of	IN	O	of	_	0	SENT_162	[p4l1628t1389r1663b1419],
23	the	DT	O	the	det	25	SENT_162	[p4l1677t1389r1726b1419],
24	dose	NN	O	dose	nn	25	SENT_162	[p4l1743t1389r1818b1419],
25	interval	NN	O	interval	prep_of	21	SENT_162	[p4l1834t1389r1878b1418, p4l536t1439r628b1469],
26	(	CD	NUMBER	(	num	27	SENT_162	[p4l644t1439r725b1475],
27	PM	NN	O	pm	dep	25	SENT_162	[p4l644t1439r725b1475],
28	,	,	O	,	_	0	SENT_162	[p4l644t1439r725b1475],
29	753	CD	NUMBER	753	num	30	SENT_162	[p4l742t1439r801b1469],
30	ng/ml	NN	O	ng/ml	appos	27	SENT_162	[p4l818t1439r924b1477],
31	;	:	O	;	_	0	SENT_162	[p4l818t1439r924b1477],
32	hetEM	NNP	O	hetEM	dep	27	SENT_162	[p4l941t1439r1062b1474],
33	,	,	O	,	_	0	SENT_162	[p4l941t1439r1062b1474],
34	59	CD	NUMBER	59	appos	32	SENT_162	[p4l1079t1439r1129b1474],
35	;	:	O	;	_	0	SENT_162	[p4l1079t1439r1129b1474],
36	EM	NNP	O	EM	dep	27	SENT_162	[p4l1146t1440r1216b1474],
37	,	,	O	,	_	0	SENT_162	[p4l1146t1440r1216b1474],
38	21	CD	NUMBER	21	num	39	SENT_162	[p4l1233t1439r1295b1475],
39	)	NN	O	)	appos	36	SENT_162	[p4l1233t1439r1295b1475],
40	.	.	O	.	_	0	SENT_162	[p4l1233t1439r1295b1475],

1	Multivariate	JJ	O	multivariate	amod	2	SENT_163	[p4l1312t1439r1515b1469],
2	analysis	NN	O	analysis	nsubj	3	SENT_163	[p4l1531t1439r1662b1477],
3	showed	VBD	O	show	_	0	SENT_163	[p4l1679t1439r1803b1469],
4	that	IN	O	that	complm	11	SENT_163	[p4l1818t1439r1880b1469],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_163	[p4l536t1489r704b1519],
6	polymorphism	NN	O	polymorphism	nsubj	11	SENT_163	[p4l722t1489r965b1527],
7	was	VBD	O	be	cop	11	SENT_163	[p4l982t1498r1044b1518],
8	the	DT	O	the	det	11	SENT_163	[p4l1062t1489r1112b1518],
9	most	RBS	O	most	advmod	10	SENT_163	[p4l1130t1493r1210b1518],
10	important	JJ	O	important	amod	11	SENT_163	[p4l1227t1489r1388b1527],
11	factor	NN	O	factor	ccomp	3	SENT_163	[p4l1405t1489r1507b1524],
12	,	,	O	,	_	0	SENT_163	[p4l1405t1489r1507b1524],
13	apart	RB	O	apart	_	0	SENT_163	[p4l1528t1493r1609b1527],
14	from	IN	O	from	_	0	SENT_163	[p4l1626t1489r1707b1518],
15	antibiotic	JJ	O	antibiotic	amod	16	SENT_163	[p4l1724t1489r1879b1518],
16	resistance	NN	O	resistance	prep_apart_from	11	SENT_163	[p4l535t1538r707b1572],
17	,	,	O	,	_	0	SENT_163	[p4l535t1538r707b1572],
18	inﬂuencing	VBG	O	inﬂuencing	amod	20	SENT_163	[p4l721t1538r906b1576],
19	successful	JJ	O	successful	amod	20	SENT_163	[p4l920t1538r1088b1567],
20	eradication	NN	O	eradication	appos	16	SENT_163	[p4l1101t1538r1292b1567],
21	.	.	O	.	_	0	SENT_163	[p4l1101t1538r1292b1567],

1	The	DT	O	the	det	2	SENT_164	[p4l1307t1538r1370b1567],
2	difference	NN	O	difference	nsubj	19	SENT_164	[p4l1383t1538r1548b1567],
3	in	IN	O	in	_	0	SENT_164	[p4l1561t1538r1592b1567],
4	absolute	JJ	O	absolute	amod	5	SENT_164	[p4l1605t1538r1741b1567],
5	risk	NN	O	risk	prep_in	2	SENT_164	[p4l1753t1538r1816b1567],
6	between	IN	O	between	_	0	SENT_164	[p4l1827t1538r1878b1567, p4l536t1592r634b1616],
7	patients	NNS	O	patient	prep_between	5	SENT_164	[p4l641t1587r768b1625],
8	with	IN	O	with	_	0	SENT_164	[p4l777t1587r850b1616],
9	the	DT	O	the	det	12	SENT_164	[p4l858t1587r907b1616],
10	wild	JJ	O	wild	amod	12	SENT_164	[p4l915t1587r1073b1625],
11	—	NN	O	—	nn	12	SENT_164	[p4l915t1587r1073b1625],
12	type	NN	O	type	prep_with	7	SENT_164	[p4l915t1587r1073b1625],
13	and	CC	O	and	_	0	SENT_164	[p4l1082t1587r1140b1616],
14	variant	JJ	O	variant	amod	15	SENT_164	[p4l1148t1587r1261b1617],
15	alleles	NNS	O	allele	conj_and	12	SENT_164	[p4l1269t1587r1372b1616],
16	was	VBD	O	be	cop	19	SENT_164	[p4l1382t1596r1443b1617],
17	~	RB	O	~	advmod	19	SENT_164	[p4l1454t1587r1568b1617],
18	20	CD	PERCENT	20	num	19	SENT_164	[p4l1454t1587r1568b1617],
19	%	NN	PERCENT	%	_	0	SENT_164	[p4l1454t1587r1568b1617],
20	.	.	O	.	_	0	SENT_164	[p4l1454t1587r1568b1617],

1	This	DT	O	this	det	2	SENT_165	[p4l1577t1587r1649b1616],
2	study	NN	O	study	nsubj	3	SENT_165	[p4l1659t1587r1746b1625],
3	showed	VBD	O	show	_	0	SENT_165	[p4l1756t1587r1880b1617],
4	similar	JJ	O	similar	amod	6	SENT_165	[p4l537t1636r651b1665],
5	lansoprazole	NN	O	lansoprazole	nn	6	SENT_165	[p4l664t1636r872b1674],
6	concentrations	NNS	O	concentration	dobj	3	SENT_165	[p4l887t1636r1126b1665],
7	in	IN	O	in	_	0	SENT_165	[p4l1141t1636r1173b1665],
8	EM	NN	O	em	nn	9	SENT_165	[p4l1186t1637r1247b1665],
9	patients	NNS	O	patient	prep_in	6	SENT_165	[p4l1261t1636r1389b1674],
10	regardless	RB	O	regardless	_	0	SENT_165	[p4l1403t1636r1569b1674],
11	of	IN	O	of	_	0	SENT_165	[p4l1585t1636r1620b1665],
12	Hp	NNP	O	Hp	prep_regardless_of	6	SENT_165	[p4l1632t1636r1879b1674],
13	—	CD	NUMBER	—	num	12	SENT_165	[p4l1632t1636r1879b1674],
14	eradication	NN	O	eradication	nn	15	SENT_165	[p4l1632t1636r1879b1674],
15	Success	NN	O	success	dep	6	SENT_165	[p4l537t1694r669b1720],
16	;	:	O	;	_	0	SENT_165	[p4l537t1694r669b1720],
17	other	JJ	O	other	amod	18	SENT_165	[p4l685t1685r770b1715],
18	factors	NNS	O	factor	nsubj	24	SENT_165	[p4l784t1685r894b1715],
19	modifying	VBG	O	modify	partmod	18	SENT_165	[p4l909t1685r1081b1723],
20	treatment	NN	O	treatment	nn	21	SENT_165	[p4l1096t1689r1252b1715],
21	response	NN	O	response	dobj	19	SENT_165	[p4l1265t1694r1410b1723],
22	were	VBD	O	be	cop	24	SENT_165	[p4l1425t1694r1504b1715],
23	bacterial	JJ	O	bacterial	amod	24	SENT_165	[p4l1518t1685r1660b1715],
24	Strain	NNP	O	Strain	parataxis	3	SENT_165	[p4l1676t1685r1775b1720],
25	,	,	O	,	_	0	SENT_165	[p4l1676t1685r1775b1720],
26	resistance	NN	O	resistance	parataxis	3	SENT_165	[p4l1790t1685r1878b1715, p4l536t1740r622b1764],
27	to	TO	O	to	_	0	SENT_165	[p4l639t1739r669b1764],
28	antibiotics	NNS	O	antibiotic	prep_to	26	SENT_165	[p4l687t1735r867b1770],
29	,	,	O	,	_	0	SENT_165	[p4l687t1735r867b1770],
30	and	CC	O	and	_	0	SENT_165	[p4l886t1735r945b1764],
31	promoter	NN	O	promoter	nn	33	SENT_165	[p4l960t1740r1113b1773],
32	-511	CD	NUMBER	-511	num	33	SENT_165	[p4l1128t1735r1207b1765],
33	polymorphism	NN	O	polymorphism	parataxis	3	SENT_165	[p4l1227t1735r1469b1773],
34	of	IN	O	of	_	0	SENT_165	[p4l1486t1735r1521b1764],
35	the	DT	O	the	det	38	SENT_165	[p4l1535t1735r1585b1764],
36	proinﬂammatory	JJ	O	proinﬂammatory	amod	38	SENT_165	[p4l1601t1735r1879b1773],
37	cytokine	NN	O	cytokine	nn	38	SENT_165	[p4l536t1785r677b1823],
38	interleukin-1	NN	O	interleukin-1	prep_of	33	SENT_165	[p4l686t1785r896b1814],
39	[	CD	NUMBER	[	number	40	SENT_165	[p4l904t1784r924b1822],
40	3	CD	NUMBER	3	num	44	SENT_165	[p4l904t1784r924b1822],
41	(	NN	O	(	nn	44	SENT_165	[p4l938t1785r1019b1821],
42	IL-1	NN	O	il-1	nn	44	SENT_165	[p4l938t1785r1019b1821],
43	B	NN	O	b	nn	44	SENT_165	[p4l1028t1784r1072b1822],
44	)	NN	O	)	dep	33	SENT_165	[p4l1028t1784r1072b1822],
45	.	.	O	.	_	0	SENT_165	[p4l1028t1784r1072b1822],

1	IL-1	NN	O	il-1	nsubj	5	SENT_166	[p4l1084t1785r1153b1814],
2	[	CD	NUMBER	[	num	3	SENT_166	[p4l1162t1784r1181b1822],
3	3	CD	NUMBER	3	dep	1	SENT_166	[p4l1162t1784r1181b1822],
4	is	VBZ	O	be	cop	5	SENT_166	[p4l1193t1785r1219b1814],
5	important	JJ	O	important	_	0	SENT_166	[p4l1229t1785r1390b1823],
6	in	IN	O	in	_	0	SENT_166	[p4l1399t1785r1430b1814],
7	initiating	VBG	O	initiate	prepc_in	5	SENT_166	[p4l1440t1785r1588b1823],
8	the	DT	O	the	det	10	SENT_166	[p4l1598t1785r1647b1814],
9	inﬂammatory	JJ	O	inﬂammatory	amod	10	SENT_166	[p4l1657t1785r1879b1823],
10	response	NN	O	response	dobj	7	SENT_166	[p4l535t1843r679b1872],
11	to	TO	O	to	_	0	SENT_166	[p4l696t1838r727b1863],
12	Hp	NNP	O	Hp	prep_to	7	SENT_166	[p4l743t1835r801b1872],
13	.	.	O	.	_	0	SENT_166	[p4l743t1835r801b1872],

1	In	IN	O	in	_	0	SENT_167	[p4l820t1835r853b1863],
2	one	CD	NUMBER	one	num	3	SENT_167	[p4l870t1843r928b1863],
3	study	NN	O	study	prep_in	9	SENT_167	[p4l946t1834r1040b1872],
4	,	,	O	,	_	0	SENT_167	[p4l946t1834r1040b1872],
5	the	DT	O	the	det	7	SENT_167	[p4l1057t1834r1107b1863],
6	eradication	NN	O	eradication	nn	7	SENT_167	[p4l1124t1834r1307b1863],
7	rate	NN	O	rate	nsubj	9	SENT_167	[p4l1323t1839r1384b1863],
8	was	VBD	O	be	cop	9	SENT_167	[p4l1401t1843r1463b1863],
9	highest	JJS	O	highest	_	0	SENT_167	[p4l1479t1834r1599b1872],
10	in	IN	O	in	_	0	SENT_167	[p4l1615t1834r1646b1863],
11	patients	NNS	O	patient	prep_in	9	SENT_167	[p4l1662t1834r1789b1872],
12	with	IN	O	with	_	0	SENT_167	[p4l1807t1834r1880b1863],
13	the	DT	O	the	det	16	SENT_167	[p4l535t1884r585b1913],
14	IL-1	NN	O	il-1	nn	16	SENT_167	[p4l599t1883r844b1921],
15	[	CD	NUMBER	[	num	16	SENT_167	[p4l599t1883r844b1921],
16	3-511T	NN	O	3-511t	prep_with	11	SENT_167	[p4l599t1883r844b1921],
17	/	:	O	/	punct	19	SENT_167	[p4l599t1883r844b1921],
18	T	NN	O	t	nn	19	SENT_167	[p4l599t1883r844b1921],
19	genotype	NN	O	genotype	dep	16	SENT_167	[p4l858t1888r1008b1922],
20	and	CC	O	and	_	0	SENT_167	[p4l1023t1884r1081b1913],
21	lowest	JJS	O	lowest	dep	16	SENT_167	[p4l1094t1884r1201b1913],
22	in	IN	O	in	_	0	SENT_167	[p4l1214t1884r1245b1913],
23	the	DT	O	the	det	26	SENT_167	[p4l1258t1884r1307b1913],
24	-511	CD	NUMBER	-511	num	26	SENT_167	[p4l1320t1884r1469b1913],
25	C/C	NN	O	c/c	nn	26	SENT_167	[p4l1320t1884r1469b1913],
26	genotype	NN	O	genotype	prep_in	16	SENT_167	[p4l1484t1888r1644b1922],
27	;	:	O	;	_	0	SENT_167	[p4l1484t1888r1644b1922],
28	heterozygous	JJ	O	heterozygous	amod	29	SENT_167	[p4l1659t1884r1878b1922],
29	patients	NNS	O	patient	nsubj	30	SENT_167	[p4l535t1934r663b1972],
30	had	VBD	O	have	parataxis	9	SENT_167	[p4l675t1934r734b1963],
31	intermediate	JJ	O	intermediate	amod	33	SENT_167	[p4l745t1934r951b1963],
32	eradication	NN	O	eradication	nn	33	SENT_167	[p4l964t1934r1146b1963],
33	rates	NNS	O	rate	dobj	30	SENT_167	[p4l1158t1938r1234b1963],
34	(	VBP	O	(	rcmod	33	SENT_167	[p4l1248t1934r1323b1970],
35	42	CD	NUMBER	42	number	36	SENT_167	[p4l1248t1934r1323b1970],
36	)	CD	NUMBER	)	dobj	34	SENT_167	[p4l1248t1934r1323b1970],
37	.	.	O	.	_	0	SENT_167	[p4l1248t1934r1323b1970],

1	The	DT	O	the	det	2	SENT_168	[p4l585t1984r648b2013],
2	impact	NN	O	impact	nsubjpass	16	SENT_168	[p4l658t1984r771b2022],
3	of	IN	O	of	_	0	SENT_168	[p4l780t1984r816b2013],
4	the	DT	O	the	det	6	SENT_168	[p4l822t1984r872b2013],
5	CYPZCI9	NN	O	cypzci9	nn	6	SENT_168	[p4l884t1984r1047b2013],
6	genotype	NN	O	genotype	prep_of	2	SENT_168	[p4l1056t1988r1207b2022],
7	on	IN	O	on	_	0	SENT_168	[p4l1217t1993r1257b2013],
8	cure	NN	O	cure	nn	9	SENT_168	[p4l1267t1993r1336b2013],
9	rates	NNS	O	rate	prep_on	6	SENT_168	[p4l1346t1988r1422b2013],
10	for	IN	O	for	_	0	SENT_168	[p4l1433t1984r1481b2013],
11	gastroesophageal	NN	O	gastroesophageal	nn	13	SENT_168	[p4l1490t1984r1774b2022],
12	reﬂux	NN	O	reﬂux	nn	13	SENT_168	[p4l1783t1984r1879b2013],
13	disease	NN	O	disease	prep_for	9	SENT_168	[p4l536t2034r654b2063],
14	has	VBZ	O	have	aux	16	SENT_168	[p4l664t2034r718b2063],
15	been	VBN	O	be	auxpass	16	SENT_168	[p4l728t2034r806b2063],
16	studied	VBN	O	study	dep	25	SENT_168	[p4l817t2034r935b2063],
17	only	RB	O	only	advmod	16	SENT_168	[p4l945t2034r1017b2071],
18	in	IN	O	in	_	0	SENT_168	[p4l1028t2034r1059b2062],
19	Japanese	JJ	MISC	japanese	amod	20	SENT_168	[p4l1069t2034r1215b2071],
20	patients	NNS	O	patient	prep_in	16	SENT_168	[p4l1225t2034r1353b2071],
21	in	IN	O	in	_	0	SENT_168	[p4l1364t2034r1395b2062],
22	two	CD	NUMBER	two	num	24	SENT_168	[p4l1405t2038r1465b2063],
23	small	JJ	O	small	amod	24	SENT_168	[p4l1477t2034r1564b2063],
24	trials	NNS	O	trial	prep_in	20	SENT_168	[p4l1574t2034r1656b2063],
25	(	VBP	O	(	_	0	SENT_168	[p4l1668t2034r1730b2069],
26	43	CD	NUMBER	43	nsubj	25	SENT_168	[p4l1668t2034r1730b2069],
27	,	,	O	,	_	0	SENT_168	[p4l1668t2034r1730b2069],
28	44	CD	NUMBER	44	num	29	SENT_168	[p4l1741t2034r1804b2069],
29	)	NN	O	)	appos	26	SENT_168	[p4l1741t2034r1804b2069],
30	.	.	O	.	_	0	SENT_168	[p4l1741t2034r1804b2069],

1	The	DT	O	the	det	4	SENT_169	[p4l1816t2034r1879b2063],
2	highest	JJS	O	highest	amod	4	SENT_169	[p4l535t2083r655b2121],
3	cure	NN	O	cure	nn	4	SENT_169	[p4l670t2092r739b2112],
4	rates	NNS	O	rate	nsubjpass	6	SENT_169	[p4l754t2087r831b2112],
5	were	VBD	O	be	auxpass	6	SENT_169	[p4l847t2092r926b2112],
6	observed	VBN	O	observe	_	0	SENT_169	[p4l941t2083r1090b2112],
7	in	IN	O	in	_	0	SENT_169	[p4l1104t2083r1135b2112],
8	PMS	NNP	O	PMS	prep_in	6	SENT_169	[p4l1150t2084r1224b2112],
9	(	CD	PERCENT	(	number	14	SENT_169	[p4l1241t2083r1358b2119],
10	84.6	CD	PERCENT	84.6	number	14	SENT_169	[p4l1241t2083r1358b2119],
11	%	NN	PERCENT	%	dep	14	SENT_169	[p4l1241t2083r1358b2119],
12	and	CC	O	and	_	0	SENT_169	[p4l1376t2083r1434b2112],
13	100	CD	PERCENT	100	num	15	SENT_169	[p4l1452t2083r1566b2119],
14	%	NN	PERCENT	%	num	15	SENT_169	[p4l1452t2083r1566b2119],
15	)	CD	NUMBER	)	dep	6	SENT_169	[p4l1452t2083r1566b2119],
16	.	.	O	.	_	0	SENT_169	[p4l1452t2083r1566b2119],

1	Rates	NNS	O	rate	nsubj	9	SENT_170	[p4l1583t2084r1673b2112],
2	for	IN	O	for	_	0	SENT_170	[p4l1689t2083r1737b2112],
3	hetEMs	NNS	O	hetem	prep_for	1	SENT_170	[p4l1751t2083r1878b2112],
4	were	VBD	O	be	cop	9	SENT_170	[p4l536t2142r615b2162],
5	67.9	CD	PERCENT	67.9	number	9	SENT_170	[p4l626t2133r730b2163],
6	%	NN	PERCENT	%	dep	9	SENT_170	[p4l626t2133r730b2163],
7	and	CC	O	and	_	0	SENT_170	[p4l742t2133r801b2162],
8	95	CD	PERCENT	95	conj_and	9	SENT_170	[p4l811t2133r894b2167],
9	%	NN	PERCENT	%	_	0	SENT_170	[p4l811t2133r894b2167],
10	,	,	O	,	_	0	SENT_170	[p4l811t2133r894b2167],
11	and	CC	O	and	_	0	SENT_170	[p4l907t2133r966b2162],
12	for	IN	O	for	dep	16	SENT_170	[p4l975t2133r1023b2162],
13	EMS	NNP	ORGANIZATION	EMS	pobj	12	SENT_170	[p4l1033t2134r1119b2167],
14	,	,	O	,	_	0	SENT_170	[p4l1033t2134r1119b2167],
15	45.8	CD	PERCENT	45.8	num	16	SENT_170	[p4l1130t2133r1235b2162],
16	%	NN	PERCENT	%	conj_and	9	SENT_170	[p4l1130t2133r1235b2162],
17	and	CC	O	and	_	0	SENT_170	[p4l1248t2133r1306b2162],
18	77.4	CD	PERCENT	77.4	num	19	SENT_170	[p4l1316t2133r1430b2162],
19	%	NN	PERCENT	%	conj_and	16	SENT_170	[p4l1316t2133r1430b2162],
20	.	.	O	.	_	0	SENT_170	[p4l1316t2133r1430b2162],

1	PMS	NNP	O	PMS	nsubj	4	SENT_171	[p4l1443t2134r1517b2162],
2	and	CC	O	and	_	0	SENT_171	[p4l1529t2133r1587b2162],
3	hetEMs	NNP	O	hetEMs	conj_and	1	SENT_171	[p4l1597t2133r1724b2162],
4	had	VBD	O	have	_	0	SENT_171	[p4l1735t2133r1795b2162],
5	20	CD	PERCENT	20	num	6	SENT_171	[p4l1805t2133r1878b2162],
6	%	NN	PERCENT	%	npadvmod	7	SENT_171	[p4l1805t2133r1878b2162],
7	more	JJR	O	more	amod	9	SENT_171	[p4l536t2192r619b2212],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_171	[p4l634t2183r817b2221],
9	success	NN	O	success	dobj	4	SENT_171	[p4l833t2192r954b2212],
10	against	IN	O	against	_	0	SENT_171	[p4l970t2183r1087b2221],
11	Hp	NNP	O	Hp	prep_against	4	SENT_171	[p4l1101t2183r1149b2221],
12	than	IN	O	than	_	0	SENT_171	[p4l1164t2183r1235b2212],
13	EMS	NNP	O	EMS	prep_than	4	SENT_171	[p4l1249t2183r1335b2212],
14	.	.	O	.	_	0	SENT_171	[p4l1249t2183r1335b2212],

1	Based	VBN	O	base	_	0	SENT_172	[p4l1351t2183r1452b2212],
2	on	IN	O	on	prepc_based_on	10	SENT_172	[p4l1466t2192r1506b2212],
3	these	DT	O	these	det	4	SENT_172	[p4l1521t2183r1605b2212],
4	studies	NNS	O	study	pobj	10	SENT_172	[p4l1621t2183r1742b2217],
5	,	,	O	,	_	0	SENT_172	[p4l1621t2183r1742b2217],
6	clinical	JJ	O	clinical	amod	7	SENT_172	[p4l1759t2183r1879b2212],
7	outcome	NN	O	outcome	nsubjpass	10	SENT_172	[p4l536t2237r677b2262],
8	may	MD	O	may	aux	10	SENT_172	[p4l685t2242r755b2270],
9	be	VB	O	be	auxpass	10	SENT_172	[p4l763t2233r801b2262],
10	improved	VBN	O	improve	_	0	SENT_172	[p4l809t2233r966b2270],
11	by	IN	O	by	_	0	SENT_172	[p4l973t2233r1014b2270],
12	genotyping	VBG	O	genotype	agent	10	SENT_172	[p4l1022t2233r1207b2270],
13	and	CC	O	and	_	0	SENT_172	[p4l1216t2233r1274b2262],
14	giving	VBG	O	give	agent	10	SENT_172	[p4l1282t2233r1385b2270],
15	EM	NN	O	em	nn	16	SENT_172	[p4l1393t2233r1454b2261],
16	patients	NNS	O	patient	iobj	14	SENT_172	[p4l1462t2233r1589b2270],
17	a	DT	O	a	det	19	SENT_172	[p4l1599t2242r1616b2262],
18	two	CD	NUMBER	two	number	19	SENT_172	[p4l1623t2237r1697b2262],
19	—	CD	NUMBER	—	dobj	14	SENT_172	[p4l1623t2237r1697b2262],
20	to	TO	O	to	_	0	SENT_172	[p4l1705t2237r1736b2262],
21	fourfold	RB	O	fourfold	advmod	22	SENT_172	[p4l1745t2233r1880b2262],
22	higher	JJR	O	higher	amod	23	SENT_172	[p4l535t2282r641b2320],
23	dose	NN	O	dose	prep_to	19	SENT_172	[p4l653t2283r727b2312],
24	of	IN	O	of	_	0	SENT_172	[p4l740t2282r776b2312],
25	PPIS	NNP	O	PPIS	prep_of	23	SENT_172	[p4l785t2283r869b2312],
26	.	.	O	.	_	0	SENT_172	[p4l785t2283r869b2312],

1	However	RB	O	however	advmod	7	SENT_173	[p4l883t2283r1038b2317],
2	,	,	O	,	_	0	SENT_173	[p4l883t2283r1038b2317],
3	prospective	JJ	O	prospective	amod	5	SENT_173	[p4l1052t2282r1241b2320],
4	clinical	JJ	O	clinical	amod	5	SENT_173	[p4l1253t2282r1374b2312],
5	trials	NNS	O	trial	nsubjpass	7	SENT_173	[p4l1386t2282r1467b2312],
6	are	VBP	O	be	auxpass	7	SENT_173	[p4l1481t2292r1530b2312],
7	needed	VBN	O	need	_	0	SENT_173	[p4l1542t2282r1659b2312],
8	to	TO	O	to	aux	9	SENT_173	[p4l1670t2287r1701b2312],
9	prove	VB	O	prove	xcomp	7	SENT_173	[p4l1713t2292r1806b2320],
10	that	IN	O	that	complm	13	SENT_173	[p4l1818t2283r1880b2312],
11	this	DT	O	this	det	12	SENT_173	[p4l536t2332r593b2362],
12	approach	NN	O	approach	nsubj	13	SENT_173	[p4l607t2332r757b2370],
13	improves	VBZ	O	improve	ccomp	9	SENT_173	[p4l768t2332r920b2370],
14	clinical	JJ	O	clinical	amod	15	SENT_173	[p4l932t2332r1053b2362],
15	outcome	NN	O	outcome	dobj	13	SENT_173	[p4l1065t2337r1206b2362],
16	and	CC	O	and	_	0	SENT_173	[p4l1219t2332r1277b2362],
17	is	VBZ	O	be	cop	18	SENT_173	[p4l1288t2332r1314b2362],
18	coSt	NN	O	cost	conj_and	13	SENT_173	[p4l1327t2332r1557b2362],
19	—	CD	NUMBER	—	num	18	SENT_173	[p4l1327t2332r1557b2362],
20	effectiVe	NNP	O	effectiVe	dep	18	SENT_173	[p4l1327t2332r1557b2362],
21	.	.	O	.	_	0	SENT_173	[p4l1327t2332r1557b2362],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_174	[p4l437t2473r611b2508],
2	and	CC	O	and	_	0	SENT_174	[p4l625t2471r699b2507],
3	Antidepressant	JJ	O	antidepressant	amod	4	SENT_174	[p4l710t2471r1017b2518],
4	Therapy	NN	O	therapy	conj_and	1	SENT_174	[p4l1029t2471r1199b2519],

1	More	JJR	O	more	mwe	2	SENT_175	[p4l535t2554r624b2582],
2	than	IN	O	than	quantmod	3	SENT_175	[p4l642t2553r712b2582],
3	51	CD	NUMBER	51	num	8	SENT_175	[p4l730t2553r766b2582],
4	different	JJ	O	different	amod	8	SENT_175	[p4l788t2553r929b2582],
5	major	JJ	O	major	amod	8	SENT_175	[p4l945t2553r1042b2591],
6	polymorphic	JJ	O	polymorphic	amod	8	SENT_175	[p4l1058t2553r1269b2591],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_175	[p4l1289t2553r1435b2583],
8	alleles	NNS	O	allele	nsubjpass	10	SENT_175	[p4l1452t2553r1555b2582],
9	are	VBP	O	be	auxpass	10	SENT_175	[p4l1574t2562r1623b2582],
10	known	VBN	O	know	_	0	SENT_175	[p4l1640t2553r1759b2582],
11	.	.	O	.	_	0	SENT_175	[p4l1640t2553r1759b2582],

1	Those	DT	O	those	det	3	SENT_176	[p4l1779t2553r1879b2582],
2	most	RBS	O	most	advmod	3	SENT_176	[p4l536t2607r616b2632],
3	common	JJ	O	common	nsubjpass	9	SENT_176	[p4l627t2612r770b2632],
4	in	IN	O	in	_	0	SENT_176	[p4l782t2603r813b2632],
5	various	JJ	O	various	amod	7	SENT_176	[p4l824t2603r943b2632],
6	ethnic	JJ	O	ethnic	amod	7	SENT_176	[p4l955t2603r1054b2632],
7	groups	NNS	O	group	prep_in	3	SENT_176	[p4l1067t2612r1177b2641],
8	are	VBP	O	be	auxpass	9	SENT_176	[p4l1190t2612r1239b2632],
9	listed	VBN	O	list	_	0	SENT_176	[p4l1250t2603r1339b2632],
10	in	IN	O	in	_	0	SENT_176	[p4l1350t2603r1381b2632],
11	Table	NNP	O	Table	prep_in	9	SENT_176	[p4l1392t2603r1482b2632],
12	1	CD	NUMBER	1	num	11	SENT_176	[p4l1497t2603r1521b2632],
13	.	.	O	.	_	0	SENT_176	[p4l1497t2603r1521b2632],

1	The	DT	O	the	det	4	SENT_177	[p4l1534t2603r1597b2632],
2	variant	JJ	O	variant	amod	4	SENT_177	[p4l1609t2603r1722b2632],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_177	[p4l1735t2603r1881b2632],
4	alleles	NNS	O	allele	nsubjpass	6	SENT_177	[p4l536t2653r640b2682],
5	are	VBP	O	be	auxpass	6	SENT_177	[p4l656t2662r704b2682],
6	classiﬁed	VBN	O	classiﬁed	_	0	SENT_177	[p4l719t2653r872b2682],
7	on	IN	O	on	_	0	SENT_177	[p4l887t2662r927b2682],
8	the	DT	O	the	det	9	SENT_177	[p4l941t2653r990b2682],
9	basis	NN	O	basis	prep_on	6	SENT_177	[p4l1004t2653r1086b2682],
10	of	IN	O	of	_	0	SENT_177	[p4l1102t2653r1137b2682],
11	the	DT	O	the	det	12	SENT_177	[p4l1149t2653r1198b2682],
12	enzyme	NN	O	enzyme	prep_of	9	SENT_177	[p4l1213t2653r1367b2691],
13	’s	POS	O	’s	possessive	12	SENT_177	[p4l1213t2653r1367b2691],
14	abolished	VBD	O	abolish	rcmod	12	SENT_177	[p4l1383t2653r1549b2687],
15	,	,	O	,	_	0	SENT_177	[p4l1383t2653r1549b2687],
16	decreased	VBD	O	decrease	dep	14	SENT_177	[p4l1566t2653r1737b2687],
17	,	,	O	,	_	0	SENT_177	[p4l1566t2653r1737b2687],
18	normal	JJ	O	normal	prep_on	6	SENT_177	[p4l1752t2653r1878b2687],
19	,	,	O	,	_	0	SENT_177	[p4l1752t2653r1878b2687],
20	increased	VBN	O	increase	partmod	18	SENT_177	[p4l535t2702r700b2737],
21	,	,	O	,	_	0	SENT_177	[p4l535t2702r700b2737],
22	or	CC	O	or	_	0	SENT_177	[p4l718t2711r752b2732],
23	qualitatively	RB	O	qualitatively	advmod	9	SENT_177	[p4l768t2702r972b2740],
24	altered	JJ	O	altered	amod	26	SENT_177	[p4l989t2702r1100b2732],
25	catalytic	JJ	O	catalytic	amod	26	SENT_177	[p4l1116t2702r1255b2740],
26	activity	NN	O	activity	conj_or	9	SENT_177	[p4l1273t2702r1400b2740],
27	.	.	O	.	_	0	SENT_177	[p4l1273t2702r1400b2740],

1	Among	IN	O	among	_	0	SENT_178	[p4l1418t2702r1541b2740],
2	the	DT	O	the	det	5	SENT_178	[p4l1558t2702r1607b2732],
3	most	RBS	O	most	advmod	4	SENT_178	[p4l1623t2707r1704b2732],
4	important	JJ	O	important	amod	5	SENT_178	[p4l1719t2702r1880b2740],
5	variants	NNS	O	variant	prep_among	8	SENT_178	[p4l536t2752r664b2782],
6	are	VBP	O	be	cop	8	SENT_178	[p4l679t2762r727b2782],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_178	[p4l742t2752r934b2787],
8	*	NN	O	*	_	0	SENT_178	[p4l742t2752r934b2787],
9	2	CD	NUMBER	2	dep	8	SENT_178	[p4l742t2752r934b2787],
10	,	,	O	,	_	0	SENT_178	[p4l742t2752r934b2787],
11	CYP2D6	NN	O	cyp2d6	nn	12	SENT_178	[p4l950t2752r1141b2787],
12	*	NN	O	*	conj_and	8	SENT_178	[p4l950t2752r1141b2787],
13	4	CD	NUMBER	4	dep	12	SENT_178	[p4l950t2752r1141b2787],
14	,	,	O	,	_	0	SENT_178	[p4l950t2752r1141b2787],
15	CYP2D6	NN	O	cyp2d6	conj_and	8	SENT_178	[p4l1158t2752r1349b2787],
16	*	CD	NUMBER	*	number	17	SENT_178	[p4l1158t2752r1349b2787],
17	5	CD	NUMBER	5	dep	15	SENT_178	[p4l1158t2752r1349b2787],
18	,	,	O	,	_	0	SENT_178	[p4l1158t2752r1349b2787],
19	CYP2D6	NN	O	cyp2d6	conj_and	8	SENT_178	[p4l1366t2752r1578b2787],
20	*	CD	NUMBER	*	num	21	SENT_178	[p4l1366t2752r1578b2787],
21	l0	NN	O	l0	dep	19	SENT_178	[p4l1366t2752r1578b2787],
22	,	,	O	,	_	0	SENT_178	[p4l1366t2752r1578b2787],
23	CYP2D6	NN	O	cyp2d6	conj_and	8	SENT_178	[p4l1594t2752r1806b2787],
24	*	CD	NUMBER	*	num	23	SENT_178	[p4l1594t2752r1806b2787],
25	]	NN	O	]	dep	23	SENT_178	[p4l1594t2752r1806b2787],
26	7	CD	NUMBER	7	num	25	SENT_178	[p4l1594t2752r1806b2787],
27	,	,	O	,	_	0	SENT_178	[p4l1594t2752r1806b2787],
28	and	CC	O	and	_	0	SENT_178	[p4l1821t2752r1880b2782],
29	CYP2D6	NN	O	cyp2d6	conj_and	8	SENT_178	[p4l538t2802r738b2832],
30	*	CD	NUMBER	*	num	31	SENT_178	[p4l538t2802r738b2832],
31	4I	NN	O	4us	nsubj	8	SENT_178	[p4l538t2802r738b2832],
32	.	.	O	.	_	0	SENT_178	[p4l744t2827r749b2832],

1	There	EX	O	there	expl	2	SENT_179	[p4l761t2802r857b2832],
2	are	VBP	O	be	_	0	SENT_179	[p4l868t2812r917b2832],
3	also	RB	O	also	advmod	2	SENT_179	[p4l928t2802r992b2832],
4	alleles	NNS	O	allele	nsubj	2	SENT_179	[p4l1004t2802r1107b2832],
5	carrying	VBG	O	carry	partmod	4	SENT_179	[p4l1119t2802r1255b2840],
6	2-13	CD	NUMBER	2-13	num	9	SENT_179	[p4l1266t2803r1346b2832],
7	active	JJ	O	active	amod	9	SENT_179	[p4l1359t2802r1454b2832],
8	gene	NN	O	gene	nn	9	SENT_179	[p4l1465t2812r1542b2840],
9	copies	NNS	O	copy	dobj	5	SENT_179	[p4l1552t2802r1666b2840],
10	,	,	O	,	_	0	SENT_179	[p4l1552t2802r1666b2840],
11	which	WDT	O	which	nsubj	12	SENT_179	[p4l1678t2802r1778b2832],
12	cause	VBP	O	cause	rcmod	9	SENT_179	[p4l1789t2812r1879b2832],
13	ultrarapid	JJ	O	ultrarapid	amod	15	SENT_179	[p4l535t2852r696b2890],
14	metabolism	NN	O	metabolism	nn	15	SENT_179	[p4l707t2852r901b2882],
15	(	NN	O	(	dobj	12	SENT_179	[p4l913t2852r974b2888],
16	45	CD	NUMBER	45	tmod	5	SENT_179	[p4l913t2852r974b2888],
17	,	,	O	,	_	0	SENT_179	[p4l913t2852r974b2888],
18	46	CD	NUMBER	46	num	19	SENT_179	[p4l987t2852r1050b2888],
19	)	NN	O	)	appos	16	SENT_179	[p4l987t2852r1050b2888],
20	.	.	O	.	_	0	SENT_179	[p4l987t2852r1050b2888],

1	Approximately	RB	O	approximately	quantmod	2	SENT_180	[p4l585t2902r835b2940],
2	20	CD	PERCENT	20	num	3	SENT_180	[p4l849t2902r1019b2932],
3	%	NN	PERCENT	%	_	0	SENT_180	[p4l849t2902r1019b2932],
4	.	.	O	.	_	0	SENT_180	[p4l849t2902r1019b2932],

1	—	NN	O	—	_	0	SENT_181	[p4l849t2902r1019b2932],
2	.	.	O	.	_	0	SENT_181	[p4l849t2902r1019b2932],

1	25	CD	PERCENT	25	num	2	SENT_182	[p4l849t2902r1019b2932],
2	%	NN	PERCENT	%	nsubjpass	10	SENT_182	[p4l849t2902r1019b2932],
3	of	IN	O	of	_	0	SENT_182	[p4l1034t2902r1070b2931],
4	all	DT	O	all	det	5	SENT_182	[p4l1081t2902r1121b2931],
5	drugs	NNS	O	drug	prep_of	2	SENT_182	[p4l1135t2902r1224b2940],
6	in	IN	O	in	_	0	SENT_182	[p4l1238t2902r1270b2931],
7	clinical	JJ	O	clinical	amod	8	SENT_182	[p4l1283t2902r1404b2931],
8	use	NN	O	use	prep_in	5	SENT_182	[p4l1417t2912r1471b2931],
9	are	VBP	O	be	auxpass	10	SENT_182	[p4l1485t2912r1534b2931],
10	metabolized	VBN	O	metabolize	_	0	SENT_182	[p4l1547t2902r1749b2931],
11	at	IN	O	at	advmod	10	SENT_182	[p4l1763t2907r1792b2931],
12	least	JJS	O	least	pobj	11	SENT_182	[p4l1804t2902r1880b2931],
13	partly	RB	O	partly	advmod	11	SENT_182	[p4l535t2951r631b2989],
14	by	IN	O	by	_	0	SENT_182	[p4l638t2951r678b2989],
15	CYP2D6	NN	O	cyp2d6	prep_by	11	SENT_182	[p4l686t2951r836b2980],
16	(	CD	NUMBER	(	number	17	SENT_182	[p4l845t2951r920b2987],
17	46	CD	NUMBER	46	num	18	SENT_182	[p4l845t2951r920b2987],
18	)	NN	O	)	dobj	10	SENT_182	[p4l845t2951r920b2987],
19	.	.	O	.	_	0	SENT_182	[p4l845t2951r920b2987],

1	Subjects	NNS	O	subject	nsubj	7	SENT_183	[p4l931t2951r1068b2989],
2	with	IN	O	with	_	0	SENT_183	[p4l1076t2951r1149b2980],
3	multiple	JJ	O	multiple	amod	6	SENT_183	[p4l1156t2951r1293b2989],
4	active	JJ	O	active	amod	6	SENT_183	[p4l1301t2951r1396b2980],
5	gene	NN	O	gene	nn	6	SENT_183	[p4l1404t2960r1481b2989],
6	copies	NNS	O	copy	prep_with	1	SENT_183	[p4l1488t2951r1592b2989],
7	metabolize	VBZ	O	metabolize	_	0	SENT_183	[p4l1600t2951r1781b2980],
8	drugs	NNS	O	drug	nsubj	10	SENT_183	[p4l1789t2951r1878b2989],
9	more	RBR	O	more	advmod	10	SENT_183	[p4l535t3009r620b3029],
10	rapidly	RB	O	rapidly	xcomp	7	SENT_183	[p4l633t3000r756b3038],
11	,	,	O	,	_	0	SENT_183	[p4l633t3000r756b3038],
12	whereas	IN	O	whereas	mark	19	SENT_183	[p4l771t3000r905b3030],
13	individuals	NNS	O	individual	nsubj	19	SENT_183	[p4l920t3000r1101b3029],
14	lacking	VBG	O	lack	partmod	13	SENT_183	[p4l1116t3000r1236b3038],
15	functional	JJ	O	functional	dep	16	SENT_183	[p4l1250t3000r1417b3029],
16	C	NN	O	c	amod	18	SENT_183	[p4l1433t3001r1459b3030],
17	YPZD6	NN	O	ypzd6	nn	18	SENT_183	[p4l1461t3000r1579b3029],
18	genes	NNS	O	gene	dobj	14	SENT_183	[p4l1592t3009r1684b3038],
19	metabolize	VBZ	O	metabolize	advcl	7	SENT_183	[p4l1698t3000r1879b3029],
20	some	DT	O	some	det	22	SENT_183	[p4l537t3059r622b3079],
21	CYP2D6	NN	O	cyp2d6	nn	22	SENT_183	[p4l633t3050r783b3079],
22	substrates	NNS	O	substrate	dobj	19	SENT_183	[p4l795t3050r955b3079],
23	at	IN	O	at	_	0	SENT_183	[p4l967t3054r996b3079],
24	a	DT	O	a	det	26	SENT_183	[p4l1006t3059r1023b3079],
25	lower	JJR	O	lower	amod	26	SENT_183	[p4l1033t3050r1126b3079],
26	rate	NN	O	rate	prep_at	19	SENT_183	[p4l1135t3054r1196b3079],
27	and	CC	O	and	_	0	SENT_183	[p4l1208t3050r1266b3079],
28	have	VBP	O	have	advcl	7	SENT_183	[p4l1275t3050r1351b3079],
29	a	DT	O	a	det	31	SENT_183	[p4l1363t3059r1380b3079],
30	higher	JJR	O	higher	amod	31	SENT_183	[p4l1389t3050r1495b3088],
31	risk	NN	O	risk	dobj	28	SENT_183	[p4l1504t3050r1567b3079],
32	of	IN	O	of	_	0	SENT_183	[p4l1576t3050r1612b3079],
33	ADRS	NNP	O	ADRS	prep_of	31	SENT_183	[p4l1619t3050r1730b3079],
34	.	.	O	.	_	0	SENT_183	[p4l1619t3050r1730b3079],

1	Adverse	JJ	O	adverse	amod	2	SENT_184	[p4l1743t3050r1879b3079],
2	effects	NNS	O	effect	nsubj	9	SENT_184	[p4l536t3099r643b3128],
3	due	JJ	O	due	_	0	SENT_184	[p4l659t3099r717b3128],
4	to	TO	O	to	_	0	SENT_184	[p4l731t3104r762b3128],
5	elevated	JJ	O	elevated	amod	8	SENT_184	[p4l777t3099r912b3128],
6	drug	NN	O	drug	nn	8	SENT_184	[p4l926t3099r1001b3137],
7	plasma	NN	O	plasma	nn	8	SENT_184	[p4l1015t3099r1132b3137],
8	concentrations	NNS	O	concentration	prep_due_to	2	SENT_184	[p4l1146t3099r1386b3128],
9	occur	VBP	O	occur	dep	24	SENT_184	[p4l1402t3108r1493b3128],
10	more	RBR	O	more	advmod	11	SENT_184	[p4l1506t3108r1590b3128],
11	often	RB	O	often	advmod	9	SENT_184	[p4l1605t3099r1689b3128],
12	in	IN	O	in	_	0	SENT_184	[p4l1703t3099r1735b3128],
13	PMS	NNP	O	PMS	prep_in	9	SENT_184	[p4l1748t3100r1832b3133],
14	,	,	O	,	_	0	SENT_184	[p4l1748t3100r1832b3133],
15	in	IN	O	in	_	0	SENT_184	[p4l1848t3099r1880b3128],
16	whom	WP	O	whom	rel	19	SENT_184	[p4l536t3148r639b3177],
17	drug	NN	O	drug	nn	18	SENT_184	[p4l650t3148r724b3186],
18	clearance	NN	O	clearance	nsubj	19	SENT_184	[p4l736t3148r892b3177],
19	depends	VBZ	O	depend	rcmod	13	SENT_184	[p4l904t3148r1037b3186],
20	mostly	RB	O	mostly	advmod	19	SENT_184	[p4l1050t3148r1161b3186],
21	on	IN	O	on	_	0	SENT_184	[p4l1174t3157r1214b3177],
22	CYP2D6	NN	O	cyp2d6	prep_on	19	SENT_184	[p4l1225t3148r1376b3178],
23	(	CD	NUMBER	(	num	22	SENT_184	[p4l1389t3148r1453b3184],
24	see	VBP	O	see	_	0	SENT_184	[p4l1389t3148r1453b3184],
25	Reference	NNP	O	Reference	dobj	24	SENT_184	[p4l1465t3148r1632b3177],
26	46	CD	NUMBER	46	num	25	SENT_184	[p4l1643t3148r1706b3184],
27	)	CD	NUMBER	)	nsubj	24	SENT_184	[p4l1643t3148r1706b3184],
28	.	.	O	.	_	0	SENT_184	[p4l1643t3148r1706b3184],

1	In	IN	O	in	_	0	SENT_185	[p4l585t3198r619b3226],
2	Western	NNP	LOCATION	Western	nn	3	SENT_185	[p4l636t3198r771b3226],
3	Europe	NNP	LOCATION	Europe	prep_in	10	SENT_185	[p4l788t3198r916b3235],
4	,	,	O	,	_	0	SENT_185	[p4l788t3198r916b3235],
5	the	DT	O	the	det	6	SENT_185	[p4l935t3197r985b3226],
6	incidence	NN	O	incidence	nsubj	10	SENT_185	[p4l1002t3197r1160b3226],
7	of	IN	O	of	_	0	SENT_185	[p4l1179t3197r1214b3226],
8	PMS	NNP	O	PMS	prep_of	6	SENT_185	[p4l1229t3198r1303b3226],
9	is	VBZ	O	be	cop	10	SENT_185	[p4l1322t3197r1348b3226],
10	~	NN	O	~	_	0	SENT_185	[p4l1368t3197r1461b3226],
11	7	CD	PERCENT	7	number	12	SENT_185	[p4l1368t3197r1461b3226],
12	%	NN	PERCENT	%	amod	10	SENT_185	[p4l1368t3197r1461b3226],
13	.	.	O	.	_	0	SENT_185	[p4l1368t3197r1461b3226],

1	Ultrarapid	JJ	O	ultrarapid	amod	2	SENT_186	[p4l1481t3197r1651b3235],
2	metabolizers	NNS	O	metabolizer	nsubj	3	SENT_186	[p4l1668t3197r1878b3226],
3	(	VBP	O	(	_	0	SENT_186	[p4l537t3246r644b3282],
4	UMS	NN	O	um	nn	5	SENT_186	[p4l537t3246r644b3282],
5	)	NN	O	)	nsubjpass	8	SENT_186	[p4l537t3246r644b3282],
6	are	VBP	O	be	auxpass	8	SENT_186	[p4l658t3255r706b3276],
7	preferentially	RB	O	preferentially	advmod	8	SENT_186	[p4l717t3246r940b3284],
8	distributed	VBN	O	distribute	ccomp	3	SENT_186	[p4l953t3246r1128b3276],
9	in	IN	O	in	_	0	SENT_186	[p4l1139t3246r1171b3275],
10	the	DT	O	the	det	12	SENT_186	[p4l1182t3246r1232b3276],
11	Mediterranean	NNP	LOCATION	Mediterranean	nn	12	SENT_186	[p4l1243t3246r1485b3276],
12	area	NN	O	area	prep_in	8	SENT_186	[p4l1497t3255r1573b3281],
13	,	,	O	,	_	0	SENT_186	[p4l1497t3255r1573b3281],
14	where	WRB	O	where	advmod	27	SENT_186	[p4l1586t3246r1686b3276],
15	10	CD	PERCENT	10	num	16	SENT_186	[p4l1702t3246r1771b3276],
16	%	NN	PERCENT	%	nsubj	27	SENT_186	[p4l1702t3246r1771b3276],
17	of	IN	O	of	_	0	SENT_186	[p4l1785t3246r1821b3276],
18	the	DT	O	the	det	19	SENT_186	[p4l1830t3246r1879b3276],
19	population	NN	O	population	prep_of	16	SENT_186	[p4l535t3296r712b3334],
20	in	IN	O	in	_	0	SENT_186	[p4l721t3296r752b3325],
21	Portugal	NNP	LOCATION	Portugal	prep_in	19	SENT_186	[p4l761t3296r910b3334],
22	,	,	O	,	_	0	SENT_186	[p4l761t3296r910b3334],
23	Spain	NNP	LOCATION	Spain	conj_and	21	SENT_186	[p4l922t3296r1023b3334],
24	,	,	O	,	_	0	SENT_186	[p4l922t3296r1023b3334],
25	and	CC	O	and	_	0	SENT_186	[p4l1034t3296r1093b3325],
26	Italy	NNP	LOCATION	Italy	conj_and	21	SENT_186	[p4l1101t3296r1176b3334],
27	carries	VBZ	O	carry	rcmod	12	SENT_186	[p4l1186t3296r1294b3325],
28	alleles	NNS	O	allele	nsubj	35	SENT_186	[p4l1305t3296r1408b3325],
29	with	IN	O	with	_	0	SENT_186	[p4l1419t3296r1491b3325],
30	multiple	JJ	O	multiple	amod	34	SENT_186	[p4l1500t3296r1637b3334],
31	C	NN	O	c	nn	34	SENT_186	[p4l1648t3296r1675b3326],
32	YPZD6	NN	O	ypzd6	nn	34	SENT_186	[p4l1677t3296r1795b3325],
33	gene	NN	O	gene	nn	34	SENT_186	[p4l1803t3305r1879b3334],
34	copies	NNS	O	copy	prep_with	28	SENT_186	[p4l536t3345r640b3383],
35	(	VBP	O	(	ccomp	27	SENT_186	[p4l651t3345r713b3381],
36	17	CD	NUMBER	17	dobj	35	SENT_186	[p4l651t3345r713b3381],
37	,	,	O	,	_	0	SENT_186	[p4l651t3345r713b3381],
38	46	CD	NUMBER	46	num	39	SENT_186	[p4l724t3345r786b3381],
39	)	NN	O	)	appos	36	SENT_186	[p4l724t3345r786b3381],
40	.	.	O	.	_	0	SENT_186	[p4l724t3345r786b3381],

1	Northern	NNP	O	Northern	nn	2	SENT_187	[p4l798t3345r947b3374],
2	Europe	NNP	LOCATION	Europe	nsubj	3	SENT_187	[p4l956t3346r1075b3383],
3	has	VBZ	O	have	_	0	SENT_187	[p4l1084t3345r1138b3374],
4	only	RB	O	only	advmod	5	SENT_187	[p4l1149t3345r1220b3383],
5	~	NN	O	~	dobj	3	SENT_187	[p4l1232t3345r1391b3374],
6	1	CD	PERCENT	1	num	7	SENT_187	[p4l1232t3345r1391b3374],
7	%	NN	PERCENT	%	dep	5	SENT_187	[p4l1232t3345r1391b3374],
8	-2	CD	PERCENT	-2	num	10	SENT_187	[p4l1232t3345r1391b3374],
9	%	NN	PERCENT	%	nn	10	SENT_187	[p4l1232t3345r1391b3374],
10	UMS	NN	O	um	dep	7	SENT_187	[p4l1402t3346r1493b3380],
11	,	,	O	,	_	0	SENT_187	[p4l1402t3346r1493b3380],
12	but	CC	O	but	_	0	SENT_187	[p4l1503t3345r1556b3374],
13	as	RB	O	as	quantmod	16	SENT_187	[p4l1566t3354r1597b3374],
14	much	JJ	O	much	quantmod	16	SENT_187	[p4l1608t3345r1699b3374],
15	as	IN	O	as	quantmod	16	SENT_187	[p4l1709t3354r1741b3374],
16	5.5	CD	PERCENT	5.5	num	17	SENT_187	[p4l1752t3345r1835b3374],
17	%	NN	PERCENT	%	nsubj	23	SENT_187	[p4l1752t3345r1835b3374],
18	of	IN	O	of	_	0	SENT_187	[p4l1846t3345r1882b3374],
19	the	DT	O	the	det	22	SENT_187	[p4l535t3394r585b3423],
20	Western	JJ	MISC	western	amod	22	SENT_187	[p4l596t3395r731b3423],
21	European	JJ	MISC	european	amod	22	SENT_187	[p4l743t3395r901b3432],
22	population	NN	O	population	prep_of	17	SENT_187	[p4l912t3394r1089b3432],
23	consists	VBZ	O	consist	conj_but	3	SENT_187	[p4l1101t3394r1230b3423],
24	of	IN	O	of	_	0	SENT_187	[p4l1244t3394r1280b3423],
25	UMS	NNP	O	UMS	prep_of	23	SENT_187	[p4l1288t3395r1370b3424],
26	who	WP	O	who	nsubj	27	SENT_187	[p4l1383t3394r1452b3423],
27	carry	VBP	O	carry	rcmod	25	SENT_187	[p4l1465t3403r1548b3432],
28	>	JJR	O	>	dobj	27	SENT_187	[p4l1564t3394r1612b3423],
29	2	CD	NUMBER	2	number	31	SENT_187	[p4l1564t3394r1612b3423],
30	active	JJ	O	active	dep	31	SENT_187	[p4l1625t3394r1721b3424],
31	C	NN	O	c	amod	34	SENT_187	[p4l1735t3395r1761b3424],
32	YP2D6	NN	O	yp2d6	nn	34	SENT_187	[p4l1763t3394r1881b3423],
33	gene	NN	O	gene	nn	34	SENT_187	[p4l536t3453r613b3482],
34	copies	NNS	O	copy	dep	28	SENT_187	[p4l625t3444r738b3482],
35	.	.	O	.	_	0	SENT_187	[p4l625t3444r738b3482],

1	An	DT	O	a	det	5	SENT_188	[p4l752t3444r802b3473],
2	estimated	VBN	O	estimate	amod	5	SENT_188	[p4l815t3444r973b3473],
3	25	CD	NUMBER	25	number	4	SENT_188	[p4l985t3444r1023b3473],
4	million	CD	NUMBER	million	num	5	SENT_188	[p4l1037t3444r1156b3473],
5	people	NNS	O	people	nsubj	10	SENT_188	[p4l1167t3444r1277b3482],
6	in	IN	O	in	_	0	SENT_188	[p4l1290t3444r1321b3473],
7	Western	NNP	LOCATION	Western	nn	8	SENT_188	[p4l1332t3445r1467b3473],
8	Europe	NNP	LOCATION	Europe	prep_in	10	SENT_188	[p4l1479t3445r1598b3482],
9	are	VBP	O	be	cop	10	SENT_188	[p4l1611t3453r1659b3473],
10	PMS	NNP	O	PMS	_	0	SENT_188	[p4l1672t3445r1746b3473],
11	and	CC	O	and	_	0	SENT_188	[p4l1760t3444r1818b3473],
12	are	VBP	O	be	cop	13	SENT_188	[p4l1831t3453r1879b3473],
13	PHARMACOGENOMICS	NN	O	pharmacogenomic	conj_and	10	SENT_188	[p4l1335t3505r1738b3532],
14	125	CD	NUMBER	125	num	13	SENT_188	[p4l1830t3502r1889b3532],

1	TABLE	NN	O	table	_	0	SENT_189	[p4l454t3627r575b3654],
2	1	CD	NUMBER	1	num	8	SENT_189	[p4l588t3627r602b3654],
3	Major	JJ	O	major	amod	8	SENT_189	[p4l623t3627r714b3662],
4	human	JJ	O	human	amod	8	SENT_189	[p4l724t3628r825b3654],
5	polymorphic	JJ	O	polymorphic	amod	8	SENT_189	[p4l834t3627r1024b3662],
6	Variant	JJ	O	variant	amod	8	SENT_189	[p4l1036t3627r1138b3654],
7	CYP2D6	NN	O	cyp2d6	nn	8	SENT_189	[p4l1149t3627r1281b3654],
8	alleles	NNS	O	allele	dep	1	SENT_189	[p4l1291t3627r1384b3654],
9	and	CC	O	and	_	0	SENT_189	[p4l1395t3628r1448b3654],
10	their	PRP$	O	they	poss	12	SENT_189	[p4l1458t3627r1526b3654],
11	global	JJ	O	global	amod	12	SENT_189	[p4l1536t3627r1628b3662],
12	distribution	NN	O	distribution	dep	1	SENT_189	[p4l1639t3627r1809b3654],

1	6.57	CD	NUMBER	6.57	_	0	SENT_190	[p5l278t3514r301b3579],
2	:	:	O	:	_	0	SENT_190	[p5l278t3514r301b3579],
3	1	CD	NUMBER	1	number	4	SENT_190	[p5l278t3498r301b3508],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_190	[p5l278t3394r302b3491],
5	.	.	O	.	_	0	SENT_190	[p5l278t3394r302b3491],

1	Downloaded	VBN	O	download	_	0	SENT_191	[p5l278t3213r301b3383],
2	from	IN	O	from	_	0	SENT_191	[p5l278t3139r301b3204],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	nn	4	SENT_191	[p5l278t2806r308b3131],
4	Annu	NN	PERSON	annu	prep_from	1	SENT_191	[p5l268t1478r291b1558],
5	.	.	O	.	_	0	SENT_191	[p5l268t1478r291b1558],

1	Rev.	NNP	O	Rev.	nn	2	SENT_192	[p5l268t1407r291b1467],
2	Med	NNP	O	Med	_	0	SENT_192	[p5l268t1329r291b1396],
3	.	.	O	.	_	0	SENT_192	[p5l268t1329r291b1396],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_193	[p5l268t1204r291b1318],
2	:	:	O	:	_	0	SENT_193	[p5l268t1204r291b1318],
3	1	CD	NUMBER	1	number	4	SENT_193	[p5l268t1188r291b1198],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_193	[p5l268t1084r292b1181],
5	.	.	O	.	_	0	SENT_193	[p5l268t1084r292b1181],

1	Downloaded	VBN	O	download	_	0	SENT_194	[p5l268t903r291b1073],
2	from	IN	O	from	_	0	SENT_194	[p5l268t830r291b894],
3	www.annua1reviews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_194	[p5l268t496r298b820],
4	by	IN	O	by	_	0	SENT_194	[p5l301t1491r332b1524],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_194	[p5l302t1342r332b1482],
6	of	IN	ORGANIZATION	of	_	0	SENT_194	[p5l301t1303r325b1332],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	18	SENT_194	[p5l302t1156r325b1297],
8	-	:	O	-	_	0	SENT_194	[p5l315t1138r318b1147],
9	Madison	NNP	O	Madison	dep	18	SENT_194	[p5l301t1012r325b1128],
10	on	IN	O	on	dep	9	SENT_194	[p5l309t969r325b1002],
11	01/05/14	NN	DATE	01/05/14	pobj	10	SENT_194	[p5l301t843r325b961],
12	For	IN	O	for	dep	9	SENT_194	[p5l302t779r325b826],
13	personal	JJ	O	personal	amod	14	SENT_194	[p5l301t659r332b772],
14	use	NN	O	use	pobj	12	SENT_194	[p5l309t607r325b650],
15	only	RB	O	only	advmod	16	SENT_194	[p5l301t539r332b597],
16	isconsin	NN	O	isconsin	dep	14	SENT_194	[p5l311t3467r335b3579],
17	-	:	O	-	_	0	SENT_194	[p5l325t3448r328b3457],
18	Madison	NNP	O	Madison	prep_of	5	SENT_194	[p5l311t3322r335b3438],
19	on	IN	O	on	_	0	SENT_194	[p5l319t3280r335b3312],
20	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_194	[p5l311t3146r335b3271],
21	.	.	O	.	_	0	SENT_194	[p5l311t3146r335b3271],

1	For	IN	O	for	_	0	SENT_195	[p5l312t3089r335b3136],
2	personal	JJ	O	personal	amod	3	SENT_195	[p5l311t2969r342b3082],
3	use	NN	O	use	pobj	1	SENT_195	[p5l319t2917r335b2960],
4	only	RB	O	only	advmod	3	SENT_195	[p5l311t2842r342b2907],
5	.	.	O	.	_	0	SENT_195	[p5l311t2842r342b2907],

1	Allele	NN	O	allele	nn	2	SENT_196	[p5l1404t19r1495b46],
2	frequency	NN	O	frequency	_	0	SENT_196	[p5l1505t19r1663b53],
3	(	CD	PERCENT	(	num	4	SENT_196	[p5l1675t19r1734b51],
4	%	NN	PERCENT	%	dep	2	SENT_196	[p5l1675t19r1734b51],
5	)	CD	NUMBER	)	dep	2	SENT_196	[p5l1675t19r1734b51],

1	Major	JJ	O	major	amod	2	SENT_197	[p5l453t65r554b99],
2	Ethiopians	NNPS	MISC	Ethiopians	_	0	SENT_197	[p5l1707t65r1878b99],
3	variant	JJ	O	variant	amod	4	SENT_197	[p5l453t107r569b134],
4	Cauca	NN	LOCATION	cauca	dep	2	SENT_197	[p5l1268t107r1379b134],
5	-	:	O	-	_	0	SENT_197	[p5l1268t107r1379b134],
6	Black	JJ	O	black	dep	2	SENT_197	[p5l1549t107r1640b134],
7	and	CC	O	and	_	0	SENT_197	[p5l1708t107r1766b134],
8	Saudi	JJ	MISC	saudi	amod	13	SENT_197	[p5l1777t107r1867b134],
9	allele	NN	O	allele	nn	13	SENT_197	[p5l453t140r548b175],
10	*	NN	O	*	nn	13	SENT_197	[p5l453t140r548b175],
11	Mutation	NN	O	mutation	nn	13	SENT_197	[p5l686t148r834b175],
12	Consequence	NN	O	consequence	nn	13	SENT_197	[p5l957t148r1164b182],
13	sians	NNS	O	sian	dep	2	SENT_197	[p5l1267t148r1345b175],
14	Asians	NNPS	MISC	Asians	dep	2	SENT_197	[p5l1420t148r1525b175],
15	Africans	NNPS	MISC	Africans	nn	16	SENT_197	[p5l1549t148r1685b175],
16	Arabians	NNPS	MISC	Arabians	dep	14	SENT_197	[p5l1707t148r1853b175],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_198	[p5l455t241r654b268],
2	*	CD	NUMBER	*	num	4	SENT_198	[p5l455t241r654b268],
3	2xn	JJ	O	2xn	amod	4	SENT_198	[p5l455t241r654b268],
4	Gene	NN	O	gene	dep	1	SENT_198	[p5l686t241r763b268],
5	Increased	VBN	O	increase	partmod	1	SENT_198	[p5l956t241r1098b268],
6	1-5	CD	NUMBER	1-5	num	7	SENT_198	[p5l1289t241r1339b268],
7	0-2	CD	NUMBER	0-2	iobj	5	SENT_198	[p5l1421t241r1476b268],
8	2	CD	NUMBER	2	num	9	SENT_198	[p5l1569t241r1586b267],
9	10-16	CD	DATE	10-16	dobj	5	SENT_198	[p5l1711t241r1799b268],

1	duplicationl	NN	O	duplicationl	nn	4	SENT_199	[p5l705t286r883b320],
2	enzyme	NN	O	enzyme	nn	4	SENT_199	[p5l975t294r1089b320],
3	activity	NN	O	activity	nn	4	SENT_199	[p5l1101t286r1210b320],
4	multiduplication	NN	O	multiduplication	_	0	SENT_199	[p5l704t331r871b365, p5l705t376r795b402],

1	C	NN	O	c	nn	2	SENT_200	[p5l455t427r479b453],
2	YP2D6	NN	O	yp2d6	_	0	SENT_200	[p5l480t426r619b452],
3	*	CD	NUMBER	*	number	4	SENT_200	[p5l480t426r619b452],
4	4	CD	NUMBER	4	num	7	SENT_200	[p5l480t426r619b452],
5	Defective	JJ	O	defective	amod	7	SENT_200	[p5l686t426r828b452],
6	Inactive	JJ	O	inactive	amod	7	SENT_200	[p5l956t426r1073b452],
7	enzyme	NN	O	enzyme	dep	2	SENT_200	[p5l1084t434r1199b460],
8	12-21	CD	NUMBER	12-21	number	9	SENT_200	[p5l1271t426r1356b452],
9	1	CD	NUMBER	1	num	7	SENT_200	[p5l1424t426r1435b452],
10	2	CD	NUMBER	2	num	11	SENT_200	[p5l1569t426r1586b452],
11	1-4	CD	NUMBER	1-4	dep	7	SENT_200	[p5l1730t426r1781b452],

1	splicing	NN	O	splicing	_	0	SENT_201	[p5l706t471r821b506],

1	CYP2D6	NN	O	cyp2d6	dep	7	SENT_202	[p5l455t530r619b556],
2	*	CD	NUMBER	*	number	3	SENT_202	[p5l455t530r619b556],
3	5	CD	NUMBER	5	dep	1	SENT_202	[p5l455t530r619b556],
4	Gene	NNP	O	Gene	dep	3	SENT_202	[p5l686t530r763b556],
5	deletion	NN	O	deletion	dep	7	SENT_202	[p5l774t530r894b556],
6	No	DT	O	no	det	7	SENT_202	[p5l956t531r1000b556],
7	enzyme	NN	O	enzyme	dep	11	SENT_202	[p5l1011t538r1126b564],
8	2-7	CD	NUMBER	2-7	num	9	SENT_202	[p5l1286t530r1340b556],
9	6	CD	NUMBER	6	dep	7	SENT_202	[p5l1421t530r1438b556],
10	4	CD	NUMBER	4	num	11	SENT_202	[p5l1568t530r1586b556],
11	1-3	CD	NUMBER	1-3	_	0	SENT_202	[p5l1730t530r1779b556],

1	CYP2D6	NN	O	cyp2d6	nn	4	SENT_203	[p5l455t588r638b615],
2	*	CD	NUMBER	*	num	4	SENT_203	[p5l455t588r638b615],
3	I0	NN	O	i0	nn	4	SENT_203	[p5l455t588r638b615],
4	P34S	NN	O	p34	_	0	SENT_203	[p5l686t588r772b619],
5	,	,	O	,	_	0	SENT_203	[p5l686t588r772b619],
6	S486T	NN	O	s486t	nn	8	SENT_203	[p5l784t588r882b615],
7	Unstable	JJ	O	unstable	amod	8	SENT_203	[p5l956t588r1087b615],
8	enzyme	NN	O	enzyme	appos	4	SENT_203	[p5l1098t596r1213b622],
9	1-2	CD	NUMBER	1-2	num	10	SENT_203	[p5l1290t588r1340b614],
10	51	CD	NUMBER	51	dep	4	SENT_203	[p5l1421t588r1454b615],
11	6	CD	NUMBER	6	num	12	SENT_203	[p5l1569t588r1585b615],
12	3-9	CD	NUMBER	3-9	dep	10	SENT_203	[p5l1727t588r1780b615],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_204	[p5l455t646r616b673],
2	*	NN	O	*	_	0	SENT_204	[p5l455t646r616b673],
3	1	CD	NUMBER	1	number	4	SENT_204	[p5l455t646r616b673],
4	7	CD	NUMBER	7	num	5	SENT_204	[p5l622t647r640b673],
5	T1071	NN	O	t1071	dep	2	SENT_204	[p5l686t647r784b677],
6	,	,	O	,	_	0	SENT_204	[p5l686t647r784b677],
7	Altered	JJ	O	altered	amod	10	SENT_204	[p5l956t646r1067b673],
8	afﬁnity	NN	O	afﬁnity	nn	10	SENT_204	[p5l1078t646r1183b680],
9	o	NN	O	o	nn	10	SENT_204	[p5l1286t647r1303b673],
10	o	NN	O	o	appos	5	SENT_204	[p5l1421t647r1438b673],
11	20-35	CD	NUMBER	20-35	num	12	SENT_204	[p5l1550t646r1640b673],
12	3-9	CD	NUMBER	3-9	dep	2	SENT_204	[p5l1727t647r1780b673],

1	R296C	NN	O	r296c	_	0	SENT_205	[p5l704t692r817b723],
2	,	,	O	,	_	0	SENT_205	[p5l704t692r817b723],
3	for	IN	O	for	dep	1	SENT_205	[p5l974t692r1018b718],
4	substrates	NNS	O	substrate	nn	5	SENT_205	[p5l1028t692r1173b718],
5	S486T	NN	O	s486t	pobj	3	SENT_205	[p5l705t738r803b764],

1	*	NN	O	*	nsubjpass	6	SENT_206	[p5l454t810r462b820],
2	All	DT	O	all	det	4	SENT_206	[p5l468t818r504b838],
3	variant	JJ	O	variant	amod	4	SENT_206	[p5l510t818r589b839],
4	alleles	NNS	O	allele	dep	1	SENT_206	[p5l595t818r667b839],
5	are	VBP	O	be	auxpass	6	SENT_206	[p5l673t825r708b839],
6	listed	VBN	O	list	_	0	SENT_206	[p5l713t818r775b839],
7	by	IN	O	by	_	0	SENT_206	[p5l780t818r809b845],
8	the	DT	O	the	det	13	SENT_206	[p5l814t818r849b839],
9	Human	JJ	ORGANIZATION	human	amod	13	SENT_206	[p5l854t819r939b839],
10	CYP	NNP	ORGANIZATION	CYP	nn	13	SENT_206	[p5l945t819r997b839],
11	Allele	NNP	ORGANIZATION	Allele	nn	13	SENT_206	[p5l1002t818r1072b839],
12	Nomenclature	NNP	ORGANIZATION	Nomenclature	nn	13	SENT_206	[p5l1077t818r1241b839],
13	Committee	NNP	ORGANIZATION	Committee	agent	6	SENT_206	[p5l1247t818r1375b839],
14	at	IN	O	at	_	0	SENT_206	[p5l1381t822r1401b839],
15	http://www.imm.ki.se/cypalleles/cyp2d6	NN	O	http://www.imm.ki.se/cypalleles/cyp2d6	prep_at	6	SENT_206	[p5l1405t818r1880b845],
16	.	.	O	.	_	0	SENT_206	[p5l1405t818r1880b845],

1	htm	NN	O	htm	_	0	SENT_207	[p5l453t856r503b876],
2	.	.	O	.	_	0	SENT_207	[p5l453t856r503b876],

1	often	RB	O	often	advmod	2	SENT_208	[p5l546t968r630b998],
2	prescribed	VBN	O	prescribe	_	0	SENT_208	[p5l640t968r812b1006],
3	doses	NNS	O	dose	dobj	2	SENT_208	[p5l823t968r913b998],
4	that	WDT	O	that	nsubj	7	SENT_208	[p5l925t968r987b998],
5	are	VBP	O	be	cop	7	SENT_208	[p5l997t977r1046b998],
6	too	RB	O	too	advmod	7	SENT_208	[p5l1057t973r1108b998],
7	high	JJ	O	high	rcmod	3	SENT_208	[p5l1119t968r1201b1006],
8	,	,	O	,	_	0	SENT_208	[p5l1119t968r1201b1006],
9	whereas	IN	O	whereas	mark	13	SENT_208	[p5l1214t968r1348b998],
10	20	CD	NUMBER	20	number	11	SENT_208	[p5l1360t968r1400b998],
11	million	CD	NUMBER	million	num	12	SENT_208	[p5l1410t968r1530b998],
12	UMs	NNS	O	um	nsubj	13	SENT_208	[p5l1540t969r1621b998],
13	are	VBP	O	be	advcl	7	SENT_208	[p5l1634t977r1682b998],
14	at	IN	O	at	_	0	SENT_208	[p5l1694t973r1723b998],
15	risk	NN	O	risk	prep_at	13	SENT_208	[p5l1732t968r1795b998],
16	of	IN	O	of	_	0	SENT_208	[p5l1805t968r1841b998],
17	no	DT	O	no	det	18	SENT_208	[p5l1849t977r1889b998],
18	response	NN	O	response	prep_of	15	SENT_208	[p5l545t1028r689b1056],
19	to	TO	O	to	_	0	SENT_208	[p5l701t1023r732b1048],
20	drug	NN	O	drug	nn	21	SENT_208	[p5l744t1018r818b1056],
21	treatment	NN	O	treatment	prep_to	18	SENT_208	[p5l830t1023r986b1048],
22	(	CD	NUMBER	(	nsubj	2	SENT_208	[p5l999t1018r1074b1054],
23	16	CD	NUMBER	16	num	24	SENT_208	[p5l999t1018r1074b1054],
24	)	NN	O	)	dep	22	SENT_208	[p5l999t1018r1074b1054],
25	.	.	O	.	_	0	SENT_208	[p5l999t1018r1074b1054],

1	CYP2D6	NN	O	cyp2d6	nsubj	2	SENT_209	[p5l595t1068r746b1098],
2	metabolizes	VBZ	O	metabolize	_	0	SENT_209	[p5l764t1068r961b1098],
3	most	RBS	O	most	advmod	5	SENT_209	[p5l980t1073r1060b1098],
4	tricyclic	JJ	O	tricyclic	amod	5	SENT_209	[p5l1078t1068r1212b1106],
5	antidepressants	NNS	O	antidepressant	nsubj	6	SENT_209	[p5l1232t1068r1482b1106],
6	(	VBP	O	(	ccomp	2	SENT_209	[p5l1503t1069r1583b1106],
7	e.g.	FW	O	e.g.	dobj	6	SENT_209	[p5l1503t1069r1583b1106],
8	,	,	O	,	_	0	SENT_209	[p5l1503t1069r1583b1106],
9	imipramine	NN	O	imipramine	conj_and	7	SENT_209	[p5l1603t1068r1802b1106],
10	,	,	O	,	_	0	SENT_209	[p5l1603t1068r1802b1106],
11	nortriptyline	NN	O	nortriptyline	conj_and	7	SENT_209	[p5l1822t1078r1888b1098, p5l545t1118r705b1156],
12	,	,	O	,	_	0	SENT_209	[p5l1822t1078r1888b1098, p5l545t1118r705b1156],
13	maprotiline	NN	O	maprotiline	conj_and	7	SENT_209	[p5l717t1118r916b1156],
14	,	,	O	,	_	0	SENT_209	[p5l717t1118r916b1156],
15	and	CC	O	and	_	0	SENT_209	[p5l929t1118r987b1147],
16	others	NNS	O	other	conj_and	7	SENT_209	[p5l997t1118r1120b1154],
17	)	RB	O	)	advmod	6	SENT_209	[p5l997t1118r1120b1154],
18	,	,	O	,	_	0	SENT_209	[p5l997t1118r1120b1154],
19	whereas	IN	O	whereas	mark	27	SENT_209	[p5l1132t1118r1266b1148],
20	the	DT	O	the	det	21	SENT_209	[p5l1277t1118r1326b1147],
21	metabolism	NN	O	metabolism	nsubj	27	SENT_209	[p5l1337t1118r1530b1147],
22	of	IN	O	of	_	0	SENT_209	[p5l1540t1118r1576b1147],
23	selective	JJ	O	selective	amod	26	SENT_209	[p5l1585t1118r1726b1148],
24	serotonin	NN	O	serotonin	nn	26	SENT_209	[p5l1737t1118r1890b1147],
25	reuptake	NN	O	reuptake	nn	26	SENT_209	[p5l545t1168r687b1206],
26	inhibitors	NNS	O	inhibitor	prep_of	21	SENT_209	[p5l696t1168r854b1197],
27	depends	VBZ	O	depend	advcl	6	SENT_209	[p5l865t1168r998b1206],
28	mainly	RB	O	mainly	advmod	27	SENT_209	[p5l1009t1168r1123b1206],
29	on	IN	O	on	_	0	SENT_209	[p5l1133t1177r1173b1197],
30	CYP2C19	NN	O	cyp2c19	prep_on	27	SENT_209	[p5l1183t1168r1361b1198],
31	.	.	O	.	_	0	SENT_209	[p5l1183t1168r1361b1198],

1	However	RB	O	however	advmod	9	SENT_210	[p5l1373t1169r1528b1203],
2	,	,	O	,	_	0	SENT_210	[p5l1373t1169r1528b1203],
3	ﬂuoxetine	NN	O	ﬂuoxetine	nn	6	SENT_210	[p5l1540t1168r1704b1197],
4	and	CC	O	and	_	0	SENT_210	[p5l1714t1168r1773b1197],
5	paroxetine	NN	O	paroxetine	conj_and	3	SENT_210	[p5l1782t1177r1888b1206, p5l545t1218r625b1247],
6	phamiacokinetics	NNS	O	phamiacokinetic	nsubjpass	9	SENT_210	[p5l636t1218r927b1256],
7	have	VBP	O	have	aux	9	SENT_210	[p5l939t1218r1015b1247],
8	been	VBN	O	be	auxpass	9	SENT_210	[p5l1026t1218r1104b1247],
9	correlated	VBN	O	correlate	_	0	SENT_210	[p5l1116t1218r1281b1247],
10	with	IN	O	with	_	0	SENT_210	[p5l1292t1218r1365b1247],
11	C	NN	O	c	nn	13	SENT_210	[p5l1378t1219r1405b1248],
12	YP2D6	NN	O	yp2d6	nn	13	SENT_210	[p5l1407t1218r1525b1247],
13	genotype	NN	O	genotype	prep_with	9	SENT_210	[p5l1535t1223r1685b1256],
14	(	CD	NUMBER	(	number	15	SENT_210	[p5l1698t1218r1773b1254],
15	47	CD	NUMBER	47	num	16	SENT_210	[p5l1698t1218r1773b1254],
16	)	NN	O	)	dep	9	SENT_210	[p5l1698t1218r1773b1254],
17	.	.	O	.	_	0	SENT_210	[p5l1698t1218r1773b1254],

1	A	DT	O	a	det	4	SENT_211	[p5l595t1268r624b1297],
2	meta	NN	O	meta	nn	4	SENT_211	[p5l641t1268r867b1306],
3	—	NN	O	—	nn	4	SENT_211	[p5l641t1268r867b1306],
4	analysis	NN	O	analysis	nsubj	20	SENT_211	[p5l641t1268r867b1306],
5	of	IN	O	of	_	0	SENT_211	[p5l885t1268r921b1297],
6	the	DT	O	the	det	8	SENT_211	[p5l935t1268r985b1297],
7	quantitative	JJ	O	quantitative	amod	8	SENT_211	[p5l1002t1268r1195b1306],
8	contribution	NN	O	contribution	prep_of	4	SENT_211	[p5l1212t1268r1413b1297],
9	of	IN	O	of	_	0	SENT_211	[p5l1430t1268r1466b1297],
10	CYP2D6	NN	O	cyp2d6	nn	11	SENT_211	[p5l1481t1268r1631b1297],
11	polymorphism	NN	O	polymorphism	prep_of	8	SENT_211	[p5l1648t1268r1890b1306],
12	to	TO	O	to	_	0	SENT_211	[p5l545t1322r576b1347],
13	the	DT	O	the	det	15	SENT_211	[p5l590t1318r640b1347],
14	interindividual	JJ	O	interindividual	amod	15	SENT_211	[p5l654t1318r896b1347],
15	variation	NN	O	variation	prep_to	11	SENT_211	[p5l911t1318r1056b1347],
16	in	IN	O	in	_	0	SENT_211	[p5l1070t1318r1101b1347],
17	dosage	NN	O	dosage	prep_in	15	SENT_211	[p5l1116t1318r1229b1356],
18	of	IN	O	of	_	0	SENT_211	[p5l1244t1318r1280b1347],
19	antidepressants	NNS	O	antidepressant	prep_of	17	SENT_211	[p5l1292t1318r1543b1356],
20	(	VBP	O	(	_	0	SENT_211	[p5l1559t1318r1624b1354],
21	48	CD	NUMBER	48	num	22	SENT_211	[p5l1559t1318r1624b1354],
22	)	NN	O	)	nsubj	24	SENT_211	[p5l1559t1318r1624b1354],
23	has	VBZ	O	have	aux	24	SENT_211	[p5l1639t1318r1693b1347],
24	shown	VBN	O	show	ccomp	20	SENT_211	[p5l1709t1318r1814b1347],
25	that	IN	O	that	complm	50	SENT_211	[p5l1828t1318r1890b1347],
26	the	DT	O	the	det	27	SENT_211	[p5l545t1367r595b1397],
27	metabolism	NN	O	metabolism	nsubj	50	SENT_211	[p5l610t1367r804b1397],
28	and	CC	O	and	_	0	SENT_211	[p5l820t1367r878b1397],
29	dosage	NN	O	dosage	conj_and	27	SENT_211	[p5l894t1367r1007b1405],
30	of	IN	O	of	_	0	SENT_211	[p5l1024t1367r1060b1397],
31	imipramine	NN	O	imipramine	nn	43	SENT_211	[p5l1072t1367r1272b1405],
32	,	,	O	,	_	0	SENT_211	[p5l1072t1367r1272b1405],
33	doxepin	NN	O	doxepin	dep	43	SENT_211	[p5l1289t1367r1430b1405],
34	,	,	O	,	_	0	SENT_211	[p5l1289t1367r1430b1405],
35	maprotiline	NN	O	maprotiline	dep	43	SENT_211	[p5l1447t1367r1646b1405],
36	,	,	O	,	_	0	SENT_211	[p5l1447t1367r1646b1405],
37	trimipramine	NN	O	trimipramine	dep	43	SENT_211	[p5l1663t1367r1888b1405],
38	,	,	O	,	_	0	SENT_211	[p5l1663t1367r1888b1405],
39	desipramine	NN	O	desipramine	dep	43	SENT_211	[p5l546t1417r756b1455],
40	,	,	O	,	_	0	SENT_211	[p5l546t1417r756b1455],
41	nortriptyline	NN	O	nortriptyline	dep	43	SENT_211	[p5l767t1417r983b1455],
42	,	,	O	,	_	0	SENT_211	[p5l767t1417r983b1455],
43	clomipramine	NN	O	clomipramine	prep_of	27	SENT_211	[p5l994t1417r1232b1455],
44	,	,	O	,	_	0	SENT_211	[p5l994t1417r1232b1455],
45	and	CC	O	and	_	0	SENT_211	[p5l1245t1417r1311b1452],
46	,	,	O	,	_	0	SENT_211	[p5l1245t1417r1311b1452],
47	partially	RB	O	partially	dep	43	SENT_211	[p5l1322t1417r1466b1455],
48	,	,	O	,	_	0	SENT_211	[p5l1322t1417r1466b1455],
49	paroxetine	NN	O	paroxetine	prep_of	27	SENT_211	[p5l1477t1417r1651b1455],
50	depend	VBP	O	depend	ccomp	24	SENT_211	[p5l1661t1417r1780b1455],
51	on	IN	O	on	_	0	SENT_211	[p5l1790t1427r1830b1447],
52	the	DT	O	the	det	55	SENT_211	[p5l1840t1417r1889b1447],
53	CYP2D6	NN	O	cyp2d6	nn	55	SENT_211	[p5l546t1467r696b1497],
54	pheno	NN	O	pheno	nn	55	SENT_211	[p5l710t1467r824b1505],
55	—	NN	O	—	prep_on	50	SENT_211	[p5l710t1467r824b1505],
56	and	CC	O	and	_	0	SENT_211	[p5l841t1467r899b1497],
57	genotype	NN	O	genotype	conj_and	55	SENT_211	[p5l914t1472r1073b1505],
58	.	.	O	.	_	0	SENT_211	[p5l914t1472r1073b1505],

1	Pharmacokinetic	JJ	MISC	pharmacokinetic	amod	2	SENT_212	[p5l1089t1467r1367b1497],
2	data	NNS	O	datum	nsubj	3	SENT_212	[p5l1382t1467r1451b1497],
3	suggest	VBP	O	suggest	_	0	SENT_212	[p5l1466t1472r1589b1505],
4	dose	NN	O	dose	nn	5	SENT_212	[p5l1603t1467r1677b1497],
5	adjustments	NNS	O	adjustment	dobj	3	SENT_212	[p5l1693t1467r1889b1505],
6	for	IN	O	for	_	0	SENT_212	[p5l545t1517r593b1547],
7	these	DT	O	these	det	8	SENT_212	[p5l609t1517r693b1547],
8	drugs	NNS	O	drug	prep_for	3	SENT_212	[p5l711t1517r801b1555],
9	that	WDT	O	that	nsubj	10	SENT_212	[p5l818t1517r880b1547],
10	range	VBP	O	range	rcmod	8	SENT_212	[p5l896t1527r987b1555],
11	from	IN	O	from	_	0	SENT_212	[p5l1004t1517r1085b1547],
12	28	CD	PERCENT	28	number	16	SENT_212	[p5l1101t1518r1174b1547],
13	%	NN	PERCENT	%	dep	16	SENT_212	[p5l1101t1518r1174b1547],
14	to	TO	O	to	dep	16	SENT_212	[p5l1193t1522r1223b1547],
15	60	CD	PERCENT	60	number	16	SENT_212	[p5l1241t1517r1314b1547],
16	%	NN	PERCENT	%	prep_from	10	SENT_212	[p5l1241t1517r1314b1547],
17	of	IN	O	of	_	0	SENT_212	[p5l1333t1517r1369b1547],
18	the	DT	O	the	det	20	SENT_212	[p5l1383t1517r1432b1547],
19	normal	JJ	O	normal	amod	20	SENT_212	[p5l1449t1518r1566b1547],
20	dose	NN	O	dose	prep_of	16	SENT_212	[p5l1583t1517r1658b1547],
21	for	IN	O	for	_	0	SENT_212	[p5l1675t1517r1723b1547],
22	PMs	NNS	O	pm	prep_for	20	SENT_212	[p5l1739t1518r1813b1547],
23	and	CC	O	and	_	0	SENT_212	[p5l1831t1517r1890b1547],
24	180	CD	PERCENT	180	number	28	SENT_212	[p5l549t1567r639b1597],
25	%	NN	PERCENT	%	dep	28	SENT_212	[p5l549t1567r639b1597],
26	to	TO	O	to	dep	28	SENT_212	[p5l657t1571r688b1596],
27	140	CD	PERCENT	140	number	28	SENT_212	[p5l708t1567r798b1597],
28	%	NN	PERCENT	%	conj_and	16	SENT_212	[p5l708t1567r798b1597],
29	of	IN	O	of	_	0	SENT_212	[p5l816t1567r852b1596],
30	normal	JJ	O	normal	amod	31	SENT_212	[p5l865t1567r982b1596],
31	dosage	NN	O	dosage	prep_of	28	SENT_212	[p5l998t1567r1112b1605],
32	for	IN	O	for	_	0	SENT_212	[p5l1128t1567r1176b1596],
33	UMs	NNS	O	um	prep_for	31	SENT_212	[p5l1191t1568r1282b1596],
34	.	.	O	.	_	0	SENT_212	[p5l1191t1568r1282b1596],

1	In	IN	O	in	_	0	SENT_213	[p5l1300t1568r1333b1596],
2	general	JJ	O	general	prep_in	26	SENT_213	[p5l1350t1567r1479b1605],
3	,	,	O	,	_	0	SENT_213	[p5l1350t1567r1479b1605],
4	based	VBN	O	base	partmod	2	SENT_213	[p5l1496t1567r1591b1596],
5	on	IN	O	on	_	0	SENT_213	[p5l1607t1576r1647b1596],
6	the	DT	O	the	det	7	SENT_213	[p5l1662t1567r1712b1596],
7	impact	NN	O	impact	prep_on	4	SENT_213	[p5l1728t1567r1840b1605],
8	of	IN	O	of	_	0	SENT_213	[p5l1856t1567r1892b1596],
9	CYP2D6	NN	O	cyp2d6	prep_of	7	SENT_213	[p5l546t1616r696b1645],
10	on	IN	O	on	_	0	SENT_213	[p5l705t1625r745b1645],
11	dosage	NN	O	dosage	nn	12	SENT_213	[p5l753t1616r866b1654],
12	adaptation	NN	O	adaptation	prep_on	4	SENT_213	[p5l875t1616r1046b1654],
13	of	IN	O	of	_	0	SENT_213	[p5l1054t1616r1090b1645],
14	antidepressants	NNS	O	antidepressant	prep_of	12	SENT_213	[p5l1096t1616r1347b1654],
15	and	CC	O	and	_	0	SENT_213	[p5l1356t1616r1415b1645],
16	antipsychotics	NNS	O	antipsychotic	prep_of	12	SENT_213	[p5l1423t1616r1667b1654],
17	,	,	O	,	_	0	SENT_213	[p5l1423t1616r1667b1654],
18	40	CD	PERCENT	40	number	19	SENT_213	[p5l1676t1616r1847b1645],
19	%	NN	PERCENT	%	amod	2	SENT_213	[p5l1676t1616r1847b1645],
20	-50	CD	PERCENT	-50	num	21	SENT_213	[p5l1676t1616r1847b1645],
21	%	NN	PERCENT	%	nsubj	26	SENT_213	[p5l1676t1616r1847b1645],
22	of	IN	O	of	_	0	SENT_213	[p5l1856t1616r1892b1645],
23	drugs	NNS	O	drug	prep_of	21	SENT_213	[p5l546t1665r635b1703],
24	may	MD	O	may	aux	26	SENT_213	[p5l647t1674r717b1703],
25	be	VB	O	be	cop	26	SENT_213	[p5l727t1665r766b1694],
26	subject	JJ	O	subject	_	0	SENT_213	[p5l778t1665r893b1703],
27	to	TO	O	to	_	0	SENT_213	[p5l903t1670r934b1694],
28	important	JJ	O	important	amod	30	SENT_213	[p5l945t1665r1106b1703],
29	pharmacokinetic	JJ	O	pharmacokinetic	amod	30	SENT_213	[p5l1115t1665r1391b1703],
30	alterations	NNS	O	alteration	prep_to	26	SENT_213	[p5l1403t1665r1573b1694],
31	owing	VBG	O	owe	partmod	30	SENT_213	[p5l1585t1665r1686b1703],
32	to	TO	O	to	_	0	SENT_213	[p5l1697t1670r1727b1694],
33	CYP2D6	NN	O	cyp2d6	nn	34	SENT_213	[p5l1739t1665r1889b1695],
34	polymorphism	NN	O	polymorphism	prep_to	31	SENT_213	[p5l545t1715r795b1753],
35	.	.	O	.	_	0	SENT_213	[p5l545t1715r795b1753],

1	This	DT	O	this	det	2	SENT_214	[p5l805t1715r877b1744],
2	ﬁgure	NN	O	ﬁgure	nsubj	3	SENT_214	[p5l887t1715r982b1753],
3	extrapolates	VBZ	O	extrapolate	_	0	SENT_214	[p5l991t1715r1189b1753],
4	to	TO	O	to	aux	5	SENT_214	[p5l1198t1720r1229b1744],
5	~	VB	O	~	xcomp	3	SENT_214	[p5l1240t1715r1441b1745],
6	10	CD	PERCENT	10	num	7	SENT_214	[p5l1240t1715r1441b1745],
7	%	NN	PERCENT	%	dobj	5	SENT_214	[p5l1240t1715r1441b1745],
8	-12	CD	PERCENT	-12	num	9	SENT_214	[p5l1240t1715r1441b1745],
9	%	NN	PERCENT	%	npadvmod	5	SENT_214	[p5l1240t1715r1441b1745],
10	of	IN	O	of	_	0	SENT_214	[p5l1452t1715r1487b1744],
11	all	DT	O	all	det	14	SENT_214	[p5l1494t1715r1534b1744],
12	clinically	RB	O	clinically	advmod	13	SENT_214	[p5l1543t1715r1695b1753],
13	used	VBN	O	use	amod	14	SENT_214	[p5l1704t1715r1780b1744],
14	drugs	NNS	O	drug	prep_of	5	SENT_214	[p5l1788t1715r1887b1753],
15	.	.	O	.	_	0	SENT_214	[p5l1788t1715r1887b1753],

1	An	DT	O	a	det	3	SENT_215	[p5l595t1764r645b1793],
2	interesting	JJ	O	interesting	amod	3	SENT_215	[p5l652t1764r826b1802],
3	relationship	NN	O	relationship	nsubj	4	SENT_215	[p5l833t1764r1028b1802],
4	exists	VBZ	O	exist	_	0	SENT_215	[p5l1037t1764r1128b1793],
5	between	IN	O	between	_	0	SENT_215	[p5l1136t1764r1274b1793],
6	nonresponders	NNS	O	nonresponder	prep_between	4	SENT_215	[p5l1282t1764r1522b1802],
7	to	TO	O	to	_	0	SENT_215	[p5l1530t1769r1561b1793],
8	antidepressant	JJ	O	antidepressant	amod	9	SENT_215	[p5l1570t1764r1806b1802],
9	therapy	NN	O	therapy	prep_to	4	SENT_215	[p5l1813t1764r1888b1793, p5l546t1822r603b1851],
10	and	CC	O	and	_	0	SENT_215	[p5l616t1813r674b1842],
11	the	DT	O	the	det	13	SENT_215	[p5l685t1813r734b1842],
12	UM	NNP	O	UM	nn	13	SENT_215	[p5l745t1814r811b1843],
13	phenotype	NN	O	phenotype	conj_and	9	SENT_215	[p5l822t1813r1002b1851],
14	.	.	O	.	_	0	SENT_215	[p5l822t1813r1002b1851],

1	Initial	JJ	O	initial	amod	2	SENT_216	[p5l1016t1813r1114b1842],
2	studies	NNS	O	study	nsubj	3	SENT_216	[p5l1126t1813r1238b1842],
3	(	VBP	O	(	_	0	SENT_216	[p5l1252t1813r1317b1849],
4	49	CD	NUMBER	49	num	5	SENT_216	[p5l1252t1813r1317b1849],
5	)	CD	NUMBER	)	nsubj	6	SENT_216	[p5l1252t1813r1317b1849],
6	revealed	VBD	O	reveal	ccomp	3	SENT_216	[p5l1329t1813r1468b1842],
7	that	IN	O	that	complm	15	SENT_216	[p5l1478t1813r1540b1842],
8	the	DT	O	the	det	9	SENT_216	[p5l1551t1813r1600b1842],
9	number	NN	O	number	nsubj	15	SENT_216	[p5l1611t1813r1738b1842],
10	of	IN	O	of	_	0	SENT_216	[p5l1749t1813r1785b1842],
11	active	JJ	O	active	amod	14	SENT_216	[p5l1794t1813r1889b1842],
12	CYP2D6	NN	O	cyp2d6	nn	14	SENT_216	[p5l547t1862r693b1892],
13	gene	NN	O	gene	nn	14	SENT_216	[p5l706t1871r783b1900],
14	copies	NNS	O	copy	prep_of	9	SENT_216	[p5l797t1862r901b1900],
15	had	VBD	O	have	ccomp	6	SENT_216	[p5l915t1862r975b1891],
16	a	DT	O	a	det	18	SENT_216	[p5l989t1871r1006b1891],
17	strong	JJ	O	strong	amod	18	SENT_216	[p5l1020t1867r1121b1900],
18	impact	NN	O	impact	dobj	15	SENT_216	[p5l1135t1862r1248b1900],
19	on	IN	O	on	_	0	SENT_216	[p5l1262t1871r1302b1891],
20	the	DT	O	the	det	21	SENT_216	[p5l1315t1862r1365b1891],
21	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	18	SENT_216	[p5l1378t1862r1669b1900],
22	of	IN	O	of	_	0	SENT_216	[p5l1685t1862r1720b1891],
23	nortriptyline	NN	O	nortriptyline	prep_of	21	SENT_216	[p5l1731t1862r1888b1900, p5l545t1911r615b1941],
24	.	.	O	.	_	0	SENT_216	[p5l1731t1862r1888b1900, p5l545t1911r615b1941],

1	Later	RB	O	later	advmod	6	SENT_217	[p5l631t1912r725b1946],
2	,	,	O	,	_	0	SENT_217	[p5l631t1912r725b1946],
3	two	CD	NUMBER	two	num	5	SENT_217	[p5l742t1916r802b1941],
4	independent	JJ	O	independent	amod	5	SENT_217	[p5l817t1911r1020b1949],
5	studies	NNS	O	study	nsubj	6	SENT_217	[p5l1035t1911r1147b1941],
6	indicated	VBD	O	indicate	_	0	SENT_217	[p5l1163t1911r1314b1941],
7	a	DT	O	a	det	21	SENT_217	[p5l1330t1920r1347b1941],
8	5-10-fold	RB	O	5-10-fold	advmod	9	SENT_217	[p5l1362t1911r1524b1941],
9	higher	JJR	O	higher	amod	21	SENT_217	[p5l1538t1911r1644b1949],
10	than	IN	O	than	mark	17	SENT_217	[p5l1658t1911r1729b1941],
11	expected	VBN	O	expect	amod	12	SENT_217	[p5l1744t1911r1890b1949],
12	incidence	NN	O	incidence	nsubj	17	SENT_217	[p5l545t1960r703b1989],
13	of	IN	O	of	_	0	SENT_217	[p5l717t1960r752b1989],
14	UMs	NN	O	um	prep_of	12	SENT_217	[p5l762t1961r844b1990],
15	among	IN	O	among	_	0	SENT_217	[p5l858t1970r969b1998],
16	nonresponders	NNS	O	nonresponder	prep_among	14	SENT_217	[p5l982t1960r1222b1998],
17	(	VBP	O	(	ccomp	9	SENT_217	[p5l1237t1960r1299b1996],
18	50	CD	NUMBER	50	dobj	17	SENT_217	[p5l1237t1960r1299b1996],
19	,	,	O	,	_	0	SENT_217	[p5l1237t1960r1299b1996],
20	51	CD	NUMBER	51	amod	21	SENT_217	[p5l1314t1960r1376b1996],
21	)	NN	O	)	dobj	6	SENT_217	[p5l1314t1960r1376b1996],
22	.	.	O	.	_	0	SENT_217	[p5l1314t1960r1376b1996],

1	This	DT	O	this	det	2	SENT_218	[p5l1391t1960r1463b1989],
2	ﬁnding	JJ	O	ﬁnding	nsubj	3	SENT_218	[p5l1477t1960r1593b1998],
3	implies	VBZ	O	imply	_	0	SENT_218	[p5l1606t1960r1727b1998],
4	that	IN	O	that	complm	20	SENT_218	[p5l1740t1960r1802b1989],
5	nonresponse	JJ	O	nonresponse	amod	7	SENT_218	[p5l1814t1969r1888b1989, p5l545t2018r689b2047],
6	to	TO	O	to	dep	7	SENT_218	[p5l701t2014r732b2038],
7	antidepressant	JJ	O	antidepressant	amod	8	SENT_218	[p5l745t2009r982b2047],
8	therapy	NN	O	therapy	nsubj	20	SENT_218	[p5l993t2009r1116b2047],
9	due	JJ	O	due	_	0	SENT_218	[p5l1128t2009r1187b2038],
10	to	TO	O	to	_	0	SENT_218	[p5l1199t2014r1229b2038],
11	ultrarapid	JJ	O	ultrarapid	amod	12	SENT_218	[p5l1242t2009r1403b2047],
12	metabolism	NN	O	metabolism	prep_due_to	8	SENT_218	[p5l1414t2009r1607b2038],
13	of	IN	O	of	_	0	SENT_218	[p5l1619t2009r1655b2038],
14	the	DT	O	the	det	15	SENT_218	[p5l1664t2009r1714b2038],
15	drug	NN	O	drug	prep_of	12	SENT_218	[p5l1726t2009r1800b2047],
16	is	VBZ	O	be	cop	20	SENT_218	[p5l1813t2009r1838b2038],
17	an	DT	O	a	det	20	SENT_218	[p5l1852t2018r1890b2038],
18	important	JJ	O	important	amod	20	SENT_218	[p5l545t2058r706b2096],
19	clinical	JJ	O	clinical	amod	20	SENT_218	[p5l713t2058r834b2087],
20	issue	NN	O	issue	ccomp	3	SENT_218	[p5l842t2058r924b2087],
21	and	CC	O	and	_	0	SENT_218	[p5l932t2058r991b2087],
22	that	IN	O	that	complm	29	SENT_218	[p5l998t2058r1060b2087],
23	a	DT	O	a	det	26	SENT_218	[p5l1067t2067r1085b2087],
24	higher	JJR	O	higher	amod	26	SENT_218	[p5l1091t2058r1197b2096],
25	response	NN	O	response	nn	26	SENT_218	[p5l1204t2067r1348b2096],
26	rate	NN	O	rate	nsubjpass	29	SENT_218	[p5l1355t2062r1417b2087],
27	could	MD	O	could	aux	29	SENT_218	[p5l1425t2058r1516b2087],
28	be	VB	O	be	auxpass	29	SENT_218	[p5l1523t2058r1561b2087],
29	obtained	VBN	O	obtain	conj_and	20	SENT_218	[p5l1569t2058r1711b2087],
30	in	IN	O	in	_	0	SENT_218	[p5l1718t2058r1750b2087],
31	a	DT	O	a	det	33	SENT_218	[p5l1758t2067r1775b2087],
32	significant	JJ	O	significant	amod	33	SENT_218	[p5l1783t2058r1888b2096, p5l545t2108r625b2137],
33	fraction	NN	O	fraction	prep_in	29	SENT_218	[p5l634t2108r763b2137],
34	of	IN	O	of	_	0	SENT_218	[p5l773t2108r808b2137],
35	Europeans	NNPS	MISC	Europeans	prep_of	33	SENT_218	[p5l815t2109r989b2146],
36	if	IN	O	if	mark	39	SENT_218	[p5l999t2108r1026b2137],
37	dosing	NN	O	dosing	nsubjpass	39	SENT_218	[p5l1033t2108r1142b2146],
38	were	VBD	O	be	auxpass	39	SENT_218	[p5l1153t2117r1232b2137],
39	based	VBN	O	base	advcl	29	SENT_218	[p5l1241t2108r1335b2137],
40	on	IN	O	on	_	0	SENT_218	[p5l1345t2117r1385b2137],
41	the	DT	O	the	det	43	SENT_218	[p5l1395t2108r1444b2137],
42	CYP2D6	NN	O	cyp2d6	nn	43	SENT_218	[p5l1455t2108r1605b2137],
43	pheno	NN	O	pheno	prep_on	39	SENT_218	[p5l1614t2108r1728b2146],
44	/	:	O	/	punct	45	SENT_218	[p5l1614t2108r1728b2146],
45	genotype	NN	O	genotype	dep	43	SENT_218	[p5l1728t2112r1887b2146],
46	.	.	O	.	_	0	SENT_218	[p5l1728t2112r1887b2146],

1	126	CD	NUMBER	126	num	2	SENT_219	[p5l438t2162r497b2192],
2	EICHELBAUM	NN	O	eichelbaum	_	0	SENT_219	[p5l585t2165r826b2192],
3	I	PRP	O	I	nsubj	4	SENT_219	[p5l844t2168r861b2186],
4	INGELMAN-SUNDBERG	VBP	O	ingelman-sundberg	rcmod	2	SENT_219	[p5l880t2165r1292b2192],
5	I	PRP	O	I	nsubj	6	SENT_219	[p5l1310t2168r1327b2186],
6	EVANS	NNS	O	evan	xcomp	4	SENT_219	[p5l1346t2165r1463b2192],

1	Further	JJ	O	further	amod	3	SENT_220	[p5l535t2288r658b2318],
2	prospective	JJ	O	prospective	amod	3	SENT_220	[p5l668t2288r857b2326],
3	studies	NNS	O	study	nsubjpass	5	SENT_220	[p5l871t2288r983b2318],
4	are	VBP	O	be	auxpass	5	SENT_220	[p5l997t2297r1046b2318],
5	needed	VBN	O	need	_	0	SENT_220	[p5l1058t2288r1175b2318],
6	to	TO	O	to	aux	7	SENT_220	[p5l1187t2293r1218b2318],
7	deﬁne	VB	O	deﬁne	xcomp	5	SENT_220	[p5l1231t2288r1331b2318],
8	the	DT	O	the	det	12	SENT_220	[p5l1343t2288r1392b2318],
9	cost	NN	O	cost	nn	12	SENT_220	[p5l1405t2288r1598b2318],
10	—	NN	O	—	nn	12	SENT_220	[p5l1405t2288r1598b2318],
11	beneﬁt	NN	O	beneﬁt	nn	12	SENT_220	[p5l1405t2288r1598b2318],
12	ratio	NN	O	ratio	dobj	7	SENT_220	[p5l1609t2288r1684b2318],
13	of	IN	O	of	_	0	SENT_220	[p5l1697t2288r1733b2318],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_220	[p5l1742t2288r1879b2326, p5l536t2338r693b2376],
15	individualization	NN	O	individualization	prep_of	12	SENT_220	[p5l705t2338r985b2367],
16	of	IN	O	of	_	0	SENT_220	[p5l996t2338r1032b2367],
17	therapy	NN	O	therapy	prep_of	15	SENT_220	[p5l1041t2338r1163b2376],
18	with	IN	O	with	_	0	SENT_220	[p5l1176t2338r1248b2367],
19	these	DT	O	these	nn	23	SENT_220	[p5l1259t2338r1344b2367],
20	and	CC	O	and	_	0	SENT_220	[p5l1356t2338r1414b2367],
21	other	JJ	O	other	nn	23	SENT_220	[p5l1426t2338r1511b2367],
22	CYP2D6	NN	O	cyp2d6	nn	23	SENT_220	[p5l1522t2338r1672b2368],
23	substrates	NNS	O	substrate	prep_with	7	SENT_220	[p5l1685t2338r1855b2367],
24	.	.	O	.	_	0	SENT_220	[p5l1685t2338r1855b2367],

1	TPMT	NN	O	tpmt	_	0	SENT_221	[p5l436t2438r568b2473],
2	and	CC	O	and	_	0	SENT_221	[p5l582t2437r656b2473],
3	Thiopurine	NN	O	thiopurine	nn	4	SENT_221	[p5l668t2437r899b2484],
4	Therapy	NN	O	therapy	conj_and	1	SENT_221	[p5l912t2437r1082b2485],

1	TPMT	NN	ORGANIZATION	tpmt	nsubj	2	SENT_222	[p5l536t2497r645b2525],
2	catalyzes	VBZ	O	catalyze	dep	12	SENT_222	[p5l657t2496r806b2534],
3	the	DT	O	the	det	7	SENT_222	[p5l819t2496r868b2525],
4	S-methylation	NN	O	s-methylation	nn	7	SENT_222	[p5l881t2496r1114b2534],
5	(	NN	O	(	nn	7	SENT_222	[p5l1126t2496r1344b2532],
6	inactivation	NN	O	inactivation	nn	7	SENT_222	[p5l1126t2496r1344b2532],
7	)	NN	O	)	dobj	2	SENT_222	[p5l1126t2496r1344b2532],
8	of	IN	O	of	_	0	SENT_222	[p5l1357t2496r1393b2525],
9	the	DT	O	the	det	11	SENT_222	[p5l1401t2496r1451b2525],
10	thiopurine	NN	O	thiopurine	nn	11	SENT_222	[p5l1462t2496r1631b2534],
11	drugs	NNS	O	drug	prep_of	7	SENT_222	[p5l1643t2496r1733b2534],
12	mercap	VBP	O	mercap	_	0	SENT_222	[p5l1745t2505r1879b2534],
13	—	NN	O	—	nn	14	SENT_222	[p5l1745t2505r1879b2534],
14	topurine	NN	O	topurine	dobj	12	SENT_222	[p5l536t2545r682b2583],
15	,	,	O	,	_	0	SENT_222	[p5l536t2545r682b2583],
16	azathioprine	NN	O	azathioprine	dobj	12	SENT_222	[p5l694t2545r906b2583],
17	,	,	O	,	_	0	SENT_222	[p5l694t2545r906b2583],
18	and	CC	O	and	_	0	SENT_222	[p5l918t2545r976b2574],
19	thioguanine	NN	O	thioguanine	dobj	12	SENT_222	[p5l985t2545r1180b2583],
20	(	CD	NUMBER	(	num	21	SENT_222	[p5l1191t2545r1253b2581],
21	52	CD	NUMBER	52	nsubj	12	SENT_222	[p5l1191t2545r1253b2581],
22	,	,	O	,	_	0	SENT_222	[p5l1191t2545r1253b2581],
23	53	CD	NUMBER	53	num	24	SENT_222	[p5l1264t2545r1326b2581],
24	)	NN	O	)	appos	21	SENT_222	[p5l1264t2545r1326b2581],
25	.	.	O	.	_	0	SENT_222	[p5l1264t2545r1326b2581],

1	These	DT	O	these	det	2	SENT_223	[p5l1338t2545r1436b2574],
2	agents	NNS	O	agent	nsubjpass	5	SENT_223	[p5l1446t2550r1549b2583],
3	are	VBP	O	be	auxpass	5	SENT_223	[p5l1561t2554r1609b2574],
4	commonly	RB	O	commonly	advmod	5	SENT_223	[p5l1619t2545r1795b2583],
5	used	VBN	O	use	_	0	SENT_223	[p5l1804t2545r1880b2574],
6	to	TO	O	to	aux	7	SENT_223	[p5l536t2599r566b2623],
7	treat	VB	O	treat	xcomp	5	SENT_223	[p5l574t2599r647b2623],
8	leukemia	NN	O	leukemia	dobj	7	SENT_223	[p5l654t2594r813b2628],
9	,	,	O	,	_	0	SENT_223	[p5l654t2594r813b2628],
10	rheumatic	JJ	O	rheumatic	amod	11	SENT_223	[p5l821t2594r986b2623],
11	diseases	NNS	O	disease	conj_and	8	SENT_223	[p5l994t2594r1137b2628],
12	,	,	O	,	_	0	SENT_223	[p5l994t2594r1137b2628],
13	inﬂammatory	JJ	O	inﬂammatory	amod	15	SENT_223	[p5l1146t2594r1368b2632],
14	bowel	NN	O	bowel	nn	15	SENT_223	[p5l1375t2594r1475b2623],
15	diseases	NNS	O	disease	dobj	7	SENT_223	[p5l1482t2594r1626b2628],
16	,	,	O	,	_	0	SENT_223	[p5l1482t2594r1626b2628],
17	and	CC	O	and	_	0	SENT_223	[p5l1635t2594r1694b2623],
18	solid	JJ	O	solid	amod	20	SENT_223	[p5l1702t2594r1780b2623],
19	organ	NN	O	organ	nn	20	SENT_223	[p5l1788t2603r1880b2632],
20	transplantation	NN	O	transplantation	conj_and	8	SENT_223	[p5l536t2643r790b2681],
21	.	.	O	.	_	0	SENT_223	[p5l536t2643r790b2681],

1	In	IN	O	in	_	0	SENT_224	[p5l806t2644r839b2672],
2	hematopoietic	JJ	O	hematopoietic	amod	3	SENT_224	[p5l853t2643r1087b2681],
3	tissues	NNS	O	tissue	prep_in	10	SENT_224	[p5l1102t2643r1220b2678],
4	,	,	O	,	_	0	SENT_224	[p5l1102t2643r1220b2678],
5	TPMT	NN	O	tpmt	nsubj	10	SENT_224	[p5l1236t2644r1346b2672],
6	is	VBZ	O	be	cop	10	SENT_224	[p5l1360t2643r1385b2672],
7	the	DT	O	the	det	10	SENT_224	[p5l1400t2643r1450b2672],
8	predominant	JJ	O	predominant	amod	10	SENT_224	[p5l1463t2643r1673b2681],
9	inactivation	NN	O	inactivation	nn	10	SENT_224	[p5l1687t2643r1880b2672],
10	pathway	NN	O	pathway	_	0	SENT_224	[p5l535t2692r681b2730],
11	,	,	O	,	_	0	SENT_224	[p5l535t2692r681b2730],
12	so	RB	O	so	advmod	13	SENT_224	[p5l699t2701r733b2721],
13	patients	NNS	O	patient	appos	10	SENT_224	[p5l749t2692r876b2730],
14	who	WP	O	who	nsubj	15	SENT_224	[p5l893t2692r963b2721],
15	inherit	VBP	O	inherit	rcmod	13	SENT_224	[p5l979t2692r1087b2721],
16	TPMT	NN	O	tpmt	nn	17	SENT_224	[p5l1101t2693r1211b2721],
17	deﬁciency	NN	O	deﬁciency	nsubj	18	SENT_224	[p5l1227t2692r1395b2730],
18	accumulate	VBP	O	accumulate	ccomp	15	SENT_224	[p5l1412t2692r1599b2721],
19	excessive	JJ	O	excessive	amod	20	SENT_224	[p5l1615t2692r1770b2721],
20	levels	NNS	O	level	dobj	18	SENT_224	[p5l1786t2692r1879b2721],
21	of	IN	O	of	_	0	SENT_224	[p5l536t2741r572b2771],
22	active	JJ	O	active	amod	24	SENT_224	[p5l586t2741r682b2771],
23	thioguanine	NN	O	thioguanine	nn	24	SENT_224	[p5l698t2741r893b2779],
24	nucleotides	NNS	O	nucleotide	prep_of	20	SENT_224	[p5l910t2741r1097b2771],
25	after	IN	O	after	_	0	SENT_224	[p5l1115t2741r1190b2771],
26	receiving	VBG	O	receive	prepc_after	18	SENT_224	[p5l1205t2741r1358b2779],
27	standard	JJ	O	standard	amod	28	SENT_224	[p5l1376t2741r1515b2771],
28	doses	NNS	O	dose	dobj	26	SENT_224	[p5l1531t2741r1630b2771],
29	.	.	O	.	_	0	SENT_224	[p5l1531t2741r1630b2771],

1	Genetic	JJ	O	genetic	amod	2	SENT_225	[p5l1649t2741r1776b2771],
2	polymorphism	NN	O	polymorphism	nsubj	5	SENT_225	[p5l1793t2741r1879b2779, p5l536t2791r703b2829],
3	of	IN	O	of	_	0	SENT_225	[p5l714t2791r750b2820],
4	TPMT	NN	O	tpmt	prep_of	2	SENT_225	[p5l757t2792r867b2820],
5	affects	VBZ	O	affect	_	0	SENT_225	[p5l878t2791r985b2820],
6	its	PRP$	O	its	poss	7	SENT_225	[p5l997t2791r1034b2820],
7	activity	NN	O	activity	dobj	5	SENT_225	[p5l1046t2791r1176b2829],
8	:	:	O	:	_	0	SENT_225	[p5l1046t2791r1176b2829],
9	Approximately	RB	O	approximately	quantmod	10	SENT_225	[p5l1189t2791r1439b2829],
10	90	CD	PERCENT	90	num	11	SENT_225	[p5l1451t2791r1523b2820],
11	%	NN	PERCENT	%	nsubj	14	SENT_225	[p5l1451t2791r1523b2820],
12	of	IN	O	of	_	0	SENT_225	[p5l1536t2791r1572b2820],
13	individuals	NNS	O	individual	prep_of	11	SENT_225	[p5l1580t2791r1761b2820],
14	inherit	VBP	O	inherit	parataxis	5	SENT_225	[p5l1773t2791r1881b2820],
15	high	JJ	O	high	amod	16	SENT_225	[p5l535t2841r608b2878],
16	activity	NN	O	activity	dobj	14	SENT_225	[p5l624t2841r751b2878],
17	,	,	O	,	_	0	SENT_225	[p5l624t2841r751b2878],
18	10	CD	PERCENT	10	number	19	SENT_225	[p5l771t2841r840b2870],
19	%	NN	PERCENT	%	amod	21	SENT_225	[p5l771t2841r840b2870],
20	intermediate	JJ	O	intermediate	amod	21	SENT_225	[p5l857t2841r1063b2870],
21	activity	NN	O	activity	dobj	14	SENT_225	[p5l1078t2841r1200b2878],
22	due	JJ	O	due	_	0	SENT_225	[p5l1215t2841r1273b2870],
23	to	TO	O	to	_	0	SENT_225	[p5l1288t2845r1318b2870],
24	heterozygosity	NN	O	heterozygosity	prep_due_to	21	SENT_225	[p5l1333t2841r1583b2878],
25	,	,	O	,	_	0	SENT_225	[p5l1333t2841r1583b2878],
26	and	CC	O	and	_	0	SENT_225	[p5l1600t2841r1658b2870],
27	0.3	CD	PERCENT	0.3	num	28	SENT_225	[p5l1672t2841r1756b2870],
28	%	NN	PERCENT	%	npadvmod	29	SENT_225	[p5l1672t2841r1756b2870],
29	low	JJ	O	low	conj_and	21	SENT_225	[p5l1772t2841r1832b2870],
30	or	CC	O	or	_	0	SENT_225	[p5l1847t2850r1881b2870],
31	no	DT	O	no	det	33	SENT_225	[p5l536t2900r575b2920],
32	detectable	JJ	O	detectable	amod	33	SENT_225	[p5l588t2891r754b2920],
33	activity	NN	O	activity	conj_or	16	SENT_225	[p5l767t2890r888b2928],
34	because	IN	O	because	_	0	SENT_225	[p5l900t2891r1030b2920],
35	of	IN	O	of	_	0	SENT_225	[p5l1042t2890r1078b2920],
36	two	CD	NUMBER	two	num	39	SENT_225	[p5l1087t2895r1147b2920],
37	nonfunctional	JJ	O	nonfunctional	amod	39	SENT_225	[p5l1159t2890r1388b2920],
38	TPMT	NN	O	tpmt	nn	39	SENT_225	[p5l1400t2891r1510b2919],
39	alleles	NNS	O	allele	prep_of	43	SENT_225	[p5l1522t2891r1625b2920],
40	(	CD	NUMBER	(	num	41	SENT_225	[p5l1639t2890r1759b2928],
41	Figure	NN	O	figure	dep	39	SENT_225	[p5l1639t2890r1759b2928],
42	2	CD	NUMBER	2	number	43	SENT_225	[p5l1771t2891r1803b2927],
43	)	CD	NUMBER	)	prep_because	14	SENT_225	[p5l1771t2891r1803b2927],
44	(	NN	O	(	tmod	43	SENT_225	[p5l1816t2890r1878b2927],
45	54	CD	NUMBER	54	num	44	SENT_225	[p5l1816t2890r1878b2927],
46	,	,	O	,	_	0	SENT_225	[p5l1816t2890r1878b2927],
47	55	CD	NUMBER	55	num	48	SENT_225	[p5l536t2940r598b2976],
48	)	NN	O	)	appos	44	SENT_225	[p5l536t2940r598b2976],
49	.	.	O	.	_	0	SENT_225	[p5l536t2940r598b2976],

1	Numerous	JJ	O	numerous	amod	2	SENT_226	[p5l613t2941r785b2970],
2	studies	NNS	O	study	nsubj	4	SENT_226	[p5l800t2940r912b2970],
3	have	VBP	O	have	aux	4	SENT_226	[p5l926t2941r1002b2970],
4	shown	VBN	O	show	dep	28	SENT_226	[p5l1017t2940r1122b2970],
5	that	IN	O	that	complm	10	SENT_226	[p5l1135t2941r1197b2970],
6	TPMT	NN	O	tpmt	nsubj	10	SENT_226	[p5l1210t2940r1473b2970],
7	—	CD	NUMBER	—	num	9	SENT_226	[p5l1210t2940r1473b2970],
8	deﬁcient	JJ	O	deﬁcient	amod	9	SENT_226	[p5l1210t2940r1473b2970],
9	patients	NNS	O	patient	dep	6	SENT_226	[p5l1485t2940r1613b2978],
10	are	VBP	O	be	ccomp	4	SENT_226	[p5l1628t2950r1677b2970],
11	at	IN	O	at	_	0	SENT_226	[p5l1691t2945r1720b2970],
12	high	JJ	O	high	amod	13	SENT_226	[p5l1732t2940r1806b2978],
13	risk	NN	O	risk	prep_at	10	SENT_226	[p5l1818t2940r1881b2970],
14	of	IN	O	of	_	0	SENT_226	[p5l536t2990r572b3020],
15	severe	JJ	O	severe	amod	18	SENT_226	[p5l586t3000r697b3025],
16	,	,	O	,	_	0	SENT_226	[p5l586t3000r697b3025],
17	sometimes	RB	O	sometimes	advmod	18	SENT_226	[p5l716t2990r890b3020],
18	fatal	JJ	O	fatal	amod	21	SENT_226	[p5l907t2990r988b3025],
19	,	,	O	,	_	0	SENT_226	[p5l907t2990r988b3025],
20	hematologic	JJ	O	hematologic	amod	21	SENT_226	[p5l1005t2990r1209b3028],
21	toxicity	NN	O	toxicity	prep_of	13	SENT_226	[p5l1225t2990r1351b3028],
22	(	CD	NUMBER	(	num	24	SENT_226	[p5l1368t2990r1507b3026],
23	56-58	CD	NUMBER	56-58	num	24	SENT_226	[p5l1368t2990r1507b3026],
24	)	NN	O	)	dep	21	SENT_226	[p5l1368t2990r1507b3026],
25	;	:	O	;	_	0	SENT_226	[p5l1368t2990r1507b3026],
26	TPMT	NN	O	tpmt	nn	27	SENT_226	[p5l1525t2991r1635b3019],
27	heterozygotes	NNS	O	heterozygote	dep	21	SENT_226	[p5l1650t2991r1879b3028],
28	have	VBP	O	have	_	0	SENT_226	[p5l535t3040r611b3070],
29	an	DT	O	a	det	31	SENT_226	[p5l627t3050r664b3070],
30	intermediate	JJ	O	intermediate	amod	31	SENT_226	[p5l679t3040r885b3070],
31	risk	NN	O	risk	dobj	28	SENT_226	[p5l900t3040r962b3070],
32	of	IN	O	of	_	0	SENT_226	[p5l977t3040r1013b3070],
33	hematologic	JJ	O	hematologic	amod	35	SENT_226	[p5l1024t3040r1228b3078],
34	toxicity	NN	O	toxicity	nn	35	SENT_226	[p5l1243t3040r1369b3078],
35	(	NN	O	(	prep_of	31	SENT_226	[p5l1385t3040r1447b3076],
36	59	CD	NUMBER	59	nsubj	28	SENT_226	[p5l1385t3040r1447b3076],
37	,	,	O	,	_	0	SENT_226	[p5l1385t3040r1447b3076],
38	60	CD	NUMBER	60	num	39	SENT_226	[p5l1464t3040r1526b3076],
39	)	NN	O	)	appos	36	SENT_226	[p5l1464t3040r1526b3076],
40	.	.	O	.	_	0	SENT_226	[p5l1464t3040r1526b3076],

1	Patients	NNS	O	patient	nsubjpass	10	SENT_227	[p5l1543t3040r1672b3070],
2	who	WP	O	who	nsubj	3	SENT_227	[p5l1687t3041r1757b3070],
3	inherit	VBP	O	inherit	rcmod	1	SENT_227	[p5l1772t3040r1880b3070],
4	two	CD	NUMBER	two	num	7	SENT_227	[p5l535t3094r596b3119],
5	nonfunctional	JJ	O	nonfunctional	amod	7	SENT_227	[p5l610t3090r839b3119],
6	variant	JJ	O	variant	amod	7	SENT_227	[p5l853t3090r967b3119],
7	alleles	NNS	O	allele	dobj	3	SENT_227	[p5l981t3090r1084b3119],
8	should	MD	O	should	aux	10	SENT_227	[p5l1100t3090r1209b3119],
9	be	VB	O	be	auxpass	10	SENT_227	[p5l1221t3090r1260b3119],
10	given	VBN	O	give	_	0	SENT_227	[p5l1274t3090r1363b3128],
11	6	CD	PERCENT	6	num	12	SENT_227	[p5l1377t3090r1526b3119],
12	%	NN	PERCENT	%	iobj	10	SENT_227	[p5l1377t3090r1526b3119],
13	-10	CD	PERCENT	-10	num	14	SENT_227	[p5l1377t3090r1526b3119],
14	%	NN	PERCENT	%	dobj	10	SENT_227	[p5l1377t3090r1526b3119],
15	of	IN	O	of	_	0	SENT_227	[p5l1542t3090r1578b3119],
16	the	DT	O	the	det	18	SENT_227	[p5l1588t3090r1638b3119],
17	standard	JJ	O	standard	amod	18	SENT_227	[p5l1653t3090r1792b3119],
18	dose	NN	O	dose	prep_of	14	SENT_227	[p5l1805t3090r1880b3119],
19	of	IN	O	of	_	0	SENT_227	[p5l536t3139r572b3168],
20	thiopurines	NNS	O	thiopurine	prep_of	18	SENT_227	[p5l581t3139r766b3177],
21	(	CD	NUMBER	(	num	22	SENT_227	[p5l780t3139r900b3177],
22	Figure	NN	O	figure	dep	20	SENT_227	[p5l780t3139r900b3177],
23	2	CD	NUMBER	2	num	24	SENT_227	[p5l913t3139r955b3175],
24	)	NN	O	)	dep	22	SENT_227	[p5l913t3139r955b3175],
25	,	,	O	,	_	0	SENT_227	[p5l913t3139r955b3175],
26	whereas	IN	O	whereas	mark	31	SENT_227	[p5l969t3139r1102b3168],
27	heterozygous	JJ	O	heterozygous	amod	28	SENT_227	[p5l1115t3139r1335b3177],
28	patients	NNS	O	patient	nsubj	39	SENT_227	[p5l1348t3139r1475b3177],
29	can	MD	O	can	aux	31	SENT_227	[p5l1489t3148r1545b3168],
30	usually	RB	O	usually	advmod	31	SENT_227	[p5l1557t3139r1676b3177],
31	start	VB	O	start	advcl	10	SENT_227	[p5l1690t3143r1759b3168],
32	on	IN	O	on	_	0	SENT_227	[p5l1771t3148r1811b3168],
33	full	JJ	O	full	amod	34	SENT_227	[p5l1823t3139r1880b3168],
34	doses	NNS	O	dose	prep_on	31	SENT_227	[p5l536t3189r626b3218],
35	but	CC	O	but	_	0	SENT_227	[p5l638t3189r690b3218],
36	are	VBP	O	be	cop	39	SENT_227	[p5l702t3199r750b3218],
37	signiﬁcantly	RB	O	signiﬁcantly	advmod	39	SENT_227	[p5l763t3189r966b3227],
38	more	RBR	O	more	advmod	39	SENT_227	[p5l978t3199r1062b3218],
39	likely	JJ	O	likely	conj_but	31	SENT_227	[p5l1074t3189r1166b3227],
40	to	TO	O	to	aux	41	SENT_227	[p5l1178t3194r1209b3218],
41	require	VB	O	require	xcomp	39	SENT_227	[p5l1220t3189r1337b3227],
42	dose	NN	O	dose	nn	43	SENT_227	[p5l1349t3189r1424b3218],
43	reduction	NN	O	reduction	dobj	41	SENT_227	[p5l1435t3189r1591b3218],
44	to	TO	O	to	aux	45	SENT_227	[p5l1603t3194r1633b3218],
45	avoid	VB	O	avoid	xcomp	41	SENT_227	[p5l1646t3189r1735b3218],
46	toxicity	NN	O	toxicity	dobj	45	SENT_227	[p5l1746t3189r1878b3227],
47	.	.	O	.	_	0	SENT_227	[p5l1746t3189r1878b3227],

1	TPMT	NN	O	tpmt	nn	2	SENT_228	[p5l536t3240r645b3268],
2	deﬁciency	NN	O	deﬁciency	nsubjpass	6	SENT_228	[p5l657t3239r825b3277],
3	has	VBZ	O	have	aux	6	SENT_228	[p5l836t3239r890b3268],
4	also	RB	O	also	advmod	6	SENT_228	[p5l903t3239r968b3268],
5	been	VBN	O	be	auxpass	6	SENT_228	[p5l979t3239r1057b3268],
6	associated	VBN	O	associate	dep	14	SENT_228	[p5l1069t3239r1238b3268],
7	with	IN	O	with	_	0	SENT_228	[p5l1249t3239r1322b3268],
8	a	DT	O	a	det	10	SENT_228	[p5l1334t3248r1351b3268],
9	high	JJ	O	high	amod	10	SENT_228	[p5l1361t3239r1434b3277],
10	risk	NN	O	risk	prep_with	6	SENT_228	[p5l1445t3239r1508b3268],
11	of	IN	O	of	_	0	SENT_228	[p5l1518t3239r1554b3268],
12	irradiation	NN	O	irradiation	nn	13	SENT_228	[p5l1563t3239r1880b3268],
13	—	NN	O	—	prep_of	10	SENT_228	[p5l1563t3239r1880b3268],
14	induced	VBD	O	induce	_	0	SENT_228	[p5l1563t3239r1880b3268],
15	brain	NN	O	brain	nn	16	SENT_228	[p5l535t3289r620b3318],
16	tumors	NNS	O	tumor	dobj	14	SENT_228	[p5l635t3294r748b3318],
17	in	IN	O	in	_	0	SENT_228	[p5l763t3289r795b3318],
18	patients	NNS	O	patient	prep_in	14	SENT_228	[p5l809t3289r937b3327],
19	given	VBN	O	give	partmod	18	SENT_228	[p5l953t3289r1042b3327],
20	thiopurines	NNS	O	thiopurine	dobj	19	SENT_228	[p5l1056t3289r1241b3327],
21	concomitantly	RB	O	concomitantly	advmod	19	SENT_228	[p5l1257t3289r1493b3327],
22	with	IN	O	with	_	0	SENT_228	[p5l1508t3289r1581b3318],
23	radiation	NN	O	radiation	nn	24	SENT_228	[p5l1595t3289r1742b3318],
24	therapy	NN	O	therapy	prep_with	19	SENT_228	[p5l1757t3289r1879b3327],
25	(	CD	NUMBER	(	num	24	SENT_228	[p5l537t3339r612b3375],
26	61	CD	NUMBER	61	num	27	SENT_228	[p5l537t3339r612b3375],
27	)	NN	O	)	nsubj	14	SENT_228	[p5l537t3339r612b3375],
28	.	.	O	.	_	0	SENT_228	[p5l537t3339r612b3375],

1	Three	CD	NUMBER	three	num	3	SENT_229	[p5l585t3389r681b3418],
2	variant	JJ	O	variant	amod	3	SENT_229	[p5l693t3389r807b3418],
3	alleles	NNS	O	allele	nsubj	4	SENT_229	[p5l819t3389r922b3418],
4	(	VBP	O	(	_	0	SENT_229	[p5l936t3389r1100b3425],
5	TPMT	NN	O	tpmt	nn	6	SENT_229	[p5l936t3389r1100b3425],
6	*	NN	O	*	dobj	4	SENT_229	[p5l936t3389r1100b3425],
7	2	CD	NUMBER	2	dep	6	SENT_229	[p5l936t3389r1100b3425],
8	,	,	O	,	_	0	SENT_229	[p5l936t3389r1100b3425],
9	TPMT	NN	O	tpmt	nn	11	SENT_229	[p5l1115t3389r1291b3423],
10	*	CD	NUMBER	*	num	11	SENT_229	[p5l1115t3389r1291b3423],
11	3A	NN	O	3a	dobj	4	SENT_229	[p5l1115t3389r1291b3423],
12	,	,	O	,	_	0	SENT_229	[p5l1115t3389r1291b3423],
13	and	CC	O	and	_	0	SENT_229	[p5l1305t3389r1364b3418],
14	TPMT	NN	O	tpmt	nn	17	SENT_229	[p5l1377t3389r1558b3425],
15	*	CD	NUMBER	*	num	17	SENT_229	[p5l1377t3389r1558b3425],
16	3C	NN	O	3c	nn	17	SENT_229	[p5l1377t3389r1558b3425],
17	)	NN	O	)	conj_and	6	SENT_229	[p5l1377t3389r1558b3425],
18	account	NN	O	account	nsubj	42	SENT_229	[p5l1572t3393r1700b3418],
19	for	IN	O	for	_	0	SENT_229	[p5l1711t3389r1759b3418],
20	TPMT	NN	O	tpmt	nn	21	SENT_229	[p5l1770t3390r1880b3418],
21	deﬁciency	NN	O	deﬁciency	prep_for	18	SENT_229	[p5l536t3439r704b3477],
22	in	IN	O	in	_	0	SENT_229	[p5l719t3439r750b3468],
23	>	JJR	PERCENT	>	prep_in	21	SENT_229	[p5l767t3439r869b3468],
24	95	CD	PERCENT	95	number	25	SENT_229	[p5l767t3439r869b3468],
25	%	NN	PERCENT	%	amod	23	SENT_229	[p5l767t3439r869b3468],
26	of	IN	O	of	_	0	SENT_229	[p5l886t3439r921b3468],
27	patients	NNS	O	patient	prep_of	23	SENT_229	[p5l932t3439r1060b3477],
28	(	IN	O	(	_	0	SENT_229	[p5l1076t3439r1138b3475],
29	54	CD	NUMBER	54	prep_(	27	SENT_229	[p5l1076t3439r1138b3475],
30	,	,	O	,	_	0	SENT_229	[p5l1076t3439r1138b3475],
31	55	CD	NUMBER	55	prep_(	27	SENT_229	[p5l1154t3439r1203b3473],
32	,	,	O	,	_	0	SENT_229	[p5l1154t3439r1203b3473],
33	62	CD	NUMBER	62	prep_(	27	SENT_229	[p5l1219t3439r1267b3473],
34	,	,	O	,	_	0	SENT_229	[p5l1219t3439r1267b3473],
35	63	CD	NUMBER	63	num	36	SENT_229	[p5l1284t3439r1346b3475],
36	)	NN	O	)	prep_(	27	SENT_229	[p5l1284t3439r1346b3475],
37	,	,	O	,	_	0	SENT_229	[p5l1284t3439r1346b3475],
38	and	CC	O	and	_	0	SENT_229	[p5l1362t3439r1421b3468],
39	reference	NN	O	reference	nn	40	SENT_229	[p5l1434t3439r1587b3468],
40	laboratories	NNS	O	laboratory	prep_(	27	SENT_229	[p5l1602t3439r1796b3468],
41	now	RB	DATE	now	advmod	42	SENT_229	[p5l1810t3448r1879b3468],
42	offer	VBP	O	offer	rcmod	17	SENT_229	[p5l536t3489r615b3518],
43	TPMT	NN	ORGANIZATION	tpmt	nn	44	SENT_229	[p5l632t3489r742b3518],
44	genotyping	NN	O	genotyping	dobj	42	SENT_229	[p5l760t3489r945b3527],
45	as	IN	O	as	_	0	SENT_229	[p5l964t3498r996b3518],
46	a	DT	O	a	det	49	SENT_229	[p5l1015t3498r1033b3518],
47	Clinical	JJ	O	clinical	amod	49	SENT_229	[p5l1050t3489r1180b3518],
48	Laboratory	NN	O	laboratory	nn	49	SENT_229	[p5l1198t3489r1381b3527],
49	Improvement	NN	O	improvement	prep_as	42	SENT_229	[p5l1400t3489r1622b3527],
50	Amendmentscertiﬁed	JJ	O	amendmentscertiﬁed	amod	51	SENT_229	[p5l1639t3489r1881b3518, p5l536t3539r671b3568],
51	molecular	JJ	O	molecular	dep	49	SENT_229	[p5l680t3539r845b3568],
52	diagnostic	JJ	O	diagnostic	amod	51	SENT_229	[p5l854t3539r1032b3577],
53	.	.	O	.	_	0	SENT_229	[p5l854t3539r1032b3577],

1	More	JJR	O	more	mwe	2	SENT_230	[p5l1043t3540r1131b3568],
2	than	IN	O	than	quantmod	3	SENT_230	[p5l1140t3539r1211b3568],
3	98	CD	PERCENT	98	dep	4	SENT_230	[p5l1221t3539r1293b3569],
4	%	NN	PERCENT	%	dep	5	SENT_230	[p5l1221t3539r1293b3569],
5	concordance	NN	O	concordance	nsubj	6	SENT_230	[p5l1304t3539r1513b3568],
6	exists	VBZ	O	exist	_	0	SENT_230	[p5l1522t3539r1614b3568],
7	between	IN	O	between	_	0	SENT_230	[p5l1623t3539r1761b3568],
8	TPMT	NN	O	tpmt	prep_between	6	SENT_230	[p5l1770t3540r1880b3568],

1	Annu	NNP	PERSON	Annu	_	0	SENT_231	[p6l278t248r301b329],
2	.	.	O	.	_	0	SENT_231	[p6l278t248r301b329],

1	Rev.	NNP	O	Rev.	nn	2	SENT_232	[p6l278t177r301b237],
2	Med	NNP	O	Med	_	0	SENT_232	[p6l278t98r301b166],
3	.	.	O	.	_	0	SENT_232	[p6l278t98r301b166],

1	200	CD	NUMBER	200	_	0	SENT_233	[p6l278t38r301b87],
2	by	IN	O	by	_	0	SENT_233	[p6l311t261r342b294],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_233	[p6l312t111r342b252],
4	of	IN	ORGANIZATION	of	_	0	SENT_233	[p6l311t72r335b101],
5	W	NNP	ORGANIZATION	W	nn	6	SENT_233	[p6l312t37r335b66],
6	Annu	NNP	ORGANIZATION	Annu	prep_of	1	SENT_233	[p6l269t2593r292b2673],
7	.	.	O	.	_	0	SENT_233	[p6l269t2593r292b2673],

1	Rev	NN	O	rev	_	0	SENT_234	[p6l269t2530r292b2582],
2	.	.	O	.	_	0	SENT_234	[p6l288t2516r292b2520],

1	Med	NNP	O	Med	_	0	SENT_235	[p6l269t2438r292b2505],
2	.	.	O	.	_	0	SENT_235	[p6l269t2438r292b2505],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_236	[p6l269t2313r292b2426],
2	:	:	O	:	_	0	SENT_236	[p6l269t2313r292b2426],
3	1	CD	NUMBER	1	number	4	SENT_236	[p6l269t2297r292b2307],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_236	[p6l269t2193r293b2290],
5	.	.	O	.	_	0	SENT_236	[p6l269t2193r293b2290],

1	Downloaded	VBN	O	download	_	0	SENT_237	[p6l269t2013r292b2182],
2	from	IN	O	from	_	0	SENT_237	[p6l269t1939r292b2004],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_237	[p6l269t1606r299b1930],
4	by	IN	O	by	_	0	SENT_237	[p6l302t2607r333b2639],
5	Univ	NNP	MISC	Univ	nn	6	SENT_237	[p6l302t2531r326b2597],
6	ersity	NN	O	ersity	prep_by	1	SENT_237	[p6l302t2450r333b2524],
7	of	IN	O	of	_	0	SENT_237	[p6l302t2411r326b2441],
8	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	6	SENT_237	[p6l302t2266r326b2405],
9	-	:	O	-	_	0	SENT_237	[p6l316t2247r319b2256],
10	Madison	NNP	O	Madison	dep	6	SENT_237	[p6l302t2121r326b2237],
11	on	IN	O	on	_	0	SENT_237	[p6l310t2079r326b2112],
12	01/05/14	CD	DATE	01/05/14	prep_on	10	SENT_237	[p6l302t1946r326b2070],
13	.	.	O	.	_	0	SENT_237	[p6l302t1946r326b2070],

1	For	IN	O	for	_	0	SENT_238	[p6l303t1889r326b1935],
2	personal	JJ	O	personal	amod	3	SENT_238	[p6l302t1769r333b1881],
3	use	NN	O	use	pobj	1	SENT_238	[p6l310t1716r326b1760],
4	only	RB	O	only	advmod	3	SENT_238	[p6l302t1641r333b1706],
5	.	.	O	.	_	0	SENT_238	[p6l302t1641r333b1706],

1	genotype	NN	O	genotype	nsubj	10	SENT_239	[p6l536t51r686b85],
2	and	CC	O	and	_	0	SENT_239	[p6l702t47r761b76],
3	phenotype	NN	O	phenotype	nsubj	10	SENT_239	[p6l774t47r955b85],
4	,	,	O	,	_	0	SENT_239	[p6l774t47r955b85],
5	and	CC	O	and	_	0	SENT_239	[p6l972t47r1031b76],
6	genotyping	NN	O	genotyping	nsubj	10	SENT_239	[p6l1046t47r1230b85],
7	is	VBZ	O	be	cop	10	SENT_239	[p6l1246t47r1271b76],
8	highly	RB	O	highly	advmod	9	SENT_239	[p6l1286t47r1391b85],
9	sensitive	JJ	O	sensitive	amod	10	SENT_239	[p6l1408t47r1549b76],
10	(	NN	O	(	_	0	SENT_239	[p6l1565t47r1665b83],
11	90	CD	PERCENT	90	number	12	SENT_239	[p6l1565t47r1665b83],
12	%	NN	PERCENT	%	amod	13	SENT_239	[p6l1565t47r1665b83],
13	)	NN	O	)	dep	10	SENT_239	[p6l1565t47r1665b83],
14	and	CC	O	and	_	0	SENT_239	[p6l1681t47r1740b76],
15	speciﬁc	NN	O	speciﬁc	dep	10	SENT_239	[p6l1755t47r1879b85],
16	(	CD	PERCENT	(	number	17	SENT_239	[p6l537t97r637b133],
17	99	CD	PERCENT	99	num	18	SENT_239	[p6l537t97r637b133],
18	%	NN	PERCENT	%	dep	15	SENT_239	[p6l537t97r637b133],
19	)	CD	NUMBER	)	dep	45	SENT_239	[p6l537t97r637b133],
20	in	IN	O	in	_	0	SENT_239	[p6l649t97r680b126],
21	identifying	VBG	O	identify	prepc_in	19	SENT_239	[p6l691t97r871b135],
22	patients	NNS	O	patient	dobj	21	SENT_239	[p6l882t97r1009b135],
23	who	WP	O	who	nsubj	25	SENT_239	[p6l1021t97r1091b126],
24	have	VBP	O	have	aux	25	SENT_239	[p6l1102t97r1178b126],
25	inherited	VBN	O	inherit	rcmod	22	SENT_239	[p6l1188t97r1335b126],
26	one	CD	NUMBER	one	nn	31	SENT_239	[p6l1346t106r1404b126],
27	or	CC	O	or	_	0	SENT_239	[p6l1415t106r1449b126],
28	two	CD	NUMBER	two	conj_or	26	SENT_239	[p6l1459t101r1519b126],
29	nonfunctional	JJ	O	nonfunctional	amod	31	SENT_239	[p6l1530t97r1759b126],
30	TPMT	NN	O	tpmt	nn	31	SENT_239	[p6l1770t98r1880b126],
31	alleles	NNS	O	allele	dobj	25	SENT_239	[p6l536t147r649b182],
32	,	,	O	,	_	0	SENT_239	[p6l536t147r649b182],
33	so	IN	O	so	mark	38	SENT_239	[p6l669t156r703b176],
34	it	PRP	O	it	nsubj	38	SENT_239	[p6l720t147r743b176],
35	is	VBZ	O	be	cop	38	SENT_239	[p6l759t147r785b176],
36	a	DT	O	a	det	38	SENT_239	[p6l804t156r821b176],
37	reliable	JJ	O	reliable	amod	38	SENT_239	[p6l836t147r960b176],
38	method	NN	O	method	advcl	25	SENT_239	[p6l977t147r1101b176],
39	for	IN	O	for	_	0	SENT_239	[p6l1117t147r1166b176],
40	guiding	VBG	O	guide	amod	42	SENT_239	[p6l1182t147r1307b185],
41	thiopurine	JJ	O	thiopurine	amod	42	SENT_239	[p6l1324t147r1494b185],
42	therapy	NN	O	therapy	prep_for	38	SENT_239	[p6l1511t147r1633b185],
43	(	CD	NUMBER	(	number	44	SENT_239	[p6l1652t147r1727b183],
44	64	CD	NUMBER	64	num	45	SENT_239	[p6l1652t147r1727b183],
45	)	NN	O	)	rcmod	10	SENT_239	[p6l1652t147r1727b183],
46	.	.	O	.	_	0	SENT_239	[p6l1652t147r1727b183],

1	Furthermore	RB	O	furthermore	advmod	14	SENT_240	[p6l1745t147r1879b176, p6l536t207r629b232],
2	,	,	O	,	_	0	SENT_240	[p6l1745t147r1879b176, p6l536t207r629b232],
3	outcome	NN	O	outcome	nsubjpass	14	SENT_240	[p6l645t202r786b227],
4	of	IN	O	of	_	0	SENT_240	[p6l802t197r837b227],
5	acute	JJ	O	acute	amod	6	SENT_240	[p6l850t202r935b227],
6	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_240	[p6l950t197r1184b236],
7	leukemia	NN	O	leukemia	nn	10	SENT_240	[p6l1199t197r1350b227],
8	(	CD	NUMBER	(	num	10	SENT_240	[p6l1365t198r1470b234],
9	ALL	NN	O	all	nn	10	SENT_240	[p6l1365t198r1470b234],
10	)	NN	O	)	prep_of	3	SENT_240	[p6l1365t198r1470b234],
11	in	IN	O	in	_	0	SENT_240	[p6l1486t197r1517b226],
12	children	NNS	O	child	prep_in	10	SENT_240	[p6l1532t197r1667b227],
13	is	VBZ	O	be	auxpass	14	SENT_240	[p6l1681t197r1707b227],
14	related	VBN	O	relate	_	0	SENT_240	[p6l1722t197r1834b227],
15	to	TO	O	to	_	0	SENT_240	[p6l1849t202r1879b227],
16	mercaptopurine	NN	O	mercaptopurine	nn	18	SENT_240	[p6l536t248r795b286],
17	dose	NN	O	dose	nn	18	SENT_240	[p6l811t248r886b277],
18	intensity	NN	O	intensity	prep_to	14	SENT_240	[p6l902t248r1053b286],
19	:	:	O	:	_	0	SENT_240	[p6l902t248r1053b286],
20	Better	NNP	O	Better	nn	21	SENT_240	[p6l1072t248r1173b277],
21	event	NN	O	event	dep	18	SENT_240	[p6l1188t248r1353b277],
22	—	CD	NUMBER	—	num	24	SENT_240	[p6l1188t248r1353b277],
23	free	JJ	O	free	amod	24	SENT_240	[p6l1188t248r1353b277],
24	survival	NN	O	survival	nsubjpass	30	SENT_240	[p6l1371t248r1500b277],
25	or	CC	O	or	_	0	SENT_240	[p6l1516t257r1550b277],
26	early	JJ	O	early	amod	28	SENT_240	[p6l1566t248r1647b286],
27	treatment	NN	O	treatment	nn	28	SENT_240	[p6l1663t252r1820b277],
28	response	NN	O	response	nsubjpass	30	SENT_240	[p6l1835t257r1879b277, p6l537t307r647b336],
29	was	VBD	O	be	auxpass	30	SENT_240	[p6l660t307r722b327],
30	observed	VBN	O	observe	rcmod	21	SENT_240	[p6l736t298r884b327],
31	in	IN	O	in	_	0	SENT_240	[p6l896t298r927b327],
32	children	NNS	O	child	prep_in	30	SENT_240	[p6l940t298r1075b327],
33	with	IN	O	with	_	0	SENT_240	[p6l1087t298r1160b327],
34	intermediate	JJ	O	intermediate	amod	38	SENT_240	[p6l1172t298r1378b327],
35	or	CC	O	or	_	0	SENT_240	[p6l1391t307r1425b327],
36	low	JJ	O	low	amod	38	SENT_240	[p6l1437t298r1496b328],
37	TPMT	NN	O	tpmt	nn	38	SENT_240	[p6l1509t299r1619b327],
38	activity	NN	O	activity	prep_with	32	SENT_240	[p6l1632t298r1753b336],
39	than	IN	O	than	_	0	SENT_240	[p6l1766t298r1836b327],
40	in	IN	O	in	_	0	SENT_240	[p6l1849t298r1880b327],
41	those	DT	O	those	prep_in	49	SENT_240	[p6l536t347r622b376],
42	of	IN	O	of	_	0	SENT_240	[p6l638t347r674b376],
43	homozygous	JJ	O	homozygous	amod	47	SENT_240	[p6l687t347r897b385],
44	wild	JJ	O	wild	amod	47	SENT_240	[p6l914t347r1072b385],
45	—	NN	O	—	nn	47	SENT_240	[p6l914t347r1072b385],
46	type	NN	O	type	nn	47	SENT_240	[p6l914t347r1072b385],
47	phenotype	NN	O	phenotype	prep_of	41	SENT_240	[p6l1087t347r1259b385],
48	(	CD	NUMBER	(	number	49	SENT_240	[p6l1277t347r1338b383],
49	65	CD	NUMBER	65	prep_than	30	SENT_240	[p6l1277t347r1338b383],
50	,	,	O	,	_	0	SENT_240	[p6l1277t347r1338b383],
51	66	CD	NUMBER	66	num	52	SENT_240	[p6l1356t347r1418b383],
52	)	NN	O	)	appos	49	SENT_240	[p6l1356t347r1418b383],
53	.	.	O	.	_	0	SENT_240	[p6l1356t347r1418b383],

1	These	DT	O	these	det	2	SENT_241	[p6l1436t347r1534b376],
2	results	NNS	O	result	nsubj	3	SENT_241	[p6l1549t347r1656b376],
3	indicate	VBP	O	indicate	_	0	SENT_241	[p6l1673t347r1803b376],
4	that	IN	O	that	complm	16	SENT_241	[p6l1819t347r1880b376],
5	increasing	VBG	O	increase	amod	7	SENT_241	[p6l536t396r705b434],
6	mercaptopurine	NN	O	mercaptopurine	nn	7	SENT_241	[p6l717t396r977b434],
7	doses	NNS	O	dose	nsubj	16	SENT_241	[p6l990t396r1080b426],
8	in	IN	O	in	_	0	SENT_241	[p6l1093t396r1124b425],
9	children	NNS	O	child	prep_in	7	SENT_241	[p6l1137t396r1271b426],
10	with	IN	O	with	_	0	SENT_241	[p6l1284t396r1357b426],
11	wild	JJ	O	wild	amod	14	SENT_241	[p6l1369t396r1527b434],
12	—	NN	O	—	nn	14	SENT_241	[p6l1369t396r1527b434],
13	type	NN	O	type	nn	14	SENT_241	[p6l1369t396r1527b434],
14	TPMT	NN	O	tpmt	prep_with	9	SENT_241	[p6l1539t397r1649b425],
15	may	MD	O	may	aux	16	SENT_241	[p6l1661t405r1731b434],
16	improve	VB	O	improve	ccomp	3	SENT_241	[p6l1744t396r1880b434],
17	treatment	NN	O	treatment	nn	18	SENT_241	[p6l536t450r692b475],
18	outcome	NN	O	outcome	dobj	16	SENT_241	[p6l708t451r858b475],
19	.	.	O	.	_	0	SENT_241	[p6l708t451r858b475],

1	In	IN	O	in	_	0	SENT_242	[p6l877t447r910b475],
2	a	DT	O	a	det	4	SENT_242	[p6l928t455r945b475],
3	recent	JJ	O	recent	amod	4	SENT_242	[p6l960t450r1062b475],
4	study	NN	O	study	prep_in	23	SENT_242	[p6l1079t446r1166b484],
5	in	IN	O	in	_	0	SENT_242	[p6l1183t446r1214b475],
6	which	WDT	O	which	rel	10	SENT_242	[p6l1231t446r1332b475],
7	mercaptopurine	NN	O	mercaptopurine	nn	8	SENT_242	[p6l1348t446r1607b484],
8	doses	NNS	O	dose	nsubjpass	10	SENT_242	[p6l1624t446r1714b475],
9	were	VBD	O	be	auxpass	10	SENT_242	[p6l1732t455r1811b475],
10	adjusted	VBN	O	adjust	rcmod	4	SENT_242	[p6l1829t446r1879b475, p6l532t495r634b533],
11	based	VBN	O	base	_	0	SENT_242	[p6l651t495r745b524],
12	on	IN	O	on	prepc_based_on	10	SENT_242	[p6l763t504r803b524],
13	TPMT	NN	O	tpmt	nn	14	SENT_242	[p6l820t496r930b524],
14	status	NN	O	status	pobj	10	SENT_242	[p6l949t500r1050b529],
15	,	,	O	,	_	0	SENT_242	[p6l949t500r1050b529],
16	the	DT	O	the	det	17	SENT_242	[p6l1069t495r1119b524],
17	efﬁcacy	NN	O	efﬁcacy	nsubjpass	23	SENT_242	[p6l1137t495r1265b533],
18	of	IN	O	of	_	0	SENT_242	[p6l1283t495r1319b524],
19	childhood	NN	O	childhood	nn	21	SENT_242	[p6l1334t495r1499b524],
20	ALL	NN	O	all	nn	21	SENT_242	[p6l1516t495r1596b524],
21	therapy	NN	O	therapy	prep_of	17	SENT_242	[p6l1614t495r1736b533],
22	was	VBD	O	be	auxpass	23	SENT_242	[p6l1754t504r1816b524],
23	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_242	[p6l1835t495r1879b524, p6l536t544r676b573],
24	by	IN	O	by	_	0	SENT_242	[p6l688t544r729b582],
25	glutathione-S-transferase	NN	O	glutathione-s-transferase	nn	26	SENT_242	[p6l744t544r1159b582],
26	M1	NN	O	m1	agent	23	SENT_242	[p6l1173t544r1226b573],
27	and	CC	O	and	_	0	SENT_242	[p6l1244t544r1303b573],
28	thymidylate	JJ	O	thymidylate	amod	30	SENT_242	[p6l1316t544r1513b582],
29	synthetase	NN	O	synthetase	nn	30	SENT_242	[p6l1528t544r1699b582],
30	genotypes	NNS	O	genotype	nsubj	31	SENT_242	[p6l1713t549r1879b582],
31	(	VBP	O	(	conj_and	23	SENT_242	[p6l537t594r612b630],
32	67	CD	NUMBER	67	number	33	SENT_242	[p6l537t594r612b630],
33	)	CD	NUMBER	)	dobj	31	SENT_242	[p6l537t594r612b630],
34	.	.	O	.	_	0	SENT_242	[p6l537t594r612b630],

1	Irinotecan	NNP	MISC	Irinotecan	nn	6	SENT_243	[p6l437t694r646b730],
2	and	CC	O	and	_	0	SENT_243	[p6l659t693r733b730],
3	Uridine	NNP	O	Uridine	nn	6	SENT_243	[p6l746t693r901b730],
4	Diphospho	NNP	O	Diphospho	nn	6	SENT_243	[p6l913t693r1138b741],
5	Glucuronosyl	NNP	O	Glucuronosyl	nn	6	SENT_243	[p6l1153t693r1427b741],
6	Transferase	NNP	O	Transferase	_	0	SENT_243	[p6l436t751r666b787],
7	1A1	NN	O	1a1	dep	6	SENT_243	[p6l682t754r754b787],
8	(	CD	NUMBER	(	num	7	SENT_243	[p6l773t751r984b795],
9	UGTIAI	NNP	O	UGTIAI	dep	6	SENT_243	[p6l773t751r984b795],
10	)	CD	NUMBER	)	num	9	SENT_243	[p6l773t751r984b795],

1	Irinotecan	NNP	MISC	Irinotecan	nsubjpass	5	SENT_244	[p6l536t833r703b863],
2	is	VBZ	O	be	aux	5	SENT_244	[p6l715t833r741b863],
3	now	RB	DATE	now	advmod	5	SENT_244	[p6l753t842r822b863],
4	being	VBG	O	be	auxpass	5	SENT_244	[p6l834t833r926b871],
5	used	VBN	O	use	_	0	SENT_244	[p6l938t833r1014b863],
6	to	TO	O	to	aux	7	SENT_244	[p6l1025t838r1056b863],
7	treat	VB	O	treat	xcomp	5	SENT_244	[p6l1068t838r1142b863],
8	several	JJ	O	several	amod	10	SENT_244	[p6l1155t833r1268b863],
9	human	JJ	O	human	amod	10	SENT_244	[p6l1280t833r1392b863],
10	cancers	NNS	O	cancer	dobj	7	SENT_244	[p6l1405t842r1536b868],
11	,	,	O	,	_	0	SENT_244	[p6l1405t842r1536b868],
12	including	VBG	O	include	_	0	SENT_244	[p6l1550t833r1705b871],
13	colon	NN	O	colon	nn	16	SENT_244	[p6l1718t833r1809b863],
14	and	CC	O	and	_	0	SENT_244	[p6l1822t833r1880b863],
15	lung	NN	O	lung	nn	16	SENT_244	[p6l536t883r608b921],
16	cancer	NN	O	cancer	prep_including	5	SENT_244	[p6l622t892r730b912],
17	in	IN	O	in	_	0	SENT_244	[p6l742t883r773b912],
18	adults	NNS	O	adult	prep_in	16	SENT_244	[p6l787t883r883b912],
19	and	CC	O	and	_	0	SENT_244	[p6l898t883r957b912],
20	pediatric	JJ	O	pediatric	amod	22	SENT_244	[p6l969t883r1113b921],
21	solid	JJ	O	solid	amod	22	SENT_244	[p6l1128t883r1207b912],
22	tumors	NNS	O	tumor	conj_and	16	SENT_244	[p6l1219t888r1333b912],
23	such	JJ	O	such	_	0	SENT_244	[p6l1348t883r1422b912],
24	as	IN	O	as	_	0	SENT_244	[p6l1436t892r1467b912],
25	rhabdomyosarcoma	NN	O	rhabdomyosarcoma	prep_such_as	22	SENT_244	[p6l1481t883r1809b921],
26	and	CC	O	and	_	0	SENT_244	[p6l1822t883r1880b912],
27	PHARMACOGENOMICS	NN	O	pharmacogenomic	prep_such_as	22	SENT_244	[p6l1336t944r1739b971],
28	127	CD	NUMBER	127	num	27	SENT_244	[p6l1831t941r1890b971],

1	neuroblastoma	NN	O	neuroblastoma	_	0	SENT_245	[p6l546t1067r798b1097],
2	.	.	O	.	_	0	SENT_245	[p6l546t1067r798b1097],

1	It	PRP	O	it	nsubjpass	4	SENT_246	[p6l814t1068r839b1097],
2	must	MD	O	must	aux	4	SENT_246	[p6l853t1072r934b1097],
3	be	VB	O	be	auxpass	4	SENT_246	[p6l947t1067r986b1097],
4	activated	VBN	O	activate	_	0	SENT_246	[p6l1001t1067r1147b1097],
5	by	IN	O	by	_	0	SENT_246	[p6l1161t1067r1202b1105],
6	carboxylesterase	NN	O	carboxylesterase	agent	4	SENT_246	[p6l1217t1067r1492b1105],
7	to	TO	O	to	_	0	SENT_246	[p6l1507t1072r1538b1097],
8	7	CD	NUMBER	7	number	9	SENT_246	[p6l1553t1067r1889b1105],
9	—	CD	NUMBER	—	num	10	SENT_246	[p6l1553t1067r1889b1105],
10	ethy1	NN	O	ethy1	prep_to	6	SENT_246	[p6l1553t1067r1889b1105],
11	—	CD	NUMBER	—	number	12	SENT_246	[p6l1553t1067r1889b1105],
12	10	CD	NUMBER	10	num	16	SENT_246	[p6l1553t1067r1889b1105],
13	—	NN	O	—	nn	16	SENT_246	[p6l1553t1067r1889b1105],
14	hydroxy	NN	O	hydroxy	nn	16	SENT_246	[p6l1553t1067r1889b1105],
15	—	NN	O	—	nn	16	SENT_246	[p6l1553t1067r1889b1105],
16	camptothecin	NN	O	camptothecin	tmod	4	SENT_246	[p6l547t1117r778b1155],
17	,	,	O	,	_	0	SENT_246	[p6l547t1117r778b1155],
18	which	WDT	O	which	nsubj	19	SENT_246	[p6l789t1117r889b1146],
19	inhibits	VBZ	O	inhibit	rcmod	16	SENT_246	[p6l898t1117r1021b1146],
20	topoisomerase	NN	O	topoisomerase	nn	22	SENT_246	[p6l1031t1117r1269b1155],
21	I.	NN	O	i.	nn	22	SENT_246	[p6l1279t1118r1300b1146],
22	UGTlAl	NN	O	ugtlal	nsubj	23	SENT_246	[p6l1311t1117r1463b1147],
23	catalyzes	VBZ	O	catalyze	ccomp	19	SENT_246	[p6l1477t1117r1626b1155],
24	the	DT	O	the	det	25	SENT_246	[p6l1636t1117r1686b1146],
25	conjugation	NN	O	conjugation	dobj	23	SENT_246	[p6l1696t1117r1891b1155],
26	of	IN	O	of	_	0	SENT_246	[p6l547t1166r582b1195],
27	glucuronide	NN	O	glucuronide	prep_of	25	SENT_246	[p6l590t1166r786b1204],
28	to	TO	O	to	_	0	SENT_246	[p6l796t1171r827b1195],
29	SN	NNP	O	SN	prep_to	23	SENT_246	[p6l838t1166r954b1201],
30	—	CD	NUMBER	—	num	29	SENT_246	[p6l838t1166r954b1201],
31	38	CD	NUMBER	38	dep	16	SENT_246	[p6l838t1166r954b1201],
32	;	:	O	;	_	0	SENT_246	[p6l838t1166r954b1201],
33	the	DT	O	the	nsubj	42	SENT_246	[p6l966t1166r1015b1195],
34	conjugated	VBN	O	conjugate	parataxis	4	SENT_246	[p6l1025t1166r1206b1204],
35	metabolite	NN	O	metabolite	nsubj	38	SENT_246	[p6l1216t1166r1390b1195],
36	is	VBZ	O	be	cop	38	SENT_246	[p6l1399t1166r1425b1195],
37	relatively	RB	O	relatively	advmod	38	SENT_246	[p6l1435t1166r1589b1204],
38	inactive	JJ	O	inactive	ccomp	34	SENT_246	[p6l1599t1166r1728b1195],
39	and	CC	O	and	_	0	SENT_246	[p6l1739t1166r1797b1195],
40	more	RBR	O	more	advmod	41	SENT_246	[p6l1806t1175r1890b1195],
41	readily	RB	O	readily	advmod	42	SENT_246	[p6l546t1215r660b1253],
42	eliminated	VBN	O	eliminate	conj_and	34	SENT_246	[p6l677t1215r852b1245],
43	in	IN	O	in	_	0	SENT_246	[p6l868t1215r899b1244],
44	bile	NN	O	bile	prep_in	42	SENT_246	[p6l915t1215r977b1245],
45	and	CC	O	and	_	0	SENT_246	[p6l994t1215r1053b1245],
46	urine	NN	O	urine	conj_and	44	SENT_246	[p6l1069t1215r1161b1245],
47	.	.	O	.	_	0	SENT_246	[p6l1069t1215r1161b1245],

1	The	DT	O	the	det	3	SENT_247	[p6l1180t1215r1243b1245],
2	dose	NN	O	dose	nn	3	SENT_247	[p6l1261t1215r1480b1253],
3	—	NN	O	—	nsubjpass	17	SENT_247	[p6l1261t1215r1480b1253],
4	limiting	VBG	O	limit	partmod	3	SENT_247	[p6l1261t1215r1480b1253],
5	toxicities	NNS	O	toxicity	dobj	4	SENT_247	[p6l1497t1215r1647b1245],
6	of	IN	O	of	_	0	SENT_247	[p6l1666t1215r1701b1245],
7	irinotecan	NN	O	irinotecan	prep_of	5	SENT_247	[p6l1715t1215r1889b1250],
8	,	,	O	,	_	0	SENT_247	[p6l1715t1215r1889b1250],
9	diarrhea	NN	O	diarrhea	appos	3	SENT_247	[p6l547t1265r682b1294],
10	and	CC	O	and	_	0	SENT_247	[p6l692t1265r751b1294],
11	leukopenia	NN	O	leukopenia	conj_and	9	SENT_247	[p6l760t1265r942b1303],
12	(	CD	NUMBER	(	number	13	SENT_247	[p6l952t1265r1028b1301],
13	68	CD	NUMBER	68	num	14	SENT_247	[p6l952t1265r1028b1301],
14	)	NN	O	)	dep	9	SENT_247	[p6l952t1265r1028b1301],
15	,	,	O	,	_	0	SENT_247	[p6l952t1265r1028b1301],
16	are	VBP	O	be	auxpass	17	SENT_247	[p6l1041t1274r1089b1294],
17	associated	VBN	O	associate	_	0	SENT_247	[p6l1100t1265r1270b1294],
18	with	IN	O	with	_	0	SENT_247	[p6l1280t1265r1352b1294],
19	higher	JJR	O	higher	amod	20	SENT_247	[p6l1362t1265r1468b1303],
20	levels	NNS	O	level	prep_with	17	SENT_247	[p6l1478t1265r1571b1294],
21	of	IN	O	of	_	0	SENT_247	[p6l1582t1265r1618b1294],
22	SN	NN	O	sn	prep_of	20	SENT_247	[p6l1626t1265r1741b1294],
23	—	CD	NUMBER	—	number	24	SENT_247	[p6l1626t1265r1741b1294],
24	38	CD	NUMBER	38	num	22	SENT_247	[p6l1626t1265r1741b1294],
25	.	.	O	.	_	0	SENT_247	[p6l1626t1265r1741b1294],

1	Because	IN	O	because	mark	4	SENT_248	[p6l1753t1266r1890b1294],
2	UGTIAI	NN	O	ugtiaus	nn	3	SENT_248	[p6l550t1314r692b1344],
3	expression	NN	O	expression	nsubj	4	SENT_248	[p6l707t1314r882b1352],
4	differs	VBZ	O	differ	advcl	40	SENT_248	[p6l894t1314r999b1343],
5	widely	RB	O	widely	advmod	4	SENT_248	[p6l1011t1314r1123b1352],
6	among	IN	O	among	_	0	SENT_248	[p6l1135t1323r1246b1352],
7	patients	NNS	O	patient	prep_among	4	SENT_248	[p6l1257t1314r1394b1352],
8	,	,	O	,	_	0	SENT_248	[p6l1257t1314r1394b1352],
9	and	CC	O	and	_	0	SENT_248	[p6l1408t1314r1467b1343],
10	studies	NNS	O	study	nsubj	12	SENT_248	[p6l1479t1314r1591b1343],
11	have	VBP	O	have	aux	12	SENT_248	[p6l1603t1314r1679b1343],
12	shown	VBN	O	show	conj_and	4	SENT_248	[p6l1691t1314r1796b1343],
13	up	IN	O	up	advmod	12	SENT_248	[p6l1807t1323r1848b1352],
14	to	TO	O	to	_	0	SENT_248	[p6l1859t1319r1890b1343],
15	50-fold	JJ	O	50-fold	amod	17	SENT_248	[p6l547t1363r668b1393],
16	interpatient	NN	O	interpatient	nn	17	SENT_248	[p6l679t1363r868b1401],
17	differences	NNS	O	difference	prep_to	13	SENT_248	[p6l879t1363r1060b1392],
18	in	IN	O	in	_	0	SENT_248	[p6l1073t1363r1104b1392],
19	the	DT	O	the	det	20	SENT_248	[p6l1116t1363r1165b1392],
20	rate	NN	O	rate	prep_in	12	SENT_248	[p6l1177t1368r1238b1392],
21	of	IN	O	of	_	0	SENT_248	[p6l1251t1363r1287b1392],
22	SN	NNP	O	SN	prep_of	20	SENT_248	[p6l1296t1363r1401b1393],
23	—	CD	NUMBER	—	num	22	SENT_248	[p6l1296t1363r1401b1393],
24	38	CD	NUMBER	38	num	25	SENT_248	[p6l1296t1363r1401b1393],
25	glucuronidation	NN	O	glucuronidation	dep	20	SENT_248	[p6l1415t1363r1676b1401],
26	(	CD	NUMBER	(	number	27	SENT_248	[p6l1689t1363r1751b1399],
27	69	CD	NUMBER	69	dep	25	SENT_248	[p6l1689t1363r1751b1399],
28	,	,	O	,	_	0	SENT_248	[p6l1689t1363r1751b1399],
29	70	CD	NUMBER	70	num	30	SENT_248	[p6l1765t1363r1828b1399],
30	)	NN	O	)	appos	20	SENT_248	[p6l1765t1363r1828b1399],
31	,	,	O	,	_	0	SENT_248	[p6l1765t1363r1828b1399],
32	the	DT	O	the	det	35	SENT_248	[p6l1841t1363r1890b1392],
33	clinical	JJ	O	clinical	amod	35	SENT_248	[p6l547t1412r667b1441],
34	pharmacological	JJ	O	pharmacological	amod	35	SENT_248	[p6l676t1412r952b1450],
35	effects	NNS	O	effect	nsubjpass	40	SENT_248	[p6l962t1412r1070b1441],
36	of	IN	O	of	_	0	SENT_248	[p6l1081t1412r1117b1441],
37	irinotecan	NN	O	irinotecan	prep_of	35	SENT_248	[p6l1123t1412r1288b1441],
38	have	VBP	O	have	aux	40	SENT_248	[p6l1297t1412r1374b1441],
39	been	VBN	O	be	auxpass	40	SENT_248	[p6l1383t1412r1461b1441],
40	associated	VBN	O	associate	_	0	SENT_248	[p6l1471t1412r1640b1441],
41	with	IN	O	with	_	0	SENT_248	[p6l1649t1412r1722b1441],
42	the	DT	O	the	det	43	SENT_248	[p6l1732t1412r1781b1441],
43	extent	NN	O	extent	prep_with	40	SENT_248	[p6l1791t1417r1891b1441],
44	of	IN	O	of	_	0	SENT_248	[p6l547t1461r582b1491],
45	SN	NNP	O	SN	prep_of	43	SENT_248	[p6l592t1461r697b1491],
46	—	CD	NUMBER	—	num	45	SENT_248	[p6l592t1461r697b1491],
47	38	CD	NUMBER	38	num	48	SENT_248	[p6l592t1461r697b1491],
48	glucuronidation	NN	O	glucuronidation	dep	43	SENT_248	[p6l710t1461r980b1499],
49	.	.	O	.	_	0	SENT_248	[p6l710t1461r980b1499],

1	UGTIAI	NNP	ORGANIZATION	UGTIAI	nsubj	4	SENT_249	[p6l600t1511r742b1541],
2	is	VBZ	O	be	cop	4	SENT_249	[p6l752t1511r778b1540],
3	a	DT	O	a	det	4	SENT_249	[p6l788t1520r805b1540],
4	member	NN	O	member	_	0	SENT_249	[p6l812t1511r947b1540],
5	of	IN	O	of	_	0	SENT_249	[p6l955t1511r991b1540],
6	a	DT	O	a	det	9	SENT_249	[p6l996t1520r1013b1540],
7	large	JJ	O	large	amod	9	SENT_249	[p6l1021t1511r1101b1549],
8	gene	NN	O	gene	nn	9	SENT_249	[p6l1110t1520r1186b1549],
9	family	NN	O	family	prep_of	4	SENT_249	[p6l1194t1511r1301b1549],
10	of	IN	O	of	_	0	SENT_249	[p6l1309t1511r1345b1540],
11	up	RB	O	up	quantmod	13	SENT_249	[p6l1350t1520r1390b1549],
12	to	TO	O	to	dep	13	SENT_249	[p6l1398t1515r1429b1540],
13	12	CD	NUMBER	12	num	16	SENT_249	[p6l1441t1511r1477b1540],
14	UGT-glucuronosyltrans	JJ	O	ugt-glucuronosyltrans	amod	16	SENT_249	[p6l1485t1511r1889b1549],
15	—	NN	O	—	nn	16	SENT_249	[p6l1485t1511r1889b1549],
16	ferases	NNS	O	ferase	prep_of	9	SENT_249	[p6l546t1560r659b1589],
17	encoded	VBN	O	encode	partmod	16	SENT_249	[p6l678t1560r816b1589],
18	by	IN	O	by	_	0	SENT_249	[p6l833t1560r874b1598],
19	the	DT	O	the	det	22	SENT_249	[p6l892t1560r941b1589],
20	human	JJ	O	human	amod	22	SENT_249	[p6l959t1560r1071b1589],
21	UGT1	NN	O	ugt1	nn	22	SENT_249	[p6l1092t1561r1189b1590],
22	locus	NN	O	locus	agent	17	SENT_249	[p6l1209t1560r1304b1589],
23	.	.	O	.	_	0	SENT_249	[p6l1209t1560r1304b1589],

1	Reduced	VBN	O	reduce	amod	2	SENT_250	[p6l1324t1560r1469b1589],
2	expression	NN	O	expression	nsubjpass	21	SENT_250	[p6l1487t1560r1662b1598],
3	of	IN	O	of	_	0	SENT_250	[p6l1680t1560r1716b1589],
4	UGTIAI	NNP	LOCATION	UGTIAI	prep_of	2	SENT_250	[p6l1735t1560r1889b1595],
5	,	,	O	,	_	0	SENT_250	[p6l1735t1560r1889b1595],
6	which	WDT	O	which	nsubjpass	8	SENT_250	[p6l546t1609r647b1638],
7	is	VBZ	O	be	auxpass	8	SENT_250	[p6l661t1609r686b1638],
8	associated	VBN	O	associate	rcmod	2	SENT_250	[p6l702t1609r871b1638],
9	with	IN	O	with	_	0	SENT_250	[p6l885t1609r958b1638],
10	increased	VBN	O	increase	amod	12	SENT_250	[p6l971t1609r1128b1638],
11	blood	NN	O	blood	nn	12	SENT_250	[p6l1140t1609r1235b1638],
12	concentrations	NNS	O	concentration	prep_with	8	SENT_250	[p6l1249t1609r1489b1638],
13	of	IN	O	of	_	0	SENT_250	[p6l1504t1609r1540b1638],
14	unconjugated	JJ	O	unconjugated	amod	17	SENT_250	[p6l1551t1609r1774b1647],
15	biliru	NN	O	biliru	nn	17	SENT_250	[p6l1787t1609r1889b1638],
16	—	NN	O	—	nn	17	SENT_250	[p6l1787t1609r1889b1638],
17	bin	NN	O	bin	prep_of	12	SENT_250	[p6l546t1659r607b1693],
18	,	,	O	,	_	0	SENT_250	[p6l546t1659r607b1693],
19	may	MD	O	may	aux	21	SENT_250	[p6l620t1668r690b1697],
20	be	VB	O	be	auxpass	21	SENT_250	[p6l702t1659r740b1688],
21	linked	VBN	O	link	_	0	SENT_250	[p6l752t1659r854b1688],
22	to	TO	O	to	_	0	SENT_250	[p6l865t1663r896b1688],
23	polymorphism	NN	O	polymorphism	prep_to	21	SENT_250	[p6l908t1659r1150b1697],
24	in	IN	O	in	_	0	SENT_250	[p6l1161t1659r1192b1688],
25	the	DT	O	the	det	26	SENT_250	[p6l1203t1659r1253b1688],
26	UGTJA	NNP	O	UGTJA	prep_in	23	SENT_250	[p6l1268t1659r1391b1688],
27	coding	VBG	O	code	xcomp	21	SENT_250	[p6l1404t1659r1516b1697],
28	region	NN	O	region	nn	30	SENT_250	[p6l1527t1659r1632b1697],
29	(	CD	NUMBER	(	num	30	SENT_250	[p6l1645t1659r1891b1697],
30	Crigler-Najjar	NNP	O	Crigler-Najjar	dobj	27	SENT_250	[p6l1645t1659r1891b1697],
31	syndromes	NNS	O	syndrome	dep	30	SENT_250	[p6l548t1709r738b1747],
32	)	CD	NUMBER	)	num	31	SENT_250	[p6l548t1709r738b1747],
33	or	CC	O	or	_	0	SENT_250	[p6l752t1718r786b1738],
34	differences	NNS	O	difference	conj_or	30	SENT_250	[p6l797t1709r978b1738],
35	in	IN	O	in	_	0	SENT_250	[p6l992t1709r1023b1738],
36	the	DT	O	the	det	37	SENT_250	[p6l1035t1709r1085b1738],
37	number	NN	O	number	prep_in	34	SENT_250	[p6l1097t1709r1224b1738],
38	of	IN	O	of	_	0	SENT_250	[p6l1236t1709r1272b1738],
39	TA	NNP	O	TA	nn	40	SENT_250	[p6l1281t1709r1331b1738],
40	repeats	NNS	O	repeat	prep_of	37	SENT_250	[p6l1343t1713r1459b1747],
41	in	IN	O	in	_	0	SENT_250	[p6l1473t1709r1504b1738],
42	the	DT	O	the	det	45	SENT_250	[p6l1516t1709r1566b1738],
43	UGTIAI	NN	O	ugtiaus	nn	45	SENT_250	[p6l1582t1709r1724b1738],
44	promoter	NN	O	promoter	nn	45	SENT_250	[p6l1739t1713r1891b1747],
45	region	NN	O	region	prep_in	27	SENT_250	[p6l546t1759r651b1797],
46	(	CD	NUMBER	(	num	47	SENT_250	[p6l665t1759r821b1795],
47	Gi1bert	NN	O	gi1bert	poss	50	SENT_250	[p6l665t1759r821b1795],
48	’s	POS	O	’s	_	0	SENT_250	[p6l665t1759r821b1795],
49	syndrome	NN	O	syndrome	nn	50	SENT_250	[p6l837t1759r1020b1797],
50	)	NN	O	)	dep	27	SENT_250	[p6l837t1759r1020b1797],
51	.	.	O	.	_	0	SENT_250	[p6l837t1759r1020b1797],

1	In	IN	O	in	_	0	SENT_251	[p6l1035t1759r1069b1788],
2	patients	NNS	O	patient	prep_in	15	SENT_251	[p6l1082t1759r1209b1797],
3	with	IN	O	with	_	0	SENT_251	[p6l1224t1759r1296b1788],
4	Gi1bert	NN	O	gi1bert	poss	6	SENT_251	[p6l1310t1759r1453b1788],
5	’s	POS	O	’s	_	0	SENT_251	[p6l1310t1759r1453b1788],
6	syndrome	NN	O	syndrome	prep_with	2	SENT_251	[p6l1468t1759r1638b1797],
7	,	,	O	,	_	0	SENT_251	[p6l1468t1759r1638b1797],
8	who	WP	O	who	nsubj	10	SENT_251	[p6l1654t1759r1723b1788],
9	generally	RB	O	generally	advmod	10	SENT_251	[p6l1738t1759r1890b1797],
10	have	VBP	O	have	rcmod	6	SENT_251	[p6l546t1809r622b1838],
11	six	CD	NUMBER	six	num	13	SENT_251	[p6l634t1809r680b1838],
12	TA	NNP	O	TA	nn	13	SENT_251	[p6l690t1809r741b1837],
13	repeats	NNS	O	repeat	dobj	10	SENT_251	[p6l750t1813r876b1846],
14	,	,	O	,	_	0	SENT_251	[p6l750t1813r876b1846],
15	reduced	VBD	O	reduce	_	0	SENT_251	[p6l888t1809r1019b1838],
16	glucuronidation	NN	O	glucuronidation	nsubjpass	18	SENT_251	[p6l1029t1809r1291b1846],
17	is	VBZ	O	be	auxpass	18	SENT_251	[p6l1301t1809r1326b1838],
18	associated	VBN	O	associate	ccomp	15	SENT_251	[p6l1339t1809r1508b1838],
19	with	IN	O	with	_	0	SENT_251	[p6l1518t1809r1591b1838],
20	seven	CD	NUMBER	seven	prep_with	18	SENT_251	[p6l1602t1818r1693b1838],
21	TA	NNP	O	TA	nn	22	SENT_251	[p6l1703t1809r1753b1837],
22	repeats	NNS	O	repeat	nsubj	15	SENT_251	[p6l1763t1813r1889b1846],
23	,	,	O	,	_	0	SENT_251	[p6l1763t1813r1889b1846],
24	homozygosity	NN	O	homozygosity	appos	22	SENT_251	[p6l546t1858r780b1896],
25	for	IN	O	for	_	0	SENT_251	[p6l793t1858r841b1887],
26	which	WDT	O	which	rel	32	SENT_251	[p6l853t1858r953b1887],
27	(	NN	O	(	nn	28	SENT_251	[p6l967t1858r1200b1894],
28	UGT1A1	NN	O	ugt1a1	nsubj	32	SENT_251	[p6l967t1858r1200b1894],
29	*	CD	NUMBER	*	num	31	SENT_251	[p6l967t1858r1200b1894],
30	28	CD	NUMBER	28	num	31	SENT_251	[p6l967t1858r1200b1894],
31	)	NN	O	)	dep	28	SENT_251	[p6l967t1858r1200b1894],
32	occurs	VBZ	O	occur	rcmod	24	SENT_251	[p6l1214t1867r1320b1887],
33	in	IN	O	in	_	0	SENT_251	[p6l1333t1858r1365b1887],
34	12	CD	PERCENT	12	num	35	SENT_251	[p6l1381t1858r1548b1887],
35	%	NN	PERCENT	%	prep_in	32	SENT_251	[p6l1381t1858r1548b1887],
36	.	.	O	.	_	0	SENT_251	[p6l1381t1858r1548b1887],

1	—	NN	O	—	_	0	SENT_252	[p6l1381t1858r1548b1887],
2	.	.	O	.	_	0	SENT_252	[p6l1381t1858r1548b1887],

1	16	CD	PERCENT	16	num	2	SENT_253	[p6l1381t1858r1548b1887],
2	%	NN	PERCENT	%	_	0	SENT_253	[p6l1381t1858r1548b1887],
3	of	IN	O	of	_	0	SENT_253	[p6l1562t1858r1598b1887],
4	patients	NNS	O	patient	prep_of	2	SENT_253	[p6l1607t1858r1735b1896],
5	(	IN	O	(	_	0	SENT_253	[p6l1750t1858r1812b1894],
6	68	CD	NUMBER	68	prep_(	2	SENT_253	[p6l1750t1858r1812b1894],
7	,	,	O	,	_	0	SENT_253	[p6l1750t1858r1812b1894],
8	69	CD	NUMBER	69	num	9	SENT_253	[p6l1827t1858r1888b1894],
9	)	NN	O	)	appos	6	SENT_253	[p6l1827t1858r1888b1894],
10	.	.	O	.	_	0	SENT_253	[p6l1827t1858r1888b1894],

1	SN	NN	O	sn	nsubj	13	SENT_254	[p6l547t1908r652b1937],
2	—	CD	NUMBER	—	num	1	SENT_254	[p6l547t1908r652b1937],
3	38	CD	NUMBER	38	num	4	SENT_254	[p6l547t1908r652b1937],
4	glucuronidation	NN	O	glucuronidation	nsubjpass	6	SENT_254	[p6l667t1908r928b1946],
5	is	VBZ	O	be	auxpass	6	SENT_254	[p6l941t1908r966b1937],
6	correlated	VBN	O	correlate	rcmod	1	SENT_254	[p6l980t1908r1145b1937],
7	with	IN	O	with	_	0	SENT_254	[p6l1158t1908r1230b1937],
8	the	DT	O	the	det	9	SENT_254	[p6l1243t1908r1292b1937],
9	number	NN	O	number	prep_with	6	SENT_254	[p6l1305t1908r1432b1937],
10	of	IN	O	of	_	0	SENT_254	[p6l1444t1908r1480b1937],
11	TA	NNP	O	TA	nn	12	SENT_254	[p6l1490t1908r1540b1937],
12	repeats	NNS	O	repeat	prep_of	9	SENT_254	[p6l1553t1912r1669b1946],
13	(	VBP	O	(	_	0	SENT_254	[p6l1683t1908r1745b1944],
14	69	CD	NUMBER	69	dobj	13	SENT_254	[p6l1683t1908r1745b1944],
15	,	,	O	,	_	0	SENT_254	[p6l1683t1908r1745b1944],
16	70	CD	NUMBER	70	num	17	SENT_254	[p6l1760t1908r1822b1944],
17	)	NN	O	)	appos	14	SENT_254	[p6l1760t1908r1822b1944],
18	.	.	O	.	_	0	SENT_254	[p6l1760t1908r1822b1944],

1	Patients	NNS	O	patient	nsubj	9	SENT_255	[p6l1837t1909r1889b1937, p6l546t1958r634b1987],
2	homozygous	JJ	O	homozygous	amod	1	SENT_255	[p6l646t1958r857b1995],
3	or	CC	O	or	_	0	SENT_255	[p6l870t1967r904b1987],
4	heterozygous	JJ	O	heterozygous	amod	1	SENT_255	[p6l914t1958r1134b1995],
5	for	IN	O	for	_	0	SENT_255	[p6l1147t1958r1195b1987],
6	seven	CD	NUMBER	seven	num	8	SENT_255	[p6l1207t1967r1297b1987],
7	TA	NNP	O	TA	nn	8	SENT_255	[p6l1309t1958r1359b1986],
8	repeats	NNS	O	repeat	prep_for	1	SENT_255	[p6l1370t1962r1486b1995],
9	have	VBP	O	have	_	0	SENT_255	[p6l1499t1958r1574b1987],
10	a	DT	O	a	det	13	SENT_255	[p6l1587t1967r1604b1987],
11	sevenfold	RB	O	sevenfold	advmod	12	SENT_255	[p6l1617t1958r1774b1987],
12	higher	JJR	O	higher	amod	13	SENT_255	[p6l1785t1958r1891b1995],
13	likelihood	NN	O	likelihood	dobj	9	SENT_255	[p6l546t2007r713b2037],
14	of	IN	O	of	_	0	SENT_255	[p6l726t2007r762b2037],
15	diarrhea	NN	O	diarrhea	nn	17	SENT_255	[p6l772t2007r907b2037],
16	and/or	NN	O	and/or	nn	17	SENT_255	[p6l919t2008r1024b2037],
17	leukopenia	NN	O	leukopenia	prep_of	13	SENT_255	[p6l1036t2007r1217b2045],
18	with	IN	O	with	_	0	SENT_255	[p6l1229t2007r1302b2037],
19	irinotecan	NN	O	irinotecan	nn	20	SENT_255	[p6l1314t2007r1479b2037],
20	therapy	NN	O	therapy	prep_with	17	SENT_255	[p6l1491t2008r1614b2045],
21	than	IN	O	than	_	0	SENT_255	[p6l1627t2008r1697b2037],
22	do	VB	O	do	prepc_than	9	SENT_255	[p6l1710t2008r1750b2037],
23	patients	NNS	O	patient	dobj	22	SENT_255	[p6l1762t2007r1890b2045],
24	with	IN	O	with	_	0	SENT_255	[p6l546t2057r619b2086],
25	the	DT	O	the	det	29	SENT_255	[p6l631t2057r680b2086],
26	wild	JJ	O	wild	amod	29	SENT_255	[p6l692t2057r849b2095],
27	—	NN	O	—	nn	29	SENT_255	[p6l692t2057r849b2095],
28	type	NN	O	type	nn	29	SENT_255	[p6l692t2057r849b2095],
29	genotype	NN	O	genotype	prep_with	22	SENT_255	[p6l862t2062r1012b2095],
30	(	CD	NUMBER	(	number	31	SENT_255	[p6l1025t2057r1085b2093],
31	six	CD	NUMBER	six	num	33	SENT_255	[p6l1025t2057r1085b2093],
32	TA	NNP	O	TA	nn	33	SENT_255	[p6l1096t2058r1147b2086],
33	repeats	NNS	O	repeat	nsubj	34	SENT_255	[p6l1158t2058r1287b2095],
34	)	VBP	O	)	rcmod	29	SENT_255	[p6l1158t2058r1287b2095],
35	(	CD	NUMBER	(	number	36	SENT_255	[p6l1301t2057r1363b2093],
36	68	CD	NUMBER	68	dobj	34	SENT_255	[p6l1301t2057r1363b2093],
37	,	,	O	,	_	0	SENT_255	[p6l1301t2057r1363b2093],
38	69	CD	NUMBER	69	appos	36	SENT_255	[p6l1377t2057r1425b2092],
39	,	,	O	,	_	0	SENT_255	[p6l1377t2057r1425b2092],
40	71	CD	NUMBER	71	num	41	SENT_255	[p6l1439t2058r1501b2093],
41	)	NN	O	)	appos	38	SENT_255	[p6l1439t2058r1501b2093],
42	.	.	O	.	_	0	SENT_255	[p6l1439t2058r1501b2093],

1	Interpatient	JJ	O	interpatient	amod	2	SENT_256	[p6l596t2107r787b2145],
2	differences	NNS	O	difference	nsubjpass	8	SENT_256	[p6l801t2107r982b2136],
3	in	IN	O	in	_	0	SENT_256	[p6l998t2107r1029b2136],
4	irinotecan	JJ	O	irinotecan	amod	5	SENT_256	[p6l1044t2107r1209b2136],
5	metabolism	NN	O	metabolism	prep_in	2	SENT_256	[p6l1223t2107r1417b2136],
6	are	VBP	O	be	auxpass	8	SENT_256	[p6l1431t2116r1480b2136],
7	also	RB	O	also	advmod	8	SENT_256	[p6l1496t2107r1560b2136],
8	linked	VBN	O	link	_	0	SENT_256	[p6l1575t2107r1678b2136],
9	to	TO	O	to	_	0	SENT_256	[p6l1692t2112r1723b2136],
10	polymorphism	NN	O	polymorphism	prep_to	8	SENT_256	[p6l1737t2107r1889b2145, p6l546t2157r647b2195],
11	of	IN	O	of	_	0	SENT_256	[p6l656t2157r691b2186],
12	carboxylesterase	NN	O	carboxylesterase	prep_of	10	SENT_256	[p6l697t2157r972b2195],
13	(	CD	NUMBER	(	number	14	SENT_256	[p6l982t2157r1044b2193],
14	72	CD	NUMBER	72	dep	12	SENT_256	[p6l982t2157r1044b2193],
15	,	,	O	,	_	0	SENT_256	[p6l982t2157r1044b2193],
16	73	CD	NUMBER	73	num	17	SENT_256	[p6l1054t2157r1107b2193],
17	)	NN	O	)	conj_and	12	SENT_256	[p6l1054t2157r1107b2193],
18	and	CC	O	and	_	0	SENT_256	[p6l1118t2157r1184b2191],
19	,	,	O	,	_	0	SENT_256	[p6l1118t2157r1184b2191],
20	possibly	RB	O	possibly	advmod	12	SENT_256	[p6l1194t2157r1338b2195],
21	,	,	O	,	_	0	SENT_256	[p6l1194t2157r1338b2195],
22	CYP3A4	NN	O	cyp3a4	conj_and	12	SENT_256	[p6l1350t2157r1490b2186],
23	(	CD	NUMBER	(	number	24	SENT_256	[p6l1499t2157r1565b2193],
24	74	CD	NUMBER	74	num	25	SENT_256	[p6l1499t2157r1565b2193],
25	)	NN	O	)	dep	22	SENT_256	[p6l1499t2157r1565b2193],
26	and	CC	O	and	_	0	SENT_256	[p6l1576t2157r1634b2186],
27	CYP3A5	NN	O	cyp3a5	conj_and	12	SENT_256	[p6l1644t2157r1792b2186],
28	.	.	O	.	_	0	SENT_256	[p6l1644t2157r1792b2186],

1	Also	RB	O	also	advmod	11	SENT_257	[p6l1803t2157r1889b2191],
2	,	,	O	,	_	0	SENT_257	[p6l1803t2157r1889b2191],
3	the	DT	O	the	det	4	SENT_257	[p6l546t2207r596b2236],
4	expression	NN	O	expression	nsubjpass	11	SENT_257	[p6l611t2207r786b2244],
5	and	CC	O	and	_	0	SENT_257	[p6l802t2207r860b2236],
6	function	NN	O	function	nsubjpass	11	SENT_257	[p6l875t2207r1012b2236],
7	of	IN	O	of	_	0	SENT_257	[p6l1027t2207r1063b2236],
8	UGTIA1	NN	O	ugtia1	prep_of	4	SENT_257	[p6l1075t2207r1227b2236],
9	may	MD	O	may	aux	11	SENT_257	[p6l1246t2216r1316b2244],
10	be	VB	O	be	auxpass	11	SENT_257	[p6l1330t2207r1369b2236],
11	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_257	[p6l1384t2207r1556b2236],
12	by	IN	O	by	_	0	SENT_257	[p6l1570t2207r1610b2244],
13	the	DT	O	the	det	14	SENT_257	[p6l1625t2207r1675b2236],
14	presence	NN	O	presence	agent	11	SENT_257	[p6l1690t2216r1843b2244],
15	,	,	O	,	_	0	SENT_257	[p6l1690t2216r1843b2244],
16	in	IN	O	in	_	0	SENT_257	[p6l1859t2207r1890b2235],
17	its	PRP$	O	its	poss	18	SENT_257	[p6l546t2257r583b2286],
18	promoter	NN	O	promoter	prep_in	11	SENT_257	[p6l601t2261r760b2294],
19	,	,	O	,	_	0	SENT_257	[p6l601t2261r760b2294],
20	of	IN	O	of	_	0	SENT_257	[p6l779t2257r815b2286],
21	a	DT	O	a	det	24	SENT_257	[p6l830t2266r847b2286],
22	DNA	NN	O	dna	nn	24	SENT_257	[p6l863t2257r951b2286],
23	recognition/binding	NN	O	recognition/binding	nn	24	SENT_257	[p6l967t2257r1294b2294],
24	site	NN	O	site	prep_of	18	SENT_257	[p6l1313t2257r1368b2286],
25	for	IN	O	for	_	0	SENT_257	[p6l1385t2257r1433b2286],
26	the	DT	O	the	det	29	SENT_257	[p6l1449t2257r1499b2286],
27	nuclear	JJ	O	nuclear	amod	29	SENT_257	[p6l1516t2257r1638b2286],
28	receptor	NN	O	receptor	nn	29	SENT_257	[p6l1654t2261r1790b2294],
29	CAR	NN	O	car	prep_for	24	SENT_257	[p6l1807t2257r1891b2286],
30	(	CD	NUMBER	(	npadvmod	31	SENT_257	[p6l547t2306r751b2342],
31	constitutive	JJ	O	constitutive	amod	29	SENT_257	[p6l547t2306r751b2342],
32	activated	VBN	O	activate	partmod	29	SENT_257	[p6l763t2306r910b2336],
33	receptor	NN	O	receptor	nn	34	SENT_257	[p6l920t2307r1078b2344],
34	)	NN	O	)	dobj	32	SENT_257	[p6l920t2307r1078b2344],
35	,	,	O	,	_	0	SENT_257	[p6l920t2307r1078b2344],
36	a	DT	O	a	det	39	SENT_257	[p6l1092t2316r1109b2336],
37	phenobarbital	JJ	O	phenobarbital	amod	39	SENT_257	[p6l1120t2306r1347b2344],
38	response	NN	O	response	nn	39	SENT_257	[p6l1358t2316r1503b2344],
39	element	NN	O	element	appos	34	SENT_257	[p6l1515t2306r1646b2336],
40	(	CD	NUMBER	(	number	41	SENT_257	[p6l1658t2306r1733b2342],
41	75	CD	NUMBER	75	num	42	SENT_257	[p6l1658t2306r1733b2342],
42	)	NN	O	)	dep	39	SENT_257	[p6l1658t2306r1733b2342],
43	.	.	O	.	_	0	SENT_257	[p6l1658t2306r1733b2342],

1	DRUG	NN	O	drug	nn	2	SENT_258	[p6l447t2471r583b2506],
2	TRANSPORT	NN	O	transport	_	0	SENT_258	[p6l596t2470r876b2506],

1	Until	IN	O	until	prep	12	SENT_259	[p6l546t2583r630b2612],
2	recently	RB	DATE	recently	pcomp	1	SENT_259	[p6l642t2583r782b2620],
3	,	,	O	,	_	0	SENT_259	[p6l642t2583r782b2620],
4	absorption	NN	O	absorption	nsubjpass	12	SENT_259	[p6l796t2583r970b2620],
5	of	IN	O	of	_	0	SENT_259	[p6l983t2583r1019b2612],
6	drugs	NNS	O	drug	prep_of	4	SENT_259	[p6l1029t2583r1118b2620],
7	from	IN	O	from	_	0	SENT_259	[p6l1132t2583r1212b2612],
8	the	DT	O	the	det	10	SENT_259	[p6l1224t2583r1273b2612],
9	gastrointestinal	JJ	O	gastrointestinal	amod	10	SENT_259	[p6l1287t2583r1538b2620],
10	tract	NN	O	tract	prep_from	6	SENT_259	[p6l1551t2587r1624b2612],
11	was	VBD	O	be	auxpass	12	SENT_259	[p6l1636t2592r1698b2612],
12	considered	VBN	O	consider	_	0	SENT_259	[p6l1712t2583r1891b2612],
13	to	TO	O	to	aux	18	SENT_259	[p6l546t2637r577b2662],
14	be	VB	O	be	cop	18	SENT_259	[p6l589t2633r627b2662],
15	a	DT	O	a	det	18	SENT_259	[p6l640t2642r658b2662],
16	largely	RB	O	largely	advmod	17	SENT_259	[p6l669t2633r782b2670],
17	passive	JJ	O	passive	amod	18	SENT_259	[p6l794t2632r914b2670],
18	process	NN	O	process	xcomp	12	SENT_259	[p6l925t2642r1048b2670],
19	depending	VBG	O	depend	_	0	SENT_259	[p6l1062t2633r1233b2670],
20	on	IN	O	on	prepc_depending_on	18	SENT_259	[p6l1246t2642r1286b2662],
21	crystal	NN	O	crystal	nn	22	SENT_259	[p6l1298t2633r1407b2670],
22	size	NN	O	size	pobj	18	SENT_259	[p6l1421t2632r1492b2667],
23	,	,	O	,	_	0	SENT_259	[p6l1421t2632r1492b2667],
24	solubility	NN	O	solubility	pobj	18	SENT_259	[p6l1507t2632r1667b2670],
25	,	,	O	,	_	0	SENT_259	[p6l1507t2632r1667b2670],
26	lipophilicity	NN	O	lipophilicity	conj_and	22	SENT_259	[p6l1681t2632r1889b2670],
27	,	,	O	,	_	0	SENT_259	[p6l1681t2632r1889b2670],
28	pKa	NN	O	pka	conj_and	22	SENT_259	[p6l546t2683r615b2720],
29	of	IN	O	of	_	0	SENT_259	[p6l631t2682r667b2711],
30	the	DT	O	the	det	31	SENT_259	[p6l681t2682r731b2711],
31	drug	NN	O	drug	prep_of	28	SENT_259	[p6l748t2682r831b2720],
32	,	,	O	,	_	0	SENT_259	[p6l748t2682r831b2720],
33	and	CC	O	and	_	0	SENT_259	[p6l851t2682r909b2711],
34	pH	NN	O	ph	conj_and	22	SENT_259	[p6l925t2683r975b2720],
35	of	IN	O	of	_	0	SENT_259	[p6l992t2682r1028b2711],
36	the	DT	O	the	det	38	SENT_259	[p6l1042t2682r1091b2711],
37	intestinal	JJ	O	intestinal	amod	38	SENT_259	[p6l1108t2682r1259b2711],
38	ﬂuid	NN	O	ﬂuid	prep_of	34	SENT_259	[p6l1277t2682r1360b2711],
39	.	.	O	.	_	0	SENT_259	[p6l1277t2682r1360b2711],

1	Transfer	NN	O	transfer	nsubjpass	9	SENT_260	[p6l1378t2682r1517b2711],
2	of	IN	O	of	_	0	SENT_260	[p6l1534t2682r1570b2711],
3	the	DT	O	the	det	5	SENT_260	[p6l1583t2682r1633b2711],
4	absorbed	VBN	O	absorb	amod	5	SENT_260	[p6l1651t2682r1799b2711],
5	drug	NN	O	drug	prep_of	1	SENT_260	[p6l1816t2682r1890b2720],
6	into	IN	O	into	_	0	SENT_260	[p6l546t2731r609b2760],
7	tissues	NNS	O	tissue	prep_into	5	SENT_260	[p6l622t2731r731b2760],
8	was	VBD	O	be	auxpass	9	SENT_260	[p6l745t2740r806b2760],
9	thought	VBN	O	think	_	0	SENT_260	[p6l820t2731r946b2769],
10	to	TO	O	to	aux	11	SENT_260	[p6l958t2736r989b2760],
11	depend	VB	O	depend	xcomp	9	SENT_260	[p6l1002t2731r1121b2769],
12	on	IN	O	on	_	0	SENT_260	[p6l1134t2740r1174b2760],
13	the	DT	O	the	det	14	SENT_260	[p6l1186t2731r1236b2760],
14	drug	NN	O	drug	poss	17	SENT_260	[p6l1249t2731r1350b2769],
15	’s	POS	O	’s	_	0	SENT_260	[p6l1249t2731r1350b2769],
16	physicochemical	NN	O	physicochemical	nn	17	SENT_260	[p6l1363t2731r1641b2769],
17	properties	NNS	O	property	prep_on	11	SENT_260	[p6l1654t2731r1818b2769],
18	and	CC	O	and	_	0	SENT_260	[p6l1832t2731r1891b2760],
19	protein	NN	O	protein	nn	21	SENT_260	[p6l546t2780r663b2818],
20	binding	NN	O	binding	nn	21	SENT_260	[p6l674t2780r800b2818],
21	ability	NN	O	ability	prep_on	11	SENT_260	[p6l812t2780r922b2818],
22	.	.	O	.	_	0	SENT_260	[p6l812t2780r922b2818],

1	It	PRP	O	it	nsubjpass	4	SENT_261	[p6l596t2831r621b2859],
2	is	VBZ	O	be	auxpass	4	SENT_261	[p6l629t2830r654b2859],
3	now	RB	DATE	now	advmod	4	SENT_261	[p6l663t2839r732b2859],
4	known	VBN	O	know	_	0	SENT_261	[p6l741t2830r852b2859],
5	that	IN	O	that	complm	9	SENT_261	[p6l860t2830r922b2859],
6	many	JJ	O	many	amod	7	SENT_261	[p6l929t2839r1020b2868],
7	drugs	NNS	O	drug	nsubj	9	SENT_261	[p6l1029t2830r1118b2868],
8	are	VBP	O	be	cop	9	SENT_261	[p6l1129t2839r1177b2859],
9	substrates	NNS	O	substrate	ccomp	4	SENT_261	[p6l1187t2830r1347b2859],
10	of	IN	O	of	_	0	SENT_261	[p6l1357t2830r1393b2859],
11	active	JJ	O	active	amod	12	SENT_261	[p6l1399t2830r1494b2859],
12	transporters	NNS	O	transporter	prep_of	9	SENT_261	[p6l1503t2834r1707b2868],
13	,	,	O	,	_	0	SENT_261	[p6l1503t2834r1707b2868],
14	membrane	NN	O	membrane	nn	15	SENT_261	[p6l1716t2830r1890b2859],
15	proteins	NNS	O	protein	appos	12	SENT_261	[p6l546t2879r678b2917],
16	that	WDT	O	that	nsubj	17	SENT_261	[p6l693t2879r755b2908],
17	maintain	VBP	O	maintain	rcmod	15	SENT_261	[p6l769t2879r913b2908],
18	cellular	JJ	O	cellular	amod	19	SENT_261	[p6l928t2879r1051b2908],
19	homeostasis	NN	O	homeostasis	dobj	17	SENT_261	[p6l1065t2879r1266b2908],
20	by	IN	O	by	_	0	SENT_261	[p6l1281t2879r1321b2917],
21	importing	VBG	O	import	prepc_by	17	SENT_261	[p6l1336t2879r1498b2917],
22	and	CC	O	and	_	0	SENT_261	[p6l1514t2879r1572b2908],
23	exporting	VBG	O	export	conj_and	21	SENT_261	[p6l1586t2879r1743b2917],
24	endogenous	JJ	O	endogenous	amod	25	SENT_261	[p6l1758t2879r1889b2917, p6l546t2937r623b2957],
25	compounds	NNS	O	compound	dobj	21	SENT_261	[p6l640t2928r839b2966],
26	.	.	O	.	_	0	SENT_261	[p6l640t2928r839b2966],

1	Because	IN	O	because	_	0	SENT_262	[p6l857t2929r994b2957],
2	of	IN	O	of	prepc_because_of	18	SENT_262	[p6l1012t2928r1047b2957],
3	their	PRP$	O	they	poss	4	SENT_262	[p6l1061t2928r1137b2957],
4	localization	NN	O	localization	pobj	18	SENT_262	[p6l1153t2928r1345b2957],
5	in	IN	O	in	_	0	SENT_262	[p6l1362t2928r1393b2957],
6	intestinal	JJ	O	intestinal	dep	12	SENT_262	[p6l1409t2928r1570b2963],
7	,	,	O	,	_	0	SENT_262	[p6l1409t2928r1570b2963],
8	hepatic	JJ	O	hepatic	amod	13	SENT_262	[p6l1587t2928r1715b2966],
9	,	,	O	,	_	0	SENT_262	[p6l1587t2928r1715b2966],
10	and	CC	O	and	_	0	SENT_262	[p6l1734t2928r1792b2957],
11	renal	JJ	O	renal	amod	13	SENT_262	[p6l1808t2928r1890b2957],
12	epithelial	JJ	O	epithelial	amod	13	SENT_262	[p6l547t2977r700b3015],
13	cells	NNS	O	cell	prep_in	4	SENT_262	[p6l716t2977r800b3011],
14	,	,	O	,	_	0	SENT_262	[p6l716t2977r800b3011],
15	these	DT	O	these	det	16	SENT_262	[p6l817t2977r901b3006],
16	transporters	NNS	O	transporter	nsubj	18	SENT_262	[p6l917t2982r1111b3015],
17	are	VBP	O	be	cop	18	SENT_262	[p6l1129t2986r1178b3006],
18	important	JJ	O	important	_	0	SENT_262	[p6l1194t2977r1355b3015],
19	in	IN	O	in	_	0	SENT_262	[p6l1370t2977r1402b3006],
20	the	DT	O	the	det	21	SENT_262	[p6l1417t2977r1467b3006],
21	absorption	NN	O	absorption	prep_in	18	SENT_262	[p6l1484t2977r1666b3015],
22	,	,	O	,	_	0	SENT_262	[p6l1484t2977r1666b3015],
23	bioavailabil	NN	O	bioavailabil	nn	25	SENT_262	[p6l1683t2977r1889b3006],
24	—	NN	O	—	nn	25	SENT_262	[p6l1683t2977r1889b3006],
25	ity	NN	O	ity	conj_and	21	SENT_262	[p6l546t3026r595b3064],
26	,	,	O	,	_	0	SENT_262	[p6l546t3026r595b3064],
27	and	CC	O	and	_	0	SENT_262	[p6l610t3026r668b3056],
28	elimination	NN	O	elimination	prep_in	18	SENT_262	[p6l681t3026r869b3056],
29	of	IN	O	of	_	0	SENT_262	[p6l881t3026r917b3056],
30	many	JJ	O	many	amod	31	SENT_262	[p6l927t3035r1017b3064],
31	drugs	NNS	O	drug	prep_of	28	SENT_262	[p6l1030t3026r1129b3064],
32	.	.	O	.	_	0	SENT_262	[p6l1030t3026r1129b3064],

1	Moreover	RB	O	moreover	advmod	6	SENT_263	[p6l1144t3027r1312b3061],
2	,	,	O	,	_	0	SENT_263	[p6l1144t3027r1312b3061],
3	they	PRP	O	they	nsubj	6	SENT_263	[p6l1326t3026r1396b3064],
4	can	MD	O	can	aux	6	SENT_263	[p6l1409t3035r1465b3056],
5	be	VB	O	be	cop	6	SENT_263	[p6l1477t3026r1516b3056],
6	important	JJ	O	important	_	0	SENT_263	[p6l1528t3026r1689b3064],
7	in	IN	O	in	_	0	SENT_263	[p6l1701t3026r1732b3055],
8	targeting	VBG	O	target	prepc_in	6	SENT_263	[p6l1745t3026r1890b3064],
9	drugs	NNS	O	drug	dobj	8	SENT_263	[p6l547t3076r636b3114],
10	to	TO	O	to	_	0	SENT_263	[p6l649t3080r680b3105],
11	organs	NNS	O	organ	prep_to	8	SENT_263	[p6l693t3085r800b3114],
12	because	IN	O	because	mark	15	SENT_263	[p6l813t3076r943b3105],
13	they	PRP	O	they	nsubj	15	SENT_263	[p6l956t3076r1025b3114],
14	are	VBP	O	be	cop	15	SENT_263	[p6l1038t3085r1087b3105],
15	localized	JJ	O	localized	advcl	6	SENT_263	[p6l1099t3076r1248b3105],
16	in	IN	O	in	_	0	SENT_263	[p6l1260t3076r1291b3105],
17	blood	NN	O	blood	nn	20	SENT_263	[p6l1303t3076r1504b3114],
18	—	NN	O	—	nn	20	SENT_263	[p6l1303t3076r1504b3114],
19	organ	NN	O	organ	nn	20	SENT_263	[p6l1303t3076r1504b3114],
20	barriers	NNS	O	barrier	prep_in	15	SENT_263	[p6l1516t3076r1650b3105],
21	.	.	O	.	_	0	SENT_263	[p6l1516t3076r1650b3105],

1	Genetic	JJ	O	genetic	amod	2	SENT_264	[p6l1665t3076r1791b3105],
2	polymorphisms	NNS	O	polymorphism	nsubj	27	SENT_264	[p6l1804t3076r1889b3114, p6l546t3125r729b3163],
3	affecting	VBG	O	affect	dep	2	SENT_264	[p6l742t3125r887b3163],
4	their	PRP$	O	they	poss	5	SENT_264	[p6l899t3125r975b3154],
5	expression	NN	O	expression	dobj	3	SENT_264	[p6l987t3125r1162b3163],
6	or	CC	O	or	_	0	SENT_264	[p6l1175t3134r1208b3154],
7	changing	VBG	O	change	dep	2	SENT_264	[p6l1220t3125r1370b3163],
8	their	PRP$	O	they	poss	9	SENT_264	[p6l1383t3125r1459b3154],
9	afﬁnity	NN	O	afﬁnity	dobj	7	SENT_264	[p6l1471t3125r1588b3163],
10	for	IN	O	for	_	0	SENT_264	[p6l1600t3125r1648b3154],
11	substrates	NNS	O	substrate	prep_for	7	SENT_264	[p6l1661t3125r1821b3154],
12	can	MD	O	can	aux	13	SENT_264	[p6l1834t3134r1891b3154],
13	alter	VB	O	alter	_	0	SENT_264	[p6l547t3174r620b3203],
14	the	DT	O	the	det	15	SENT_264	[p6l631t3174r681b3203],
15	absorption	NN	O	absorption	dobj	13	SENT_264	[p6l694t3174r867b3212],
16	and	CC	O	and	_	0	SENT_264	[p6l880t3174r939b3203],
17	elimination	NN	O	elimination	conj_and	15	SENT_264	[p6l951t3174r1139b3203],
18	of	IN	O	of	_	0	SENT_264	[p6l1151t3174r1187b3203],
19	drugs	NNS	O	drug	prep_of	15	SENT_264	[p6l1197t3174r1287b3212],
20	that	WDT	O	that	nsubj	23	SENT_264	[p6l1300t3174r1362b3203],
21	are	VBP	O	be	cop	23	SENT_264	[p6l1374t3183r1423b3203],
22	their	PRP$	O	they	poss	23	SENT_264	[p6l1435t3174r1511b3203],
23	substrates	NNS	O	substrate	rcmod	19	SENT_264	[p6l1524t3174r1694b3209],
24	,	,	O	,	_	0	SENT_264	[p6l1524t3174r1694b3209],
25	and	CC	O	and	_	0	SENT_264	[p6l1709t3174r1767b3203],
26	can	MD	O	can	aux	27	SENT_264	[p6l1779t3183r1836b3203],
27	alter	VB	O	alter	conj_and	13	SENT_264	[p6l1849t3174r1889b3203, p6l546t3228r590b3253],
28	drug	NN	O	drug	nn	29	SENT_264	[p6l602t3224r676b3262],
29	concentrations	NNS	O	concentration	dobj	27	SENT_264	[p6l690t3224r930b3253],
30	at	IN	O	at	_	0	SENT_264	[p6l944t3228r973b3253],
31	the	DT	O	the	det	32	SENT_264	[p6l985t3224r1034b3253],
32	site	NN	O	site	prep_at	27	SENT_264	[p6l1049t3224r1104b3253],
33	of	IN	O	of	_	0	SENT_264	[p6l1117t3224r1153b3253],
34	action	NN	O	action	prep_of	32	SENT_264	[p6l1164t3224r1264b3253],
35	despite	IN	O	despite	_	0	SENT_264	[p6l1277t3224r1393b3262],
36	similar	JJ	O	similar	amod	38	SENT_264	[p6l1407t3224r1521b3253],
37	blood	NN	O	blood	nn	38	SENT_264	[p6l1532t3224r1627b3253],
38	concentrations	NNS	O	concentration	prep_despite	27	SENT_264	[p6l1639t3224r1888b3253],
39	.	.	O	.	_	0	SENT_264	[p6l1639t3224r1888b3253],

1	EICHELBAUM	NNP	O	EICHELBAUM	nsubj	5	SENT_265	[p6l586t3282r827b3309],
2	I	PRP	O	I	dep	1	SENT_265	[p6l845t3285r862b3303],
3	INGELMAN-SUNDBERG	NN	O	ingelman-sundberg	dep	1	SENT_265	[p6l881t3282r1293b3309],
4	I	PRP	O	I	dep	3	SENT_265	[p6l1311t3285r1328b3303],
5	EVANS	VBP	O	evan	_	0	SENT_265	[p6l1347t3282r1464b3309],

1	.	.	O	.	_	0	SENT_266	[p7l287t3824r291b3828],

1	Rev.	NNP	O	Rev.	nn	2	SENT_267	[p7l268t3752r291b3813],
2	Med	NNP	O	Med	_	0	SENT_267	[p7l268t3676r291b3742],
3	.	.	O	.	_	0	SENT_267	[p7l268t3676r291b3742],

1	2006.57:119	CD	NUMBER	2006.57:119	num	2	SENT_268	[p7l268t3431r292b3664],
2	-137	CD	NUMBER	-137	_	0	SENT_268	[p7l268t3431r292b3664],
3	.	.	O	.	_	0	SENT_268	[p7l268t3431r292b3664],

1	Downloaded	VBN	O	download	_	0	SENT_269	[p7l268t3251r291b3420],
2	from	IN	O	from	_	0	SENT_269	[p7l268t3177r291b3242],
3	www.annualreviews.org	NNP	ORGANIZATION	www.annualreviews.org	nn	4	SENT_269	[p7l268t2844r298b3168],
4	University	NNP	ORGANIZATION	University	prep_from	1	SENT_269	[p7l301t3687r332b3828],
5	of	IN	ORGANIZATION	of	_	0	SENT_269	[p7l301t3649r325b3679],
6	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	4	SENT_269	[p7l301t3504r325b3643],
7	-	:	O	-	_	0	SENT_269	[p7l315t3485r318b3494],
8	Madison	NNP	O	Madison	dep	4	SENT_269	[p7l301t3359r325b3475],
9	on	IN	O	on	_	0	SENT_269	[p7l309t3317r325b3350],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_269	[p7l301t3184r325b3308],
11	.	.	O	.	_	0	SENT_269	[p7l301t3184r325b3308],

1	For	IN	O	for	_	0	SENT_270	[p7l302t3127r325b3173],
2	personal	JJ	O	personal	amod	3	SENT_270	[p7l301t3007r332b3119],
3	use	NN	O	use	pobj	1	SENT_270	[p7l309t2954r325b2998],
4	only	RB	O	only	advmod	3	SENT_270	[p7l301t2879r332b2944],
5	.	.	O	.	_	0	SENT_270	[p7l301t2879r332b2944],

1	Annu	NNP	PERSON	Annu	_	0	SENT_271	[p7l279t1561r302b1641],
2	.	.	O	.	_	0	SENT_271	[p7l279t1561r302b1641],

1	Rev.	NNP	O	Rev.	nn	2	SENT_272	[p7l279t1490r302b1550],
2	Med	NNP	O	Med	_	0	SENT_272	[p7l279t1413r302b1480],
3	.	.	O	.	_	0	SENT_272	[p7l279t1413r302b1480],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_273	[p7l279t1288r302b1402],
2	:	:	O	:	_	0	SENT_273	[p7l279t1288r302b1402],
3	1	CD	NUMBER	1	number	4	SENT_273	[p7l279t1272r302b1282],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_273	[p7l279t1168r303b1265],
5	.	.	O	.	_	0	SENT_273	[p7l279t1168r303b1265],

1	Downloaded	VBN	O	download	_	0	SENT_274	[p7l279t988r302b1157],
2	from	IN	O	from	_	0	SENT_274	[p7l279t914r302b979],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_274	[p7l279t581r309b905],
4	by	IN	O	by	_	0	SENT_274	[p7l312t1574r343b1607],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_274	[p7l312t1425r343b1565],
6	of	IN	ORGANIZATION	of	_	0	SENT_274	[p7l312t1387r336b1416],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_274	[p7l312t1241r336b1380],
8	-	:	O	-	_	0	SENT_274	[p7l326t1222r329b1231],
9	Madison	NNP	O	Madison	dep	7	SENT_274	[p7l312t1096r336b1212],
10	on	IN	O	on	_	0	SENT_274	[p7l320t1054r336b1087],
11	01/05	CD	NUMBER	01/05	prep_on	9	SENT_274	[p7l312t960r336b1045],
12	/	:	O	/	punct	9	SENT_274	[p7l312t960r336b1045],
13	14	CD	NUMBER	14	tmod	5	SENT_274	[p7l312t921r336b957],
14	.	.	O	.	_	0	SENT_274	[p7l312t921r336b957],

1	For	IN	O	for	_	0	SENT_275	[p7l313t864r336b910],
2	personal	JJ	O	personal	amod	3	SENT_275	[p7l312t744r343b856],
3	use	NN	O	use	pobj	1	SENT_275	[p7l320t691r336b735],
4	only	RB	O	only	advmod	3	SENT_275	[p7l312t616r343b681],
5	.	.	O	.	_	0	SENT_275	[p7l312t616r343b681],

1	MDR1	NN	O	mdr1	nsubj	14	SENT_276	[p7l536t41r660b76],
2	,	,	O	,	_	0	SENT_276	[p7l536t41r660b76],
3	MRPs	NNS	O	mrp	conj_and	1	SENT_276	[p7l670t42r782b76],
4	,	,	O	,	_	0	SENT_276	[p7l670t42r782b76],
5	OATPs	NNS	O	oatp	conj_and	1	SENT_276	[p7l794t41r919b76],
6	,	,	O	,	_	0	SENT_276	[p7l794t41r919b76],
7	OCTs	NNS	O	oct	conj_and	1	SENT_276	[p7l931t41r1037b76],
8	,	,	O	,	_	0	SENT_276	[p7l931t41r1037b76],
9	OATs	NNS	O	oats	conj_and	1	SENT_276	[p7l1049t41r1151b76],
10	,	,	O	,	_	0	SENT_276	[p7l1049t41r1151b76],
11	and	CC	O	and	_	0	SENT_276	[p7l1163t41r1221b71],
12	nucleoside	NN	O	nucleoside	nn	13	SENT_276	[p7l1230t41r1407b71],
13	transporters	NNS	O	transporter	conj_and	1	SENT_276	[p7l1416t46r1610b79],
14	are	VBP	O	be	_	0	SENT_276	[p7l1621t50r1670b71],
15	of	IN	O	of	_	0	SENT_276	[p7l1680t41r1716b71],
16	particular	JJ	O	particular	amod	17	SENT_276	[p7l1722t41r1881b79],
17	interest	NN	O	interest	prep_of	14	SENT_276	[p7l536t91r658b120],
18	because	IN	O	because	mark	20	SENT_276	[p7l670t91r801b120],
19	they	PRP	O	they	nsubj	20	SENT_276	[p7l814t91r884b129],
20	transport	VBP	O	transport	advcl	14	SENT_276	[p7l898t96r1045b129],
21	exogenous	JJ	O	exogenous	amod	22	SENT_276	[p7l1058t100r1232b129],
22	substrates	NNS	O	substrate	dobj	20	SENT_276	[p7l1248t91r1418b126],
23	,	,	O	,	_	0	SENT_276	[p7l1248t91r1418b126],
24	including	VBG	O	include	_	0	SENT_276	[p7l1433t91r1588b129],
25	drugs	NNS	O	drug	prep_including	22	SENT_276	[p7l1602t91r1702b129],
26	,	,	O	,	_	0	SENT_276	[p7l1602t91r1702b129],
27	as	RB	O	as	_	0	SENT_276	[p7l1717t100r1749b120],
28	well	RB	O	well	_	0	SENT_276	[p7l1764t91r1833b121],
29	as	IN	O	as	_	0	SENT_276	[p7l1848t100r1879b120],
30	endogenous	JJ	O	endogenous	amod	31	SENT_276	[p7l537t141r733b179],
31	compounds	NNS	O	compound	prep_including	22	SENT_276	[p7l746t141r944b179],
32	.	.	O	.	_	0	SENT_276	[p7l746t141r944b179],

1	P	NN	O	p	nsubj	24	SENT_277	[p7l586t190r832b228],
2	—	CD	NUMBER	—	num	1	SENT_277	[p7l586t190r832b228],
3	glycoprotein	NN	O	glycoprotein	nn	6	SENT_277	[p7l586t190r832b228],
4	(	CD	NUMBER	(	num	6	SENT_277	[p7l842t190r941b228],
5	Pgp	NNP	O	Pgp	nn	6	SENT_277	[p7l842t190r941b228],
6	)	NNP	O	)	dep	1	SENT_277	[p7l842t190r941b228],
7	,	,	O	,	_	0	SENT_277	[p7l842t190r941b228],
8	the	DT	O	the	det	9	SENT_277	[p7l951t190r1001b220],
9	product	NN	O	product	appos	1	SENT_277	[p7l1009t190r1136b228],
10	of	IN	O	of	_	0	SENT_277	[p7l1145t190r1181b220],
11	ABCBI	NNP	O	ABCBI	nn	13	SENT_277	[p7l1184t190r1307b220],
12	(	CD	NUMBER	(	num	13	SENT_277	[p7l1320t190r1407b226],
13	alias	NNS	O	alias	prep_of	9	SENT_277	[p7l1320t190r1407b226],
14	MDR1	NN	O	mdr1	dep	9	SENT_277	[p7l1415t190r1535b225],
15	,	,	O	,	_	0	SENT_277	[p7l1415t190r1535b225],
16	for	IN	O	for	_	0	SENT_277	[p7l1546t190r1594b220],
17	“	CD	NUMBER	“	num	19	SENT_277	[p7l1603t190r1782b228],
18	multidrug	JJ	O	multidrug	amod	19	SENT_277	[p7l1603t190r1782b228],
19	resistance	NN	O	resistance	prep_for	1	SENT_277	[p7l1791t190r1879b220, p7l536t240r664b276],
20	”	CD	NUMBER	”	num	21	SENT_277	[p7l1791t190r1879b220, p7l536t240r664b276],
21	)	NN	O	)	dep	19	SENT_277	[p7l1791t190r1879b220, p7l536t240r664b276],
22	,	,	O	,	_	0	SENT_277	[p7l1791t190r1879b220, p7l536t240r664b276],
23	has	VBZ	O	have	aux	24	SENT_277	[p7l674t240r727b269],
24	received	VBN	O	receive	_	0	SENT_277	[p7l736t240r875b269],
25	much	JJ	O	much	amod	26	SENT_277	[p7l883t240r974b269],
26	attention	NN	O	attention	dobj	24	SENT_277	[p7l983t240r1127b269],
27	because	IN	O	because	mark	30	SENT_277	[p7l1135t240r1265b269],
28	its	PRP$	O	its	poss	29	SENT_277	[p7l1274t240r1311b269],
29	substrates	NNS	O	substrate	nsubj	30	SENT_277	[p7l1322t240r1482b269],
30	include	VBP	O	include	advcl	24	SENT_277	[p7l1491t240r1612b269],
31	many	JJ	O	many	amod	33	SENT_277	[p7l1621t249r1711b278],
32	important	JJ	O	important	amod	33	SENT_277	[p7l1720t240r1881b278],
33	drugs	NNS	O	drug	dobj	30	SENT_277	[p7l537t289r636b327],
34	.	.	O	.	_	0	SENT_277	[p7l537t289r636b327],

1	Studies	NNS	O	study	nsubj	9	SENT_278	[p7l646t289r765b318],
2	on	IN	O	on	_	0	SENT_278	[p7l774t298r814b318],
3	mdr	NN	O	mdr	prep_on	1	SENT_278	[p7l821t289r904b318],
4	]	CD	NUMBER	]	num	3	SENT_278	[p7l821t289r904b318],
5	a	DT	O	a	det	6	SENT_278	[p7l909t289r1086b318],
6	—	NN	O	—	dep	3	SENT_278	[p7l909t289r1086b318],
7	deﬁcient	JJ	O	deﬁcient	amod	8	SENT_278	[p7l909t289r1086b318],
8	mice	NNS	O	mouse	dep	6	SENT_278	[p7l1092t289r1172b318],
9	(	VBP	O	(	_	0	SENT_278	[p7l1180t289r1246b325],
10	76	CD	NUMBER	76	number	11	SENT_278	[p7l1180t289r1246b325],
11	)	CD	NUMBER	)	dobj	9	SENT_278	[p7l1180t289r1246b325],
12	provided	VBN	O	provide	partmod	11	SENT_278	[p7l1254t289r1400b327],
13	convincing	JJ	O	convincing	amod	14	SENT_278	[p7l1407t289r1588b327],
14	evidence	NN	O	evidence	dobj	12	SENT_278	[p7l1596t289r1741b318],
15	that	IN	O	that	complm	17	SENT_278	[p7l1749t289r1810b318],
16	Pgp	NNP	ORGANIZATION	Pgp	nsubj	17	SENT_278	[p7l1817t290r1880b327],
17	plays	VBZ	O	play	ccomp	12	SENT_278	[p7l536t338r622b376],
18	a	DT	O	a	det	20	SENT_278	[p7l638t347r655b367],
19	prominent	JJ	O	prominent	amod	20	SENT_278	[p7l668t338r838b376],
20	role	NN	O	role	dobj	17	SENT_278	[p7l851t338r915b367],
21	in	IN	O	in	_	0	SENT_278	[p7l929t338r960b367],
22	the	DT	O	the	det	26	SENT_278	[p7l974t338r1023b367],
23	blood	NN	O	blood	nn	26	SENT_278	[p7l1037t338r1239b367],
24	—	NN	O	—	nn	26	SENT_278	[p7l1037t338r1239b367],
25	tissue	NN	O	tissue	nn	26	SENT_278	[p7l1037t338r1239b367],
26	barrier	NN	O	barrier	prep_in	20	SENT_278	[p7l1253t338r1369b367],
27	.	.	O	.	_	0	SENT_278	[p7l1253t338r1369b367],

1	Pgp	NNP	O	Pgp	nsubj	19	SENT_279	[p7l1385t338r1617b376],
2	—	CD	NUMBER	—	num	1	SENT_279	[p7l1385t338r1617b376],
3	knockout	JJ	O	knockout	amod	4	SENT_279	[p7l1385t338r1617b376],
4	mice	NNS	O	mouse	nsubj	5	SENT_279	[p7l1630t338r1709b367],
5	had	VBD	O	have	rcmod	1	SENT_279	[p7l1723t338r1783b367],
6	brain	NN	O	brain	nn	7	SENT_279	[p7l1796t338r1881b367],
7	concentrations	NNS	O	concentration	dobj	5	SENT_279	[p7l537t387r777b416],
8	of	IN	O	of	_	0	SENT_279	[p7l789t387r825b416],
9	cardiac	JJ	O	cardiac	amod	10	SENT_279	[p7l834t387r951b416],
10	glycosides	NNS	O	glycoside	prep_of	7	SENT_279	[p7l964t387r1146b425],
11	,	,	O	,	_	0	SENT_279	[p7l964t387r1146b425],
12	HIV-1	NN	MISC	hiv-1	nn	14	SENT_279	[p7l1159t388r1259b416],
13	protease	NN	O	protease	nn	14	SENT_279	[p7l1273t392r1411b425],
14	inhibitors	NNS	O	inhibitor	conj_and	10	SENT_279	[p7l1422t387r1589b422],
15	,	,	O	,	_	0	SENT_279	[p7l1422t387r1589b422],
16	and	CC	O	and	_	0	SENT_279	[p7l1602t387r1661b416],
17	immunosup	NN	O	immunosup	nn	18	SENT_279	[p7l1672t387r1879b425],
18	—	NN	O	—	conj_and	10	SENT_279	[p7l1672t387r1879b425],
19	pressants	VBZ	O	pressant	_	0	SENT_279	[p7l536t441r687b474],
20	up	RP	O	up	dep	22	SENT_279	[p7l699t445r739b474],
21	to	TO	O	to	dep	22	SENT_279	[p7l751t441r782b466],
22	50	CD	NUMBER	50	num	23	SENT_279	[p7l794t436r834b466],
23	times	NNS	O	time	npadvmod	24	SENT_279	[p7l846t436r933b466],
24	higher	JJR	O	higher	acomp	19	SENT_279	[p7l945t436r1052b474],
25	than	IN	O	than	_	0	SENT_279	[p7l1062t436r1133b466],
26	those	DT	O	those	prep_than	24	SENT_279	[p7l1144t436r1230b466],
27	in	IN	O	in	_	0	SENT_279	[p7l1242t436r1274b465],
28	wild-type	JJ	O	wild-type	amod	29	SENT_279	[p7l1285t436r1443b474],
29	animals	NNS	O	animal	prep_in	26	SENT_279	[p7l1455t436r1591b466],
30	.	.	O	.	_	0	SENT_279	[p7l1455t436r1591b466],

1	Systemic	JJ	MISC	systemic	amod	2	SENT_280	[p7l587t486r737b524],
2	screening	NN	O	screening	nsubj	4	SENT_280	[p7l751t486r907b524],
3	initially	RB	O	initially	advmod	4	SENT_280	[p7l920t486r1048b524],
4	revealed	VBD	O	reveal	_	0	SENT_280	[p7l1060t486r1198b516],
5	15	CD	NUMBER	15	num	7	SENT_280	[p7l1214t486r1249b516],
6	genetic	JJ	O	genetic	amod	7	SENT_280	[p7l1263t486r1381b524],
7	variants	NNS	O	variant	dobj	4	SENT_280	[p7l1394t486r1522b515],
8	of	IN	O	of	_	0	SENT_280	[p7l1536t486r1572b515],
9	human	JJ	O	human	amod	10	SENT_280	[p7l1581t486r1693b515],
10	ABCBI	NN	O	abcbus	prep_of	7	SENT_280	[p7l1703t486r1837b516],
11	.	.	O	.	_	0	SENT_280	[p7l1703t486r1837b516],

1	A	DT	O	a	det	2	SENT_281	[p7l1851t486r1881b515],
2	total	NN	O	total	nsubjpass	9	SENT_281	[p7l537t535r609b564],
3	of	IN	O	of	_	0	SENT_281	[p7l624t535r660b564],
4	28	CD	NUMBER	28	num	5	SENT_281	[p7l672t535r710b564],
5	SNPs	NNS	O	snp	prep_of	2	SENT_281	[p7l727t535r816b564],
6	have	VBP	O	have	aux	9	SENT_281	[p7l831t535r907b564],
7	now	RB	DATE	now	advmod	9	SENT_281	[p7l921t544r990b564],
8	been	VBN	O	be	auxpass	9	SENT_281	[p7l1004t535r1082b564],
9	identiﬁed	VBN	O	identiﬁed	_	0	SENT_281	[p7l1096t535r1262b569],
10	;	:	O	;	_	0	SENT_281	[p7l1096t535r1262b569],
11	those	DT	O	those	nsubj	23	SENT_281	[p7l1278t535r1364b564],
12	in	IN	O	in	_	0	SENT_281	[p7l1378t535r1410b564],
13	exons	NNS	O	exon	prep_in	11	SENT_281	[p7l1424t544r1518b564],
14	21	CD	NUMBER	21	number	15	SENT_281	[p7l1534t535r1570b564],
15	(	CD	NUMBER	(	num	17	SENT_281	[p7l1589t535r1751b571],
16	G2677T	NN	O	g2677t	nn	17	SENT_281	[p7l1589t535r1751b571],
17	)	NN	O	)	dep	13	SENT_281	[p7l1589t535r1751b571],
18	and	CC	O	and	_	0	SENT_281	[p7l1768t535r1826b564],
19	26	CD	NUMBER	26	number	20	SENT_281	[p7l1840t535r1880b564],
20	(	CD	NUMBER	(	num	22	SENT_281	[p7l538t584r698b620],
21	C3435T	NN	O	c3435t	nn	22	SENT_281	[p7l538t584r698b620],
22	)	NN	O	)	prep_in	11	SENT_281	[p7l538t584r698b620],
23	are	VBP	O	be	parataxis	9	SENT_281	[p7l710t593r759b613],
24	of	IN	O	of	_	0	SENT_281	[p7l770t584r806b613],
25	particular	JJ	O	particular	amod	26	SENT_281	[p7l813t584r972b622],
26	interest	NN	O	interest	prep_of	23	SENT_281	[p7l982t584r1104b613],
27	because	IN	O	because	mark	29	SENT_281	[p7l1113t584r1244b613],
28	they	PRP	O	they	nsubj	29	SENT_281	[p7l1255t584r1324b622],
29	affect	VBP	O	affect	advcl	23	SENT_281	[p7l1336t584r1428b613],
30	expression	NN	O	expression	dobj	29	SENT_281	[p7l1438t584r1614b622],
31	or	CC	O	or	_	0	SENT_281	[p7l1625t593r1658b613],
32	function	NN	O	function	conj_or	30	SENT_281	[p7l1668t584r1805b613],
33	(	CD	NUMBER	(	number	34	SENT_281	[p7l1817t584r1879b620],
34	77	CD	NUMBER	77	dep	30	SENT_281	[p7l1817t584r1879b620],
35	,	,	O	,	_	0	SENT_281	[p7l1817t584r1879b620],
36	78	CD	NUMBER	78	num	37	SENT_281	[p7l537t634r599b670],
37	)	NN	O	)	appos	30	SENT_281	[p7l537t634r599b670],
38	.	.	O	.	_	0	SENT_281	[p7l537t634r599b670],

1	Although	IN	O	although	mark	5	SENT_282	[p7l611t634r766b672],
2	several	JJ	O	several	amod	3	SENT_282	[p7l777t634r890b663],
3	studies	NNS	O	study	nsubj	5	SENT_282	[p7l901t634r1013b663],
4	have	VBP	O	have	aux	5	SENT_282	[p7l1023t634r1099b663],
5	addressed	VBN	O	address	advcl	20	SENT_282	[p7l1110t634r1272b663],
6	the	DT	O	the	det	7	SENT_282	[p7l1281t634r1330b663],
7	association	NN	O	association	dobj	5	SENT_282	[p7l1341t634r1523b663],
8	of	IN	O	of	_	0	SENT_282	[p7l1533t634r1569b663],
9	these	DT	O	these	det	10	SENT_282	[p7l1575t634r1659b663],
10	variants	NNS	O	variant	prep_of	7	SENT_282	[p7l1669t634r1797b663],
11	with	IN	O	with	_	0	SENT_282	[p7l1808t634r1880b663],
12	disposition	NN	O	disposition	prep_with	5	SENT_282	[p7l537t684r718b722],
13	and	CC	O	and	_	0	SENT_282	[p7l729t684r788b713],
14	effects	NNS	O	effect	prep_with	5	SENT_282	[p7l799t684r906b713],
15	of	IN	O	of	_	0	SENT_282	[p7l918t684r954b713],
16	Pgp	NNP	O	Pgp	nn	17	SENT_282	[p7l962t684r1025b722],
17	substrates	NNS	O	substrate	prep_of	12	SENT_282	[p7l1038t684r1208b718],
18	,	,	O	,	_	0	SENT_282	[p7l1038t684r1208b718],
19	controversy	NN	O	controversy	nsubj	20	SENT_282	[p7l1221t688r1414b722],
20	remains	VBZ	O	remain	_	0	SENT_282	[p7l1425t684r1555b713],
21	about	IN	O	about	_	0	SENT_282	[p7l1567t684r1658b713],
22	the	DT	O	the	det	23	SENT_282	[p7l1669t684r1718b713],
23	inﬂuence	NN	O	inﬂuence	prep_about	20	SENT_282	[p7l1729t684r1880b713],
24	of	IN	O	of	_	0	SENT_282	[p7l537t734r573b763],
25	different	JJ	O	different	amod	26	SENT_282	[p7l582t734r723b763],
26	variants	NNS	O	variant	prep_of	23	SENT_282	[p7l734t734r862b763],
27	on	IN	O	on	_	0	SENT_282	[p7l875t743r915b763],
28	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	20	SENT_282	[p7l926t734r1217b772],
29	and	CC	O	and	_	0	SENT_282	[p7l1230t734r1289b763],
30	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	20	SENT_282	[p7l1300t734r1630b772],
31	.	.	O	.	_	0	SENT_282	[p7l1300t734r1630b772],

1	Tissues	NNS	O	tissue	nsubj	6	SENT_283	[p7l586t784r707b813],
2	studied	VBN	O	study	partmod	1	SENT_283	[p7l719t784r837b813],
3	so	RB	O	so	advmod	4	SENT_283	[p7l847t793r881b813],
4	far	RB	O	far	advmod	2	SENT_283	[p7l891t784r936b813],
5	have	VBP	O	have	aux	6	SENT_283	[p7l945t784r1021b813],
6	shown	VBN	O	show	_	0	SENT_283	[p7l1032t784r1137b813],
7	an	DT	O	a	det	9	SENT_283	[p7l1147t793r1184b813],
8	average	JJ	O	average	amod	9	SENT_283	[p7l1194t793r1320b821],
9	eight	CD	NUMBER	eight	dobj	6	SENT_283	[p7l1330t784r1424b821],
10	-	:	O	-	_	0	SENT_283	[p7l1330t784r1424b821],
11	to	TO	O	to	_	0	SENT_283	[p7l1434t788r1465b813],
12	tenfold	RB	O	tenfold	advmod	13	SENT_283	[p7l1475t784r1592b813],
13	difference	NN	O	difference	prep_to	6	SENT_283	[p7l1601t784r1767b813],
14	in	IN	O	in	_	0	SENT_283	[p7l1776t784r1808b812],
15	Pgp	NN	O	pgp	nn	16	SENT_283	[p7l1817t784r1880b821],
16	expression	NN	O	expression	prep_in	13	SENT_283	[p7l537t833r721b871],
17	.	.	O	.	_	0	SENT_283	[p7l537t833r721b871],

1	The	DT	O	the	det	5	SENT_284	[p7l735t833r798b862],
2	3435CC	NN	O	3435cc	nn	5	SENT_284	[p7l812t833r948b862],
3	and	CC	O	and	_	0	SENT_284	[p7l962t833r1020b862],
4	3435TT	NN	O	3435tt	conj_and	2	SENT_284	[p7l1034t833r1165b862],
5	genotypes	NNS	O	genotype	nsubj	6	SENT_284	[p7l1178t838r1344b871],
6	show	VBP	O	show	_	0	SENT_284	[p7l1359t833r1442b862],
7	a	DT	O	a	det	8	SENT_284	[p7l1456t842r1473b862],
8	two	CD	NUMBER	two	dep	6	SENT_284	[p7l1485t837r1559b862],
9	-	:	O	-	_	0	SENT_284	[p7l1485t837r1559b862],
10	to	TO	O	to	dep	8	SENT_284	[p7l1572t838r1603b862],
11	threefold	RB	O	threefold	advmod	12	SENT_284	[p7l1616t833r1765b862],
12	difference	NN	O	difference	pobj	10	SENT_284	[p7l1778t833r1879b862, p7l537t892r611b912],
13	in	IN	O	in	_	0	SENT_284	[p7l622t883r653b912],
14	Pgp	NN	O	pgp	nn	15	SENT_284	[p7l663t884r727b921],
15	expression	NN	O	expression	prep_in	12	SENT_284	[p7l738t883r913b921],
16	in	IN	O	in	_	0	SENT_284	[p7l924t883r955b912],
17	duodenum	NN	O	duodenum	prep_in	6	SENT_284	[p7l966t883r1148b917],
18	,	,	O	,	_	0	SENT_284	[p7l966t883r1148b917],
19	kidney	NN	O	kidney	prep_in	6	SENT_284	[p7l1160t883r1278b921],
20	,	,	O	,	_	0	SENT_284	[p7l1160t883r1278b921],
21	peripheral	JJ	O	peripheral	amod	22	SENT_284	[p7l1289t883r1457b921],
22	leukocytes	NNS	O	leukocyte	prep_in	6	SENT_284	[p7l1467t883r1652b921],
23	,	,	O	,	_	0	SENT_284	[p7l1467t883r1652b921],
24	and	CC	O	and	_	0	SENT_284	[p7l1664t883r1723b912],
25	placenta	NN	O	placenta	conj_and	17	SENT_284	[p7l1732t883r1879b921],
26	,	,	O	,	_	0	SENT_284	[p7l1732t883r1879b921],
27	with	IN	O	with	mark	29	SENT_284	[p7l537t933r609b962],
28	substantial	JJ	O	substantial	nsubj	29	SENT_284	[p7l626t933r801b962],
29	overlap	VBP	O	overlap	advcl	6	SENT_284	[p7l818t933r939b970],
30	between	IN	O	between	_	0	SENT_284	[p7l955t933r1093b962],
31	genotypes	NNS	O	genotype	prep_between	29	SENT_284	[p7l1109t937r1284b970],
32	.	.	O	.	_	0	SENT_284	[p7l1109t937r1284b970],

1	This	DT	O	this	det	3	SENT_285	[p7l1302t933r1374b962],
2	modest	JJ	O	modest	amod	3	SENT_285	[p7l1391t933r1510b962],
3	difference	NN	O	difference	nsubj	4	SENT_285	[p7l1526t933r1691b962],
4	suggests	VBZ	O	suggest	_	0	SENT_285	[p7l1709t937r1846b970],
5	a	DT	O	a	det	7	SENT_285	[p7l1864t942r1881b962],
6	moderate	JJ	O	moderate	amod	7	SENT_285	[p7l536t983r690b1012],
7	impact	NN	O	impact	dobj	4	SENT_285	[p7l704t982r817b1020],
8	of	IN	O	of	_	0	SENT_285	[p7l831t982r866b1012],
9	the	DT	O	the	det	11	SENT_285	[p7l878t983r927b1012],
10	ABCBI	NN	O	abcbus	nn	11	SENT_285	[p7l938t983r1062b1012],
11	genotypes	NNS	O	genotype	prep_of	7	SENT_285	[p7l1079t987r1245b1020],
12	on	IN	O	on	_	0	SENT_285	[p7l1261t992r1301b1012],
13	the	DT	O	the	det	14	SENT_285	[p7l1315t983r1364b1012],
14	disposition	NN	O	disposition	prep_on	11	SENT_285	[p7l1379t982r1560b1020],
15	and	CC	O	and	_	0	SENT_285	[p7l1575t982r1633b1012],
16	effects	NNS	O	effect	conj_and	11	SENT_285	[p7l1647t982r1754b1012],
17	of	IN	O	of	_	0	SENT_285	[p7l1770t982r1806b1012],
18	Pgp	NNP	O	Pgp	nn	19	SENT_285	[p7l1817t983r1880b1020],
19	substrates	NNS	O	substrate	prep_of	16	SENT_285	[p7l538t1032r709b1067],
20	;	:	O	;	_	0	SENT_285	[p7l538t1032r709b1067],
21	nongenetic	JJ	O	nongenetic	amod	22	SENT_285	[p7l724t1032r904b1070],
22	factors	NNS	O	factor	nsubj	24	SENT_285	[p7l918t1032r1029b1061],
23	probably	RB	O	probably	advmod	24	SENT_285	[p7l1042t1032r1189b1070],
24	play	VBP	O	play	parataxis	4	SENT_285	[p7l1202t1032r1273b1070],
25	an	DT	O	a	det	27	SENT_285	[p7l1287t1041r1324b1061],
26	important	JJ	O	important	amod	27	SENT_285	[p7l1337t1032r1498b1070],
27	role	NN	O	role	dobj	24	SENT_285	[p7l1510t1032r1574b1061],
28	in	IN	O	in	_	0	SENT_285	[p7l1587t1032r1619b1061],
29	modifying	VBG	O	modify	prepc_in	24	SENT_285	[p7l1632t1032r1803b1070],
30	Pgp	NN	O	pgp	nn	31	SENT_285	[p7l1817t1033r1880b1070],
31	expression	NN	O	expression	dobj	29	SENT_285	[p7l537t1082r721b1120],
32	.	.	O	.	_	0	SENT_285	[p7l537t1082r721b1120],

1	Differences	NNS	O	difference	nsubjpass	28	SENT_286	[p7l735t1082r926b1111],
2	of	IN	O	of	_	0	SENT_286	[p7l940t1082r976b1111],
3	~	NN	O	~	prep_of	1	SENT_286	[p7l987t1082r1057b1111],
4	25	CD	PERCENT	25	number	5	SENT_286	[p7l987t1082r1057b1111],
5	%	NN	PERCENT	%	amod	3	SENT_286	[p7l1062t1082r1188b1111],
6	-35	CD	PERCENT	-35	num	7	SENT_286	[p7l1062t1082r1188b1111],
7	%	NN	PERCENT	%	dep	3	SENT_286	[p7l1062t1082r1188b1111],
8	in	IN	O	in	_	0	SENT_286	[p7l1203t1082r1234b1111],
9	the	DT	O	the	det	10	SENT_286	[p7l1247t1082r1296b1111],
10	bioavailability	NN	O	bioavailability	prep_in	7	SENT_286	[p7l1308t1082r1546b1120],
11	and	CC	O	and	_	0	SENT_286	[p7l1559t1082r1618b1111],
12	renal	JJ	O	renal	amod	13	SENT_286	[p7l1630t1082r1712b1111],
13	clearance	NN	O	clearance	conj_and	3	SENT_286	[p7l1725t1082r1880b1111],
14	of	IN	O	of	_	0	SENT_286	[p7l537t1132r573b1161],
15	digoxin	NN	O	digoxin	prep_of	13	SENT_286	[p7l582t1132r707b1170],
16	in	IN	O	in	_	0	SENT_286	[p7l718t1132r749b1161],
17	relation	NN	O	relation	prep_in	15	SENT_286	[p7l760t1132r886b1161],
18	to	TO	O	to	_	0	SENT_286	[p7l898t1136r928b1161],
19	the	DT	O	the	det	20	SENT_286	[p7l940t1132r989b1161],
20	exon	NN	O	exon	prep_to	17	SENT_286	[p7l1001t1141r1080b1161],
21	21	CD	NUMBER	21	num	20	SENT_286	[p7l1092t1132r1128b1161],
22	or	CC	O	or	_	0	SENT_286	[p7l1143t1141r1177b1161],
23	exon	NN	O	exon	prep_in	15	SENT_286	[p7l1188t1141r1266b1161],
24	26	CD	NUMBER	26	num	25	SENT_286	[p7l1278t1132r1318b1161],
25	SNP	NN	ORGANIZATION	snp	dep	23	SENT_286	[p7l1330t1132r1405b1161],
26	have	VBP	O	have	aux	28	SENT_286	[p7l1415t1132r1491b1161],
27	been	VBN	O	be	auxpass	28	SENT_286	[p7l1502t1132r1580b1161],
28	reported	VBN	O	report	_	0	SENT_286	[p7l1591t1132r1729b1170],
29	(	CD	NUMBER	(	num	31	SENT_286	[p7l1741t1132r1878b1168],
30	79-82	CD	NUMBER	79-82	num	31	SENT_286	[p7l1741t1132r1878b1168],
31	)	NN	O	)	dobj	28	SENT_286	[p7l1741t1132r1878b1168],
32	.	.	O	.	_	0	SENT_286	[p7l1741t1132r1878b1168],

1	Several	JJ	O	several	amod	2	SENT_287	[p7l587t1182r708b1211],
2	studies	NNS	O	study	nsubj	4	SENT_287	[p7l720t1182r832b1211],
3	have	VBP	O	have	aux	4	SENT_287	[p7l844t1182r920b1211],
4	addressed	VBN	O	address	_	0	SENT_287	[p7l932t1182r1094b1211],
5	the	DT	O	the	det	6	SENT_287	[p7l1105t1182r1154b1211],
6	relevance	NN	O	relevance	dobj	4	SENT_287	[p7l1165t1182r1321b1211],
7	of	IN	O	of	_	0	SENT_287	[p7l1333t1182r1368b1211],
8	ABCBI	NNP	ORGANIZATION	ABCBI	nn	9	SENT_287	[p7l1374t1182r1497b1211],
9	polymorphism	NN	O	polymorphism	prep_of	6	SENT_287	[p7l1511t1182r1753b1219],
10	to	TO	O	to	_	0	SENT_287	[p7l1763t1186r1794b1211],
11	dose	NN	O	dose	nn	12	SENT_287	[p7l1806t1182r1880b1211],
12	requirements	NNS	O	requirement	prep_to	4	SENT_287	[p7l536t1232r761b1269],
13	,	,	O	,	_	0	SENT_287	[p7l536t1232r761b1269],
14	blood	NN	O	blood	nn	15	SENT_287	[p7l772t1232r866b1261],
15	concentrations	NNS	O	concentration	conj_and	12	SENT_287	[p7l877t1232r1126b1266],
16	,	,	O	,	_	0	SENT_287	[p7l877t1232r1126b1266],
17	chronic	JJ	O	chronic	amod	18	SENT_287	[p7l1138t1232r1261b1261],
18	rejection	NN	O	rejection	conj_and	12	SENT_287	[p7l1271t1232r1425b1269],
19	,	,	O	,	_	0	SENT_287	[p7l1271t1232r1425b1269],
20	and	CC	O	and	_	0	SENT_287	[p7l1437t1232r1496b1261],
21	chronic	JJ	O	chronic	amod	22	SENT_287	[p7l1506t1232r1628b1261],
22	nephrotoxicity	NN	O	nephrotoxicity	conj_and	12	SENT_287	[p7l1639t1232r1880b1269],
23	in	IN	O	in	_	0	SENT_287	[p7l536t1281r568b1310],
24	renal	JJ	O	renal	amod	26	SENT_287	[p7l577t1281r659b1311],
25	transplant	NN	O	transplant	nn	26	SENT_287	[p7l669t1281r833b1319],
26	patients	NNS	O	patient	prep_in	4	SENT_287	[p7l841t1281r969b1319],
27	receiving	VBG	O	receive	partmod	26	SENT_287	[p7l979t1281r1132b1319],
28	the	DT	O	the	det	32	SENT_287	[p7l1142t1282r1191b1310],
29	calcineurin	NN	O	calcineurin	nn	32	SENT_287	[p7l1202t1281r1385b1311],
30	inhibitors	NNS	O	inhibitor	nn	32	SENT_287	[p7l1395t1281r1552b1311],
31	cyclosporine	NN	O	cyclosporine	nn	32	SENT_287	[p7l1563t1281r1773b1319],
32	A	NN	O	a	dobj	27	SENT_287	[p7l1783t1282r1812b1310],
33	and	CC	O	and	_	0	SENT_287	[p7l1822t1281r1881b1311],
34	tacrolimus	NN	O	tacrolimus	conj_and	32	SENT_287	[p7l536t1331r719b1360],
35	.	.	O	.	_	0	SENT_287	[p7l536t1331r719b1360],

1	Animal	NN	O	animal	nn	2	SENT_288	[p7l732t1331r855b1360],
2	studies	NNS	O	study	nsubj	4	SENT_288	[p7l868t1331r980b1360],
3	have	VBP	O	have	aux	4	SENT_288	[p7l991t1331r1067b1360],
4	linked	VBN	O	link	_	0	SENT_288	[p7l1079t1331r1181b1360],
5	low	JJ	O	low	amod	6	SENT_288	[p7l1192t1331r1251b1360],
6	expression	NN	O	expression	dobj	4	SENT_288	[p7l1263t1331r1438b1368],
7	of	IN	O	of	_	0	SENT_288	[p7l1450t1331r1486b1360],
8	Pgp	NNP	ORGANIZATION	Pgp	prep_of	6	SENT_288	[p7l1494t1331r1557b1368],
9	in	IN	O	in	_	0	SENT_288	[p7l1568t1331r1600b1359],
10	renal	JJ	O	renal	amod	11	SENT_288	[p7l1610t1331r1692b1360],
11	tissue	NN	O	tissue	prep_in	4	SENT_288	[p7l1703t1331r1796b1360],
12	with	IN	O	with	_	0	SENT_288	[p7l1808t1331r1880b1360],
13	chronic	JJ	O	chronic	amod	15	SENT_288	[p7l537t1380r659b1410],
14	cyclosporine	NN	O	cyclosporine	nn	15	SENT_288	[p7l675t1380r885b1418],
15	nephrotoxicity	NN	O	nephrotoxicity	prep_with	4	SENT_288	[p7l899t1380r1146b1418],
16	.	.	O	.	_	0	SENT_288	[p7l899t1380r1146b1418],

1	Published	VBN	O	publish	csubj	8	SENT_289	[p7l1162t1380r1325b1410],
2	data	NNS	O	datum	dobj	1	SENT_289	[p7l1340t1381r1408b1410],
3	on	IN	O	on	_	0	SENT_289	[p7l1423t1390r1463b1410],
4	other	JJ	O	other	amod	6	SENT_289	[p7l1478t1381r1562b1410],
5	Pgp	NNP	O	Pgp	nn	6	SENT_289	[p7l1576t1381r1639b1418],
6	substrates	NNS	O	substrate	prep_on	2	SENT_289	[p7l1655t1381r1815b1410],
7	are	VBP	O	be	cop	8	SENT_289	[p7l1832t1390r1880b1410],
8	controversial	JJ	O	controversial	dep	20	SENT_289	[p7l537t1430r761b1464],
9	;	:	O	;	_	0	SENT_289	[p7l537t1430r761b1464],
10	no	DT	O	no	det	12	SENT_289	[p7l775t1439r815b1459],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_289	[p7l829t1430r1001b1468],
12	differences	NNS	O	difference	nsubjpass	14	SENT_289	[p7l1013t1430r1194b1459],
13	were	VBD	O	be	auxpass	14	SENT_289	[p7l1208t1439r1287b1459],
14	observed	VBN	O	observe	parataxis	8	SENT_289	[p7l1300t1430r1448b1459],
15	for	IN	O	for	_	0	SENT_289	[p7l1460t1430r1508b1459],
16	any	DT	O	any	prep_for	14	SENT_289	[p7l1521t1439r1578b1468],
17	of	IN	O	of	_	0	SENT_289	[p7l1592t1430r1627b1459],
18	the	DT	O	the	det	19	SENT_289	[p7l1637t1430r1686b1459],
19	parameters	NNS	O	parameter	prep_of	16	SENT_289	[p7l1699t1434r1879b1468],
20	investigated	VBD	O	investigate	_	0	SENT_289	[p7l537t1480r734b1518],
21	(	CD	NUMBER	(	dobj	20	SENT_289	[p7l746t1480r884b1516],
22	83-85	CD	NUMBER	83-85	num	23	SENT_289	[p7l746t1480r884b1516],
23	)	NN	O	)	nsubj	20	SENT_289	[p7l746t1480r884b1516],
24	.	.	O	.	_	0	SENT_289	[p7l746t1480r884b1516],

1	These	DT	O	these	det	2	SENT_290	[p7l897t1480r995b1509],
2	studies	NNS	O	study	nsubj	8	SENT_290	[p7l1008t1480r1130b1514],
3	,	,	O	,	_	0	SENT_290	[p7l1008t1480r1130b1514],
4	however	RB	O	however	advmod	8	SENT_290	[p7l1143t1480r1289b1514],
5	,	,	O	,	_	0	SENT_290	[p7l1143t1480r1289b1514],
6	did	VBD	O	do	aux	8	SENT_290	[p7l1302t1480r1354b1509],
7	not	RB	O	not	neg	8	SENT_290	[p7l1365t1484r1418b1509],
8	consider	VB	O	consider	_	0	SENT_290	[p7l1429t1480r1569b1509],
9	discordance	NN	O	discordance	dobj	8	SENT_290	[p7l1580t1480r1776b1509],
10	in	IN	O	in	_	0	SENT_290	[p7l1788t1480r1819b1509],
11	the	DT	O	the	det	12	SENT_290	[p7l1831t1480r1880b1509],
12	genotypes	NNS	O	genotype	prep_in	8	SENT_290	[p7l537t1534r703b1568],
13	of	IN	O	of	_	0	SENT_290	[p7l718t1530r754b1559],
14	the	DT	O	the	det	15	SENT_290	[p7l765t1530r814b1559],
15	organ	NN	O	organ	prep_of	12	SENT_290	[p7l829t1539r921b1568],
16	recipient	JJ	O	recipient	amod	15	SENT_290	[p7l934t1530r1079b1568],
17	and	CC	O	and	_	0	SENT_290	[p7l1093t1530r1151b1559],
18	donor	NN	O	donor	prep_of	12	SENT_290	[p7l1165t1530r1266b1559],
19	.	.	O	.	_	0	SENT_290	[p7l1165t1530r1266b1559],

1	Indeed	RB	O	indeed	advmod	20	SENT_291	[p7l1282t1530r1403b1564],
2	,	,	O	,	_	0	SENT_291	[p7l1282t1530r1403b1564],
3	the	DT	O	the	det	5	SENT_291	[p7l1418t1530r1468b1559],
4	ABCBI	NNP	O	ABCBI	nn	5	SENT_291	[p7l1479t1530r1602b1559],
5	genotype	NN	O	genotype	nsubj	20	SENT_291	[p7l1619t1534r1769b1568],
6	of	IN	O	of	_	0	SENT_291	[p7l1784t1530r1820b1559],
7	the	DT	O	the	det	8	SENT_291	[p7l1831t1530r1880b1559],
8	donor	NN	O	donor	prep_of	5	SENT_291	[p7l537t1580r639b1614],
9	,	,	O	,	_	0	SENT_291	[p7l537t1580r639b1614],
10	but	CC	O	but	_	0	SENT_291	[p7l655t1580r707b1609],
11	not	RB	O	not	_	0	SENT_291	[p7l720t1584r773b1609],
12	the	DT	O	the	det	13	SENT_291	[p7l786t1580r836b1609],
13	recipient	JJ	O	recipient	conj_negcc	5	SENT_291	[p7l850t1580r1003b1617],
14	,	,	O	,	_	0	SENT_291	[p7l850t1580r1003b1617],
15	may	MD	O	may	aux	20	SENT_291	[p7l1019t1589r1089b1617],
16	be	VB	O	be	cop	20	SENT_291	[p7l1103t1580r1141b1609],
17	a	DT	O	a	det	20	SENT_291	[p7l1156t1589r1174b1609],
18	major	JJ	O	major	amod	20	SENT_291	[p7l1187t1580r1284b1617],
19	risk	NN	O	risk	nn	20	SENT_291	[p7l1297t1580r1359b1609],
20	factor	NN	O	factor	_	0	SENT_291	[p7l1372t1580r1468b1609],
21	for	IN	O	for	_	0	SENT_291	[p7l1482t1580r1530b1609],
22	cyclosporine	NN	O	cyclosporine	nn	23	SENT_291	[p7l1544t1580r1881b1617],
23	—	NN	O	—	prep_for	20	SENT_291	[p7l1544t1580r1881b1617],
24	related	JJ	O	related	amod	26	SENT_291	[p7l1544t1580r1881b1617],
25	chronic	JJ	O	chronic	amod	26	SENT_291	[p7l537t1630r659b1659],
26	nephrotoxicity	NN	O	nephrotoxicity	nsubj	32	SENT_291	[p7l670t1630r910b1667],
27	in	IN	O	in	_	0	SENT_291	[p7l920t1630r951b1658],
28	recipients	NNS	O	recipient	prep_in	26	SENT_291	[p7l960t1630r1120b1667],
29	of	IN	O	of	_	0	SENT_291	[p7l1131t1630r1167b1659],
30	renal	JJ	O	renal	amod	31	SENT_291	[p7l1173t1630r1256b1659],
31	transplants	NNS	O	transplant	prep_of	28	SENT_291	[p7l1265t1630r1443b1667],
32	(	VBP	O	(	rcmod	20	SENT_291	[p7l1455t1629r1530b1665],
33	86	CD	NUMBER	86	number	34	SENT_291	[p7l1455t1629r1530b1665],
34	)	CD	NUMBER	)	dobj	32	SENT_291	[p7l1455t1629r1530b1665],
35	.	.	O	.	_	0	SENT_291	[p7l1455t1629r1530b1665],

1	The	DT	O	the	det	4	SENT_292	[p7l1542t1630r1605b1659],
2	ABCBI	NNP	O	ABCBI	nn	4	SENT_292	[p7l1612t1630r1735b1659],
3	3435TT	NNP	O	3435TT	nn	4	SENT_292	[p7l1749t1630r1880b1659],
4	genotype	NN	O	genotype	dep	20	SENT_292	[p7l537t1683r696b1717],
5	,	,	O	,	_	0	SENT_292	[p7l537t1683r696b1717],
6	which	WDT	O	which	nsubjpass	8	SENT_292	[p7l714t1679r814b1708],
7	is	VBZ	O	be	auxpass	8	SENT_292	[p7l829t1679r855b1708],
8	associated	VBN	O	associate	rcmod	4	SENT_292	[p7l872t1679r1041b1708],
9	with	IN	O	with	_	0	SENT_292	[p7l1057t1679r1129b1708],
10	lower	JJR	O	lower	amod	12	SENT_292	[p7l1145t1679r1238b1709],
11	Pgp	NN	O	pgp	nn	12	SENT_292	[p7l1253t1680r1316b1717],
12	expression	NN	O	expression	prep_with	8	SENT_292	[p7l1332t1679r1508b1717],
13	in	IN	O	in	_	0	SENT_292	[p7l1523t1679r1554b1708],
14	renal	JJ	O	renal	amod	16	SENT_292	[p7l1569t1679r1651b1708],
15	parenchymal	JJ	O	parenchymal	amod	16	SENT_292	[p7l1667t1679r1880b1717],
16	cells	NNS	O	cell	prep_in	12	SENT_292	[p7l537t1728r620b1763],
17	,	,	O	,	_	0	SENT_292	[p7l537t1728r620b1763],
18	is	VBZ	O	be	auxpass	20	SENT_292	[p7l639t1728r664b1757],
19	strongly	RB	O	strongly	advmod	20	SENT_292	[p7l684t1728r817b1766],
20	associated	VBN	O	associate	_	0	SENT_292	[p7l835t1728r1004b1757],
21	with	IN	O	with	_	0	SENT_292	[p7l1021t1728r1093b1757],
22	cyclosporine	NN	O	cyclosporine	nn	23	SENT_292	[p7l1110t1728r1320b1766],
23	nephrotoxicity	NN	O	nephrotoxicity	prep_with	20	SENT_292	[p7l1337t1728r1578b1766],
24	(	CD	NUMBER	(	num	25	SENT_292	[p7l1596t1728r1685b1764],
25	odds	NNS	O	odds	tmod	20	SENT_292	[p7l1596t1728r1685b1764],
26	ratio	NN	O	ratio	dep	25	SENT_292	[p7l1703t1728r1778b1757],
27	13.4	CD	NUMBER	13.4	num	26	SENT_292	[p7l1799t1728r1879b1764],
28	)	CD	NUMBER	)	num	31	SENT_292	[p7l1799t1728r1879b1764],
29	(	NN	O	(	nn	31	SENT_292	[p7l538t1777r613b1813],
30	86	CD	NUMBER	86	num	31	SENT_292	[p7l538t1777r613b1813],
31	)	NN	O	)	nsubjpass	20	SENT_292	[p7l538t1777r613b1813],
32	.	.	O	.	_	0	SENT_292	[p7l538t1777r613b1813],

1	Because	IN	O	because	mark	10	SENT_293	[p7l586t1827r723b1855],
2	all	DT	O	all	nsubj	10	SENT_293	[p7l737t1826r776b1855],
3	currently	RB	DATE	currently	advmod	4	SENT_293	[p7l789t1826r937b1864],
4	used	VBN	O	use	partmod	2	SENT_293	[p7l950t1826r1025b1855],
5	HIV	NN	MISC	hiv	nn	7	SENT_293	[p7l1038t1827r1110b1855],
6	protease	NN	O	protease	nn	7	SENT_293	[p7l1122t1830r1260b1864],
7	inhibitors	NNS	O	inhibitor	dobj	4	SENT_293	[p7l1272t1826r1429b1855],
8	are	VBP	O	be	cop	10	SENT_293	[p7l1444t1835r1492b1855],
9	Pgp	NNP	O	Pgp	nn	10	SENT_293	[p7l1505t1827r1568b1864],
10	substrates	NNS	O	substrate	advcl	14	SENT_293	[p7l1582t1826r1752b1861],
11	,	,	O	,	_	0	SENT_293	[p7l1582t1826r1752b1861],
12	studies	NNS	O	study	nsubj	14	SENT_293	[p7l1768t1826r1879b1855],
13	have	VBP	O	have	aux	14	SENT_293	[p7l536t1875r612b1904],
14	focused	VBN	O	focus	_	0	SENT_293	[p7l623t1875r752b1904],
15	on	IN	O	on	_	0	SENT_293	[p7l763t1884r803b1904],
16	whether	IN	O	whether	complm	24	SENT_293	[p7l814t1875r947b1904],
17	differences	NNS	O	difference	nsubj	24	SENT_293	[p7l958t1875r1139b1904],
18	in	IN	O	in	_	0	SENT_293	[p7l1151t1875r1182b1904],
19	the	DT	O	the	det	20	SENT_293	[p7l1193t1875r1243b1904],
20	expression	NN	O	expression	prep_in	17	SENT_293	[p7l1254t1875r1430b1913],
21	of	IN	O	of	_	0	SENT_293	[p7l1441t1875r1477b1904],
22	Pgp	NNP	ORGANIZATION	Pgp	prep_of	20	SENT_293	[p7l1485t1876r1549b1913],
23	could	MD	O	could	aux	24	SENT_293	[p7l1560t1875r1652b1904],
24	explain	VB	O	explain	prepc_on	14	SENT_293	[p7l1663t1875r1783b1913],
25	some	DT	O	some	dobj	24	SENT_293	[p7l1795t1884r1880b1904],
26	of	IN	O	of	_	0	SENT_293	[p7l537t1924r573b1953],
27	the	DT	O	the	det	28	SENT_293	[p7l584t1924r633b1953],
28	variability	NN	O	variability	prep_of	25	SENT_293	[p7l647t1924r815b1962],
29	observed	VBN	O	observe	partmod	28	SENT_293	[p7l830t1924r978b1953],
30	in	IN	O	in	_	0	SENT_293	[p7l991t1924r1022b1953],
31	CD4	NN	O	cd4	nn	33	SENT_293	[p7l1036t1924r1113b1954],
32	cell	NN	O	cell	nn	33	SENT_293	[p7l1127t1924r1186b1953],
33	recovery	NN	O	recovery	prep_in	29	SENT_293	[p7l1199t1933r1342b1962],
34	(	CD	NUMBER	(	num	36	SENT_293	[p7l1357t1924r1495b1960],
35	87-90	CD	NUMBER	87-90	num	36	SENT_293	[p7l1357t1924r1495b1960],
36	)	NN	O	)	dep	33	SENT_293	[p7l1357t1924r1495b1960],
37	.	.	O	.	_	0	SENT_293	[p7l1357t1924r1495b1960],

1	CD4	NN	O	cd4	nn	2	SENT_294	[p7l1511t1924r1588b1954],
2	cells	NNS	O	cell	nsubj	6	SENT_294	[p7l1602t1924r1676b1953],
3	are	VBP	O	be	cop	6	SENT_294	[p7l1691t1933r1740b1953],
4	a	DT	O	a	det	6	SENT_294	[p7l1754t1933r1772b1953],
5	major	JJ	O	major	amod	6	SENT_294	[p7l1785t1924r1881b1962],
6	target	NN	O	target	_	0	SENT_294	[p7l537t1978r630b2011],
7	of	IN	O	of	_	0	SENT_294	[p7l645t1973r681b2002],
8	HIV	NN	O	hiv	prep_of	6	SENT_294	[p7l694t1974r769b2002],
9	.	.	O	.	_	0	SENT_294	[p7l694t1974r769b2002],

1	Variability	NN	O	variability	nsubj	9	SENT_295	[p7l787t1973r961b2011],
2	of	IN	O	of	_	0	SENT_295	[p7l977t1973r1013b2002],
3	Pgp	NN	O	pgp	nn	4	SENT_295	[p7l1026t1974r1089b2011],
4	expression	NN	O	expression	prep_of	1	SENT_295	[p7l1105t1973r1281b2011],
5	in	IN	O	in	_	0	SENT_295	[p7l1296t1973r1328b2002],
6	CD4	NN	O	cd4	nn	7	SENT_295	[p7l1344t1973r1420b2002],
7	subpopulations	NNS	O	subpopulation	prep_in	4	SENT_295	[p7l1438t1973r1686b2011],
8	may	MD	O	may	aux	9	SENT_295	[p7l1702t1982r1772b2011],
9	affect	VB	O	affect	_	0	SENT_295	[p7l1789t1973r1881b2002],
10	intracellular	JJ	O	intracellular	amod	11	SENT_295	[p7l536t2022r737b2051],
11	concentrations	NNS	O	concentration	dobj	9	SENT_295	[p7l748t2022r988b2051],
12	of	IN	O	of	_	0	SENT_295	[p7l1000t2022r1036b2051],
13	HIV	NN	MISC	hiv	nn	15	SENT_295	[p7l1045t2023r1117b2051],
14	protease	NN	O	protease	nn	15	SENT_295	[p7l1129t2027r1266b2060],
15	inhibitors	NNS	O	inhibitor	prep_of	11	SENT_295	[p7l1278t2022r1435b2051],
16	and	CC	O	and	_	0	SENT_295	[p7l1448t2022r1507b2051],
17	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_295	[p7l1518t2022r1732b2051],
18	efﬁcacy	NN	O	efﬁcacy	prep_of	11	SENT_295	[p7l1744t2022r1878b2060],
19	.	.	O	.	_	0	SENT_295	[p7l1744t2022r1878b2060],

1	Indeed	RB	O	indeed	advmod	6	SENT_296	[p7l537t2071r657b2106],
2	,	,	O	,	_	0	SENT_296	[p7l537t2071r657b2106],
3	a	DT	O	a	det	5	SENT_296	[p7l670t2080r687b2100],
4	recent	JJ	O	recent	amod	5	SENT_296	[p7l696t2076r797b2100],
5	study	NN	O	study	nsubj	6	SENT_296	[p7l809t2071r896b2109],
6	showed	VBD	O	show	_	0	SENT_296	[p7l908t2071r1031b2101],
7	that	IN	O	that	complm	13	SENT_296	[p7l1041t2071r1103b2100],
8	six	CD	DURATION	six	num	9	SENT_296	[p7l1114t2071r1160b2100],
9	months	NNS	NUMBER	month	nsubj	13	SENT_296	[p7l1170t2071r1290b2100],
10	after	IN	O	after	_	0	SENT_296	[p7l1302t2071r1377b2100],
11	antiretroviral	JJ	O	antiretroviral	amod	12	SENT_296	[p7l1388t2071r1602b2100],
12	therapy	NN	O	therapy	prep_after	9	SENT_296	[p7l1612t2071r1735b2109],
13	began	VBD	O	begin	ccomp	6	SENT_296	[p7l1745t2071r1851b2109],
14	,	,	O	,	_	0	SENT_296	[p7l1745t2071r1851b2109],
15	a	DT	O	a	det	18	SENT_296	[p7l1864t2080r1881b2100],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_296	[p7l538t2120r740b2158],
17	greater	JJR	O	greater	amod	18	SENT_296	[p7l753t2125r868b2158],
18	increase	NN	O	increase	dobj	13	SENT_296	[p7l879t2120r1014b2149],
19	in	IN	O	in	_	0	SENT_296	[p7l1026t2120r1058b2149],
20	CD4	NN	O	cd4	nn	22	SENT_296	[p7l1070t2120r1147b2149],
21	cell	NN	O	cell	nn	22	SENT_296	[p7l1160t2120r1218b2149],
22	count	NN	O	count	prep_in	18	SENT_296	[p7l1231t2125r1322b2149],
23	and	CC	O	and	_	0	SENT_296	[p7l1335t2120r1394b2149],
24	a	DT	O	a	det	28	SENT_296	[p7l1406t2129r1423b2149],
25	more	RBR	O	more	advmod	26	SENT_296	[p7l1435t2129r1519b2149],
26	pronounced	JJ	O	pronounced	amod	28	SENT_296	[p7l1531t2120r1727b2158],
27	decrease	NN	O	decrease	nn	28	SENT_296	[p7l1739t2120r1880b2149],
28	PHARMACOGENOMICS	NN	O	pharmacogenomic	dobj	13	SENT_296	[p7l1335t2181r1738b2208],
29	129	CD	NUMBER	129	dep	28	SENT_296	[p7l1830t2178r1889b2208],

1	in	IN	O	in	_	0	SENT_297	[p7l545t2304r577b2333],
2	viral	JJ	O	viral	amod	3	SENT_297	[p7l587t2304r662b2334],
3	load	NN	O	load	prep_in	4	SENT_297	[p7l673t2304r743b2334],
4	occurred	VBD	O	occur	_	0	SENT_297	[p7l754t2304r898b2334],
5	in	IN	O	in	_	0	SENT_297	[p7l908t2304r939b2333],
6	patients	NNS	O	patient	prep_in	4	SENT_297	[p7l949t2304r1077b2342],
7	with	IN	O	with	_	0	SENT_297	[p7l1089t2304r1161b2334],
8	the	DT	O	the	det	10	SENT_297	[p7l1172t2304r1221b2334],
9	3435TT	NNP	O	3435TT	nn	10	SENT_297	[p7l1233t2304r1365b2334],
10	genotype	NN	O	genotype	prep_with	6	SENT_297	[p7l1376t2309r1526b2342],
11	than	IN	O	than	dep	4	SENT_297	[p7l1537t2304r1607b2334],
12	in	IN	O	in	_	0	SENT_297	[p7l1618t2304r1649b2333],
13	those	DT	O	those	prep_in	4	SENT_297	[p7l1659t2304r1746b2334],
14	with	IN	O	with	_	0	SENT_297	[p7l1757t2304r1830b2334],
15	the	DT	O	the	det	19	SENT_297	[p7l1840t2304r1889b2334],
16	3435CT	NN	O	3435ct	nn	19	SENT_297	[p7l546t2354r680b2384],
17	or	CC	O	or	_	0	SENT_297	[p7l688t2363r722b2383],
18	CC	NN	O	cc	nn	19	SENT_297	[p7l729t2354r782b2384],
19	genotype	NN	O	genotype	prep_with	13	SENT_297	[p7l792t2358r942b2392],
20	(	CD	NUMBER	(	num	22	SENT_297	[p7l951t2354r1027b2390],
21	91	CD	NUMBER	91	amod	22	SENT_297	[p7l951t2354r1027b2390],
22	)	NN	O	)	nsubj	4	SENT_297	[p7l951t2354r1027b2390],
23	,	,	O	,	_	0	SENT_297	[p7l951t2354r1027b2390],
24	but	CC	O	but	_	0	SENT_297	[p7l1036t2354r1088b2383],
25	these	DT	O	these	det	26	SENT_297	[p7l1095t2354r1179b2383],
26	ﬁndings	NNS	O	ﬁndings	nsubjpass	30	SENT_297	[p7l1187t2354r1319b2392],
27	have	VBP	O	have	aux	30	SENT_297	[p7l1327t2354r1403b2383],
28	not	RB	O	not	neg	30	SENT_297	[p7l1411t2359r1463b2383],
29	been	VBN	O	be	auxpass	30	SENT_297	[p7l1470t2354r1548b2383],
30	conﬁrmed	VBN	O	conﬁrmed	conj_but	4	SENT_297	[p7l1556t2354r1723b2383],
31	by	IN	O	by	_	0	SENT_297	[p7l1730t2354r1771b2392],
32	others	NNS	O	other	agent	30	SENT_297	[p7l1779t2354r1887b2383],
33	.	.	O	.	_	0	SENT_297	[p7l1779t2354r1887b2383],

1	Pgp	NNP	PERSON	Pgp	nsubj	2	SENT_298	[p7l595t2404r658b2441],
2	expressed	VBD	O	express	dep	15	SENT_298	[p7l672t2403r834b2441],
3	on	IN	O	on	_	0	SENT_298	[p7l847t2412r888b2432],
4	the	DT	O	the	det	6	SENT_298	[p7l901t2403r950b2432],
5	lurninal	JJ	O	lurninal	amod	6	SENT_298	[p7l963t2403r1089b2432],
6	side	NN	O	side	prep_on	2	SENT_298	[p7l1104t2403r1168b2432],
7	of	IN	O	of	_	0	SENT_298	[p7l1182t2403r1218b2432],
8	endothelial	JJ	O	endothelial	amod	9	SENT_298	[p7l1228t2403r1411b2432],
9	cells	NNS	O	cell	prep_of	6	SENT_298	[p7l1425t2403r1499b2432],
10	of	IN	O	of	_	0	SENT_298	[p7l1513t2403r1549b2432],
11	the	DT	O	the	det	13	SENT_298	[p7l1560t2403r1609b2432],
12	brain	NN	O	brain	nn	13	SENT_298	[p7l1622t2403r1707b2432],
13	capillaries	NNS	O	capillary	prep_of	9	SENT_298	[p7l1720t2403r1889b2441],
14	drastically	RB	O	drastically	advmod	15	SENT_298	[p7l546t2452r717b2490],
15	limits	VBZ	O	limit	_	0	SENT_298	[p7l727t2452r819b2482],
16	the	DT	O	the	det	17	SENT_298	[p7l829t2452r879b2482],
17	transfer	NN	O	transfer	dobj	15	SENT_298	[p7l889t2452r1015b2482],
18	of	IN	O	of	_	0	SENT_298	[p7l1024t2452r1060b2482],
19	many	JJ	O	many	amod	20	SENT_298	[p7l1067t2461r1157b2490],
20	drugs	NNS	O	drug	prep_of	17	SENT_298	[p7l1167t2452r1257b2490],
21	from	IN	O	from	_	0	SENT_298	[p7l1267t2452r1347b2482],
22	blood	NN	O	blood	prep_from	20	SENT_298	[p7l1356t2452r1450b2482],
23	to	TO	O	to	_	0	SENT_298	[p7l1459t2457r1490b2482],
24	brain	NN	O	brain	prep_to	22	SENT_298	[p7l1499t2452r1593b2487],
25	,	,	O	,	_	0	SENT_298	[p7l1499t2452r1593b2487],
26	as	IN	O	as	mark	27	SENT_298	[p7l1605t2461r1636b2482],
27	evidenced	VBN	O	evidence	dep	24	SENT_298	[p7l1647t2452r1813b2482],
28	by	IN	O	by	_	0	SENT_298	[p7l1822t2452r1862b2490],
29	a	DT	O	a	det	31	SENT_298	[p7l1873t2461r1890b2482],
30	huge	JJ	O	huge	amod	31	SENT_298	[p7l545t2502r625b2540],
31	increase	NN	O	increase	prep_by	27	SENT_298	[p7l634t2502r769b2531],
32	in	IN	O	in	_	0	SENT_298	[p7l779t2502r810b2531],
33	brain	NN	O	brain	prep_in	27	SENT_298	[p7l819t2502r1058b2531],
34	—	CD	NUMBER	—	num	33	SENT_298	[p7l819t2502r1058b2531],
35	to	TO	O	to	_	0	SENT_298	[p7l819t2502r1058b2531],
36	—	CD	NUMBER	—	num	38	SENT_298	[p7l819t2502r1058b2531],
37	b1ood	NN	O	b1ood	nn	38	SENT_298	[p7l819t2502r1058b2531],
38	concentration	NN	O	concentration	prep_to	27	SENT_298	[p7l1068t2502r1293b2531],
39	in	IN	O	in	_	0	SENT_298	[p7l1302t2502r1333b2531],
40	mdr1a	NN	O	mdr1a	prep_in	38	SENT_298	[p7l1343t2502r1616b2531],
41	—	CD	NUMBER	—	num	43	SENT_298	[p7l1343t2502r1616b2531],
42	knockout	JJ	O	knockout	amod	43	SENT_298	[p7l1343t2502r1616b2531],
43	mouse	NN	O	mouse	nsubj	15	SENT_298	[p7l1625t2511r1741b2531],
44	.	.	O	.	_	0	SENT_298	[p7l1625t2511r1741b2531],

1	Because	IN	O	because	_	0	SENT_299	[p7l1752t2503r1889b2531],
2	many	JJ	O	many	amod	3	SENT_299	[p7l545t2560r635b2589],
3	CNS	NNS	O	cn	prep_because	9	SENT_299	[p7l651t2551r841b2580],
4	—	RB	O	—	advmod	5	SENT_299	[p7l651t2551r841b2580],
5	active	JJ	O	active	amod	6	SENT_299	[p7l651t2551r841b2580],
6	drugs	NNS	O	drug	nsubj	9	SENT_299	[p7l856t2551r946b2589],
7	are	VBP	O	be	cop	9	SENT_299	[p7l962t2560r1010b2580],
8	Pgp	NNP	O	Pgp	nn	9	SENT_299	[p7l1025t2552r1088b2589],
9	substrates	NNS	O	substrate	ccomp	22	SENT_299	[p7l1104t2551r1274b2585],
10	,	,	O	,	_	0	SENT_299	[p7l1104t2551r1274b2585],
11	differences	NNS	O	difference	nsubj	22	SENT_299	[p7l1291t2551r1472b2580],
12	in	IN	O	in	_	0	SENT_299	[p7l1487t2551r1518b2580],
13	ABCBI	NN	O	abcbus	nn	14	SENT_299	[p7l1530t2551r1653b2581],
14	expression	NN	O	expression	prep_in	11	SENT_299	[p7l1671t2551r1846b2589],
15	at	IN	O	at	_	0	SENT_299	[p7l1861t2556r1890b2580],
16	the	DT	O	the	det	20	SENT_299	[p7l545t2600r595b2629],
17	blood	NN	O	blood	nn	20	SENT_299	[p7l612t2600r806b2629],
18	—	NN	O	—	nn	20	SENT_299	[p7l612t2600r806b2629],
19	brain	NN	O	brain	nn	20	SENT_299	[p7l612t2600r806b2629],
20	barrier	NN	O	barrier	prep_at	14	SENT_299	[p7l823t2600r934b2629],
21	could	MD	O	could	aux	22	SENT_299	[p7l952t2600r1043b2629],
22	help	VB	O	help	_	0	SENT_299	[p7l1060t2600r1130b2638],
23	explain	VB	O	explain	dep	22	SENT_299	[p7l1149t2600r1270b2638],
24	why	WRB	O	why	advmod	30	SENT_299	[p7l1288t2600r1358b2638],
25	patients	NNS	O	patient	nsubj	33	SENT_299	[p7l1375t2600r1503b2638],
26	with	IN	O	with	_	0	SENT_299	[p7l1522t2600r1595b2629],
27	identical	JJ	O	identical	amod	29	SENT_299	[p7l1613t2600r1755b2629],
28	plasma	NN	O	plasma	nn	29	SENT_299	[p7l1772t2600r1890b2638],
29	concentrations	NNS	O	concentration	prep_with	25	SENT_299	[p7l546t2649r785b2678],
30	respond	VBP	O	respond	advcl	23	SENT_299	[p7l794t2649r925b2687],
31	differently	RB	O	differently	advmod	30	SENT_299	[p7l934t2649r1106b2687],
32	and	CC	O	and	_	0	SENT_299	[p7l1116t2649r1174b2678],
33	have	VBP	O	have	conj_and	30	SENT_299	[p7l1182t2649r1258b2678],
34	different	JJ	O	different	amod	36	SENT_299	[p7l1267t2649r1408b2678],
35	side	JJ	O	side	amod	36	SENT_299	[p7l1417t2649r1481b2678],
36	effects	NNS	O	effect	dobj	33	SENT_299	[p7l1490t2649r1606b2678],
37	.	.	O	.	_	0	SENT_299	[p7l1490t2649r1606b2678],

1	In	IN	O	in	_	0	SENT_300	[p7l1617t2650r1650b2678],
2	a	DT	O	a	det	4	SENT_300	[p7l1659t2658r1677b2678],
3	recent	JJ	O	recent	amod	4	SENT_300	[p7l1684t2654r1785b2678],
4	study	NN	O	study	prep_in	26	SENT_300	[p7l1794t2649r1888b2687],
5	,	,	O	,	_	0	SENT_300	[p7l1794t2649r1888b2687],
6	25	CD	PERCENT	25	num	7	SENT_300	[p7l546t2698r618b2728],
7	%	NN	PERCENT	%	nsubj	26	SENT_300	[p7l546t2698r618b2728],
8	of	IN	O	of	_	0	SENT_300	[p7l632t2698r668b2728],
9	patients	NNS	O	patient	prep_of	7	SENT_300	[p7l676t2698r804b2736],
10	with	IN	O	with	_	0	SENT_300	[p7l817t2698r890b2728],
11	the	DT	O	the	det	12	SENT_300	[p7l901t2698r950b2728],
12	TT	NN	O	tt	prep_with	9	SENT_300	[p7l962t2699r1018b2733],
13	,	,	O	,	_	0	SENT_300	[p7l962t2699r1018b2733],
14	13.7	CD	PERCENT	13.7	num	15	SENT_300	[p7l1035t2698r1135b2728],
15	%	NN	PERCENT	%	prep_of	7	SENT_300	[p7l1035t2698r1135b2728],
16	with	IN	O	with	_	0	SENT_300	[p7l1149t2698r1222b2728],
17	the	DT	O	the	det	18	SENT_300	[p7l1233t2698r1282b2728],
18	CT	NNP	MISC	CT	prep_with	15	SENT_300	[p7l1295t2698r1352b2733],
19	,	,	O	,	_	0	SENT_300	[p7l1295t2698r1352b2733],
20	and	CC	O	and	_	0	SENT_300	[p7l1366t2698r1424b2728],
21	none	NN	O	none	prep_of	7	SENT_300	[p7l1436t2707r1515b2728],
22	with	IN	O	with	_	0	SENT_300	[p7l1527t2698r1600b2728],
23	the	DT	O	the	det	25	SENT_300	[p7l1611t2698r1661b2728],
24	CC	NN	O	cc	nn	25	SENT_300	[p7l1673t2698r1726b2728],
25	genotype	NN	O	genotype	prep_with	21	SENT_300	[p7l1739t2703r1889b2736],
26	developed	VBD	O	develop	_	0	SENT_300	[p7l546t2748r713b2786],
27	nortriptyline	NN	O	nortriptyline	nn	28	SENT_300	[p7l721t2748r1073b2786],
28	—	NN	O	—	nsubj	29	SENT_300	[p7l721t2748r1073b2786],
29	induced	VBD	O	induce	ccomp	26	SENT_300	[p7l721t2748r1073b2786],
30	postural	JJ	O	postural	amod	31	SENT_300	[p7l1080t2748r1213b2786],
31	hypotension	NN	O	hypotension	dobj	29	SENT_300	[p7l1221t2748r1432b2786],
32	,	,	O	,	_	0	SENT_300	[p7l1221t2748r1432b2786],
33	even	RB	O	even	advmod	38	SENT_300	[p7l1441t2757r1517b2778],
34	though	IN	O	though	dep	38	SENT_300	[p7l1524t2748r1639b2786],
35	all	DT	O	all	det	36	SENT_300	[p7l1647t2748r1687b2777],
36	patients	NNS	O	patient	nsubj	38	SENT_300	[p7l1694t2748r1822b2786],
37	had	VBD	O	have	aux	38	SENT_300	[p7l1830t2748r1890b2777],
38	received	VBN	O	receive	dep	29	SENT_300	[p7l545t2797r684b2826],
39	similar	JJ	O	similar	amod	40	SENT_300	[p7l696t2797r809b2826],
40	doses	NNS	O	dose	dobj	38	SENT_300	[p7l820t2797r910b2826],
41	of	IN	O	of	_	0	SENT_300	[p7l923t2797r958b2826],
42	nortriptyline	NN	O	nortriptyline	prep_of	40	SENT_300	[p7l967t2797r1173b2835],
43	and	CC	O	and	_	0	SENT_300	[p7l1185t2797r1244b2826],
44	had	VBD	O	have	dep	49	SENT_300	[p7l1254t2797r1314b2826],
45	similar	JJ	O	similar	amod	48	SENT_300	[p7l1326t2797r1440b2826],
46	nortriptyline	NN	O	nortriptyline	nn	48	SENT_300	[p7l1450t2797r1656b2835],
47	plasma	NN	O	plasma	nn	48	SENT_300	[p7l1667t2797r1785b2835],
48	levels	NNS	O	level	nsubj	49	SENT_300	[p7l1795t2797r1889b2826],
49	(	VBP	O	(	conj_and	38	SENT_300	[p7l546t2847r621b2883],
50	92	CD	NUMBER	92	number	51	SENT_300	[p7l546t2847r621b2883],
51	)	CD	NUMBER	)	dobj	49	SENT_300	[p7l546t2847r621b2883],
52	.	.	O	.	_	0	SENT_300	[p7l546t2847r621b2883],

1	The	DT	O	the	det	2	SENT_301	[p7l595t2897r658b2926],
2	consequences	NNS	O	consequence	nsubjpass	8	SENT_301	[p7l676t2906r902b2935],
3	of	IN	O	of	_	0	SENT_301	[p7l920t2897r956b2926],
4	genetic	JJ	O	genetic	amod	5	SENT_301	[p7l970t2897r1088b2935],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_301	[p7l1105t2897r1347b2935],
6	have	VBP	O	have	aux	8	SENT_301	[p7l1363t2897r1439b2926],
7	been	VBN	O	be	auxpass	8	SENT_301	[p7l1455t2897r1533b2926],
8	assessed	VBN	O	assess	_	0	SENT_301	[p7l1551t2897r1690b2926],
9	in	FW	O	in	nn	10	SENT_301	[p7l1707t2897r1738b2926],
10	vivo	FW	O	vivo	advmod	8	SENT_301	[p7l1755t2897r1825b2926],
11	for	IN	O	for	_	0	SENT_301	[p7l1842t2897r1890b2926],
12	only	RB	O	only	advmod	15	SENT_301	[p7l546t2947r617b2985],
13	one	CD	NUMBER	one	num	15	SENT_301	[p7l637t2956r695b2976],
14	other	JJ	O	other	amod	15	SENT_301	[p7l714t2947r799b2976],
15	transporter	NN	O	transporter	prep_for	8	SENT_301	[p7l816t2951r996b2985],
16	of	IN	O	of	_	0	SENT_301	[p7l1014t2947r1050b2976],
17	relevance	NN	O	relevance	prep_of	15	SENT_301	[p7l1065t2947r1221b2976],
18	for	IN	O	for	_	0	SENT_301	[p7l1240t2947r1288b2976],
19	drug	NN	O	drug	nn	20	SENT_301	[p7l1306t2947r1380b2985],
20	therapy	NN	O	therapy	prep_for	8	SENT_301	[p7l1399t2947r1528b2985],
21	,	,	O	,	_	0	SENT_301	[p7l1399t2947r1528b2985],
22	OATP	NN	O	oatp	appos	20	SENT_301	[p7l1549t2947r1690b2976],
23	.	.	O	.	_	0	SENT_301	[p7l1549t2947r1690b2976],

1	—	NN	O	—	_	0	SENT_302	[p7l1549t2947r1690b2976],
2	.	.	O	.	_	0	SENT_302	[p7l1549t2947r1690b2976],

1	C	NN	O	c	_	0	SENT_303	[p7l1549t2947r1690b2976],
2	(	CD	NUMBER	(	num	3	SENT_303	[p7l1711t2947r1842b2983],
3	SCPIB	NN	O	scpib	dobj	1	SENT_303	[p7l1711t2947r1842b2983],
4	1	CD	NUMBER	1	num	5	SENT_303	[p7l1850t2947r1888b2983],
5	)	NN	O	)	dep	3	SENT_303	[p7l1850t2947r1888b2983],
6	,	,	O	,	_	0	SENT_303	[p7l1850t2947r1888b2983],
7	which	WDT	O	which	nsubj	8	SENT_303	[p7l545t2997r646b3026],
8	facilitates	VBZ	O	facilitate	rcmod	3	SENT_303	[p7l656t2997r815b3026],
9	the	DT	O	the	det	10	SENT_303	[p7l827t2997r876b3026],
10	uptake	NN	O	uptake	dobj	8	SENT_303	[p7l887t2997r996b3035],
11	of	IN	O	of	_	0	SENT_303	[p7l1008t2997r1044b3026],
12	drug	NN	O	drug	nn	13	SENT_303	[p7l1052t2997r1126b3035],
13	substrates	NNS	O	substrate	prep_of	10	SENT_303	[p7l1139t2997r1299b3026],
14	from	IN	O	from	_	0	SENT_303	[p7l1311t2997r1391b3026],
15	the	DT	O	the	det	16	SENT_303	[p7l1401t2997r1451b3026],
16	blood	NN	O	blood	prep_from	13	SENT_303	[p7l1461t2997r1556b3026],
17	into	IN	O	into	_	0	SENT_303	[p7l1566t2997r1629b3026],
18	the	DT	O	the	det	19	SENT_303	[p7l1640t2997r1690b3026],
19	hepatocyte	NN	O	hepatocyte	prep_into	8	SENT_303	[p7l1701t2997r1887b3035],
20	.	.	O	.	_	0	SENT_303	[p7l1701t2997r1887b3035],

1	The	DT	O	the	det	3	SENT_304	[p7l545t3047r608b3076],
2	relatively	RB	O	relatively	advmod	3	SENT_304	[p7l623t3047r777b3084],
3	common	JJ	O	common	dep	5	SENT_304	[p7l793t3056r937b3076],
4	variant	JJ	O	variant	amod	5	SENT_304	[p7l952t3047r1066b3076],
5	OATP	NN	O	oatp	_	0	SENT_304	[p7l1080t3046r1259b3076],
6	.	.	O	.	_	0	SENT_304	[p7l1080t3046r1259b3076],

1	—	NN	O	—	_	0	SENT_305	[p7l1080t3046r1259b3076],
2	.	.	O	.	_	0	SENT_305	[p7l1080t3046r1259b3076],

1	C	NN	O	c	nsubjpass	5	SENT_306	[p7l1080t3046r1259b3076],
2	*	CD	NUMBER	*	num	3	SENT_306	[p7l1080t3046r1259b3076],
3	5	CD	NUMBER	5	dep	1	SENT_306	[p7l1080t3046r1259b3076],
4	is	VBZ	O	be	auxpass	5	SENT_306	[p7l1275t3047r1301b3076],
5	associated	VBN	O	associate	_	0	SENT_306	[p7l1318t3047r1487b3076],
6	with	IN	O	with	prep	5	SENT_306	[p7l1502t3047r1574b3076],
7	markedly	RB	O	markedly	advmod	5	SENT_306	[p7l1589t3047r1744b3084],
8	reduced	VBN	O	reduce	dep	7	SENT_306	[p7l1759t3047r1890b3076],
9	transporter	NN	O	transporter	nn	10	SENT_306	[p7l545t3101r725b3134],
10	function	NN	O	function	nsubj	13	SENT_306	[p7l739t3096r877b3125],
11	(	CD	NUMBER	(	number	12	SENT_306	[p7l893t3096r968b3132],
12	93	CD	NUMBER	93	num	13	SENT_306	[p7l893t3096r968b3132],
13	)	NN	O	)	xcomp	8	SENT_306	[p7l893t3096r968b3132],
14	.	.	O	.	_	0	SENT_306	[p7l893t3096r968b3132],

1	Carriers	NNS	O	carrier	nsubj	7	SENT_307	[p7l986t3096r1117b3125],
2	of	IN	O	of	_	0	SENT_307	[p7l1134t3096r1170b3125],
3	the	DT	O	the	det	6	SENT_307	[p7l1183t3096r1232b3125],
4	*	NN	O	*	nn	6	SENT_307	[p7l1249t3096r1283b3125],
5	5	CD	NUMBER	5	num	6	SENT_307	[p7l1249t3096r1283b3125],
6	allele	NN	O	allele	prep_of	1	SENT_307	[p7l1301t3096r1389b3125],
7	have	VBP	O	have	_	0	SENT_307	[p7l1404t3096r1480b3125],
8	high	JJ	O	high	amod	10	SENT_307	[p7l1495t3096r1568b3134],
9	plasma	NN	O	plasma	nn	10	SENT_307	[p7l1583t3096r1701b3134],
10	concentrations	NNS	O	concentration	dobj	7	SENT_307	[p7l1716t3101r1888b3125, p7l545t3146r624b3175],
11	of	IN	O	of	_	0	SENT_307	[p7l636t3146r672b3175],
12	the	DT	O	the	det	13	SENT_307	[p7l679t3146r729b3175],
13	OATP	NN	O	oatp	prep_of	10	SENT_307	[p7l741t3146r882b3175],
14	.	.	O	.	_	0	SENT_307	[p7l741t3146r882b3175],

1	—	NN	O	—	_	0	SENT_308	[p7l741t3146r882b3175],
2	.	.	O	.	_	0	SENT_308	[p7l741t3146r882b3175],

1	C	NN	O	c	nn	3	SENT_309	[p7l741t3146r882b3175],
2	substrate	NN	O	substrate	nn	3	SENT_309	[p7l895t3146r1040b3175],
3	pravastatin	NN	O	pravastatin	nsubj	8	SENT_309	[p7l1050t3146r1230b3184],
4	(	CD	NUMBER	(	num	6	SENT_309	[p7l1242t3146r1380b3182],
5	94-96	CD	NUMBER	94-96	num	6	SENT_309	[p7l1242t3146r1380b3182],
6	)	NN	O	)	dep	3	SENT_309	[p7l1242t3146r1380b3182],
7	,	,	O	,	_	0	SENT_309	[p7l1242t3146r1380b3182],
8	suggesting	VBG	O	suggest	_	0	SENT_309	[p7l1393t3146r1568b3184],
9	impaired	JJ	O	impaired	amod	10	SENT_309	[p7l1579t3146r1726b3184],
10	uptake	NN	O	uptake	dobj	8	SENT_309	[p7l1736t3146r1845b3184],
11	of	IN	O	of	_	0	SENT_309	[p7l1857t3146r1892b3175],
12	pravastatin	NN	O	pravastatin	prep_of	10	SENT_309	[p7l545t3196r724b3233],
13	by	IN	O	by	_	0	SENT_309	[p7l737t3196r777b3233],
14	hepatocytes	NNS	O	hepatocyte	prep_by	8	SENT_309	[p7l790t3196r993b3233],
15	.	.	O	.	_	0	SENT_309	[p7l790t3196r993b3233],

1	Indeed	RB	O	indeed	advmod	8	SENT_310	[p7l1008t3196r1129b3230],
2	,	,	O	,	_	0	SENT_310	[p7l1008t3196r1129b3230],
3	pravastatin	NN	O	pravastatin	nn	4	SENT_310	[p7l1142t3196r1322b3233],
4	concentrations	NNS	O	concentration	nsubj	8	SENT_310	[p7l1335t3196r1575b3225],
5	in	IN	O	in	_	0	SENT_310	[p7l1589t3196r1620b3224],
6	hepatocytes	NNS	O	hepatocyte	prep_in	4	SENT_310	[p7l1632t3196r1826b3233],
7	are	VBP	O	be	cop	8	SENT_310	[p7l1841t3205r1889b3225],
8	low	JJ	O	low	_	0	SENT_310	[p7l545t3246r611b3280],
9	,	,	O	,	_	0	SENT_310	[p7l545t3246r611b3280],
10	which	WDT	O	which	nsubj	11	SENT_310	[p7l629t3245r729b3275],
11	results	VBZ	O	result	ccomp	8	SENT_310	[p7l744t3246r851b3275],
12	in	IN	O	in	_	0	SENT_310	[p7l867t3245r898b3274],
13	less	JJR	O	less	amod	14	SENT_310	[p7l914t3246r974b3275],
14	inhibition	NN	O	inhibition	prep_in	11	SENT_310	[p7l990t3245r1151b3275],
15	of	IN	O	of	_	0	SENT_310	[p7l1166t3245r1202b3275],
16	cholesterol	NN	O	cholesterol	nn	17	SENT_310	[p7l1215t3246r1396b3275],
17	synthesis	NN	O	synthesis	prep_of	14	SENT_310	[p7l1413t3245r1562b3283],
18	as	IN	O	as	mark	19	SENT_310	[p7l1579t3255r1610b3275],
19	assessed	VBN	O	assess	advcl	11	SENT_310	[p7l1628t3246r1767b3275],
20	by	IN	O	by	_	0	SENT_310	[p7l1781t3246r1822b3283],
21	decreased	VBN	O	decrease	amod	23	SENT_310	[p7l1838t3246r1888b3275, p7l546t3295r669b3324],
22	lathosterol	NN	O	lathosterol	nn	23	SENT_310	[p7l683t3295r857b3324],
23	concentration	NN	O	concentration	prep_by	19	SENT_310	[p7l872t3295r1096b3324],
24	and	CC	O	and	_	0	SENT_310	[p7l1111t3295r1170b3324],
25	lathosterol/cholesterol	NN	O	lathosterol/cholesterol	nn	26	SENT_310	[p7l1184t3295r1551b3325],
26	ratio	NN	O	ratio	prep_by	19	SENT_310	[p7l1565t3295r1640b3324],
27	(	CD	NUMBER	(	number	28	SENT_310	[p7l1656t3296r1731b3331],
28	97	CD	NUMBER	97	num	29	SENT_310	[p7l1656t3296r1731b3331],
29	)	NN	O	)	dep	26	SENT_310	[p7l1656t3296r1731b3331],
30	.	.	O	.	_	0	SENT_310	[p7l1656t3296r1731b3331],

1	Whether	IN	O	whether	complm	7	SENT_311	[p7l1747t3295r1890b3324],
2	cholesterol	NN	O	cholesterol	nsubj	7	SENT_311	[p7l545t3345r886b3383],
3	—	CD	NUMBER	—	num	2	SENT_311	[p7l545t3345r886b3383],
4	1owering	VBG	O	1ower	partmod	2	SENT_311	[p7l545t3345r886b3383],
5	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_311	[p7l898t3345r1026b3383],
6	is	VBZ	O	be	cop	7	SENT_311	[p7l1036t3345r1062b3374],
7	impaired	JJ	O	impaired	csubj	18	SENT_311	[p7l1074t3345r1221b3383],
8	in	IN	O	in	_	0	SENT_311	[p7l1231t3345r1262b3374],
9	carriers	NNS	O	carrier	prep_in	7	SENT_311	[p7l1273t3345r1395b3374],
10	of	IN	O	of	_	0	SENT_311	[p7l1407t3345r1443b3374],
11	these	DT	O	these	det	12	SENT_311	[p7l1450t3345r1535b3374],
12	variants	NNS	O	variant	prep_of	9	SENT_311	[p7l1545t3345r1674b3374],
13	during	IN	O	during	_	0	SENT_311	[p7l1685t3345r1792b3383],
14	longterm	JJ	O	longterm	amod	15	SENT_311	[p7l1803t3345r1888b3383, p7l545t3399r621b3424],
15	treatment	NN	O	treatment	prep_during	7	SENT_311	[p7l631t3399r788b3424],
16	is	VBZ	O	be	cop	18	SENT_311	[p7l799t3395r825b3424],
17	yet	RB	O	yet	advmod	18	SENT_311	[p7l837t3399r887b3433],
18	unknown	JJ	O	unknown	_	0	SENT_311	[p7l898t3395r1059b3424],
19	.	.	O	.	_	0	SENT_311	[p7l898t3395r1059b3424],

1	A	DT	O	a	det	3	SENT_312	[p7l595t3445r624b3473],
2	profound	JJ	O	profound	amod	3	SENT_312	[p7l637t3445r789b3482],
3	impact	NN	O	impact	_	0	SENT_312	[p7l802t3445r914b3482],
4	of	IN	O	of	_	0	SENT_312	[p7l927t3445r963b3474],
5	OATP	NN	O	oatp	prep_of	3	SENT_312	[p7l974t3445r1116b3474],
6	.	.	O	.	_	0	SENT_312	[p7l974t3445r1116b3474],

1	—	NN	O	—	_	0	SENT_313	[p7l974t3445r1116b3474],
2	.	.	O	.	_	0	SENT_313	[p7l974t3445r1116b3474],

1	C	NN	O	c	nn	2	SENT_314	[p7l974t3445r1116b3474],
2	polymorphism	NN	O	polymorphism	nsubjpass	5	SENT_314	[p7l1129t3445r1371b3482],
3	was	VBD	O	be	auxpass	5	SENT_314	[p7l1384t3454r1446b3474],
4	recently	RB	DATE	recently	advmod	5	SENT_314	[p7l1460t3445r1593b3482],
5	demonstrated	VBN	O	demonstrate	_	0	SENT_314	[p7l1607t3445r1829b3474],
6	for	IN	O	for	_	0	SENT_314	[p7l1842t3445r1890b3474],
7	the	DT	O	the	det	10	SENT_314	[p7l545t3495r595b3524],
8	antidiabetic	JJ	O	antidiabetic	amod	10	SENT_314	[p7l605t3495r796b3524],
9	drug	NN	O	drug	nn	10	SENT_314	[p7l807t3495r881b3532],
10	repaglinide	NN	O	repaglinide	prep_for	5	SENT_314	[p7l890t3495r1085b3532],
11	,	,	O	,	_	0	SENT_314	[p7l890t3495r1085b3532],
12	for	IN	O	for	_	0	SENT_314	[p7l1096t3495r1144b3524],
13	which	WDT	O	which	rel	19	SENT_314	[p7l1153t3495r1253b3524],
14	AUCs	NNS	O	auc	nsubj	19	SENT_314	[p7l1262t3495r1362b3524],
15	were	VBD	O	be	cop	19	SENT_314	[p7l1372t3504r1452b3524],
16	approximately	RB	O	approximately	quantmod	17	SENT_314	[p7l1462t3495r1700b3532],
17	three	CD	NUMBER	three	num	18	SENT_314	[p7l1709t3495r1791b3524],
18	times	NNS	O	time	npadvmod	19	SENT_314	[p7l1800t3495r1889b3524],
19	higher	JJR	O	higher	rcmod	10	SENT_314	[p7l545t3544r651b3582],
20	in	IN	O	in	_	0	SENT_314	[p7l659t3544r691b3573],
21	carriers	NNS	O	carrier	prep_in	19	SENT_314	[p7l701t3544r823b3574],
22	of	IN	O	of	_	0	SENT_314	[p7l833t3544r869b3573],
23	the	DT	O	the	det	25	SENT_314	[p7l876t3545r925b3574],
24	Variant	JJ	O	variant	amod	25	SENT_314	[p7l935t3544r1049b3574],
25	*	NN	O	*	prep_of	21	SENT_314	[p7l1058t3544r1092b3574],
26	5	CD	NUMBER	5	num	27	SENT_314	[p7l1058t3544r1092b3574],
27	allele	NN	O	allele	npadvmod	28	SENT_314	[p7l1105t3544r1192b3574],
28	than	IN	O	than	advmod	19	SENT_314	[p7l1202t3544r1273b3574],
29	in	IN	O	in	_	0	SENT_314	[p7l1282t3544r1313b3573],
30	wild-type	JJ	O	wild-type	amod	31	SENT_314	[p7l1323t3544r1480b3582],
31	subjects	NNS	O	subject	prep_in	19	SENT_314	[p7l1491t3544r1631b3582],
32	.	.	O	.	_	0	SENT_314	[p7l1491t3544r1631b3582],

1	This	DT	O	this	det	2	SENT_315	[p7l1642t3544r1714b3574],
2	effect	NN	O	effect	nsubjpass	4	SENT_315	[p7l1725t3544r1818b3574],
3	was	VBD	O	be	auxpass	4	SENT_315	[p7l1827t3554r1889b3574],
4	associated	VBN	O	associate	_	0	SENT_315	[p7l546t3594r715b3623],
5	with	IN	O	with	_	0	SENT_315	[p7l727t3594r799b3623],
6	a	DT	O	a	det	9	SENT_315	[p7l811t3603r829b3623],
7	more	RBR	O	more	advmod	8	SENT_315	[p7l839t3603r923b3623],
8	pronounced	JJ	O	pronounced	amod	9	SENT_315	[p7l934t3594r1130b3631],
9	reduction	NN	O	reduction	prep_with	4	SENT_315	[p7l1141t3594r1297b3623],
10	of	IN	O	of	_	0	SENT_315	[p7l1309t3594r1345b3623],
11	blood	NN	O	blood	nn	13	SENT_315	[p7l1353t3594r1447b3623],
12	glucose	NN	O	glucose	nn	13	SENT_315	[p7l1459t3594r1584b3631],
13	levels	NNS	O	level	prep_of	9	SENT_315	[p7l1596t3594r1689b3623],
14	(	VBP	O	(	rcmod	9	SENT_315	[p7l1703t3594r1778b3629],
15	98	CD	NUMBER	98	number	16	SENT_315	[p7l1703t3594r1778b3629],
16	)	CD	NUMBER	)	dobj	14	SENT_315	[p7l1703t3594r1778b3629],
17	.	.	O	.	_	0	SENT_315	[p7l1703t3594r1778b3629],

1	RECEPTORS	NNS	O	receptor	_	0	SENT_316	[p7l446t3736r715b3771],

1	Annu	NNP	PERSON	Annu	_	0	SENT_317	[p8l268t8r291b80],
2	by	IN	O	by	dep	1	SENT_317	[p8l301t15r332b47],

1	Annu	NNP	PERSON	Annu	_	0	SENT_318	[p8l278t2234r301b2313],
2	.	.	O	.	_	0	SENT_318	[p8l278t2234r301b2313],

1	Rev.	NNP	O	Rev.	nn	2	SENT_319	[p8l278t2163r301b2223],
2	Med	NNP	O	Med	_	0	SENT_319	[p8l278t2086r301b2153],
3	.	.	O	.	_	0	SENT_319	[p8l278t2086r301b2153],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_320	[p8l278t1961r301b2075],
2	:	:	O	:	_	0	SENT_320	[p8l278t1961r301b2075],
3	1	CD	NUMBER	1	number	4	SENT_320	[p8l278t1945r301b1955],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_320	[p8l278t1841r302b1938],
5	.	.	O	.	_	0	SENT_320	[p8l278t1841r302b1938],

1	Downloaded	VBN	O	download	_	0	SENT_321	[p8l278t1661r301b1830],
2	from	IN	O	from	_	0	SENT_321	[p8l278t1587r301b1652],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_321	[p8l278t1254r308b1578],
4	by	IN	O	by	_	0	SENT_321	[p8l311t2247r342b2279],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_321	[p8l311t2098r342b2238],
6	of	IN	ORGANIZATION	of	_	0	SENT_321	[p8l311t2060r335b2089],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_321	[p8l311t1914r335b2053],
8	-	:	O	-	_	0	SENT_321	[p8l325t1895r328b1904],
9	Madison	NNP	O	Madison	prep_by	1	SENT_321	[p8l311t1769r335b1885],
10	on	IN	O	on	_	0	SENT_321	[p8l319t1727r335b1760],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_321	[p8l311t1594r335b1718],
12	.	.	O	.	_	0	SENT_321	[p8l311t1594r335b1718],

1	For	IN	O	for	_	0	SENT_322	[p8l312t1537r335b1583],
2	personal	JJ	O	personal	amod	3	SENT_322	[p8l311t1417r342b1529],
3	use	NN	O	use	pobj	1	SENT_322	[p8l319t1364r335b1408],
4	only	RB	O	only	advmod	3	SENT_322	[p8l311t1289r342b1354],
5	.	.	O	.	_	0	SENT_322	[p8l311t1289r342b1354],

1	A	DT	O	a	det	3	SENT_323	[p8l545t19r574b48],
2	growing	VBG	O	grow	amod	3	SENT_323	[p8l588t19r724b57],
3	number	NN	O	number	nsubj	7	SENT_323	[p8l738t19r864b48],
4	of	IN	O	of	_	0	SENT_323	[p8l877t19r913b48],
5	drug	NN	O	drug	nn	6	SENT_323	[p8l925t19r999b57],
6	targets	NNS	O	target	prep_of	3	SENT_323	[p8l1013t23r1121b57],
7	(	VBP	O	(	ccomp	11	SENT_323	[p8l1137t19r1217b57],
8	e.g.	FW	O	e.g.	dobj	7	SENT_323	[p8l1137t19r1217b57],
9	,	,	O	,	_	0	SENT_323	[p8l1137t19r1217b57],
10	receptors	NNS	O	receptor	nsubj	11	SENT_323	[p8l1232t19r1396b57],
11	)	VBP	O	)	_	0	SENT_323	[p8l1232t19r1396b57],
12	are	VBP	O	be	auxpass	13	SENT_323	[p8l1411t28r1460b48],
13	known	VBN	O	know	ccomp	11	SENT_323	[p8l1474t19r1585b48],
14	to	TO	O	to	aux	15	SENT_323	[p8l1598t24r1629b48],
15	exhibit	VB	O	exhibit	xcomp	13	SENT_323	[p8l1644t19r1758b48],
16	genetic	JJ	O	genetic	amod	17	SENT_323	[p8l1771t19r1889b57],
17	polymorphisms	NNS	O	polymorphism	dobj	15	SENT_323	[p8l545t68r802b106],
18	that	WDT	O	that	nsubj	19	SENT_323	[p8l812t68r874b97],
19	inﬂuence	VBP	O	inﬂuence	rcmod	17	SENT_323	[p8l883t68r1034b97],
20	drug	NN	O	drug	nn	21	SENT_323	[p8l1044t68r1119b106],
21	response	NN	O	response	nsubj	24	SENT_323	[p8l1128t77r1273b106],
22	in	IN	O	in	_	0	SENT_323	[p8l1283t68r1314b97],
23	humans	NNS	O	human	prep_in	21	SENT_323	[p8l1323t68r1451b97],
24	(	VBP	O	(	ccomp	19	SENT_323	[p8l1463t68r1504b104],
25	1	CD	NUMBER	1	dobj	24	SENT_323	[p8l1463t68r1504b104],
26	,	,	O	,	_	0	SENT_323	[p8l1463t68r1504b104],
27	2	CD	NUMBER	2	appos	25	SENT_323	[p8l1516t68r1544b102],
28	,	,	O	,	_	0	SENT_323	[p8l1516t68r1544b102],
29	99	CD	NUMBER	99	num	30	SENT_323	[p8l1556t68r1618b104],
30	)	NN	O	)	appos	27	SENT_323	[p8l1556t68r1618b104],
31	.	.	O	.	_	0	SENT_323	[p8l1556t68r1618b104],

1	Here	RB	O	here	advmod	3	SENT_324	[p8l1629t69r1709b97],
2	we	PRP	O	we	nsubj	3	SENT_324	[p8l1719t77r1766b97],
3	use	VBP	O	use	_	0	SENT_324	[p8l1776t77r1830b97],
4	the	DT	O	the	det	8	SENT_324	[p8l1840t68r1889b97],
5	B2	NN	O	b2	nn	8	SENT_324	[p8l549t117r776b155],
6	—	NN	O	—	nn	8	SENT_324	[p8l549t117r776b155],
7	adrenergic	JJ	O	adrenergic	amod	8	SENT_324	[p8l549t117r776b155],
8	receptor	NN	O	receptor	nsubj	15	SENT_324	[p8l788t122r924b155],
9	and	CC	O	and	_	0	SENT_324	[p8l936t118r995b147],
10	the	DT	O	the	det	13	SENT_324	[p8l1006t118r1056b147],
11	sodium	NN	O	sodium	nn	13	SENT_324	[p8l1070t117r1190b147],
12	channel	NN	O	channel	nn	13	SENT_324	[p8l1202t118r1329b147],
13	SCN1A	NN	O	scn1a	conj_and	8	SENT_324	[p8l1343t118r1472b147],
14	to	TO	O	to	aux	15	SENT_324	[p8l1484t122r1515b147],
15	illustrate	VB	O	illustrate	xcomp	3	SENT_324	[p8l1527t118r1671b147],
16	the	DT	O	the	det	18	SENT_324	[p8l1683t118r1733b147],
17	potential	JJ	O	potential	amod	18	SENT_324	[p8l1745t117r1889b155],
18	importance	NN	O	importance	dobj	15	SENT_324	[p8l545t167r731b205],
19	of	IN	O	of	_	0	SENT_324	[p8l743t167r779b196],
20	inherited	VBN	O	inherit	amod	21	SENT_324	[p8l787t167r934b196],
21	differences	NNS	O	difference	prep_of	18	SENT_324	[p8l946t167r1127b196],
22	in	IN	O	in	_	0	SENT_324	[p8l1139t167r1171b196],
23	drug	NN	O	drug	nn	24	SENT_324	[p8l1182t167r1256b205],
24	targets	NNS	O	target	prep_in	21	SENT_324	[p8l1268t172r1376b205],
25	in	IN	O	in	_	0	SENT_324	[p8l1389t167r1420b196],
26	drug	NN	O	drug	nn	27	SENT_324	[p8l1432t167r1506b205],
27	response	NN	O	response	prep_in	24	SENT_324	[p8l1517t176r1670b205],
28	.	.	O	.	_	0	SENT_324	[p8l1517t176r1670b205],

1	[	NN	O	[	_	0	SENT_325	[p8l450t281r493b326],
2	52	CD	NUMBER	52	num	4	SENT_325	[p8l450t281r493b326],
3	Adrenergic	JJ	O	adrenergic	amod	4	SENT_325	[p8l507t280r730b328],
4	Receptor	NN	O	receptor	dep	1	SENT_325	[p8l743t283r922b327],
5	(	CD	NUMBER	(	num	7	SENT_325	[p8l937t280r1120b324],
6	ADRB2	NN	O	adrb2	nn	7	SENT_325	[p8l937t280r1120b324],
7	)	NN	O	)	dep	1	SENT_325	[p8l937t280r1120b324],

1	Genetic	JJ	O	genetic	amod	2	SENT_326	[p8l546t339r672b368],
2	polymorphism	NN	O	polymorphism	nsubj	23	SENT_326	[p8l685t339r928b377],
3	of	IN	O	of	_	0	SENT_326	[p8l940t339r976b368],
4	the	DT	O	the	det	11	SENT_326	[p8l985t339r1035b368],
5	[	CD	NUMBER	[	number	6	SENT_326	[p8l1052t338r1354b377],
6	52	CD	NUMBER	52	num	11	SENT_326	[p8l1052t338r1354b377],
7	—	NN	O	—	nn	11	SENT_326	[p8l1052t338r1354b377],
8	adrenoreceptor	NN	O	adrenoreceptor	nn	11	SENT_326	[p8l1052t338r1354b377],
9	(	CD	NUMBER	(	num	11	SENT_326	[p8l1367t339r1538b375],
10	ADBR2	NN	O	adbr2	nn	11	SENT_326	[p8l1367t339r1538b375],
11	)	NN	O	)	prep_of	2	SENT_326	[p8l1367t339r1538b375],
12	,	,	O	,	_	0	SENT_326	[p8l1367t339r1538b375],
13	which	WDT	O	which	nsubj	14	SENT_326	[p8l1552t339r1652b368],
14	interacts	VBZ	O	interact	rcmod	11	SENT_326	[p8l1665t339r1803b368],
15	with	IN	O	with	_	0	SENT_326	[p8l1817t339r1890b368],
16	endogenous	JJ	O	endogenous	amod	17	SENT_326	[p8l545t388r741b426],
17	catecholarnines	NNS	O	catecholarnine	prep_with	14	SENT_326	[p8l753t388r1006b417],
18	and	CC	O	and	_	0	SENT_326	[p8l1018t388r1076b417],
19	various	JJ	O	various	amod	20	SENT_326	[p8l1086t388r1205b417],
20	medications	NNS	O	medication	conj_and	17	SENT_326	[p8l1215t388r1424b422],
21	,	,	O	,	_	0	SENT_326	[p8l1215t388r1424b422],
22	can	MD	O	can	aux	23	SENT_326	[p8l1436t397r1492b417],
23	alter	VB	O	alter	_	0	SENT_326	[p8l1502t388r1575b417],
24	the	DT	O	the	det	25	SENT_326	[p8l1584t388r1634b417],
25	effects	NNS	O	effect	dobj	23	SENT_326	[p8l1644t388r1751b417],
26	of	IN	O	of	_	0	SENT_326	[p8l1762t388r1798b417],
27	medications	NNS	O	medication	prep_of	25	SENT_326	[p8l1805t388r1888b417, p8l545t437r672b466],
28	that	WDT	O	that	nsubj	29	SENT_326	[p8l687t437r749b466],
29	target	VBP	O	target	rcmod	27	SENT_326	[p8l762t441r855b475],
30	it	PRP	O	it	nsubj	33	SENT_326	[p8l869t437r891b466],
31	(	JJ	O	(	amod	33	SENT_326	[p8l906t437r1084b473],
32	100-102	CD	NUMBER	100-102	num	33	SENT_326	[p8l906t437r1084b473],
33	)	NN	O	)	xcomp	29	SENT_326	[p8l906t437r1084b473],
34	.	.	O	.	_	0	SENT_326	[p8l906t437r1084b473],

1	A	DT	O	a	det	2	SENT_327	[p8l1100t437r1129b466],
2	number	NN	O	number	nsubjpass	7	SENT_327	[p8l1143t437r1270b466],
3	of	IN	O	of	_	0	SENT_327	[p8l1283t437r1319b466],
4	distinct	JJ	O	distinct	amod	5	SENT_327	[p8l1330t437r1452b466],
5	SNPs	NNS	O	snp	prep_of	2	SENT_327	[p8l1466t437r1555b467],
6	are	VBP	O	be	auxpass	7	SENT_327	[p8l1571t446r1619b466],
7	associated	VBN	O	associate	_	0	SENT_327	[p8l1634t437r1803b466],
8	with	IN	O	with	_	0	SENT_327	[p8l1817t437r1890b467],
9	altered	JJ	O	altered	amod	10	SENT_327	[p8l546t486r658b515],
10	expression	NN	O	expression	prep_with	7	SENT_327	[p8l670t486r855b524],
11	,	,	O	,	_	0	SENT_327	[p8l670t486r855b524],
12	downregulation	NN	O	downregulation	conj_or	10	SENT_327	[p8l870t486r1136b524],
13	,	,	O	,	_	0	SENT_327	[p8l870t486r1136b524],
14	or	CC	O	or	_	0	SENT_327	[p8l1151t495r1185b515],
15	coupling	NN	O	coupling	conj_or	10	SENT_327	[p8l1198t486r1341b524],
16	of	IN	O	of	_	0	SENT_327	[p8l1355t486r1391b515],
17	ADBR2	NN	O	adbr2	prep_of	15	SENT_327	[p8l1401t486r1536b515],
18	(	CD	NUMBER	(	num	17	SENT_327	[p8l1551t486r1626b522],
19	94	CD	NUMBER	94	num	20	SENT_327	[p8l1551t486r1626b522],
20	)	NN	O	)	dep	15	SENT_327	[p8l1551t486r1626b522],
21	.	.	O	.	_	0	SENT_327	[p8l1551t486r1626b522],

1	SNPs	NNS	O	snp	_	0	SENT_328	[p8l1642t486r1731b515],
2	resulting	VBG	O	result	rcmod	1	SENT_328	[p8l1745t486r1889b524],
3	in	IN	O	in	_	0	SENT_328	[p8l545t535r577b564],
4	amino	NN	O	amino	nn	6	SENT_328	[p8l594t535r696b565],
5	acid	NN	O	acid	nn	6	SENT_328	[p8l714t535r781b565],
6	alterations	NNS	O	alteration	prep_in	2	SENT_328	[p8l799t535r969b565],
7	of	IN	O	of	_	0	SENT_328	[p8l987t535r1023b565],
8	Arg	NN	O	arg	prep_of	6	SENT_328	[p8l1037t535r1099b573],
9	to	TO	O	to	_	0	SENT_328	[p8l1117t540r1147b565],
10	Gly	NN	O	gly	prep_to	2	SENT_328	[p8l1165t535r1226b573],
11	at	IN	O	at	_	0	SENT_328	[p8l1244t540r1272b565],
12	codon	NN	O	codon	prep_at	10	SENT_328	[p8l1289t535r1389b565],
13	16	CD	NUMBER	16	num	12	SENT_328	[p8l1410t535r1446b565],
14	and	CC	O	and	_	0	SENT_328	[p8l1464t535r1522b565],
15	Gln	NN	O	gln	conj_and	10	SENT_328	[p8l1540t535r1600b565],
16	to	TO	O	to	_	0	SENT_328	[p8l1617t540r1648b565],
17	Glu	NNP	ORGANIZATION	Glu	prep_to	15	SENT_328	[p8l1666t535r1726b565],
18	at	IN	O	at	dep	19	SENT_328	[p8l1744t540r1773b565],
19	codon	NN	O	codon	dep	20	SENT_328	[p8l1789t535r1890b565],
20	EICHELBAUM	NNP	O	EICHELBAUM	dep	22	SENT_328	[p8l585t593r826b620],
21	I	PRP	O	I	dep	22	SENT_328	[p8l844t596r861b614],
22	INGELMAN-SUNDBERG	NN	O	ingelman-sundberg	dep	1	SENT_328	[p8l880t593r1292b620],
23	I	PRP	O	I	nsubj	24	SENT_328	[p8l1310t596r1327b614],
24	EVANS	VBP	O	evan	rcmod	22	SENT_328	[p8l1346t593r1463b620],

1	27	CD	NUMBER	27	nsubj	6	SENT_329	[p8l536t716r575b746],
2	are	VBP	O	be	cop	6	SENT_329	[p8l591t725r639b746],
3	relatively	RB	O	relatively	advmod	4	SENT_329	[p8l653t716r807b754],
4	common	JJ	O	common	amod	6	SENT_329	[p8l822t725r966b746],
5	(	NN	O	(	nn	6	SENT_329	[p8l981t716r1082b752],
6	allele	NN	O	allele	_	0	SENT_329	[p8l981t716r1082b752],
7	frequency	NN	O	frequency	dep	6	SENT_329	[p8l1097t716r1261b754],
8	0.4	CD	NUMBER	0.4	num	7	SENT_329	[p8l1275t716r1443b752],
9	—	CD	NUMBER	—	number	10	SENT_329	[p8l1275t716r1443b752],
10	0.65	CD	NUMBER	0.65	num	11	SENT_329	[p8l1275t716r1443b752],
11	)	NN	O	)	dep	7	SENT_329	[p8l1275t716r1443b752],
12	;	:	O	;	_	0	SENT_329	[p8l1275t716r1443b752],
13	their	PRP$	O	they	poss	15	SENT_329	[p8l1459t716r1534b746],
14	clinical	JJ	O	clinical	amod	15	SENT_329	[p8l1548t716r1669b746],
15	relevance	NN	O	relevance	nsubj	16	SENT_329	[p8l1682t716r1839b746],
16	is	VBZ	O	be	parataxis	6	SENT_329	[p8l1853t716r1878b746],
17	under	IN	O	under	_	0	SENT_329	[p8l535t766r630b795],
18	intensive	JJ	O	intensive	amod	19	SENT_329	[p8l640t766r787b795],
19	investigation	NN	O	investigation	prep_under	16	SENT_329	[p8l799t766r1018b804],
20	.	.	O	.	_	0	SENT_329	[p8l799t766r1018b804],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_330	[p8l1032t766r1161b795],
2	homozygous	JJ	O	homozygous	amod	1	SENT_330	[p8l1173t766r1383b804],
3	for	IN	O	for	_	0	SENT_330	[p8l1396t766r1444b795],
4	ADBR2	NN	O	adbr2	nn	5	SENT_330	[p8l1452t766r1579b795],
5	codon	NN	O	codon	prep_for	2	SENT_330	[p8l1592t766r1692b795],
6	16	CD	NUMBER	16	num	7	SENT_330	[p8l1708t766r1744b796],
7	Arg	NN	O	arg	dep	5	SENT_330	[p8l1755t766r1818b804],
8	are	VBP	O	be	auxpass	9	SENT_330	[p8l1831t775r1879b795],
9	reported	VBN	O	report	_	0	SENT_330	[p8l535t815r673b853],
10	to	TO	O	to	aux	11	SENT_330	[p8l681t820r712b844],
11	have	VB	O	have	xcomp	9	SENT_330	[p8l721t815r797b844],
12	near	IN	O	near	_	0	SENT_330	[p8l805t815r1041b853],
13	—	CD	NUMBER	—	num	15	SENT_330	[p8l805t815r1041b853],
14	complete	JJ	O	complete	amod	15	SENT_330	[p8l805t815r1041b853],
15	desensitization	NN	O	desensitization	prep_near	11	SENT_330	[p8l1050t815r1296b844],
16	after	IN	O	after	_	0	SENT_330	[p8l1305t815r1380b844],
17	continuous	JJ	O	continuous	amod	18	SENT_330	[p8l1388t815r1568b844],
18	infusion	NN	O	infusion	prep_after	15	SENT_330	[p8l1577t815r1712b844],
19	of	IN	O	of	_	0	SENT_330	[p8l1721t815r1757b844],
20	isoproterenol	NN	O	isoproterenol	prep_of	18	SENT_330	[p8l1763t815r1878b853, p8l536t864r659b899],
21	,	,	O	,	_	0	SENT_330	[p8l1763t815r1878b853, p8l536t864r659b899],
22	with	IN	O	with	_	0	SENT_330	[p8l673t864r746b894],
23	venodilatation	NN	O	venodilatation	prep_with	9	SENT_330	[p8l758t864r994b894],
24	decreasing	VBG	O	decrease	partmod	23	SENT_330	[p8l1007t864r1182b902],
25	from	IN	O	from	_	0	SENT_330	[p8l1196t864r1276b894],
26	44	CD	PERCENT	44	num	27	SENT_330	[p8l1287t864r1361b894],
27	%	NN	PERCENT	%	prep_from	24	SENT_330	[p8l1287t864r1361b894],
28	at	IN	O	at	_	0	SENT_330	[p8l1376t868r1405b894],
29	baseline	NN	O	baseline	prep_at	27	SENT_330	[p8l1416t864r1552b894],
30	to	TO	O	to	_	0	SENT_330	[p8l1565t869r1595b894],
31	8	CD	PERCENT	8	num	32	SENT_330	[p8l1610t864r1661b894],
32	%	NN	PERCENT	%	prep_to	24	SENT_330	[p8l1610t864r1661b894],
33	at	IN	O	at	_	0	SENT_330	[p8l1676t869r1705b894],
34	90	CD	DURATION	90	num	35	SENT_330	[p8l1717t864r1757b894],
35	min	NN	DURATION	min	prep_at	32	SENT_330	[p8l1770t864r1833b893],
36	of	IN	O	of	_	0	SENT_330	[p8l1846t864r1882b894],
37	infusion	NN	O	infusion	prep_of	35	SENT_330	[p8l535t914r679b943],
38	.	.	O	.	_	0	SENT_330	[p8l535t914r679b943],

1	In	IN	O	in	_	0	SENT_331	[p8l692t915r726b943],
2	contrast	NN	O	contrast	prep_in	5	SENT_331	[p8l737t918r876b949],
3	,	,	O	,	_	0	SENT_331	[p8l737t918r876b949],
4	there	EX	O	there	expl	5	SENT_331	[p8l889t914r971b943],
5	was	VBD	O	be	_	0	SENT_331	[p8l983t923r1044b943],
6	no	DT	O	no	det	8	SENT_331	[p8l1056t923r1096b943],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_331	[p8l1110t914r1281b952],
8	change	NN	O	change	nsubj	5	SENT_331	[p8l1292t914r1408b952],
9	in	IN	O	in	_	0	SENT_331	[p8l1419t914r1450b943],
10	venodilatation	NN	O	venodilatation	prep_in	8	SENT_331	[p8l1462t914r1698b943],
11	in	IN	O	in	_	0	SENT_331	[p8l1709t914r1740b943],
12	patients	NNS	O	patient	prep_in	10	SENT_331	[p8l1751t914r1878b952],
13	homozygous	JJ	O	homozygous	amod	12	SENT_331	[p8l535t963r746b1001],
14	for	IN	O	for	_	0	SENT_331	[p8l756t963r805b992],
15	Gly	NN	O	gly	prep_for	13	SENT_331	[p8l814t963r874b1001],
16	at	IN	O	at	_	0	SENT_331	[p8l885t968r914b992],
17	codon	NN	O	codon	prep_at	15	SENT_331	[p8l924t963r1024b992],
18	16	CD	NUMBER	16	num	17	SENT_331	[p8l1037t963r1083b997],
19	,	,	O	,	_	0	SENT_331	[p8l1037t963r1083b997],
20	regardless	RB	O	regardless	_	0	SENT_331	[p8l1094t963r1260b1001],
21	of	IN	O	of	_	0	SENT_331	[p8l1271t963r1307b992],
22	their	PRP$	O	they	poss	25	SENT_331	[p8l1314t963r1390b992],
23	codon	NN	O	codon	nn	25	SENT_331	[p8l1399t963r1499b992],
24	27	CD	NUMBER	27	num	25	SENT_331	[p8l1510t963r1548b992],
25	genotype	NN	O	genotype	prep_regardless_of	5	SENT_331	[p8l1560t968r1719b1001],
26	.	.	O	.	_	0	SENT_331	[p8l1560t968r1719b1001],

1	Maximal	JJ	O	maximal	amod	2	SENT_332	[p8l1730t963r1879b992],
2	venodilatation	NN	O	venodilatation	nsubj	7	SENT_332	[p8l536t1012r771b1042],
3	in	IN	O	in	_	0	SENT_332	[p8l781t1012r812b1041],
4	response	NN	O	response	prep_in	2	SENT_332	[p8l822t1021r966b1050],
5	to	TO	O	to	_	0	SENT_332	[p8l976t1016r1007b1041],
6	isoproterenol	NN	O	isoproterenol	prep_to	4	SENT_332	[p8l1017t1012r1235b1050],
7	was	VBD	O	be	_	0	SENT_332	[p8l1245t1021r1307b1042],
8	higher	JJR	O	higher	advmod	7	SENT_332	[p8l1317t1012r1423b1050],
9	in	IN	O	in	_	0	SENT_332	[p8l1432t1012r1464b1041],
10	patients	NNS	O	patient	prep_in	8	SENT_332	[p8l1473t1012r1600b1050],
11	homozygous	JJ	O	homozygous	amod	10	SENT_332	[p8l1611t1012r1821b1050],
12	for	IN	O	for	_	0	SENT_332	[p8l1832t1012r1880b1041],
13	Glu	NNP	O	Glu	prep_for	11	SENT_332	[p8l536t1061r596b1090],
14	at	IN	O	at	_	0	SENT_332	[p8l606t1066r634b1090],
15	codon	NN	O	codon	prep_at	13	SENT_332	[p8l643t1061r743b1090],
16	27	CD	NUMBER	27	npadvmod	17	SENT_332	[p8l752t1061r790b1090],
17	than	IN	O	than	advmod	8	SENT_332	[p8l800t1061r871b1090],
18	in	IN	O	in	_	0	SENT_332	[p8l879t1061r910b1090],
19	patients	NNS	O	patient	prep_in	7	SENT_332	[p8l918t1061r1046b1099],
20	with	IN	O	with	_	0	SENT_332	[p8l1055t1061r1128b1090],
21	Gln	NN	PERSON	gln	prep_with	19	SENT_332	[p8l1137t1061r1198b1090],
22	at	IN	O	at	_	0	SENT_332	[p8l1207t1066r1235b1090],
23	codon	NN	O	codon	prep_at	7	SENT_332	[p8l1244t1061r1344b1090],
24	27	CD	NUMBER	27	num	23	SENT_332	[p8l1353t1061r1401b1096],
25	,	,	O	,	_	0	SENT_332	[p8l1353t1061r1401b1096],
26	regardless	RB	O	regardless	_	0	SENT_332	[p8l1411t1061r1577b1099],
27	of	IN	O	of	_	0	SENT_332	[p8l1587t1061r1623b1090],
28	codon	NN	O	codon	nn	30	SENT_332	[p8l1629t1061r1729b1090],
29	16	CD	NUMBER	16	num	30	SENT_332	[p8l1741t1061r1777b1090],
30	status	NN	O	status	prep_regardless_of	23	SENT_332	[p8l1787t1066r1878b1090],
31	(	CD	NUMBER	(	number	32	SENT_332	[p8l537t1110r612b1146],
32	95	CD	NUMBER	95	num	33	SENT_332	[p8l537t1110r612b1146],
33	)	NN	O	)	dep	23	SENT_332	[p8l537t1110r612b1146],
34	.	.	O	.	_	0	SENT_332	[p8l537t1110r612b1146],

1	These	DT	O	these	det	2	SENT_333	[p8l585t1159r683b1188],
2	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_333	[p8l695t1159r826b1197],
3	are	VBP	O	be	cop	5	SENT_333	[p8l839t1168r888b1188],
4	largely	RB	O	largely	advmod	5	SENT_333	[p8l899t1159r1012b1197],
5	consistent	JJ	O	consistent	_	0	SENT_333	[p8l1024t1159r1189b1188],
6	with	IN	O	with	_	0	SENT_333	[p8l1200t1159r1272b1189],
7	studies	NNS	O	study	prep_with	5	SENT_333	[p8l1285t1159r1396b1188],
8	showing	VBG	O	show	partmod	7	SENT_333	[p8l1410t1159r1547b1197],
9	that	IN	O	that	complm	22	SENT_333	[p8l1558t1159r1620b1188],
10	FEV1	NN	O	fev1	nn	11	SENT_333	[p8l1630t1160r1720b1194],
11	response	NN	O	response	nsubj	22	SENT_333	[p8l1735t1168r1879b1197],
12	to	TO	O	to	_	0	SENT_333	[p8l536t1213r566b1237],
13	a	DT	O	a	det	15	SENT_333	[p8l580t1217r598b1237],
14	single	JJ	O	single	amod	15	SENT_333	[p8l611t1208r707b1246],
15	dose	NN	O	dose	prep_to	11	SENT_333	[p8l721t1208r795b1237],
16	of	IN	O	of	_	0	SENT_333	[p8l808t1208r844b1237],
17	oral	JJ	O	oral	amod	18	SENT_333	[p8l855t1208r917b1237],
18	albuterol	NN	O	albuterol	prep_of	15	SENT_333	[p8l931t1208r1076b1237],
19	was	VBD	O	be	cop	22	SENT_333	[p8l1089t1217r1151b1237],
20	higher	JJR	O	higher	advmod	22	SENT_333	[p8l1164t1208r1270b1246],
21	(	CD	NUMBER	(	number	22	SENT_333	[p8l1283t1208r1440b1244],
22	6.5	CD	NUMBER	6.5	ccomp	8	SENT_333	[p8l1283t1208r1440b1244],
23	—	CD	NUMBER	—	num	25	SENT_333	[p8l1283t1208r1440b1244],
24	fold	JJ	O	fold	amod	25	SENT_333	[p8l1283t1208r1440b1244],
25	)	NN	O	)	dep	22	SENT_333	[p8l1283t1208r1440b1244],
26	in	IN	O	in	_	0	SENT_333	[p8l1454t1208r1485b1237],
27	patients	NNS	O	patient	prep_in	22	SENT_333	[p8l1497t1208r1625b1246],
28	with	IN	O	with	_	0	SENT_333	[p8l1638t1208r1711b1237],
29	a	DT	O	a	det	31	SENT_333	[p8l1724t1217r1742b1237],
30	ADBR2	NN	O	adbr2	nn	31	SENT_333	[p8l1751t1208r1878b1237],
31	codon	NN	O	codon	prep_with	27	SENT_333	[p8l536t1257r636b1286],
32	16	CD	NUMBER	16	num	34	SENT_333	[p8l653t1257r689b1286],
33	Arg/Arg	NN	O	arg/arg	nn	34	SENT_333	[p8l702t1257r840b1295],
34	genotype	NN	O	genotype	npadvmod	35	SENT_333	[p8l854t1261r1004b1295],
35	than	IN	O	than	advmod	31	SENT_333	[p8l1017t1257r1088b1286],
36	in	IN	O	in	_	0	SENT_333	[p8l1101t1257r1132b1286],
37	Gly/Gly	JJ	O	gly/gly	amod	41	SENT_333	[p8l1146t1257r1280b1295],
38	patients	NNS	O	patient	nn	41	SENT_333	[p8l1293t1257r1420b1295],
39	(	NN	O	(	nn	41	SENT_333	[p8l1435t1257r1531b1293],
40	103	CD	NUMBER	103	num	41	SENT_333	[p8l1435t1257r1531b1293],
41	)	NN	O	)	prep_in	31	SENT_333	[p8l1435t1257r1531b1293],
42	.	.	O	.	_	0	SENT_333	[p8l1435t1257r1531b1293],

1	The	DT	O	the	det	3	SENT_334	[p8l1546t1257r1610b1286],
2	genotype	NN	O	genotype	nn	3	SENT_334	[p8l1623t1262r1774b1295],
3	effect	NN	O	effect	nsubj	4	SENT_334	[p8l1787t1257r1880b1286],
4	differed	VBD	O	differ	_	0	SENT_334	[p8l536t1307r665b1336],
5	with	IN	O	with	_	0	SENT_334	[p8l681t1307r754b1336],
6	chronic	JJ	O	chronic	prep_with	4	SENT_334	[p8l770t1307r892b1336],
7	inhaled	VBN	O	inhale	partmod	6	SENT_334	[p8l909t1307r1031b1336],
8	[	NN	O	[	nn	10	SENT_334	[p8l1050t1306r1207b1345],
9	3-agonist	JJ	O	3-agonist	amod	10	SENT_334	[p8l1050t1306r1207b1345],
10	therapy	NN	O	therapy	dobj	7	SENT_334	[p8l1223t1307r1356b1345],
11	;	:	O	;	_	0	SENT_334	[p8l1223t1307r1356b1345],
12	moming	VBG	O	mome	dep	10	SENT_334	[p8l1374t1307r1513b1345],
13	peak	JJ	O	peak	amod	15	SENT_334	[p8l1529t1307r1607b1345],
14	expiratory	JJ	O	expiratory	amod	15	SENT_334	[p8l1623t1307r1791b1345],
15	ﬂow	NN	O	ﬂow	nsubj	17	SENT_334	[p8l1808t1307r1879b1336],
16	(	CD	NUMBER	(	num	17	SENT_334	[p8l537t1357r713b1393],
17	AM	NNP	O	AM	xcomp	12	SENT_334	[p8l537t1357r713b1393],
18	.	.	O	.	_	0	SENT_334	[p8l537t1357r713b1393],

1	—	NN	O	—	_	0	SENT_335	[p8l537t1357r713b1393],
2	.	.	O	.	_	0	SENT_335	[p8l537t1357r713b1393],

1	PEF	NN	O	pef	nsubj	14	SENT_336	[p8l537t1357r713b1393],
2	)	CD	NUMBER	)	num	1	SENT_336	[p8l537t1357r713b1393],
3	gradually	RB	O	gradually	advmod	4	SENT_336	[p8l728t1357r883b1395],
4	declined	VBD	O	decline	_	0	SENT_336	[p8l897t1357r1036b1386],
5	in	IN	O	in	_	0	SENT_336	[p8l1049t1357r1080b1386],
6	patients	NNS	O	patient	prep_in	4	SENT_336	[p8l1093t1357r1220b1395],
7	with	IN	O	with	_	0	SENT_336	[p8l1235t1357r1307b1386],
8	the	DT	O	the	det	10	SENT_336	[p8l1320t1357r1369b1386],
9	Arg/Arg	NN	O	arg/arg	nn	10	SENT_336	[p8l1383t1357r1520b1395],
10	genotype	NN	O	genotype	prep_with	4	SENT_336	[p8l1534t1361r1685b1395],
11	but	CC	O	but	_	0	SENT_336	[p8l1698t1357r1750b1386],
12	did	VBD	O	do	aux	14	SENT_336	[p8l1763t1357r1815b1386],
13	not	RB	O	not	neg	14	SENT_336	[p8l1827t1361r1880b1386],
14	change	VB	O	change	conj_but	4	SENT_336	[p8l536t1407r652b1445],
15	in	IN	O	in	_	0	SENT_336	[p8l664t1407r695b1436],
16	patients	NNS	O	patient	prep_in	14	SENT_336	[p8l707t1407r834b1445],
17	with	IN	O	with	_	0	SENT_336	[p8l847t1407r920b1436],
18	the	DT	O	the	det	23	SENT_336	[p8l931t1407r981b1436],
19	Gly/Gly	NNP	O	Gly/Gly	nn	23	SENT_336	[p8l994t1407r1128b1445],
20	genotype	NN	O	genotype	nn	23	SENT_336	[p8l1140t1411r1291b1445],
21	(	NN	O	(	nn	23	SENT_336	[p8l1304t1407r1400b1443],
22	104	CD	NUMBER	104	num	23	SENT_336	[p8l1304t1407r1400b1443],
23	)	NN	O	)	prep_with	16	SENT_336	[p8l1304t1407r1400b1443],
24	.	.	O	.	_	0	SENT_336	[p8l1304t1407r1400b1443],

1	AM	NNP	O	AM	_	0	SENT_337	[p8l1414t1407r1565b1436],
2	.	.	O	.	_	0	SENT_337	[p8l1414t1407r1565b1436],

1	—	NN	O	—	_	0	SENT_338	[p8l1414t1407r1565b1436],
2	.	.	O	.	_	0	SENT_338	[p8l1414t1407r1565b1436],

1	PEF	NN	O	pef	nsubj	2	SENT_339	[p8l1414t1407r1565b1436],
2	decreased	VBD	O	decrease	_	0	SENT_339	[p8l1577t1407r1740b1436],
3	dramatically	RB	O	dramatically	advmod	2	SENT_339	[p8l1752t1407r1878b1436, p8l536t1457r626b1494],
4	after	IN	O	after	_	0	SENT_339	[p8l640t1457r715b1486],
5	cessation	NN	O	cessation	prep_after	2	SENT_339	[p8l727t1457r878b1486],
6	of	IN	O	of	_	0	SENT_339	[p8l891t1457r927b1486],
7	inhaled	VBN	O	inhale	prepc_of	5	SENT_339	[p8l936t1457r1058b1486],
8	[	NN	O	[	nn	10	SENT_339	[p8l1074t1456r1231b1494],
9	3-agonist	JJ	O	3-agonist	amod	10	SENT_339	[p8l1074t1456r1231b1494],
10	therapy	NN	O	therapy	dobj	7	SENT_339	[p8l1243t1457r1365b1494],
11	in	IN	O	in	_	0	SENT_339	[p8l1378t1457r1409b1485],
12	Arg/Arg	NN	O	arg/arg	prep_in	7	SENT_339	[p8l1422t1457r1560b1494],
13	but	CC	O	but	_	0	SENT_339	[p8l1572t1457r1624b1486],
14	not	RB	O	not	_	0	SENT_339	[p8l1636t1461r1689b1486],
15	in	IN	O	in	_	0	SENT_339	[p8l1701t1457r1732b1485],
16	Gly/Gly	JJ	O	gly/gly	amod	17	SENT_339	[p8l1745t1457r1879b1494],
17	patients	NNS	O	patient	prep_in	7	SENT_339	[p8l535t1506r663b1544],
18	(	IN	O	(	_	0	SENT_339	[p8l678t1506r774b1542],
19	104	CD	NUMBER	104	num	20	SENT_339	[p8l678t1506r774b1542],
20	)	NN	O	)	prep_(	7	SENT_339	[p8l678t1506r774b1542],
21	.	.	O	.	_	0	SENT_339	[p8l678t1506r774b1542],

1	Patients	NNS	O	patient	nsubj	15	SENT_340	[p8l789t1506r918b1535],
2	with	IN	O	with	_	0	SENT_340	[p8l932t1506r1005b1535],
3	the	DT	O	the	det	5	SENT_340	[p8l1018t1506r1068b1535],
4	Arg/Arg	NN	O	arg/arg	nn	5	SENT_340	[p8l1081t1506r1219b1544],
5	genotype	NN	O	genotype	prep_with	1	SENT_340	[p8l1233t1511r1383b1544],
6	who	WP	O	who	nsubj	7	SENT_340	[p8l1397t1506r1467b1535],
7	receive	VBP	O	receive	rcmod	5	SENT_340	[p8l1480t1506r1597b1535],
8	regularly	RB	O	regularly	advmod	7	SENT_340	[p8l1610t1506r1759b1544],
9	scheduled	VBN	O	schedule	dep	7	SENT_340	[p8l1774t1506r1878b1535, p8l535t1556r606b1585],
10	inhaled	VBN	O	inhale	dep	9	SENT_340	[p8l621t1556r742b1585],
11	[	CD	NUMBER	[	num	12	SENT_340	[p8l760t1555r932b1594],
12	3-agonists	NNS	O	3-agonist	dobj	10	SENT_340	[p8l760t1555r932b1594],
13	may	MD	O	may	aux	15	SENT_340	[p8l947t1565r1017b1594],
14	therefore	RB	O	therefore	advmod	15	SENT_340	[p8l1032t1556r1181b1585],
15	be	VB	O	be	_	0	SENT_340	[p8l1195t1556r1234b1585],
16	at	IN	O	at	_	0	SENT_340	[p8l1250t1560r1278b1585],
17	risk	NN	O	risk	prep_at	15	SENT_340	[p8l1292t1556r1354b1585],
18	of	IN	O	of	_	0	SENT_340	[p8l1369t1556r1405b1585],
19	deleterious	JJ	O	deleterious	amod	20	SENT_340	[p8l1417t1556r1597b1585],
20	effects	NNS	O	effect	prep_of	17	SENT_340	[p8l1613t1556r1720b1585],
21	and	CC	O	and	_	0	SENT_340	[p8l1736t1556r1795b1585],
22	may	MD	O	may	aux	23	SENT_340	[p8l1809t1565r1879b1594],
23	require	VB	O	require	conj_and	15	SENT_340	[p8l535t1606r652b1643],
24	altemative	JJ	O	altemative	amod	25	SENT_340	[p8l670t1606r842b1635],
25	schedules	NNS	O	schedule	dobj	23	SENT_340	[p8l861t1606r1019b1635],
26	and/or	RB	O	and/or	advmod	23	SENT_340	[p8l1038t1606r1143b1635],
27	earlier	RBR	O	earlier	advmod	23	SENT_340	[p8l1160t1606r1265b1635],
28	anti	JJ	O	anti	amod	29	SENT_340	[p8l1283t1606r1580b1643],
29	—	NN	O	—	pobj	27	SENT_340	[p8l1283t1606r1580b1643],
30	inﬂammatory	JJ	O	inﬂammatory	amod	31	SENT_340	[p8l1283t1606r1580b1643],
31	treatment	NN	O	treatment	dobj	15	SENT_340	[p8l1598t1610r1762b1635],
32	.	.	O	.	_	0	SENT_340	[p8l1598t1610r1762b1635],

1	These	DT	O	these	det	2	SENT_341	[p8l1781t1606r1879b1635],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_341	[p8l536t1655r667b1693],
3	are	VBP	O	be	cop	4	SENT_341	[p8l678t1665r727b1685],
4	consistent	JJ	O	consistent	_	0	SENT_341	[p8l737t1655r902b1685],
5	with	IN	O	with	_	0	SENT_341	[p8l911t1655r983b1685],
6	the	DT	O	the	det	7	SENT_341	[p8l992t1656r1042b1685],
7	desensitization	NN	O	desensitization	prep_with	4	SENT_341	[p8l1052t1655r1297b1685],
8	of	IN	O	of	_	0	SENT_341	[p8l1307t1655r1342b1685],
9	ADBR2	NN	O	adbr2	prep_of	7	SENT_341	[p8l1349t1656r1483b1684],
10	in	IN	O	in	_	0	SENT_341	[p8l1493t1655r1524b1684],
11	patients	NNS	O	patient	prep_in	4	SENT_341	[p8l1533t1655r1660b1693],
12	with	IN	O	with	_	0	SENT_341	[p8l1671t1655r1744b1685],
13	a	DT	O	a	det	18	SENT_341	[p8l1753t1665r1770b1685],
14	codon	NN	O	codon	nn	18	SENT_341	[p8l1779t1656r1880b1685],
15	16	CD	NUMBER	16	num	18	SENT_341	[p8l539t1705r575b1735],
16	Arg/Arg	NN	O	arg/arg	nn	18	SENT_341	[p8l587t1705r725b1743],
17	genotype	NN	O	genotype	nn	18	SENT_341	[p8l737t1710r888b1743],
18	(	NN	O	(	prep_with	11	SENT_341	[p8l901t1706r997b1741],
19	102	CD	NUMBER	102	number	20	SENT_341	[p8l901t1706r997b1741],
20	)	CD	NUMBER	)	num	18	SENT_341	[p8l901t1706r997b1741],
21	.	.	O	.	_	0	SENT_341	[p8l901t1706r997b1741],

1	At	IN	O	at	quantmod	3	SENT_342	[p8l585t1755r626b1784],
2	least	JJS	O	least	mwe	1	SENT_342	[p8l637t1755r712b1784],
3	13	CD	NUMBER	13	num	5	SENT_342	[p8l727t1755r761b1784],
4	distinct	JJ	O	distinct	amod	5	SENT_342	[p8l775t1755r896b1784],
5	SNPs	NNS	O	snp	nsubjpass	10	SENT_342	[p8l907t1755r996b1784],
6	have	VBP	O	have	aux	10	SENT_342	[p8l1008t1755r1084b1784],
7	so	RB	O	so	advmod	8	SENT_342	[p8l1097t1764r1130b1784],
8	far	RB	O	far	advmod	10	SENT_342	[p8l1142t1755r1187b1784],
9	been	VBN	O	be	auxpass	10	SENT_342	[p8l1197t1755r1275b1784],
10	identiﬁed	VBN	O	identiﬁed	_	0	SENT_342	[p8l1286t1755r1442b1784],
11	in	IN	O	in	_	0	SENT_342	[p8l1452t1755r1484b1784],
12	ADBR2	NN	O	adbr2	nn	13	SENT_342	[p8l1492t1755r1619b1784],
13	(	NN	O	(	prep_in	10	SENT_342	[p8l1633t1755r1728b1791],
14	105	CD	NUMBER	105	num	15	SENT_342	[p8l1633t1755r1728b1791],
15	)	NN	O	)	dep	13	SENT_342	[p8l1633t1755r1728b1791],
16	.	.	O	.	_	0	SENT_342	[p8l1633t1755r1728b1791],

1	This	DT	O	this	nsubj	3	SENT_343	[p8l1741t1755r1813b1784],
2	has	VBZ	O	have	aux	3	SENT_343	[p8l1825t1755r1878b1784],
3	prompted	VBN	O	prompt	_	0	SENT_343	[p8l535t1805r694b1843],
4	evaluation	NN	O	evaluation	dobj	3	SENT_343	[p8l703t1805r872b1834],
5	of	IN	O	of	_	0	SENT_343	[p8l882t1805r918b1834],
6	the	DT	O	the	det	7	SENT_343	[p8l924t1805r973b1834],
7	importance	NN	O	importance	prep_of	4	SENT_343	[p8l983t1805r1168b1843],
8	of	IN	O	of	_	0	SENT_343	[p8l1178t1805r1214b1834],
9	haplotype	NN	O	haplotype	nn	10	SENT_343	[p8l1220t1805r1382b1843],
10	structure	NN	O	structure	prep_of	7	SENT_343	[p8l1393t1809r1536b1834],
11	instead	RB	O	instead	_	0	SENT_343	[p8l1545t1805r1662b1834],
12	of	IN	O	of	_	0	SENT_343	[p8l1671t1805r1707b1834],
13	individual	JJ	O	individual	amod	14	SENT_343	[p8l1713t1805r1879b1834],
14	SNPs	NNS	O	snp	prep_instead_of	10	SENT_343	[p8l537t1855r626b1884],
15	in	IN	O	in	_	0	SENT_343	[p8l635t1855r667b1883],
16	determining	VBG	O	determine	prepc_in	3	SENT_343	[p8l676t1855r874b1892],
17	receptor	NN	O	receptor	nn	18	SENT_343	[p8l883t1859r1019b1892],
18	function	NN	O	function	dobj	16	SENT_343	[p8l1027t1855r1164b1884],
19	and	CC	O	and	_	0	SENT_343	[p8l1174t1855r1232b1884],
20	pharmacological	JJ	O	pharmacological	amod	21	SENT_343	[p8l1240t1855r1516b1892],
21	response	NN	O	response	conj_and	18	SENT_343	[p8l1524t1864r1677b1892],
22	.	.	O	.	_	0	SENT_343	[p8l1524t1864r1677b1892],

1	Of	IN	O	of	_	0	SENT_344	[p8l1689t1855r1733b1884],
2	the	DT	O	the	det	6	SENT_344	[p8l1739t1855r1788b1884],
3	8192	CD	DATE	8192	num	6	SENT_344	[p8l1799t1855r1879b1884],
4	possible	JJ	O	possible	amod	6	SENT_344	[p8l535t1905r670b1942],
5	ADBR2	NN	O	adbr2	nn	6	SENT_344	[p8l676t1905r804b1933],
6	haplotypes	NNS	O	haplotype	prep_of	11	SENT_344	[p8l813t1905r1001b1942],
7	,	,	O	,	_	0	SENT_344	[p8l813t1905r1001b1942],
8	only	RB	O	only	quantmod	9	SENT_344	[p8l1012t1905r1083b1942],
9	12	CD	NUMBER	12	nsubjpass	11	SENT_344	[p8l1096t1905r1132b1933],
10	were	VBD	O	be	auxpass	11	SENT_344	[p8l1141t1914r1221b1934],
11	observed	VBN	O	observe	_	0	SENT_344	[p8l1230t1905r1378b1934],
12	among	IN	O	among	_	0	SENT_344	[p8l1387t1914r1497b1942],
13	77	CD	NUMBER	77	prep_among	11	SENT_344	[p8l1507t1905r1546b1934],
14	white	JJ	O	white	amod	18	SENT_344	[p8l1556t1905r1655b1939],
15	,	,	O	,	_	0	SENT_344	[p8l1556t1905r1655b1939],
16	black	JJ	O	black	amod	18	SENT_344	[p8l1665t1905r1763b1939],
17	,	,	O	,	_	0	SENT_344	[p8l1665t1905r1763b1939],
18	Asian	JJ	MISC	asian	amod	13	SENT_344	[p8l1773t1905r1878b1939],
19	,	,	O	,	_	0	SENT_344	[p8l1773t1905r1878b1939],
20	and	CC	O	and	_	0	SENT_344	[p8l536t1954r595b1984],
21	Hispanic/Latino	NN	O	hispanic/latino	nn	22	SENT_344	[p8l609t1954r875b1992],
22	subjects	NNS	O	subject	conj_and	13	SENT_344	[p8l890t1954r1021b1992],
23	(	JJ	O	(	amod	25	SENT_344	[p8l1037t1954r1133b1990],
24	105	CD	NUMBER	105	tmod	23	SENT_344	[p8l1037t1954r1133b1990],
25	)	NN	O	)	dep	22	SENT_344	[p8l1037t1954r1133b1990],
26	.	.	O	.	_	0	SENT_344	[p8l1037t1954r1133b1990],

1	Assessment	NNP	O	Assessment	nsubj	9	SENT_345	[p8l1149t1955r1345b1984],
2	of	IN	O	of	_	0	SENT_345	[p8l1359t1954r1395b1984],
3	[	CD	NUMBER	[	num	5	SENT_345	[p8l1410t1954r1567b1992],
4	5-agonist	JJ	O	5-agonist	amod	5	SENT_345	[p8l1410t1954r1567b1992],
5	therapy	NN	O	therapy	prep_of	1	SENT_345	[p8l1580t1954r1703b1992],
6	in	IN	O	in	_	0	SENT_345	[p8l1717t1954r1749b1983],
7	asthma	NN	O	asthma	nn	8	SENT_345	[p8l1764t1954r1880b1984],
8	patients	NNS	O	patient	prep_in	5	SENT_345	[p8l535t2004r663b2041],
9	revealed	VBD	O	reveal	_	0	SENT_345	[p8l677t2004r816b2033],
10	a	DT	O	a	det	12	SENT_345	[p8l831t2013r848b2033],
11	better	JJR	O	better	amod	12	SENT_345	[p8l861t2004r955b2033],
12	association	NN	O	association	dobj	9	SENT_345	[p8l970t2004r1152b2033],
13	of	IN	O	of	_	0	SENT_345	[p8l1167t2004r1203b2033],
14	bronchodilator	NN	O	bronchodilator	nn	15	SENT_345	[p8l1214t2004r1458b2033],
15	response	NN	O	response	prep_of	12	SENT_345	[p8l1471t2013r1615b2041],
16	with	IN	O	with	_	0	SENT_345	[p8l1630t2004r1703b2033],
17	haplotype	NN	O	haplotype	prep_with	9	SENT_345	[p8l1716t2004r1879b2041],
18	than	IN	O	than	advmod	25	SENT_345	[p8l535t2053r606b2083],
19	with	IN	O	with	_	0	SENT_345	[p8l616t2053r689b2083],
20	any	DT	O	any	det	21	SENT_345	[p8l699t2063r756b2091],
21	SNP	NN	O	snp	prep_with	18	SENT_345	[p8l768t2054r842b2083],
22	alone	RB	O	alone	advmod	21	SENT_345	[p8l852t2053r940b2083],
23	(	RB	O	(	advmod	18	SENT_345	[p8l951t2053r1047b2089],
24	105	CD	NUMBER	105	num	25	SENT_345	[p8l951t2053r1047b2089],
25	)	NN	O	)	rcmod	17	SENT_345	[p8l951t2053r1047b2089],
26	.	.	O	.	_	0	SENT_345	[p8l951t2053r1047b2089],

1	This	DT	O	this	nsubj	4	SENT_346	[p8l1059t2053r1131b2083],
2	is	VBZ	O	be	cop	4	SENT_346	[p8l1142t2053r1167b2083],
3	not	RB	O	not	neg	4	SENT_346	[p8l1178t2058r1231b2083],
4	surprising	JJ	O	surprising	_	0	SENT_346	[p8l1241t2053r1414b2091],
5	,	,	O	,	_	0	SENT_346	[p8l1241t2053r1414b2091],
6	as	IN	O	as	mark	10	SENT_346	[p8l1426t2063r1458b2083],
7	haplotype	NN	O	haplotype	nn	8	SENT_346	[p8l1468t2054r1631b2091],
8	structure	NN	O	structure	nsubj	10	SENT_346	[p8l1642t2058r1785b2083],
9	often	RB	O	often	advmod	10	SENT_346	[p8l1796t2053r1880b2083],
10	predicts	VBZ	O	predict	advcl	4	SENT_346	[p8l535t2103r665b2141],
11	phenotypic	JJ	O	phenotypic	amod	12	SENT_346	[p8l677t2103r860b2141],
12	consequences	NNS	O	consequence	dobj	10	SENT_346	[p8l873t2112r1098b2141],
13	better	RBR	O	better	advmod	14	SENT_346	[p8l1110t2103r1205b2132],
14	than	IN	O	than	advmod	10	SENT_346	[p8l1215t2103r1286b2132],
15	do	VB	O	do	dep	10	SENT_346	[p8l1298t2103r1337b2132],
16	SNPs	NNS	O	snp	dobj	15	SENT_346	[p8l1350t2103r1440b2132],
17	(	CD	NUMBER	(	number	18	SENT_346	[p8l1453t2103r1549b2139],
18	106	CD	NUMBER	106	num	19	SENT_346	[p8l1453t2103r1549b2139],
19	)	NN	O	)	dobj	10	SENT_346	[p8l1453t2103r1549b2139],
20	.	.	O	.	_	0	SENT_346	[p8l1453t2103r1549b2139],

1	Variants	NNS	O	variant	nsubj	15	SENT_347	[p8l585t2153r719b2182],
2	of	IN	O	of	_	0	SENT_347	[p8l743t2153r779b2182],
3	the	DT	O	the	det	4	SENT_347	[p8l798t2153r848b2182],
4	ADRB2	NN	O	adrb2	prep_of	1	SENT_347	[p8l870t2153r1014b2187],
5	,	,	O	,	_	0	SENT_347	[p8l870t2153r1014b2187],
6	ADRB1	NN	O	adrb1	prep_of	1	SENT_347	[p8l1038t2153r1182b2187],
7	,	,	O	,	_	0	SENT_347	[p8l1038t2153r1182b2187],
8	and	CC	O	and	_	0	SENT_347	[p8l1206t2153r1265b2182],
9	other	JJ	O	other	amod	12	SENT_347	[p8l1287t2153r1372b2182],
10	G	NN	O	g	nn	12	SENT_347	[p8l1394t2153r1554b2190],
11	—	NN	O	—	nn	12	SENT_347	[p8l1394t2153r1554b2190],
12	protein	NN	O	protein	conj_and	4	SENT_347	[p8l1394t2153r1554b2190],
13	coupled	VBN	O	couple	partmod	1	SENT_347	[p8l1576t2153r1706b2190],
14	receptors	NNS	O	receptor	dobj	13	SENT_347	[p8l1728t2157r1878b2190],
15	(	VBP	O	(	_	0	SENT_347	[p8l537t2203r685b2238],
16	GPCRS	NN	O	gpcr	nsubj	19	SENT_347	[p8l537t2203r685b2238],
17	)	CD	NUMBER	)	num	16	SENT_347	[p8l537t2203r685b2238],
18	generally	RB	O	generally	advmod	19	SENT_347	[p8l700t2202r852b2240],
19	encode	VBP	O	encode	ccomp	15	SENT_347	[p8l866t2202r982b2232],
20	hypomorphic	JJ	O	hypomorphic	amod	21	SENT_347	[p8l994t2202r1214b2240],
21	proteins	NNS	O	protein	dobj	19	SENT_347	[p8l1227t2202r1369b2240],
22	,	,	O	,	_	0	SENT_347	[p8l1227t2202r1369b2240],
23	not	RB	O	not	neg	15	SENT_347	[p8l1383t2207r1436b2231],
24	nonfunctional	JJ	O	nonfunctional	amod	25	SENT_347	[p8l1448t2202r1677b2232],
25	proteins	NNS	O	protein	nsubj	26	SENT_347	[p8l1690t2202r1822b2240],
26	(	VBP	O	(	ccomp	15	SENT_347	[p8l1837t2203r1878b2238],
27	3	CD	NUMBER	3	dobj	26	SENT_347	[p8l1837t2203r1878b2238],
28	,	,	O	,	_	0	SENT_347	[p8l1837t2203r1878b2238],
29	99	CD	NUMBER	99	num	30	SENT_347	[p8l536t2252r598b2288],
30	)	NN	O	)	appos	27	SENT_347	[p8l536t2252r598b2288],
31	.	.	O	.	_	0	SENT_347	[p8l536t2252r598b2288],

1	This	DT	O	this	det	2	SENT_348	[p8l611t2252r683b2281],
2	fact	NN	O	fact	nsubjpass	5	SENT_348	[p8l695t2252r756b2281],
3	may	MD	O	may	aux	5	SENT_348	[p8l766t2261r836b2290],
4	be	VB	O	be	auxpass	5	SENT_348	[p8l847t2252r885b2281],
5	related	VBN	O	relate	_	0	SENT_348	[p8l896t2252r1009b2281],
6	to	TO	O	to	_	0	SENT_348	[p8l1019t2257r1050b2281],
7	the	DT	O	the	det	9	SENT_348	[p8l1061t2252r1111b2281],
8	essential	JJ	O	essential	amod	9	SENT_348	[p8l1122t2252r1264b2281],
9	functions	NNS	O	function	prep_to	5	SENT_348	[p8l1275t2252r1427b2281],
10	of	IN	O	of	_	0	SENT_348	[p8l1439t2252r1475b2281],
11	the	DT	O	the	det	12	SENT_348	[p8l1483t2252r1533b2281],
12	GPCRS	NNP	O	GPCRS	prep_of	9	SENT_348	[p8l1544t2252r1676b2287],
13	,	,	O	,	_	0	SENT_348	[p8l1544t2252r1676b2287],
14	the	DT	O	the	det	15	SENT_348	[p8l1689t2252r1738b2281],
15	absence	NN	O	absence	nsubj	19	SENT_348	[p8l1750t2252r1879b2281],
16	of	IN	O	of	_	0	SENT_348	[p8l536t2302r572b2331],
17	which	WDT	O	which	prep_of	15	SENT_348	[p8l581t2302r681b2331],
18	is	VBZ	O	be	cop	19	SENT_348	[p8l692t2302r717b2331],
19	incompatible	JJ	O	incompatible	rcmod	9	SENT_348	[p8l729t2302r945b2340],
20	with	IN	O	with	_	0	SENT_348	[p8l957t2302r1029b2331],
21	life	NN	O	life	prep_with	19	SENT_348	[p8l1040t2302r1094b2331],
22	or	CC	O	or	_	0	SENT_348	[p8l1106t2311r1146b2336],
23	,	,	O	,	_	0	SENT_348	[p8l1106t2311r1146b2336],
24	at	IN	O	at	dep	19	SENT_348	[p8l1159t2306r1188b2331],
25	least	JJS	O	least	pobj	24	SENT_348	[p8l1199t2302r1282b2336],
26	,	,	O	,	_	0	SENT_348	[p8l1199t2302r1282b2336],
27	strongly	RB	O	strongly	advmod	28	SENT_348	[p8l1297t2302r1429b2340],
28	selected	VBN	O	select	rcmod	9	SENT_348	[p8l1443t2302r1574b2331],
29	against	IN	O	against	prep	28	SENT_348	[p8l1586t2302r1710b2340],
30	.	.	O	.	_	0	SENT_348	[p8l1586t2302r1710b2340],

1	Note	NN	O	note	_	0	SENT_349	[p8l1723t2302r1802b2331],
2	also	RB	O	also	advmod	1	SENT_349	[p8l1814t2302r1879b2331],
3	that	IN	O	that	dep	12	SENT_349	[p8l536t2351r597b2380],
4	not	RB	O	not	neg	7	SENT_349	[p8l608t2355r661b2380],
5	all	DT	O	all	det	7	SENT_349	[p8l673t2351r712b2380],
6	clinical	JJ	O	clinical	amod	7	SENT_349	[p8l724t2351r845b2380],
7	studies	NNS	O	study	nsubj	12	SENT_349	[p8l858t2351r970b2380],
8	of	IN	O	of	_	0	SENT_349	[p8l983t2351r1019b2380],
9	ADRB1/2	NN	O	adrb1/2	nn	10	SENT_349	[p8l1028t2351r1195b2381],
10	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_349	[p8l1206t2351r1463b2389],
11	have	VBP	O	have	aux	12	SENT_349	[p8l1475t2351r1551b2380],
12	yielded	VBN	O	yield	ccomp	1	SENT_349	[p8l1563t2351r1685b2389],
13	concordant	JJ	O	concordant	amod	15	SENT_349	[p8l1696t2351r1880b2380],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_349	[p8l535t2400r817b2438],
15	ﬁndings	NNS	O	ﬁndings	nsubj	16	SENT_349	[p8l836t2400r967b2438],
16	(	VBP	O	(	ccomp	12	SENT_349	[p8l986t2400r1027b2436],
17	3	CD	NUMBER	3	dobj	16	SENT_349	[p8l986t2400r1027b2436],
18	,	,	O	,	_	0	SENT_349	[p8l986t2400r1027b2436],
19	99	CD	NUMBER	99	num	20	SENT_349	[p8l1047t2400r1109b2436],
20	)	NN	O	)	appos	17	SENT_349	[p8l1047t2400r1109b2436],
21	,	,	O	,	_	0	SENT_349	[p8l1047t2400r1109b2436],
22	which	WDT	O	which	nsubj	24	SENT_349	[p8l1128t2400r1229b2429],
23	may	MD	O	may	aux	24	SENT_349	[p8l1245t2409r1316b2438],
24	reﬂect	VB	O	reﬂect	rcmod	17	SENT_349	[p8l1333t2400r1436b2429],
25	differences	NNS	O	difference	dobj	24	SENT_349	[p8l1453t2400r1634b2429],
26	in	IN	O	in	_	0	SENT_349	[p8l1652t2400r1684b2429],
27	the	DT	O	the	det	29	SENT_349	[p8l1701t2400r1750b2429],
28	patient	NN	O	patient	nn	29	SENT_349	[p8l1767t2400r1880b2438],
29	populations	NNS	O	population	prep_in	24	SENT_349	[p8l535t2449r727b2487],
30	studied	VBN	O	study	partmod	29	SENT_349	[p8l744t2449r870b2484],
31	,	,	O	,	_	0	SENT_349	[p8l744t2449r870b2484],
32	the	DT	O	the	det	35	SENT_349	[p8l886t2449r935b2479],
33	drug	NN	O	drug	nn	35	SENT_349	[p8l950t2449r1025b2487],
34	response	NN	O	response	nn	35	SENT_349	[p8l1039t2458r1183b2487],
35	phenotypes	NNS	O	phenotype	nsubj	36	SENT_349	[p8l1197t2449r1385b2487],
36	measured	VBN	O	measure	dep	12	SENT_349	[p8l1400t2449r1567b2484],
37	,	,	O	,	_	0	SENT_349	[p8l1400t2449r1567b2484],
38	and/or	IN	O	and/or	_	0	SENT_349	[p8l1584t2449r1689b2479],
39	the	DT	O	the	det	40	SENT_349	[p8l1702t2449r1752b2479],
40	way	NN	O	way	prep_and/or	56	SENT_349	[p8l1766t2458r1833b2487],
41	in	IN	O	in	_	0	SENT_349	[p8l1848t2449r1880b2478],
42	which	WDT	O	which	rel	45	SENT_349	[p8l536t2499r636b2528],
43	medications	NNS	O	medication	nsubjpass	45	SENT_349	[p8l647t2499r846b2528],
44	were	VBD	O	be	auxpass	45	SENT_349	[p8l859t2508r938b2528],
45	given	VBN	O	give	rcmod	40	SENT_349	[p8l950t2499r1039b2537],
46	or	CC	O	or	_	0	SENT_349	[p8l1051t2508r1085b2528],
47	other	JJ	O	other	amod	49	SENT_349	[p8l1096t2499r1180b2528],
48	confounding	JJ	O	confounding	amod	49	SENT_349	[p8l1191t2499r1399b2537],
49	variables	NNS	O	variable	nsubj	50	SENT_349	[p8l1412t2499r1558b2528],
50	(	VBP	O	(	rcmod	40	SENT_349	[p8l1572t2499r1652b2537],
51	e.g.	FW	O	e.g.	dobj	50	SENT_349	[p8l1572t2499r1652b2537],
52	,	,	O	,	_	0	SENT_349	[p8l1572t2499r1652b2537],
53	other	JJ	O	other	amod	55	SENT_349	[p8l1665t2499r1750b2528],
54	genetic	JJ	O	genetic	amod	55	SENT_349	[p8l1761t2499r1879b2537],
55	polymorphisms	NNS	O	polymorphism	nsubj	56	SENT_349	[p8l535t2548r815b2586],
56	)	VBP	O	)	dep	12	SENT_349	[p8l535t2548r815b2586],
57	.	.	O	.	_	0	SENT_349	[p8l535t2548r815b2586],

1	The	DT	O	the	det	3	SENT_350	[p8l436t2661r513b2697],
2	SCN1	NN	O	scn1	nn	3	SENT_350	[p8l527t2663r639b2697],
3	Sodium	NN	O	sodium	_	0	SENT_350	[p8l656t2661r812b2697],
4	Channel	NNP	O	Channel	dep	3	SENT_350	[p8l826t2661r995b2697],

1	The	DT	O	the	det	3	SENT_351	[p8l535t2742r599b2771],
2	HapMap	NNP	O	HapMap	nn	3	SENT_351	[p8l609t2743r752b2780],
3	project	NN	O	project	nsubj	6	SENT_351	[p8l762t2742r877b2780],
4	is	VBZ	O	be	aux	6	SENT_351	[p8l886t2742r912b2771],
5	rapidly	RB	O	rapidly	advmod	6	SENT_351	[p8l922t2742r1039b2780],
6	providing	VBG	O	provide	_	0	SENT_351	[p8l1048t2742r1208b2780],
7	important	JJ	O	important	amod	9	SENT_351	[p8l1218t2742r1379b2780],
8	new	JJ	O	new	amod	9	SENT_351	[p8l1388t2751r1455b2771],
9	insights	NNS	O	insight	dobj	6	SENT_351	[p8l1465t2742r1592b2780],
10	into	IN	O	into	_	0	SENT_351	[p8l1603t2742r1666b2771],
11	the	DT	O	the	det	12	SENT_351	[p8l1676t2742r1725b2771],
12	presence	NN	O	presence	prep_into	6	SENT_351	[p8l1735t2751r1879b2780],
13	and	CC	O	and	_	0	SENT_351	[p8l536t2791r595b2820],
14	evolution	NN	O	evolution	nsubj	18	SENT_351	[p8l602t2791r756b2821],
15	of	IN	O	of	_	0	SENT_351	[p8l764t2791r800b2820],
16	various	JJ	O	various	amod	17	SENT_351	[p8l805t2791r924b2820],
17	haplotype	NN	O	haplotype	prep_of	14	SENT_351	[p8l932t2791r1095b2829],
18	blocks	VBZ	O	block	conj_and	6	SENT_351	[p8l1102t2791r1209b2820],
19	in	IN	O	in	mark	24	SENT_351	[p8l1217t2791r1249b2820],
20	the	DT	O	the	det	23	SENT_351	[p8l1256t2791r1306b2820],
21	human	JJ	O	human	amod	23	SENT_351	[p8l1313t2791r1426b2820],
22	genome	NN	O	genome	nn	23	SENT_351	[p8l1434t2800r1563b2829],
23	(	NN	O	(	nsubj	24	SENT_351	[p8l1572t2791r1637b2827],
24	see	VBP	O	see	advcl	18	SENT_351	[p8l1572t2791r1637b2827],
25	http://www.ha	NN	O	http://www.ha	nn	27	SENT_351	[p8l1644t2791r1880b2829],
26	pmap.org/index.html.en	NN	O	pmap.org/index.html.en	nn	27	SENT_351	[p8l535t2840r953b2878],
27	)	NN	O	)	dobj	24	SENT_351	[p8l535t2840r953b2878],
28	.	.	O	.	_	0	SENT_351	[p8l535t2840r953b2878],

1	With	IN	O	with	_	0	SENT_352	[p8l978t2840r1059b2869],
2	the	DT	O	the	det	3	SENT_352	[p8l1082t2840r1132b2869],
3	possibility	NN	O	possibility	pobj	1	SENT_352	[p8l1155t2840r1327b2878],
4	that	IN	O	that	complm	7	SENT_352	[p8l1351t2840r1412b2869],
5	tagging	VBG	O	tag	amod	6	SENT_352	[p8l1435t2840r1558b2878],
6	SNPs	NNS	MISC	snp	nsubj	7	SENT_352	[p8l1583t2840r1672b2869],
7	reduce	VB	O	reduce	dep	3	SENT_352	[p8l1696t2840r1806b2869],
8	the	DT	O	the	det	9	SENT_352	[p8l1830t2840r1879b2869],
9	PHARMACOGENOMICS	NN	O	pharmacogenomic	dobj	7	SENT_352	[p8l1336t2900r1738b2927],
10	131	CD	NUMBER	131	num	9	SENT_352	[p8l1830t2897r1888b2927],

1	number	NN	O	number	nsubj	8	SENT_353	[p8l545t3023r672b3053],
2	of	IN	O	of	_	0	SENT_353	[p8l689t3023r725b3053],
3	SNPs	NNS	O	snp	prep_of	1	SENT_353	[p8l741t3023r830b3053],
4	indicative	JJ	O	indicative	amod	3	SENT_353	[p8l849t3023r1010b3053],
5	of	IN	O	of	_	0	SENT_353	[p8l1028t3023r1064b3053],
6	various	JJ	O	various	amod	7	SENT_353	[p8l1079t3023r1198b3053],
7	haplotype	NN	O	haplotype	prep_of	3	SENT_353	[p8l1216t3023r1379b3061],
8	blocks	VBZ	O	block	_	0	SENT_353	[p8l1396t3023r1503b3053],
9	(	CD	NUMBER	(	number	10	SENT_353	[p8l1523t3023r1620b3059],
10	107	CD	NUMBER	107	num	11	SENT_353	[p8l1523t3023r1620b3059],
11	)	NN	O	)	dobj	8	SENT_353	[p8l1523t3023r1620b3059],
12	,	,	O	,	_	0	SENT_353	[p8l1523t3023r1620b3059],
13	genotyping	VBG	O	genotype	partmod	11	SENT_353	[p8l1639t3023r1824b3061],
14	for	IN	O	for	mark	21	SENT_353	[p8l1842t3023r1890b3053],
15	various	JJ	O	various	amod	17	SENT_353	[p8l545t3073r664b3102],
16	receptor	NN	O	receptor	nn	17	SENT_353	[p8l676t3078r812b3111],
17	haplotypes	NNS	O	haplotype	nsubj	21	SENT_353	[p8l822t3073r1000b3111],
18	may	MD	O	may	aux	21	SENT_353	[p8l1012t3082r1082b3111],
19	become	VB	O	become	cop	21	SENT_353	[p8l1093t3073r1222b3102],
20	more	RBR	O	more	advmod	21	SENT_353	[p8l1233t3082r1317b3102],
21	feasible	JJ	O	feasible	advcl	13	SENT_353	[p8l1328t3073r1465b3102],
22	.	.	O	.	_	0	SENT_353	[p8l1328t3073r1465b3102],

1	Such	PDT	O	such	predet	3	SENT_354	[p8l1479t3073r1560b3103],
2	an	DT	O	a	det	3	SENT_354	[p8l1572t3082r1609b3102],
3	approach	NN	O	approach	nsubj	4	SENT_354	[p8l1621t3073r1771b3111],
4	identiﬁed	VBD	O	identiﬁed	_	0	SENT_354	[p8l1782t3073r1888b3102, p8l546t3122r607b3151],
5	an	DT	O	a	det	7	SENT_354	[p8l618t3131r655b3151],
6	intronic	JJ	O	intronic	amod	7	SENT_354	[p8l666t3122r793b3151],
7	polymorphism	NN	O	polymorphism	dobj	4	SENT_354	[p8l804t3122r1047b3160],
8	of	IN	O	of	_	0	SENT_354	[p8l1057t3122r1093b3151],
9	the	DT	O	the	det	12	SENT_354	[p8l1101t3122r1151b3151],
10	SCN1	NN	O	scn1	nn	12	SENT_354	[p8l1163t3122r1258b3151],
11	sodium	NN	O	sodium	nn	12	SENT_354	[p8l1274t3122r1394b3151],
12	channel	NN	O	channel	prep_of	7	SENT_354	[p8l1405t3122r1532b3151],
13	that	WDT	O	that	nsubj	14	SENT_354	[p8l1543t3122r1605b3151],
14	alters	VBZ	O	alter	rcmod	7	SENT_354	[p8l1616t3122r1703b3151],
15	splicing	NN	O	splicing	dobj	14	SENT_354	[p8l1716t3122r1845b3160],
16	of	IN	O	of	_	0	SENT_354	[p8l1856t3122r1892b3151],
17	the	DT	O	the	det	18	SENT_354	[p8l545t3172r595b3202],
18	receptor	NN	O	receptor	prep_of	15	SENT_354	[p8l608t3177r745b3210],
19	and	CC	O	and	_	0	SENT_354	[p8l758t3172r817b3202],
20	is	VBZ	O	be	cop	21	SENT_354	[p8l830t3172r856b3202],
21	related	JJ	O	related	rcmod	7	SENT_354	[p8l870t3172r983b3202],
22	to	TO	O	to	_	0	SENT_354	[p8l997t3177r1028b3202],
23	the	DT	O	the	det	24	SENT_354	[p8l1042t3172r1091b3202],
24	dosage	NN	O	dosage	prep_to	21	SENT_354	[p8l1106t3172r1220b3210],
25	required	VBN	O	require	partmod	24	SENT_354	[p8l1233t3172r1371b3210],
26	by	IN	O	by	_	0	SENT_354	[p8l1384t3172r1425b3210],
27	epileptic	JJ	O	epileptic	amod	28	SENT_354	[p8l1440t3172r1580b3210],
28	patients	NNS	O	patient	agent	25	SENT_354	[p8l1594t3172r1722b3210],
29	receiving	VBG	O	receive	xcomp	25	SENT_354	[p8l1737t3172r1889b3210],
30	carbamazepine	NN	O	carbamazepine	nn	31	SENT_354	[p8l546t3222r793b3260],
31	(	NN	O	(	dobj	29	SENT_354	[p8l805t3222r901b3258],
32	108	CD	NUMBER	108	num	33	SENT_354	[p8l805t3222r901b3258],
33	)	NN	O	)	dobj	14	SENT_354	[p8l805t3222r901b3258],
34	.	.	O	.	_	0	SENT_354	[p8l805t3222r901b3258],

1	This	DT	O	this	det	3	SENT_355	[p8l913t3222r985b3251],
2	efﬁcient	JJ	O	efﬁcient	amod	3	SENT_355	[p8l997t3222r1131b3251],
3	way	NN	O	way	nsubj	12	SENT_355	[p8l1141t3231r1208b3260],
4	of	IN	O	of	_	0	SENT_355	[p8l1219t3222r1255b3251],
5	identifying	VBG	O	identify	prepc_of	3	SENT_355	[p8l1263t3222r1443b3260],
6	haplotype	NN	O	haplotype	nn	7	SENT_355	[p8l1454t3222r1617b3260],
7	blocks	NNS	O	block	dobj	5	SENT_355	[p8l1627t3222r1734b3251],
8	and	CC	O	and	_	0	SENT_355	[p8l1746t3222r1804b3251],
9	SNP	NN	O	snp	nn	10	SENT_355	[p8l1815t3222r1890b3251],
10	markers	NNS	O	marker	dobj	5	SENT_355	[p8l545t3272r676b3301],
11	may	MD	O	may	aux	12	SENT_355	[p8l689t3281r759b3310],
12	facilitate	VB	O	facilitate	_	0	SENT_355	[p8l772t3272r915b3301],
13	more	RBR	O	more	advmod	14	SENT_355	[p8l927t3281r1011b3301],
14	rapid	JJ	O	rapid	amod	15	SENT_355	[p8l1023t3272r1108b3310],
15	determination	NN	O	determination	dobj	12	SENT_355	[p8l1120t3272r1349b3301],
16	of	IN	O	of	_	0	SENT_355	[p8l1362t3272r1397b3301],
17	haplotype	NN	O	haplotype	nn	19	SENT_355	[p8l1406t3272r1569b3310],
18	receptor	NN	O	receptor	nn	19	SENT_355	[p8l1581t3277r1717b3310],
19	variations	NNS	O	variation	prep_of	15	SENT_355	[p8l1728t3272r1889b3301],
20	that	WDT	O	that	nsubj	21	SENT_355	[p8l545t3321r607b3350],
21	inﬂuence	VBP	O	inﬂuence	rcmod	15	SENT_355	[p8l618t3321r769b3350],
22	drug	NN	O	drug	nn	23	SENT_355	[p8l781t3321r855b3359],
23	response	NN	O	response	dobj	21	SENT_355	[p8l866t3330r1019b3359],
24	.	.	O	.	_	0	SENT_355	[p8l866t3330r1019b3359],

1	THE	DT	O	the	det	2	SENT_356	[p8l446t3434r541b3468],
2	WAY	NN	O	way	_	0	SENT_356	[p8l553t3435r654b3469],
3	FORWARD	RB	O	forward	advmod	2	SENT_356	[p8l666t3435r900b3469],

1	A	DT	O	a	det	2	SENT_357	[p9l268t1111r291b1134],
2	nnu	NN	O	nnu	_	0	SENT_357	[p9l275t1047r291b1103],
3	.	.	O	.	_	0	SENT_357	[p9l275t1047r291b1103],

1	Rev.	NNP	O	Rev.	nn	2	SENT_358	[p9l268t976r291b1036],
2	Med	NNP	O	Med	_	0	SENT_358	[p9l268t898r291b966],
3	.	.	O	.	_	0	SENT_358	[p9l268t898r291b966],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_359	[p9l268t652r292b887],
2	:	:	O	:	_	0	SENT_359	[p9l268t652r292b887],
3	l19-137	CD	NUMBER	l19-137	dep	1	SENT_359	[p9l268t652r292b887],
4	.	.	O	.	_	0	SENT_359	[p9l268t652r292b887],

1	Downloaded	VBN	O	download	_	0	SENT_360	[p9l268t471r291b641],
2	from	IN	O	from	_	0	SENT_360	[p9l268t398r291b462],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_360	[p9l268t64r298b388],
4	by	IN	O	by	_	0	SENT_360	[p9l301t1060r332b1093],
5	University	NNP	ORGANIZATION	University	dep	9	SENT_360	[p9l301t911r332b1051],
6	of	IN	ORGANIZATION	of	_	0	SENT_360	[p9l301t872r325b901],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	5	SENT_360	[p9l301t725r325b866],
8	-	:	O	-	_	0	SENT_360	[p9l315t707r318b715],
9	Madison	NNP	O	Madison	prep_by	1	SENT_360	[p9l301t580r325b697],
10	on	IN	O	on	_	0	SENT_360	[p9l309t538r325b571],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_360	[p9l301t404r325b529],
12	.	.	O	.	_	0	SENT_360	[p9l301t404r325b529],

1	For	IN	O	for	_	0	SENT_361	[p9l302t347r325b394],
2	personal	JJ	O	personal	amod	3	SENT_361	[p9l301t227r332b339],
3	use	NN	O	use	pobj	1	SENT_361	[p9l309t174r325b218],
4	only	RB	O	only	advmod	3	SENT_361	[p9l301t100r332b165],
5	.	.	O	.	_	0	SENT_361	[p9l301t100r332b165],

1	3	LS	NUMBER	3	_	0	SENT_362	[p9l484t1652r508b1679],
2	.	.	O	.	_	0	SENT_362	[p9l484t1652r508b1679],

1	Weinshilboum	NNP	O	Weinshilboum	nn	2	SENT_363	[p9l527t1652r744b1679],
2	R.	NNP	O	R.	_	0	SENT_363	[p9l759t1653r790b1679],
3	2004	CD	DATE	2004	dep	2	SENT_363	[p9l808t1652r889b1679],
4	.	.	O	.	_	0	SENT_363	[p9l808t1652r889b1679],

1	Inheritance	NN	O	inheritance	_	0	SENT_364	[p9l906t1652r1073b1679],
2	and	CC	O	and	cc	3	SENT_364	[p9l1090t1652r1142b1679],
3	6	CD	NUMBER	6	num	1	SENT_364	[p9l1231t1652r1255b1679],
4	.	.	O	.	_	0	SENT_364	[p9l1231t1652r1255b1679],

1	EICHELBAUM	NNP	O	EICHELBAUM	_	0	SENT_365	[p9l507t1709r748b1736],
2	I	PRP	O	I	nsubj	3	SENT_365	[p9l766t1712r783b1730],
3	INGELMAN-SUNDBERG	VBP	O	ingelman-sundberg	rcmod	1	SENT_365	[p9l802t1709r1214b1736],
4	I	PRP	O	I	nsubj	5	SENT_365	[p9l1232t1712r1249b1730],
5	EVANS	VBZ	O	evan	ccomp	3	SENT_365	[p9l1268t1709r1385b1736],
6	Most	JJS	O	most	dobj	5	SENT_365	[p9l545t43r630b72],
7	of	IN	O	of	_	0	SENT_365	[p9l644t42r679b72],
8	the	DT	O	the	det	10	SENT_365	[p9l690t42r740b72],
9	genetic	JJ	O	genetic	amod	10	SENT_365	[p9l754t42r871b80],
10	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_365	[p9l885t42r1142b80],
11	characterized	VBN	O	characterize	partmod	10	SENT_365	[p9l1157t42r1377b72],
12	to	TO	O	to	_	0	SENT_365	[p9l1390t47r1421b72],
13	date	NN	O	date	prep_to	11	SENT_365	[p9l1435t42r1503b72],
14	that	IN	O	that	complm	22	SENT_365	[p9l1517t42r1578b72],
15	inﬂuence	NN	O	inﬂuence	nn	17	SENT_365	[p9l1591t42r1742b72],
16	drug	NN	O	drug	nn	17	SENT_365	[p9l1756t42r1831b80],
17	response	NN	O	response	nsubj	22	SENT_365	[p9l1844t51r1888b72, p9l547t102r657b130],
18	in	IN	O	in	_	0	SENT_365	[p9l671t92r703b121],
19	humans	NNS	O	human	prep_in	17	SENT_365	[p9l716t92r844b122],
20	are	VBP	O	be	cop	22	SENT_365	[p9l860t102r908b122],
21	highly	RB	O	highly	advmod	22	SENT_365	[p9l922t92r1028b130],
22	penetrant	JJ	O	penetrant	ccomp	11	SENT_365	[p9l1041t97r1196b130],
23	monogenic	JJ	O	monogenic	amod	24	SENT_365	[p9l1210t92r1392b130],
24	traits	NNS	O	trait	dep	26	SENT_365	[p9l1407t92r1498b122],
25	:	:	O	:	_	0	SENT_365	[p9l1407t92r1498b122],
26	Inherited	VBN	O	inherit	dep	1	SENT_365	[p9l1515t92r1664b122],
27	difference	NN	O	difference	nsubj	32	SENT_365	[p9l1678t92r1844b122],
28	in	IN	O	in	_	0	SENT_365	[p9l1858t92r1890b121],
29	a	DT	O	a	det	31	SENT_365	[p9l546t151r563b171],
30	single	JJ	O	single	amod	31	SENT_365	[p9l578t142r675b180],
31	gene	NN	O	gene	prep_in	27	SENT_365	[p9l689t151r766b180],
32	has	VBZ	O	have	ccomp	26	SENT_365	[p9l780t142r834b171],
33	such	PDT	O	such	predet	36	SENT_365	[p9l850t142r924b171],
34	a	DT	O	a	det	36	SENT_365	[p9l939t151r956b171],
35	profound	JJ	O	profound	amod	36	SENT_365	[p9l969t142r1121b180],
36	effect	NN	O	effect	dobj	32	SENT_365	[p9l1135t142r1228b171],
37	on	IN	O	on	_	0	SENT_365	[p9l1242t151r1282b171],
38	the	DT	O	the	det	39	SENT_365	[p9l1296t142r1345b171],
39	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	36	SENT_365	[p9l1359t142r1650b180],
40	or	CC	O	or	_	0	SENT_365	[p9l1666t151r1700b171],
41	pharmacodynarnics	NNS	O	pharmacodynarnic	conj_or	39	SENT_365	[p9l1712t142r1888b180, p9l546t192r702b230],
42	of	IN	O	of	_	0	SENT_365	[p9l720t192r756b221],
43	a	DT	O	a	det	44	SENT_365	[p9l771t201r788b221],
44	drug	NN	O	drug	prep_of	39	SENT_365	[p9l804t192r878b230],
45	that	WDT	O	that	dobj	51	SENT_365	[p9l895t192r957b221],
46	interindividual	JJ	O	interindividual	amod	47	SENT_365	[p9l973t192r1215b221],
47	difference	NN	O	difference	nsubj	51	SENT_365	[p9l1232t192r1398b221],
48	in	IN	O	in	_	0	SENT_365	[p9l1415t192r1446b221],
49	one	CD	NUMBER	one	num	50	SENT_365	[p9l1463t201r1521b221],
50	gene	NN	O	gene	prep_in	47	SENT_365	[p9l1538t201r1615b230],
51	has	VBZ	O	have	rcmod	44	SENT_365	[p9l1631t192r1685b221],
52	a	DT	O	a	det	55	SENT_365	[p9l1703t201r1720b221],
53	clinically	RB	O	clinically	advmod	54	SENT_365	[p9l1736t192r1889b230],
54	important	JJ	O	important	amod	55	SENT_365	[p9l545t242r706b280],
55	effect	NN	O	effect	dobj	51	SENT_365	[p9l718t242r811b271],
56	on	IN	O	on	_	0	SENT_365	[p9l824t251r863b271],
57	drug	NN	O	drug	nn	58	SENT_365	[p9l876t242r951b280],
58	response	NN	O	response	prep_on	55	SENT_365	[p9l963t251r1116b280],
59	.	.	O	.	_	0	SENT_365	[p9l963t251r1116b280],

1	These	DT	O	these	nsubj	6	SENT_366	[p9l1131t242r1229b271],
2	are	VBP	O	be	cop	6	SENT_366	[p9l1242t251r1291b271],
3	the	DT	O	the	det	6	SENT_366	[p9l1303t242r1353b271],
4	“	NN	O	“	nn	6	SENT_366	[p9l1367t242r1592b280],
5	low	JJ	O	low	amod	6	SENT_366	[p9l1367t242r1592b280],
6	—	NN	O	—	_	0	SENT_366	[p9l1367t242r1592b280],
7	hanging	VBG	O	hang	partmod	6	SENT_366	[p9l1367t242r1592b280],
8	fruit	NN	O	fruit	nn	9	SENT_366	[p9l1605t242r1692b271],
9	”	NN	O	”	dobj	7	SENT_366	[p9l1605t242r1692b271],
10	of	IN	O	of	_	0	SENT_366	[p9l1707t242r1742b271],
11	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	9	SENT_366	[p9l1752t242r1888b280, p9l546t292r728b329],
12	.	.	O	.	_	0	SENT_366	[p9l1752t242r1888b280, p9l546t292r728b329],

1	However	RB	O	however	advmod	9	SENT_367	[p9l742t292r897b326],
2	,	,	O	,	_	0	SENT_367	[p9l742t292r897b326],
3	the	DT	O	the	det	4	SENT_367	[p9l911t292r960b321],
4	effects	NNS	O	effect	nsubjpass	9	SENT_367	[p9l972t292r1080b321],
5	of	IN	O	of	_	0	SENT_367	[p9l1093t292r1129b321],
6	most	JJS	O	most	amod	7	SENT_367	[p9l1138t296r1218b321],
7	drugs	NNS	O	drug	prep_of	4	SENT_367	[p9l1230t292r1320b329],
8	are	VBP	O	be	auxpass	9	SENT_367	[p9l1333t301r1382b321],
9	determined	VBN	O	determine	_	0	SENT_367	[p9l1394t292r1580b321],
10	by	IN	O	by	_	0	SENT_367	[p9l1591t292r1632b329],
11	many	JJ	O	many	amod	12	SENT_367	[p9l1644t301r1734b329],
12	proteins	NNS	O	protein	agent	9	SENT_367	[p9l1746t292r1888b329],
13	,	,	O	,	_	0	SENT_367	[p9l1746t292r1888b329],
14	and	CC	O	and	_	0	SENT_367	[p9l546t342r604b371],
15	composite	JJ	O	composite	amod	17	SENT_367	[p9l615t341r784b379],
16	genetic	JJ	O	genetic	amod	17	SENT_367	[p9l795t341r912b379],
17	polymorphisms	NNS	O	polymorphism	nsubjpass	27	SENT_367	[p9l923t341r1180b379],
18	in	IN	O	in	_	0	SENT_367	[p9l1191t342r1223b370],
19	multiple	JJ	O	multiple	amod	20	SENT_367	[p9l1233t341r1370b379],
20	genes	NNS	O	gene	prep_in	17	SENT_367	[p9l1381t351r1473b379],
21	coupled	VBN	O	couple	partmod	20	SENT_367	[p9l1485t342r1615b379],
22	with	IN	O	with	_	0	SENT_367	[p9l1625t342r1698b371],
23	nongenetic	JJ	O	nongenetic	amod	24	SENT_367	[p9l1708t341r1889b379],
24	factors	NNS	O	factor	prep_with	21	SENT_367	[p9l545t391r656b420],
25	will	MD	O	will	aux	27	SENT_367	[p9l673t391r736b420],
26	be	VB	O	be	auxpass	27	SENT_367	[p9l752t391r791b420],
27	found	VBN	O	find	conj_and	9	SENT_367	[p9l807t391r903b420],
28	to	TO	O	to	aux	29	SENT_367	[p9l919t396r950b420],
29	determine	VB	O	determine	xcomp	27	SENT_367	[p9l967t391r1132b420],
30	drug	NN	O	drug	nn	31	SENT_367	[p9l1149t391r1223b429],
31	response	NN	O	response	dobj	29	SENT_367	[p9l1239t400r1392b429],
32	.	.	O	.	_	0	SENT_367	[p9l1239t400r1392b429],

1	New	NNP	O	New	nn	2	SENT_368	[p9l1410t392r1487b420],
2	strategies	NNS	O	strategy	nsubjpass	5	SENT_368	[p9l1505t391r1658b429],
3	are	VBP	O	be	auxpass	5	SENT_368	[p9l1676t400r1724b420],
4	therefore	RB	O	therefore	advmod	5	SENT_368	[p9l1741t391r1889b420],
5	needed	VBN	O	need	_	0	SENT_368	[p9l545t441r662b470],
6	to	TO	O	to	aux	7	SENT_368	[p9l671t446r702b470],
7	identify	VB	O	identify	xcomp	5	SENT_368	[p9l712t441r846b479],
8	,	,	O	,	_	0	SENT_368	[p9l712t441r846b479],
9	for	IN	O	for	_	0	SENT_368	[p9l857t441r905b470],
10	a	DT	O	a	det	12	SENT_368	[p9l914t450r932b470],
11	given	VBN	O	give	amod	12	SENT_368	[p9l941t441r1030b479],
12	drug	NN	O	drug	prep_for	5	SENT_368	[p9l1039t441r1123b479],
13	,	,	O	,	_	0	SENT_368	[p9l1039t441r1123b479],
14	the	DT	O	the	det	16	SENT_368	[p9l1134t441r1183b470],
15	relevant	JJ	O	relevant	amod	16	SENT_368	[p9l1192t441r1324b470],
16	genes	NNS	O	gene	prep_for	5	SENT_368	[p9l1333t450r1425b479],
17	and	CC	O	and	_	0	SENT_368	[p9l1437t441r1495b470],
18	genetic	JJ	O	genetic	amod	19	SENT_368	[p9l1504t441r1622b479],
19	polymorphisms	NNS	O	polymorphism	prep_for	5	SENT_368	[p9l1632t441r1889b479],
20	and	CC	O	and	_	0	SENT_368	[p9l546t491r604b520],
21	the	DT	O	the	det	22	SENT_368	[p9l619t491r668b520],
22	pathways	NNS	O	pathway	conj_and	12	SENT_368	[p9l683t491r838b529],
23	and	CC	O	and	_	0	SENT_368	[p9l854t491r913b520],
24	processes	NNS	O	process	conj_and	12	SENT_368	[p9l926t500r1084b529],
25	in	IN	O	in	_	0	SENT_368	[p9l1100t491r1131b520],
26	their	PRP$	O	they	poss	27	SENT_368	[p9l1146t491r1222b520],
27	interaction	NN	O	interaction	prep_in	22	SENT_368	[p9l1235t491r1420b520],
28	.	.	O	.	_	0	SENT_368	[p9l1235t491r1420b520],

1	The	DT	O	the	det	3	SENT_369	[p9l1437t491r1500b520],
2	various	JJ	O	various	amod	3	SENT_369	[p9l1515t491r1634b521],
3	strategies	NNS	O	strategy	nsubj	7	SENT_369	[p9l1652t491r1804b529],
4	now	RB	DATE	now	advmod	6	SENT_369	[p9l1820t500r1889b521],
5	being	VBG	O	be	auxpass	6	SENT_369	[p9l545t541r636b579],
6	used	VBN	O	use	partmod	3	SENT_369	[p9l648t541r724b570],
7	include	VBP	O	include	ccomp	20	SENT_369	[p9l736t541r857b570],
8	genome	NN	O	genome	nsubj	13	SENT_369	[p9l870t541r1095b579],
9	—	CD	NUMBER	—	num	8	SENT_369	[p9l870t541r1095b579],
10	wide	JJ	O	wide	amod	13	SENT_369	[p9l870t541r1095b579],
11	haplotype	NN	O	haplotype	nn	13	SENT_369	[p9l1107t541r1270b579],
12	mapping	NN	O	mapping	nn	13	SENT_369	[p9l1282t541r1426b579],
13	(	NN	O	(	xcomp	7	SENT_369	[p9l1440t542r1495b577],
14	1	CD	NUMBER	1	num	15	SENT_369	[p9l1440t542r1495b577],
15	)	NN	O	)	dep	13	SENT_369	[p9l1440t542r1495b577],
16	,	,	O	,	_	0	SENT_369	[p9l1440t542r1495b577],
17	gene	NN	O	gene	nn	19	SENT_369	[p9l1509t550r1586b579],
18	expression	NN	O	expression	nn	19	SENT_369	[p9l1599t541r1775b579],
19	analyses	NNS	O	analysis	nsubj	20	SENT_369	[p9l1788t541r1888b579, p9l547t600r594b620],
20	(	VBP	O	(	_	0	SENT_369	[p9l610t591r692b627],
21	109	CD	NUMBER	109	nsubj	37	SENT_369	[p9l610t591r692b627],
22	,	,	O	,	_	0	SENT_369	[p9l610t591r692b627],
23	110	CD	NUMBER	110	num	24	SENT_369	[p9l712t591r792b627],
24	)	NN	O	)	conj_and	21	SENT_369	[p9l712t591r792b627],
25	,	,	O	,	_	0	SENT_369	[p9l712t591r792b627],
26	and	CC	O	and	_	0	SENT_369	[p9l808t591r867b620],
27	proteornic	JJ	O	proteornic	amod	28	SENT_369	[p9l879t591r1047b629],
28	methods	NNS	O	method	conj_and	21	SENT_369	[p9l1061t591r1210b625],
29	,	,	O	,	_	0	SENT_369	[p9l1061t591r1210b625],
30	as	RB	O	as	_	0	SENT_369	[p9l1226t600r1257b620],
31	well	RB	O	well	_	0	SENT_369	[p9l1272t591r1343b620],
32	as	IN	O	as	_	0	SENT_369	[p9l1357t600r1389b620],
33	“	JJ	O	“	amod	36	SENT_369	[p9l1405t591r1580b620],
34	candidate	NN	O	candidate	nn	36	SENT_369	[p9l1405t591r1580b620],
35	gene	NN	O	gene	nn	36	SENT_369	[p9l1595t591r1689b629],
36	”	NN	O	”	conj_and	21	SENT_369	[p9l1595t591r1689b629],
37	approaches	VBZ	O	approach	ccomp	20	SENT_369	[p9l1705t591r1889b629],
38	based	VBN	O	base	_	0	SENT_369	[p9l545t641r639b670],
39	on	IN	O	on	prepc_based_on	37	SENT_369	[p9l648t650r688b670],
40	known	JJ	O	known	amod	42	SENT_369	[p9l697t641r808b670],
41	pharmacokinetic	JJ	O	pharmacokinetic	amod	42	SENT_369	[p9l817t641r1093b679],
42	(	NN	O	(	pobj	37	SENT_369	[p9l1104t641r1132b677],
43	1	CD	NUMBER	1	number	44	SENT_369	[p9l1104t641r1132b677],
44	1	CD	NUMBER	1	dobj	37	SENT_369	[p9l1141t641r1153b670],
45	1	CD	NUMBER	1	num	46	SENT_369	[p9l1162t641r1190b677],
46	)	NN	O	)	dep	44	SENT_369	[p9l1162t641r1190b677],
47	and	CC	O	and	_	0	SENT_369	[p9l1201t641r1260b670],
48	pharmacodynamic	JJ	O	pharmacodynamic	amod	49	SENT_369	[p9l1268t641r1573b679],
49	(	NN	O	(	conj_and	44	SENT_369	[p9l1584t641r1650b677],
50	67	CD	NUMBER	67	num	52	SENT_369	[p9l1584t641r1650b677],
51	)	NN	O	)	nn	52	SENT_369	[p9l1584t641r1650b677],
52	factors	NNS	O	factor	dep	49	SENT_369	[p9l1660t641r1780b670],
53	.	.	O	.	_	0	SENT_369	[p9l1660t641r1780b670],

1	These	DT	O	these	det	2	SENT_370	[p9l1791t641r1889b670],
2	approaches	NNS	O	approach	nsubj	25	SENT_370	[p9l546t691r740b729],
3	,	,	O	,	_	0	SENT_370	[p9l546t691r740b729],
4	with	IN	O	with	_	0	SENT_370	[p9l754t691r827b720],
5	evolving	VBG	O	evolve	prepc_with	2	SENT_370	[p9l840t691r982b729],
6	statistical	JJ	O	statistical	amod	10	SENT_370	[p9l996t691r1151b720],
7	and	CC	O	and	_	0	SENT_370	[p9l1164t691r1223b720],
8	biological	JJ	O	biological	amod	10	SENT_370	[p9l1234t691r1400b729],
9	(	NN	O	(	nn	10	SENT_370	[p9l1414t691r1579b729],
10	pathway	NN	O	pathway	dobj	5	SENT_370	[p9l1414t691r1579b729],
11	)	CD	NUMBER	)	num	12	SENT_370	[p9l1414t691r1579b729],
12	models	NNS	O	model	nsubj	20	SENT_370	[p9l1593t691r1711b720],
13	and	CC	O	and	_	0	SENT_370	[p9l1725t691r1784b720],
14	quantitative	JJ	O	quantitative	amod	15	SENT_370	[p9l1796t700r1888b729, p9l545t741r658b771],
15	genotyping	NN	O	genotyping	conj_and	12	SENT_370	[p9l669t741r854b779],
16	in	IN	O	in	_	0	SENT_370	[p9l865t741r896b770],
17	some	DT	O	some	det	19	SENT_370	[p9l908t751r993b771],
18	target	NN	O	target	nn	19	SENT_370	[p9l1004t746r1097b779],
19	tissues	NNS	O	tissue	prep_in	15	SENT_370	[p9l1107t741r1216b771],
20	(	VBP	O	(	dep	5	SENT_370	[p9l1229t742r1325b777],
21	112	CD	NUMBER	112	num	22	SENT_370	[p9l1229t742r1325b777],
22	)	CD	NUMBER	)	dobj	20	SENT_370	[p9l1229t742r1325b777],
23	,	,	O	,	_	0	SENT_370	[p9l1229t742r1325b777],
24	are	VBP	O	be	cop	25	SENT_370	[p9l1339t751r1387b771],
25	likely	JJ	O	likely	_	0	SENT_370	[p9l1398t741r1491b779],
26	to	TO	O	to	aux	28	SENT_370	[p9l1502t746r1532b771],
27	be	VB	O	be	cop	28	SENT_370	[p9l1543t741r1581b771],
28	critical	JJ	O	critical	xcomp	25	SENT_370	[p9l1593t741r1706b771],
29	for	IN	O	for	_	0	SENT_370	[p9l1717t741r1765b771],
30	studies	NNS	O	study	prep_for	28	SENT_370	[p9l1777t741r1889b771],
31	that	WDT	O	that	nsubj	32	SENT_370	[p9l545t791r607b820],
32	aim	VBP	O	aim	rcmod	30	SENT_370	[p9l618t791r679b820],
33	to	TO	O	to	aux	34	SENT_370	[p9l689t796r720b820],
34	elucidate	VB	O	elucidate	xcomp	32	SENT_370	[p9l732t791r880b820],
35	polygenic	JJ	O	polygenic	amod	36	SENT_370	[p9l890t791r1053b829],
36	determinants	NNS	O	determinant	dobj	34	SENT_370	[p9l1065t791r1277b820],
37	of	IN	O	of	_	0	SENT_370	[p9l1289t791r1325b820],
38	drug	NN	O	drug	nn	39	SENT_370	[p9l1333t791r1408b829],
39	response	NN	O	response	prep_of	36	SENT_370	[p9l1418t801r1571b829],
40	.	.	O	.	_	0	SENT_370	[p9l1418t801r1571b829],

1	Clinical	JJ	O	clinical	amod	2	SENT_371	[p9l1585t791r1715b821],
2	validation	NN	O	validation	nsubj	8	SENT_371	[p9l1726t791r1890b821],
3	of	IN	O	of	_	0	SENT_371	[p9l546t841r581b870],
4	these	DT	O	these	det	6	SENT_371	[p9l594t841r678b870],
5	polygenic	JJ	O	polygenic	amod	6	SENT_371	[p9l693t841r856b879],
6	models	NNS	O	model	prep_of	2	SENT_371	[p9l872t841r990b870],
7	will	MD	O	will	aux	8	SENT_371	[p9l1007t841r1070b870],
8	require	VB	O	require	_	0	SENT_371	[p9l1085t841r1202b879],
9	large	JJ	O	large	amod	11	SENT_371	[p9l1217t841r1298b879],
10	clinical	JJ	O	clinical	amod	11	SENT_371	[p9l1314t841r1435b870],
11	trials	NNS	O	trial	dobj	8	SENT_371	[p9l1451t841r1532b870],
12	of	IN	O	of	advmod	14	SENT_371	[p9l1549t841r1584b870],
13	uniformly	RB	O	uniformly	advmod	12	SENT_371	[p9l1597t841r1762b879],
14	treated	VBN	O	treat	dep	11	SENT_371	[p9l1778t841r1890b870],
15	and	CC	O	and	_	0	SENT_371	[p9l546t891r605b920],
16	systematically	RB	O	systematically	advmod	14	SENT_371	[p9l615t891r850b929],
17	characterized	VBN	O	characterize	dep	11	SENT_371	[p9l861t891r1081b920],
18	patients	NNS	O	patient	dobj	17	SENT_371	[p9l1091t891r1228b929],
19	,	,	O	,	_	0	SENT_371	[p9l1091t891r1228b929],
20	high-throughput	JJ	O	high-throughput	amod	22	SENT_371	[p9l1239t891r1509b929],
21	genomic	JJ	O	genomic	amod	22	SENT_371	[p9l1519t891r1660b929],
22	methods	NNS	O	method	dobj	17	SENT_371	[p9l1670t891r1819b925],
23	,	,	O	,	_	0	SENT_371	[p9l1670t891r1819b925],
24	and	CC	O	and	_	0	SENT_371	[p9l1831t891r1890b920],
25	sophisticated	JJ	O	sophisticated	amod	27	SENT_371	[p9l547t941r761b978],
26	bioinformatics	NN	O	bioinformatic	nn	27	SENT_371	[p9l773t941r1013b970],
27	analyses	NNS	O	analysis	conj_and	18	SENT_371	[p9l1028t941r1175b978],
28	.	.	O	.	_	0	SENT_371	[p9l1028t941r1175b978],

1	Such	JJ	O	such	amod	2	SENT_372	[p9l1190t941r1271b970],
2	studies	NNS	O	study	nsubj	3	SENT_372	[p9l1285t941r1397b970],
3	hold	VBP	O	hold	ccomp	18	SENT_372	[p9l1410t941r1483b970],
4	great	JJ	O	great	amod	5	SENT_372	[p9l1495t945r1578b978],
5	promise	NN	O	promise	dobj	3	SENT_372	[p9l1589t941r1722b978],
6	to	TO	O	to	aux	7	SENT_372	[p9l1734t945r1765b970],
7	yield	VB	O	yield	xcomp	3	SENT_372	[p9l1778t941r1860b978],
8	a	DT	O	a	det	10	SENT_372	[p9l1873t950r1890b970],
9	new	JJ	O	new	amod	10	SENT_372	[p9l545t1000r612b1020],
10	panel	NN	O	panel	nsubj	14	SENT_372	[p9l624t991r714b1028],
11	of	IN	O	of	_	0	SENT_372	[p9l727t990r763b1020],
12	molecular	JJ	O	molecular	amod	13	SENT_372	[p9l772t991r938b1020],
13	diagnostics	NNS	O	diagnostic	prep_of	10	SENT_372	[p9l950t990r1135b1028],
14	(	VBP	O	(	ccomp	7	SENT_372	[p9l1149t991r1221b1026],
15	i.e.	FW	O	i.e.	dobj	14	SENT_372	[p9l1149t991r1221b1026],
16	,	,	O	,	_	0	SENT_372	[p9l1149t991r1221b1026],
17	genotypes	NNS	O	genotype	nsubj	18	SENT_372	[p9l1235t991r1415b1028],
18	)	VBP	O	)	_	0	SENT_372	[p9l1235t991r1415b1028],
19	that	IN	O	that	complm	22	SENT_372	[p9l1428t990r1490b1020],
20	can	MD	O	can	aux	22	SENT_372	[p9l1503t1000r1559b1020],
21	be	VB	O	be	auxpass	22	SENT_372	[p9l1571t991r1609b1020],
22	used	VBN	O	use	ccomp	18	SENT_372	[p9l1622t991r1697b1020],
23	to	TO	O	to	aux	24	SENT_372	[p9l1709t995r1740b1020],
24	improve	VB	O	improve	xcomp	22	SENT_372	[p9l1753t991r1889b1028],
25	drug	NN	O	drug	nn	26	SENT_372	[p9l546t1040r620b1078],
26	therapy	NN	O	therapy	dobj	24	SENT_372	[p9l632t1040r754b1078],
27	by	IN	O	by	_	0	SENT_372	[p9l766t1040r806b1078],
28	reducing	VBG	O	reduce	prepc_by	24	SENT_372	[p9l818t1040r962b1078],
29	toxicity	NN	O	toxicity	dobj	28	SENT_372	[p9l974t1040r1099b1078],
30	and	CC	O	and	_	0	SENT_372	[p9l1112t1040r1170b1070],
31	increasing	VBG	O	increase	amod	32	SENT_372	[p9l1181t1040r1350b1078],
32	efﬁcacy	NN	O	efﬁcacy	dobj	28	SENT_372	[p9l1363t1040r1497b1078],
33	.	.	O	.	_	0	SENT_372	[p9l1363t1040r1497b1078],

1	The	DT	O	the	det	3	SENT_373	[p9l573t1148r641b1177],
2	Annual	JJ	SET	annual	amod	3	SENT_373	[p9l649t1147r782b1177],
3	Review	NN	O	review	nsubj	6	SENT_373	[p9l790t1147r912b1177],
4	of	IN	O	of	_	0	SENT_373	[p9l924t1147r964b1185],
5	Medicine	NN	O	medicine	prep_of	3	SENT_373	[p9l968t1147r1127b1177],
6	is	VBZ	O	be	_	0	SENT_373	[p9l1139t1147r1165b1177],
7	online	NN	O	online	dep	6	SENT_373	[p9l1178t1147r1284b1177],
8	at	IN	O	at	_	0	SENT_373	[p9l1296t1150r1330b1177],
9	http://med.annualreviews.org	NN	O	http://med.annualreviews.org	prep_at	6	SENT_373	[p9l1341t1147r1862b1185],

1	LITERATURE	NN	O	literature	nsubj	2	SENT_374	[p9l446t1260r685b1289],
2	CITED	VBD	O	cite	_	0	SENT_374	[p9l696t1260r815b1289],

1	1	LS	NUMBER	1	_	0	SENT_375	[p9l487t1337r508b1363],
2	.	.	O	.	_	0	SENT_375	[p9l487t1337r508b1363],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_376	[p9l527t1338r616b1363],
2	WE	NNP	O	WE	_	0	SENT_376	[p9l623t1337r806b1371],
3	,	,	O	,	_	0	SENT_376	[p9l623t1337r806b1371],
4	Relling	NNP	O	Relling	nn	5	SENT_376	[p9l623t1337r806b1371],
5	MV	NNP	O	MV	appos	2	SENT_376	[p9l812t1338r879b1363],
6	.	.	O	.	_	0	SENT_376	[p9l812t1338r879b1363],

1	2004	CD	DATE	2004	_	0	SENT_377	[p9l889t1337r969b1363],
2	.	.	O	.	_	0	SENT_377	[p9l889t1337r969b1363],

1	Moving	VBG	O	move	_	0	SENT_378	[p9l978t1337r1094b1371],
2	to	TO	O	to	_	0	SENT_378	[p9l1101t1341r1141b1363],
3	-	:	O	-	_	0	SENT_378	[p9l1101t1341r1141b1363],
4	drug	NN	O	drug	dep	5	SENT_378	[p9l1275t1337r1342b1371],
5	response	NN	O	response	prep_to	1	SENT_378	[p9l1351t1345r1489b1371],
6	.	.	O	.	_	0	SENT_378	[p9l1351t1345r1489b1371],

1	N.	NNP	O	N.	nn	2	SENT_379	[p9l1499t1338r1530b1363],
2	Engl	NNP	O	Engl	_	0	SENT_379	[p9l1542t1337r1619b1371],
3	.	.	O	.	_	0	SENT_379	[p9l1542t1337r1619b1371],

1	J.	NNP	O	J.	nn	2	SENT_380	[p9l1631t1338r1652b1364],
2	Med	NNP	O	Med	_	0	SENT_380	[p9l1664t1337r1736b1363],
3	.	.	O	.	_	0	SENT_380	[p9l1664t1337r1736b1363],

1	3481529wards	NNS	O	3481529ward	nsubj	2	SENT_381	[p9l1750t1337r1890b1364, p9l528t1382r614b1408],
2	individualized	VBD	O	individualize	_	0	SENT_381	[p9l624t1382r837b1408],
3	medicine	NN	O	medicine	dobj	2	SENT_381	[p9l845t1382r981b1408],
4	with	IN	O	with	_	0	SENT_381	[p9l991t1382r1056b1408],
5	phar	NN	O	phar	prep_with	2	SENT_381	[p9l1064t1382r1141b1416],
6	-	:	O	-	_	0	SENT_381	[p9l1064t1382r1141b1416],
7	37	CD	NUMBER	37	num	8	SENT_381	[p9l1276t1382r1310b1409],
8	macogenomics	NNS	O	macogenomic	dep	5	SENT_381	[p9l527t1427r758b1461],
9	.	.	O	.	_	0	SENT_381	[p9l527t1427r758b1461],

1	Nature	NNP	O	Nature	_	0	SENT_382	[p9l769t1428r871b1453],
2	429:464	CD	NUMBER	429:464	num	1	SENT_382	[p9l882t1427r1058b1453],
3	—	CD	NUMBER	—	number	4	SENT_382	[p9l882t1427r1058b1453],
4	68	CD	NUMBER	68	dep	1	SENT_382	[p9l882t1427r1058b1453],
5	4	CD	NUMBER	4	dep	4	SENT_382	[p9l1230t1427r1255b1453],
6	.	.	O	.	_	0	SENT_382	[p9l1230t1427r1255b1453],

1	Beutler	NNP	PERSON	Beutler	nn	2	SENT_383	[p9l1275t1427r1385b1453],
2	E.	NNP	O	E.	_	0	SENT_383	[p9l1390t1428r1420b1453],
3	1969	CD	DATE	1969	dep	2	SENT_383	[p9l1432t1427r1510b1454],
4	.	.	O	.	_	0	SENT_383	[p9l1432t1427r1510b1454],

1	Drug	NN	O	drug	nsubj	2	SENT_384	[p9l1518t1428r1594b1461],
2	induced	VBD	O	induce	_	0	SENT_384	[p9l1600t1427r1718b1453],
3	haemolytic	JJ	O	haemolytic	acomp	2	SENT_384	[p9l1724t1427r1889b1461],
4	.	.	O	.	_	0	SENT_384	[p9l504t1493r508b1497],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_385	[p9l527t1472r616b1497],
2	WE	NNP	O	WE	_	0	SENT_385	[p9l623t1471r1141b1502],
3	,	,	O	,	_	0	SENT_385	[p9l623t1471r1141b1502],
4	McLeodHL	NNP	O	McLeodHL	appos	2	SENT_385	[p9l623t1471r1141b1502],
5	.2003	CD	NUMBER	.2003	num	4	SENT_385	[p9l623t1471r1141b1502],
6	.	.	O	.	_	0	SENT_385	[p9l623t1471r1141b1502],

1	Pharmaco	NNP	ORGANIZATION	Pharmaco	_	0	SENT_386	[p9l623t1471r1141b1502],
2	-	:	O	-	_	0	SENT_386	[p9l623t1471r1141b1502],
3	anaemia	NN	O	anaemia	dep	1	SENT_386	[p9l1276t1471r1406b1497],
4	.	.	O	.	_	0	SENT_386	[p9l1276t1471r1406b1497],

1	Phdrmacol	NNP	O	Phdrmacol	_	0	SENT_387	[p9l1417t1471r1589b1497],
2	.	.	O	.	_	0	SENT_387	[p9l1417t1471r1589b1497],

1	Rev.	NNP	O	Rev.	amod	6	SENT_388	[p9l1602t1472r1660b1497],
2	2l	JJ	O	2l	amod	6	SENT_388	[p9l1675t1471r1831b1497],
3	:73	CD	NUMBER	:73	number	4	SENT_388	[p9l1675t1471r1831b1497],
4	—	CD	NUMBER	—	num	6	SENT_388	[p9l1675t1471r1831b1497],
5	l03	NN	O	l03	nn	6	SENT_388	[p9l1675t1471r1831b1497],
6	genomics	NNS	O	genomic	nsubj	7	SENT_388	[p9l528t1516r775b1550],
7	—	VBP	O	—	_	0	SENT_388	[p9l528t1516r775b1550],
8	drug	NN	O	drug	nn	9	SENT_388	[p9l528t1516r775b1550],
9	disposition	NN	O	disposition	dobj	7	SENT_388	[p9l801t1516r972b1550],
10	,	,	O	,	_	0	SENT_388	[p9l801t1516r972b1550],
11	drug	NN	O	drug	nn	12	SENT_388	[p9l999t1516r1066b1550],
12	tar	NN	O	tar	appos	9	SENT_388	[p9l1092t1521r1141b1542],
13	-	:	O	-	_	0	SENT_388	[p9l1092t1521r1141b1542],
14	5	CD	NUMBER	5	dep	9	SENT_388	[p9l1231t1516r1255b1543],
15	.	.	O	.	_	0	SENT_388	[p9l1231t1516r1255b1543],

1	Vogel	NNP	PERSON	Vogel	nn	2	SENT_389	[p9l1275t1516r1360b1550],
2	F.	NNP	O	F.	_	0	SENT_389	[p9l1395t1517r1423b1542],
3	1959	CD	DATE	1959	dep	2	SENT_389	[p9l1463t1516r1541b1543],
4	.	.	O	.	_	0	SENT_389	[p9l1463t1516r1541b1543],

1	Moderne	NNP	O	Moderne	nn	2	SENT_390	[p9l1578t1516r1712b1542],
2	Probleme	NNP	O	Probleme	nsubj	3	SENT_390	[p9l1747t1516r1889b1542],
3	gets	VBZ	O	get	_	0	SENT_390	[p9l528t1565r586b1595],
4	and	CC	O	and	_	0	SENT_390	[p9l605t1561r657b1587],
5	side	JJ	O	side	amod	6	SENT_390	[p9l675t1561r733b1587],
6	effects	NNS	O	effect	conj_and	3	SENT_390	[p9l751t1561r856b1587],
7	.	.	O	.	_	0	SENT_390	[p9l751t1561r856b1587],

1	N.	NNP	O	N.	nn	2	SENT_391	[p9l874t1562r905b1587],
2	Engl	NNP	O	Engl	_	0	SENT_391	[p9l926t1561r1002b1594],
3	.	.	O	.	_	0	SENT_391	[p9l926t1561r1002b1594],

1	J.	NNP	O	J.	nn	2	SENT_392	[p9l1024t1562r1045b1587],
2	Med	NNP	O	Med	_	0	SENT_392	[p9l1066t1561r1139b1587],
3	.	.	O	.	_	0	SENT_392	[p9l1066t1561r1139b1587],

1	der	NN	O	der	_	0	SENT_393	[p9l1275t1561r1322b1587],
2	Humangenetik	NNP	O	Humangenetik	dep	1	SENT_393	[p9l1343t1561r1570b1595],
3	.	.	O	.	_	0	SENT_393	[p9l1343t1561r1570b1595],

1	Ergebn	NNP	O	Ergebn	_	0	SENT_394	[p9l1592t1561r1706b1594],
2	.	.	O	.	_	0	SENT_394	[p9l1592t1561r1706b1594],

1	Inn	NNP	O	Inn	_	0	SENT_395	[p9l1732t1562r1788b1587],
2	.	.	O	.	_	0	SENT_395	[p9l1732t1562r1788b1587],

1	Med	NNP	O	Med	_	0	SENT_396	[p9l1813t1561r1886b1587],
2	.	.	O	.	_	0	SENT_396	[p9l1813t1561r1886b1587],

1	348:538	CD	NUMBER	348:538	number	2	SENT_397	[p9l528t1606r704b1633],
2	—	CD	NUMBER	—	_	0	SENT_397	[p9l528t1606r704b1633],
3	49	CD	NUMBER	49	num	4	SENT_397	[p9l528t1606r704b1633],
4	Kinderheilk	NN	O	kinderheilk	dep	2	SENT_397	[p9l1275t1606r1452b1633],
5	12252-125	CD	NUMBER	12252-125	dep	2	SENT_397	[p9l1465t1606r1618b1633],

1	Drews	NNP	PERSON	Drews	nn	2	SENT_398	[p9l1275t1653r1370b1679],
2	J.	NNP	O	J.	_	0	SENT_398	[p9l1380t1653r1401b1679],
3	1996	CD	DATE	1996	dep	2	SENT_398	[p9l1416t1652r1493b1679],
4	.	.	O	.	_	0	SENT_398	[p9l1416t1652r1493b1679],

1	Genomic	JJ	O	genomic	amod	2	SENT_399	[p9l1505t1652r1640b1679],
2	sciences	NNS	O	science	_	0	SENT_399	[p9l1651t1652r1772b1679],
3	and	CC	O	and	_	0	SENT_399	[p9l1783t1652r1836b1679],
4	the	DT	O	the	det	5	SENT_399	[p9l1845t1652r1889b1679],
5	medicine	NN	O	medicine	conj_and	2	SENT_399	[p9l609t1944r950b2009],
6	of	IN	O	of	_	0	SENT_399	[p9l991t1944r1071b2009],
7	tomorrow	NN	DATE	tomorrow	prep_of	5	SENT_399	[p9l1105t1954r1482b2009],
8	.	.	O	.	_	0	SENT_399	[p9l1105t1954r1482b2009],

1	Nat	NN	PERSON	nat	_	0	SENT_400	[p9l1523t1946r1674b2009],
2	.	.	O	.	_	0	SENT_400	[p9l1523t1946r1674b2009],

1	Biotechnol	NNP	O	Biotechnol	_	0	SENT_401	[p9l1723t1944r2142b2009],
2	.	.	O	.	_	0	SENT_401	[p9l1723t1944r2142b2009],

1	l1	NN	O	l1	_	0	SENT_402	[p9l618t2058r1051b2125],
2	:1516	CD	NUMBER	:1516	number	3	SENT_402	[p9l618t2058r1051b2125],
3	—	CD	NUMBER	—	dep	1	SENT_402	[p9l618t2058r1051b2125],
4	l8	NN	O	l8	dep	3	SENT_402	[p9l618t2058r1051b2125],

1	2270-79	CD	NUMBER	2270-79	num	3	SENT_403	[p9l611t3079r932b3144],
2	Lazarou	NNP	PERSON	Lazarou	nn	3	SENT_403	[p9l609t2173r913b2237],
3	J	NNP	PERSON	J	_	0	SENT_403	[p9l971t2173r1026b2249],
4	,	,	O	,	_	0	SENT_403	[p9l971t2173r1026b2249],
5	Pomeranz	NNP	PERSON	Pomeranz	nn	6	SENT_403	[p9l1087t2173r1459b2237],
6	BH	NNP	O	BH	appos	3	SENT_403	[p9l1518t2173r1665b2249],
7	,	,	O	,	_	0	SENT_403	[p9l1518t2173r1665b2249],
8	Corey	NNP	PERSON	Corey	nn	9	SENT_403	[p9l1728t2172r1951b2256],
9	PN	NNP	PERSON	PN	appos	6	SENT_403	[p9l2010t2173r2146b2237],
10	.	.	O	.	_	0	SENT_403	[p9l2010t2173r2146b2237],

1	1998	CD	DATE	1998	_	0	SENT_404	[p9l618t2285r813b2351],
2	.	.	O	.	_	0	SENT_404	[p9l618t2285r813b2351],

1	Incidence	NN	O	incidence	_	0	SENT_405	[p9l839t2285r1201b2350],
2	of	IN	O	of	_	0	SENT_405	[p9l1224t2285r1305b2350],
3	adverse	JJ	O	adverse	amod	5	SENT_405	[p9l1322t2285r1602b2350],
4	drug	NN	O	drug	nn	5	SENT_405	[p9l1625t2285r1793b2369],
5	reactions	NNS	O	reaction	prep_of	1	SENT_405	[p9l1814t2285r2149b2350],
6	in	IN	O	in	_	0	SENT_405	[p9l609t2398r680b2463],
7	hospitalized	VBN	O	hospitalize	amod	8	SENT_405	[p9l717t2398r1169b2483],
8	patients	NNS	O	patient	prep_in	5	SENT_405	[p9l1206t2398r1516b2483],
9	:	:	O	:	_	0	SENT_405	[p9l1206t2398r1516b2483],
10	a	DT	O	a	det	13	SENT_405	[p9l1562t2419r1601b2463],
11	meta	NN	O	meta	nn	13	SENT_405	[p9l1638t2398r2149b2483],
12	—	NN	O	—	nn	13	SENT_405	[p9l1638t2398r2149b2483],
13	analysis	NN	O	analysis	dep	1	SENT_405	[p9l1638t2398r2149b2483],
14	of	IN	O	of	_	0	SENT_405	[p9l610t2511r691b2577],
15	prospective	JJ	O	prospective	amod	16	SENT_405	[p9l710t2511r1136b2596],
16	studies	NNS	O	study	prep_of	13	SENT_405	[p9l1166t2511r1439b2577],
17	.	.	O	.	_	0	SENT_405	[p9l1166t2511r1439b2577],

1	JAMA	NN	O	jama	_	0	SENT_406	[p9l1468t2513r1695b2577],
2	15	CD	NUMBER	15	num	1	SENT_406	[p9l1733t2511r1835b2577],
3	:	:	O	:	_	0	SENT_406	[p9l1733t2511r1835b2577],
4	1200-5	CD	NUMBER	1200-5	num	6	SENT_406	[p9l1853t2511r2118b2577],
5	Philips	NNP	ORGANIZATION	Philips	nn	6	SENT_406	[p9l609t2625r864b2709],
6	KA	NN	ORGANIZATION	ka	dep	1	SENT_406	[p9l903t2625r1055b2702],
7	,	,	O	,	_	0	SENT_406	[p9l903t2625r1055b2702],
8	Veenstra	NNP	ORGANIZATION	Veenstra	nn	9	SENT_406	[p9l1093t2626r1415b2690],
9	DL	NNP	ORGANIZATION	DL	appos	6	SENT_406	[p9l1449t2626r1591b2702],
10	,	,	O	,	_	0	SENT_406	[p9l1449t2626r1591b2702],
11	Oren	NNP	PERSON	Oren	nn	12	SENT_406	[p9l1631t2625r1814b2690],
12	E	NNP	PERSON	E	appos	6	SENT_406	[p9l1849t2626r1924b2702],
13	,	,	O	,	_	0	SENT_406	[p9l1849t2626r1924b2702],
14	et	FW	O	et	nn	15	SENT_406	[p9l1963t2635r2029b2690],
15	al.	FW	O	al.	appos	6	SENT_406	[p9l2064t2625r2146b2690],
16	2001	CD	DATE	2001	dep	15	SENT_406	[p9l610t2739r813b2804],
17	.	.	O	.	_	0	SENT_406	[p9l610t2739r813b2804],

1	Potential	JJ	O	potential	amod	2	SENT_407	[p9l892t2738r1222b2803],
2	role	NN	O	role	_	0	SENT_407	[p9l1296t2738r1439b2803],
3	of	IN	O	of	_	0	SENT_407	[p9l1515t2738r1596b2803],
4	pharmacoge	NN	O	pharmacoge	nn	6	SENT_407	[p9l1663t2738r2148b2823],
5	—	NN	O	—	nn	6	SENT_407	[p9l1663t2738r2148b2823],
6	nomics	NNS	O	nomic	prep_of	2	SENT_407	[p9l609t2851r875b2917],
7	in	IN	O	in	_	0	SENT_407	[p9l920t2851r991b2916],
8	reducing	VBG	O	reduce	prepc_in	6	SENT_407	[p9l1033t2851r1358b2936],
9	adverse	JJ	O	adverse	amod	11	SENT_407	[p9l1404t2851r1684b2917],
10	drug	NN	O	drug	nn	11	SENT_407	[p9l1729t2851r1896b2936],
11	reactions	NNS	O	reaction	dobj	8	SENT_407	[p9l1939t2861r2148b2917, p9l609t2965r782b3030],
12	:	:	O	:	_	0	SENT_407	[p9l1939t2861r2148b2917, p9l609t2965r782b3030],
13	a	DT	O	a	det	15	SENT_407	[p9l845t2985r884b3030],
14	systematic	JJ	O	systematic	amod	15	SENT_407	[p9l940t2965r1329b3049],
15	review	NN	O	review	dep	11	SENT_407	[p9l1383t2965r1645b3030],
16	.	.	O	.	_	0	SENT_407	[p9l1383t2965r1645b3030],

1	JAMA	NN	O	jama	_	0	SENT_408	[p9l1702t2966r1930b3031],
2	286	CD	NUMBER	286	num	1	SENT_408	[p9l1988t2965r2144b3030],
3	:	:	O	:	_	0	SENT_408	[p9l1988t2965r2144b3030],

1	Annu	NNP	PERSON	Annu	_	0	SENT_409	[p10l7t2592r65b2793],
2	.	.	O	.	_	0	SENT_409	[p10l7t2592r65b2793],

1	Rev.	NNP	O	Rev.	nn	2	SENT_410	[p10l8t2416r66b2565],
2	Med	NNP	O	Med	_	0	SENT_410	[p10l7t2220r65b2389],
3	.	.	O	.	_	0	SENT_410	[p10l7t2220r65b2389],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_411	[p10l7t1906r66b2191],
2	:	:	O	:	_	0	SENT_411	[p10l7t1906r66b2191],
3	1	CD	NUMBER	1	number	4	SENT_411	[p10l7t1866r65b1889],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_411	[p10l7t1604r66b1848],
5	.	.	O	.	_	0	SENT_411	[p10l7t1604r66b1848],

1	Downloaded	VBN	O	download	_	0	SENT_412	[p10l7t1151r66b1577],
2	from	IN	O	from	_	0	SENT_412	[p10l7t967r65b1128],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_412	[p10l7t130r83b944],
4	by	IN	O	by	_	0	SENT_412	[p10l91t2626r166b2708],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_412	[p10l90t2251r166b2602],
6	of	IN	ORGANIZATION	of	_	0	SENT_412	[p10l91t2154r149b2226],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_412	[p10l90t1786r149b2138],
8	—	NNP	O	—	nn	9	SENT_412	[p10l126t1740r132b1761],
9	Madison	NNP	O	Madison	prep_of	5	SENT_412	[p10l91t1424r149b1715],
10	on	IN	O	on	_	0	SENT_412	[p10l109t1319r149b1400],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_412	[p10l90t984r149b1296],
12	.	.	O	.	_	0	SENT_412	[p10l90t984r149b1296],

1	For	IN	O	for	_	0	SENT_413	[p10l92t841r149b957],
2	personal	JJ	O	personal	amod	3	SENT_413	[p10l91t538r166b820],
3	use	NN	O	use	pobj	1	SENT_413	[p10l109t406r149b516],
4	only	RB	O	only	advmod	3	SENT_413	[p10l91t219r166b381],
5	.	.	O	.	_	0	SENT_413	[p10l91t219r166b381],

1	Hetherington	NNP	PERSON	Hetherington	nn	2	SENT_414	[p10l609t30r1101b115],
2	S	NNP	O	S	_	0	SENT_414	[p10l1120t31r1187b108],
3	,	,	O	,	_	0	SENT_414	[p10l1120t31r1187b108],
4	Hughes	NNP	ORGANIZATION	Hughes	nn	5	SENT_414	[p10l1207t30r1488b115],
5	AR	NNS	ORGANIZATION	ar	appos	2	SENT_414	[p10l1506t31r1654b108],
6	,	,	O	,	_	0	SENT_414	[p10l1506t31r1654b108],
7	Mosteller	NNP	PERSON	Mosteller	nn	8	SENT_414	[p10l1673t31r2033b96],
8	M	NNP	O	M	appos	2	SENT_414	[p10l2046t32r2148b108],
9	,	,	O	,	_	0	SENT_414	[p10l2046t32r2148b108],
10	et	FW	O	et	nn	11	SENT_414	[p10l610t155r676b210],
11	al.	FW	O	al.	appos	2	SENT_414	[p10l715t145r797b211],
12	2002	CD	DATE	2002	dep	11	SENT_414	[p10l842t145r1044b211],
13	.	.	O	.	_	0	SENT_414	[p10l842t145r1044b211],

1	Genetic	JJ	O	genetic	amod	2	SENT_415	[p10l1090t145r1375b211],
2	variations	NNS	O	variation	_	0	SENT_415	[p10l1417t145r1779b211],
3	in	IN	O	in	_	0	SENT_415	[p10l1820t145r1891b209],
4	HLA	NN	O	hlum	nn	7	SENT_415	[p10l1929t145r2148b209],
5	—	NN	O	—	nn	7	SENT_415	[p10l1929t145r2148b209],
6	B	NN	O	b	nn	7	SENT_415	[p10l609t261r664b324],
7	region	NN	O	region	prep_in	2	SENT_415	[p10l691t259r927b345],
8	and	CC	O	and	_	0	SENT_415	[p10l952t259r1084b325],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_415	[p10l1105t259r1699b345],
10	reactions	NNS	O	reaction	prep_in	2	SENT_415	[p10l1721t259r2056b325],
11	to	TO	O	to	_	0	SENT_415	[p10l2081t269r2150b325],
12	abacavir	NN	O	abacavir	prep_to	2	SENT_415	[p10l611t374r936b440],
13	.	.	O	.	_	0	SENT_415	[p10l611t374r936b440],

1	Lancet	NNP	O	Lancet	_	0	SENT_416	[p10l964t377r1222b440],
2	359	CD	NUMBER	359	num	1	SENT_416	[p10l1248t374r1403b440],
3	:	:	O	:	_	0	SENT_416	[p10l1248t374r1403b440],
4	1	CD	NUMBER	1	num	7	SENT_416	[p10l1421t375r1448b439],
5	121-22	CD	NUMBER	121-22	num	7	SENT_416	[p10l1468t375r1737b439],
6	Chung	NNP	PERSON	Chung	nn	7	SENT_416	[p10l610t489r856b574],
7	WH	NNP	PERSON	WH	dep	1	SENT_416	[p10l899t490r1074b566],
8	,	,	O	,	_	0	SENT_416	[p10l899t490r1074b566],
9	Hung	NNP	O	Hung	nn	10	SENT_416	[p10l1121t490r1326b574],
10	SI	NNP	O	SI	appos	7	SENT_416	[p10l1374t489r1472b566],
11	,	,	O	,	_	0	SENT_416	[p10l1374t489r1472b566],
12	Hong	NNP	LOCATION	Hong	nn	13	SENT_416	[p10l1519t490r1724b574],
13	HS	NN	LOCATION	h	appos	7	SENT_416	[p10l1769t489r1906b566],
14	,	,	O	,	_	0	SENT_416	[p10l1769t489r1906b566],
15	et	FW	O	et	nn	16	SENT_416	[p10l1954t499r2020b554],
16	al.	FW	O	al.	appos	7	SENT_416	[p10l2064t489r2146b554],
17	2004	CD	DATE	2004	dep	16	SENT_416	[p10l610t604r813b669],
18	.	.	O	.	_	0	SENT_416	[p10l610t604r813b669],

1	Medical	JJ	O	medical	amod	2	SENT_417	[p10l875t603r1180b669],
2	genetics	NNS	O	genetics	_	0	SENT_417	[p10l1239t603r1562b689],
3	:	:	O	:	_	0	SENT_417	[p10l1239t603r1562b689],
4	a	DT	O	a	det	5	SENT_417	[p10l1629t624r1668b669],
5	marker	NN	O	marker	dep	2	SENT_417	[p10l1724t603r1988b669],
6	for	IN	O	for	_	0	SENT_417	[p10l2045t603r2153b669],
7	Stevens	NNP	PERSON	Stevens	prep_for	5	SENT_417	[p10l612t718r1233b784],
8	.	.	O	.	_	0	SENT_417	[p10l612t718r1233b784],

1	—	NN	O	—	_	0	SENT_418	[p10l612t718r1233b784],
2	.	.	O	.	_	0	SENT_418	[p10l612t718r1233b784],

1	Johnson	NNP	PERSON	Johnson	_	0	SENT_419	[p10l612t718r1233b784],
2	syndrome	NN	O	syndrome	dep	1	SENT_419	[p10l1272t718r1655b803],
3	.	.	O	.	_	0	SENT_419	[p10l1272t718r1655b803],

1	Nature	NNP	O	Nature	_	0	SENT_420	[p10l1693t721r1949b784],
2	428	CD	NUMBER	428	num	1	SENT_420	[p10l1986t719r2144b784],
3	:	:	O	:	_	0	SENT_420	[p10l1986t719r2144b784],
4	486	CD	NUMBER	486	dep	1	SENT_420	[p10l608t833r746b899],
5	Hung	NNP	O	Hung	nn	6	SENT_420	[p10l609t949r814b1033],
6	SI	NNP	O	SI	dep	1	SENT_420	[p10l865t948r964b1025],
7	,	,	O	,	_	0	SENT_420	[p10l865t948r964b1025],
8	Chung	NNP	PERSON	Chung	nn	9	SENT_420	[p10l1017t947r1262b1033],
9	WH	NNP	PERSON	WH	appos	1	SENT_420	[p10l1311t949r1485b1025],
10	,	,	O	,	_	0	SENT_420	[p10l1311t949r1485b1025],
11	Liou	NNP	PERSON	Liou	nn	12	SENT_420	[p10l1537t947r1711b1013],
12	LB	NNP	O	LB	appos	1	SENT_420	[p10l1759t949r1897b1025],
13	,	,	O	,	_	0	SENT_420	[p10l1759t949r1897b1025],
14	et	FW	O	et	nn	15	SENT_420	[p10l1950t957r2015b1013],
15	al.	FW	O	al.	appos	1	SENT_420	[p10l2064t947r2146b1013],
16	2005	CD	DATE	2005	dep	15	SENT_420	[p10l611t1062r813b1128],
17	.	.	O	.	_	0	SENT_420	[p10l611t1062r813b1128],

1	HLA	NN	O	hlum	_	0	SENT_421	[p10l866t1062r1366b1128],
2	.	.	O	.	_	0	SENT_421	[p10l866t1062r1366b1128],

1	—	NN	O	—	_	0	SENT_422	[p10l866t1062r1366b1128],
2	.	.	O	.	_	0	SENT_422	[p10l866t1062r1366b1128],

1	B	NN	O	b	nsubj	14	SENT_423	[p10l866t1062r1366b1128],
2	*	CD	NUMBER	*	number	3	SENT_423	[p10l866t1062r1366b1128],
3	5801	CD	NUMBER	5801	num	4	SENT_423	[p10l866t1062r1366b1128],
4	allele	NN	O	allele	npadvmod	1	SENT_423	[p10l1425t1062r1623b1128],
5	as	IN	O	as	_	0	SENT_423	[p10l1674t1083r1745b1128],
6	a	DT	O	a	det	8	SENT_423	[p10l1798t1083r1836b1128],
7	genetic	JJ	O	genetic	amod	8	SENT_423	[p10l1884t1062r2149b1147],
8	marker	NN	O	marker	prep_as	1	SENT_423	[p10l609t1177r873b1243],
9	for	IN	O	for	_	0	SENT_423	[p10l908t1177r1016b1243],
10	severe	JJ	O	severe	amod	13	SENT_423	[p10l1055t1198r1284b1243],
11	cutaneous	JJ	O	cutaneous	amod	13	SENT_423	[p10l1322t1187r1691b1243],
12	adverse	JJ	O	adverse	amod	13	SENT_423	[p10l1732t1177r2013b1243],
13	reactions	NNS	O	reaction	prep_for	8	SENT_423	[p10l2049t1198r2148b1243, p10l611t1292r870b1357],
14	caused	VBN	O	cause	_	0	SENT_423	[p10l897t1292r1150b1357],
15	by	IN	O	by	_	0	SENT_423	[p10l1172t1292r1263b1377],
16	allopurinol	NN	O	allopurinol	prep_by	14	SENT_423	[p10l1291t1292r1716b1377],
17	.	.	O	.	_	0	SENT_423	[p10l1291t1292r1716b1377],

1	Proc	NNP	O	Proc	_	0	SENT_424	[p10l1744t1294r1935b1357],
2	.	.	O	.	_	0	SENT_424	[p10l1744t1294r1935b1357],

1	Natl.	NNP	O	Natl.	nn	2	SENT_425	[p10l1965t1292r2142b1358],
2	Acad	NNP	O	Acad	_	0	SENT_425	[p10l603t1406r814b1472],
3	.	.	O	.	_	0	SENT_425	[p10l603t1406r814b1472],

1	Sci	NNP	O	Sci	_	0	SENT_426	[p10l849t1408r975b1473],
2	.	.	O	.	_	0	SENT_426	[p10l849t1408r975b1473],

1	USA	NNP	ORGANIZATION	USA	nn	3	SENT_427	[p10l1018t1408r1177b1473],
2	15	CD	NUMBER	15	num	3	SENT_427	[p10l1214t1406r1852b1488],
3	(	NN	O	(	_	0	SENT_427	[p10l1214t1406r1852b1488],
4	102	CD	NUMBER	102	number	5	SENT_427	[p10l1214t1406r1852b1488],
5	)	CD	NUMBER	)	dep	3	SENT_427	[p10l1214t1406r1852b1488],
6	:4134	CD	NUMBER	:4134	num	7	SENT_427	[p10l1214t1406r1852b1488],
7	—	NN	O	—	dep	5	SENT_427	[p10l1214t1406r1852b1488],
8	39	CD	NUMBER	39	dep	3	SENT_427	[p10l1214t1406r1852b1488],
9	Jefferys	NNP	O	Jefferys	nn	10	SENT_427	[p10l608t1521r898b1606],
10	DB	NNP	O	DB	dep	8	SENT_427	[p10l935t1523r1083b1598],
11	,	,	O	,	_	0	SENT_427	[p10l935t1523r1083b1598],
12	Leakey	NNP	PERSON	Leakey	nn	13	SENT_427	[p10l1121t1521r1391b1606],
13	D	NNP	O	D	appos	3	SENT_427	[p10l1427t1523r1512b1598],
14	,	,	O	,	_	0	SENT_427	[p10l1427t1523r1512b1598],
15	Lewis	NNP	PERSON	Lewis	nn	16	SENT_427	[p10l1549t1521r1772b1587],
16	JA	NNP	O	JA	appos	3	SENT_427	[p10l1808t1521r1925b1598],
17	,	,	O	,	_	0	SENT_427	[p10l1808t1521r1925b1598],
18	et	FW	O	et	nn	19	SENT_427	[p10l1963t1531r2029b1587],
19	al.	FW	O	al.	appos	3	SENT_427	[p10l2064t1521r2146b1587],
20	1998	CD	DATE	1998	dep	19	SENT_427	[p10l618t1636r813b1702],
21	.	.	O	.	_	0	SENT_427	[p10l618t1636r813b1702],

1	New	NNP	O	New	amod	2	SENT_428	[p10l855t1637r1026b1701],
2	active	JJ	O	active	amod	3	SENT_428	[p10l1067t1636r1282b1701],
3	substances	NNS	O	substance	nsubj	4	SENT_428	[p10l1325t1636r1718b1701],
4	authorized	VBN	O	authorize	_	0	SENT_428	[p10l1760t1636r2152b1701],
5	in	IN	O	in	_	0	SENT_428	[p10l609t1750r680b1815],
6	the	DT	O	the	det	8	SENT_428	[p10l701t1750r812b1816],
7	United	NNP	LOCATION	United	nn	8	SENT_428	[p10l834t1750r1088b1816],
8	Kingdom	NNP	LOCATION	Kingdom	prep_in	4	SENT_428	[p10l1110t1750r1461b1835],
9	between	IN	O	between	_	0	SENT_428	[p10l1479t1750r1791b1816],
10	1972	CD	DATE	1972	prep_between	8	SENT_428	[p10l1820t1751r1996b1817],
11	and	CC	DATE	and	_	0	SENT_428	[p10l2020t1750r2152b1816],
12	1994	CD	DATE	1994	conj_and	10	SENT_428	[p10l618t1865r813b1931],
13	.	.	O	.	_	0	SENT_428	[p10l618t1865r813b1931],

1	Bic	NN	PERSON	bic	_	0	SENT_429	[p10l840t1868r938b1930],
2	J.	NNP	PERSON	J.	nn	3	SENT_429	[p10l971t1868r1024b1931],
3	Clin	NNP	PERSON	Clin	dep	1	SENT_429	[p10l1063t1865r1232b1931],
4	.	.	O	.	_	0	SENT_429	[p10l1063t1865r1232b1931],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_430	[p10l1265t1865r1699b1930],
2	.	.	O	.	_	0	SENT_430	[p10l1265t1865r1699b1930],

1	452151-56	CD	NUMBER	452151-56	num	3	SENT_431	[p10l1729t1864r2127b1930],
2	Colombel	NNP	O	Colombel	nn	3	SENT_431	[p10l610t1979r976b2045],
3	JF	NNP	O	JF	_	0	SENT_431	[p10l1023t1981r1130b2057],
4	,	,	O	,	_	0	SENT_431	[p10l1023t1981r1130b2057],
5	Ferrari	NNP	ORGANIZATION	Ferrari	nn	6	SENT_431	[p10l1181t1979r1434b2044],
6	N	NNP	ORGANIZATION	N	appos	3	SENT_431	[p10l1481t1981r1567b2057],
7	,	,	O	,	_	0	SENT_431	[p10l1481t1981r1567b2057],
8	Debuysere	NNP	O	Debuysere	nn	9	SENT_431	[p10l1618t1979r2014b2064],
9	H	NNP	O	H	appos	3	SENT_431	[p10l2062t1981r2148b2057],
10	,	,	O	,	_	0	SENT_431	[p10l2062t1981r2148b2057],
11	et	FW	O	et	nn	12	SENT_431	[p10l609t2103r676b2159],
12	al.	FW	O	al.	appos	3	SENT_431	[p10l716t2093r798b2159],
13	2000	CD	DATE	2000	dep	12	SENT_431	[p10l845t2094r1047b2160],
14	.	.	O	.	_	0	SENT_431	[p10l845t2094r1047b2160],

1	Genotypic	JJ	O	genotypic	amod	2	SENT_432	[p10l1094t2093r1478b2179],
2	analysis	NN	O	analysis	nsubj	5	SENT_432	[p10l1523t2093r1818b2179],
3	of	IN	O	of	_	0	SENT_432	[p10l1862t2093r1942b2159],
4	thiopurine	NN	O	thiopurine	prep_of	2	SENT_432	[p10l1976t2093r2148b2159, p10l608t2208r846b2293],
5	S	NN	O	s	_	0	SENT_432	[p10l914t2208r1659b2293],
6	—	CD	NUMBER	—	num	7	SENT_432	[p10l914t2208r1659b2293],
7	methyltransferase	NN	O	methyltransferase	dobj	5	SENT_432	[p10l914t2208r1659b2293],
8	in	IN	O	in	_	0	SENT_432	[p10l1725t2208r1796b2273],
9	patients	NNS	O	patient	prep_in	7	SENT_432	[p10l1861t2208r2149b2293],
10	with	IN	O	with	_	0	SENT_432	[p10l609t2323r774b2389],
11	Crohn	NN	PERSON	crohn	poss	13	SENT_432	[p10l811t2323r1103b2389],
12	’s	POS	O	’s	_	0	SENT_432	[p10l811t2323r1103b2389],
13	disease	NN	O	disease	prep_with	5	SENT_432	[p10l1143t2323r1410b2389],
14	and	CC	O	and	_	0	SENT_432	[p10l1449t2323r1581b2389],
15	severe	JJ	O	severe	amod	16	SENT_432	[p10l1621t2344r1850b2389],
16	myelosuppression	NN	O	myelosuppression	prep_with	5	SENT_432	[p10l1888t2323r2148b2409, p10l612t2437r1049b2523],
17	during	IN	O	during	_	0	SENT_432	[p10l1085t2437r1325b2523],
18	azathioprine	NN	O	azathioprine	nn	19	SENT_432	[p10l1362t2437r1821b2523],
19	therapy	NN	O	therapy	prep_during	13	SENT_432	[p10l1856t2438r2146b2523],
20	.	.	O	.	_	0	SENT_432	[p10l1856t2438r2146b2523],

1	Gastroenterology	NN	O	gastroenterology	_	0	SENT_433	[p10l612t2553r1258b2636],
2	1	CD	NUMBER	1	number	3	SENT_433	[p10l1293t2553r1321b2617],
3	18	CD	NUMBER	18	dep	1	SENT_433	[p10l1340t2553r1443b2618],
4	:	:	O	:	_	0	SENT_433	[p10l1340t2553r1443b2618],
5	1025-30	CD	NUMBER	1025-30	num	7	SENT_433	[p10l1460t2552r1777b2619],
6	Evans	NNP	ORGANIZATION	Evans	nn	7	SENT_433	[p10l608t2669r831b2733],
7	WE	NNP	ORGANIZATION	WE	dep	1	SENT_433	[p10l892t2669r1056b2745],
8	,	,	O	,	_	0	SENT_433	[p10l892t2669r1056b2745],
9	Relling	NNP	O	Relling	nn	10	SENT_433	[p10l1119t2667r1392b2752],
10	MV	NNP	O	MV	appos	7	SENT_433	[p10l1452t2669r1620b2733],
11	.	.	O	.	_	0	SENT_433	[p10l1452t2669r1620b2733],

1	1999	CD	DATE	1999	_	0	SENT_434	[p10l1693t2667r1888b2734],
2	.	.	O	.	_	0	SENT_434	[p10l1693t2667r1888b2734],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_435	[p10l1952t2667r2148b2733, p10l609t2782r1189b2867],
2	:	:	O	:	_	0	SENT_435	[p10l1952t2667r2148b2733, p10l609t2782r1189b2867],
3	translating	VBG	O	translate	dep	1	SENT_435	[p10l1218t2782r1610b2867],
4	functional	JJ	O	functional	amod	5	SENT_435	[p10l1634t2782r2011b2847],
5	genomics	NNS	O	genomic	dobj	3	SENT_435	[p10l2035t2803r2148b2867, p10l609t2897r875b2962],
6	into	IN	O	into	_	0	SENT_435	[p10l899t2897r1041b2962],
7	rational	JJ	O	rational	amod	8	SENT_435	[p10l1064t2897r1349b2962],
8	therapeutics	NNS	O	therapeutics	prep_into	3	SENT_435	[p10l1371t2897r1840b2981],
9	.	.	O	.	_	0	SENT_435	[p10l1371t2897r1840b2981],

1	Science	NNP	O	Science	_	0	SENT_436	[p10l1867t2898r2150b2963],
2	286:487	CD	NUMBER	286:487	number	3	SENT_436	[p10l610t3011r1046b3078],
3	—	CD	NUMBER	—	dep	1	SENT_436	[p10l610t3011r1046b3078],
4	91	CD	NUMBER	91	num	5	SENT_436	[p10l610t3011r1046b3078],
5	Kirchheiner	NN	O	kirchheiner	dep	3	SENT_436	[p10l610t3125r1056b3191],
6	J	NN	O	j	dep	1	SENT_436	[p10l1087t3127r1122b3192],
7	,	,	O	,	_	0	SENT_436	[p10l1128t3180r1142b3203],
8	Heesch	NNP	PERSON	Heesch	nn	9	SENT_436	[p10l1179t3125r1453b3191],
9	C	NNP	O	C	appos	6	SENT_436	[p10l1487t3126r1566b3203],
10	,	,	O	,	_	0	SENT_436	[p10l1487t3126r1566b3203],
11	Bauer	NNP	PERSON	Bauer	nn	12	SENT_436	[p10l1602t3127r1826b3191],
12	S	NNP	O	S	appos	1	SENT_436	[p10l1860t3126r1927b3203],
13	,	,	O	,	_	0	SENT_436	[p10l1860t3126r1927b3203],
14	et	FW	O	et	nn	15	SENT_436	[p10l1965t3135r2030b3191],
15	al.	FW	O	al.	appos	1	SENT_436	[p10l2064t3125r2146b3191],
16	2004	CD	DATE	2004	dep	15	SENT_436	[p10l610t3239r813b3304],
17	.	.	O	.	_	0	SENT_436	[p10l610t3239r813b3304],

1	Impact	NN	O	impact	_	0	SENT_437	[p10l835t3240r1094b3323],
2	of	IN	O	of	_	0	SENT_437	[p10l1111t3238r1192b3304],
3	the	DT	O	the	det	6	SENT_437	[p10l1202t3238r1314b3304],
4	ultrarapid	JJ	O	ultrarapid	amod	6	SENT_437	[p10l1331t3238r1695b3323],
5	metabolizer	NN	O	metabolizer	nn	6	SENT_437	[p10l1711t3238r2153b3304],
6	genotype	NN	O	genotype	prep_of	1	SENT_437	[p10l610t3362r950b3436],
7	of	IN	O	of	_	0	SENT_437	[p10l1001t3352r1081b3417],
8	cytochrome	NN	O	cytochrome	nn	10	SENT_437	[p10l1125t3352r1563b3436],
9	P450	NN	O	p450	nn	10	SENT_437	[p10l1612t3352r1802b3417],
10	2D6	NN	O	2d6	prep_of	1	SENT_437	[p10l1853t3352r2009b3417],
11	on	IN	O	on	_	0	SENT_437	[p10l2061t3372r2152b3417],
12	metoprolol	NN	O	metoprolol	nn	13	SENT_437	[p10l609t3465r1017b3550],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	10	SENT_437	[p10l1066t3465r1724b3550],
14	and	CC	O	and	_	0	SENT_437	[p10l1778t3465r1910b3530],
15	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	13	SENT_437	[p10l1957t3465r2148b3550, p10l609t3578r1188b3663],
16	.	.	O	.	_	0	SENT_437	[p10l1957t3465r2148b3550, p10l609t3578r1188b3663],

1	Clin	NNP	O	Clin	_	0	SENT_438	[p10l1242t3579r1410b3644],
2	.	.	O	.	_	0	SENT_438	[p10l1242t3579r1410b3644],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_439	[p10l1466t3578r1896b3644],
2	.	.	O	.	_	0	SENT_439	[p10l1466t3578r1896b3644],

1	Ther	NNP	O	Ther	_	0	SENT_440	[p10l1957t3579r2146b3644],
2	.	.	O	.	_	0	SENT_440	[p10l1957t3579r2146b3644],

1	76:302	CD	NUMBER	76:302	num	2	SENT_441	[p10l609t3692r1006b3757],
2	-12	CD	NUMBER	-12	_	0	SENT_441	[p10l609t3692r1006b3757],

1	16	CD	NUMBER	16	_	0	SENT_442	[p11l459t31r560b98],
2	.	.	O	.	_	0	SENT_442	[p11l459t31r560b98],

1	Kirchheiner	NNP	PERSON	Kirchheiner	nn	2	SENT_443	[p11l610t31r1056b97],
2	J	NNP	PERSON	J	_	0	SENT_443	[p11l1076t33r1130b109],
3	,	,	O	,	_	0	SENT_443	[p11l1076t33r1130b109],
4	Brockmoller	NNP	O	Brockmoller	nn	5	SENT_443	[p11l1156t31r1630b97],
5	J.	NNP	O	J.	appos	2	SENT_443	[p11l1650t33r1703b98],
6	2005	CD	DATE	2005	dep	5	SENT_443	[p11l1731t31r1911b98],
7	.	.	O	.	_	0	SENT_443	[p11l1923t86r1934b97],

1	Clinical	JJ	O	clinical	amod	2	SENT_444	[p11l1962t31r2148b97, p11l609t144r741b210],
2	consequences	NNS	O	consequence	_	0	SENT_444	[p11l791t165r1301b229],
3	of	IN	O	of	_	0	SENT_444	[p11l1352t144r1433b209],
4	cytochrome	NN	O	cytochrome	nn	7	SENT_444	[p11l1475t145r1912b229],
5	P450	NN	O	p450	nn	7	SENT_444	[p11l1961t144r2151b210],
6	2C9	NN	O	2c9	nn	7	SENT_444	[p11l610t258r760b324],
7	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_444	[p11l814t258r1415b342],
8	.	.	O	.	_	0	SENT_444	[p11l814t258r1415b342],

1	Clin	NNP	O	Clin	_	0	SENT_445	[p11l1478t258r1646b324],
2	.	.	O	.	_	0	SENT_445	[p11l1478t258r1646b324],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_446	[p11l1712t258r2142b323],
2	.	.	O	.	_	0	SENT_446	[p11l1712t258r2142b323],

1	Ther	NNP	O	Ther	_	0	SENT_447	[p11l613t371r802b436],
2	.	.	O	.	_	0	SENT_447	[p11l613t371r802b436],

1	77:1	CD	NUMBER	77:1	_	0	SENT_448	[p11l834t371r1137b436],
2	—	CD	NUMBER	—	num	3	SENT_448	[p11l834t371r1137b436],
3	16	CD	NUMBER	16	dep	1	SENT_448	[p11l834t371r1137b436],

1	17	CD	NUMBER	17	_	0	SENT_449	[p11l16t672r143b754],
2	.	.	O	.	_	0	SENT_449	[p11l16t672r143b754],

1	Ingelman	NNP	O	Ingelman	_	0	SENT_450	[p11l205t672r1135b779],
2	.	.	O	.	_	0	SENT_450	[p11l205t672r1135b779],

1	—	NN	O	—	_	0	SENT_451	[p11l205t672r1135b779],
2	.	.	O	.	_	0	SENT_451	[p11l205t672r1135b779],

1	Sundberg	NNP	PERSON	Sundberg	nn	2	SENT_452	[p11l205t672r1135b779],
2	M.	NNP	O	M.	_	0	SENT_452	[p11l1220t674r1345b754],
3	2005	CD	DATE	2005	dep	2	SENT_452	[p11l1436t672r1692b754],
4	.	.	O	.	_	0	SENT_452	[p11l1436t672r1692b754],

1	Genetic	JJ	O	genetic	amod	2	SENT_453	[p11l1783t672r2143b754],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_453	[p11l203t814r933b921],
3	of	IN	O	of	_	0	SENT_453	[p11l967t814r1070b896],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_453	[p11l1094t814r1643b921],
5	P450	NN	O	p450	nn	6	SENT_453	[p11l1675t814r1913b897],
6	2D6	NN	O	2d6	prep_of	2	SENT_453	[p11l1946t814r2144b897],
7	(	CD	NUMBER	(	num	8	SENT_453	[p11l208t957r737b1059],
8	CYP2D6	NN	O	cyp2d6	dep	6	SENT_453	[p11l208t957r737b1059],
9	)	CD	NUMBER	)	dep	8	SENT_453	[p11l208t957r737b1059],
10	:	:	O	:	_	0	SENT_453	[p11l208t957r737b1059],
11	clinical	JJ	O	clinical	amod	12	SENT_453	[p11l776t957r1118b1040],
12	consequences	NNS	O	consequence	dep	2	SENT_453	[p11l1149t984r1818b1064],
13	,	,	O	,	_	0	SENT_453	[p11l1149t984r1818b1064],
14	evolutionary	JJ	O	evolutionary	amod	15	SENT_453	[p11l1853t957r2142b1040, p11l205t1102r535b1208],
15	aspects	NNS	O	aspect	dep	2	SENT_453	[p11l589t1114r922b1208],
16	and	CC	O	and	_	0	SENT_453	[p11l977t1102r1143b1184],
17	functional	JJ	O	functional	amod	18	SENT_453	[p11l1193t1102r1667b1184],
18	diversity	NN	O	diversity	conj_and	12	SENT_453	[p11l1719t1102r2139b1208],
19	.	.	O	.	_	0	SENT_453	[p11l1719t1102r2139b1208],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	2	SENT_454	[p11l203t1244r1135b1350],
2	J.	NNP	O	J.	_	0	SENT_454	[p11l1166t1247r1242b1328],
3	526-13	CD	NUMBER	526-13	dep	2	SENT_454	[p11l1283t1244r1599b1328],

1	18	CD	NUMBER	18	_	0	SENT_455	[p11l16t1389r143b1471],
2	.	.	O	.	_	0	SENT_455	[p11l16t1389r143b1471],

1	Landefeld	NNP	PERSON	Landefeld	nn	2	SENT_456	[p11l205t1388r681b1471],
2	CS	NNP	O	CS	_	0	SENT_456	[p11l731t1389r895b1486],
3	,	,	O	,	_	0	SENT_456	[p11l731t1389r895b1486],
4	Beyth	NNP	O	Beyth	nn	5	SENT_456	[p11l950t1388r1226b1495],
5	RJ	NN	O	rj	appos	2	SENT_456	[p11l1275t1391r1421b1471],
6	.	.	O	.	_	0	SENT_456	[p11l1275t1391r1421b1471],

1	1993	CD	DATE	1993	_	0	SENT_457	[p11l1487t1389r1732b1472],
2	.	.	O	.	_	0	SENT_457	[p11l1487t1389r1732b1472],

1	Anticoagulant	JJ	O	anticoagulant	amod	4	SENT_458	[p11l1788t1388r2142b1471, p11l208t1532r911b1639],
2	—	NN	O	—	nn	4	SENT_458	[p11l1788t1388r2142b1471, p11l208t1532r911b1639],
3	related	JJ	O	related	amod	4	SENT_458	[p11l1788t1388r2142b1471, p11l208t1532r911b1639],
4	bleeding	NN	O	bleeding	_	0	SENT_458	[p11l999t1532r1429b1638],
5	:	:	O	:	_	0	SENT_458	[p11l999t1532r1429b1638],
6	clinical	JJ	O	clinical	amod	7	SENT_458	[p11l1529t1532r1872b1614],
7	epidemiology	NN	O	epidemiology	dep	4	SENT_458	[p11l1965t1532r2142b1638, p11l206t1675r724b1782],
8	,	,	O	,	_	0	SENT_458	[p11l1965t1532r2142b1638, p11l206t1675r724b1782],
9	prediction	NN	O	prediction	dep	4	SENT_458	[p11l800t1675r1302b1782],
10	,	,	O	,	_	0	SENT_458	[p11l800t1675r1302b1782],
11	and	CC	O	and	_	0	SENT_458	[p11l1381t1675r1547b1757],
12	prevention	NN	O	prevention	dep	4	SENT_458	[p11l1618t1675r2139b1782],
13	.	.	O	.	_	0	SENT_458	[p11l1618t1675r2139b1782],

1	Am	NNP	O	Am	_	0	SENT_459	[p11l197t1820r377b1902],
2	.	.	O	.	_	0	SENT_459	[p11l197t1820r377b1902],

1	J.	NNP	O	J.	nn	2	SENT_460	[p11l418t1822r486b1902],
2	Med	NNP	O	Med	_	0	SENT_460	[p11l525t1818r754b1902],
3	.	.	O	.	_	0	SENT_460	[p11l525t1818r754b1902],

1	95:315	CD	NUMBER	95:315	_	0	SENT_461	[p11l800t1818r1296b1902],
2	—	CD	NUMBER	—	num	3	SENT_461	[p11l800t1818r1296b1902],
3	28	CD	NUMBER	28	dep	1	SENT_461	[p11l800t1818r1296b1902],

1	19	CD	NUMBER	19	_	0	SENT_462	[p11l17t1963r143b2046],
2	.	.	O	.	_	0	SENT_462	[p11l17t1963r143b2046],

1	Landefeld	NNP	PERSON	Landefeld	nn	2	SENT_463	[p11l205t1963r681b2045],
2	CS	NNP	O	CS	_	0	SENT_463	[p11l724t1963r889b2059],
3	,	,	O	,	_	0	SENT_463	[p11l724t1963r889b2059],
4	Goldman	NNP	ORGANIZATION	Goldman	nn	5	SENT_463	[p11l937t1963r1372b2045],
5	L.	NNP	O	L.	appos	2	SENT_463	[p11l1414t1965r1506b2045],
6	1989	CD	DATE	1989	dep	5	SENT_463	[p11l1566t1963r1811b2046],
7	.	.	O	.	_	0	SENT_463	[p11l1566t1963r1811b2046],

1	Major	JJ	O	major	amod	2	SENT_464	[p11l1859t1963r2147b2069],
2	bleeding	NN	O	bleeding	nsubj	5	SENT_464	[p11l203t2106r606b2213],
3	in	IN	O	in	_	0	SENT_464	[p11l648t2106r737b2187],
4	outpatients	NNS	O	outpatient	prep_in	2	SENT_464	[p11l778t2106r1288b2213],
5	treated	VBN	O	treat	_	0	SENT_464	[p11l1330t2106r1650b2188],
6	with	IN	O	with	_	0	SENT_464	[p11l1689t2106r1896b2188],
7	warfarin	NN	O	warfarin	prep_with	5	SENT_464	[p11l1936t2132r2142b2188, p11l205t2248r448b2331],
8	:	:	O	:	_	0	SENT_464	[p11l1936t2132r2142b2188, p11l205t2248r448b2331],
9	incidence	NN	O	incidence	nsubj	14	SENT_464	[p11l489t2248r938b2331],
10	and	CC	O	and	_	0	SENT_464	[p11l974t2248r1140b2331],
11	prediction	NN	O	prediction	nsubj	14	SENT_464	[p11l1171t2248r1647b2355],
12	by	IN	O	by	_	0	SENT_464	[p11l1679t2248r1795b2355],
13	factors	NNS	O	factor	prep_by	9	SENT_464	[p11l1829t2248r2142b2331],
14	known	VBN	O	know	parataxis	5	SENT_464	[p11l203t2393r521b2475],
15	at	IN	O	at	_	0	SENT_464	[p11l567t2406r649b2475],
16	the	DT	O	the	det	17	SENT_464	[p11l691t2393r832b2475],
17	start	NN	O	start	prep_at	14	SENT_464	[p11l880t2405r1078b2475],
18	of	IN	O	of	_	0	SENT_464	[p11l1122t2393r1223b2475],
19	outpatient	NN	O	outpatient	nn	20	SENT_464	[p11l1262t2393r1731b2499],
20	therapy	NN	O	therapy	prep_of	17	SENT_464	[p11l1774t2393r2139b2499],
21	.	.	O	.	_	0	SENT_464	[p11l1774t2393r2139b2499],

1	Am	NNP	O	Am	_	0	SENT_465	[p11l197t2538r377b2620],
2	.	.	O	.	_	0	SENT_465	[p11l197t2538r377b2620],

1	J.	NNP	O	J.	nn	2	SENT_466	[p11l418t2540r486b2621],
2	Med	NNP	O	Med	_	0	SENT_466	[p11l525t2537r759b2620],
3	.	.	O	.	_	0	SENT_466	[p11l525t2537r759b2620],

1	872144-52	CD	NUMBER	872144-52	_	0	SENT_467	[p11l803t2537r1299b2620],

1	20	CD	NUMBER	20	_	0	SENT_468	[p11l6t2680r143b2763],
2	.	.	O	.	_	0	SENT_468	[p11l6t2680r143b2763],

1	Rettie	NNP	O	Rettie	nn	2	SENT_469	[p11l205t2679r483b2763],
2	AE	NNP	O	AE	_	0	SENT_469	[p11l549t2680r728b2777],
3	,	,	O	,	_	0	SENT_469	[p11l549t2680r728b2777],
4	Korzekwa	NNP	ORGANIZATION	Korzekwa	nn	5	SENT_469	[p11l800t2679r1275b2763],
5	KR	NNP	ORGANIZATION	KR	appos	2	SENT_469	[p11l1340t2682r1524b2777],
6	,	,	O	,	_	0	SENT_469	[p11l1340t2682r1524b2777],
7	Kunze	NNP	ORGANIZATION	Kunze	nn	8	SENT_469	[p11l1596t2682r1896b2763],
8	KL	NNP	ORGANIZATION	KL	appos	2	SENT_469	[p11l1963t2682r2140b2777],
9	,	,	O	,	_	0	SENT_469	[p11l1963t2682r2140b2777],
10	et	FW	O	et	nn	11	SENT_469	[p11l206t2836r289b2907],
11	al.	FW	O	al.	appos	2	SENT_469	[p11l322t2825r425b2907],
12	1992	CD	DATE	1992	dep	11	SENT_469	[p11l475t2825r720b2909],
13	.	.	O	.	_	0	SENT_469	[p11l475t2825r720b2909],

1	Hydroxylation	NN	O	hydroxylation	nsubj	8	SENT_470	[p11l759t2825r1444b2931],
2	of	IN	O	of	_	0	SENT_470	[p11l1477t2825r1579b2907],
3	warfarin	NN	O	warfarin	prep_of	1	SENT_470	[p11l1604t2825r1998b2907],
4	by	IN	O	by	_	0	SENT_470	[p11l2028t2825r2144b2931],
5	human	JJ	O	human	amod	7	SENT_470	[p11l203t2968r524b3050],
6	cDNA	NN	O	cdna	nn	7	SENT_470	[p11l579t2968r1383b3075],
7	—	NN	O	—	prep_by	3	SENT_470	[p11l579t2968r1383b3075],
8	eXpressed	VBD	O	express	_	0	SENT_470	[p11l579t2968r1383b3075],
9	cytochrome	NN	O	cytochrome	nn	10	SENT_470	[p11l1438t2968r1987b3075],
10	P450	NN	O	p450	dobj	8	SENT_470	[p11l2042t2971r2142b3049, p11l205t3110r404b3193],
11	:	:	O	:	_	0	SENT_470	[p11l2042t2971r2142b3049, p11l205t3110r404b3193],
12	a	DT	O	a	det	13	SENT_470	[p11l454t3137r503b3193],
13	role	NN	O	role	dep	10	SENT_470	[p11l540t3110r721b3193],
14	for	IN	O	for	_	0	SENT_470	[p11l762t3110r898b3192],
15	P	NN	O	p	nn	17	SENT_470	[p11l936t3110r1408b3194],
16	—	CD	NUMBER	—	num	17	SENT_470	[p11l936t3110r1408b3194],
17	4502C9	NN	O	4502c9	prep_for	13	SENT_470	[p11l936t3110r1408b3194],
18	in	IN	O	in	_	0	SENT_470	[p11l1452t3110r1540b3192],
19	the	DT	O	the	det	20	SENT_470	[p11l1580t3110r1721b3193],
20	etiology	NN	O	etiology	prep_in	8	SENT_470	[p11l1763t3110r2144b3217],
21	of	IN	O	of	_	0	SENT_470	[p11l206t3255r308b3337],
22	(	CD	NUMBER	(	num	24	SENT_470	[p11l348t3255r1176b3361],
23	S	NN	O	s	nn	24	SENT_470	[p11l348t3255r1176b3361],
24	)	NN	O	)	prep_of	20	SENT_470	[p11l348t3255r1176b3361],
25	.	.	O	.	_	0	SENT_470	[p11l348t3255r1176b3361],

1	—	NN	O	—	_	0	SENT_471	[p11l348t3255r1176b3361],
2	.	.	O	.	_	0	SENT_471	[p11l348t3255r1176b3361],

1	warfarin	NN	O	warfarin	_	0	SENT_472	[p11l348t3255r1176b3361],
2	.	.	O	.	_	0	SENT_472	[p11l348t3255r1176b3361],

1	—	NN	O	—	_	0	SENT_473	[p11l348t3255r1176b3361],
2	.	.	O	.	_	0	SENT_473	[p11l348t3255r1176b3361],

1	drug	NN	O	drug	nn	2	SENT_474	[p11l348t3255r1176b3361],
2	interactions	NNS	O	interaction	_	0	SENT_474	[p11l1222t3255r1793b3337],
3	.	.	O	.	_	0	SENT_474	[p11l1222t3255r1793b3337],

1	Chem	NNP	O	Chem	_	0	SENT_475	[p11l1849t3255r2134b3338],
2	.	.	O	.	_	0	SENT_475	[p11l1849t3255r2134b3338],

1	Res	NNP	O	Res	_	0	SENT_476	[p11l202t3400r390b3480],
2	.	.	O	.	_	0	SENT_476	[p11l202t3400r390b3480],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_477	[p11l440t3397r797b3480],
2	.	.	O	.	_	0	SENT_477	[p11l440t3397r797b3480],

1	5:54	CD	TIME	5:54	num	2	SENT_478	[p11l838t3397r1217b3481],
2	-59	CD	NUMBER	-59	_	0	SENT_478	[p11l838t3397r1217b3481],

1	21	CD	NUMBER	21	_	0	SENT_479	[p11l6t3542r143b3623],
2	.	.	O	.	_	0	SENT_479	[p11l6t3542r143b3623],

1	Furuya	NN	PERSON	furuya	nn	2	SENT_480	[p11l205t3544r538b3648],
2	H	NN	O	h	_	0	SENT_480	[p11l598t3544r704b3639],
3	,	,	O	,	_	0	SENT_480	[p11l598t3544r704b3639],
4	Fernandez	NNP	PERSON	Fernandez	appos	2	SENT_480	[p11l770t3541r1716b3648],
5	.	.	O	.	_	0	SENT_480	[p11l770t3541r1716b3648],

1	—	NN	O	—	_	0	SENT_481	[p11l770t3541r1716b3648],
2	.	.	O	.	_	0	SENT_481	[p11l770t3541r1716b3648],

1	Salguero	FW	PERSON	salguero	_	0	SENT_482	[p11l770t3541r1716b3648],
2	P	NN	O	p	dep	1	SENT_482	[p11l1779t3544r1866b3639],
3	,	,	O	,	_	0	SENT_482	[p11l1779t3544r1866b3639],
4	Gregory	NNP	PERSON	Gregory	nn	5	SENT_482	[p11l1934t3542r2142b3624, p11l206t3711r417b3791],
5	W	NNP	PERSON	W	appos	2	SENT_482	[p11l473t3687r608b3782],
6	,	,	O	,	_	0	SENT_482	[p11l473t3687r608b3782],
7	et	FW	O	et	nn	8	SENT_482	[p11l669t3698r751b3767],
8	al.	FW	O	al.	appos	2	SENT_482	[p11l808t3685r911b3767],
9	1995	CD	DATE	1995	dep	8	SENT_482	[p11l985t3684r1230b3769],
10	.	.	O	.	_	0	SENT_482	[p11l985t3684r1230b3769],

1	Genetic	JJ	O	genetic	amod	2	SENT_483	[p11l1294t3685r1653b3768],
2	polymorphism	NN	O	polymorphism	_	0	SENT_483	[p11l1709t3685r2142b3791, p12l203t25r492b132],

1	of	IN	O	of	_	0	SENT_484	[p12l573t25r674b107],
2	CYP2C9	NN	O	cyp2c9	prep_of	6	SENT_484	[p12l748t25r1167b109],
3	and	CC	O	and	_	0	SENT_484	[p12l1253t25r1419b107],
4	its	PRP$	O	its	poss	5	SENT_484	[p12l1498t25r1604b107],
5	effect	NN	O	effect	conj_and	2	SENT_484	[p12l1688t25r1951b107],
6	on	IN	O	on	_	0	SENT_484	[p12l2031t51r2145b107],
7	warfarin	NN	O	warfarin	nn	10	SENT_484	[p12l205t167r600b250],
8	maintenance	NN	O	maintenance	nn	10	SENT_484	[p12l620t167r1212b249],
9	dose	NN	O	dose	nn	10	SENT_484	[p12l1236t167r1446b249],
10	requirement	NN	O	requirement	pobj	6	SENT_484	[p12l1467t167r2037b274],
11	in	IN	O	in	_	0	SENT_484	[p12l2057t167r2145b249],
12	patients	NNS	O	patient	prep_in	10	SENT_484	[p12l203t312r566b418],
13	undergoing	VBG	O	undergo	partmod	6	SENT_484	[p12l602t312r1133b418],
14	anticoagulation	NN	O	anticoagulation	nn	15	SENT_484	[p12l1172t312r1894b418],
15	therapy	NN	O	therapy	dobj	13	SENT_484	[p12l1927t312r2142b394, p12l208t482r387b562],
16	.	.	O	.	_	0	SENT_484	[p12l1927t312r2142b394, p12l208t482r387b562],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_485	[p12l424t456r1297b562],
2	5:389	CD	NUMBER	5:389	number	3	SENT_485	[p12l1332t456r1771b540],
3	—	CD	NUMBER	—	dep	1	SENT_485	[p12l1332t456r1771b540],
4	92	CD	NUMBER	92	dep	3	SENT_485	[p12l1332t456r1771b540],

1	22	CD	NUMBER	22	_	0	SENT_486	[p12l6t599r143b680],
2	.	.	O	.	_	0	SENT_486	[p12l6t599r143b680],

1	Aithal	NNP	O	Aithal	nn	2	SENT_487	[p12l205t598r497b680],
2	GP	NNP	O	GP	_	0	SENT_487	[p12l549t599r719b696],
3	,	,	O	,	_	0	SENT_487	[p12l549t599r719b696],
4	Day	NNP	DURATION	Day	nn	5	SENT_487	[p12l773t601r966b705],
5	CP	NNP	O	CP	appos	2	SENT_487	[p12l1018t599r1182b696],
6	,	,	O	,	_	0	SENT_487	[p12l1018t599r1182b696],
7	Kesteven	NNP	O	Kesteven	nn	8	SENT_487	[p12l1239t601r1665b680],
8	PJ	NNP	O	PJ	appos	2	SENT_487	[p12l1714t601r1848b696],
9	,	,	O	,	_	0	SENT_487	[p12l1714t601r1848b696],
10	et	FW	O	et	nn	11	SENT_487	[p12l1902t611r1986b680],
11	al.	FW	O	al.	appos	2	SENT_487	[p12l2036t598r2139b680],
12	1999	CD	DATE	1999	dep	11	SENT_487	[p12l216t743r461b827],
13	.	.	O	.	_	0	SENT_487	[p12l216t743r461b827],

1	Association	NNP	O	Association	_	0	SENT_488	[p12l519t743r1073b825],
2	of	IN	O	of	_	0	SENT_488	[p12l1127t743r1228b825],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_488	[p12l1272t743r2001b849],
4	in	IN	O	in	_	0	SENT_488	[p12l2057t743r2145b824],
5	the	DT	O	the	det	8	SENT_488	[p12l205t887r346b969],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_488	[p12l442t887r992b993],
7	P450	NN	O	p450	nn	8	SENT_488	[p12l1087t887r1326b969],
8	CYP2C9	NN	O	cyp2c9	prep_in	1	SENT_488	[p12l1422t887r1841b971],
9	with	IN	O	with	_	0	SENT_488	[p12l1939t887r2145b970],
10	warfarin	NN	O	warfarin	nn	12	SENT_488	[p12l205t1029r600b1112],
11	dose	NN	O	dose	nn	12	SENT_488	[p12l666t1029r877b1111],
12	requirement	NN	O	requirement	prep_with	1	SENT_488	[p12l942t1029r1512b1136],
13	and	CC	O	and	_	0	SENT_488	[p12l1580t1029r1745b1111],
14	risk	NN	O	risk	conj_and	12	SENT_488	[p12l1809t1029r1986b1111],
15	of	IN	O	of	_	0	SENT_488	[p12l2052t1029r2153b1111],
16	bleeding	VBG	O	bleed	amod	17	SENT_488	[p12l203t1173r606b1279],
17	complications	NNS	O	complication	prep_of	1	SENT_488	[p12l639t1173r1320b1279],
18	.	.	O	.	_	0	SENT_488	[p12l639t1173r1320b1279],

1	Lancet	NNP	O	Lancet	_	0	SENT_489	[p12l1352t1176r1677b1255],
2	353:7	CD	NUMBER	353:7	num	3	SENT_489	[p12l1706t1172r2147b1256],
3	l7	NN	O	l7	dep	1	SENT_489	[p12l1706t1172r2147b1256],
4	—	CD	NUMBER	—	number	5	SENT_489	[p12l1706t1172r2147b1256],
5	19	CD	NUMBER	19	dep	3	SENT_489	[p12l216t1317r317b1401],

1	23	CD	NUMBER	23	_	0	SENT_490	[p12l6t1460r143b1542],
2	.	.	O	.	_	0	SENT_490	[p12l6t1460r143b1542],

1	Taube	NNP	PERSON	Taube	nn	2	SENT_491	[p12l205t1459r486b1541],
2	J	NNP	PERSON	J	_	0	SENT_491	[p12l517t1462r585b1557],
3	,	,	O	,	_	0	SENT_491	[p12l517t1462r585b1557],
4	Halsall	NNP	PERSON	Halsall	nn	8	SENT_491	[p12l620t1459r950b1541],
5	D	NNP	O	D	nn	8	SENT_491	[p12l981t1462r1089b1557],
6	,	,	O	,	_	0	SENT_491	[p12l981t1462r1089b1557],
7	Baglin	NNP	O	Baglin	appos	8	SENT_491	[p12l1123t1459r1435b1566],
8	T.	NNP	O	T.	appos	2	SENT_491	[p12l1465t1462r1557b1541],
9	2000	CD	DATE	2000	num	8	SENT_491	[p12l1595t1460r1850b1542],
10	.	.	O	.	_	0	SENT_491	[p12l1595t1460r1850b1542],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_492	[p12l1886t1459r2142b1541, p12l206t1629r417b1685],
2	of	IN	O	of	_	0	SENT_492	[p12l446t1602r548b1684],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_492	[p12l568t1602r1117b1709],
4	P	NN	O	p	prep_of	1	SENT_492	[p12l1144t1602r1422b1685],
5	—	CD	NUMBER	—	number	6	SENT_492	[p12l1144t1602r1422b1685],
6	450	CD	NUMBER	450	num	8	SENT_492	[p12l1144t1602r1422b1685],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_492	[p12l1450t1603r1869b1686],
8	polymorphisms	NNS	O	polymorphism	dep	1	SENT_492	[p12l1897t1602r2142b1709, p12l205t1747r723b1853],
9	on	IN	O	on	_	0	SENT_492	[p12l794t1772r908b1829],
10	warfarin	NN	O	warfarin	nn	11	SENT_492	[p12l974t1747r1367b1829],
11	sensitivity	NN	O	sensitivity	prep_on	8	SENT_492	[p12l1436t1747r1910b1853],
12	and	CC	O	and	_	0	SENT_492	[p12l1981t1747r2146b1829],
13	risk	NN	O	risk	conj_and	11	SENT_492	[p12l203t1889r382b1971],
14	of	IN	O	of	_	0	SENT_492	[p12l443t1889r545b1971],
15	oVer	NN	O	over	nn	17	SENT_492	[p12l601t1889r1567b1996],
16	—	CD	NUMBER	—	num	17	SENT_492	[p12l601t1889r1567b1996],
17	anticoagulation	NN	O	anticoagulation	prep_of	8	SENT_492	[p12l601t1889r1567b1996],
18	in	IN	O	in	_	0	SENT_492	[p12l1629t1889r1719b1971],
19	patients	NNS	O	patient	prep_in	17	SENT_492	[p12l1780t1889r2142b1996],
20	on	IN	O	on	_	0	SENT_492	[p12l206t2059r320b2114],
21	long	JJ	O	long	amod	24	SENT_492	[p12l363t2033r825b2139],
22	—	JJ	O	—	amod	24	SENT_492	[p12l363t2033r825b2139],
23	term	NN	O	term	nn	24	SENT_492	[p12l363t2033r825b2139],
24	treatment	NN	O	treatment	prep_on	19	SENT_492	[p12l866t2045r1332b2115],
25	.	.	O	.	_	0	SENT_492	[p12l866t2045r1332b2115],

1	Blood	NN	O	blood	_	0	SENT_493	[p12l1378t2032r1665b2115],
2	962181619	CD	NUMBER	962181619	num	1	SENT_493	[p12l1704t2032r2147b2116, p12l216t2177r317b2261],

1	24	CD	NUMBER	24	_	0	SENT_494	[p12l6t2320r143b2402],
2	.	.	O	.	_	0	SENT_494	[p12l6t2320r143b2402],

1	Margaglione	NNP	O	Margaglione	nn	2	SENT_495	[p12l205t2320r802b2427],
2	M	NNP	O	M	_	0	SENT_495	[p12l822t2323r950b2418],
3	,	,	O	,	_	0	SENT_495	[p12l822t2323r950b2418],
4	Colaizzo	NNP	O	Colaizzo	nn	5	SENT_495	[p12l977t2320r1389b2402],
5	D	NNP	O	D	appos	2	SENT_495	[p12l1412t2322r1519b2417],
6	,	,	O	,	_	0	SENT_495	[p12l1412t2322r1519b2417],
7	D’Andrea	NNP	O	D’Andrea	nn	8	SENT_495	[p12l1545t2320r2014b2402],
8	G	NNP	O	G	appos	2	SENT_495	[p12l2036t2320r2141b2417],
9	,	,	O	,	_	0	SENT_495	[p12l2036t2320r2141b2417],
10	et	FW	O	et	nn	11	SENT_495	[p12l206t2475r289b2546],
11	al.	FW	O	al.	appos	2	SENT_495	[p12l341t2463r444b2546],
12	2000	CD	DATE	2000	dep	11	SENT_495	[p12l505t2463r759b2546],
13	.	.	O	.	_	0	SENT_495	[p12l505t2463r759b2546],

1	Genetic	JJ	O	genetic	amod	2	SENT_496	[p12l818t2462r1178b2546],
2	modulation	NN	O	modulation	_	0	SENT_496	[p12l1231t2462r1766b2546],
3	of	IN	O	of	_	0	SENT_496	[p12l1820t2462r1921b2546],
4	oral	JJ	O	oral	amod	5	SENT_496	[p12l1966t2462r2145b2546],
5	anticoagulation	NN	O	anticoagulation	prep_of	2	SENT_496	[p12l208t2607r930b2713],
6	with	IN	O	with	_	0	SENT_496	[p12l996t2607r1201b2689],
7	warfarin	NN	O	warfarin	prep_with	2	SENT_496	[p12l1267t2607r1684b2689],
8	.	.	O	.	_	0	SENT_496	[p12l1267t2607r1684b2689],

1	T	NN	O	t	_	0	SENT_497	[p12l1760t2610r1828b2687],
2	hromb	NN	O	hromb	dep	1	SENT_497	[p12l1821t2607r2134b2689],
3	.	.	O	.	_	0	SENT_497	[p12l1821t2607r2134b2689],

1	Haemost	NNP	O	Haemost	_	0	SENT_498	[p12l202t2753r644b2832],
2	.	.	O	.	_	0	SENT_498	[p12l202t2753r644b2832],

1	841775-78	CD	NUMBER	841775-78	_	0	SENT_499	[p12l688t2750r1181b2832],

1	25	CD	NUMBER	25	_	0	SENT_500	[p12l7t2893r143b2977],
2	.	.	O	.	_	0	SENT_500	[p12l7t2893r143b2977],

1	Freeman	NNP	PERSON	Freeman	nn	2	SENT_501	[p12l205t2896r614b2977],
2	BD	NNP	O	BD	_	0	SENT_501	[p12l642t2896r828b2991],
3	,	,	O	,	_	0	SENT_501	[p12l642t2896r828b2991],
4	Zehnbauer	NNP	O	Zehnbauer	nn	5	SENT_501	[p12l860t2893r1364b2977],
5	BA	NN	O	ba	appos	2	SENT_501	[p12l1389t2894r1571b2991],
6	,	,	O	,	_	0	SENT_501	[p12l1389t2894r1571b2991],
7	McGrath	NNP	PERSON	McGrath	nn	8	SENT_501	[p12l1602t2894r2025b2977],
8	S	NNP	PERSON	S	appos	2	SENT_501	[p12l2056t2894r2140b2991],
9	,	,	O	,	_	0	SENT_501	[p12l2056t2894r2140b2991],
10	et	FW	O	et	nn	11	SENT_501	[p12l206t3051r289b3121],
11	al.	FW	O	al.	appos	2	SENT_501	[p12l336t3039r439b3121],
12	2000	CD	DATE	2000	dep	11	SENT_501	[p12l492t3039r748b3121],
13	.	.	O	.	_	0	SENT_501	[p12l492t3039r748b3121],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_502	[p12l800t3039r1380b3145],
2	P450	NN	O	p450	nn	3	SENT_502	[p12l1425t3039r1664b3121],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	5	SENT_502	[p12l1709t3039r2142b3145, p12l203t3182r533b3289],
4	are	VBP	O	be	auxpass	5	SENT_502	[p12l579t3208r716b3264],
5	associated	VBN	O	associate	_	0	SENT_502	[p12l759t3182r1240b3264],
6	with	IN	O	with	_	0	SENT_502	[p12l1280t3182r1486b3264],
7	reduced	VBN	O	reduce	amod	9	SENT_502	[p12l1524t3182r1897b3264],
8	warfarin	NN	O	warfarin	nn	9	SENT_502	[p12l1936t3208r2142b3264, p12l206t3324r423b3408],
9	dose	NN	O	dose	prep_with	5	SENT_502	[p12l457t3324r693b3408],
10	.	.	O	.	_	0	SENT_502	[p12l457t3324r693b3408],

1	Surgery	NN	O	surgery	nn	2	SENT_503	[p12l732t3327r1096b3430],
2	l28	NN	O	l28	_	0	SENT_503	[p12l1139t3324r1684b3408],
3	:28	CD	NUMBER	:28	num	4	SENT_503	[p12l1139t3324r1684b3408],
4	l	NN	O	l	dep	2	SENT_503	[p12l1139t3324r1684b3408],
5	—	CD	NUMBER	—	number	6	SENT_503	[p12l1139t3324r1684b3408],
6	85	CD	NUMBER	85	dep	4	SENT_503	[p12l1139t3324r1684b3408],

1	26	CD	NUMBER	26	_	0	SENT_504	[p12l6t3468r143b3552],
2	.	.	O	.	_	0	SENT_504	[p12l6t3468r143b3552],

1	Higashi	NNP	PERSON	Higashi	nn	2	SENT_505	[p12l205t3469r568b3575],
2	MK	NNP	O	MK	_	0	SENT_505	[p12l620t3471r832b3566],
3	,	,	O	,	_	0	SENT_505	[p12l620t3471r832b3566],
4	Veenstra	NNP	PERSON	Veenstra	nn	5	SENT_505	[p12l887t3471r1293b3552],
5	DL	NNP	O	DL	appos	2	SENT_505	[p12l1342t3471r1520b3566],
6	,	,	O	,	_	0	SENT_505	[p12l1342t3471r1520b3566],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_505	[p12l1578t3469r1889b3551],
8	LM	NNP	O	LM	appos	2	SENT_505	[p12l1941t3471r2140b3566],
9	,	,	O	,	_	0	SENT_505	[p12l1941t3471r2140b3566],
10	et	FW	O	et	nn	11	SENT_505	[p12l206t3626r289b3696],
11	al.	FW	O	al.	appos	2	SENT_505	[p12l313t3613r415b3696],
12	2002	CD	DATE	2002	dep	11	SENT_505	[p12l447t3613r701b3696],
13	.	.	O	.	_	0	SENT_505	[p12l447t3613r701b3696],

1	Association	NNP	O	Association	_	0	SENT_506	[p12l731t3613r1285b3696],
2	between	IN	O	between	_	0	SENT_506	[p12l1307t3613r1699b3696],
3	CYP2C9	NNP	O	CYP2C9	prep_between	1	SENT_506	[p12l1723t3613r2142b3697],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	_	0	SENT_507	[p12l1248t3775r1650b3802],
2	133	CD	NUMBER	133	num	1	SENT_507	[p12l1742t3772r1801b3802],

1	ed	VBN	O	ed	_	0	SENT_508	[p13l6t3549r63b3640],
2	.	.	O	.	_	0	SENT_508	[p13l6t3549r63b3640],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_509	[p13l6t3242r64b3521],
2	:	:	O	:	_	0	SENT_509	[p13l6t3242r64b3521],
3	1	CD	NUMBER	1	number	4	SENT_509	[p13l6t3203r62b3226],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_509	[p13l6t2948r64b3186],
5	.	.	O	.	_	0	SENT_509	[p13l6t2948r64b3186],

1	Downloaded	VBN	O	download	_	0	SENT_510	[p13l6t2506r63b2921],
2	from	IN	O	from	_	0	SENT_510	[p13l6t2326r63b2484],
3	www.annualreViews.org	NNP	O	www.annualreViews.org	nn	4	SENT_510	[p13l6t1510r80b2304],
4	ty	NN	O	ty	prep_from	1	SENT_510	[p13l96t3580r162b3641],
5	of	IN	O	of	_	0	SENT_510	[p13l87t3485r145b3555],
6	Wisconsin	NNP	LOCATION	Wisconsin	nn	8	SENT_510	[p13l87t3125r145b3469],
7	—	NNP	O	—	nn	8	SENT_510	[p13l122t3080r128b3101],
8	Madison	NNP	O	Madison	prep_of	4	SENT_510	[p13l88t2772r145b3056],
9	on	IN	O	on	_	0	SENT_510	[p13l105t2670r145b2749],
10	01/05/14	CD	DATE	01/05/14	prep_on	8	SENT_510	[p13l87t2343r145b2647],
11	.	.	O	.	_	0	SENT_510	[p13l87t2343r145b2647],

1	For	IN	O	for	_	0	SENT_511	[p13l89t2203r145b2317],
2	personal	JJ	O	personal	amod	3	SENT_511	[p13l88t1908r162b2183],
3	use	NN	O	use	pobj	1	SENT_511	[p13l105t1779r145b1886],
4	only	RB	O	only	advmod	3	SENT_511	[p13l88t1597r162b1755],
5	.	.	O	.	_	0	SENT_511	[p13l88t1597r162b1755],

1	genetic	JJ	O	genetic	amod	2	SENT_512	[p13l643t198r902b280],
2	Variants	NNS	O	variant	nsubj	6	SENT_512	[p13l982t198r1265b262],
3	and	CC	O	and	_	0	SENT_512	[p13l1347t198r1476b262],
4	anticoagulationrelated	JJ	O	anticoagulationrelated	amod	5	SENT_512	[p13l1556t198r2144b280, p13l640t308r889b372],
5	outcomes	NNS	O	outcome	nsubj	6	SENT_512	[p13l909t318r1254b372],
6	during	IN	O	during	_	0	SENT_512	[p13l1277t308r1512b391],
7	warfarin	NN	O	warfarin	nn	8	SENT_512	[p13l1533t308r1838b372],
8	therapy	NN	O	therapy	pobj	6	SENT_512	[p13l1858t308r2142b391],
9	.	.	O	.	_	0	SENT_512	[p13l1858t308r2142b391],

1	JAMA	NN	O	jama	_	0	SENT_513	[p13l639t421r861b484],
2	287:1690	CD	NUMBER	287:1690	num	1	SENT_513	[p13l890t420r1367b485],
3	—	CD	NUMBER	—	number	4	SENT_513	[p13l890t420r1367b485],
4	98	CD	NUMBER	98	dep	1	SENT_513	[p13l890t420r1367b485],
5	Sanderson	NNP	ORGANIZATION	Sanderson	dep	4	SENT_513	[p13l644t530r1020b594],
6	S	NN	ORGANIZATION	s	dep	1	SENT_513	[p13l1058t530r1123b605],
7	,	,	O	,	_	0	SENT_513	[p13l1058t530r1123b605],
8	Emery	NNP	PERSON	Emery	nn	9	SENT_513	[p13l1161t531r1402b612],
9	J	NNP	PERSON	J	appos	6	SENT_513	[p13l1438t531r1471b594],
10	,	,	O	,	_	0	SENT_513	[p13l1478t582r1491b605],
11	Higgins	NNP	PERSON	Higgins	nn	12	SENT_513	[p13l1529t530r1815b612],
12	J	NNP	O	J	appos	1	SENT_513	[p13l1851t531r1885b594],
13	.	.	O	.	_	0	SENT_513	[p13l1892t583r1903b594],

1	2005	CD	DATE	2005	_	0	SENT_514	[p13l1944t530r2142b594],
2	.	.	O	.	_	0	SENT_514	[p13l1944t530r2142b594],

1	CYP2C9	NN	O	cyp2c9	nn	3	SENT_515	[p13l643t641r968b705],
2	gene	NN	O	gene	nn	3	SENT_515	[p13l1014t661r1182b723],
3	Variants	NNS	O	variant	_	0	SENT_515	[p13l1226t640r1531b716],
4	,	,	O	,	_	0	SENT_515	[p13l1226t640r1531b716],
5	drug	NN	O	drug	nn	6	SENT_515	[p13l1578t640r1741b723],
6	dose	NN	O	dose	conj_and	3	SENT_515	[p13l1787t640r1970b716],
7	,	,	O	,	_	0	SENT_515	[p13l1787t640r1970b716],
8	and	CC	O	and	_	0	SENT_515	[p13l2018t640r2147b704],
9	bleeding	VBG	O	bleed	amod	10	SENT_515	[p13l640t750r953b833],
10	risk	NN	O	risk	conj_and	3	SENT_515	[p13l977t750r1115b814],
11	in	IN	O	in	_	0	SENT_515	[p13l1137t750r1206b814],
12	warfarin	NN	O	warfarin	nn	13	SENT_515	[p13l1229t750r1815b815],
13	—	NN	O	—	prep_in	10	SENT_515	[p13l1229t750r1815b815],
14	treated	VBN	O	treat	partmod	10	SENT_515	[p13l1229t750r1815b815],
15	patients	NNS	O	patient	dobj	14	SENT_515	[p13l1838t750r2140b833],
16	:	:	O	:	_	0	SENT_515	[p13l1838t750r2140b833],
17	a	DT	O	a	det	20	SENT_515	[p13l643t881r681b925],
18	HuGEnet	NNP	O	HuGEnet	nn	20	SENT_515	[p13l712t861r1057b925],
19	systematic	JJ	O	systematic	amod	20	SENT_515	[p13l1091t861r1470b943],
20	review	NN	O	review	dep	3	SENT_515	[p13l1503t861r1745b925],
21	and	CC	O	and	_	0	SENT_515	[p13l1780t861r1908b925],
22	metaanalysis	NN	O	metaanalysis	conj_and	20	SENT_515	[p13l1941t871r2144b925, p13l643t971r952b1054],
23	.	.	O	.	_	0	SENT_515	[p13l1941t871r2144b925, p13l643t971r952b1054],

1	Genet	NNP	PERSON	Genet	_	0	SENT_516	[p13l986t973r1212b1036],
2	.	.	O	.	_	0	SENT_516	[p13l986t973r1212b1036],

1	Med	NNP	O	Med	_	0	SENT_517	[p13l1243t971r1425b1035],
2	.	.	O	.	_	0	SENT_517	[p13l1243t971r1425b1035],

1	7:97	CD	NUMBER	7:97	num	4	SENT_518	[p13l1455t972r1797b1036],
2	-104	CD	NUMBER	-104	num	4	SENT_518	[p13l1455t972r1797b1036],
3	Rieder	NNP	PERSON	Rieder	nn	4	SENT_518	[p13l641t1081r884b1145],
4	MJ	NNP	PERSON	MJ	_	0	SENT_518	[p13l922t1083r1056b1157],
5	,	,	O	,	_	0	SENT_518	[p13l922t1083r1056b1157],
6	Reiner	NNP	ORGANIZATION	Reiner	nn	7	SENT_518	[p13l1098t1081r1342b1145],
7	AP	NNP	ORGANIZATION	AP	appos	4	SENT_518	[p13l1379t1082r1513b1157],
8	,	,	O	,	_	0	SENT_518	[p13l1379t1082r1513b1157],
9	Gage	NNP	PERSON	Gage	nn	10	SENT_518	[p13l1557t1082r1746b1164],
10	BF	NNP	O	BF	appos	4	SENT_518	[p13l1785t1083r1914b1157],
11	,	,	O	,	_	0	SENT_518	[p13l1785t1083r1914b1157],
12	et	FW	O	et	nn	13	SENT_518	[p13l1958t1091r2022b1145],
13	al.	FW	O	al.	appos	4	SENT_518	[p13l2062t1081r2142b1145],
14	2005	CD	DATE	2005	dep	13	SENT_518	[p13l643t1192r840b1256],
15	.	.	O	.	_	0	SENT_518	[p13l643t1192r840b1256],

1	Effect	NN	O	effect	_	0	SENT_519	[p13l878t1192r1098b1256],
2	of	IN	O	of	_	0	SENT_519	[p13l1131t1192r1210b1256],
3	VKORC1	NN	O	vkorc1	nn	4	SENT_519	[p13l1237t1192r1590b1256],
4	haplotypes	NNS	O	haplotype	prep_of	1	SENT_519	[p13l1630t1192r2022b1274],
5	on	IN	O	on	_	0	SENT_519	[p13l2059t1212r2147b1256],
6	transcriptional	JJ	O	transcriptional	amod	7	SENT_519	[p13l641t1302r1167b1385],
7	regulation	NN	O	regulation	prep_on	1	SENT_519	[p13l1225t1302r1594b1385],
8	and	CC	O	and	_	0	SENT_519	[p13l1654t1302r1783b1366],
9	warfarin	NN	O	warfarin	nn	10	SENT_519	[p13l1841t1302r2147b1366],
10	dose	NN	O	dose	prep_on	1	SENT_519	[p13l643t1413r825b1477],
11	.	.	O	.	_	0	SENT_519	[p13l643t1413r825b1477],

1	N.	NNP	O	N.	nn	2	SENT_520	[p13l852t1415r927b1477],
2	Engl	NNP	O	Engl	_	0	SENT_520	[p13l960t1413r1146b1494],
3	.	.	O	.	_	0	SENT_520	[p13l960t1413r1146b1494],

1	J.	NNP	O	J.	nn	2	SENT_521	[p13l1178t1415r1231b1477],
2	Med	NNP	O	Med	_	0	SENT_521	[p13l1261t1412r1443b1477],
3	.	.	O	.	_	0	SENT_521	[p13l1261t1412r1443b1477],

1	352:2285	CD	NUMBER	352:2285	num	2	SENT_522	[p13l1476t1412r1949b1477],
2	—	CD	NUMBER	—	_	0	SENT_522	[p13l1476t1412r1949b1477],
3	93	CD	NUMBER	93	num	5	SENT_522	[p13l1476t1412r1949b1477],
4	D’Andrea	NN	O	d’andrea	nn	5	SENT_522	[p13l641t1525r1007b1588],
5	G	NN	O	g	dep	2	SENT_522	[p13l1039t1525r1121b1600],
6	,	,	O	,	_	0	SENT_522	[p13l1039t1525r1121b1600],
7	D’Ambrosio	NNP	O	D’Ambrosio	nn	8	SENT_522	[p13l1156t1524r1615b1588],
8	RL	NNP	O	RL	appos	5	SENT_522	[p13l1649t1526r1783b1600],
9	,	,	O	,	_	0	SENT_522	[p13l1649t1526r1783b1600],
10	Di	NNP	PERSON	Di	nn	12	SENT_522	[p13l1819t1524r1907b1587],
11	Perna	NNP	PERSON	Perna	nn	12	SENT_522	[p13l1941t1526r2148b1588],
12	P	NN	O	p	appos	5	SENT_522	[p13l641t1637r709b1712],
13	,	,	O	,	_	0	SENT_522	[p13l641t1637r709b1712],
14	et	FW	O	et	nn	15	SENT_522	[p13l757t1646r822b1700],
15	al.	FW	O	al.	appos	5	SENT_522	[p13l866t1636r946b1700],
16	2005	CD	DATE	2005	dep	15	SENT_522	[p13l995t1636r1193b1700],
17	.	.	O	.	_	0	SENT_522	[p13l995t1636r1193b1700],

1	A	DT	O	a	det	2	SENT_523	[p13l1242t1637r1306b1699],
2	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_523	[p13l1348t1636r1882b1719],
3	in	IN	O	in	_	0	SENT_523	[p13l1924t1636r1994b1699],
4	the	DT	O	the	det	6	SENT_523	[p13l2037t1636r2146b1700],
5	VKORC1	NN	O	vkorc1	nn	6	SENT_523	[p13l641t1748r994b1812],
6	gene	NN	O	gene	prep_in	2	SENT_523	[p13l1020t1768r1189b1831],
7	is	VBZ	O	be	auxpass	8	SENT_523	[p13l1206t1748r1263b1812],
8	associated	VBN	O	associate	_	0	SENT_523	[p13l1284t1748r1656b1812],
9	with	IN	O	with	_	0	SENT_523	[p13l1673t1748r1833b1812],
10	an	DT	O	a	det	12	SENT_523	[p13l1852t1768r1934b1812],
11	interindividual	JJ	O	interindividual	amod	12	SENT_523	[p13l1951t1748r2144b1812, p13l641t1860r1008b1924],
12	Variability	NN	O	variability	prep_with	8	SENT_523	[p13l1043t1860r1413b1943],
13	in	IN	O	in	_	0	SENT_523	[p13l1449t1860r1518b1923],
14	the	DT	O	the	det	16	SENT_523	[p13l1553t1860r1662b1924],
15	doseanticoagulant	NN	O	doseanticoagulant	nn	16	SENT_523	[p13l1697t1860r2144b1924, p13l643t1972r910b2055],
16	effect	NN	O	effect	prep_in	12	SENT_523	[p13l960t1972r1165b2036],
17	of	IN	O	of	_	0	SENT_523	[p13l1216t1972r1294b2036],
18	warfarin	NN	O	warfarin	prep_of	16	SENT_523	[p13l1340t1972r1663b2036],
19	.	.	O	.	_	0	SENT_523	[p13l1340t1972r1663b2036],

1	Blood	NN	O	blood	_	0	SENT_524	[p13l1717t1972r1939b2036],
2	105	CD	NUMBER	105	num	1	SENT_524	[p13l1995t1971r2140b2036],
3	:	:	O	:	_	0	SENT_524	[p13l1995t1971r2140b2036],
4	645-49	CD	NUMBER	645-49	num	6	SENT_524	[p13l643t2083r911b2148],
5	Klok	NNP	PERSON	Klok	nn	6	SENT_524	[p13l643t2196r824b2260],
6	RM	NN	O	rm	dep	1	SENT_524	[p13l849t2197r1008b2271],
7	,	,	O	,	_	0	SENT_524	[p13l849t2197r1008b2271],
8	Postma	NNP	PERSON	Postma	nn	9	SENT_524	[p13l1038t2197r1307b2260],
9	MJ	NNP	PERSON	MJ	appos	6	SENT_524	[p13l1331t2197r1466b2271],
10	,	,	O	,	_	0	SENT_524	[p13l1331t2197r1466b2271],
11	Van	NNP	O	Van	nn	13	SENT_524	[p13l1495t2216r1623b2260],
12	Hout	NNP	O	Hout	nn	13	SENT_524	[p13l1650t2197r1831b2260],
13	A	NNP	O	A	appos	6	SENT_524	[p13l1856t2196r1940b2271],
14	,	,	O	,	_	0	SENT_524	[p13l1856t2196r1940b2271],
15	et	FW	O	et	nn	16	SENT_524	[p13l1970t2205r2034b2260],
16	al.	FW	O	al.	appos	6	SENT_524	[p13l2062t2196r2142b2260],
17	2003	CD	DATE	2003	dep	16	SENT_524	[p13l643t2308r840b2372],
18	.	.	O	.	_	0	SENT_524	[p13l643t2308r840b2372],

1	Meta	NN	O	meta	nn	3	SENT_525	[p13l874t2307r1405b2391],
2	—	NN	O	—	nn	3	SENT_525	[p13l874t2307r1405b2391],
3	analysis	NN	O	analysis	_	0	SENT_525	[p13l874t2307r1405b2391],
4	:	:	O	:	_	0	SENT_525	[p13l874t2307r1405b2391],
5	comparing	VBG	O	compare	dep	3	SENT_525	[p13l1441t2307r1829b2391],
6	the	DT	O	the	det	8	SENT_525	[p13l1859t2307r1968b2371],
7	efﬁ	NN	O	efﬁ	nn	8	SENT_525	[p13l2000t2307r2144b2371],
8	cacy	NN	O	cacy	dobj	5	SENT_525	[p13l642t2440r805b2502],
9	of	IN	O	of	_	0	SENT_525	[p13l839t2419r918b2483],
10	proton	NN	O	proton	nn	12	SENT_525	[p13l944t2429r1181b2502],
11	pump	NN	O	pump	nn	12	SENT_525	[p13l1213t2440r1418b2502],
12	inhibitors	NNS	O	inhibitor	prep_of	8	SENT_525	[p13l1453t2419r1799b2484],
13	in	IN	O	in	_	0	SENT_525	[p13l1834t2419r1902b2483],
14	shortterm	JJ	O	shortterm	amod	15	SENT_525	[p13l1939t2419r2144b2484, p13l641t2541r808b2595],
15	use	NN	O	use	prep_in	5	SENT_525	[p13l837t2551r975b2595],
16	.	.	O	.	_	0	SENT_525	[p13l837t2551r975b2595],

1	Aliment	NNP	O	Aliment	_	0	SENT_526	[p13l1005t2531r1308b2595],
2	.	.	O	.	_	0	SENT_526	[p13l1005t2531r1308b2595],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_527	[p13l1347t2531r1767b2595],
2	.	.	O	.	_	0	SENT_527	[p13l1347t2531r1767b2595],

1	Ther	NNP	O	Ther	_	0	SENT_528	[p13l1812t2531r1996b2595],
2	.	.	O	.	_	0	SENT_528	[p13l1812t2531r1996b2595],

1	17	CD	NUMBER	17	_	0	SENT_529	[p13l2040t2532r2140b2595],
2	:	:	O	:	_	0	SENT_529	[p13l2040t2532r2140b2595],
3	1237-45	CD	NUMBER	1237-45	num	5	SENT_529	[p13l650t2643r955b2707],
4	Lind	NN	PERSON	lind	nn	5	SENT_529	[p13l641t2755r812b2819],
5	T	NN	O	t	dep	1	SENT_529	[p13l848t2757r921b2831],
6	,	,	O	,	_	0	SENT_529	[p13l848t2757r921b2831],
7	Cederberg	NNP	ORGANIZATION	Cederberg	nn	8	SENT_529	[p13l961t2755r1336b2838],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_529	[p13l1374t2756r1451b2831],
9	,	,	O	,	_	0	SENT_529	[p13l1374t2756r1451b2831],
10	Ekenved	NNP	O	Ekenved	nn	11	SENT_529	[p13l1490t2755r1803b2819],
11	G	NNP	O	G	appos	5	SENT_529	[p13l1839t2756r1921b2831],
12	,	,	O	,	_	0	SENT_529	[p13l1839t2756r1921b2831],
13	et	FW	O	et	nn	14	SENT_529	[p13l1961t2765r2026b2819],
14	al.	FW	O	al.	appos	5	SENT_529	[p13l2062t2755r2142b2819],
15	1983	CD	DATE	1983	dep	14	SENT_529	[p13l650t2867r840b2932],
16	.	.	O	.	_	0	SENT_529	[p13l650t2867r840b2932],

1	Effect	NN	O	effect	nsubj	8	SENT_530	[p13l897t2867r1117b2931],
2	of	IN	O	of	_	0	SENT_530	[p13l1171t2867r1249b2931],
3	omeprazole	NN	O	omeprazole	prep_of	1	SENT_530	[p13l1297t2867r1853b2949],
4	—	CD	NUMBER	—	num	3	SENT_530	[p13l1297t2867r1853b2949],
5	a	DT	O	a	det	8	SENT_530	[p13l1297t2867r1853b2949],
6	gastric	JJ	O	gastric	amod	8	SENT_530	[p13l1906t2867r2145b2949],
7	proton	NN	O	proton	nn	8	SENT_530	[p13l640t2988r878b3062],
8	pump	NN	O	pump	_	0	SENT_530	[p13l918t2999r1124b3062],
9	inhibitor	NN	O	inhibitor	nn	10	SENT_530	[p13l1167t2978r1661b3043],
10	—	NN	O	—	dobj	8	SENT_530	[p13l1167t2978r1661b3043],
11	on	IN	O	on	_	0	SENT_530	[p13l1167t2978r1661b3043],
12	pentagastrin	NN	O	pentagastrin	nn	15	SENT_530	[p13l1701t2979r2147b3062],
13	stimulated	JJ	O	stimulated	amod	15	SENT_530	[p13l644t3090r1021b3154],
14	acid	NN	O	acid	nn	15	SENT_530	[p13l1048t3090r1197b3154],
15	secretion	NN	O	secretion	prep_on	10	SENT_530	[p13l1224t3090r1549b3154],
16	in	IN	O	in	_	0	SENT_530	[p13l1575t3090r1643b3154],
17	man	NN	O	man	prep_in	8	SENT_530	[p13l1668t3111r1842b3154],
18	.	.	O	.	_	0	SENT_530	[p13l1668t3111r1842b3154],

1	Gut	NN	O	gut	_	0	SENT_531	[p13l1875t3092r2010b3155],
2	24	CD	NUMBER	24	num	1	SENT_531	[p13l2033t3091r2140b3154],
3	:	:	O	:	_	0	SENT_531	[p13l2033t3091r2140b3154],
4	270-76	CD	NUMBER	270-76	num	6	SENT_531	[p13l643t3202r912b3266],
5	Junghard	NN	ORGANIZATION	junghard	nn	6	SENT_531	[p13l641t3314r975b3397],
6	O	NN	ORGANIZATION	o	dep	1	SENT_531	[p13l1007t3314r1089b3390],
7	,	,	O	,	_	0	SENT_531	[p13l1007t3314r1089b3390],
8	Hassan-Alin	NN	O	hassan-alin	nn	9	SENT_531	[p13l1123t3314r1579b3378],
9	M	NN	O	m	appos	1	SENT_531	[p13l1609t3315r1707b3389],
10	,	,	O	,	_	0	SENT_531	[p13l1609t3315r1707b3389],
11	Hasselgren	NNP	O	Hasselgren	nn	12	SENT_531	[p13l1742t3314r2147b3397],
12	G.	NNP	O	G.	appos	1	SENT_531	[p13l643t3426r723b3490],
13	2002	CD	DATE	2002	dep	12	SENT_531	[p13l757t3426r954b3490],
14	.	.	O	.	_	0	SENT_531	[p13l757t3426r954b3490],

1	The	DT	O	the	det	2	SENT_532	[p13l987t3425r1127b3489],
2	effect	NN	O	effect	nsubj	10	SENT_532	[p13l1156t3425r1360b3489],
3	of	IN	O	of	_	0	SENT_532	[p13l1387t3425r1466b3489],
4	the	DT	O	the	det	5	SENT_532	[p13l1488t3425r1597b3489],
5	area	NN	O	area	prep_of	2	SENT_532	[p13l1627t3446r1777b3489],
6	under	IN	O	under	_	0	SENT_532	[p13l1803t3425r2011b3489],
7	the	DT	O	the	det	9	SENT_532	[p13l2037t3425r2146b3489],
8	plasma	NN	O	plasma	nn	9	SENT_532	[p13l640t3538r900b3620],
9	concentrations	NNS	O	concentration	prep_under	5	SENT_532	[p13l929t3538r1457b3602],
10	VS	VBP	O	v	_	0	SENT_532	[p13l1489t3558r1565b3602],
11	time	NN	O	time	nn	12	SENT_532	[p13l1598t3538r1758b3602],
12	curve	NN	O	curve	dobj	10	SENT_532	[p13l1788t3558r1987b3602],
13	and	CC	O	and	advmod	10	SENT_532	[p13l2018t3538r2147b3602],

1	Annu	NNP	PERSON	Annu	_	0	SENT_533	[p14l7t276r63b472],
2	.	.	O	.	_	0	SENT_533	[p14l7t276r63b472],

1	Rev.	NNP	O	Rev.	_	0	SENT_534	[p14l7t104r63b249],
2	M	NN	O	m	dep	1	SENT_534	[p14l7t8r62b78],

1	by	IN	O	by	_	0	SENT_535	[p14l88t309r162b389],
2	Universi	NNP	O	Universi	prep_by	6	SENT_535	[p14l87t8r145b286],
3	the	DT	O	the	det	6	SENT_535	[p14l641t14r751b78],
4	maximum	NN	O	maximum	nn	6	SENT_535	[p14l792t14r1162b78],
5	plasma	NN	O	plasma	nn	6	SENT_535	[p14l1201t14r1460b96],
6	concentrations	NNS	O	concentration	_	0	SENT_535	[p14l1501t14r2029b78],
7	of	IN	O	of	_	0	SENT_535	[p14l2074t14r2153b78],
8	esomeprazole	NN	O	esomeprazole	prep_of	6	SENT_535	[p14l642t126r1142b209],
9	on	IN	O	on	_	0	SENT_535	[p14l1177t146r1265b189],
10	intragastric	JJ	O	intragastric	amod	11	SENT_535	[p14l1298t125r1705b209],
11	pH.	NN	O	ph.	prep_on	8	SENT_535	[p14l1739t128r1868b209],
12	.	.	O	.	_	0	SENT_535	[p14l1739t128r1868b209],

1	Em	NNP	O	Em	_	0	SENT_536	[p14l1904t128r2044b189],
2	:	:	O	:	_	0	SENT_536	[p14l1904t128r2044b189],
3	J.	NNP	PERSON	J.	nn	4	SENT_536	[p14l2085t128r2138b190],
4	Clin	NNP	PERSON	Clin	dep	1	SENT_536	[p14l646t238r811b302],
5	.	.	O	.	_	0	SENT_536	[p14l646t238r811b302],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_537	[p14l844t238r1267b302],
2	.	.	O	.	_	0	SENT_537	[p14l844t238r1267b302],

1	58:453	CD	NUMBER	58:453	num	2	SENT_538	[p14l1299t237r1683b302],
2	—	CD	NUMBER	—	_	0	SENT_538	[p14l1299t237r1683b302],
3	58	CD	NUMBER	58	num	5	SENT_538	[p14l1299t237r1683b302],
4	Desta	NNP	ORGANIZATION	Desta	nn	5	SENT_538	[p14l641t351r849b413],
5	Z	NN	ORGANIZATION	z	dep	2	SENT_538	[p14l885t351r959b425],
6	,	,	O	,	_	0	SENT_538	[p14l885t351r959b425],
7	Zhao	NNP	PERSON	Zhao	nn	8	SENT_538	[p14l1000t349r1186b413],
8	X	NNP	PERSON	X	appos	5	SENT_538	[p14l1225t351r1308b424],
9	,	,	O	,	_	0	SENT_538	[p14l1225t351r1308b424],
10	Shin	NNP	PERSON	Shin	nn	11	SENT_538	[p14l1353t349r1516b413],
11	JG	NNP	PERSON	JG	appos	5	SENT_538	[p14l1554t349r1673b424],
12	,	,	O	,	_	0	SENT_538	[p14l1554t349r1673b424],
13	et	FW	O	et	nn	14	SENT_538	[p14l1717t359r1781b413],
14	al.	FW	O	al.	appos	5	SENT_538	[p14l1820t349r1900b413],
15	2002	CD	DATE	2002	dep	14	SENT_538	[p14l1944t349r2142b413],
16	.	.	O	.	_	0	SENT_538	[p14l1944t349r2142b413],

1	Clinical	JJ	O	clinical	amod	2	SENT_539	[p14l643t461r928b525],
2	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_539	[p14l975t461r1406b544],
3	of	IN	O	of	_	0	SENT_539	[p14l1450t461r1529b525],
4	the	DT	O	the	det	6	SENT_539	[p14l1566t461r1674b525],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_539	[p14l1719t461r2146b544],
6	P4502C19	NN	O	p4502c19	prep_of	2	SENT_539	[p14l641t572r1023b638],
7	genetic	JJ	O	genetic	amod	8	SENT_539	[p14l1069t573r1328b655],
8	polymorphism	NN	O	polymorphism	dep	6	SENT_539	[p14l1370t573r1921b655],
9	.	.	O	.	_	0	SENT_539	[p14l1370t573r1921b655],

1	Clin	NNP	O	Clin	_	0	SENT_540	[p14l1973t573r2138b637],
2	.	.	O	.	_	0	SENT_540	[p14l1973t573r2138b637],

1	Pharmacokinez	NNP	O	Pharmacokinez	_	0	SENT_541	[p14l640t684r1216b748],
2	‘	CD	NUMBER	‘	dep	1	SENT_541	[p14l640t684r1216b748],
3	.	.	O	.	_	0	SENT_541	[p14l640t684r1216b748],

1	4l	NN	O	4l	_	0	SENT_542	[p14l1246t684r1632b749],
2	:9	CD	NUMBER	:9	num	1	SENT_542	[p14l1246t684r1632b749],
3	l3	NN	O	l3	nn	7	SENT_542	[p14l1246t684r1632b749],
4	—	CD	NUMBER	—	num	7	SENT_542	[p14l1246t684r1632b749],
5	58	CD	NUMBER	58	num	7	SENT_542	[p14l1246t684r1632b749],
6	Xie	NNP	O	Xie	nn	7	SENT_542	[p14l641t794r770b858],
7	HG	NNP	O	HG	dep	1	SENT_542	[p14l798t795r947b870],
8	,	,	O	,	_	0	SENT_542	[p14l798t795r947b870],
9	Stein	NNP	PERSON	Stein	nn	10	SENT_542	[p14l981t794r1164b859],
10	CM	NN	O	cm	appos	7	SENT_542	[p14l1192t795r1351b870],
11	,	,	O	,	_	0	SENT_542	[p14l1192t795r1351b870],
12	Kim	NNP	PERSON	Kim	nn	13	SENT_542	[p14l1383t794r1543b858],
13	RB	NN	O	rb	appos	7	SENT_542	[p14l1569t796r1707b870],
14	,	,	O	,	_	0	SENT_542	[p14l1569t796r1707b870],
15	et	FW	O	et	nn	16	SENT_542	[p14l1739t804r1803b858],
16	al.	FW	O	al.	appos	7	SENT_542	[p14l1831t794r1911b858],
17	1999	CD	DATE	1999	dep	16	SENT_542	[p14l1952t795r2142b859],
18	.	.	O	.	_	0	SENT_542	[p14l1952t795r2142b859],

1	Allelic	JJ	PERSON	allelic	amod	6	SENT_543	[p14l641t905r908b981],
2	,	,	O	,	_	0	SENT_543	[p14l641t905r908b981],
3	genotypic	JJ	O	genotypic	amod	6	SENT_543	[p14l944t905r1300b988],
4	and	CC	O	and	_	0	SENT_543	[p14l1335t905r1463b969],
5	phenotypic	JJ	O	phenotypic	conj_and	3	SENT_543	[p14l1493t905r1897b988],
6	distributions	NNS	O	distribution	nsubj	10	SENT_543	[p14l1931t905r2144b969, p14l640t1016r905b1081],
7	of	IN	O	of	_	0	SENT_543	[p14l941t1016r1019b1081],
8	S-mephenytoin	NN	O	s-mephenytoin	prep_of	6	SENT_543	[p14l1048t1016r1602b1099],
9	4	CD	NUMBER	4	num	10	SENT_543	[p14l1634t1014r2146b1099],
10	’	CD	NUMBER	’	_	0	SENT_543	[p14l1634t1014r2146b1099],
11	hydroXylase	NN	O	hydroxylase	nn	14	SENT_543	[p14l1634t1014r2146b1099],
12	(	CD	NUMBER	(	num	14	SENT_543	[p14l644t1128r1073b1206],
13	CYP2Cl9	NN	O	cyp2cl9	nn	14	SENT_543	[p14l644t1128r1073b1206],
14	)	NN	O	)	dobj	10	SENT_543	[p14l644t1128r1073b1206],
15	in	IN	O	in	_	0	SENT_543	[p14l1097t1127r1166b1190],
16	healthy	JJ	O	healthy	amod	18	SENT_543	[p14l1186t1127r1453b1210],
17	Caucasian	JJ	MISC	caucasian	amod	18	SENT_543	[p14l1476t1127r1848b1192],
18	populations	NNS	O	population	prep_in	14	SENT_543	[p14l1869t1127r2143b1210, p14l641t1237r815b1301],
19	of	IN	O	of	_	0	SENT_543	[p14l844t1237r922b1301],
20	European	JJ	MISC	european	amod	21	SENT_543	[p14l941t1239r1290b1320],
21	descent	NN	O	descent	prep_of	18	SENT_543	[p14l1316t1238r1589b1301],
22	throughout	IN	O	throughout	_	0	SENT_543	[p14l1612t1237r2013b1320],
23	the	DT	O	the	det	24	SENT_543	[p14l2037t1237r2146b1301],
24	World	NNP	O	World	prep_throughout	10	SENT_543	[p14l642t1348r870b1412],
25	.	.	O	.	_	0	SENT_543	[p14l642t1348r870b1412],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_544	[p14l898t1348r1576b1430],
2	92539-49	CD	NUMBER	92539-49	num	4	SENT_544	[p14l1603t1348r1943b1413],
3	Furuta	NNP	ORGANIZATION	Furuta	nn	4	SENT_544	[p14l641t1460r879b1522],
4	T	NN	ORGANIZATION	t	dep	1	SENT_544	[p14l895t1460r968b1534],
5	,	,	O	,	_	0	SENT_544	[p14l895t1460r968b1534],
6	Ohashi	NNP	ORGANIZATION	Ohashi	nn	7	SENT_544	[p14l989t1458r1244b1523],
7	K	NNP	ORGANIZATION	K	appos	4	SENT_544	[p14l1263t1460r1345b1534],
8	,	,	O	,	_	0	SENT_544	[p14l1263t1460r1345b1534],
9	Kosuge	NNP	PERSON	Kosuge	nn	10	SENT_544	[p14l1366t1460r1639b1541],
10	K	NNP	PERSON	K	appos	4	SENT_544	[p14l1657t1460r1739b1534],
11	,	,	O	,	_	0	SENT_544	[p14l1657t1460r1739b1534],
12	et	FW	O	et	nn	13	SENT_544	[p14l1760t1468r1824b1522],
13	al.	FW	O	al.	appos	4	SENT_544	[p14l1842t1458r1921b1522],
14	1999	CD	DATE	1999	dep	13	SENT_544	[p14l1952t1459r2142b1523],
15	.	.	O	.	_	0	SENT_544	[p14l1952t1459r2142b1523],

1	CYP2Cl9	NN	O	cyp2cl9	nn	2	SENT_545	[p14l643t1569r1013b1633],
2	genotype	NN	O	genotype	_	0	SENT_545	[p14l1053t1578r1385b1651],
3	status	NN	O	status	dep	2	SENT_545	[p14l1425t1578r1626b1632],
4	and	CC	O	and	_	0	SENT_545	[p14l1667t1568r1796b1632],
5	effect	NN	O	effect	dep	2	SENT_545	[p14l1833t1568r2037b1632],
6	of	IN	O	of	_	0	SENT_545	[p14l2074t1568r2153b1632],
7	omeprazole	NN	O	omeprazole	prep_of	3	SENT_545	[p14l643t1679r1066b1761],
8	on	IN	O	on	_	0	SENT_545	[p14l1087t1699r1175b1743],
9	intragastric	JJ	O	intragastric	amod	10	SENT_545	[p14l1195t1679r1602b1761],
10	pH	NN	O	ph	prep_on	7	SENT_545	[p14l1622t1680r1733b1761],
11	in	IN	O	in	_	0	SENT_545	[p14l1752t1679r1822b1741],
12	humans	NNS	O	human	prep_in	10	SENT_545	[p14l1840t1679r2142b1743],
13	.	.	O	.	_	0	SENT_545	[p14l1840t1679r2142b1743],

1	Clin	NNP	O	Clin	_	0	SENT_546	[p14l646t1789r811b1854],
2	.	.	O	.	_	0	SENT_546	[p14l646t1789r811b1854],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_547	[p14l844t1789r1263b1853],
2	.	.	O	.	_	0	SENT_547	[p14l844t1789r1263b1853],

1	Ther	NNP	O	Ther	_	0	SENT_548	[p14l1302t1789r1486b1853],
2	.	.	O	.	_	0	SENT_548	[p14l1302t1789r1486b1853],

1	65:552	CD	NUMBER	65:552	number	2	SENT_549	[p14l1517t1789r1897b1854],
2	—	CD	NUMBER	—	num	3	SENT_549	[p14l1517t1789r1897b1854],
3	6l	NN	O	6l	_	0	SENT_549	[p14l1517t1789r1897b1854],

1	36	CD	NUMBER	36	_	0	SENT_550	[p14l10t2091r145b2173],
2	.	.	O	.	_	0	SENT_550	[p14l10t2091r145b2173],

1	Klotz	NNP	PERSON	Klotz	nn	2	SENT_551	[p14l209t2091r466b2173],
2	U	NNP	PERSON	U	_	0	SENT_551	[p14l525t2093r633b2187],
3	,	,	O	,	_	0	SENT_551	[p14l525t2093r633b2187],
4	Schwab	NNP	ORGANIZATION	Schwab	nn	8	SENT_551	[p14l699t2091r1063b2173],
5	M	NNP	ORGANIZATION	M	nn	8	SENT_551	[p14l1124t2093r1252b2187],
6	,	,	O	,	_	0	SENT_551	[p14l1124t2093r1252b2187],
7	Treiber	NNP	PERSON	Treiber	appos	8	SENT_551	[p14l1316t2091r1658b2173],
8	G.	NNP	O	G.	appos	2	SENT_551	[p14l1717t2091r1820b2173],
9	2004	CD	DATE	2004	num	8	SENT_551	[p14l1887t2091r2142b2173],
10	.	.	O	.	_	0	SENT_551	[p14l1887t2091r2142b2173],

1	CYP2Cl9	NN	O	cyp2cl9	nn	2	SENT_552	[p14l208t2234r687b2317],
2	polymorphism	NN	O	polymorphism	_	0	SENT_552	[p14l788t2233r1477b2340],
3	and	CC	O	and	_	0	SENT_552	[p14l1578t2233r1744b2315],
4	proton	NN	O	proton	conj_and	2	SENT_552	[p14l1842t2245r2148b2340],
5	pump	NN	O	pump	nn	6	SENT_552	[p14l205t2403r472b2484],
6	inhibitors	NNS	O	inhibitor	dep	2	SENT_552	[p14l511t2378r984b2460],
7	.	.	O	.	_	0	SENT_552	[p14l511t2378r984b2460],

1	Basic	JJ	O	basic	amod	2	SENT_553	[p14l1026t2381r1287b2460],
2	Clin	NN	O	clin	_	0	SENT_553	[p14l1334t2378r1546b2461],
3	.	.	O	.	_	0	SENT_553	[p14l1334t2378r1546b2461],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_554	[p14l1595t2378r2137b2460],
2	.	.	O	.	_	0	SENT_554	[p14l1595t2378r2137b2460],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_555	[p14l212t2522r565b2605],
2	.	.	O	.	_	0	SENT_555	[p14l212t2522r565b2605],

1	95	CD	NUMBER	95	num	2	SENT_556	[p14l611t2522r719b2606],
2	22-8	CD	NUMBER	22-8	_	0	SENT_556	[p14l735t2522r930b2605],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_557	[p14l206t2667r513b2746],
2	T	NN	O	t	_	0	SENT_557	[p14l534t2667r628b2762],
3	,	,	O	,	_	0	SENT_557	[p14l534t2667r628b2762],
4	Ohashi	NNP	ORGANIZATION	Ohashi	nn	5	SENT_557	[p14l657t2664r985b2748],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_557	[p14l1009t2667r1115b2762],
6	,	,	O	,	_	0	SENT_557	[p14l1009t2667r1115b2762],
7	Kamata	NNP	ORGANIZATION	Kamata	nn	8	SENT_557	[p14l1143t2667r1507b2746],
8	T	NN	ORGANIZATION	t	appos	2	SENT_557	[p14l1527t2667r1622b2762],
9	,	,	O	,	_	0	SENT_557	[p14l1527t2667r1622b2762],
10	et	FW	O	et	nn	11	SENT_557	[p14l1649t2677r1732b2746],
11	al.	FW	O	al.	appos	2	SENT_557	[p14l1755t2664r1858b2747],
12	1998	CD	DATE	1998	dep	11	SENT_557	[p14l1897t2665r2142b2748],
13	.	.	O	.	_	0	SENT_557	[p14l1897t2665r2142b2748],

1	Effect	NN	O	effect	_	0	SENT_558	[p14l206t2808r491b2891],
2	of	IN	O	of	_	0	SENT_558	[p14l514t2808r616b2890],
3	genetic	JJ	O	genetic	amod	4	SENT_558	[p14l633t2808r967b2915],
4	difference	NN	O	difference	prep_of	1	SENT_558	[p14l994t2808r1464b2891],
5	in	IN	O	in	_	0	SENT_558	[p14l1489t2808r1578b2890],
6	omeprazole	NN	O	omeprazole	nn	7	SENT_558	[p14l1602t2808r2147b2915],
7	metabolism	NN	O	metabolism	prep_in	1	SENT_558	[p14l206t2953r757b3035],
8	on	IN	O	on	dep	1	SENT_558	[p14l797t2978r910b3035],
9	cure	NN	O	cure	nn	10	SENT_558	[p14l952t2978r1150b3035],
10	rates	NNS	O	rate	pobj	8	SENT_558	[p14l1190t2965r1409b3035],
11	for	IN	O	for	dep	1	SENT_558	[p14l1452t2953r1589b3035],
12	Helicobacter	NNP	PERSON	Helicobacter	pobj	11	SENT_558	[p14l1624t2953r2144b3035, p14l210t3111r340b3177],

1	pylori	NN	O	pylorus	_	0	SENT_559	[p14l357t3095r646b3201],
2	infection	NN	O	infection	dep	1	SENT_559	[p14l679t3095r1095b3177],
3	and	CC	O	and	_	0	SENT_559	[p14l1129t3095r1295b3177],
4	peptic	JJ	O	peptic	amod	5	SENT_559	[p14l1325t3095r1610b3202],
5	ulcer	NN	O	ulcer	dep	1	SENT_559	[p14l1643t3095r1894b3177],
6	.	.	O	.	_	0	SENT_559	[p14l1643t3095r1894b3177],

1	Ann	NNP	PERSON	Ann	_	0	SENT_560	[p14l1924t3097r2137b3177],
2	.	.	O	.	_	0	SENT_560	[p14l1924t3097r2137b3177],

1	Intern	NNP	O	Intern	_	0	SENT_561	[p14l205t3242r510b3322],
2	.	.	O	.	_	0	SENT_561	[p14l205t3242r510b3322],

1	Med	NNP	O	Med	_	0	SENT_562	[p14l551t3238r785b3322],
2	.	.	O	.	_	0	SENT_562	[p14l551t3238r785b3322],

1	l29	NN	O	l29	_	0	SENT_563	[p14l834t3239r1442b3322],
2	:	:	O	:	_	0	SENT_563	[p14l834t3239r1442b3322],
3	l027	NN	O	l027	dep	1	SENT_563	[p14l834t3239r1442b3322],
4	—	CD	NUMBER	—	number	5	SENT_563	[p14l834t3239r1442b3322],
5	30	CD	NUMBER	30	dep	3	SENT_563	[p14l834t3239r1442b3322],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_564	[p14l206t3386r513b3466],
2	T	NN	O	t	_	0	SENT_564	[p14l557t3386r651b3481],
3	,	,	O	,	_	0	SENT_564	[p14l557t3386r651b3481],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_564	[p14l704t3384r979b3466],
5	N	NNP	O	N	appos	2	SENT_564	[p14l1025t3386r1133b3482],
6	,	,	O	,	_	0	SENT_564	[p14l1025t3386r1133b3482],
7	Takashima	NNP	PERSON	Takashima	nn	8	SENT_564	[p14l1182t3384r1689b3466],
8	M	NNP	O	M	appos	2	SENT_564	[p14l1732t3386r1859b3482],
9	,	,	O	,	_	0	SENT_564	[p14l1732t3386r1859b3482],
10	et	FW	O	et	nn	11	SENT_564	[p14l1911t3397r1994b3466],
11	al.	FW	O	al.	appos	2	SENT_564	[p14l2039t3384r2142b3466],
12	2001	CD	DATE	2001	dep	11	SENT_564	[p14l208t3527r463b3609],
13	.	.	O	.	_	0	SENT_564	[p14l208t3527r463b3609],

1	Effects	NNS	O	effect	_	0	SENT_565	[p14l506t3527r832b3609],
2	of	IN	O	of	_	0	SENT_565	[p14l873t3527r975b3609],
3	genotypic	JJ	O	genotypic	amod	4	SENT_565	[p14l1006t3527r1465b3634],
4	differences	NNS	O	difference	prep_of	1	SENT_565	[p14l1505t3527r2019b3609],
5	in	IN	O	in	_	0	SENT_565	[p14l2060t3527r2148b3608],
6	CYP2Cl9	NN	O	cyp2cl9	nn	7	SENT_565	[p14l208t3670r687b3753],
7	status	NN	O	status	prep_in	1	SENT_565	[p14l741t3682r1000b3753],
8	on	IN	O	on	dep	1	SENT_565	[p14l1052t3696r1164b3753],
9	cure	NN	O	cure	nn	10	SENT_565	[p14l1213t3696r1412b3753],
10	rates	NNS	O	rate	pobj	8	SENT_565	[p14l1458t3682r1676b3753],
11	for	IN	O	for	dep	1	SENT_565	[p14l1728t3669r1864b3753],
12	Helicobacter	NNP	PERSON	Helicobacter	pobj	11	SENT_565	[p14l1906t3669r2144b3753, p15l208t38r622b120],

1	pylori	NN	O	pylorus	nn	2	SENT_566	[p15l641t38r930b144],
2	infection	NN	O	infection	_	0	SENT_566	[p15l965t38r1381b120],
3	by	IN	O	by	_	0	SENT_566	[p15l1413t38r1529b144],
4	dual	JJ	O	dual	amod	5	SENT_566	[p15l1565t38r1764b120],
5	therapy	NN	O	therapy	prep_by	2	SENT_566	[p15l1799t38r2147b144],
6	with	IN	O	with	_	0	SENT_566	[p15l208t181r414b263],
7	rabeprazole	NN	O	rabeprazole	prep_with	2	SENT_566	[p15l453t181r1000b288],
8	plus	CC	O	plus	prep	2	SENT_566	[p15l1039t181r1232b288],
9	amoxicillin	NNP	O	amoxicillin	dep	8	SENT_566	[p15l1276t181r1832b263],
10	.	.	O	.	_	0	SENT_566	[p15l1276t181r1832b263],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_567	[p15l1876t181r2144b263, p15l207t327r843b428],
2	112341-48	CD	NUMBER	112341-48	num	4	SENT_567	[p15l888t324r1374b406],
3	Furuta	NNP	ORGANIZATION	Furuta	nn	4	SENT_567	[p15l206t468r513b549],
4	T	NN	ORGANIZATION	t	dep	1	SENT_567	[p15l557t468r651b563],
5	,	,	O	,	_	0	SENT_567	[p15l557t468r651b563],
6	Shirai	NNP	ORGANIZATION	Shirai	nn	7	SENT_567	[p15l704t467r979b549],
7	N	NNP	ORGANIZATION	N	appos	4	SENT_567	[p15l1025t468r1133b563],
8	,	,	O	,	_	0	SENT_567	[p15l1025t468r1133b563],
9	Takashima	NNP	PERSON	Takashima	nn	10	SENT_567	[p15l1181t467r1689b549],
10	M	NNP	O	M	appos	4	SENT_567	[p15l1733t468r1859b563],
11	,	,	O	,	_	0	SENT_567	[p15l1733t468r1859b563],
12	et	FW	O	et	nn	13	SENT_567	[p15l1911t479r1993b549],
13	al.	FW	O	al.	appos	4	SENT_567	[p15l2039t467r2142b549],
14	2001	CD	DATE	2001	dep	13	SENT_567	[p15l208t610r464b692],
15	.	.	O	.	_	0	SENT_567	[p15l208t610r464b692],

1	Effect	NN	O	effect	_	0	SENT_568	[p15l515t610r799b692],
2	of	IN	O	of	_	0	SENT_568	[p15l846t610r948b692],
3	genotypic	JJ	O	genotypic	amod	4	SENT_568	[p15l987t610r1447b717],
4	differences	NNS	O	difference	prep_of	1	SENT_568	[p15l1496t610r2011b692],
5	in	IN	O	in	_	0	SENT_568	[p15l2060t610r2148b691],
6	CYP2C19	NN	O	cyp2c19	prep_in	1	SENT_568	[p15l208t753r687b836],
7	on	IN	O	on	_	0	SENT_568	[p15l726t779r840b836],
8	cure	NN	O	cure	nn	9	SENT_568	[p15l876t779r1074b836],
9	rates	NNS	O	rate	prep_on	1	SENT_568	[p15l1109t765r1327b836],
10	for	IN	O	for	_	0	SENT_568	[p15l1366t752r1502b836],
11	Helicobacter	NNP	PERSON	Helicobacter	nn	13	SENT_568	[p15l1532t752r2153b836],
12	pylori	NN	O	pylorus	nn	13	SENT_568	[p15l196t898r486b1003],
13	infection	NN	O	infection	prep_for	1	SENT_568	[p15l532t898r949b980],
14	by	IN	O	by	_	0	SENT_568	[p15l993t898r1109b1004],
15	triple	JJ	O	triple	amod	16	SENT_568	[p15l1157t898r1403b1004],
16	therapy	NN	O	therapy	prep_by	1	SENT_568	[p15l1450t898r1799b1004],
17	with	IN	O	with	_	0	SENT_568	[p15l1846t898r2053b980],
18	a	DT	O	a	det	21	SENT_568	[p15l2101t923r2150b980],
19	proton	NN	O	proton	nn	21	SENT_568	[p15l205t1054r513b1149],
20	pump	NN	O	pump	nn	21	SENT_568	[p15l563t1068r829b1149],
21	inhibitor	NN	O	inhibitor	prep_with	1	SENT_568	[p15l883t1042r1307b1139],
22	,	,	O	,	_	0	SENT_568	[p15l883t1042r1307b1139],
23	amoxicillin	NNP	O	amoxicillin	prep_with	1	SENT_568	[p15l1366t1042r1924b1140],
24	,	,	O	,	_	0	SENT_568	[p15l1366t1042r1924b1140],
25	and	CC	O	and	_	0	SENT_568	[p15l1984t1042r2150b1124],
26	clarithromycin	NN	O	clarithromycin	prep_with	1	SENT_568	[p15l208t1184r922b1291],
27	.	.	O	.	_	0	SENT_568	[p15l208t1184r922b1291],

1	Clin	NNP	O	Clin	_	0	SENT_569	[p15l993t1184r1207b1268],
2	.	.	O	.	_	0	SENT_569	[p15l993t1184r1207b1268],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_570	[p15l1281t1184r1823b1267],
2	.	.	O	.	_	0	SENT_570	[p15l1281t1184r1823b1267],

1	Ther	NNP	O	Ther	_	0	SENT_571	[p15l1905t1184r2142b1267],
2	.	.	O	.	_	0	SENT_571	[p15l1905t1184r2142b1267],

1	69:158	CD	NUMBER	69:158	num	2	SENT_572	[p15l209t1327r704b1412],
2	—	CD	NUMBER	—	_	0	SENT_572	[p15l209t1327r704b1412],
3	68	CD	NUMBER	68	num	5	SENT_572	[p15l209t1327r704b1412],
4	Kawabata	NNP	ORGANIZATION	Kawabata	nn	5	SENT_572	[p15l209t1472r675b1555],
5	H	NN	ORGANIZATION	h	dep	2	SENT_572	[p15l714t1474r820b1570],
6	,	,	O	,	_	0	SENT_572	[p15l714t1474r820b1570],
7	Habu	NNP	PERSON	Habu	nn	8	SENT_572	[p15l865t1472r1115b1554],
8	Y	NN	PERSON	y	appos	5	SENT_572	[p15l1156t1475r1263b1570],
9	,	,	O	,	_	0	SENT_572	[p15l1156t1475r1263b1570],
10	Tomioka	NN	PERSON	tomioka	nn	11	SENT_572	[p15l1308t1472r1723b1554],
11	H	NN	PERSON	h	appos	5	SENT_572	[p15l1763t1474r1869b1570],
12	,	,	O	,	_	0	SENT_572	[p15l1763t1474r1869b1570],
13	et	FW	O	et	nn	14	SENT_572	[p15l1916t1485r1998b1554],
14	al.	FW	O	al.	appos	5	SENT_572	[p15l2039t1472r2142b1554],
15	2003	CD	DATE	2003	dep	14	SENT_572	[p15l208t1615r464b1697],
16	.	.	O	.	_	0	SENT_572	[p15l208t1615r464b1697],

1	Effect	NN	O	effect	_	0	SENT_573	[p15l535t1614r820b1696],
2	of	IN	O	of	_	0	SENT_573	[p15l886t1614r987b1696],
3	different	JJ	O	different	amod	6	SENT_573	[p15l1047t1614r1447b1696],
4	proton	NN	O	proton	nn	6	SENT_573	[p15l1510t1626r1817b1721],
5	pump	NN	O	pump	nn	6	SENT_573	[p15l1881t1641r2147b1721],
6	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_573	[p15l207t1759r682b1856],
7	,	,	O	,	_	0	SENT_573	[p15l207t1759r682b1856],
8	differences	NNS	O	difference	prep_of	1	SENT_573	[p15l714t1759r1229b1841],
9	in	IN	O	in	_	0	SENT_573	[p15l1259t1759r1347b1840],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_573	[p15l1375t1759r1853b1843],
11	genotype	NN	O	genotype	prep_in	8	SENT_573	[p15l1884t1784r2145b1865, p15l206t1914r406b2009],
12	and	CC	O	and	_	0	SENT_573	[p15l439t1902r605b1984],
13	antibiotic	JJ	O	antibiotic	amod	14	SENT_573	[p15l635t1902r1073b1984],
14	resistance	NN	O	resistance	conj_and	6	SENT_573	[p15l1102t1902r1565b1984],
15	on	IN	O	on	_	0	SENT_573	[p15l1597t1928r1711b1984],
16	the	DT	O	the	det	18	SENT_573	[p15l1739t1902r1880b1984],
17	eradication	NN	O	eradication	nn	18	SENT_573	[p15l1910t1902r2145b1984, p15l207t2044r526b2127],
18	rate	NN	O	rate	prep_on	14	SENT_573	[p15l562t2057r736b2127],
19	of	IN	O	of	_	0	SENT_573	[p15l777t2044r878b2127],
20	Helicobacter	NNP	O	Helicobacter	nn	22	SENT_573	[p15l905t2044r1526b2127],
21	pylori	NN	O	pylorus	nn	22	SENT_573	[p15l1549t2044r1839b2150],
22	infection	NN	O	infection	prep_of	1	SENT_573	[p15l1876t2044r2145b2127, p15l207t2190r388b2272],
23	by	IN	O	by	_	0	SENT_573	[p15l415t2190r531b2296],
24	a	DT	O	a	det	26	SENT_573	[p15l563t2215r611b2272],
25	1-week	JJ	DURATION	1-week	amod	26	SENT_573	[p15l650t2190r986b2272],
26	regimen	NN	O	regimen	prep_by	1	SENT_573	[p15l1012t2190r1395b2296],
27	of	IN	O	of	_	0	SENT_573	[p15l1426t2190r1527b2272],
28	proton	NN	O	proton	nn	30	SENT_573	[p15l1546t2202r1853b2296],
29	pump	NN	O	pump	nn	30	SENT_573	[p15l1881t2215r2147b2296],
30	inhibitor	NN	O	inhibitor	prep_of	26	SENT_573	[p15l207t2334r630b2431],
31	,	,	O	,	_	0	SENT_573	[p15l207t2334r630b2431],
32	amoxicillin	NNP	O	amoxicillin	conj_and	30	SENT_573	[p15l668t2334r1200b2416],
33	and	CC	O	and	_	0	SENT_573	[p15l1232t2334r1398b2416],
34	clarithromycin	NN	O	clarithromycin	conj_and	30	SENT_573	[p15l1428t2334r2142b2440],
35	.	.	O	.	_	0	SENT_573	[p15l1428t2334r2142b2440],

1	Aliment	NNP	O	Aliment	_	0	SENT_574	[p15l199t2476r589b2559],
2	.	.	O	.	_	0	SENT_574	[p15l199t2476r589b2559],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_575	[p15l631t2476r1173b2559],
2	.	.	O	.	_	0	SENT_575	[p15l631t2476r1173b2559],

1	Ther	NNP	O	Ther	_	0	SENT_576	[p15l1222t2476r1460b2559],
2	.	.	O	.	_	0	SENT_576	[p15l1222t2476r1460b2559],

1	17:259	CD	NUMBER	17:259	num	2	SENT_577	[p15l1510t2476r2000b2560],
2	—	CD	NUMBER	—	_	0	SENT_577	[p15l1510t2476r2000b2560],
3	64	CD	NUMBER	64	num	5	SENT_577	[p15l1510t2476r2000b2560],
4	Schwab	NNP	ORGANIZATION	Schwab	nn	5	SENT_577	[p15l210t2621r575b2703],
5	M	NN	ORGANIZATION	m	dep	2	SENT_577	[p15l664t2622r791b2717],
6	,	,	O	,	_	0	SENT_577	[p15l664t2622r791b2717],
7	Schaeffeler	NN	O	schaeffeler	nn	8	SENT_577	[p15l887t2621r1417b2703],
8	E	NN	O	e	appos	5	SENT_577	[p15l1502t2622r1597b2717],
9	,	,	O	,	_	0	SENT_577	[p15l1502t2622r1597b2717],
10	Klotz	NNP	PERSON	Klotz	nn	11	SENT_577	[p15l1692t2621r1948b2703],
11	U	NNP	PERSON	U	appos	5	SENT_577	[p15l2036t2622r2144b2717],
12	,	,	O	,	_	0	SENT_577	[p15l2036t2622r2144b2717],
13	et	FW	O	et	nn	14	SENT_577	[p15l208t2777r291b2847],
14	al.	FW	O	al.	appos	5	SENT_577	[p15l339t2765r442b2847],
15	2004	CD	DATE	2004	dep	14	SENT_577	[p15l499t2765r754b2847],
16	.	.	O	.	_	0	SENT_577	[p15l499t2765r754b2847],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_578	[p15l810t2765r1288b2849],
2	polymorphism	NN	O	polymorphism	nsubj	6	SENT_578	[p15l1337t2765r2026b2871],
3	is	VBZ	O	be	cop	6	SENT_578	[p15l2072t2765r2145b2847],
4	a	DT	O	a	det	6	SENT_578	[p15l210t2934r258b2989],
5	major	JJ	O	major	amod	6	SENT_578	[p15l327t2907r602b3014],
6	predictor	NN	O	predictor	_	0	SENT_578	[p15l669t2907r1096b3014],
7	of	IN	O	of	_	0	SENT_578	[p15l1166t2907r1268b2989],
8	treatment	NN	O	treatment	nn	9	SENT_578	[p15l1330t2919r1776b2989],
9	failure	NN	O	failure	prep_of	6	SENT_578	[p15l1845t2907r2147b2989],
10	in	IN	O	in	_	0	SENT_578	[p15l207t3052r295b3133],
11	Caucasians	NNS	MISC	caucasian	prep_in	9	SENT_578	[p15l350t3052r874b3134],
12	using	VBG	O	use	partmod	11	SENT_578	[p15l929t3052r1182b3158],
13	lansoprazole	JJ	O	lansoprazole	amod	16	SENT_578	[p15l1236t3052r1829b3158],
14	based	VBN	O	base	amod	16	SENT_578	[p15l1881t3052r2149b3134],
15	quadruple	NN	O	quadruple	nn	16	SENT_578	[p15l208t3196r676b3302],
16	therapy	NN	O	therapy	dobj	12	SENT_578	[p15l715t3196r1065b3302],
17	for	IN	O	for	_	0	SENT_578	[p15l1105t3196r1242b3278],
18	eradication	NN	O	eradication	prep_for	12	SENT_578	[p15l1280t3196r1801b3278],
19	of	IN	O	of	_	0	SENT_578	[p15l1842t3196r1943b3278],
20	Helicobacter	NNP	PERSON	Helicobacter	nn	21	SENT_578	[p15l1971t3199r2144b3278, p15l210t3338r687b3421],
21	pylori	NNP	PERSON	pylori	prep_of	18	SENT_578	[p15l704t3338r1017b3444],
22	.	.	O	.	_	0	SENT_578	[p15l704t3338r1017b3444],

1	Clin	NNP	O	Clin	_	0	SENT_579	[p15l1061t3338r1273b3422],
2	.	.	O	.	_	0	SENT_579	[p15l1061t3338r1273b3422],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_580	[p15l1314t3338r1856b3421],
2	.	.	O	.	_	0	SENT_580	[p15l1314t3338r1856b3421],

1	Ther	NNP	O	Ther	_	0	SENT_581	[p15l1905t3338r2142b3421],
2	.	.	O	.	_	0	SENT_581	[p15l1905t3338r2142b3421],

1	76:201	CD	NUMBER	76:201	_	0	SENT_582	[p15l208t3482r647b3566],
2	—	CD	NUMBER	—	num	3	SENT_582	[p15l208t3482r647b3566],
3	9	CD	NUMBER	9	dep	1	SENT_582	[p15l208t3482r647b3566],

1	42	CD	NUMBER	42	_	0	SENT_583	[p15l6t3628r145b3710],
2	.	.	O	.	_	0	SENT_583	[p15l6t3628r145b3710],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_584	[p15l206t3630r513b3710],
2	T	NN	O	t	_	0	SENT_584	[p15l559t3630r652b3725],
3	,	,	O	,	_	0	SENT_584	[p15l559t3630r652b3725],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_584	[p15l707t3628r982b3710],
5	N	NNP	O	N	appos	2	SENT_584	[p15l1028t3630r1136b3725],
6	,	,	O	,	_	0	SENT_584	[p15l1028t3630r1136b3725],
7	Xiao	NNP	O	Xiao	nn	8	SENT_584	[p15l1186t3628r1412b3710],
8	F	NN	O	f	appos	2	SENT_584	[p15l1459t3630r1548b3726],
9	,	,	O	,	_	0	SENT_584	[p15l1459t3630r1548b3726],
10	et	FW	O	et	nn	11	SENT_584	[p15l1600t3640r1683b3710],
11	al.	FW	O	al.	appos	2	SENT_584	[p15l1730t3628r1833b3710],
12	2004	CD	DATE	2004	dep	11	SENT_584	[p15l1887t3628r2142b3710],
13	.	.	O	.	_	0	SENT_584	[p15l1887t3628r2142b3710],

1	Polymorphism	NN	O	polymorphism	nsubj	8	SENT_585	[p16l207t29r900b136],
2	of	IN	O	of	_	0	SENT_585	[p16l975t29r1077b111],
3	interleul	NN	O	interleul	prep_of	1	SENT_585	[p16l1143t29r1948b111],
4	<	JJR	O	<	amod	3	SENT_585	[p16l1143t29r1948b111],
5	in	IN	O	in	_	0	SENT_585	[p16l1143t29r1948b111],
6	—	CD	NUMBER	—	num	7	SENT_585	[p16l1143t29r1948b111],
7	lbeta	NN	O	lbeta	prep_in	4	SENT_585	[p16l1143t29r1948b111],
8	affects	VBZ	O	affect	_	0	SENT_585	[p16l2023t29r2145b111, p16l208t172r423b256],
9	the	DT	O	the	det	11	SENT_585	[p16l453t173r594b256],
10	eradication	NN	O	eradication	nn	11	SENT_585	[p16l622t172r1142b256],
11	rates	NNS	O	rate	dobj	8	SENT_585	[p16l1167t185r1385b256],
12	of	IN	O	of	_	0	SENT_585	[p16l1415t172r1517b256],
13	Helicobacter	NNP	PERSON	Helicobacter	nn	14	SENT_585	[p16l1532t172r2153b256],
14	pylori	NN	PERSON	pylorus	prep_of	11	SENT_585	[p16l196t318r486b424],
15	by	IN	O	by	_	0	SENT_585	[p16l530t318r646b424],
16	triple	JJ	O	triple	amod	17	SENT_585	[p16l692t318r937b424],
17	therapy	NN	O	therapy	prep_by	8	SENT_585	[p16l983t318r1349b424],
18	.	.	O	.	_	0	SENT_585	[p16l983t318r1349b424],

1	Clin	NNP	O	Clin	_	0	SENT_586	[p16l1406t318r1619b402],
2	.	.	O	.	_	0	SENT_586	[p16l1406t318r1619b402],

1	Gastroenterol	NNP	PERSON	Gastroenterol	_	0	SENT_587	[p16l1682t319r2144b402, p16l210t462r439b544],
2	.	.	O	.	_	0	SENT_587	[p16l1682t319r2144b402, p16l210t462r439b544],

1	Hepatol	NNP	O	Hepatol	_	0	SENT_588	[p16l481t462r884b568],
2	.	.	O	.	_	0	SENT_588	[p16l481t462r884b568],

1	2:22	CD	TIME	2:22	num	2	SENT_589	[p16l925t462r1306b545],
2	-30	CD	NUMBER	-30	_	0	SENT_589	[p16l925t462r1306b545],

1	43	CD	NUMBER	43	_	0	SENT_590	[p16l6t605r145b688],
2	.	.	O	.	_	0	SENT_590	[p16l6t605r145b688],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_591	[p16l206t607r513b688],
2	T	NN	O	t	_	0	SENT_591	[p16l570t607r663b702],
3	,	,	O	,	_	0	SENT_591	[p16l570t607r663b702],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_591	[p16l728t604r1003b688],
5	N	NNP	O	N	appos	2	SENT_591	[p16l1061t607r1169b702],
6	,	,	O	,	_	0	SENT_591	[p16l1061t607r1169b702],
7	Watanabe	NNP	PERSON	Watanabe	nn	8	SENT_591	[p16l1230t604r1690b688],
8	F	NN	O	f	appos	2	SENT_591	[p16l1747t607r1835b702],
9	,	,	O	,	_	0	SENT_591	[p16l1747t607r1835b702],
10	et	FW	O	et	nn	11	SENT_591	[p16l1898t617r1981b687],
11	al.	FW	O	al.	appos	2	SENT_591	[p16l2039t604r2142b688],
12	2002	CD	DATE	2002	dep	11	SENT_591	[p16l208t750r463b832],
13	.	.	O	.	_	0	SENT_591	[p16l208t750r463b832],

1	Effect	NN	O	effect	_	0	SENT_592	[p16l532t750r817b832],
2	of	IN	O	of	_	0	SENT_592	[p16l880t750r982b832],
3	cytochrome	NN	O	cytochrome	nn	6	SENT_592	[p16l1039t750r1589b856],
4	P4502C19	NN	O	p4502c19	nn	6	SENT_592	[p16l1653t750r2145b834],
5	genotypic	JJ	O	genotypic	amod	6	SENT_592	[p16l208t893r668b1000],
6	differences	NNS	O	difference	prep_of	1	SENT_592	[p16l729t893r1243b975],
7	on	IN	O	on	_	0	SENT_592	[p16l1306t919r1420b975],
8	cure	NN	O	cure	nn	9	SENT_592	[p16l1478t919r1676b975],
9	rates	NNS	O	rate	prep_on	1	SENT_592	[p16l1734t906r1953b975],
10	for	IN	O	for	_	0	SENT_592	[p16l2014t893r2150b975],
11	gastroesophageal	NN	O	gastroesophageal	nn	13	SENT_592	[p16l208t1036r1016b1142],
12	reﬂux	NN	O	reﬂux	nn	13	SENT_592	[p16l1046t1035r1319b1117],
13	disease	NN	O	disease	prep_for	1	SENT_592	[p16l1351t1035r1687b1118],
14	by	IN	O	by	_	0	SENT_592	[p16l1717t1035r1832b1142],
15	lanso	NN	O	lanso	nn	17	SENT_592	[p16l1864t1035r2145b1118],
16	—	NN	O	—	nn	17	SENT_592	[p16l1864t1035r2145b1118],
17	prazole	NN	O	prazole	prep_by	13	SENT_592	[p16l205t1180r575b1286],
18	.	.	O	.	_	0	SENT_592	[p16l205t1180r575b1286],

1	Clin	NNP	O	Clin	_	0	SENT_593	[p16l625t1180r837b1264],
2	.	.	O	.	_	0	SENT_593	[p16l625t1180r837b1264],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_594	[p16l886t1180r1427b1262],
2	.	.	O	.	_	0	SENT_594	[p16l886t1180r1427b1262],

1	Ther	NNP	O	Ther	_	0	SENT_595	[p16l1483t1180r1720b1262],
2	.	.	O	.	_	0	SENT_595	[p16l1483t1180r1720b1262],

1	72:45360	CD	NUMBER	72:45360	_	0	SENT_596	[p16l1766t1180r2150b1263, p16l209t1323r321b1405],

1	134	CD	NUMBER	134	num	2	SENT_597	[p16l360t1480r419b1510],
2	EICHELBAUM	NN	O	eichelbaum	_	0	SENT_597	[p16l507t1483r748b1510],
3	I	PRP	O	I	nsubj	4	SENT_597	[p16l766t1486r783b1504],
4	INGELMAN-SUNDBERG	VBP	O	ingelman-sundberg	rcmod	2	SENT_597	[p16l802t1483r1214b1510],
5	I	PRP	O	I	nsubj	6	SENT_597	[p16l1232t1486r1249b1504],
6	EVANS	NNS	O	evan	xcomp	4	SENT_597	[p16l1268t1483r1385b1510],

1	44	CD	NUMBER	44	_	0	SENT_598	[p16l448t1718r558b1784],
2	.	.	O	.	_	0	SENT_598	[p16l448t1718r558b1784],

1	Kawamura	NNP	PERSON	Kawamura	nn	2	SENT_599	[p16l609t1719r1015b1784],
2	M	NNP	O	M	_	0	SENT_599	[p16l1052t1719r1153b1795],
3	,	,	O	,	_	0	SENT_599	[p16l1052t1719r1153b1795],
4	Ohara	NNP	PERSON	Ohara	nn	5	SENT_599	[p16l1198t1718r1424b1784],
5	S	NNP	O	S	appos	2	SENT_599	[p16l1465t1718r1532b1796],
6	,	,	O	,	_	0	SENT_599	[p16l1465t1718r1532b1796],
7	Koike	NNP	ORGANIZATION	Koike	nn	8	SENT_599	[p16l1576t1718r1797b1784],
8	T	NN	ORGANIZATION	t	appos	2	SENT_599	[p16l1836t1719r1911b1796],
9	,	,	O	,	_	0	SENT_599	[p16l1836t1719r1911b1796],
10	et	FW	O	et	nn	11	SENT_599	[p16l1955t1728r2020b1784],
11	al.	FW	O	al.	appos	2	SENT_599	[p16l2060t1718r2142b1784],
12	2003	CD	DATE	2003	dep	11	SENT_599	[p16l609t1832r811b1897],
13	.	.	O	.	_	0	SENT_599	[p16l609t1832r811b1897],

1	The	DT	O	the	det	2	SENT_600	[p16l842t1831r984b1896],
2	effects	NNS	O	effect	nsubjpass	10	SENT_600	[p16l1012t1831r1254b1896],
3	of	IN	O	of	_	0	SENT_600	[p16l1283t1831r1364b1896],
4	lansoprazole	NN	O	lansoprazole	prep_of	2	SENT_600	[p16l1385t1831r1855b1916],
5	on	IN	O	on	_	0	SENT_600	[p16l1882t1852r1973b1896],
6	erosive	JJ	O	erosive	amod	8	SENT_600	[p16l2000t1852r2144b1896, p16l610t1945r752b2010],
7	reﬂux	NN	O	reﬂux	nn	8	SENT_600	[p16l775t1945r992b2010],
8	oesophagitis	NN	O	oesophagitis	prep_on	4	SENT_600	[p16l1018t1945r1480b2029],
9	are	VBP	O	be	auxpass	10	SENT_600	[p16l1510t1965r1619b2010],
10	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_600	[p16l1644t1945r2033b2010],
11	by	IN	O	by	_	0	SENT_600	[p16l2055t1945r2147b2029],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_600	[p16l608t2058r988b2125],
13	polymorphism	NN	O	polymorphism	agent	10	SENT_600	[p16l1010t2058r1573b2142],
14	.	.	O	.	_	0	SENT_600	[p16l1010t2058r1573b2142],

1	Aliment	NNP	O	Aliment	_	0	SENT_601	[p16l1593t2058r1903b2123],
2	.	.	O	.	_	0	SENT_601	[p16l1593t2058r1903b2123],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_602	[p16l1931t2058r2144b2123, p16l607t2171r848b2236],
2	.	.	O	.	_	0	SENT_602	[p16l1931t2058r2144b2123, p16l607t2171r848b2236],

1	Ther	NNP	O	Ther	_	0	SENT_603	[p16l887t2171r1076b2236],
2	.	.	O	.	_	0	SENT_603	[p16l887t2171r1076b2236],

1	172965-73	CD	NUMBER	172965-73	_	0	SENT_604	[p16l1115t2171r1500b2237],

1	45	CD	NUMBER	45	_	0	SENT_605	[p16l448t2284r558b2350],
2	.	.	O	.	_	0	SENT_605	[p16l448t2284r558b2350],

1	Johansson	NNP	PERSON	Johansson	_	0	SENT_606	[p16l606t2284r990b2350],
2	1	CD	NUMBER	1	num	1	SENT_606	[p16l1029t2286r1077b2362],
3	,	,	O	,	_	0	SENT_606	[p16l1029t2286r1077b2362],
4	Lundqvist	NNP	PERSON	Lundqvist	nn	5	SENT_606	[p16l1119t2284r1498b2369],
5	E	NNP	O	E	appos	1	SENT_606	[p16l1535t2286r1610b2362],
6	,	,	O	,	_	0	SENT_606	[p16l1535t2286r1610b2362],
7	Bertilsson	NNP	ORGANIZATION	Bertilsson	nn	8	SENT_606	[p16l1653t2284r2030b2350],
8	L	NNP	ORGANIZATION	L	appos	1	SENT_606	[p16l2069t2286r2144b2362],
9	,	,	O	,	_	0	SENT_606	[p16l2069t2286r2144b2362],
10	et	FW	O	et	nn	11	SENT_606	[p16l608t2408r674b2463],
11	al.	FW	O	al.	appos	1	SENT_606	[p16l729t2398r811b2463],
12	1993	CD	DATE	1993	dep	11	SENT_606	[p16l880t2398r1074b2464],
13	.	.	O	.	_	0	SENT_606	[p16l880t2398r1074b2464],

1	Inherited	VBN	O	inherit	_	0	SENT_607	[p16l1134t2398r1471b2463],
2	ampliﬁcation	NN	O	ampliﬁcation	dobj	1	SENT_607	[p16l1527t2398r2017b2482],
3	of	IN	O	of	_	0	SENT_607	[p16l2073t2398r2153b2463],
4	an	DT	O	a	det	6	SENT_607	[p16l609t2532r693b2576],
5	active	JJ	O	active	amod	6	SENT_607	[p16l737t2511r952b2576],
6	gene	NN	O	gene	prep_of	2	SENT_607	[p16l996t2532r1168b2596],
7	in	IN	O	in	_	0	SENT_607	[p16l1211t2511r1281b2576],
8	the	DT	O	the	det	12	SENT_607	[p16l1323t2511r1435b2576],
9	cytochrome	NN	O	cytochrome	nn	12	SENT_607	[p16l1478t2511r1915b2596],
10	P450	NN	O	p450	nn	12	SENT_607	[p16l1957t2511r2147b2577],
11	CYP2D	NN	O	cyp2d	nn	12	SENT_607	[p16l608t2625r900b2690],
12	locus	NN	O	locus	prep_in	6	SENT_607	[p16l951t2624r1143b2690],
13	as	IN	O	as	_	0	SENT_607	[p16l1196t2645r1268b2690],
14	a	DT	O	a	det	15	SENT_607	[p16l1321t2645r1360b2690],
15	cause	NN	O	cause	prep_as	1	SENT_607	[p16l1407t2645r1612b2690],
16	of	IN	O	of	_	0	SENT_607	[p16l1663t2624r1743b2690],
17	ultrarapid	JJ	O	ultrarapid	amod	18	SENT_607	[p16l1785t2624r2148b2709],
18	metabolism	NN	O	metabolism	prep_of	15	SENT_607	[p16l607t2738r1043b2803],
19	of	IN	O	of	_	0	SENT_607	[p16l1079t2738r1159b2803],
20	debrisoquine	NN	O	debrisoquine	prep_of	18	SENT_607	[p16l1189t2738r1688b2822],
21	.	.	O	.	_	0	SENT_607	[p16l1189t2738r1688b2822],

1	Proc	NNP	O	Proc	_	0	SENT_608	[p16l1727t2740r1919b2803],
2	.	.	O	.	_	0	SENT_608	[p16l1727t2740r1919b2803],

1	Natl.	NNP	O	Natl.	nn	2	SENT_609	[p16l1961t2738r2138b2803],
2	Acad	NNP	O	Acad	_	0	SENT_609	[p16l601t2851r812b2917],
3	.	.	O	.	_	0	SENT_609	[p16l601t2851r812b2917],

1	Sci	NNP	O	Sci	_	0	SENT_610	[p16l847t2852r973b2917],
2	.	.	O	.	_	0	SENT_610	[p16l847t2852r973b2917],

1	USA	NNP	O	USA	_	0	SENT_611	[p16l1016t2852r1174b2917],
2	90	CD	NUMBER	90	num	1	SENT_611	[p16l1204t2851r1692b2917],
3	:	:	O	:	_	0	SENT_611	[p16l1204t2851r1692b2917],
4	l1825	CD	NUMBER	l1825	dep	1	SENT_611	[p16l1204t2851r1692b2917],
5	—	CD	NUMBER	—	number	6	SENT_611	[p16l1204t2851r1692b2917],
6	29	CD	NUMBER	29	dep	4	SENT_611	[p16l1204t2851r1692b2917],

1	46	CD	NUMBER	46	_	0	SENT_612	[p16l448t2964r558b3030],
2	.	.	O	.	_	0	SENT_612	[p16l448t2964r558b3030],

1	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	2	SENT_613	[p16l607t2964r1346b3049],
2	M.	NNP	O	M.	_	0	SENT_613	[p16l1404t2966r1504b3030],
3	2004	CD	DATE	2004	dep	2	SENT_613	[p16l1568t2965r1770b3030],
4	.	.	O	.	_	0	SENT_613	[p16l1568t2965r1770b3030],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_614	[p16l1832t2965r2144b3030, p16l608t3078r998b3163],
2	of	IN	O	of	_	0	SENT_614	[p16l1046t3078r1127b3143],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_614	[p16l1166t3078r1603b3163],
4	P450	NN	O	p450	prep_of	1	SENT_614	[p16l1649t3078r1838b3144],
5	and	CC	O	and	_	0	SENT_614	[p16l1886t3078r2017b3143],
6	its	PRP$	O	its	poss	7	SENT_614	[p16l2061t3078r2145b3143],
7	applications	NNS	O	application	conj_and	1	SENT_614	[p16l609t3192r1055b3277],
8	in	IN	O	in	_	0	SENT_614	[p16l1110t3192r1181b3257],
9	drug	NN	O	drug	nn	10	SENT_614	[p16l1234t3192r1401b3277],
10	therapy	NN	O	therapy	prep_in	7	SENT_614	[p16l1455t3192r1752b3277],
11	:	:	O	:	_	0	SENT_614	[p16l1455t3192r1752b3277],
12	the	DT	DATE	the	det	13	SENT_614	[p16l1811t3192r1922b3258],
13	past	NN	DATE	past	dep	1	SENT_614	[p16l1975t3202r2144b3277],
14	,	,	DATE	,	_	0	SENT_614	[p16l1975t3202r2144b3277],
15	present	JJ	DATE	present	conj_and	13	SENT_614	[p16l606t3317r877b3392],
16	and	CC	O	and	_	0	SENT_614	[p16l928t3307r1059b3372],
17	future	JJ	DATE	future	dep	1	SENT_614	[p16l1110t3306r1350b3372],
18	.	.	O	.	_	0	SENT_614	[p16l1110t3306r1350b3372],

1	Trends	NNS	O	trend	_	0	SENT_615	[p16l1410t3307r1653b3373],
2	Pharmacol	NNP	O	Pharmacol	dep	1	SENT_615	[p16l1709t3307r2138b3373],
3	.	.	O	.	_	0	SENT_615	[p16l1709t3307r2138b3373],

1	Sci	NNP	O	Sci	_	0	SENT_616	[p16l607t3423r733b3487],
2	.	.	O	.	_	0	SENT_616	[p16l607t3423r733b3487],

1	252193-200	CD	NUMBER	252193-200	_	0	SENT_617	[p16l769t3421r1213b3488],

1	47	CD	NUMBER	47	_	0	SENT_618	[p16l448t3536r558b3601],
2	.	.	O	.	_	0	SENT_618	[p16l448t3536r558b3601],

1	Charlier	NNP	O	Charlier	nn	2	SENT_619	[p16l608t3535r913b3601],
2	C	NNP	O	C	_	0	SENT_619	[p16l947t3536r1026b3613],
3	,	,	O	,	_	0	SENT_619	[p16l947t3536r1026b3613],
4	Broly	NNP	O	Broly	nn	5	SENT_619	[p16l1065t3535r1275b3621],
5	F	NN	O	f	appos	2	SENT_619	[p16l1309t3538r1380b3613],
6	,	,	O	,	_	0	SENT_619	[p16l1309t3538r1380b3613],
7	Lhermitte	NNP	PERSON	Lhermitte	nn	8	SENT_619	[p16l1417t3535r1785b3601],
8	M	NNP	O	M	appos	2	SENT_619	[p16l1819t3538r1920b3613],
9	,	,	O	,	_	0	SENT_619	[p16l1819t3538r1920b3613],
10	et	FW	O	et	nn	11	SENT_619	[p16l1960t3545r2025b3601],
11	al.	FW	O	al.	appos	2	SENT_619	[p16l2060t3535r2142b3601],
12	2003	CD	DATE	2003	dep	11	SENT_619	[p16l609t3651r811b3716],
13	.	.	O	.	_	0	SENT_619	[p16l609t3651r811b3716],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_620	[p16l861t3650r1444b3735],
2	in	IN	O	in	_	0	SENT_620	[p16l1491t3650r1562b3715],
3	the	DT	O	the	det	5	SENT_620	[p16l1607t3650r1718b3716],
4	CYP	NN	O	cyp	nn	5	SENT_620	[p16l1765t3651r1944b3716],
5	2D6	NN	O	2d6	prep_in	1	SENT_620	[p16l1990t3650r2146b3716],

1	W.	NNP	O	W.	nn	2	SENT_621	[p16l6t3063r81b3755],
2	annua1reViews	NNPS	O	annua1reViews	_	0	SENT_621	[p16l6t3063r81b3755],
3	.	.	O	.	_	0	SENT_621	[p16l6t3063r81b3755],

1	org	RB	O	org	advmod	2	SENT_622	[p16l6t3063r81b3755],
2	personal	JJ	O	personal	amod	3	SENT_622	[p16l90t3470r165b3752],
3	use	NN	O	use	_	0	SENT_622	[p16l108t3339r148b3448],
4	only	RB	O	only	advmod	3	SENT_622	[p16l90t3152r165b3314],
5	.	.	O	.	_	0	SENT_622	[p16l90t3152r165b3314],

1	Annu	NNP	PERSON	Annu	_	0	SENT_623	[p17l6t1773r64b1973],
2	.	.	O	.	_	0	SENT_623	[p17l6t1773r64b1973],

1	Rev.	NNP	O	Rev.	nn	2	SENT_624	[p17l7t1597r64b1745],
2	Med	NNP	O	Med	_	0	SENT_624	[p17l6t1402r64b1570],
3	.	.	O	.	_	0	SENT_624	[p17l6t1402r64b1570],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_625	[p17l6t1087r65b1373],
2	:	:	O	:	_	0	SENT_625	[p17l6t1087r65b1373],
3	1	CD	NUMBER	1	number	4	SENT_625	[p17l6t1048r64b1071],
4	19-137	CD	NUMBER	19-137	dep	1	SENT_625	[p17l6t786r65b1029],
5	.	.	O	.	_	0	SENT_625	[p17l6t786r65b1029],

1	Downloaded	VBN	O	download	_	0	SENT_626	[p17l6t332r65b759],
2	from	IN	O	from	_	0	SENT_626	[p17l6t148r64b310],
3	ww	NN	O	ww	prep_from	1	SENT_626	[p17l25t9r64b126],
4	by	IN	O	by	_	0	SENT_626	[p17l90t1806r165b1888],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_626	[p17l89t1433r165b1783],
6	of	IN	ORGANIZATION	of	_	0	SENT_626	[p17l90t1336r148b1408],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_626	[p17l89t968r148b1320],
8	—	NNP	O	—	nn	9	SENT_626	[p17l125t921r131b943],
9	Madison	NNP	O	Madison	prep_of	5	SENT_626	[p17l90t604r148b896],
10	on	IN	O	on	_	0	SENT_626	[p17l108t500r148b581],
11	O1/O5	NNP	O	O1/O5	prep_on	9	SENT_626	[p17l89t263r148b477],
12	/	:	O	/	punct	13	SENT_626	[p17l89t263r148b477],
13	14	CD	NUMBER	14	dep	11	SENT_626	[p17l90t165r148b256],
14	.	.	O	.	_	0	SENT_626	[p17l90t165r148b256],

1	For	IN	O	for	dep	4	SENT_627	[p17l91t23r148b138],
2	gene	NN	O	gene	pobj	1	SENT_627	[p17l608t35r801b99],
3	:	:	O	:	_	0	SENT_627	[p17l608t35r801b99],
4	association	NN	O	association	_	0	SENT_627	[p17l836t15r1248b80],
5	with	IN	O	with	_	0	SENT_627	[p17l1275t15r1439b80],
6	plasma	NN	O	plasma	nn	7	SENT_627	[p17l1464t15r1730b99],
7	concentrations	NNS	O	concentration	prep_with	4	SENT_627	[p17l1755t25r2144b80, p17l607t129r785b194],
8	of	IN	O	of	_	0	SENT_627	[p17l824t129r905b194],
9	ﬂuoxetine	NN	O	ﬂuoxetine	prep_of	4	SENT_627	[p17l936t129r1304b194],
10	and	CC	O	and	_	0	SENT_627	[p17l1342t129r1474b194],
11	paroxetine	NN	O	paroxetine	prep_of	4	SENT_627	[p17l1508t129r1919b214],
12	.	.	O	.	_	0	SENT_627	[p17l1508t129r1919b214],

1	Ther	NNP	O	Ther	_	0	SENT_628	[p17l1964t129r2138b195],
2	.	.	O	.	_	0	SENT_628	[p17l1964t129r2138b195],

1	Drug	NN	O	drug	_	0	SENT_629	[p17l605t246r801b327],
2	Moniz	NN	PERSON	moniz	nn	3	SENT_629	[p17l825t246r1068b309],
3	‘	NN	O	‘	dep	1	SENT_629	[p17l825t246r1068b309],
4	.	.	O	.	_	0	SENT_629	[p17l825t246r1068b309],

1	25:738	CD	NUMBER	25:738	num	2	SENT_630	[p17l1100t243r1496b310],
2	—	CD	NUMBER	—	_	0	SENT_630	[p17l1100t243r1496b310],
3	42	CD	NUMBER	42	num	5	SENT_630	[p17l1100t243r1496b310],
4	Kirchheiner	NN	O	kirchheiner	nn	5	SENT_630	[p17l609t358r1054b424],
5	J	NN	O	j	dep	2	SENT_630	[p17l1105t360r1159b435],
6	,	,	O	,	_	0	SENT_630	[p17l1105t360r1159b435],
7	Nickchen	NN	O	nickchen	nn	8	SENT_630	[p17l1216t358r1573b424],
8	K	NN	O	k	appos	5	SENT_630	[p17l1628t360r1711b435],
9	,	,	O	,	_	0	SENT_630	[p17l1628t360r1711b435],
10	Bauer	NNP	PERSON	Bauer	nn	11	SENT_630	[p17l1768t360r1991b424],
11	M	NNP	O	M	appos	5	SENT_630	[p17l2043t360r2144b435],
12	,	,	O	,	_	0	SENT_630	[p17l2043t360r2144b435],
13	et	FW	O	et	nn	14	SENT_630	[p17l608t483r674b538],
14	al.	FW	O	al.	appos	5	SENT_630	[p17l708t472r789b538],
15	2004	CD	DATE	2004	dep	14	SENT_630	[p17l829t473r1030b538],
16	.	.	O	.	_	0	SENT_630	[p17l829t473r1030b538],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_631	[p17l1069t472r1746b558],
2	of	IN	O	of	_	0	SENT_631	[p17l1782t472r1863b538],
3	antidepressants	NNS	O	antidepressant	prep_of	1	SENT_631	[p17l1892t473r2144b538, p17l606t597r946b672],
4	and	CC	O	and	_	0	SENT_631	[p17l987t588r1118b653],
5	antipsychotics	NNS	O	antipsychotic	prep_of	1	SENT_631	[p17l1157t587r1708b672],
6	:	:	O	:	_	0	SENT_631	[p17l1157t587r1708b672],
7	the	DT	O	the	det	8	SENT_631	[p17l1751t587r1862b653],
8	contribution	NN	O	contribution	dep	1	SENT_631	[p17l1901t587r2144b653, p17l606t703r842b768],
9	of	IN	O	of	_	0	SENT_631	[p17l877t703r957b768],
10	allelic	JJ	O	allelic	amod	11	SENT_631	[p17l986t703r1208b768],
11	Variations	NNS	O	variation	prep_of	8	SENT_631	[p17l1244t703r1606b769],
12	to	TO	O	to	_	0	SENT_631	[p17l1641t712r1711b768],
13	the	DT	O	the	det	14	SENT_631	[p17l1744t703r1856b768],
14	phenotype	NN	O	phenotype	prep_to	11	SENT_631	[p17l1888t703r2144b787, p17l607t827r766b902],
15	of	IN	O	of	_	0	SENT_631	[p17l792t817r872b883],
16	drug	NN	O	drug	nn	17	SENT_631	[p17l892t817r1059b902],
17	response	NN	O	response	prep_of	14	SENT_631	[p17l1084t838r1429b902],
18	.	.	O	.	_	0	SENT_631	[p17l1084t838r1429b902],

1	Mol	NNP	O	Mol	_	0	SENT_632	[p17l1455t817r1622b883],
2	.	.	O	.	_	0	SENT_632	[p17l1455t817r1622b883],

1	Psychiatry	NNP	O	Psychiatry	_	0	SENT_633	[p17l1654t817r2052b901],
2	9	CD	NUMBER	9	num	1	SENT_633	[p17l2078t818r2141b884],
3	:	:	O	:	_	0	SENT_633	[p17l2078t818r2141b884],
4	442-73	CD	NUMBER	442-73	num	6	SENT_633	[p17l606t932r881b998],
5	Dalen	NN	PERSON	dalen	nn	6	SENT_633	[p17l607t1046r828b1112],
6	P	NN	PERSON	p	dep	1	SENT_633	[p17l888t1048r957b1124],
7	,	,	O	,	_	0	SENT_633	[p17l888t1048r957b1124],
8	Dahl	NNP	PERSON	Dahl	nn	9	SENT_633	[p17l1020t1046r1199b1112],
9	ML	NNP	O	ML	appos	6	SENT_633	[p17l1259t1048r1417b1124],
10	,	,	O	,	_	0	SENT_633	[p17l1259t1048r1417b1124],
11	Ruiz	NNP	PERSON	Ruiz	nn	12	SENT_633	[p17l1480t1046r1653b1112],
12	ML	NNP	O	ML	appos	6	SENT_633	[p17l1713t1048r1871b1124],
13	,	,	O	,	_	0	SENT_633	[p17l1713t1048r1871b1124],
14	et	FW	O	et	nn	15	SENT_633	[p17l1935t1056r2000b1112],
15	al.	FW	O	al.	appos	6	SENT_633	[p17l2060t1046r2142b1112],
16	1998	CD	DATE	1998	dep	15	SENT_633	[p17l616t1161r811b1228],
17	.	.	O	.	_	0	SENT_633	[p17l616t1161r811b1228],

1	10-Hydroxylation	NN	O	10-hydroxylation	_	0	SENT_634	[p17l865t1161r1525b1246],
2	of	IN	O	of	_	0	SENT_634	[p17l1566t1161r1647b1226],
3	nortriptyline	NN	O	nortriptyline	prep_of	1	SENT_634	[p17l1681t1161r2147b1246],
4	in	IN	O	in	_	0	SENT_634	[p17l607t1275r678b1340],
5	white	JJ	O	white	amod	6	SENT_634	[p17l714t1275r918b1341],
6	persons	NNS	O	person	prep_in	1	SENT_634	[p17l953t1296r1236b1361],
7	with	IN	O	with	_	0	SENT_634	[p17l1274t1275r1439b1341],
8	o	NN	O	o	prep_with	1	SENT_634	[p17l1475t1276r1538b1353],
9	,	,	O	,	_	0	SENT_634	[p17l1475t1276r1538b1353],
10	1	CD	NUMBER	1	conj_and	8	SENT_634	[p17l1586t1276r1642b1353],
11	,	,	O	,	_	0	SENT_634	[p17l1586t1276r1642b1353],
12	2	CD	NUMBER	2	conj_and	8	SENT_634	[p17l1682t1276r1745b1353],
13	,	,	O	,	_	0	SENT_634	[p17l1682t1276r1745b1353],
14	3	CD	NUMBER	3	conj_and	8	SENT_634	[p17l1787t1276r1849b1353],
15	,	,	O	,	_	0	SENT_634	[p17l1787t1276r1849b1353],
16	and	CC	NUMBER	and	_	0	SENT_634	[p17l1890t1275r2021b1341],
17	13	CD	NUMBER	13	num	20	SENT_634	[p17l2065t1276r2143b1342],
18	functional	JJ	O	functional	amod	20	SENT_634	[p17l607t1390r984b1456],
19	CYPZD6	NN	O	cypzd6	nn	20	SENT_634	[p17l1004t1390r1342b1456],
20	genes	NNS	O	gene	conj_and	8	SENT_634	[p17l1363t1411r1592b1475],
21	.	.	O	.	_	0	SENT_634	[p17l1363t1411r1592b1475],

1	Clin	NNP	O	Clin	_	0	SENT_635	[p17l1620t1390r1789b1456],
2	.	.	O	.	_	0	SENT_635	[p17l1620t1390r1789b1456],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_636	[p17l1816t1390r2144b1456, p17l609t1505r733b1570],
2	.	.	O	.	_	0	SENT_636	[p17l1816t1390r2144b1456, p17l609t1505r733b1570],

1	Ther	NNP	O	Ther	_	0	SENT_637	[p17l773t1505r961b1570],
2	.	.	O	.	_	0	SENT_637	[p17l773t1505r961b1570],

1	63:444	CD	NUMBER	63:444	num	2	SENT_638	[p17l994t1505r1389b1570],
2	—	CD	NUMBER	—	_	0	SENT_638	[p17l994t1505r1389b1570],
3	52	CD	NUMBER	52	num	5	SENT_638	[p17l994t1505r1389b1570],
4	Rau	NN	PERSON	rau	nn	5	SENT_638	[p17l607t1621r756b1684],
5	T	NN	O	t	dep	2	SENT_638	[p17l801t1621r875b1696],
6	,	,	O	,	_	0	SENT_638	[p17l801t1621r875b1696],
7	Wohlleben	JJ	O	wohlleben	amod	8	SENT_638	[p17l922t1618r1325b1684],
8	G	NN	O	g	appos	5	SENT_638	[p17l1371t1619r1455b1696],
9	,	,	O	,	_	0	SENT_638	[p17l1371t1619r1455b1696],
10	Wuttke	NNP	ORGANIZATION	Wuttke	nn	11	SENT_638	[p17l1501t1619r1770b1684],
11	H	NNP	ORGANIZATION	H	appos	5	SENT_638	[p17l1816t1621r1900b1696],
12	,	,	O	,	_	0	SENT_638	[p17l1816t1621r1900b1696],
13	et	FW	O	et	nn	14	SENT_638	[p17l1950t1628r2015b1684],
14	a1	FW	O	a1	appos	5	SENT_638	[p17l2060t1619r2142b1684],
15	.	.	O	.	_	0	SENT_638	[p17l2060t1619r2142b1684],

1	2004	CD	DATE	2004	_	0	SENT_639	[p17l609t1734r811b1799],
2	.	.	O	.	_	0	SENT_639	[p17l609t1734r811b1799],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_640	[p17l849t1733r1188b1799],
2	genotype	NN	O	genotype	_	0	SENT_640	[p17l1223t1743r1582b1818],
3	:	:	O	:	_	0	SENT_640	[p17l1223t1743r1582b1818],
4	impact	NN	O	impact	nsubj	14	SENT_640	[p17l1621t1733r1875b1818],
5	on	IN	O	on	_	0	SENT_640	[p17l1907t1754r1998b1799],
6	adVerse	JJ	O	adverse	amod	7	SENT_640	[p17l2032t1733r2144b1799, p17l607t1868r801b1913],
7	effects	NNS	O	effect	prep_on	4	SENT_640	[p17l867t1848r1109b1913],
8	and	CC	O	and	_	0	SENT_640	[p17l1178t1848r1310b1913],
9	nonresponse	JJ	O	nonresponse	nsubj	14	SENT_640	[p17l1374t1868r1840b1932],
10	during	IN	O	during	_	0	SENT_640	[p17l1906t1848r2146b1932],
11	treatment	NN	O	treatment	prep_during	9	SENT_640	[p17l607t1972r960b2027],
12	with	IN	O	with	_	0	SENT_640	[p17l1009t1962r1173b2028],
13	antidepressants	NNS	O	antidepressant	prep_with	11	SENT_640	[p17l1225t1962r1929b2047],
14	—	VBP	O	—	dep	2	SENT_640	[p17l1225t1962r1929b2047],
15	a	DT	O	a	det	17	SENT_640	[p17l1225t1962r1929b2047],
16	pilot	NN	O	pilot	nn	17	SENT_640	[p17l1977t1962r2148b2047],
17	study	NN	O	study	dobj	14	SENT_640	[p17l610t2077r826b2161],
18	.	.	O	.	_	0	SENT_640	[p17l610t2077r826b2161],

1	Clin	NNP	O	Clin	_	0	SENT_641	[p17l856t2077r1025b2143],
2	.	.	O	.	_	0	SENT_641	[p17l856t2077r1025b2143],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_642	[p17l1053t2077r1483b2142],
2	.	.	O	.	_	0	SENT_642	[p17l1053t2077r1483b2142],

1	Ther	NNP	O	Ther	_	0	SENT_643	[p17l1517t2077r1706b2142],
2	.	.	O	.	_	0	SENT_643	[p17l1517t2077r1706b2142],

1	752386-93	CD	NUMBER	752386-93	num	3	SENT_644	[p17l1732t2076r2124b2143],
2	Kawanishi	NNP	ORGANIZATION	Kawanishi	nn	3	SENT_644	[p17l609t2190r1002b2255],
3	C	NNP	ORGANIZATION	C	_	0	SENT_644	[p17l1065t2190r1144b2267],
4	,	,	O	,	_	0	SENT_644	[p17l1065t2190r1144b2267],
5	Lundgren	NNP	PERSON	Lundgren	nn	6	SENT_644	[p17l1208t2190r1570b2274],
6	S	NNP	O	S	appos	3	SENT_644	[p17l1634t2190r1701b2267],
7	,	,	O	,	_	0	SENT_644	[p17l1634t2190r1701b2267],
8	Agren	NNP	PERSON	Agren	nn	9	SENT_644	[p17l1766t2190r1998b2274],
9	H	NNP	PERSON	H	appos	3	SENT_644	[p17l2059t2191r2144b2267],
10	,	,	O	,	_	0	SENT_644	[p17l2059t2191r2144b2267],
11	et	FW	O	et	nn	12	SENT_644	[p17l608t2313r674b2368],
12	al.	FW	O	al.	appos	3	SENT_644	[p17l752t2303r834b2368],
13	2004	CD	DATE	2004	dep	12	SENT_644	[p17l918t2304r1120b2369],
14	.	.	O	.	_	0	SENT_644	[p17l918t2304r1120b2369],

1	Increased	VBN	O	increase	amod	2	SENT_645	[p17l1203t2303r1560b2368],
2	incidence	NN	O	incidence	_	0	SENT_645	[p17l1638t2303r1993b2368],
3	of	IN	O	of	_	0	SENT_645	[p17l2073t2303r2153b2368],
4	CYPZD6	NN	O	cypzd6	nn	6	SENT_645	[p17l608t2416r947b2482],
5	gene	NN	O	gene	nn	6	SENT_645	[p17l1011t2437r1183b2501],
6	duplication	NN	O	duplication	prep_of	2	SENT_645	[p17l1247t2416r1664b2501],
7	in	IN	O	in	_	0	SENT_645	[p17l1727t2416r1797b2481],
8	patients	NNS	O	patient	prep_in	6	SENT_645	[p17l1857t2416r2145b2501],
9	with	IN	O	with	_	0	SENT_645	[p17l608t2530r772b2595],
10	persistent	JJ	O	persistent	amod	12	SENT_645	[p17l790t2530r1149b2614],
11	mood	NN	O	mood	nn	12	SENT_645	[p17l1168t2530r1380b2595],
12	disorders	NNS	O	disorder	prep_with	8	SENT_645	[p17l1400t2530r1759b2595],
13	:	:	O	:	_	0	SENT_645	[p17l1400t2530r1759b2595],
14	ultrarapid	JJ	O	ultrarapid	amod	15	SENT_645	[p17l1785t2530r2148b2614],
15	metabolism	NN	O	metabolism	dep	2	SENT_645	[p17l607t2643r1043b2708],
16	of	IN	O	of	_	0	SENT_645	[p17l1071t2643r1152b2708],
17	antidepressants	NNS	O	antidepressant	prep_of	15	SENT_645	[p17l1175t2643r1741b2728],
18	as	IN	O	as	_	0	SENT_645	[p17l1773t2664r1845b2708],
19	a	DT	O	a	det	20	SENT_645	[p17l1877t2664r1915b2708],
20	cause	NN	O	cause	prep_as	17	SENT_645	[p17l1942t2664r2147b2708],
21	of	IN	O	of	_	0	SENT_645	[p17l608t2756r689b2822],
22	nonresponse	JJ	O	nonresponse	prep_of	20	SENT_645	[p17l701t2777r1186b2841],
23	.	.	O	.	_	0	SENT_645	[p17l701t2777r1186b2841],

1	A	DT	O	a	det	2	SENT_646	[p17l1208t2757r1273b2821],
2	pilot	NN	O	pilot	_	0	SENT_646	[p17l1291t2756r1463b2841],
3	study	NN	O	study	dep	2	SENT_646	[p17l1483t2756r1693b2841],
4	.	.	O	.	_	0	SENT_646	[p17l1483t2756r1693b2841],

1	Eur	NNP	O	Eur	_	0	SENT_647	[p17l1714t2759r1858b2822],
2	.	.	O	.	_	0	SENT_647	[p17l1714t2759r1858b2822],

1	J.	NNP	O	J.	nn	2	SENT_648	[p17l1883t2759r1937b2822],
2	C	NNP	O	C	_	0	SENT_648	[p17l1970t2758r2029b2822],
3	lin	NN	O	lin	dep	2	SENT_648	[p17l2030t2756r2138b2822],
4	.	.	O	.	_	0	SENT_648	[p17l2030t2756r2138b2822],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_649	[p17l605t2870r1039b2935],
2	.	.	O	.	_	0	SENT_649	[p17l605t2870r1039b2935],

1	59:803	CD	NUMBER	59:803	num	2	SENT_650	[p17l1072t2870r1419b2936],
2	—	NN	O	—	_	0	SENT_650	[p17l1072t2870r1419b2936],
3	7	CD	NUMBER	7	num	5	SENT_650	[p17l1072t2870r1419b2936],
4	Krynetski	NNP	O	Krynetski	nn	5	SENT_650	[p17l609t2982r974b3067],
5	GY	NNP	O	GY	dep	2	SENT_650	[p17l996t2982r1147b3059],
6	,	,	O	,	_	0	SENT_650	[p17l996t2982r1147b3059],
7	Evans	NNP	PERSON	Evans	nn	8	SENT_650	[p17l1171t2984r1393b3047],
8	WE	NNP	O	WE	appos	5	SENT_650	[p17l1415t2984r1578b3047],
9	.	.	O	.	_	0	SENT_650	[p17l1415t2984r1578b3047],

1	1998	CD	DATE	1998	_	0	SENT_651	[p17l1613t2982r1807b3048],
2	.	.	O	.	_	0	SENT_651	[p17l1613t2982r1807b3048],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	10	SENT_652	[p17l1832t2982r2144b3047, p17l608t3095r998b3180],
2	of	IN	O	of	_	0	SENT_652	[p17l1035t3095r1115b3161],
3	cancer	NN	O	cancer	nn	4	SENT_652	[p17l1143t3116r1386b3161],
4	chemotherapy	NN	O	chemotherapy	prep_of	1	SENT_652	[p17l1418t3095r1964b3180],
5	:	:	O	:	_	0	SENT_652	[p17l1418t3095r1964b3180],
6	getting	VBG	O	get	dep	4	SENT_652	[p17l2005t3105r2144b3180, p17l607t3209r749b3293],
7	personal	JJ	O	personal	amod	9	SENT_652	[p17l777t3209r1092b3293],
8	(	NN	O	(	nn	9	SENT_652	[p17l1123t3209r1651b3289],
9	mini	NNS	O	minus	dobj	6	SENT_652	[p17l1123t3209r1651b3289],
10	—	VBP	O	—	_	0	SENT_652	[p17l1123t3209r1651b3289],
11	reView	NN	O	review	nn	12	SENT_652	[p17l1123t3209r1651b3289],
12	)	NN	O	)	dobj	10	SENT_652	[p17l1123t3209r1651b3289],
13	.	.	O	.	_	0	SENT_652	[p17l1123t3209r1651b3289],

1	Am	NNP	O	Am	_	0	SENT_653	[p17l1677t3210r1820b3274],
2	.	.	O	.	_	0	SENT_653	[p17l1677t3210r1820b3274],

1	J.	NNP	O	J.	nn	2	SENT_654	[p17l1855t3211r1908b3275],
2	Hum	NNP	O	Hum	_	0	SENT_654	[p17l1942t3211r2138b3274],
3	.	.	O	.	_	0	SENT_654	[p17l1942t3211r2138b3274],

1	Genet	NNP	PERSON	Genet	_	0	SENT_655	[p17l610t3323r843b3388],
2	.	.	O	.	_	0	SENT_655	[p17l610t3323r843b3388],

1	63:11	CD	NUMBER	63:11	num	2	SENT_656	[p17l879t3322r1228b3387],
2	-16	CD	NUMBER	-16	_	0	SENT_656	[p17l879t3322r1228b3387],

1	53	CD	NUMBER	53	_	0	SENT_657	[p17l6t3625r142b3707],
2	.	.	O	.	_	0	SENT_657	[p17l6t3625r142b3707],

1	McLeod	NNP	PERSON	McLeod	nn	2	SENT_658	[p17l203t3625r602b3707],
2	HL	NNS	O	hl	_	0	SENT_658	[p17l631t3627r810b3722],
3	,	,	O	,	_	0	SENT_658	[p17l631t3627r810b3722],
4	Krynetski	NNP	PERSON	Krynetski	nn	5	SENT_658	[p17l848t3625r1308b3731],
5	EY	NNP	PERSON	EY	dep	2	SENT_658	[p17l1338t3627r1518b3722],
6	,	,	O	,	_	0	SENT_658	[p17l1338t3627r1518b3722],
7	Relling	NNP	O	Relling	nn	8	SENT_658	[p17l1553t3625r1896b3731],
8	MV	NNP	O	MV	appos	5	SENT_658	[p17l1927t3627r2140b3721],
9	,	,	O	,	_	0	SENT_658	[p17l1927t3627r2140b3721],

1	et	FW	O	et	nn	2	SENT_659	[p18l205t37r287b106],
2	al.	FW	O	al.	_	0	SENT_659	[p18l357t24r459b106],
3	2000	CD	DATE	2000	dep	2	SENT_659	[p18l535t25r790b107],
4	.	.	O	.	_	0	SENT_659	[p18l535t25r790b107],

1	Genetic	JJ	O	genetic	amod	2	SENT_660	[p18l866t24r1226b107],
2	polymorphism	NN	O	polymorphism	_	0	SENT_660	[p18l1295t24r1983b131],
3	of	IN	O	of	_	0	SENT_660	[p18l2052t24r2153b106],
4	thiopurine	JJ	O	thiopurine	amod	5	SENT_660	[p18l203t167r685b274],
5	methyltransferase	NN	O	methyltransferase	prep_of	2	SENT_660	[p18l720t167r1554b274],
6	and	CC	O	and	_	0	SENT_660	[p18l1591t167r1757b250],
7	its	PRP$	O	its	poss	9	SENT_660	[p18l1790t167r1895b250],
8	clinical	JJ	O	clinical	amod	9	SENT_660	[p18l1933t167r2142b250, p18l203t312r371b394],
9	relevance	NN	O	relevance	conj_and	5	SENT_660	[p18l421t312r866b394],
10	for	IN	O	for	_	0	SENT_660	[p18l919t312r1055b394],
11	childhood	NN	O	childhood	nn	14	SENT_660	[p18l1107t312r1575b394],
12	acute	JJ	O	acute	amod	14	SENT_660	[p18l1630t324r1872b394],
13	lymphoblastic	JJ	O	lymphoblastic	amod	14	SENT_660	[p18l1925t312r2142b418, p18l202t455r684b562],
14	leukemia	NN	O	leukemia	prep_for	2	SENT_660	[p18l740t455r1191b537],
15	.	.	O	.	_	0	SENT_660	[p18l740t455r1191b537],

1	Leukemia	NN	O	leukemia	_	0	SENT_661	[p18l1249t455r1706b537],
2	14:56772	CD	NUMBER	14:56772	num	1	SENT_661	[p18l1772t455r2147b537, p18l205t600r317b681],

1	Yates	NNP	PERSON	Yates	nn	2	SENT_662	[p18l204t746r455b826],
2	CR	NN	O	cr	_	0	SENT_662	[p18l496t744r674b841],
3	,	,	O	,	_	0	SENT_662	[p18l496t744r674b841],
4	Krynetski	NNP	PERSON	Krynetski	nn	5	SENT_662	[p18l717t744r1177b850],
5	EY	NNP	PERSON	EY	appos	2	SENT_662	[p18l1214t746r1394b842],
6	,	,	O	,	_	0	SENT_662	[p18l1214t746r1394b842],
7	Loennechen	NNP	O	Loennechen	nn	8	SENT_662	[p18l1435t744r2009b826],
8	T	NN	O	t	appos	2	SENT_662	[p18l2047t746r2140b842],
9	,	,	O	,	_	0	SENT_662	[p18l2047t746r2140b842],
10	et	FW	O	et	nn	11	SENT_662	[p18l205t899r287b969],
11	al.	FW	O	al.	appos	2	SENT_662	[p18l330t887r431b969],
12	1997	CD	DATE	1997	dep	11	SENT_662	[p18l491t887r735b971],
13	.	.	O	.	_	0	SENT_662	[p18l491t887r735b971],

1	Molecular	JJ	O	molecular	amod	2	SENT_663	[p18l782t887r1267b969],
2	diagnosis	NN	O	diagnosis	_	0	SENT_663	[p18l1306t887r1745b994],
3	of	IN	O	of	_	0	SENT_663	[p18l1791t887r1892b969],
4	thio	FW	O	thio	nn	7	SENT_663	[p18l1925t887r2142b969],
5	—	FW	O	—	nn	7	SENT_663	[p18l1925t887r2142b969],
6	purine	NN	O	purine	nn	7	SENT_663	[p18l202t1029r501b1136],
7	S	NN	O	s	prep_of	2	SENT_663	[p18l600t1029r1537b1136],
8	—	CD	NUMBER	—	num	10	SENT_663	[p18l600t1029r1537b1136],
9	methyltransferase	NN	O	methyltransferase	nn	10	SENT_663	[p18l600t1029r1537b1136],
10	deﬁciency	NN	O	deﬁciency	dep	7	SENT_663	[p18l1633t1029r2137b1136],
11	:	:	O	:	_	0	SENT_663	[p18l1633t1029r2137b1136],
12	genetic	JJ	O	genetic	amod	13	SENT_663	[p18l205t1173r540b1279],
13	basis	NN	O	basis	dep	2	SENT_663	[p18l560t1173r793b1255],
14	for	IN	O	for	_	0	SENT_663	[p18l816t1173r953b1255],
15	azathioprine	NN	O	azathioprine	nn	18	SENT_663	[p18l974t1173r1551b1279],
16	and	CC	O	and	_	0	SENT_663	[p18l1576t1173r1741b1255],
17	mercaptopurine	NN	O	mercaptopurine	nn	18	SENT_663	[p18l1761t1198r2142b1279, p18l203t1316r594b1423],
18	intolerance	NN	O	intolerance	prep_for	13	SENT_663	[p18l649t1316r1194b1398],
19	.	.	O	.	_	0	SENT_663	[p18l649t1316r1194b1398],

1	Ann	NNP	PERSON	Ann	_	0	SENT_664	[p18l1249t1317r1461b1398],
2	.	.	O	.	_	0	SENT_664	[p18l1249t1317r1461b1398],

1	Intern	NNP	O	Intern	_	0	SENT_665	[p18l1530t1319r1837b1398],
2	.	.	O	.	_	0	SENT_665	[p18l1530t1319r1837b1398],

1	Med	NNP	O	Med	_	0	SENT_666	[p18l1905t1316r2139b1398],
2	.	.	O	.	_	0	SENT_666	[p18l1905t1316r2139b1398],

1	126:608	CD	NUMBER	126:608	num	2	SENT_667	[p18l214t1458r763b1542],
2	—	CD	NUMBER	—	_	0	SENT_667	[p18l214t1458r763b1542],
3	14	CD	NUMBER	14	num	5	SENT_667	[p18l214t1458r763b1542],
4	Otterness	NN	ORGANIZATION	otterness	nn	5	SENT_667	[p18l205t1603r643b1686],
5	D	NN	ORGANIZATION	d	dep	2	SENT_667	[p18l695t1605r802b1700],
6	,	,	O	,	_	0	SENT_667	[p18l695t1605r802b1700],
7	Szumlanski	NN	O	szumlanskus	nn	8	SENT_667	[p18l859t1603r1403b1686],
8	C	NN	O	c	appos	5	SENT_667	[p18l1454t1603r1554b1700],
9	,	,	O	,	_	0	SENT_667	[p18l1454t1603r1554b1700],
10	Lennard	NNP	PERSON	Lennard	nn	11	SENT_667	[p18l1606t1603r1998b1686],
11	L	NNP	PERSON	L	appos	5	SENT_667	[p18l2046t1605r2140b1700],
12	,	,	O	,	_	0	SENT_667	[p18l2046t1605r2140b1700],
13	et	FW	O	et	nn	14	SENT_667	[p18l205t1759r287b1829],
14	al.	FW	O	al.	appos	5	SENT_667	[p18l347t1747r450b1829],
15	1997	CD	DATE	1997	dep	14	SENT_667	[p18l527t1747r771b1831],
16	.	.	O	.	_	0	SENT_667	[p18l527t1747r771b1831],

1	Human	JJ	O	human	amod	4	SENT_668	[p18l837t1749r1182b1829],
2	thiopurine	NN	O	thiopurine	nn	4	SENT_668	[p18l1240t1747r1722b1854],
3	methyltransferase	NN	O	methyltransferase	nn	4	SENT_668	[p18l1780t1747r2142b1854, p18l203t1890r711b1973],
4	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_668	[p18l775t1890r1651b1997],
5	:	:	O	:	_	0	SENT_668	[p18l775t1890r1651b1997],
6	gene	NN	O	gene	nn	8	SENT_668	[p18l1726t1917r1944b1997],
7	sequence	NN	O	sequence	nn	8	SENT_668	[p18l2014t1917r2142b1973, p18l205t2060r534b2141],
8	polymorphisms	NNS	O	polymorphism	dep	4	SENT_668	[p18l556t2035r1312b2141],
9	.	.	O	.	_	0	SENT_668	[p18l556t2035r1312b2141],

1	C	NN	O	c	_	0	SENT_669	[p18l1347t2036r1420b2118],
2	lin	NN	O	lin	dep	1	SENT_669	[p18l1423t2035r1559b2117],
3	.	.	O	.	_	0	SENT_669	[p18l1423t2035r1559b2117],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_670	[p18l1592t2035r2134b2117],
2	.	.	O	.	_	0	SENT_670	[p18l1592t2035r2134b2117],

1	T	NN	O	t	_	0	SENT_671	[p18l208t2182r276b2260],
2	her	PRP$	O	she	dep	1	SENT_671	[p18l270t2179r447b2261],
3	.	.	O	.	_	0	SENT_671	[p18l270t2179r447b2261],

1	62:60	CD	NUMBER	62:60	num	4	SENT_672	[p18l488t2179r922b2261],
2	-73	CD	NUMBER	-73	num	4	SENT_672	[p18l488t2179r922b2261],
3	Evans	NNP	O	Evans	nn	4	SENT_672	[p18l203t2324r483b2405],
4	WE	NNP	O	WE	_	0	SENT_672	[p18l542t2324r749b2419],
5	,	,	O	,	_	0	SENT_672	[p18l542t2324r749b2419],
6	Horner	NNP	PERSON	Horner	nn	7	SENT_672	[p18l811t2324r1144b2404],
7	M	NNP	O	M	appos	4	SENT_672	[p18l1199t2324r1327b2419],
8	,	,	O	,	_	0	SENT_672	[p18l1199t2324r1327b2419],
9	Chu	NNP	O	Chu	nn	10	SENT_672	[p18l1390t2321r1581b2405],
10	YQ	NNP	O	YQ	appos	4	SENT_672	[p18l1640t2322r1832b2424],
11	,	,	O	,	_	0	SENT_672	[p18l1640t2322r1832b2424],
12	et	FW	O	et	nn	13	SENT_672	[p18l1895t2334r1978b2404],
13	al.	FW	O	al.	appos	4	SENT_672	[p18l2036t2321r2139b2404],
14	1991	CD	DATE	1991	dep	13	SENT_672	[p18l214t2467r460b2551],
15	.	.	O	.	_	0	SENT_672	[p18l214t2467r460b2551],

1	Altered	JJ	O	altered	amod	3	SENT_673	[p18l535t2467r886b2549],
2	mercaptopurine	NN	O	mercaptopurine	nn	3	SENT_673	[p18l954t2467r1692b2573],
3	metabolism	NN	O	metabolism	_	0	SENT_673	[p18l1761t2467r2142b2549, p18l203t2610r429b2707],
4	,	,	O	,	_	0	SENT_673	[p18l1761t2467r2142b2549, p18l203t2610r429b2707],
5	toxic	JJ	O	toxic	amod	6	SENT_673	[p18l489t2610r720b2692],
6	effects	NNS	O	effect	conj_and	3	SENT_673	[p18l778t2610r1111b2707],
7	,	,	O	,	_	0	SENT_673	[p18l778t2610r1111b2707],
8	and	CC	O	and	_	0	SENT_673	[p18l1173t2610r1340b2692],
9	dosage	NN	O	dosage	nn	10	SENT_673	[p18l1395t2610r1718b2717],
10	requirement	NN	O	requirement	conj_and	3	SENT_673	[p18l1773t2610r2142b2717, p18l203t2765r439b2834],
11	in	IN	O	in	_	0	SENT_673	[p18l490t2752r578b2834],
12	a	DT	O	a	det	15	SENT_673	[p18l635t2779r683b2834],
13	thiopurine	JJ	O	thiopurine	amod	15	SENT_673	[p18l734t2752r1216b2859],
14	methyltransferase	NN	O	methyltransferase	nn	15	SENT_673	[p18l1270t2752r2142b2859],
15	—	NN	O	—	prep_in	10	SENT_673	[p18l1270t2752r2142b2859],
16	deﬁcient	JJ	O	deﬁcient	amod	17	SENT_673	[p18l205t2897r608b2979],
17	child	NN	O	child	dep	3	SENT_673	[p18l674t2897r908b2979],
18	with	IN	O	with	_	0	SENT_673	[p18l974t2897r1180b2979],
19	acute	JJ	O	acute	amod	21	SENT_673	[p18l1249t2909r1493b2979],
20	lymphocytic	JJ	O	lymphocytic	amod	21	SENT_673	[p18l1560t2897r2142b3003],
21	leukemia	NN	O	leukemia	prep_with	17	SENT_673	[p18l204t3041r655b3124],
22	.	.	O	.	_	0	SENT_673	[p18l204t3041r655b3124],

1	J.	NNP	PERSON	J.	nn	2	SENT_674	[p18l691t3044r758b3125],
2	Pediatr	NNP	PERSON	Pediatr	_	0	SENT_674	[p18l800t3041r1167b3124],
3	.	.	O	.	_	0	SENT_674	[p18l800t3041r1167b3124],

1	119:985	CD	NUMBER	119:985	num	5	SENT_675	[p18l1218t3041r1764b3125],
2	—	CD	NUMBER	—	num	5	SENT_675	[p18l1218t3041r1764b3125],
3	89	CD	NUMBER	89	num	5	SENT_675	[p18l1218t3041r1764b3125],
4	Schutz	NNP	ORGANIZATION	Schutz	nn	5	SENT_675	[p18l207t3183r521b3267],
5	E	NNP	ORGANIZATION	E	_	0	SENT_675	[p18l557t3186r652b3281],
6	,	,	O	,	_	0	SENT_675	[p18l557t3186r652b3281],
7	Gummert	NNP	O	Gummert	nn	8	SENT_675	[p18l694t3184r1144b3267],
8	J	NNP	O	J	appos	5	SENT_675	[p18l1177t3186r1245b3281],
9	,	,	O	,	_	0	SENT_675	[p18l1177t3186r1245b3281],
10	Mohr	NNP	PERSON	Mohr	nn	11	SENT_675	[p18l1285t3183r1547b3265],
11	F	NN	O	f	appos	5	SENT_675	[p18l1580t3186r1668b3281],
12	,	,	O	,	_	0	SENT_675	[p18l1580t3186r1668b3281],
13	Oellerich	NNP	O	Oellerich	nn	14	SENT_675	[p18l1711t3183r2145b3267],
14	M.	NNP	O	M.	appos	5	SENT_675	[p18l203t3330r329b3411],
15	1993	CD	DATE	1993	dep	14	SENT_675	[p18l409t3329r654b3413],
16	.	.	O	.	_	0	SENT_675	[p18l409t3329r654b3413],

1	Azathioprine	NNP	O	Azathioprine	nn	2	SENT_676	[p18l724t3329r1752b3435],
2	—	NN	O	—	nsubj	3	SENT_676	[p18l724t3329r1752b3435],
3	induced	VBD	O	induce	_	0	SENT_676	[p18l724t3329r1752b3435],
4	myelo	JJ	O	myelo	amod	6	SENT_676	[p18l1813t3329r2142b3435],
5	—	NN	O	—	nn	6	SENT_676	[p18l1813t3329r2142b3435],
6	suppression	NN	O	suppression	nsubj	13	SENT_676	[p18l208t3473r758b3579],
7	in	IN	O	in	_	0	SENT_676	[p18l832t3473r921b3554],
8	thiopurine	JJ	O	thiopurine	amod	12	SENT_676	[p18l995t3473r1477b3579],
9	methyltransferase	NN	O	methyltransferase	nn	12	SENT_676	[p18l1552t3473r2142b3579, p18l204t3615r482b3697],
10	deﬁcient	JJ	O	deﬁcient	amod	12	SENT_676	[p18l515t3615r919b3697],
11	heart	NN	O	heart	nn	12	SENT_676	[p18l947t3615r1183b3697],
12	transplant	NN	O	transplant	prep_in	6	SENT_676	[p18l1211t3615r1676b3722],
13	recipient	JJ	O	recipient	xcomp	3	SENT_676	[p18l1704t3615r2139b3722],
14	.	.	O	.	_	0	SENT_676	[p18l1704t3615r2139b3722],

1	Lancet	NNP	O	Lancet	_	0	SENT_677	[p19l200t30r545b109],
2	.	.	O	.	_	0	SENT_677	[p19l200t30r545b109],

1	13	CD	NUMBER	13	_	0	SENT_678	[p19l595t25r1117b123],
2	;	:	O	;	_	0	SENT_678	[p19l595t25r1117b123],
3	341:436	CD	NUMBER	341:436	dep	1	SENT_678	[p19l595t25r1117b123],

1	58	CD	NUMBER	58	_	0	SENT_679	[p19l6t170r142b252],
2	.	.	O	.	_	0	SENT_679	[p19l6t170r142b252],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_680	[p19l203t172r483b252],
2	WE	NNP	O	WE	_	0	SENT_680	[p19l526t172r733b266],
3	,	,	O	,	_	0	SENT_680	[p19l526t172r733b266],
4	Hon	NNP	O	Hon	nn	5	SENT_680	[p19l777t172r978b252],
5	YY	NNP	O	YY	appos	2	SENT_680	[p19l1019t172r1210b266],
6	,	,	O	,	_	0	SENT_680	[p19l1019t172r1210b266],
7	Bomgaars	NNP	ORGANIZATION	Bomgaars	nn	8	SENT_680	[p19l1255t172r1728b277],
8	L	NNP	ORGANIZATION	L	appos	2	SENT_680	[p19l1770t172r1865b266],
9	,	,	O	,	_	0	SENT_680	[p19l1770t172r1865b266],
10	et	FW	O	et	nn	11	SENT_680	[p19l1911t182r1995b252],
11	al.	FW	O	al.	appos	2	SENT_680	[p19l2036t170r2139b252],
12	2001	CD	DATE	2001	dep	11	SENT_680	[p19l205t313r460b395],
13	.	.	O	.	_	0	SENT_680	[p19l205t313r460b395],

1	Preponderance	NNP	O	Preponderance	_	0	SENT_681	[p19l541t312r1239b419],
2	of	IN	O	of	_	0	SENT_681	[p19l1317t312r1418b394],
3	thiopurine	JJ	O	thiopurine	amod	5	SENT_681	[p19l1485t312r1967b419],
4	Smethyltransferase	NN	O	smethyltransferase	nn	5	SENT_681	[p19l2047t313r2142b395, p19l203t455r1038b562],
5	deﬁciency	NN	O	deﬁciency	prep_of	1	SENT_681	[p19l1133t455r1611b562],
6	and	CC	O	and	_	0	SENT_681	[p19l1707t455r1872b538],
7	heterozygosity	NN	O	heterozygosity	conj_and	1	SENT_681	[p19l1963t455r2142b537, p19l205t599r750b705],
8	among	IN	O	among	_	0	SENT_681	[p19l797t624r1112b705],
9	patients	NNS	O	patient	prep_among	7	SENT_681	[p19l1154t599r1518b705],
10	intolerant	JJ	O	intolerant	amod	1	SENT_681	[p19l1563t599r2014b681],
11	to	TO	O	to	_	0	SENT_681	[p19l2056t611r2144b681],
12	mercaptopurine	NN	O	mercaptopurine	prep_to	10	SENT_681	[p19l203t741r940b848],
13	or	CC	O	or	_	0	SENT_681	[p19l990t768r1086b823],
14	azathioprine	NN	O	azathioprine	conj_or	12	SENT_681	[p19l1134t741r1736b848],
15	.	.	O	.	_	0	SENT_681	[p19l1134t741r1736b848],

1	J.	NNP	PERSON	J.	nn	2	SENT_682	[p19l1786t744r1853b825],
2	Clin	NNP	PERSON	Clin	_	0	SENT_682	[p19l1921t741r2134b825],
3	.	.	O	.	_	0	SENT_682	[p19l1921t741r2134b825],

1	Oncol	NN	O	oncol	_	0	SENT_683	[p19l208t884r512b968],
2	.	.	O	.	_	0	SENT_683	[p19l208t884r512b968],

1	19:2293	CD	NUMBER	19:2293	num	2	SENT_684	[p19l562t885r1161b968],
2	—	NN	O	—	_	0	SENT_684	[p19l562t885r1161b968],
3	301	CD	NUMBER	301	dep	2	SENT_684	[p19l562t885r1161b968],

1	59	CD	NUMBER	59	_	0	SENT_685	[p19l6t1030r142b1114],
2	.	.	O	.	_	0	SENT_685	[p19l6t1030r142b1114],

1	Black	JJ	O	black	amod	2	SENT_686	[p19l203t1030r479b1112],
2	AJ	NN	O	aj	_	0	SENT_686	[p19l562t1030r715b1127],
3	,	,	O	,	_	0	SENT_686	[p19l562t1030r715b1127],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_686	[p19l804t1030r1202b1112],
5	HL	NNS	O	hl	appos	2	SENT_686	[p19l1287t1032r1467b1127],
6	,	,	O	,	_	0	SENT_686	[p19l1287t1032r1467b1127],
7	Capell	NNP	ORGANIZATION	Capell	nn	8	SENT_686	[p19l1559t1030r1862b1136],
8	HA	NNP	ORGANIZATION	HA	appos	2	SENT_686	[p19l1949t1030r2140b1128],
9	,	,	O	,	_	0	SENT_686	[p19l1949t1030r2140b1128],
10	et	FW	O	et	nn	11	SENT_686	[p19l205t1185r287b1254],
11	al.	FW	O	al.	appos	2	SENT_686	[p19l320t1172r423b1254],
12	1998	CD	DATE	1998	dep	11	SENT_686	[p19l472t1173r717b1256],
13	.	.	O	.	_	0	SENT_686	[p19l472t1173r717b1256],

1	Thiopurine	NNP	O	Thiopurine	nn	3	SENT_687	[p19l756t1172r1276b1279],
2	methyltransferase	NN	O	methyltransferase	nn	3	SENT_687	[p19l1309t1172r2144b1279],
3	genotype	NN	O	genotype	nsubj	4	SENT_687	[p19l205t1328r632b1422],
4	predicts	VBZ	O	predict	_	0	SENT_687	[p19l660t1315r1030b1422],
5	therapy	NN	O	therapy	dobj	4	SENT_687	[p19l1060t1315r1821b1422],
6	—	CD	NUMBER	—	num	5	SENT_687	[p19l1060t1315r1821b1422],
7	limiting	VBG	O	limit	partmod	5	SENT_687	[p19l1060t1315r1821b1422],
8	severe	JJ	O	severe	amod	9	SENT_687	[p19l1856t1342r2144b1399],
9	toxicity	NN	O	toxicity	dobj	7	SENT_687	[p19l203t1460r560b1566],
10	from	IN	O	from	_	0	SENT_687	[p19l614t1460r842b1542],
11	azathioprine	NN	O	azathioprine	prep_from	7	SENT_687	[p19l896t1460r1497b1566],
12	.	.	O	.	_	0	SENT_687	[p19l896t1460r1497b1566],

1	Ann	NNP	PERSON	Ann	_	0	SENT_688	[p19l1548t1461r1761b1542],
2	.	.	O	.	_	0	SENT_688	[p19l1548t1461r1761b1542],

1	Intern	NNP	O	Intern	_	0	SENT_689	[p19l1827t1463r2134b1542],
2	.	.	O	.	_	0	SENT_689	[p19l1827t1463r2134b1542],

1	Med	NNP	O	Med	_	0	SENT_690	[p19l199t1604r433b1687],
2	.	.	O	.	_	0	SENT_690	[p19l199t1604r433b1687],

1	129:716	CD	NUMBER	129:716	_	0	SENT_691	[p19l483t1604r1028b1688],
2	—	CD	NUMBER	—	num	3	SENT_691	[p19l483t1604r1028b1688],
3	18	CD	NUMBER	18	dep	1	SENT_691	[p19l483t1604r1028b1688],

1	60	CD	NUMBER	60	_	0	SENT_692	[p19l6t1746r142b1829],
2	.	.	O	.	_	0	SENT_692	[p19l6t1746r142b1829],

1	Relling	VBG	ORGANIZATION	rell	_	0	SENT_693	[p19l203t1746r546b1853],
2	MV	NN	ORGANIZATION	mv	dobj	1	SENT_693	[p19l598t1749r812b1844],
3	,	,	O	,	_	0	SENT_693	[p19l598t1749r812b1844],
4	Hancock	NNP	PERSON	Hancock	nn	5	SENT_693	[p19l867t1746r1286b1829],
5	ML	NNP	O	ML	appos	2	SENT_693	[p19l1334t1749r1534b1844],
6	,	,	O	,	_	0	SENT_693	[p19l1334t1749r1534b1844],
7	Rivera	NNP	PERSON	Rivera	nn	8	SENT_693	[p19l1590t1746r1899b1830],
8	GK	NNP	PERSON	GK	appos	2	SENT_693	[p19l1949t1747r2140b1844],
9	,	,	O	,	_	0	SENT_693	[p19l1949t1747r2140b1844],
10	et	FW	O	et	nn	11	SENT_693	[p19l205t1903r287b1973],
11	a1	FW	O	a1	appos	2	SENT_693	[p19l339t1891r442b1973],
12	.	.	O	.	_	0	SENT_693	[p19l339t1891r442b1973],

1	1999	CD	DATE	1999	_	0	SENT_694	[p19l511t1891r757b1975],
2	.	.	O	.	_	0	SENT_694	[p19l511t1891r757b1975],

1	Mercaptopurine	JJ	O	mercaptopurine	amod	3	SENT_695	[p19l813t1891r1564b1997],
2	therapy	NN	O	therapy	nn	3	SENT_695	[p19l1616t1891r1965b1997],
3	intolerance	NN	O	intolerance	nsubj	9	SENT_695	[p19l2017t1891r2142b1972, p19l203t2034r632b2116],
4	and	CC	O	and	_	0	SENT_695	[p19l677t2034r844b2116],
5	heterozygosity	NN	O	heterozygosity	nsubj	9	SENT_695	[p19l883t2034r1575b2141],
6	at	IN	O	at	_	0	SENT_695	[p19l1620t2046r1702b2116],
7	the	DT	O	the	det	8	SENT_695	[p19l1742t2034r1883b2116],
8	thiopurine	NN	O	thiopurine	prep_at	3	SENT_695	[p19l1925t2034r2142b2116, p19l202t2176r501b2283],
9	S	NN	O	s	_	0	SENT_695	[p19l538t2176r1474b2283],
10	—	CD	NUMBER	—	num	13	SENT_695	[p19l538t2176r1474b2283],
11	methyltransferase	NN	O	methyltransferase	nn	13	SENT_695	[p19l538t2176r1474b2283],
12	gene	NN	O	gene	nn	13	SENT_695	[p19l1510t2203r1727b2283],
13	locus	NN	O	locus	dobj	9	SENT_695	[p19l1761t2176r2030b2259],
14	.	.	O	.	_	0	SENT_695	[p19l1761t2176r2030b2259],

1	J.	NNP	O	J.	nn	4	SENT_696	[p19l2066t2180r2134b2260],
2	Natl.	NNP	O	Natl.	nn	4	SENT_696	[p19l199t2321r422b2404],
3	Cancer	NNP	O	Cancer	nn	4	SENT_696	[p19l472t2322r815b2404],
4	Inst	NNP	O	Inst	_	0	SENT_696	[p19l840t2324r1041b2403],
5	.	.	O	.	_	0	SENT_696	[p19l840t2324r1041b2403],

1	91:200	CD	NUMBER	91:200	num	2	SENT_697	[p19l1080t2321r1577b2405],
2	l	NN	O	l	_	0	SENT_697	[p19l1080t2321r1577b2405],
3	—	CD	NUMBER	—	num	4	SENT_697	[p19l1080t2321r1577b2405],
4	8	CD	NUMBER	8	dep	2	SENT_697	[p19l1080t2321r1577b2405],

1	61	CD	NUMBER	61	_	0	SENT_698	[p19l6t2464r142b2546],
2	.	.	O	.	_	0	SENT_698	[p19l6t2464r142b2546],

1	Relling	VBG	ORGANIZATION	rell	_	0	SENT_699	[p19l203t2464r547b2571],
2	MV	NN	ORGANIZATION	mv	dobj	1	SENT_699	[p19l620t2467r832b2562],
3	,	,	O	,	_	0	SENT_699	[p19l620t2467r832b2562],
4	Rubnitz	NNP	PERSON	Rubnitz	nn	5	SENT_699	[p19l909t2464r1279b2546],
5	JE	NNP	O	JE	appos	2	SENT_699	[p19l1352t2467r1492b2562],
6	,	,	O	,	_	0	SENT_699	[p19l1352t2467r1492b2562],
7	Rivera	NNP	PERSON	Rivera	nn	8	SENT_699	[p19l1569t2464r1878b2546],
8	GK	NNP	PERSON	GK	appos	2	SENT_699	[p19l1950t2464r2140b2562],
9	,	,	O	,	_	0	SENT_699	[p19l1950t2464r2140b2562],
10	et	FW	O	et	nn	11	SENT_699	[p19l205t2619r287b2688],
11	al.	FW	O	al.	appos	2	SENT_699	[p19l327t2606r430b2689],
12	1999	CD	DATE	1999	dep	11	SENT_699	[p19l486t2607r731b2690],
13	.	.	O	.	_	0	SENT_699	[p19l486t2607r731b2690],

1	High	JJ	O	high	amod	2	SENT_700	[p19l777t2606r1009b2713],
2	incidence	NN	O	incidence	nsubj	7	SENT_700	[p19l1048t2606r1496b2689],
3	of	IN	O	of	_	0	SENT_700	[p19l1537t2606r1638b2689],
4	secondary	JJ	O	secondary	amod	6	SENT_700	[p19l1674t2606r2144b2713],
5	brain	NN	O	brain	nn	6	SENT_700	[p19l202t2751r444b2833],
6	tumors	NNS	O	tumor	prep_of	2	SENT_700	[p19l470t2763r793b2833],
7	related	VBN	O	relate	_	0	SENT_700	[p19l822t2751r1142b2833],
8	to	TO	O	to	_	0	SENT_700	[p19l1169t2762r1256b2833],
9	irradiation	NN	O	irradiation	nn	12	SENT_700	[p19l1286t2751r1774b2833],
10	and	CC	O	and	_	0	SENT_700	[p19l1805t2751r1970b2833],
11	antimetabolite	JJ	O	antimetabolite	nn	12	SENT_700	[p19l2000t2776r2142b2833, p19l203t2894r764b2976],
12	therapy	NN	O	therapy	prep_to	7	SENT_700	[p19l797t2894r1163b3001],
13	.	.	O	.	_	0	SENT_700	[p19l797t2894r1163b3001],

1	Lancet	NNP	O	Lancet	_	0	SENT_701	[p19l1199t2897r1523b2976],
2	354234-39	CD	NUMBER	354234-39	dep	1	SENT_701	[p19l1556t2894r2051b2978],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	_	0	SENT_702	[p19l1248t3079r1650b3106],
2	135	CD	NUMBER	135	num	1	SENT_702	[p19l1742t3076r1801b3106],

1	62	CD	NUMBER	62	_	0	SENT_703	[p19l489t3310r595b3374],
2	.	.	O	.	_	0	SENT_703	[p19l489t3310r595b3374],

1	Krynetski	NNP	PERSON	Krynetski	nn	2	SENT_704	[p19l644t3310r1001b3392],
2	EY	NNP	PERSON	EY	_	0	SENT_704	[p19l1046t3311r1186b3386],
3	,	,	O	,	_	0	SENT_704	[p19l1046t3311r1186b3386],
4	Schuetz	NNP	PERSON	Schuetz	nn	5	SENT_704	[p19l1237t3310r1521b3374],
5	JD	NNP	O	JD	appos	2	SENT_704	[p19l1567t3311r1687b3385],
6	,	,	O	,	_	0	SENT_704	[p19l1567t3311r1687b3385],
7	Galpin	NNP	PERSON	Galpin	nn	8	SENT_704	[p19l1737t3310r1982b3392],
8	AJ	NNP	PERSON	AJ	appos	2	SENT_704	[p19l2027t3310r2147b3385],
9	,	,	O	,	_	0	SENT_704	[p19l2027t3310r2147b3385],
10	et	FW	O	et	nn	11	SENT_704	[p19l643t3430r708b3484],
11	al.	FW	O	al.	appos	2	SENT_704	[p19l769t3420r849b3484],
12	1995	CD	DATE	1995	dep	11	SENT_704	[p19l923t3420r1113b3485],
13	.	.	O	.	_	0	SENT_704	[p19l923t3420r1113b3485],

1	A	DT	O	a	det	4	SENT_705	[p19l1178t3421r1243b3483],
2	single	JJ	O	single	amod	4	SENT_705	[p19l1306t3420r1519b3503],
3	point	NN	O	point	nn	4	SENT_705	[p19l1579t3420r1768b3503],
4	mutation	NN	O	mutation	_	0	SENT_705	[p19l1826t3420r2150b3484],
5	leading	VBG	O	lead	partmod	4	SENT_705	[p19l642t3531r909b3613],
6	to	TO	O	to	_	0	SENT_705	[p19l961t3541r1029b3595],
7	loss	NN	O	loss	prep_to	5	SENT_705	[p19l1082t3531r1220b3595],
8	of	IN	O	of	_	0	SENT_705	[p19l1275t3531r1354b3595],
9	catalytic	JJ	O	catalytic	amod	10	SENT_705	[p19l1400t3531r1705b3613],
10	activity	NN	O	activity	prep_of	7	SENT_705	[p19l1761t3531r2029b3613],
11	in	IN	O	in	_	0	SENT_705	[p19l2081t3531r2150b3594],
12	human	JJ	O	human	amod	16	SENT_705	[p19l641t3641r890b3705],
13	thiopurine	NN	O	thiopurine	nn	16	SENT_705	[p19l956t3641r1330b3723],
14	S	NN	O	s	nn	16	SENT_705	[p19l1399t3641r2145b3723],
15	—	CD	NUMBER	—	num	16	SENT_705	[p19l1399t3641r2145b3723],
16	methyltransferase	NN	O	methyltransferase	prep_in	10	SENT_705	[p19l1399t3641r2145b3723],
17	.	.	O	.	_	0	SENT_705	[p19l1399t3641r2145b3723],

1	Annu	NNP	PERSON	Annu	_	0	SENT_706	[p20l7t3298r63b3494],
2	.	.	O	.	_	0	SENT_706	[p20l7t3298r63b3494],

1	Rev.	NNP	O	Rev.	nn	2	SENT_707	[p20l7t3125r63b3271],
2	Med	NNP	O	Med	_	0	SENT_707	[p20l6t2935r63b3099],
3	.	.	O	.	_	0	SENT_707	[p20l6t2935r63b3099],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_708	[p20l6t2628r64b2907],
2	:	:	O	:	_	0	SENT_708	[p20l6t2628r64b2907],
3	1	CD	NUMBER	1	num	4	SENT_708	[p20l6t2588r62b2612],
4	19	CD	NUMBER	19	dep	1	SENT_708	[p20l6t2474r64b2571],
5	-	:	O	-	_	0	SENT_708	[p20l6t2474r64b2571],
6	137	CD	NUMBER	137	dep	4	SENT_708	[p20l6t2332r64b2461],
7	.	.	O	.	_	0	SENT_708	[p20l6t2332r64b2461],

1	Downloaded	VBN	O	download	_	0	SENT_709	[p20l6t1889r63b2306],
2	from	IN	O	from	_	0	SENT_709	[p20l6t1710r63b1867],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_709	[p20l6t893r80b1687],
4	by	IN	O	by	_	0	SENT_709	[p20l87t3330r162b3410],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_709	[p20l87t2966r162b3307],
6	of	IN	ORGANIZATION	of	_	0	SENT_709	[p20l87t2871r145b2941],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_709	[p20l88t2510r145b2855],
8	—	NNP	O	—	nn	9	SENT_709	[p20l122t2465r128b2486],
9	Madison	NNP	O	Madison	prep_of	5	SENT_709	[p20l88t2156r145b2440],
10	on	IN	O	on	_	0	SENT_709	[p20l105t2054r145b2132],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_709	[p20l87t1726r145b2031],
12	.	.	O	.	_	0	SENT_709	[p20l87t1726r145b2031],

1	For	IN	O	for	_	0	SENT_710	[p20l89t1586r145b1700],
2	personal	JJ	O	personal	amod	3	SENT_710	[p20l88t1291r162b1566],
3	use	NN	O	use	pobj	1	SENT_710	[p20l105t1162r145b1269],
4	only	RB	O	only	advmod	3	SENT_710	[p20l88t980r162b1138],
5	.	.	O	.	_	0	SENT_710	[p20l88t980r162b1138],

1	Proc	NNP	O	Proc	_	0	SENT_711	[p20l641t24r828b85],
2	.	.	O	.	_	0	SENT_711	[p20l641t24r828b85],

1	Natl.	NNP	O	Natl.	nn	2	SENT_712	[p20l859t21r1032b86],
2	Acad	NNP	O	Acad	_	0	SENT_712	[p20l1060t21r1266b86],
3	.	.	O	.	_	0	SENT_712	[p20l1060t21r1266b86],

1	Sci	NNP	O	Sci	_	0	SENT_713	[p20l1300t22r1424b86],
2	.	.	O	.	_	0	SENT_713	[p20l1300t22r1424b86],

1	USA	NNP	LOCATION	USA	nn	3	SENT_714	[p20l1466t22r1621b86],
2	923949-53	CD	NUMBER	923949-53	num	3	SENT_714	[p20l1650t21r2034b86],
3	Tai	NNP	O	Tai	nsubj	4	SENT_714	[p20l642t132r754b196],
4	H	NN	O	h	_	0	SENT_714	[p20l788t134r958b208],
5	.	.	O	.	_	0	SENT_714	[p20l788t134r958b208],

1	—	NN	O	—	_	0	SENT_715	[p20l788t134r958b208],
2	.	.	O	.	_	0	SENT_715	[p20l788t134r958b208],

1	L	NN	O	l	_	0	SENT_716	[p20l788t134r958b208],
2	,	,	O	,	_	0	SENT_716	[p20l788t134r958b208],
3	Krynetski	NNP	PERSON	Krynetski	nn	4	SENT_716	[p20l995t132r1352b215],
4	EY	NNP	PERSON	EY	appos	1	SENT_716	[p20l1385t134r1525b208],
5	,	,	O	,	_	0	SENT_716	[p20l1385t134r1525b208],
6	Yates	NNP	PERSON	Yates	nn	7	SENT_716	[p20l1562t134r1756b196],
7	CR	NN	O	cr	appos	1	SENT_716	[p20l1792t133r1930b208],
8	,	,	O	,	_	0	SENT_716	[p20l1792t133r1930b208],
9	et	FW	O	et	nn	10	SENT_716	[p20l1967t142r2032b196],
10	al.	FW	O	al.	appos	1	SENT_716	[p20l2065t133r2145b196],
11	1996	CD	DATE	1996	dep	10	SENT_716	[p20l651t243r842b308],
12	.	.	O	.	_	0	SENT_716	[p20l651t243r842b308],

1	Thiopurine	NN	O	thiopurine	nn	2	SENT_717	[p20l931t243r1335b325],
2	S	NN	O	s	_	0	SENT_717	[p20l1422t243r2149b325],
3	—	CD	NUMBER	—	num	5	SENT_717	[p20l1422t243r2149b325],
4	methyltransferase	NN	O	methyltransferase	nn	5	SENT_717	[p20l1422t243r2149b325],
5	deﬁciency	NN	O	deﬁciency	dep	2	SENT_717	[p20l644t353r1034b436],
6	:	:	O	:	_	0	SENT_717	[p20l644t353r1034b436],
7	Two	CD	NUMBER	two	num	9	SENT_717	[p20l1105t355r1261b417],
8	nucleotide	NN	O	nucleotide	nn	9	SENT_717	[p20l1327t353r1705b417],
9	transitions	NNS	O	transition	dep	2	SENT_717	[p20l1770t353r2148b417],
10	deﬁne	VBP	O	deﬁne	rcmod	9	SENT_717	[p20l644t463r864b527],
11	the	DT	O	the	det	15	SENT_717	[p20l883t464r992b527],
12	most	RBS	O	most	advmod	13	SENT_717	[p20l1012t473r1189b527],
13	prevalent	JJ	O	prevalent	amod	15	SENT_717	[p20l1205t463r1542b546],
14	mutant	JJ	O	mutant	amod	15	SENT_717	[p20l1559t473r1813b527],
15	allele	NN	O	allele	dobj	10	SENT_717	[p20l1832t463r2026b527],
16	associated	VBN	O	associate	partmod	15	SENT_717	[p20l2047t484r2147b527, p20l645t574r941b638],
17	with	IN	O	with	_	0	SENT_717	[p20l972t574r1133b638],
18	loss	NN	O	loss	prep_with	16	SENT_717	[p20l1164t574r1302b638],
19	of	IN	O	of	_	0	SENT_717	[p20l1336t574r1415b638],
20	catalytic	JJ	O	catalytic	amod	21	SENT_717	[p20l1441t574r1747b656],
21	activity	NN	O	activity	prep_of	18	SENT_717	[p20l1781t574r2049b656],
22	in	IN	O	in	_	0	SENT_717	[p20l2081t574r2150b637],
23	Caucasians	NNPS	MISC	Caucasians	prep_in	21	SENT_717	[p20l644t684r1071b749],
24	.	.	O	.	_	0	SENT_717	[p20l644t684r1071b749],

1	Am	NNP	O	Am	_	0	SENT_718	[p20l1096t685r1237b748],
2	.	.	O	.	_	0	SENT_718	[p20l1096t685r1237b748],

1	J.	NNP	O	J.	nn	2	SENT_719	[p20l1271t687r1323b749],
2	Hum	NNP	O	Hum	_	0	SENT_719	[p20l1357t687r1549b748],
3	.	.	O	.	_	0	SENT_719	[p20l1357t687r1549b748],

1	Genet	NNP	PERSON	Genet	_	0	SENT_720	[p20l1588t686r1816b749],
2	.	.	O	.	_	0	SENT_720	[p20l1588t686r1816b749],

1	58:694702	CD	NUMBER	58:694702	num	3	SENT_721	[p20l1853t684r2152b749, p20l643t796r777b860],
2	Schaeffeler	NN	O	schaeffeler	nn	3	SENT_721	[p20l645t907r1057b971],
3	E	NN	O	e	_	0	SENT_721	[p20l1115t909r1188b982],
4	,	,	O	,	_	0	SENT_721	[p20l1115t909r1188b982],
5	Fischer	NNP	PERSON	Fischer	nn	6	SENT_721	[p20l1251t907r1520b971],
6	C	NNP	O	C	appos	3	SENT_721	[p20l1579t908r1656b983],
7	,	,	O	,	_	0	SENT_721	[p20l1579t908r1656b983],
8	Brockmeier	NNP	PERSON	Brockmeier	nn	9	SENT_721	[p20l1719t907r2152b971],
9	D	NNP	O	D	appos	3	SENT_721	[p20l642t1020r726b1095],
10	,	,	O	,	_	0	SENT_721	[p20l642t1020r726b1095],
11	et	FW	O	et	nn	12	SENT_721	[p20l793t1029r857b1083],
12	al.	FW	O	al.	appos	3	SENT_721	[p20l921t1019r1001b1083],
13	2004	CD	DATE	2004	dep	12	SENT_721	[p20l1071t1019r1268b1083],
14	.	.	O	.	_	0	SENT_721	[p20l1071t1019r1268b1083],

1	Comprehensive	JJ	O	comprehensive	amod	2	SENT_722	[p20l1337t1019r1905b1102],
2	analysis	NN	O	analysis	nsubj	8	SENT_722	[p20l1971t1019r2147b1083, p20l642t1131r780b1214],
3	of	IN	O	of	_	0	SENT_722	[p20l846t1131r926b1195],
4	thiopurine	NN	O	thiopurine	nn	5	SENT_722	[p20l982t1131r1356b1214],
5	S	NN	O	s	prep_of	2	SENT_722	[p20l1422t1131r2149b1214],
6	—	CD	NUMBER	—	num	8	SENT_722	[p20l1422t1131r2149b1214],
7	methyltransferase	NN	O	methyltransferase	nn	8	SENT_722	[p20l1422t1131r2149b1214],
8	phenotype	NN	O	phenotype	_	0	SENT_722	[p20l641t1243r1050b1326],
9	—	CD	NUMBER	—	num	11	SENT_722	[p20l641t1243r1050b1326],
10	genotype	NN	O	genotype	nn	11	SENT_722	[p20l1056t1253r1388b1326],
11	correlation	NN	O	correlation	dobj	8	SENT_722	[p20l1409t1243r1803b1307],
12	in	IN	O	in	_	0	SENT_722	[p20l1823t1243r1893b1306],
13	a	DT	O	a	det	15	SENT_722	[p20l1914t1263r1952b1307],
14	large	JJ	O	large	amod	15	SENT_722	[p20l1971t1243r2149b1326],
15	population	NN	O	population	prep_in	11	SENT_722	[p20l641t1355r1033b1438],
16	of	IN	O	of	_	0	SENT_722	[p20l1093t1355r1172b1419],
17	German	JJ	MISC	german	prep_of	8	SENT_722	[p20l1226t1355r1958b1419],
18	.	.	O	.	_	0	SENT_722	[p20l1226t1355r1958b1419],

1	—	NN	O	—	_	0	SENT_723	[p20l1226t1355r1958b1419],
2	.	.	O	.	_	0	SENT_723	[p20l1226t1355r1958b1419],

1	Caucasians	NNPS	MISC	Caucasians	_	0	SENT_724	[p20l1226t1355r1958b1419],
2	and	CC	O	and	_	0	SENT_724	[p20l2022t1355r2150b1419],
3	identiﬁcation	NN	O	identiﬁcation	conj_and	1	SENT_724	[p20l643t1467r1124b1531],
4	of	IN	O	of	_	0	SENT_724	[p20l1176t1466r1255b1531],
5	novel	JJ	O	novel	amod	7	SENT_724	[p20l1299t1467r1498b1531],
6	TPMT	NN	O	tpmt	nn	7	SENT_724	[p20l1549t1469r1791b1530],
7	variants	NNS	O	variant	prep_of	3	SENT_724	[p20l1841t1467r2145b1531],
8	.	.	O	.	_	0	SENT_724	[p20l1841t1467r2145b1531],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_725	[p20l641t1579r1320b1660],
2	14:407	CD	NUMBER	14:407	num	6	SENT_725	[p20l1354t1579r1732b1643],
3	—	CD	NUMBER	—	num	6	SENT_725	[p20l1354t1579r1732b1643],
4	17	CD	NUMBER	17	num	6	SENT_725	[p20l1354t1579r1732b1643],
5	Relling	NNP	ORGANIZATION	Relling	nn	6	SENT_725	[p20l642t1691r909b1774],
6	MV	NNP	ORGANIZATION	MV	dep	1	SENT_725	[p20l952t1692r1117b1766],
7	,	,	O	,	_	0	SENT_725	[p20l952t1692r1117b1766],
8	Hancock	NNP	PERSON	Hancock	nn	9	SENT_725	[p20l1163t1691r1488b1755],
9	ML	NNP	O	ML	appos	6	SENT_725	[p20l1528t1692r1683b1767],
10	,	,	O	,	_	0	SENT_725	[p20l1528t1692r1683b1767],
11	Boyett	NNP	PERSON	Boyett	nn	12	SENT_725	[p20l1729t1692r1971b1774],
12	JM	NN	O	jm	appos	6	SENT_725	[p20l2012t1692r2147b1767],
13	,	,	O	,	_	0	SENT_725	[p20l2012t1692r2147b1767],
14	et	FW	O	et	nn	15	SENT_725	[p20l643t1813r708b1867],
15	al.	FW	O	al.	appos	6	SENT_725	[p20l742t1803r822b1867],
16	1999	CD	DATE	1999	dep	15	SENT_725	[p20l870t1803r1060b1868],
17	.	.	O	.	_	0	SENT_725	[p20l870t1803r1060b1868],

1	Prognostic	JJ	O	prognostic	amod	2	SENT_726	[p20l1099t1803r1488b1886],
2	importance	NN	O	importance	_	0	SENT_726	[p20l1523t1803r1933b1886],
3	of	IN	O	of	_	0	SENT_726	[p20l1969t1803r2048b1867],
4	6mercaptopurine	JJ	O	6mercaptopurine	amod	6	SENT_726	[p20l2078t1802r2147b1867, p20l642t1915r1215b1998],
5	dose	NN	O	dose	nn	6	SENT_726	[p20l1266t1915r1429b1979],
6	intensity	NN	O	intensity	prep_of	2	SENT_726	[p20l1479t1915r1791b1998],
7	in	IN	O	in	_	0	SENT_726	[p20l1841t1915r1910b1978],
8	acute	JJ	O	acute	amod	10	SENT_726	[p20l1961t1925r2149b1979],
9	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_726	[p20l643t2027r1158b2110],
10	leukemia	NN	O	leukemia	prep_in	2	SENT_726	[p20l1185t2027r1535b2091],
11	.	.	O	.	_	0	SENT_726	[p20l1185t2027r1535b2091],

1	Blood	NN	O	blood	nn	4	SENT_727	[p20l1562t2027r1785b2091],
2	932281723	CD	NUMBER	932281723	num	4	SENT_727	[p20l1807t2027r2152b2092, p20l644t2139r727b2203],
3	Stanulla	NN	O	stanullum	nn	4	SENT_727	[p20l645t2251r942b2315],
4	M	NN	O	m	_	0	SENT_727	[p20l1009t2252r1108b2326],
5	,	,	O	,	_	0	SENT_727	[p20l1009t2252r1108b2326],
6	Schaeffeler	NN	O	schaeffeler	nn	7	SENT_727	[p20l1183t2251r1595b2315],
7	E	NN	O	e	appos	4	SENT_727	[p20l1662t2252r1736b2326],
8	,	,	O	,	_	0	SENT_727	[p20l1662t2252r1736b2326],
9	Flohr	NNP	ORGANIZATION	Flohr	nn	10	SENT_727	[p20l1808t2251r2006b2315],
10	T	NN	ORGANIZATION	t	appos	4	SENT_727	[p20l2073t2252r2147b2326],
11	,	,	O	,	_	0	SENT_727	[p20l2073t2252r2147b2326],
12	et	FW	O	et	nn	13	SENT_727	[p20l643t2373r708b2427],
13	al.	FW	O	al.	appos	4	SENT_727	[p20l733t2363r813b2427],
14	2005	CD	DATE	2005	dep	13	SENT_727	[p20l844t2363r1042b2427],
15	.	.	O	.	_	0	SENT_727	[p20l844t2363r1042b2427],

1	T	NN	O	t	nn	3	SENT_728	[p20l1071t2365r1125b2426],
2	hiopurine	NN	O	hiopurine	nn	3	SENT_728	[p20l1127t2363r1476b2446],
3	methyltransferase	NN	O	methyltransferase	nsubj	5	SENT_728	[p20l1501t2363r2149b2446],
4	(	CD	NUMBER	(	num	5	SENT_728	[p20l645t2476r942b2555],
5	TPMT	NN	O	tpmt	_	0	SENT_728	[p20l645t2476r942b2555],
6	)	CD	NUMBER	)	num	7	SENT_728	[p20l645t2476r942b2555],
7	genotype	NN	O	genotype	dobj	5	SENT_728	[p20l970t2485r1302b2559],
8	and	CC	O	and	_	0	SENT_728	[p20l1328t2475r1456b2539],
9	early	JJ	O	early	amod	11	SENT_728	[p20l1480t2475r1660b2559],
10	treatment	NN	O	treatment	nn	11	SENT_728	[p20l1683t2485r2028b2539],
11	response	NN	O	response	dobj	5	SENT_728	[p20l2050t2496r2147b2539, p20l645t2608r889b2671],
12	to	TO	O	to	_	0	SENT_728	[p20l936t2598r1004b2652],
13	mercaptopurine	NN	O	mercaptopurine	prep_to	5	SENT_728	[p20l1051t2588r1624b2671],
14	in	IN	O	in	_	0	SENT_728	[p20l1671t2588r1739b2651],
15	childhood	NN	O	childhood	nn	18	SENT_728	[p20l1787t2588r2150b2652],
16	acute	JJ	O	acute	amod	18	SENT_728	[p20l644t2710r833b2764],
17	lymphoblastic	JJ	O	lymphoblastic	amod	18	SENT_728	[p20l907t2700r1423b2783],
18	leukemia	NN	O	leukemia	prep_in	13	SENT_728	[p20l1498t2700r1849b2764],
19	.	.	O	.	_	0	SENT_728	[p20l1498t2700r1849b2764],

1	JAMA	NN	O	jama	nn	6	SENT_729	[p20l1925t2701r2147b2765],
2	293:1485	CD	NUMBER	293:1485	num	6	SENT_729	[p20l644t2811r1121b2876],
3	—	CD	NUMBER	—	num	6	SENT_729	[p20l644t2811r1121b2876],
4	89	CD	NUMBER	89	num	6	SENT_729	[p20l644t2811r1121b2876],
5	Rocha	NNP	ORGANIZATION	Rocha	nn	6	SENT_729	[p20l643t2924r876b2988],
6	JC	NNP	ORGANIZATION	JC	_	0	SENT_729	[p20l905t2924r1020b2999],
7	,	,	O	,	_	0	SENT_729	[p20l905t2924r1020b2999],
8	Cheng	NNP	PERSON	Cheng	nn	9	SENT_729	[p20l1056t2924r1291b3006],
9	C	NNP	PERSON	C	appos	6	SENT_729	[p20l1325t2924r1402b2999],
10	,	,	O	,	_	0	SENT_729	[p20l1325t2924r1402b2999],
11	Liu	NNP	O	Liu	nn	12	SENT_729	[p20l1436t2924r1562b2988],
12	W	NNP	O	W	appos	6	SENT_729	[p20l1592t2925r1697b2999],
13	,	,	O	,	_	0	SENT_729	[p20l1592t2925r1697b2999],
14	et	FW	O	et	nn	15	SENT_729	[p20l1733t2933r1797b2988],
15	al.	FW	O	al.	appos	6	SENT_729	[p20l1830t2924r1910b2988],
16	2005	CD	DATE	2005	dep	15	SENT_729	[p20l1948t2923r2145b2988],
17	.	.	O	.	_	0	SENT_729	[p20l1948t2923r2145b2988],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_730	[p20l642t3035r1305b3118],
2	of	IN	O	of	_	0	SENT_730	[p20l1331t3035r1409b3099],
3	outcome	NN	O	outcome	prep_of	1	SENT_730	[p20l1426t3045r1738b3099],
4	in	IN	O	in	_	0	SENT_730	[p20l1761t3035r1830b3098],
5	children	NNS	O	child	prep_in	1	SENT_730	[p20l1853t3035r2150b3099],
6	with	IN	O	with	_	0	SENT_730	[p20l643t3146r804b3211],
7	acute	JJ	O	acute	amod	9	SENT_730	[p20l822t3156r1010b3211],
8	lymphoblastic	JJ	O	lymphoblastic	amod	9	SENT_730	[p20l1028t3146r1543b3230],
9	leukemia	NN	O	leukemia	prep_with	5	SENT_730	[p20l1561t3146r1912b3211],
10	.	.	O	.	_	0	SENT_730	[p20l1561t3146r1912b3211],

1	Blood	NN	O	blood	advmod	3	SENT_731	[p20l1931t3146r2154b3211],
2	105:4752	CD	NUMBER	105:4752	number	3	SENT_731	[p20l651t3258r1120b3323],
3	—	CD	NUMBER	—	_	0	SENT_731	[p20l651t3258r1120b3323],
4	58	CD	NUMBER	58	num	6	SENT_731	[p20l651t3258r1120b3323],
5	Ando	NNP	O	Ando	nn	6	SENT_731	[p20l642t3371r843b3435],
6	Y	NN	O	y	dep	3	SENT_731	[p20l882t3372r964b3447],
7	,	,	O	,	_	0	SENT_731	[p20l882t3372r964b3447],
8	Saka	FW	LOCATION	saka	dep	3	SENT_731	[p20l1008t3371r1183b3435],
9	H	NN	O	h	dep	3	SENT_731	[p20l1219t3372r1302b3446],
10	,	,	O	,	_	0	SENT_731	[p20l1219t3372r1302b3446],
11	Ando	NNP	PERSON	Ando	nn	12	SENT_731	[p20l1343t3371r1542b3435],
12	M	NNP	O	M	appos	9	SENT_731	[p20l1581t3372r1680b3446],
13	,	,	O	,	_	0	SENT_731	[p20l1581t3372r1680b3446],
14	et	FW	O	et	nn	15	SENT_731	[p20l1721t3381r1786b3435],
15	al.	FW	O	al.	appos	3	SENT_731	[p20l1824t3371r1904b3435],
16	2000	CD	DATE	2000	dep	15	SENT_731	[p20l1948t3371r2145b3435],
17	.	.	O	.	_	0	SENT_731	[p20l1948t3371r2145b3435],

1	Polymorphisms	NNS	O	polymorphism	dep	8	SENT_732	[p20l642t3483r1213b3566],
2	of	IN	O	of	_	0	SENT_732	[p20l1287t3483r1365b3547],
3	UDP	NNP	O	UDP	prep_of	1	SENT_732	[p20l1429t3483r2147b3566],
4	—	CD	NUMBER	—	num	5	SENT_732	[p20l1429t3483r2147b3566],
5	glucuronosyl	NN	O	glucuronosyl	dep	8	SENT_732	[p20l1429t3483r2147b3566],
6	—	NN	O	—	nn	8	SENT_732	[p20l1429t3483r2147b3566],
7	transferase	NN	O	transferase	nn	8	SENT_732	[p20l642t3595r1037b3659],
8	gene	NN	O	gene	dep	15	SENT_732	[p20l1074t3615r1244b3677],
9	and	CC	O	and	_	0	SENT_732	[p20l1282t3595r1411b3659],
10	irinotecan	NN	O	irinotecan	nn	11	SENT_732	[p20l1446t3595r1811b3659],
11	toxicity	NN	O	toxicity	conj_and	8	SENT_732	[p20l1847t3595r2143b3677],
12	:	:	O	:	_	0	SENT_732	[p20l1847t3595r2143b3677],
13	a	DT	O	a	det	15	SENT_732	[p20l644t3725r682b3769],
14	pharmacogenetic	JJ	O	pharmacogenetic	amod	15	SENT_732	[p20l707t3705r1330b3787],
15	analysis	NN	O	analysis	_	0	SENT_732	[p20l1361t3705r1670b3787],
16	.	.	O	.	_	0	SENT_732	[p20l1361t3705r1670b3787],

1	Cancer	NN	O	cancer	_	0	SENT_733	[p20l1706t3706r1973b3769],
2	Res	NNP	O	Res	dep	1	SENT_733	[p20l1994t3707r2145b3769],
3	.	.	O	.	_	0	SENT_733	[p20l1994t3707r2145b3769],

1	60:6921	CD	NUMBER	60:6921	num	5	SENT_734	[p21l644t20r1077b85],
2	—	CD	NUMBER	—	num	5	SENT_734	[p21l644t20r1077b85],
3	26	CD	NUMBER	26	num	5	SENT_734	[p21l644t20r1077b85],
4	Iyer	NNP	O	Iyer	nn	5	SENT_734	[p21l642t133r789b214],
5	L	NNP	O	L	_	0	SENT_734	[p21l847t133r920b207],
6	,	,	O	,	_	0	SENT_734	[p21l847t133r920b207],
7	Hall	NNP	ORGANIZATION	Hall	nn	8	SENT_734	[p21l984t131r1138b195],
8	D	NNP	ORGANIZATION	D	appos	5	SENT_734	[p21l1199t133r1282b207],
9	,	,	O	,	_	0	SENT_734	[p21l1199t133r1282b207],
10	Das	NNP	LOCATION	Das	nn	11	SENT_734	[p21l1345t133r1483b195],
11	S	NNP	LOCATION	S	appos	5	SENT_734	[p21l1548t132r1613b207],
12	,	,	O	,	_	0	SENT_734	[p21l1548t132r1613b207],
13	et	FW	O	et	nn	14	SENT_734	[p21l1677t141r1741b195],
14	al.	FW	O	al.	appos	5	SENT_734	[p21l1802t131r1882b195],
15	1999	CD	DATE	1999	dep	14	SENT_734	[p21l1955t132r2145b196],
16	.	.	O	.	_	0	SENT_734	[p21l1955t132r2145b196],

1	Phenotype	NN	O	phenotype	nn	4	SENT_735	[p21l642t242r1393b324],
2	—	CD	NUMBER	—	num	4	SENT_735	[p21l642t242r1393b324],
3	genotype	NN	O	genotype	nn	4	SENT_735	[p21l642t242r1393b324],
4	correlation	NN	O	correlation	_	0	SENT_735	[p21l1467t242r1862b306],
5	of	IN	O	of	prep	4	SENT_735	[p21l1935t242r2014b306],
6	in	FW	O	in	nn	7	SENT_735	[p21l2081t242r2150b304],
7	vitro	FW	O	vitro	dep	8	SENT_735	[p21l643t352r812b416],
8	SN-38	NN	O	sn-38	dep	11	SENT_735	[p21l842t353r1072b417],
9	(	CD	NUMBER	(	num	8	SENT_735	[p21l1105t352r1345b432],
10	active	JJ	O	active	amod	11	SENT_735	[p21l1105t352r1345b432],
11	metabolite	NN	O	metabolite	dep	5	SENT_735	[p21l1372t352r1756b416],
12	of	IN	O	of	_	0	SENT_735	[p21l1783t352r1862b416],
13	irinotecan	JJ	O	irinotecan	amod	14	SENT_735	[p21l1883t352r2147b416, p21l643t464r795b542],
14	)	NN	O	)	prep_of	11	SENT_735	[p21l1883t352r2147b416, p21l643t464r795b542],
15	and	CC	O	and	_	0	SENT_735	[p21l828t464r957b527],
16	bilirubin	NN	O	bilirubin	nn	17	SENT_735	[p21l983t463r1298b527],
17	glucuronidation	NN	O	glucuronidation	prep_of	11	SENT_735	[p21l1327t463r1905b546],
18	in	IN	O	in	_	0	SENT_735	[p21l1933t463r2002b527],
19	human	JJ	O	human	amod	21	SENT_735	[p21l2029t464r2147b527, p21l642t594r798b638],
20	liver	NN	O	liver	nn	21	SENT_735	[p21l828t574r991b638],
21	tissue	NN	O	tissue	prep_in	14	SENT_735	[p21l1018t574r1224b638],
22	with	IN	O	with	_	0	SENT_735	[p21l1254t574r1415b638],
23	UGTlAl	NN	O	ugtlal	nn	25	SENT_735	[p21l1443t574r1779b638],
24	promoter	NN	O	promoter	nn	25	SENT_735	[p21l1815t584r2152b656],
25	polymorphism	NN	O	polymorphism	prep_with	4	SENT_735	[p21l641t684r1193b767],
26	.	.	O	.	_	0	SENT_735	[p21l641t684r1193b767],

1	Clin	NNP	O	Clin	_	0	SENT_736	[p21l1250t684r1415b749],
2	.	.	O	.	_	0	SENT_736	[p21l1250t684r1415b749],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_737	[p21l1474t684r1895b748],
2	.	.	O	.	_	0	SENT_737	[p21l1474t684r1895b748],

1	Ther	NNP	O	Ther	_	0	SENT_738	[p21l1960t684r2145b748],
2	.	.	O	.	_	0	SENT_738	[p21l1960t684r2145b748],

1	65:576	CD	NUMBER	65:576	num	5	SENT_739	[p21l644t794r1031b859],
2	—	CD	NUMBER	—	num	5	SENT_739	[p21l644t794r1031b859],
3	82	CD	NUMBER	82	num	5	SENT_739	[p21l644t794r1031b859],
4	Fisher	NNP	O	Fisher	nn	5	SENT_739	[p21l642t906r871b970],
5	MB	NNP	O	MB	_	0	SENT_739	[p21l895t907r1055b982],
6	,	,	O	,	_	0	SENT_739	[p21l895t907r1055b982],
7	Vandenbranden	NNP	O	Vandenbranden	nn	8	SENT_739	[p21l1084t906r1652b970],
8	M	NNP	O	M	appos	5	SENT_739	[p21l1678t907r1777b981],
9	,	,	O	,	_	0	SENT_739	[p21l1678t907r1777b981],
10	Finley	NNP	PERSON	Finley	nn	11	SENT_739	[p21l1806t906r2036b988],
11	K	NNP	PERSON	K	appos	5	SENT_739	[p21l2064t907r2147b981],
12	,	,	O	,	_	0	SENT_739	[p21l2064t907r2147b981],
13	et	FW	O	et	nn	14	SENT_739	[p21l643t1026r708b1080],
14	al.	FW	O	al.	appos	5	SENT_739	[p21l753t1016r833b1080],
15	2000	CD	DATE	2000	dep	14	SENT_739	[p21l884t1016r1082b1080],
16	.	.	O	.	_	0	SENT_739	[p21l884t1016r1082b1080],

1	Tissue	NN	O	tissue	_	0	SENT_740	[p21l1133t1016r1366b1080],
2	distribution	NN	O	distribution	dep	1	SENT_740	[p21l1413t1016r1830b1080],
3	and	CC	O	and	_	0	SENT_740	[p21l1877t1016r2006b1080],
4	in69	NN	O	in69	dep	1	SENT_740	[p21l2051t1016r2147b1079, p21l489t131r595b196],
5	.	.	O	.	_	0	SENT_740	[p21l2051t1016r2147b1079, p21l489t131r595b196],

1	terindividual	JJ	O	terindividual	amod	2	SENT_741	[p21l205t1316r802b1398],
2	variation	NN	O	variation	_	0	SENT_741	[p21l865t1316r1279b1398],
3	in	IN	O	in	_	0	SENT_741	[p21l1341t1316r1430b1397],
4	human	JJ	O	human	amod	8	SENT_741	[p21l1491t1316r1811b1398],
5	UDP	NN	O	udp	nn	8	SENT_741	[p21l1873t1318r2142b1398],
6	—	NN	O	—	nn	8	SENT_741	[p21l1873t1318r2142b1398],
7	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	8	SENT_741	[p21l206t1458r1328b1565],
8	activity	NN	O	activity	prep_in	2	SENT_741	[p21l1351t1458r1721b1565],
9	:	:	O	:	_	0	SENT_741	[p21l1351t1458r1721b1565],
10	relationship	NN	O	relationship	dep	2	SENT_741	[p21l1747t1458r2142b1540, p21l209t1601r397b1708],
11	between	IN	O	between	_	0	SENT_741	[p21l452t1601r844b1684],
12	UGT1Al	NN	O	ugt1al	nn	14	SENT_741	[p21l898t1602r1330b1684],
13	promoter	NN	O	promoter	nn	14	SENT_741	[p21l1394t1614r1827b1708],
14	genotype	NN	O	genotype	prep_between	10	SENT_741	[p21l1881t1628r2142b1708, p21l205t1758r405b1852],
15	and	CC	O	and	_	0	SENT_741	[p21l489t1746r655b1828],
16	variability	NN	O	variability	conj_and	10	SENT_741	[p21l737t1746r1214b1852],
17	in	IN	O	in	_	0	SENT_741	[p21l1297t1746r1386b1827],
18	a	DT	O	a	det	20	SENT_741	[p21l1471t1771r1519b1828],
19	liver	NN	O	liver	nn	20	SENT_741	[p21l1599t1746r1809b1828],
20	bank	NN	O	bank	prep_in	16	SENT_741	[p21l1888t1746r2139b1828],
21	.	.	O	.	_	0	SENT_741	[p21l1888t1746r2139b1828],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	2	SENT_742	[p21l203t1890r1077b1996],
2	l0	VBP	O	l0	_	0	SENT_742	[p21l1122t1890r1609b1974],
3	:727	CD	NUMBER	:727	number	4	SENT_742	[p21l1122t1890r1609b1974],
4	—	CD	NUMBER	—	dobj	2	SENT_742	[p21l1122t1890r1609b1974],
5	39	CD	NUMBER	39	num	7	SENT_742	[p21l1122t1890r1609b1974],
6	Innocenti	NNP	O	Innocenti	nn	7	SENT_742	[p21l205t2032r647b2115],
7	F	NN	O	f	dep	4	SENT_742	[p21l699t2035r786b2130],
8	,	,	O	,	_	0	SENT_742	[p21l699t2035r786b2130],
9	Undevia	NNP	O	Undevia	nn	10	SENT_742	[p21l841t2032r1236b2115],
10	SD	NN	O	sd	appos	4	SENT_742	[p21l1289t2033r1458b2130],
11	,	,	O	,	_	0	SENT_742	[p21l1289t2033r1458b2130],
12	Iyer	NNP	PERSON	Iyer	nn	13	SENT_742	[p21l1514t2035r1703b2139],
13	L	NNP	PERSON	L	appos	10	SENT_742	[p21l1750t2035r1845b2130],
14	,	,	O	,	_	0	SENT_742	[p21l1750t2035r1845b2130],
15	et	FW	O	et	nn	16	SENT_742	[p21l1902t2045r1984b2114],
16	al.	FW	O	al.	appos	4	SENT_742	[p21l2036t2032r2139b2115],
17	2004	CD	DATE	2004	dep	16	SENT_742	[p21l206t2177r461b2259],
18	.	.	O	.	_	0	SENT_742	[p21l206t2177r461b2259],

1	Genetic	JJ	O	genetic	amod	2	SENT_743	[p21l558t2177r919b2259],
2	variants	NNS	O	variant	nsubj	10	SENT_743	[p21l1010t2177r1373b2259],
3	in	IN	O	in	_	0	SENT_743	[p21l1466t2177r1555b2258],
4	the	DT	O	the	det	9	SENT_743	[p21l1643t2177r1784b2259],
5	UDP	NNP	O	UDP	nn	9	SENT_743	[p21l1873t2179r2142b2259],
6	—	NN	O	—	nn	9	SENT_743	[p21l1873t2179r2142b2259],
7	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	9	SENT_743	[p21l206t2320r1328b2427],
8	1A1	NN	O	1a1	nn	9	SENT_743	[p21l1364t2320r1542b2401],
9	gene	NN	O	gene	prep_in	2	SENT_743	[p21l1578t2346r1796b2427],
10	predict	VBP	O	predict	_	0	SENT_743	[p21l1820t2320r2147b2427],
11	the	DT	O	the	det	12	SENT_743	[p21l205t2462r346b2544],
12	risk	NN	O	risk	nsubj	19	SENT_743	[p21l385t2462r563b2545],
13	of	IN	O	of	_	0	SENT_743	[p21l603t2462r704b2544],
14	severe	JJ	O	severe	amod	15	SENT_743	[p21l741t2489r1029b2545],
15	neutropenia	NN	O	neutropenia	prep_of	12	SENT_743	[p21l1071t2462r1626b2569],
16	of	IN	O	of	_	0	SENT_743	[p21l1667t2462r1768b2544],
17	irinote	JJ	O	irinote	amod	18	SENT_743	[p21l1801t2462r2142b2545],
18	—	NN	O	—	prep_of	15	SENT_743	[p21l1801t2462r2142b2545],
19	can	MD	O	can	ccomp	10	SENT_743	[p21l206t2633r390b2690],
20	.	.	O	.	_	0	SENT_743	[p21l206t2633r390b2690],

1	J.	NNP	PERSON	J.	nn	2	SENT_744	[p21l426t2610r492b2691],
2	Clin	NNP	PERSON	Clin	_	0	SENT_744	[p21l543t2607r755b2691],
3	.	.	O	.	_	0	SENT_744	[p21l543t2607r755b2691],

1	Oncol	NN	O	oncol	_	0	SENT_745	[p21l804t2607r1107b2691],
2	.	.	O	.	_	0	SENT_745	[p21l804t2607r1107b2691],

1	22:1382	CD	NUMBER	22:1382	num	5	SENT_746	[p21l1147t2607r1702b2690],
2	—	CD	NUMBER	—	num	5	SENT_746	[p21l1147t2607r1702b2690],
3	88	CD	NUMBER	88	num	5	SENT_746	[p21l1147t2607r1702b2690],
4	Humerickhouse	NNP	ORGANIZATION	Humerickhouse	nn	5	SENT_746	[p21l205t2751r949b2833],
5	R	NNP	ORGANIZATION	R	_	0	SENT_746	[p21l969t2753r1069b2849],
6	,	,	O	,	_	0	SENT_746	[p21l969t2753r1069b2849],
7	Lohrbach	NNP	LOCATION	Lohrbach	nn	8	SENT_746	[p21l1092t2751r1542b2833],
8	K	NNP	LOCATION	K	appos	5	SENT_746	[p21l1564t2754r1669b2849],
9	,	,	O	,	_	0	SENT_746	[p21l1564t2754r1669b2849],
10	Li	NNP	PERSON	Li	nn	11	SENT_746	[p21l1692t2751r1793b2832],
11	L	NNP	PERSON	L	appos	5	SENT_746	[p21l1813t2754r1908b2849],
12	,	,	O	,	_	0	SENT_746	[p21l1813t2754r1908b2849],
13	et	FW	O	et	nn	14	SENT_746	[p21l1933t2763r2016b2833],
14	al.	FW	O	al.	appos	5	SENT_746	[p21l2036t2751r2139b2833],
15	2000	CD	DATE	2000	dep	14	SENT_746	[p21l207t2894r461b2976],
16	.	.	O	.	_	0	SENT_746	[p21l207t2894r461b2976],

1	Characterization	NN	O	characterization	_	0	SENT_747	[p21l495t2893r1269b2976],
2	of	IN	O	of	_	0	SENT_747	[p21l1297t2893r1398b2975],
3	CPT	NNP	O	CPT	prep_of	1	SENT_747	[p21l1417t2894r1765b2976],
4	—	CD	NUMBER	—	num	3	SENT_747	[p21l1417t2894r1765b2976],
5	ll	NN	O	ll	nn	6	SENT_747	[p21l1417t2894r1765b2976],
6	hydrolysis	NN	O	hydrolysis	dep	1	SENT_747	[p21l1801t2893r2142b3000, p21l205t3038r383b3144],
7	by	IN	O	by	_	0	SENT_747	[p21l416t3038r532b3144],
8	human	JJ	O	human	amod	12	SENT_747	[p21l565t3038r884b3120],
9	liver	NN	O	liver	nn	12	SENT_747	[p21l915t3038r1126b3120],
10	carboxylesterase	NN	O	carboxylesterase	nn	12	SENT_747	[p21l1157t3038r1939b3144],
11	isoforms	NNS	O	isoform	nn	12	SENT_747	[p21l1971t3038r2142b3120, p21l205t3182r475b3265],
12	hCE-l	NN	O	hce-l	prep_by	6	SENT_747	[p21l539t3182r835b3265],
13	and	CC	O	and	_	0	SENT_747	[p21l910t3182r1077b3265],
14	hCE-2	NN	O	hce-2	conj_and	12	SENT_747	[p21l1138t3182r1466b3265],
15	.	.	O	.	_	0	SENT_747	[p21l1138t3182r1466b3265],

1	Cancer	NN	O	cancer	_	0	SENT_748	[p21l1542t3184r1885b3266],
2	Res	NNP	O	Res	dep	1	SENT_748	[p21l1945t3185r2139b3265],
3	.	.	O	.	_	0	SENT_748	[p21l1945t3185r2139b3265],

1	60:1	CD	NUMBER	60:1	_	0	SENT_749	[p21l208t3324r401b3408],
2	189-92	CD	NUMBER	189-92	num	4	SENT_749	[p21l426t3325r765b3408],
3	Khanna	NNP	PERSON	Khanna	nn	4	SENT_749	[p21l208t3469r571b3551],
4	R	NN	PERSON	r	dep	1	SENT_749	[p21l603t3470r704b3565],
5	,	,	O	,	_	0	SENT_749	[p21l603t3470r704b3565],
6	Morton	NNP	ORGANIZATION	Morton	nn	7	SENT_749	[p21l741t3470r1092b3551],
7	CL	NN	ORGANIZATION	cl	appos	4	SENT_749	[p21l1127t3469r1298b3565],
8	,	,	O	,	_	0	SENT_749	[p21l1127t3469r1298b3565],
9	Danks	NNP	PERSON	Danks	nn	10	SENT_749	[p21l1337t3469r1632b3551],
10	MK	NNP	O	MK	appos	4	SENT_749	[p21l1667t3470r1880b3565],
11	,	,	O	,	_	0	SENT_749	[p21l1667t3470r1880b3565],
12	et	FW	O	et	nn	13	SENT_749	[p21l1919t3480r2002b3551],
13	al.	FW	O	al.	appos	4	SENT_749	[p21l2036t3469r2139b3551],
14	2000	CD	DATE	2000	dep	13	SENT_749	[p21l206t3613r461b3695],
15	.	.	O	.	_	0	SENT_749	[p21l206t3613r461b3695],

1	Proﬁcient	JJ	O	proﬁcient	amod	2	SENT_750	[p21l495t3613r953b3695],
2	metabolism	NN	O	metabolism	_	0	SENT_750	[p21l978t3613r1528b3695],
3	of	IN	O	of	_	0	SENT_750	[p21l1555t3613r1657b3695],
4	irinotecan	NN	O	irinotecan	prep_of	2	SENT_750	[p21l1676t3613r2145b3695],
5	by	IN	O	by	_	0	SENT_750	[p22l203t37r319b144],
6	a	DT	O	a	det	9	SENT_750	[p22l377t64r425b119],
7	human	JJ	O	human	amod	9	SENT_750	[p22l476t37r796b119],
8	intestinal	JJ	O	intestinal	amod	9	SENT_750	[p22l849t37r1278b119],
9	carboxylesterase	NN	O	carboxylesterase	prep_by	2	SENT_750	[p22l1334t37r2139b144],
10	.	.	O	.	_	0	SENT_750	[p22l1334t37r2139b144],

1	Cancer	NN	O	cancer	_	0	SENT_751	[p22l211t183r554b264],
2	Res	NNP	O	Res	dep	1	SENT_751	[p22l579t185r772b264],
3	.	.	O	.	_	0	SENT_751	[p22l579t185r772b264],

1	60:4725	CD	NUMBER	60:4725	num	5	SENT_752	[p22l814t180r1367b264],
2	—	CD	NUMBER	—	num	5	SENT_752	[p22l814t180r1367b264],
3	28	CD	NUMBER	28	num	5	SENT_752	[p22l814t180r1367b264],
4	Santos	NNP	ORGANIZATION	Santos	nn	5	SENT_752	[p22l208t326r514b409],
5	A	NNP	ORGANIZATION	A	_	0	SENT_752	[p22l536t327r644b424],
6	,	,	O	,	_	0	SENT_752	[p22l536t327r644b424],
7	Zanetta	NNP	LOCATION	Zanetta	nn	8	SENT_752	[p22l666t329r1020b408],
8	S	NNP	LOCATION	S	appos	5	SENT_752	[p22l1040t326r1094b409],
9	,	,	O	,	_	0	SENT_752	[p22l1108t394r1125b424],
10	Cresteil	NNP	ORGANIZATION	Cresteil	nn	11	SENT_752	[p22l1150t326r1512b409],
11	T	NN	ORGANIZATION	t	appos	5	SENT_752	[p22l1532t329r1626b424],
12	,	,	O	,	_	0	SENT_752	[p22l1532t329r1626b424],
13	et	FW	O	et	nn	14	SENT_752	[p22l1651t339r1735b408],
14	al.	FW	O	al.	appos	5	SENT_752	[p22l1755t326r1857b408],
15	2000	CD	DATE	2000	dep	14	SENT_752	[p22l1884t326r2139b409],
16	.	.	O	.	_	0	SENT_752	[p22l1884t326r2139b409],

1	Metabolism	NN	O	metabolism	_	0	SENT_753	[p22l205t468r767b550],
2	of	IN	O	of	_	0	SENT_753	[p22l833t468r934b550],
3	irinotecan	NN	O	irinotecan	nn	5	SENT_753	[p22l992t468r1461b550],
4	(	CD	NUMBER	(	num	5	SENT_753	[p22l1531t469r1856b570],
5	CPT	NNP	O	CPT	prep_of	1	SENT_753	[p22l1531t469r1856b570],
6	—	CD	NUMBER	—	num	7	SENT_753	[p22l1531t469r1856b570],
7	l	NN	O	l	tmod	5	SENT_753	[p22l1531t469r1856b570],
8	1	CD	NUMBER	1	num	9	SENT_753	[p22l1881t469r1961b570],
9	)	NN	O	)	dep	1	SENT_753	[p22l1881t469r1961b570],
10	by	IN	O	by	_	0	SENT_753	[p22l2028t468r2144b575],
11	CYP3A4	NN	O	cyp3a4	prep_by	9	SENT_753	[p22l206t612r633b695],
12	and	CC	O	and	_	0	SENT_753	[p22l677t612r843b695],
13	CYP3A5	NN	O	cyp3a5	prep_by	9	SENT_753	[p22l884t611r1307b695],
14	in	IN	O	in	_	0	SENT_753	[p22l1352t612r1441b694],
15	humans	NNS	O	human	prep_in	9	SENT_753	[p22l1480t612r1869b695],
16	.	.	O	.	_	0	SENT_753	[p22l1480t612r1869b695],

1	Clin	NNP	O	Clin	_	0	SENT_754	[p22l1921t612r2134b695],
2	.	.	O	.	_	0	SENT_754	[p22l1921t612r2134b695],

1	Cancer	NN	O	cancer	_	0	SENT_755	[p22l211t759r554b841],
2	Res	NNP	O	Res	dep	1	SENT_755	[p22l579t760r772b840],
3	.	.	O	.	_	0	SENT_755	[p22l579t760r772b840],

1	6:20	CD	NUMBER	6:20	num	2	SENT_756	[p22l814t757r1312b840],
2	l2	NN	O	l2	_	0	SENT_756	[p22l814t757r1312b840],
3	—	CD	NUMBER	—	num	6	SENT_756	[p22l814t757r1312b840],
4	20	CD	NUMBER	20	num	6	SENT_756	[p22l814t757r1312b840],
5	Sugatani	NNP	O	Sugatani	nn	6	SENT_756	[p22l208t899r614b1006],
6	J	NNP	O	J	dep	2	SENT_756	[p22l637t902r706b997],
7	,	,	O	,	_	0	SENT_756	[p22l637t902r706b997],
8	Kojima	NNP	PERSON	Kojima	nn	9	SENT_756	[p22l736t899r1083b1006],
9	H	NNP	O	H	appos	6	SENT_756	[p22l1104t902r1211b997],
10	,	,	O	,	_	0	SENT_756	[p22l1104t902r1211b997],
11	Ueda	NNP	PERSON	Ueda	nn	12	SENT_756	[p22l1239t899r1487b982],
12	A	NNP	O	A	appos	6	SENT_756	[p22l1507t900r1615b997],
13	,	,	O	,	_	0	SENT_756	[p22l1507t900r1615b997],
14	et	FW	O	et	nn	15	SENT_756	[p22l1643t912r1727b981],
15	al.	FW	O	al.	appos	6	SENT_756	[p22l1750t899r1853b981],
16	2001	CD	DATE	2001	dep	15	SENT_756	[p22l1885t900r2139b982],
17	.	.	O	.	_	0	SENT_756	[p22l1885t900r2139b982],

1	The	DT	O	the	det	5	SENT_757	[p22l205t1044r385b1126],
2	phenobarbital	JJ	O	phenobarbital	amod	5	SENT_757	[p22l478t1044r1125b1150],
3	response	NN	O	response	nn	5	SENT_757	[p22l1218t1069r1628b1150],
4	enhancer	NN	O	enhancer	nn	5	SENT_757	[p22l1723t1044r2147b1126],
5	module	NN	O	module	_	0	SENT_757	[p22l205t1188r556b1270],
6	in	IN	O	in	_	0	SENT_757	[p22l629t1188r718b1269],
7	the	DT	O	the	det	14	SENT_757	[p22l791t1188r931b1270],
8	human	JJ	O	human	amod	14	SENT_757	[p22l1005t1188r1324b1270],
9	bilirubin	NN	O	bilirubin	nn	14	SENT_757	[p22l1395t1188r1801b1270],
10	UDP	NN	O	udp	nn	14	SENT_757	[p22l1873t1190r2142b1270],
11	—	CD	NUMBER	—	num	14	SENT_757	[p22l1873t1190r2142b1270],
12	glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	14	SENT_757	[p22l206t1330r1328b1437],
13	UGTIA1	NN	O	ugtia1	nn	14	SENT_757	[p22l1406t1331r1838b1413],
14	gene	NN	O	gene	prep_in	5	SENT_757	[p22l1927t1357r2144b1437],
15	and	CC	O	and	_	0	SENT_757	[p22l208t1475r374b1557],
16	regulation	NN	O	regulation	prep_in	5	SENT_757	[p22l434t1475r909b1581],
17	by	IN	O	by	_	0	SENT_757	[p22l970t1475r1086b1581],
18	the	DT	O	the	det	21	SENT_757	[p22l1150t1475r1291b1557],
19	nuclear	JJ	O	nuclear	amod	21	SENT_757	[p22l1354t1475r1701b1557],
20	receptor	NN	O	receptor	nn	21	SENT_757	[p22l1760t1487r2147b1581],
21	CAR	NN	O	car	prep_by	5	SENT_757	[p22l206t1619r467b1701],
22	.	.	O	.	_	0	SENT_757	[p22l206t1619r467b1701],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_758	[p22l503t1619r1053b1725],
2	33	CD	NUMBER	33	num	1	SENT_758	[p22l1089t1619r1642b1702],
3	:	:	O	:	_	0	SENT_758	[p22l1089t1619r1642b1702],
4	l232	CD	NUMBER	l232	num	8	SENT_758	[p22l1089t1619r1642b1702],
5	—	CD	NUMBER	—	num	8	SENT_758	[p22l1089t1619r1642b1702],
6	38	CD	NUMBER	38	num	8	SENT_758	[p22l1089t1619r1642b1702],
7	Schinkel	NNP	ORGANIZATION	Schinkel	nn	8	SENT_758	[p22l208t1761r614b1844],
8	AH	NNP	ORGANIZATION	AH	dep	1	SENT_758	[p22l655t1762r847b1859],
9	,	,	O	,	_	0	SENT_758	[p22l655t1762r847b1859],
10	Wagenaar	NNP	PERSON	Wagenaar	nn	11	SENT_758	[p22l890t1764r1359b1868],
11	E	NNP	O	E	appos	8	SENT_758	[p22l1397t1764r1492b1859],
12	,	,	O	,	_	0	SENT_758	[p22l1397t1764r1492b1859],
13	Van	NNP	PERSON	Van	nn	15	SENT_758	[p22l1537t1788r1702b1843],
14	Deemter	NNP	PERSON	Deemter	nn	15	SENT_758	[p22l1742t1764r2147b1843],
15	L	NNP	PERSON	L	appos	8	SENT_758	[p22l205t1907r300b2002],
16	,	,	O	,	_	0	SENT_758	[p22l205t1907r300b2002],
17	et	FW	O	et	nn	18	SENT_758	[p22l348t1917r431b1987],
18	al.	FW	O	al.	appos	8	SENT_758	[p22l475t1904r578b1988],
19	1995	CD	DATE	1995	dep	18	SENT_758	[p22l639t1904r884b1988],
20	.	.	O	.	_	0	SENT_758	[p22l639t1904r884b1988],

1	Absence	NN	O	absence	nsubj	8	SENT_759	[p22l932t1905r1335b1988],
2	of	IN	O	of	_	0	SENT_759	[p22l1381t1904r1482b1987],
3	the	DT	O	the	det	5	SENT_759	[p22l1517t1904r1658b1988],
4	mdrla	NN	O	mdrlum	nn	5	SENT_759	[p22l1702t1904r2002b1988],
5	Pglycoprotein	NN	O	pglycoprotein	prep_of	1	SENT_759	[p22l2044t1907r2142b1986, p22l206t2049r799b2155],
6	in	IN	O	in	_	0	SENT_759	[p22l835t2049r923b2130],
7	mice	NNS	O	mouse	prep_in	5	SENT_759	[p22l959t2049r1184b2131],
8	affects	VBZ	O	affect	_	0	SENT_759	[p22l1223t2049r1526b2131],
9	tissue	NN	O	tissue	nn	10	SENT_759	[p22l1565t2049r1830b2131],
10	distribution	NN	O	distribution	dobj	8	SENT_759	[p22l1867t2049r2142b2131, p22l203t2191r502b2273],
11	and	CC	O	and	_	0	SENT_759	[p22l555t2191r721b2273],
12	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	10	SENT_759	[p22l769t2191r1596b2298],
13	of	IN	O	of	_	0	SENT_759	[p22l1652t2191r1754b2273],
14	deXam	NN	O	dexam	nn	16	SENT_759	[p22l1798t2191r2142b2273],
15	—	CD	NUMBER	—	num	16	SENT_759	[p22l1798t2191r2142b2273],
16	ethasone	NN	O	ethasone	prep_of	10	SENT_759	[p22l206t2334r640b2432],
17	,	,	O	,	_	0	SENT_759	[p22l206t2334r640b2432],
18	digoxin	NN	O	digoxin	conj_and	16	SENT_759	[p22l688t2334r1070b2441],
19	,	,	O	,	_	0	SENT_759	[p22l688t2334r1070b2441],
20	and	CC	O	and	_	0	SENT_759	[p22l1119t2334r1285b2417],
21	cyclosporin	NN	O	cyclosporin	nn	24	SENT_759	[p22l1327t2334r1872b2441],
22	A.	NN	PERSON	a.	nn	24	SENT_759	[p22l1915t2335r2020b2417],
23	J.	NNP	PERSON	J.	nn	24	SENT_759	[p22l2066t2338r2134b2418],
24	Clin	NNP	PERSON	Clin	prep_of	10	SENT_759	[p22l211t2479r423b2563],
25	.	.	O	.	_	0	SENT_759	[p22l211t2479r423b2563],

1	Invest	VB	O	invest	_	0	SENT_760	[p22l465t2482r764b2563],
2	.	.	O	.	_	0	SENT_760	[p22l465t2482r764b2563],

1	96	CD	NUMBER	96	_	0	SENT_761	[p22l805t2479r1476b2563],
2	:	:	O	:	_	0	SENT_761	[p22l805t2479r1476b2563],
3	l698	CD	NUMBER	l698	num	4	SENT_761	[p22l805t2479r1476b2563],
4	—	CD	NUMBER	—	dep	1	SENT_761	[p22l805t2479r1476b2563],
5	l705	NN	O	l705	nn	7	SENT_761	[p22l805t2479r1476b2563],
6	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	7	SENT_761	[p22l205t2621r717b2728],
7	S	NNP	O	S	dep	4	SENT_761	[p22l754t2622r838b2719],
8	,	,	O	,	_	0	SENT_761	[p22l754t2622r838b2719],
9	Burk	NNP	PERSON	Burk	nn	10	SENT_761	[p22l880t2621r1116b2703],
10	o	NN	O	o	appos	7	SENT_761	[p22l1152t2622r1256b2719],
11	,	,	O	,	_	0	SENT_761	[p22l1152t2622r1256b2719],
12	Von	NNP	PERSON	Von	nn	13	SENT_761	[p22l1297t2648r1468b2703],
13	Richter	NNP	PERSON	Richter	appos	7	SENT_761	[p22l1505t2621r1874b2719],
14	,	,	O	,	_	0	SENT_761	[p22l1505t2621r1874b2719],
15	et	FW	O	et	nn	16	SENT_761	[p22l1916t2633r1999b2703],
16	al.	FW	O	al.	appos	7	SENT_761	[p22l2036t2621r2139b2703],
17	2000	CD	DATE	2000	dep	16	SENT_761	[p22l207t2765r462b2847],
18	.	.	O	.	_	0	SENT_761	[p22l207t2765r462b2847],

1	Functional	JJ	O	functional	amod	2	SENT_762	[p22l519t2764r1021b2847],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_762	[p22l1072t2764r1801b2871],
3	of	IN	O	of	_	0	SENT_762	[p22l1858t2764r1960b2847],
4	the	DT	O	the	det	9	SENT_762	[p22l2004t2764r2144b2847],
5	human	JJ	O	human	amod	9	SENT_762	[p22l205t2908r524b2990],
6	multidrug	JJ	O	multidrug	amod	9	SENT_762	[p22l563t2908r1528b3014],
7	—	NN	O	—	nn	9	SENT_762	[p22l563t2908r1528b3014],
8	resistance	NN	O	resistance	nn	9	SENT_762	[p22l563t2908r1528b3014],
9	gene	NN	O	gene	prep_of	2	SENT_762	[p22l1570t2933r1812b3014],
10	:	:	O	:	_	0	SENT_762	[p22l1570t2933r1812b3014],
11	multiple	JJ	O	multiple	amod	13	SENT_762	[p22l1859t2908r2142b2990, p22l203t3051r346b3158],
12	sequence	NN	O	sequence	nn	13	SENT_762	[p22l378t3077r803b3158],
13	variations	NNS	O	variation	dep	2	SENT_762	[p22l832t3051r1288b3133],
14	and	CC	O	and	_	0	SENT_762	[p22l1321t3051r1487b3133],
15	correlation	NN	O	correlation	dep	2	SENT_762	[p22l1515t3051r2022b3133],
16	of	IN	O	of	_	0	SENT_762	[p22l2052t3051r2153b3133],
17	one	CD	NUMBER	one	num	18	SENT_762	[p22l206t3220r372b3276],
18	allele	NN	O	allele	prep_of	15	SENT_762	[p22l404t3193r653b3276],
19	with	IN	O	with	_	0	SENT_762	[p22l683t3193r890b3276],
20	P-glycoprotein	NN	MISC	p-glycoprotein	nn	21	SENT_762	[p22l918t3193r1616b3300],
21	expression	NN	O	expression	prep_with	18	SENT_762	[p22l1646t3193r2145b3300],
22	and	CC	O	and	_	0	SENT_762	[p22l208t3338r374b3420],
23	activity	NN	O	activity	conj_and	21	SENT_762	[p22l402t3338r747b3444],
24	in	FW	O	in	prep	15	SENT_762	[p22l779t3341r862b3420],
25	vivo	FW	O	vivo	pobj	24	SENT_762	[p22l893t3341r1108b3421],
26	.	.	O	.	_	0	SENT_762	[p22l893t3341r1108b3421],

1	Proc	NNP	O	Proc	_	0	SENT_763	[p22l1140t3341r1381b3420],
2	.	.	O	.	_	0	SENT_763	[p22l1140t3341r1381b3420],

1	Natl.	NNP	O	Natl.	nn	2	SENT_764	[p22l1416t3338r1639b3421],
2	Acad	NNP	O	Acad	_	0	SENT_764	[p22l1670t3338r1935b3420],
3	.	.	O	.	_	0	SENT_764	[p22l1670t3338r1935b3420],

1	Sci	NNP	O	Sci	_	0	SENT_765	[p22l1974t3339r2134b3422],
2	.	.	O	.	_	0	SENT_765	[p22l1974t3339r2134b3422],

1	USA	NNP	LOCATION	USA	nn	3	SENT_766	[p22l216t3483r415b3566],
2	97:3473	CD	NUMBER	97:3473	num	3	SENT_766	[p22l453t3482r1007b3566],
3	—	NN	O	—	_	0	SENT_766	[p22l453t3482r1007b3566],
4	78	CD	NUMBER	78	num	6	SENT_766	[p22l453t3482r1007b3566],
5	Schwab	NNP	ORGANIZATION	Schwab	nn	6	SENT_766	[p22l208t3624r573b3708],
6	M	NN	ORGANIZATION	m	dep	3	SENT_766	[p22l615t3627r743b3722],
7	,	,	O	,	_	0	SENT_766	[p22l615t3627r743b3722],
8	Eichelbaum	NNP	PERSON	Eichelbaum	nn	9	SENT_766	[p22l787t3624r1350b3708],
9	M	NNP	O	M	appos	6	SENT_766	[p22l1389t3627r1517b3722],
10	,	,	O	,	_	0	SENT_766	[p22l1389t3627r1517b3722],
11	Fromm	NNP	PERSON	Fromm	nn	12	SENT_766	[p22l1562t3627r1908b3707],
12	MF	NN	O	mf	appos	6	SENT_766	[p22l1948t3627r2139b3708],
13	.	.	O	.	_	0	SENT_766	[p22l1948t3627r2139b3708],

1	from	IN	O	from	_	0	SENT_767	[p23l6t3204r64b3365],
2	Www.annualreViews.org	NNP	O	Www.annualreViews.org	pobj	1	SENT_767	[p23l6t2368r81b3181],
3	5/14	CD	NUMBER	5/14	num	2	SENT_767	[p23l89t3221r148b3382],
4	.	.	O	.	_	0	SENT_767	[p23l89t3221r148b3382],

1	For	IN	O	for	_	0	SENT_768	[p23l91t3078r148b3193],
2	personal	JJ	O	personal	amod	3	SENT_768	[p23l90t2775r165b3057],
3	use	NN	O	use	pobj	1	SENT_768	[p23l108t2644r148b2753],
4	only	RB	O	only	advmod	3	SENT_768	[p23l90t2457r165b2619],
5	.	.	O	.	_	0	SENT_768	[p23l90t2457r165b2619],

1	2003	CD	DATE	2003	_	0	SENT_769	[p23l207t31r461b113],
2	.	.	O	.	_	0	SENT_769	[p23l207t31r461b113],

1	Genetic	JJ	O	genetic	amod	2	SENT_770	[p23l508t31r868b113],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_770	[p23l907t31r1637b137],
3	of	IN	O	of	_	0	SENT_770	[p23l1679t31r1781b113],
4	the	DT	O	the	det	8	SENT_770	[p23l1812t31r1952b113],
5	human	JJ	O	human	amod	8	SENT_770	[p23l1990t31r2142b113, p23l205t200r406b256],
6	MDR1	NN	O	mdr1	nn	8	SENT_770	[p23l445t174r759b255],
7	drug	NN	O	drug	nn	8	SENT_770	[p23l811t174r1022b281],
8	transporter	NN	O	transporter	prep_of	2	SENT_770	[p23l1064t186r1588b281],
9	.	.	O	.	_	0	SENT_770	[p23l1064t186r1588b281],

1	Annu	NNP	PERSON	Annu	_	0	SENT_771	[p23l1627t175r1899b256],
2	.	.	O	.	_	0	SENT_771	[p23l1627t175r1899b256],

1	Rev.	NNP	O	Rev.	nn	2	SENT_772	[p23l1949t177r2134b257],
2	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_772	[p23l203t316r745b400],
3	.	.	O	.	_	0	SENT_772	[p23l203t316r745b400],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_773	[p23l794t316r1152b400],
2	.	.	O	.	_	0	SENT_773	[p23l794t316r1152b400],

1	432285-307	CD	NUMBER	432285-307	_	0	SENT_774	[p23l1190t316r1747b400],

1	79	CD	NUMBER	79	_	0	SENT_775	[p23l6t461r144b544],
2	.	.	O	.	_	0	SENT_775	[p23l6t461r144b544],

1	Sakaeda	FW	ORGANIZATION	sakaeda	_	0	SENT_776	[p23l208t461r597b543],
2	T	NN	ORGANIZATION	t	dep	1	SENT_776	[p23l658t462r751b557],
3	,	,	O	,	_	0	SENT_776	[p23l658t462r751b557],
4	Nakamura	NNP	PERSON	Nakamura	nn	5	SENT_776	[p23l817t461r1308b543],
5	T	NN	O	t	appos	2	SENT_776	[p23l1368t462r1462b557],
6	,	,	O	,	_	0	SENT_776	[p23l1368t462r1462b557],
7	Okumura	NNP	PERSON	Okumura	nn	8	SENT_776	[p23l1531t461r1973b543],
8	K.	NNP	O	K.	appos	2	SENT_776	[p23l2036t462r2139b543],
9	2003	CD	DATE	2003	dep	8	SENT_776	[p23l206t604r461b686],
10	.	.	O	.	_	0	SENT_776	[p23l206t604r461b686],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_777	[p23l493t604r1345b711],
2	of	IN	O	of	_	0	SENT_777	[p23l1375t604r1476b686],
3	MDR1	NN	O	mdr1	prep_of	1	SENT_777	[p23l1493t605r1809b685],
4	and	CC	O	and	_	0	SENT_777	[p23l1847t604r2013b686],
5	its	PRP$	O	its	prep_of	1	SENT_777	[p23l2036t604r2142b686],

1	EICHELBAUM	NNP	O	EICHELBAUM	nsubj	5	SENT_778	[p23l507t789r748b816],
2	I	PRP	O	I	dep	1	SENT_778	[p23l766t792r783b810],
3	INGELMAN-SUNDBERG	NN	O	ingelman-sundberg	dep	1	SENT_778	[p23l802t789r1214b816],
4	I	PRP	O	I	dep	3	SENT_778	[p23l1232t792r1249b810],
5	EVANS	VBP	O	evan	_	0	SENT_778	[p23l1268t789r1385b816],

1	impact	NN	O	impact	_	0	SENT_779	[p23l607t1024r861b1108],
2	on	IN	O	on	_	0	SENT_779	[p23l881t1044r971b1089],
3	the	DT	O	the	det	4	SENT_779	[p23l991t1024r1103b1089],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_779	[p23l1121t1024r1779b1108],
5	and	CC	O	and	_	0	SENT_779	[p23l1803t1024r1935b1089],
6	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	1	SENT_779	[p23l1953t1024r2144b1108, p23l607t1137r1164b1222],
7	of	IN	O	of	_	0	SENT_779	[p23l1224t1137r1306b1202],
8	drugs	NNS	O	drug	prep_of	1	SENT_779	[p23l1357t1137r1580b1222],
9	.	.	O	.	_	0	SENT_779	[p23l1357t1137r1580b1222],

1	Pharmacoge	NNP	O	Pharmacoge	nn	3	SENT_780	[p23l1640t1137r2144b1221],
2	—	CD	NUMBER	—	num	3	SENT_780	[p23l1640t1137r2144b1221],
3	nomics	NNS	O	nomic	_	0	SENT_780	[p23l607t1253r870b1316],
4	42397-410	CD	NUMBER	42397-410	num	6	SENT_780	[p23l896t1251r1293b1317],
5	Kurata	NNP	O	Kurata	nn	6	SENT_780	[p23l609t1364r860b1428],
6	Y	NN	O	y	dep	3	SENT_780	[p23l889t1364r974b1439],
7	,	,	O	,	_	0	SENT_780	[p23l889t1364r974b1439],
8	Ieiri	NNP	O	Ieiri	nn	12	SENT_780	[p23l1008t1363r1161b1428],
9	I	PRP	O	I	dep	12	SENT_780	[p23l1192t1364r1241b1439],
10	,	,	O	,	_	0	SENT_780	[p23l1192t1364r1241b1439],
11	Kimura	NNP	PERSON	Kimura	dep	12	SENT_780	[p23l1277t1363r1560b1428],
12	M	NNP	O	M	appos	6	SENT_780	[p23l1589t1364r1690b1439],
13	,	,	O	,	_	0	SENT_780	[p23l1589t1364r1690b1439],
14	et	FW	O	et	nn	15	SENT_780	[p23l1725t1373r1791b1428],
15	al.	FW	O	al.	appos	6	SENT_780	[p23l1822t1363r1904b1428],
16	2002	CD	DATE	2002	dep	15	SENT_780	[p23l1940t1363r2142b1428],
17	.	.	O	.	_	0	SENT_780	[p23l1940t1363r2142b1428],

1	Role	NN	O	role	_	0	SENT_781	[p23l607t1475r781b1540],
2	of	IN	O	of	_	0	SENT_781	[p23l835t1475r916b1540],
3	human	JJ	O	human	amod	6	SENT_781	[p23l961t1475r1214b1540],
4	MDR1	NN	O	mdr1	nn	6	SENT_781	[p23l1266t1476r1516b1540],
5	gene	NN	O	gene	nn	6	SENT_781	[p23l1578t1496r1750b1560],
6	polymorphism	NN	O	polymorphism	prep_of	1	SENT_781	[p23l1802t1475r2144b1560, p23l606t1588r835b1673],
7	in	IN	O	in	_	0	SENT_781	[p23l878t1588r949b1653],
8	bioavailability	NN	O	bioavailability	prep_in	1	SENT_781	[p23l992t1588r1527b1673],
9	and	CC	O	and	_	0	SENT_781	[p23l1574t1588r1706b1654],
10	interaction	NN	O	interaction	conj_and	8	SENT_781	[p23l1749t1588r2148b1654],
11	of	IN	O	of	_	0	SENT_781	[p23l609t1702r689b1767],
12	digoxin	NN	O	digoxin	prep_of	1	SENT_781	[p23l710t1702r1013b1786],
13	,	,	O	,	_	0	SENT_781	[p23l710t1702r1013b1786],
14	a	DT	O	a	det	15	SENT_781	[p23l1046t1722r1084b1767],
15	substrate	NN	O	substrate	appos	12	SENT_781	[p23l1113t1702r1440b1767],
16	of	IN	O	of	_	0	SENT_781	[p23l1468t1702r1549b1767],
17	P-glycoprotein	NN	O	p-glycoprotein	prep_of	15	SENT_781	[p23l1570t1702r2142b1786],
18	.	.	O	.	_	0	SENT_781	[p23l1570t1702r2142b1786],

1	Clin	NNP	O	Clin	_	0	SENT_782	[p23l612t1815r781b1881],
2	.	.	O	.	_	0	SENT_782	[p23l612t1815r781b1881],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_783	[p23l814t1815r1243b1880],
2	.	.	O	.	_	0	SENT_783	[p23l814t1815r1243b1880],

1	Ther	NNP	O	Ther	_	0	SENT_784	[p23l1283t1815r1471b1880],
2	.	.	O	.	_	0	SENT_784	[p23l1283t1815r1471b1880],

1	722209-21	CD	NUMBER	722209-21	num	3	SENT_785	[p23l1502t1816r1892b1881],
2	Johne	NNP	O	Johne	nn	3	SENT_785	[p23l607t1928r822b1994],
3	A	NNP	O	A	_	0	SENT_785	[p23l881t1929r966b2006],
4	,	,	O	,	_	0	SENT_785	[p23l881t1929r966b2006],
5	Kopke	NNP	PERSON	Kopke	nn	6	SENT_785	[p23l1028t1929r1269b2013],
6	K	NNP	PERSON	K	appos	3	SENT_785	[p23l1328t1930r1412b2006],
7	,	,	O	,	_	0	SENT_785	[p23l1328t1930r1412b2006],
8	Gerloff	NNP	PERSON	Gerloff	nn	9	SENT_785	[p23l1474t1928r1750b1994],
9	T	NN	O	t	appos	3	SENT_785	[p23l1801t1930r1875b2006],
10	,	,	O	,	_	0	SENT_785	[p23l1801t1930r1875b2006],
11	et	FW	O	et	nn	12	SENT_785	[p23l1937t1938r2003b1994],
12	al.	FW	O	al.	appos	3	SENT_785	[p23l2060t1929r2143b1994],
13	2002	CD	DATE	2002	dep	12	SENT_785	[p23l609t2042r811b2107],
14	.	.	O	.	_	0	SENT_785	[p23l609t2042r811b2107],

1	Modulation	NN	O	modulation	_	0	SENT_786	[p23l857t2042r1292b2107],
2	of	IN	O	of	_	0	SENT_786	[p23l1334t2042r1415b2107],
3	steady	JJ	O	steady	amod	6	SENT_786	[p23l1453t2042r1890b2126],
4	—	JJ	O	—	amod	6	SENT_786	[p23l1453t2042r1890b2126],
5	state	NN	O	state	nn	6	SENT_786	[p23l1453t2042r1890b2126],
6	kinetics	NNS	O	kinetics	prep_of	1	SENT_786	[p23l1930t2042r2144b2107, p23l607t2155r707b2220],
7	of	IN	O	of	_	0	SENT_786	[p23l776t2155r857b2220],
8	digoxin	NN	O	digoxin	prep_of	6	SENT_786	[p23l917t2155r1201b2240],
9	by	IN	O	by	_	0	SENT_786	[p23l1265t2155r1357b2240],
10	haplotypes	NNS	O	haplotype	prep_by	1	SENT_786	[p23l1423t2155r1825b2240],
11	of	IN	O	of	_	0	SENT_786	[p23l1895t2155r1975b2220],
12	the	DT	O	the	det	15	SENT_786	[p23l2035t2155r2147b2220],
13	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_786	[p23l607t2268r1162b2353],
14	MDR1	NN	O	mdr1	nn	15	SENT_786	[p23l1194t2269r1444b2333],
15	gene	NN	O	gene	prep_of	10	SENT_786	[p23l1486t2289r1678b2353],
16	.	.	O	.	_	0	SENT_786	[p23l1486t2289r1678b2353],

1	Clin	NNP	O	Clin	_	0	SENT_787	[p23l1721t2268r1890b2334],
2	.	.	O	.	_	0	SENT_787	[p23l1721t2268r1890b2334],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_788	[p23l1932t2268r2144b2334, p23l607t2383r848b2449],
2	.	.	O	.	_	0	SENT_788	[p23l1932t2268r2144b2334, p23l607t2383r848b2449],

1	Ther	NNP	O	Ther	_	0	SENT_789	[p23l887t2383r1076b2449],
2	.	.	O	.	_	0	SENT_789	[p23l887t2383r1076b2449],

1	722584-94	CD	NUMBER	722584-94	num	3	SENT_790	[p23l1107t2383r1504b2450],
2	Verstuyft	NN	O	verstuyft	nn	3	SENT_790	[p23l607t2497r950b2582],
3	C	NN	O	c	_	0	SENT_790	[p23l993t2498r1072b2575],
4	,	,	O	,	_	0	SENT_790	[p23l993t2498r1072b2575],
5	Schwab	NNP	PERSON	Schwab	nn	6	SENT_790	[p23l1121t2497r1411b2563],
6	M	NNP	O	M	appos	3	SENT_790	[p23l1455t2499r1557b2575],
7	,	,	O	,	_	0	SENT_790	[p23l1455t2499r1557b2575],
8	Schaeffeler	NNP	O	Schaeffeler	nn	9	SENT_790	[p23l1606t2497r2027b2563],
9	E	NNP	O	E	appos	3	SENT_790	[p23l2069t2499r2144b2575],
10	,	,	O	,	_	0	SENT_790	[p23l2069t2499r2144b2575],
11	et	FW	O	et	nn	12	SENT_790	[p23l608t2622r674b2677],
12	al.	FW	O	al.	appos	3	SENT_790	[p23l691t2612r772b2677],
13	2003	CD	DATE	2003	dep	12	SENT_790	[p23l795t2612r997b2678],
14	.	.	O	.	_	0	SENT_790	[p23l795t2612r997b2678],

1	Digoxin	NN	O	digoxin	nn	2	SENT_791	[p23l1019t2612r1323b2697],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_791	[p23l1339t2611r1995b2697],
3	and	CC	O	and	_	0	SENT_791	[p23l2016t2612r2148b2677],
4	MDR1	NN	O	mdr1	conj_and	2	SENT_791	[p23l607t2727r857b2791],
5	genetic	JJ	O	genetic	amod	6	SENT_791	[p23l915t2726r1180b2811],
6	polymorphisms	NNS	O	polymorphism	dep	2	SENT_791	[p23l1229t2726r1829b2811],
7	.	.	O	.	_	0	SENT_791	[p23l1229t2726r1829b2811],

1	Eur	NNP	O	Eur	_	0	SENT_792	[p23l1881t2729r2025b2792],
2	.	.	O	.	_	0	SENT_792	[p23l1881t2729r2025b2792],

1	J.	NNP	PERSON	J.	nn	2	SENT_793	[p23l2085t2729r2138b2792],
2	Clin	NNP	PERSON	Clin	_	0	SENT_793	[p23l612t2840r781b2907],
3	.	.	O	.	_	0	SENT_793	[p23l612t2840r781b2907],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_794	[p23l814t2840r1247b2906],
2	.	.	O	.	_	0	SENT_794	[p23l814t2840r1247b2906],

1	582809-12	CD	NUMBER	582809-12	num	4	SENT_795	[p23l1280t2840r1676b2907],
2	Von	NNP	PERSON	Von	nn	4	SENT_795	[p23l607t2976r743b3021],
3	Ahsen	NNP	PERSON	Ahsen	nn	4	SENT_795	[p23l772t2955r1009b3021],
4	N	NNP	PERSON	N	_	0	SENT_795	[p23l1036t2957r1122b3032],
5	,	,	O	,	_	0	SENT_795	[p23l1036t2957r1122b3032],
6	Richter	NNP	PERSON	Richter	nn	7	SENT_795	[p23l1154t2955r1429b3021],
7	M	NNP	O	M	appos	4	SENT_795	[p23l1455t2957r1556b3033],
8	,	,	O	,	_	0	SENT_795	[p23l1455t2957r1556b3033],
9	Grupp	NNP	PERSON	Grupp	nn	10	SENT_795	[p23l1590t2956r1824b3040],
10	C	NNP	O	C	appos	4	SENT_795	[p23l1855t2956r1933b3032],
11	,	,	O	,	_	0	SENT_795	[p23l1855t2956r1933b3032],
12	et	FW	O	et	nn	13	SENT_795	[p23l1966t2965r2032b3021],
13	al.	FW	O	al.	appos	4	SENT_795	[p23l2060t2955r2143b3021],
14	2001	CD	DATE	2001	dep	13	SENT_795	[p23l609t3070r811b3136],
15	.	.	O	.	_	0	SENT_795	[p23l609t3070r811b3136],

1	No	DT	O	no	det	2	SENT_796	[p23l832t3071r942b3135],
2	inﬂuence	NN	O	inﬂuence	_	0	SENT_796	[p23l960t3070r1301b3135],
3	of	IN	O	of	_	0	SENT_796	[p23l1318t3070r1399b3135],
4	the	DT	O	the	det	5	SENT_796	[p23l1409t3070r1521b3135],
5	MDR-1	NN	O	mdr-1	prep_of	2	SENT_796	[p23l1537t3070r1818b3134],
6	C3435T	NN	O	c3435t	nn	7	SENT_796	[p23l1844t3069r2147b3136],
7	polymorphisms	NNS	O	polymorphism	dep	2	SENT_796	[p23l606t3184r1185b3269],
8	or	CC	O	or	_	0	SENT_796	[p23l1229t3205r1306b3250],
9	a	DT	O	a	det	16	SENT_796	[p23l1347t3205r1385b3250],
10	CYP3A4	NN	O	cyp3a4	nn	16	SENT_796	[p23l1426t3184r1765b3250],
11	promoter	NN	O	promoter	nn	16	SENT_796	[p23l1806t3194r2149b3269],
12	polymorphism	NN	O	polymorphism	nn	16	SENT_796	[p23l606t3298r1152b3384],
13	(	NN	O	(	nn	16	SENT_796	[p23l1222t3299r1688b3380],
14	CYP3A4-V	NN	O	cyp3a4-v	nn	16	SENT_796	[p23l1222t3299r1688b3380],
15	allele	NN	O	allele	nn	16	SENT_796	[p23l1759t3299r1986b3379],
16	)	NN	O	)	dep	2	SENT_796	[p23l1759t3299r1986b3379],
17	on	IN	O	on	prep	16	SENT_796	[p23l2058t3319r2148b3364],

1	Annu	NNP	PERSON	Annu	_	0	SENT_797	[p24l6t1491r64b1691],
2	.	.	O	.	_	0	SENT_797	[p24l6t1491r64b1691],

1	Rev.	NNP	O	Rev.	nn	2	SENT_798	[p24l7t1315r64b1463],
2	Med	NNP	O	Med	_	0	SENT_798	[p24l6t1121r64b1288],
3	.	.	O	.	_	0	SENT_798	[p24l6t1121r64b1288],

1	1	CD	NUMBER	1	num	3	SENT_799	[p24l14t1088r64b1092],
2	2006.57:119	CD	NUMBER	2006.57:119	num	3	SENT_799	[p24l6t462r65b1046],
3	—	NN	O	—	_	0	SENT_799	[p24l6t462r65b1046],
4	137	CD	NUMBER	137	num	3	SENT_799	[p24l6t462r65b1046],
5	.	.	O	.	_	0	SENT_799	[p24l6t462r65b1046],

1	Downloaded	VBN	O	download	_	0	SENT_800	[p24l6t9r64b434],
2	by	IN	O	by	_	0	SENT_800	[p24l90t1524r165b1606],
3	University	NNP	ORGANIZATION	University	nn	7	SENT_800	[p24l89t1152r165b1501],
4	o	NN	O	o	nn	7	SENT_800	[p24l108t1090r148b1127],
5	f	FW	O	f	nn	7	SENT_800	[p24l89t1012r147b1043],
6	Wisconsin	NNP	LOCATION	Wisconsin	nn	7	SENT_800	[p24l89t643r148b996],
7	—	NNP	O	—	prep_by	1	SENT_800	[p24l125t597r131b619],
8	Madison	NNP	O	Madison	dobj	1	SENT_800	[p24l90t281r148b572],
9	on	IN	O	on	_	0	SENT_800	[p24l108t177r148b257],
10	01/0	CD	NUMBER	01/0	prep_on	8	SENT_800	[p24l90t8r148b153],

1	dose	NN	O	dose	nsubj	3	SENT_801	[p24l609t35r1120b120],
2	—	RB	O	—	advmod	3	SENT_801	[p24l609t35r1120b120],
3	adjusted	VBN	O	adjust	_	0	SENT_801	[p24l609t35r1120b120],
4	cyclosporin	NN	O	cyclosporin	nn	7	SENT_801	[p24l1151t35r1584b120],
5	A	NN	O	a	nn	7	SENT_801	[p24l1614t36r1680b100],
6	trough	NN	O	trough	nn	7	SENT_801	[p24l1710t35r1953b120],
7	concentrations	NNS	O	concentration	dobj	3	SENT_801	[p24l1984t56r2144b101, p24l608t149r1014b215],
8	or	CC	O	or	_	0	SENT_801	[p24l1035t170r1110b215],
9	rejection	NN	O	rejection	nn	10	SENT_801	[p24l1125t149r1452b235],
10	incidence	NN	O	incidence	dobj	3	SENT_801	[p24l1470t149r1825b215],
11	in	IN	O	in	_	0	SENT_801	[p24l1843t149r1914b214],
12	stable	JJ	O	stable	amod	15	SENT_801	[p24l1935t149r2147b215],
13	renal	JJ	O	renal	amod	15	SENT_801	[p24l606t264r791b330],
14	transplant	NN	O	transplant	nn	15	SENT_801	[p24l837t264r1205b349],
15	recipients	NNS	O	recipient	prep_in	7	SENT_801	[p24l1247t264r1628b349],
16	.	.	O	.	_	0	SENT_801	[p24l1247t264r1628b349],

1	Clin	NNP	O	Clin	_	0	SENT_802	[p24l1682t264r1851b330],
2	.	.	O	.	_	0	SENT_802	[p24l1682t264r1851b330],

1	Chem	NNP	O	Chem	_	0	SENT_803	[p24l1912t264r2142b330],
2	.	.	O	.	_	0	SENT_803	[p24l1912t264r2142b330],

1	47	CD	NUMBER	47	_	0	SENT_804	[p24l607t378r1051b444],
2	:	:	O	:	_	0	SENT_804	[p24l607t378r1051b444],
3	l048	CD	NUMBER	l048	num	7	SENT_804	[p24l607t378r1051b444],
4	—	CD	NUMBER	—	num	7	SENT_804	[p24l607t378r1051b444],
5	52	CD	DURATION	52	num	7	SENT_804	[p24l607t378r1051b444],
6	Min	NNP	DURATION	Min	nn	7	SENT_804	[p24l607t493r761b557],
7	DI	NNP	O	DI	dep	1	SENT_804	[p24l779t494r895b570],
8	,	,	O	,	_	0	SENT_804	[p24l779t494r895b570],
9	Ellingrod	NNP	O	Ellingrod	nn	10	SENT_804	[p24l916t493r1269b578],
10	VL	NNP	O	VL	appos	7	SENT_804	[p24l1286t494r1427b558],
11	.	.	O	.	_	0	SENT_804	[p24l1286t494r1427b558],

1	2002	CD	DATE	2002	_	0	SENT_805	[p24l1451t493r1653b558],
2	.	.	O	.	_	0	SENT_805	[p24l1451t493r1653b558],

1	C3435T	NN	O	c3435t	nn	2	SENT_806	[p24l1678t493r1981b558],
2	mutation	NN	O	mutation	_	0	SENT_806	[p24l1999t514r2144b558, p24l607t607r818b673],
3	in	IN	O	in	_	0	SENT_806	[p24l859t607r930b672],
4	exon	NN	O	exon	prep_in	2	SENT_806	[p24l972t628r1150b673],
5	26	CD	NUMBER	26	num	4	SENT_806	[p24l1193t607r1282b674],
6	of	IN	O	of	_	0	SENT_806	[p24l1326t607r1406b673],
7	the	DT	O	the	det	10	SENT_806	[p24l1441t607r1553b673],
8	human	JJ	O	human	amod	10	SENT_806	[p24l1595t607r1848b673],
9	MDRl	NN	O	mdrl	nn	10	SENT_806	[p24l1889t608r2139b672],
10	gene	NN	O	gene	prep_of	2	SENT_806	[p24l609t743r781b807],
11	and	CC	O	and	_	0	SENT_806	[p24l817t722r949b788],
12	cyclosporine	NN	O	cyclosporine	nn	13	SENT_806	[p24l982t722r1455b807],
13	pharrnacokinetics	NNS	O	pharrnacokinetic	conj_and	10	SENT_806	[p24l1488t722r2145b807],
14	in	IN	O	in	_	0	SENT_806	[p24l607t837r678b901],
15	healthy	JJ	O	healthy	amod	16	SENT_806	[p24l698t837r971b922],
16	subjects	NNS	O	subject	prep_in	2	SENT_806	[p24l996t837r1311b922],
17	.	.	O	.	_	0	SENT_806	[p24l996t837r1311b922],

1	Ther	NNP	O	Ther	_	0	SENT_807	[p24l1342t837r1516b902],
2	.	.	O	.	_	0	SENT_807	[p24l1342t837r1516b902],

1	Drug	NN	O	drug	_	0	SENT_808	[p24l1545t839r1741b921],
2	Monit	NN	O	monit	dep	1	SENT_808	[p24l1761t839r2004b902],
3	.	.	O	.	_	0	SENT_808	[p24l1761t839r2004b902],

1	24	CD	NUMBER	24	_	0	SENT_809	[p24l2031t837r2141b902],
2	:	:	O	:	_	0	SENT_809	[p24l2031t837r2141b902],
3	400-4	CD	NUMBER	400-4	dep	1	SENT_809	[p24l607t952r838b1017],

1	Chowbay	NN	O	chowbay	nn	2	SENT_810	[p24l609t1109r961b1194],
2	B	NN	O	b	_	0	SENT_810	[p24l1007t1111r1087b1186],
3	,	,	O	,	_	0	SENT_810	[p24l1007t1111r1087b1186],
4	Cumaraswamy	NNP	PERSON	Cumaraswamy	nn	5	SENT_810	[p24l1137t1109r1693b1194],
5	S	NNP	O	S	appos	2	SENT_810	[p24l1742t1109r1810b1186],
6	,	,	O	,	_	0	SENT_810	[p24l1742t1109r1810b1186],
7	Cheung	NNP	ORGANIZATION	Cheung	nn	8	SENT_810	[p24l1860t1109r2146b1194],
8	YB	NNP	ORGANIZATION	YB	appos	2	SENT_810	[p24l607t1224r754b1300],
9	,	,	O	,	_	0	SENT_810	[p24l607t1224r754b1300],
10	et	FW	O	et	nn	11	SENT_810	[p24l790t1232r856b1288],
11	al.	FW	O	al.	appos	2	SENT_810	[p24l888t1222r970b1288],
12	2003	CD	DATE	2003	dep	11	SENT_810	[p24l1008t1222r1210b1288],
13	.	.	O	.	_	0	SENT_810	[p24l1008t1222r1210b1288],

1	Genetic	JJ	O	genetic	amod	2	SENT_811	[p24l1248t1222r1534b1288],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_811	[p24l1566t1222r2145b1307],
3	im	VBP	O	im	_	0	SENT_811	[p24l607t1336r705b1402],
4	MDR1	NN	O	mdr1	nn	7	SENT_811	[p24l733t1338r983b1402],
5	and	CC	O	and	_	0	SENT_811	[p24l1023t1336r1154b1402],
6	CYP3A4	NN	O	cyp3a4	nn	7	SENT_811	[p24l1184t1337r1523b1403],
7	genes	NNS	O	gene	dobj	3	SENT_811	[p24l1555t1358r1763b1422],
8	in	IN	O	in	_	0	SENT_811	[p24l1795t1336r1865b1402],
9	Asians	NNPS	MISC	Asians	prep_in	7	SENT_811	[p24l1895t1336r2145b1402],
10	and	CC	O	and	_	0	SENT_811	[p24l609t1451r741b1517],
11	the	DT	O	the	det	12	SENT_811	[p24l817t1452r929b1517],
12	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_811	[p24l1006t1451r1346b1517],
13	of	IN	O	of	_	0	SENT_811	[p24l1425t1451r1505b1517],
14	MDRl	NN	O	mdrl	nn	15	SENT_811	[p24l1575t1452r1825b1516],
15	haplotypes	NNS	O	haplotype	prep_of	12	SENT_811	[p24l1910t1451r2144b1536, p24l607t1576r800b1650],
16	on	IN	O	on	_	0	SENT_811	[p24l827t1586r917b1631],
17	cyclosporine	NN	O	cyclosporine	nn	18	SENT_811	[p24l941t1566r1414b1650],
18	disposition	NN	O	disposition	prep_on	3	SENT_811	[p24l1438t1566r1846b1650],
19	in	IN	O	in	_	0	SENT_811	[p24l1869t1566r1940b1630],
20	heart	NN	O	heart	nn	22	SENT_811	[p24l1962t1566r2148b1631],
21	transplant	NN	O	transplant	nn	22	SENT_811	[p24l607t1680r975b1765],
22	recipients	NNS	O	recipient	prep_in	18	SENT_811	[p24l1021t1680r1402b1765],
23	.	.	O	.	_	0	SENT_811	[p24l1021t1680r1402b1765],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_812	[p24l1453t1680r2147b1764],
2	74:245	CD	NUMBER	74:245	num	6	SENT_812	[p24l608t1794r1004b1860],
3	—	CD	NUMBER	—	num	6	SENT_812	[p24l608t1794r1004b1860],
4	54	CD	NUMBER	54	num	6	SENT_812	[p24l608t1794r1004b1860],
5	Hauser	NNP	ORGANIZATION	Hauser	nn	6	SENT_812	[p24l607t1909r872b1974],
6	IA	NNP	ORGANIZATION	IA	dep	1	SENT_812	[p24l899t1908r1015b1985],
7	,	,	O	,	_	0	SENT_812	[p24l899t1908r1015b1985],
8	Schaeffeler	NNP	O	Schaeffeler	nn	9	SENT_812	[p24l1051t1908r1471b1974],
9	E	NNP	O	E	appos	6	SENT_812	[p24l1498t1909r1574b1986],
10	,	,	O	,	_	0	SENT_812	[p24l1498t1909r1574b1986],
11	Gauer	NNP	PERSON	Gauer	nn	12	SENT_812	[p24l1608t1908r1835b1974],
12	S	NNP	O	S	appos	6	SENT_812	[p24l1865t1908r1931b1986],
13	,	,	O	,	_	0	SENT_812	[p24l1865t1908r1931b1986],
14	et	FW	O	et	nn	15	SENT_812	[p24l1965t1918r2031b1974],
15	al.	FW	O	al.	appos	6	SENT_812	[p24l2060t1908r2142b1974],
16	2005	CD	DATE	2005	dep	15	SENT_812	[p24l609t2021r811b2087],
17	.	.	O	.	_	0	SENT_812	[p24l609t2021r811b2087],

1	ABCBI	NNP	O	ABCBI	nn	2	SENT_813	[p24l844t2022r1135b2087],
2	genotype	NN	O	genotype	nsubj	15	SENT_813	[p24l1174t2031r1513b2106],
3	of	IN	O	of	_	0	SENT_813	[p24l1543t2021r1624b2086],
4	the	DT	O	the	det	5	SENT_813	[p24l1646t2021r1758b2086],
5	donor	NN	O	donor	prep_of	2	SENT_813	[p24l1788t2021r2005b2086],
6	but	CC	O	but	_	0	SENT_813	[p24l2030t2021r2149b2086],
7	not	RB	O	not	_	0	SENT_813	[p24l607t2144r726b2200],
8	of	IN	O	of	_	0	SENT_813	[p24l765t2134r846b2200],
9	the	DT	O	the	det	10	SENT_813	[p24l878t2134r990b2200],
10	recipient	JJ	O	recipient	conj_negcc	5	SENT_813	[p24l1029t2134r1357b2219],
11	is	VBZ	O	be	cop	15	SENT_813	[p24l1395t2134r1453b2199],
12	a	DT	O	a	det	15	SENT_813	[p24l1496t2155r1534b2200],
13	major	JJ	O	major	amod	15	SENT_813	[p24l1573t2134r1790b2219],
14	risk	NN	O	risk	nn	15	SENT_813	[p24l1827t2134r1968b2199],
15	factor	NN	O	factor	_	0	SENT_813	[p24l2006t2134r2144b2200, p24l607t2258r711b2313],
16	for	IN	O	for	_	0	SENT_813	[p24l740t2248r849b2313],
17	cyclosporine	NN	O	cyclosporine	nn	20	SENT_813	[p24l879t2248r1641b2332],
18	—	NN	O	—	nn	20	SENT_813	[p24l879t2248r1641b2332],
19	related	JJ	O	related	amod	20	SENT_813	[p24l879t2248r1641b2332],
20	nephrotoXicity	NN	O	nephrotoxicity	prep_for	15	SENT_813	[p24l1671t2248r2144b2332, p24l607t2361r703b2446],
21	after	IN	O	after	_	0	SENT_813	[p24l730t2361r900b2426],
22	renal	JJ	O	renal	amod	23	SENT_813	[p24l922t2361r1107b2426],
23	transplantation	NN	O	transplantation	prep_after	15	SENT_813	[p24l1132t2361r1706b2446],
24	.	.	O	.	_	0	SENT_813	[p24l1132t2361r1706b2446],

1	J.	NNP	O	J.	nn	2	SENT_814	[p24l1733t2364r1786b2427],
2	Am	NNP	O	Am	_	0	SENT_814	[p24l1814t2362r1957b2426],
3	.	.	O	.	_	0	SENT_814	[p24l1814t2362r1957b2426],

1	Soc	NN	O	soc	_	0	SENT_815	[p24l1991t2362r2138b2427],
2	.	.	O	.	_	0	SENT_815	[p24l1991t2362r2138b2427],

1	Nephrol	NNP	O	Nephrol	_	0	SENT_816	[p24l604t2474r926b2558],
2	.	.	O	.	_	0	SENT_816	[p24l604t2474r926b2558],

1	16	CD	NUMBER	16	num	2	SENT_817	[p24l966t2474r1046b2541],
2	(	CD	NUMBER	(	_	0	SENT_817	[p24l1077t2474r1526b2556],
3	5	CD	NUMBER	5	num	4	SENT_817	[p24l1077t2474r1526b2556],
4	)	NN	O	)	dep	2	SENT_817	[p24l1077t2474r1526b2556],
5	:	:	O	:	_	0	SENT_817	[p24l1077t2474r1526b2556],
6	l50l	NN	O	l50l	dep	10	SENT_817	[p24l1077t2474r1526b2556],
7	—	CD	NUMBER	—	num	8	SENT_817	[p24l1077t2474r1526b2556],
8	ll	NN	O	ll	dep	6	SENT_817	[p24l1077t2474r1526b2556],
9	Kim	NNP	O	Kim	dep	10	SENT_817	[p24l609t2588r772b2652],
10	RB	NN	O	rb	dep	20	SENT_817	[p24l812t2589r954b2664],
11	,	,	O	,	_	0	SENT_817	[p24l812t2589r954b2664],
12	Fromm	NNP	ORGANIZATION	Fromm	nn	13	SENT_817	[p24l997t2589r1272b2653],
13	MF	NN	ORGANIZATION	mf	appos	10	SENT_817	[p24l1311t2589r1464b2664],
14	,	,	O	,	_	0	SENT_817	[p24l1311t2589r1464b2664],
15	Wandel	NNP	ORGANIZATION	Wandel	nn	16	SENT_817	[p24l1507t2588r1789b2653],
16	C	NNP	ORGANIZATION	C	appos	10	SENT_817	[p24l1831t2588r1910b2664],
17	,	,	O	,	_	0	SENT_817	[p24l1831t2588r1910b2664],
18	et	FW	O	et	nn	19	SENT_817	[p24l1954t2598r2020b2653],
19	al.	FW	O	al.	appos	10	SENT_817	[p24l2060t2588r2142b2653],
20	1998	CD	DATE	1998	dep	2	SENT_817	[p24l616t2700r811b2766],
21	.	.	O	.	_	0	SENT_817	[p24l616t2700r811b2766],

1	The	DT	O	the	det	4	SENT_818	[p24l831t2700r974b2765],
2	drug	NN	O	drug	nn	4	SENT_818	[p24l991t2700r1158b2785],
3	transporter	NN	O	transporter	nn	4	SENT_818	[p24l1174t2710r1579b2785],
4	P	NN	O	p	_	0	SENT_818	[p24l1593t2700r2148b2785],
5	—	CD	NUMBER	—	num	7	SENT_818	[p24l1593t2700r2148b2785],
6	glycoprotein	NN	O	glycoprotein	nn	7	SENT_818	[p24l1593t2700r2148b2785],
7	limits	NNS	O	limit	dep	4	SENT_818	[p24l607t2813r816b2878],
8	oral	JJ	O	oral	amod	9	SENT_818	[p24l853t2813r995b2879],
9	absorption	NN	O	absorption	dep	7	SENT_818	[p24l1031t2813r1422b2898],
10	and	CC	O	and	_	0	SENT_818	[p24l1458t2813r1590b2879],
11	brain	NN	O	brain	nn	12	SENT_818	[p24l1622t2813r1813b2879],
12	entry	NN	O	entry	dep	7	SENT_818	[p24l1848t2823r2037b2898],
13	of	IN	O	of	_	0	SENT_818	[p24l2073t2813r2153b2879],
14	HIV-1	NN	MISC	hiv-1	nn	16	SENT_818	[p24l607t2927r832b2992],
15	protease	NN	O	protease	nn	16	SENT_818	[p24l866t2937r1176b3011],
16	inhibitors	NNS	O	inhibitor	prep_of	4	SENT_818	[p24l1203t2927r1578b2992],
17	.	.	O	.	_	0	SENT_818	[p24l1203t2927r1578b2992],

1	J.	NNP	PERSON	J.	nn	2	SENT_819	[p24l1608t2929r1661b2993],
2	Clin	NNP	PERSON	Clin	_	0	SENT_819	[p24l1702t2927r1871b2993],
3	.	.	O	.	_	0	SENT_819	[p24l1702t2927r1871b2993],

1	Invest	VB	O	invest	_	0	SENT_820	[p24l1904t2929r2142b2993],
2	.	.	O	.	_	0	SENT_820	[p24l1904t2929r2142b2993],

1	l0l	NN	O	l0l	_	0	SENT_821	[p24l616t3040r1051b3106],
2	:289	CD	NUMBER	:289	number	3	SENT_821	[p24l616t3040r1051b3106],
3	—	CD	NUMBER	—	dep	1	SENT_821	[p24l616t3040r1051b3106],
4	94	CD	NUMBER	94	dep	3	SENT_821	[p24l616t3040r1051b3106],

1	88	CD	NUMBER	88	_	0	SENT_822	[p24l10t3343r144b3425],
2	.	.	O	.	_	0	SENT_822	[p24l10t3343r144b3425],

1	Alsenz	NNP	PERSON	Alsenz	nn	2	SENT_823	[p24l205t3343r530b3425],
2	J	NNP	PERSON	J	_	0	SENT_823	[p24l559t3345r627b3440],
3	,	,	O	,	_	0	SENT_823	[p24l559t3345r627b3440],
4	Steffen	NNP	PERSON	Steffen	nn	8	SENT_823	[p24l663t3343r996b3425],
5	H	NNP	PERSON	H	nn	8	SENT_823	[p24l1024t3345r1132b3441],
6	,	,	O	,	_	0	SENT_823	[p24l1024t3345r1132b3441],
7	Alex	NNP	PERSON	Alex	appos	8	SENT_823	[p24l1165t3343r1390b3425],
8	R.	NNP	PERSON	R.	appos	2	SENT_823	[p24l1418t3345r1517b3425],
9	1998	CD	DATE	1998	num	8	SENT_823	[p24l1564t3343r1809b3427],
10	.	.	O	.	_	0	SENT_823	[p24l1564t3343r1809b3427],

1	Active	JJ	O	active	amod	4	SENT_824	[p24l1843t3343r2151b3425],
2	apical	JJ	O	apical	amod	4	SENT_824	[p24l208t3486r484b3594],
3	secretory	JJ	O	secretory	amod	4	SENT_824	[p24l544t3499r969b3594],
4	efﬂux	NN	O	efﬂux	_	0	SENT_824	[p24l1026t3486r1295b3569],
5	of	IN	O	of	_	0	SENT_824	[p24l1350t3486r1453b3569],
6	the	DT	O	the	det	10	SENT_824	[p24l1499t3486r1640b3569],
7	HIV	NN	MISC	hiv	nn	10	SENT_824	[p24l1695t3489r1902b3569],
8	protease	NN	O	protease	nn	10	SENT_824	[p24l1956t3513r2148b3594, p24l205t3644r438b3715],
9	inhibitors	NNS	O	inhibitor	nn	10	SENT_824	[p24l490t3631r937b3715],
10	saquinavir	NN	O	saquinavir	prep_of	4	SENT_824	[p24l996t3631r1482b3739],
11	and	CC	O	and	_	0	SENT_824	[p24l1532t3631r1699b3715],
12	ritonavir	NN	O	ritonavir	prep_of	4	SENT_824	[p24l1748t3631r2153b3715],
13	in	IN	O	in	_	0	SENT_824	[p25l205t26r294b107],
14	Coco-2	NN	O	coco-2	nn	16	SENT_824	[p25l340t26r682b108],
15	cell	NN	O	cell	nn	16	SENT_824	[p25l728t26r894b108],
16	monolayers	NNS	O	monolayer	prep_in	4	SENT_824	[p25l938t26r1510b132],
17	.	.	O	.	_	0	SENT_824	[p25l938t26r1510b132],

1	Pharm	NNP	O	Pharm	_	0	SENT_825	[p25l1558t26r1897b108],
2	.	.	O	.	_	0	SENT_825	[p25l1558t26r1897b108],

1	Res	NNP	O	Res	_	0	SENT_826	[p25l1950t29r2145b108],
2	.	.	O	.	_	0	SENT_826	[p25l1950t29r2145b108],

1	152423-28	CD	NUMBER	152423-28	num	3	SENT_827	[p25l217t170r704b252],
2	Lee	NNP	PERSON	Lee	nn	3	SENT_827	[p25l205t315r380b395],
3	CG	NNP	PERSON	CG	_	0	SENT_827	[p25l416t313r601b410],
4	,	,	O	,	_	0	SENT_827	[p25l416t313r601b410],
5	Gottesman	NNP	PERSON	Gottesman	nn	6	SENT_827	[p25l642t313r1149b396],
6	MM	NN	O	mm	appos	3	SENT_827	[p25l1184t315r1417b410],
7	,	,	O	,	_	0	SENT_827	[p25l1184t315r1417b410],
8	Cardarelli	NNP	ORGANIZATION	Cardarelli	nn	9	SENT_827	[p25l1457t312r1925b396],
9	CO	NNP	ORGANIZATION	CO	appos	3	SENT_827	[p25l1961t313r2147b410],
10	,	,	O	,	_	0	SENT_827	[p25l1961t313r2147b410],
11	et	FW	O	et	nn	12	SENT_827	[p25l207t470r290b540],
12	al.	FW	O	al.	appos	3	SENT_827	[p25l326t458r429b540],
13	1998	CD	DATE	1998	dep	12	SENT_827	[p25l481t458r727b542],
14	.	.	O	.	_	0	SENT_827	[p25l481t458r727b542],

1	HIV-1	NN	MISC	hiv-1	nn	3	SENT_828	[p25l769t458r1053b540],
2	protease	NN	O	protease	nn	3	SENT_828	[p25l1097t470r1488b564],
3	inhibitors	NNS	O	inhibitor	nsubj	5	SENT_828	[p25l1524t458r1971b540],
4	are	VBP	O	be	cop	5	SENT_828	[p25l2012t484r2151b540],
5	substrates	NNS	O	substrate	_	0	SENT_828	[p25l210t603r666b686],
6	for	IN	O	for	_	0	SENT_828	[p25l699t603r836b686],
7	the	DT	O	the	det	10	SENT_828	[p25l864t603r1005b686],
8	MDR1	NN	O	mdr1	nn	10	SENT_828	[p25l1035t603r1351b684],
9	multidrug	JJ	O	multidrug	amod	10	SENT_828	[p25l1391t603r1854b711],
10	transporter	NN	O	transporter	prep_for	5	SENT_828	[p25l1885t616r2148b686, p25l204t759r502b854],
11	.	.	O	.	_	0	SENT_828	[p25l1885t616r2148b686, p25l204t759r502b854],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_829	[p25l576t746r1198b853],
2	(	CD	NUMBER	(	num	1	SENT_829	[p25l1279t749r1586b849],
3	Mosc	NNP	O	Mosc	dep	1	SENT_829	[p25l1279t749r1586b849],
4	.	.	O	.	_	0	SENT_829	[p25l1279t749r1586b849],
5	)	NN	O	)	dep	1	SENT_829	[p25l1602t749r1634b849],

1	37:35943601	CD	NUMBER	37:35943601	num	4	SENT_830	[p25l1711t746r2153b831, p25l209t892r429b974],
2	Polli	NNP	PERSON	Polli	nn	4	SENT_830	[p25l205t1037r426b1120],
3	J	NNP	PERSON	J	nn	4	SENT_830	[p25l454t1040r497b1120],
4	W	NNP	PERSON	W	_	0	SENT_830	[p25l500t1039r634b1135],
5	,	,	O	,	_	0	SENT_830	[p25l500t1039r634b1135],
6	Jarrett	NNP	PERSON	Jarrett	nn	7	SENT_830	[p25l666t1039r961b1120],
7	JL	NNP	O	JL	appos	4	SENT_830	[p25l987t1040r1128b1135],
8	,	,	O	,	_	0	SENT_830	[p25l987t1040r1128b1135],
9	Studenberg	NNP	O	Studenberg	nn	10	SENT_830	[p25l1165t1037r1693b1145],
10	SD	NN	O	sd	appos	4	SENT_830	[p25l1727t1037r1896b1135],
11	,	,	O	,	_	0	SENT_830	[p25l1727t1037r1896b1135],
12	et	FW	O	et	nn	13	SENT_830	[p25l1930t1050r2012b1120],
13	al.	FW	O	al.	appos	4	SENT_830	[p25l2042t1037r2145b1120],
14	1999	CD	DATE	1999	dep	13	SENT_830	[p25l217t1181r462b1265],
15	.	.	O	.	_	0	SENT_830	[p25l217t1181r462b1265],

1	Role	NN	O	role	_	0	SENT_831	[p25l500t1181r719b1264],
2	of	IN	O	of	_	0	SENT_831	[p25l752t1180r853b1264],
3	P	NN	O	p	nn	5	SENT_831	[p25l876t1180r1575b1288],
4	—	CD	NUMBER	—	num	5	SENT_831	[p25l876t1180r1575b1288],
5	glycoprotein	NN	O	glycoprotein	prep_of	1	SENT_831	[p25l876t1180r1575b1288],
6	on	IN	O	on	_	0	SENT_831	[p25l1608t1207r1721b1264],
7	the	DT	O	the	det	9	SENT_831	[p25l1752t1181r1893b1264],
8	CNS	NN	O	cn	nn	9	SENT_831	[p25l1925t1181r2145b1264],
9	disposition	NN	O	disposition	prep_on	1	SENT_831	[p25l207t1326r722b1432],
10	of	IN	O	of	_	0	SENT_831	[p25l768t1326r870b1408],
11	amprenavir	NN	O	amprenavir	nn	14	SENT_831	[p25l910t1326r1442b1432],
12	(	CD	NUMBER	(	num	14	SENT_831	[p25l1489t1326r1993b1427],
13	141W94	NN	O	141w94	nn	14	SENT_831	[p25l1489t1326r1993b1427],
14	)	NN	O	)	prep_of	1	SENT_831	[p25l1489t1326r1993b1427],
15	,	,	O	,	_	0	SENT_831	[p25l1489t1326r1993b1427],
16	an	DT	O	a	det	19	SENT_831	[p25l2045t1351r2152b1408],
17	HIV	NN	MISC	hiv	nn	19	SENT_831	[p25l206t1473r412b1554],
18	protease	NN	O	protease	nn	19	SENT_831	[p25l456t1484r848b1579],
19	inhibitor	NN	O	inhibitor	appos	14	SENT_831	[p25l893t1471r1314b1554],
20	.	.	O	.	_	0	SENT_831	[p25l893t1471r1314b1554],

1	Pharm	NNP	O	Pharm	_	0	SENT_832	[p25l1363t1471r1702b1554],
2	.	.	O	.	_	0	SENT_832	[p25l1363t1471r1702b1554],

1	Res	NNP	O	Res	_	0	SENT_833	[p25l1757t1474r1952b1554],
2	.	.	O	.	_	0	SENT_833	[p25l1757t1474r1952b1554],

1	16	CD	NUMBER	16	_	0	SENT_834	[p25l2015t1471r2143b1554],
2	:	:	O	:	_	0	SENT_834	[p25l2015t1471r2143b1554],
3	1206-12	CD	DATE	1206-12	dep	1	SENT_834	[p25l217t1613r616b1697],
4	Fellay	NNP	O	Fellay	nn	5	SENT_834	[p25l205t1759r497b1865],
5	J	NNP	O	J	dep	1	SENT_834	[p25l535t1760r603b1856],
6	,	,	O	,	_	0	SENT_834	[p25l535t1760r603b1856],
7	Marzolini	NNP	PERSON	Marzolini	nn	8	SENT_834	[p25l645t1759r1108b1841],
8	C	NNP	O	C	appos	1	SENT_834	[p25l1148t1759r1247b1856],
9	,	,	O	,	_	0	SENT_834	[p25l1148t1759r1247b1856],
10	Meaden	NNP	PERSON	Meaden	nn	11	SENT_834	[p25l1288t1759r1667b1841],
11	ER	NN	O	er	appos	1	SENT_834	[p25l1705t1760r1878b1856],
12	,	,	O	,	_	0	SENT_834	[p25l1705t1760r1878b1856],
13	et	FW	O	et	nn	14	SENT_834	[p25l1920t1771r2003b1841],
14	al.	FW	O	al.	appos	1	SENT_834	[p25l2042t1759r2145b1841],
15	2002	CD	DATE	2002	dep	14	SENT_834	[p25l207t1904r462b1987],
16	.	.	O	.	_	0	SENT_834	[p25l207t1904r462b1987],

1	Response	NN	O	response	_	0	SENT_835	[p25l539t1907r989b2012],
2	to	TO	O	to	_	0	SENT_835	[p25l1061t1917r1148b1987],
3	antiretroviral	JJ	O	antiretroviral	amod	4	SENT_835	[p25l1223t1904r1833b1987],
4	treatment	NN	O	treatment	prep_to	1	SENT_835	[p25l1904t1917r2148b1987, p25l206t2059r441b2129],
5	in	IN	O	in	_	0	SENT_835	[p25l484t2046r573b2128],
6	HIV	NN	MISC	hiv	nn	7	SENT_835	[p25l619t2046r1335b2129],
7	—	NN	O	—	prep_in	4	SENT_835	[p25l619t2046r1335b2129],
8	l	NN	O	l	tmod	4	SENT_835	[p25l619t2046r1335b2129],
9	—	RB	O	—	advmod	10	SENT_835	[p25l619t2046r1335b2129],
10	infected	JJ	O	infected	amod	11	SENT_835	[p25l619t2046r1335b2129],
11	individuals	NNS	O	individual	npadvmod	1	SENT_835	[p25l1379t2046r1895b2130],
12	with	IN	O	with	_	0	SENT_835	[p25l1944t2046r2152b2130],
13	allelic	JJ	O	allelic	amod	14	SENT_835	[p25l208t2192r489b2274],
14	Variants	NNS	O	variant	prep_with	1	SENT_835	[p25l517t2192r883b2274],
15	of	IN	O	of	_	0	SENT_835	[p25l913t2192r1015b2274],
16	the	DT	O	the	det	19	SENT_835	[p25l1032t2192r1173b2274],
17	multidru	FW	O	multidru	nn	19	SENT_835	[p25l1198t2192r1602b2274],
18	g	NN	O	g	nn	19	SENT_835	[p25l1608t2217r1661b2298],
19	resistance	NN	O	resistance	prep_of	14	SENT_835	[p25l1686t2192r2151b2274],
20	transporter	NN	O	transporter	dep	19	SENT_835	[p25l205t2350r717b2445],
21	1	CD	NUMBER	1	num	20	SENT_835	[p25l767t2338r837b2420],
22	:	:	O	:	_	0	SENT_835	[p25l767t2338r837b2420],
23	a	DT	O	a	det	24	SENT_835	[p25l888t2364r937b2420],
24	pharmacogenetics	NNS	O	pharmacogenetic	dep	1	SENT_835	[p25l975t2337r1824b2445],
25	study	NN	O	study	dep	24	SENT_835	[p25l1873t2337r2145b2445],
26	.	.	O	.	_	0	SENT_835	[p25l1873t2337r2145b2445],

1	Lancet	NNP	O	Lancet	_	0	SENT_836	[p25l203t2482r529b2562],
2	359130-36	CD	NUMBER	359130-36	num	4	SENT_836	[p25l560t2479r1059b2563],
3	Roberts	NNP	ORGANIZATION	Roberts	nn	4	SENT_836	[p25l206t2625r568b2707],
4	R	NN	ORGANIZATION	r	dep	1	SENT_836	[p25l629t2626r730b2722],
5	,	,	O	,	_	0	SENT_836	[p25l629t2626r730b2722],
6	Joyce	NNP	PERSON	Joyce	nn	7	SENT_836	[p25l791t2626r1057b2731],
7	P	NN	PERSON	p	appos	4	SENT_836	[p25l1116t2626r1203b2722],
8	,	,	O	,	_	0	SENT_836	[p25l1116t2626r1203b2722],
9	Mulder	NNP	ORGANIZATION	Mulder	nn	10	SENT_836	[p25l1266t2625r1613b2707],
10	RT	NN	ORGANIZATION	rt	appos	4	SENT_836	[p25l1670t2626r1836b2722],
11	,	,	O	,	_	0	SENT_836	[p25l1670t2626r1836b2722],
12	et	FW	O	et	nn	13	SENT_836	[p25l1900t2637r1982b2707],
13	al.	FW	O	al.	appos	4	SENT_836	[p25l2042t2625r2145b2707],
14	2002	CD	DATE	2002	dep	13	SENT_836	[p25l207t2770r462b2853],
15	.	.	O	.	_	0	SENT_836	[p25l207t2770r462b2853],

1	A	DT	O	a	det	3	SENT_837	[p25l529t2771r612b2851],
2	common	JJ	O	common	amod	3	SENT_837	[p25l673t2797r1083b2853],
3	P	NN	O	p	nsubj	12	SENT_837	[p25l1144t2770r1844b2878],
4	—	CD	NUMBER	—	num	6	SENT_837	[p25l1144t2770r1844b2878],
5	g1ycoprotein	NN	O	g1ycoprotein	nn	6	SENT_837	[p25l1144t2770r1844b2878],
6	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_837	[p25l1903t2770r2148b2878, p25l205t2913r684b3021],
7	is	VBZ	O	be	auxpass	8	SENT_837	[p25l810t2913r883b2996],
8	associated	VBN	O	associate	rcmod	3	SENT_837	[p25l1015t2913r1496b2996],
9	with	IN	O	with	_	0	SENT_837	[p25l1624t2913r1830b2997],
10	nortriptyline	NN	O	nortriptyline	nn	11	SENT_837	[p25l1957t2940r2148b2996, p25l205t3059r1051b3165],
11	—	NN	O	—	prep_with	8	SENT_837	[p25l1957t2940r2148b2996, p25l205t3059r1051b3165],
12	induced	VBD	O	induce	_	0	SENT_837	[p25l1957t2940r2148b2996, p25l205t3059r1051b3165],
13	postural	JJ	O	postural	amod	14	SENT_837	[p25l1106t3059r1485b3165],
14	hypertension	NN	O	hypertension	dobj	12	SENT_837	[p25l1542t3059r2152b3165],
15	in	IN	O	in	_	0	SENT_837	[p25l205t3203r294b3284],
16	patients	NNS	O	patient	prep_in	12	SENT_837	[p25l340t3203r703b3309],
17	treated	VBN	O	treat	partmod	16	SENT_837	[p25l753t3203r1073b3285],
18	for	IN	O	for	_	0	SENT_837	[p25l1119t3203r1255b3285],
19	major	JJ	O	major	amod	20	SENT_837	[p25l1299t3203r1575b3309],
20	depression	NN	O	depression	prep_for	17	SENT_837	[p25l1620t3203r2145b3309],
21	.	.	O	.	_	0	SENT_837	[p25l1620t3203r2145b3309],

1	Pharmacogenom	NNP	O	Pharmacogenom	_	0	SENT_838	[p25l204t3345r1027b3451],
2	.	.	O	.	_	0	SENT_838	[p25l204t3345r1027b3451],

1	J.	NNP	O	J.	nn	5	SENT_839	[p25l1068t3348r1143b3429],
2	2:191	CD	NUMBER	2:191	num	5	SENT_839	[p25l1184t3345r1624b3429],
3	-96	CD	NUMBER	-96	num	5	SENT_839	[p25l1184t3345r1624b3429],
4	Tirona	NNP	O	Tirona	nn	5	SENT_839	[p25l205t3491r516b3574],
5	ERG	NNP	O	ERG	_	0	SENT_839	[p25l551t3491r810b3588],
6	,	,	O	,	_	0	SENT_839	[p25l551t3491r810b3588],
7	Leake	NNP	PERSON	Leake	nn	8	SENT_839	[p25l853t3491r1138b3574],
8	BF	NNP	O	BF	appos	5	SENT_839	[p25l1176t3492r1343b3588],
9	,	,	O	,	_	0	SENT_839	[p25l1176t3492r1343b3588],
10	Merino	NNP	O	Merino	nn	11	SENT_839	[p25l1385t3491r1729b3574],
11	G	NNP	O	G	appos	5	SENT_839	[p25l1771t3491r1876b3588],
12	,	,	O	,	_	0	SENT_839	[p25l1771t3491r1876b3588],
13	et	FW	O	et	nn	14	SENT_839	[p25l1920t3502r2003b3574],
14	al.	FW	O	al.	appos	5	SENT_839	[p25l2042t3491r2145b3574],
15	2001	CD	DATE	2001	dep	14	SENT_839	[p25l207t3636r462b3718],
16	.	.	O	.	_	0	SENT_839	[p25l207t3636r462b3718],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_840	[p25l495t3636r1232b3742],
2	in	IN	O	in	_	0	SENT_840	[p25l1261t3636r1350b3717],
3	OAT	NN	O	oat	nn	4	SENT_840	[p25l1379t3636r1599b3719],
4	P-C	NN	O	p-c	prep_in	1	SENT_840	[p25l1602t3636r1806b3718],
5	.	.	O	.	_	0	SENT_840	[p25l1602t3636r1806b3718],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_841	[p25l1839t3636r2148b3718, p26l207t25r557b108],

1	of	IN	O	of	_	0	SENT_842	[p26l584t25r687b108],
2	multiple	JJ	O	multiple	amod	4	SENT_842	[p26l704t25r1094b133],
3	allelic	JJ	O	allelic	amod	4	SENT_842	[p26l1123t25r1404b108],
4	variants	NNS	O	variant	pobj	1	SENT_842	[p26l1432t25r1797b109],
5	associated	VBN	O	associate	partmod	4	SENT_842	[p26l1828t25r2148b108, p26l208t170r400b254],
6	with	IN	O	with	_	0	SENT_842	[p26l428t170r635b254],
7	altered	JJ	O	altered	amod	9	SENT_842	[p26l666t170r983b254],
8	transport	NN	O	transport	nn	9	SENT_842	[p26l1010t183r1430b278],
9	activity	NN	O	activity	prep_with	5	SENT_842	[p26l1458t170r1803b278],
10	among	IN	O	among	_	0	SENT_842	[p26l1835t197r2150b278],
11	European	JJ	MISC	european	amod	12	SENT_842	[p26l205t318r692b422],
12	—	NN	O	—	prep_among	9	SENT_842	[p26l205t318r692b422],
13	and	CC	O	and	_	0	SENT_842	[p26l788t316r955b398],
14	African-Americans	NNPS	MISC	African-Americans	conj_and	12	SENT_842	[p26l1044t316r1978b398],
15	.	.	O	.	_	0	SENT_842	[p26l1044t316r1978b398],

1	J.	NNP	O	J.	nn	2	SENT_843	[p26l2072t319r2140b399],
2	Biol	NNP	O	Biol	_	0	SENT_843	[p26l203t458r418b541],
3	.	.	O	.	_	0	SENT_843	[p26l203t458r418b541],

1	Chem	NNP	O	Chem	_	0	SENT_844	[p26l468t458r758b542],
2	.	.	O	.	_	0	SENT_844	[p26l468t458r758b542],

1	276:35669	CD	NUMBER	276:35669	number	2	SENT_845	[p26l799t458r1472b542],
2	—	CD	NUMBER	—	_	0	SENT_845	[p26l799t458r1472b542],
3	75	CD	NUMBER	75	num	5	SENT_845	[p26l799t458r1472b542],
4	Nishizato	NNP	O	Nishizato	nn	5	SENT_845	[p26l205t602r654b686],
5	Y	NN	O	y	dep	2	SENT_845	[p26l685t605r792b700],
6	,	,	O	,	_	0	SENT_845	[p26l685t605r792b700],
7	Ieiri	NNP	O	Ieiri	nn	11	SENT_845	[p26l826t602r1018b685],
8	I	PRP	O	I	dep	11	SENT_845	[p26l1048t605r1109b700],
9	,	,	O	,	_	0	SENT_845	[p26l1048t605r1109b700],
10	Suzuki	NNP	PERSON	Suzuki	dep	11	SENT_845	[p26l1146t602r1466b686],
11	H	NNP	O	H	appos	2	SENT_845	[p26l1496t605r1604b700],
12	,	,	O	,	_	0	SENT_845	[p26l1496t605r1604b700],
13	et	FW	O	et	nn	14	SENT_845	[p26l1638t615r1721b685],
14	al.	FW	O	al.	appos	11	SENT_845	[p26l1750t602r1854b686],
15	2003	CD	DATE	2003	dep	14	SENT_845	[p26l1890t603r2145b686],
16	.	.	O	.	_	0	SENT_845	[p26l1890t603r2145b686],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_846	[p26l205t748r942b854],
2	of	IN	O	of	_	0	SENT_846	[p26l996t748r1098b830],
3	OATP	NN	O	oatp	prep_of	1	SENT_846	[p26l1141t748r1544b830],
4	.	.	O	.	_	0	SENT_846	[p26l1141t748r1544b830],

1	—	NN	O	—	_	0	SENT_847	[p26l1141t748r1544b830],
2	.	.	O	.	_	0	SENT_847	[p26l1141t748r1544b830],

1	C	NN	O	c	nn	4	SENT_848	[p26l1141t748r1544b830],
2	(	CD	NUMBER	(	num	4	SENT_848	[p26l1599t748r2147b849],
3	SLC2lA6	NN	O	slc2la6	nn	4	SENT_848	[p26l1599t748r2147b849],
4	)	NN	O	)	_	0	SENT_848	[p26l1599t748r2147b849],
5	and	CC	O	and	_	0	SENT_848	[p26l208t891r375b974],
6	OAT3	NN	O	oat3	conj_and	4	SENT_848	[p26l459t892r733b975],
7	(	CD	NUMBER	(	num	10	SENT_848	[p26l826t892r1374b994],
8	SLC22A8	NN	O	slc22a8	nn	10	SENT_848	[p26l826t892r1374b994],
9	)	NN	O	)	nn	10	SENT_848	[p26l826t892r1374b994],
10	genes	NNS	O	gene	dep	6	SENT_848	[p26l1464t918r1754b999],
11	:	:	O	:	_	0	SENT_848	[p26l1464t918r1754b999],
12	consequences	NNS	O	consequence	dep	4	SENT_848	[p26l1846t918r2148b974, p26l207t1063r581b1144],
13	for	IN	O	for	_	0	SENT_848	[p26l604t1036r741b1120],
14	pravastatin	NN	O	pravastatin	nn	15	SENT_848	[p26l758t1036r1270b1144],
15	pharmacokinetics	NNS	O	pharmacokinetic	prep_for	12	SENT_848	[p26l1289t1036r2145b1144],
16	.	.	O	.	_	0	SENT_848	[p26l1289t1036r2145b1144],

1	Clin	NNP	O	Clin	_	0	SENT_849	[p26l212t1182r424b1266],
2	.	.	O	.	_	0	SENT_849	[p26l212t1182r424b1266],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_850	[p26l467t1182r1010b1265],
2	.	.	O	.	_	0	SENT_850	[p26l467t1182r1010b1265],

1	Ther	NNP	O	Ther	_	0	SENT_851	[p26l1059t1182r1297b1265],
2	.	.	O	.	_	0	SENT_851	[p26l1059t1182r1297b1265],

1	73:554	CD	NUMBER	73:554	num	5	SENT_852	[p26l1337t1182r1833b1265],
2	—	CD	NUMBER	—	num	5	SENT_852	[p26l1337t1182r1833b1265],
3	65	CD	NUMBER	65	num	5	SENT_852	[p26l1337t1182r1833b1265],
4	Mwinyi	NNP	PERSON	Mwinyi	nn	5	SENT_852	[p26l205t1327r575b1435],
5	J	NNP	PERSON	J	_	0	SENT_852	[p26l611t1330r679b1424],
6	,	,	O	,	_	0	SENT_852	[p26l611t1330r679b1424],
7	J	NNP	O	J	nn	9	SENT_852	[p26l720t1330r763b1410],
8	ohne	NN	O	ohne	nn	9	SENT_852	[p26l768t1327r993b1410],
9	A	NN	O	a	appos	5	SENT_852	[p26l1029t1328r1137b1425],
10	,	,	O	,	_	0	SENT_852	[p26l1029t1328r1137b1425],
11	Bauer	NNP	PERSON	Bauer	nn	12	SENT_852	[p26l1177t1330r1459b1410],
12	S	NNP	O	S	appos	5	SENT_852	[p26l1496t1327r1581b1425],
13	,	,	O	,	_	0	SENT_852	[p26l1496t1327r1581b1425],
14	et	FW	O	et	nn	15	SENT_852	[p26l1622t1340r1705b1410],
15	al.	FW	O	al.	appos	5	SENT_852	[p26l1743t1327r1846b1410],
16	2004	CD	DATE	2004	dep	15	SENT_852	[p26l1890t1327r2145b1410],
17	.	.	O	.	_	0	SENT_852	[p26l1890t1327r2145b1410],

1	Evidence	NN	O	evidence	_	0	SENT_853	[p26l205t1469r643b1553],
2	for	IN	O	for	_	0	SENT_853	[p26l705t1469r842b1553],
3	inverse	JJ	O	inverse	amod	4	SENT_853	[p26l902t1469r1233b1553],
4	effects	NNS	O	effect	prep_for	1	SENT_853	[p26l1296t1469r1602b1553],
5	of	IN	O	of	_	0	SENT_853	[p26l1668t1469r1770b1553],
6	OATPC	NN	O	oatpc	nn	8	SENT_853	[p26l1825t1470r2148b1553, p26l207t1615r280b1697],
7	(	CD	NUMBER	(	num	8	SENT_853	[p26l359t1615r907b1717],
8	SLC2lA6	NN	O	slc2la6	prep_of	4	SENT_853	[p26l359t1615r907b1717],
9	)	CD	NUMBER	)	num	8	SENT_853	[p26l359t1615r907b1717],
10	*	NN	O	*	dep	1	SENT_853	[p26l988t1615r1083b1697],
11	5	CD	NUMBER	5	num	10	SENT_853	[p26l988t1615r1083b1697],
12	and	CC	O	and	_	0	SENT_853	[p26l1165t1615r1331b1697],
13	*	CD	NUMBER	*	num	15	SENT_853	[p26l1407t1615r1566b1697],
14	lb	NN	O	lb	nn	15	SENT_853	[p26l1407t1615r1566b1697],
15	haplotypes	NNS	O	haplotype	conj_and	10	SENT_853	[p26l1641t1615r2148b1721],
16	on	IN	O	on	_	0	SENT_853	[p26l207t1785r321b1841],
17	pravastatin	NN	O	pravastatin	nn	18	SENT_853	[p26l354t1758r867b1866],
18	kinetics	NNS	O	kinetics	prep_on	15	SENT_853	[p26l902t1758r1290b1841],
19	.	.	O	.	_	0	SENT_853	[p26l902t1758r1290b1841],

1	Clin	NNP	O	Clin	_	0	SENT_854	[p26l1339t1758r1552b1842],
2	.	.	O	.	_	0	SENT_854	[p26l1339t1758r1552b1842],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_855	[p26l1597t1758r2140b1841],
2	.	.	O	.	_	0	SENT_855	[p26l1597t1758r2140b1841],

1	Ther	NNP	O	Ther	_	0	SENT_856	[p26l210t1902r449b1986],
2	.	.	O	.	_	0	SENT_856	[p26l210t1902r449b1986],

1	752415-21	CD	NUMBER	752415-21	_	0	SENT_857	[p26l489t1902r980b1986],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_858	[p26l205t2049r497b2132],
2	M	NNP	O	M	_	0	SENT_858	[p26l549t2051r676b2146],
3	,	,	O	,	_	0	SENT_858	[p26l549t2051r676b2146],
4	Schaeffeler	NNP	O	Schaeffeler	nn	5	SENT_858	[p26l736t2049r1267b2132],
5	E	NNP	O	E	appos	2	SENT_858	[p26l1315t2051r1410b2146],
6	,	,	O	,	_	0	SENT_858	[p26l1315t2051r1410b2146],
7	Lang	NNP	PERSON	Lang	nn	8	SENT_858	[p26l1464t2051r1704b2156],
8	T	NN	O	t	appos	2	SENT_858	[p26l1756t2051r1851b2146],
9	,	,	O	,	_	0	SENT_858	[p26l1756t2051r1851b2146],
10	et	FW	O	et	nn	11	SENT_858	[p26l1907t2062r1990b2132],
11	al.	FW	O	al.	appos	2	SENT_858	[p26l2042t2049r2145b2132],
12	2004	CD	DATE	2004	dep	11	SENT_858	[p26l207t2193r462b2276],
13	.	.	O	.	_	0	SENT_858	[p26l207t2193r462b2276],

1	High	JJ	O	high	amod	4	SENT_859	[p26l497t2192r730b2300],
2	plasma	NN	O	plasma	nn	4	SENT_859	[p26l756t2192r1091b2300],
3	pravastatin	NN	O	pravastatin	nn	4	SENT_859	[p26l1116t2192r1628b2300],
4	concentrations	NNS	O	concentration	nsubjpass	6	SENT_859	[p26l1656t2205r2148b2275, p26l205t2337r430b2421],
5	are	VBP	O	be	auxpass	6	SENT_859	[p26l459t2364r597b2421],
6	associated	VBN	O	associate	_	0	SENT_859	[p26l623t2337r1105b2421],
7	with	IN	O	with	_	0	SENT_859	[p26l1128t2337r1336b2421],
8	single	JJ	O	single	amod	10	SENT_859	[p26l1363t2337r1637b2445],
9	nucleotide	NN	O	nucleotide	nn	10	SENT_859	[p26l1662t2337r2150b2421],
10	polymorphisms	NNS	O	polymorphism	prep_with	6	SENT_859	[p26l204t2483r936b2589],
11	and	CC	O	and	_	0	SENT_859	[p26l1018t2483r1184b2565],
12	haplotypes	NNS	O	haplotype	conj_and	10	SENT_859	[p26l1260t2483r1767b2589],
13	of	IN	O	of	_	0	SENT_859	[p26l1848t2483r1950b2565],
14	organic	JJ	O	organic	amod	15	SENT_859	[p26l2020t2508r2148b2565, p26l207t2626r457b2734],
15	anion	NN	O	anion	prep_of	10	SENT_859	[p26l525t2626r782b2709],
16	transporting	VBG	O	transport	xcomp	6	SENT_859	[p26l845t2626r1412b2734],
17	polypeptide	NN	O	polypeptide	dobj	16	SENT_859	[p26l1477t2626r2149b2734],
18	.	.	O	.	_	0	SENT_859	[p26l1477t2626r2149b2734],

1	—	NN	O	—	_	0	SENT_860	[p26l1477t2626r2149b2734],
2	.	.	O	.	_	0	SENT_860	[p26l1477t2626r2149b2734],

1	C	NN	O	c	_	0	SENT_861	[p26l1477t2626r2149b2734],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	_	0	SENT_862	[p26l1248t2812r1650b2839],
2	137	CD	NUMBER	137	num	1	SENT_862	[p26l1742t2809r1801b2839],

1	(	NN	O	(	_	0	SENT_863	[p26l646t3043r1008b3122],
2	OATP	NN	O	oatp	dep	1	SENT_863	[p26l646t3043r1008b3122],
3	.	.	O	.	_	0	SENT_863	[p26l646t3043r1008b3122],

1	—	NN	O	—	_	0	SENT_864	[p26l646t3043r1008b3122],
2	.	.	O	.	_	0	SENT_864	[p26l646t3043r1008b3122],

1	C	NN	O	c	_	0	SENT_865	[p26l646t3043r1008b3122],
2	,	,	O	,	_	0	SENT_865	[p26l646t3043r1008b3122],
3	SLCOlB	NN	O	slcolb	nn	5	SENT_865	[p26l1061t3043r1392b3107],
4	1	CD	NUMBER	1	num	5	SENT_865	[p26l1409t3043r1492b3122],
5	)	NN	O	)	appos	1	SENT_865	[p26l1409t3043r1492b3122],
6	.	.	O	.	_	0	SENT_865	[p26l1409t3043r1492b3122],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_866	[p26l1542t3043r2147b3125, p26l646t3155r742b3218],
2	14:429	CD	NUMBER	14:429	number	3	SENT_866	[p26l777t3154r1157b3218],
3	—	CD	NUMBER	—	dep	1	SENT_866	[p26l777t3154r1157b3218],
4	4O	NN	O	4o	dep	3	SENT_866	[p26l777t3154r1157b3218],

1	97	CD	NUMBER	97	_	0	SENT_867	[p26l489t3266r596b3331],
2	.	.	O	.	_	0	SENT_867	[p26l489t3266r596b3331],

1	Niemi	NNP	PERSON	Niemi	nn	2	SENT_868	[p26l643t3266r869b3330],
2	M	NNP	O	M	_	0	SENT_868	[p26l923t3267r1022b3341],
3	,	,	O	,	_	0	SENT_868	[p26l923t3267r1022b3341],
4	Neuvonen	NNP	PERSON	Neuvonen	nn	5	SENT_868	[p26l1079t3267r1452b3330],
5	PJ	NNP	PERSON	PJ	appos	2	SENT_868	[p26l1506t3267r1609b3341],
6	,	,	O	,	_	0	SENT_868	[p26l1506t3267r1609b3341],
7	Hofmann	NNP	ORGANIZATION	Hofmann	nn	8	SENT_868	[p26l1666t3266r2010b3330],
8	U	NNP	ORGANIZATION	U	appos	2	SENT_868	[p26l2064t3267r2147b3341],
9	,	,	O	,	_	0	SENT_868	[p26l2064t3267r2147b3341],
10	et	FW	O	et	nn	11	SENT_868	[p26l644t3386r708b3440],
11	al.	FW	O	al.	appos	2	SENT_868	[p26l729t3376r808b3440],
12	2005	CD	DATE	2005	dep	11	SENT_868	[p26l835t3376r1032b3440],
13	.	.	O	.	_	0	SENT_868	[p26l835t3376r1032b3440],

1	Acute	JJ	O	acute	amod	2	SENT_869	[p26l1057t3376r1273b3440],
2	effects	NNS	O	effect	nsubjpass	9	SENT_869	[p26l1294t3376r1530b3440],
3	of	IN	O	of	_	0	SENT_869	[p26l1553t3376r1632b3440],
4	pravastatin	NN	O	pravastatin	prep_of	2	SENT_869	[p26l1644t3376r2042b3458],
5	on	IN	O	on	_	0	SENT_869	[p26l2062t3396r2151b3440],
6	cholesterol	NN	O	cholesterol	nn	7	SENT_869	[p26l644t3486r1042b3550],
7	synthesis	NN	O	synthesis	prep_on	4	SENT_869	[p26l1079t3486r1407b3569],
8	are	VBP	O	be	auxpass	9	SENT_869	[p26l1443t3507r1550b3550],
9	associated	VBN	O	associate	_	0	SENT_869	[p26l1585t3486r1958b3550],
10	with	IN	O	with	_	0	SENT_869	[p26l1990t3486r2151b3550],
11	SLCOIBI	NN	O	slcoibus	prep_with	9	SENT_869	[p26l646t3597r1020b3661],
12	(	CD	NUMBER	(	num	11	SENT_869	[p26l1070t3596r1431b3679],
13	encoding	VBG	O	encode	xcomp	9	SENT_869	[p26l1070t3596r1431b3679],
14	OATPIBI	NNP	O	OATPIBI	nn	16	SENT_869	[p26l1474t3597r1876b3675],
15	)	CD	NUMBER	)	num	16	SENT_869	[p26l1474t3597r1876b3675],
16	haplotype	NN	O	haplotype	dobj	13	SENT_869	[p26l1918t3596r2147b3679, p26l643t3717r798b3789],
17	*	CD	NUMBER	*	num	18	SENT_869	[p26l832t3707r974b3771],
18	l7	NN	O	l7	dep	16	SENT_869	[p26l832t3707r974b3771],
19	.	.	O	.	_	0	SENT_869	[p26l832t3707r974b3771],

1	Pharmacogenet	NNP	O	Pharmacogenet	_	0	SENT_870	[p26l1008t3707r1600b3789],
2	.	.	O	.	_	0	SENT_870	[p26l1008t3707r1600b3789],

1	Genomics	NNS	O	genomic	_	0	SENT_871	[p26l1644t3708r2004b3771],
2	15	CD	NUMBER	15	num	1	SENT_871	[p26l2044t3707r2144b3771],
3	:	:	O	:	_	0	SENT_871	[p26l2044t3707r2144b3771],

1	Annu	NNP	PERSON	Annu	_	0	SENT_872	[p27l8t2965r64b3161],
2	.	.	O	.	_	0	SENT_872	[p27l8t2965r64b3161],

1	Rev.	NNP	O	Rev.	nn	2	SENT_873	[p27l8t2792r64b2938],
2	Med	NNP	O	Med	_	0	SENT_873	[p27l7t2602r64b2766],
3	.	.	O	.	_	0	SENT_873	[p27l7t2602r64b2766],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_874	[p27l7t2295r65b2574],
2	:	:	O	:	_	0	SENT_874	[p27l7t2295r65b2574],
3	1	CD	NUMBER	1	num	4	SENT_874	[p27l7t2255r64b2279],
4	19	CD	NUMBER	19	dep	1	SENT_874	[p27l7t2142r65b2238],
5	-	:	O	-	_	0	SENT_874	[p27l7t2142r65b2238],
6	137	CD	NUMBER	137	dep	4	SENT_874	[p27l7t2000r65b2129],
7	.	.	O	.	_	0	SENT_874	[p27l7t2000r65b2129],

1	Downloaded	VBN	O	download	_	0	SENT_875	[p27l7t1557r64b1973],
2	from	IN	O	from	_	0	SENT_875	[p27l7t1378r64b1536],
3	www.annualreviews.org	NN	O	www.annualreviews.org	prep_from	1	SENT_875	[p27l7t561r81b1355],
4	by	IN	O	by	_	0	SENT_875	[p27l89t2997r163b3077],
5	University	NNP	ORGANIZATION	University	prep_by	1	SENT_875	[p27l88t2633r163b2974],
6	of	IN	ORGANIZATION	of	_	0	SENT_875	[p27l88t2538r146b2608],
7	Wisconsin	NNP	ORGANIZATION	Wisconsin	nn	9	SENT_875	[p27l88t2177r146b2522],
8	—	NNP	O	—	nn	9	SENT_875	[p27l123t2132r129b2153],
9	Madison	NNP	O	Madison	prep_of	5	SENT_875	[p27l89t1823r146b2108],
10	on	IN	O	on	_	0	SENT_875	[p27l106t1721r146b1800],
11	01/05/14	CD	DATE	01/05/14	prep_on	1	SENT_875	[p27l88t1394r146b1698],
12	.	.	O	.	_	0	SENT_875	[p27l88t1394r146b1698],

1	For	IN	O	for	_	0	SENT_876	[p27l90t1254r146b1368],
2	personal	JJ	O	personal	amod	3	SENT_876	[p27l89t959r163b1234],
3	use	NN	O	use	pobj	1	SENT_876	[p27l106t830r146b937],
4	only	RB	O	only	advmod	3	SENT_876	[p27l89t648r163b806],
5	.	.	O	.	_	0	SENT_876	[p27l89t648r163b806],

1	303-9	CD	NUMBER	303-9	num	3	SENT_877	[p27l646t21r868b85],
2	Niemi	NNP	O	Niemi	nn	3	SENT_877	[p27l643t131r869b196],
3	M	NN	O	m	_	0	SENT_877	[p27l907t133r1005b207],
4	,	,	O	,	_	0	SENT_877	[p27l907t133r1005b207],
5	Backman	NNP	PERSON	Backman	nn	6	SENT_877	[p27l1046t131r1389b196],
6	JT	NNP	O	JT	appos	3	SENT_877	[p27l1426t133r1535b207],
7	,	,	O	,	_	0	SENT_877	[p27l1426t133r1535b207],
8	Lauri	NNP	PERSON	Lauri	nn	9	SENT_877	[p27l1575t131r1771b196],
9	IK	NNP	PERSON	IK	appos	3	SENT_877	[p27l1809t133r1923b207],
10	,	,	O	,	_	0	SENT_877	[p27l1809t133r1923b207],
11	et	FW	O	et	nn	12	SENT_877	[p27l1964t141r2028b196],
12	al.	FW	O	al.	appos	3	SENT_877	[p27l2066t131r2146b196],
13	2005	CD	DATE	2005	dep	12	SENT_877	[p27l644t243r842b307],
14	.	.	O	.	_	0	SENT_877	[p27l644t243r842b307],

1	Polymorphic	JJ	O	polymorphic	amod	3	SENT_878	[p27l885t243r1355b325],
2	organic	JJ	O	organic	amod	3	SENT_878	[p27l1396t243r1664b325],
3	anion	NN	O	anion	_	0	SENT_878	[p27l1707t243r1906b307],
4	transporting	VBG	O	transport	partmod	3	SENT_878	[p27l1945t253r2148b307, p27l642t353r905b436],
5	polypeptide	NN	O	polypeptide	nn	6	SENT_878	[p27l946t353r1377b436],
6	lBl	NN	O	lbl	dobj	4	SENT_878	[p27l1429t354r1562b416],
7	(	CD	NUMBER	(	num	9	SENT_878	[p27l1615t354r2047b432],
8	OATPlBl	NN	O	oatplbl	nn	9	SENT_878	[p27l1615t354r2047b432],
9	)	NN	O	)	nsubj	13	SENT_878	[p27l1615t354r2047b432],
10	is	VBZ	O	be	cop	13	SENT_878	[p27l2092t353r2148b417],
11	a	DT	O	a	det	13	SENT_878	[p27l645t484r683b527],
12	major	JJ	O	major	amod	13	SENT_878	[p27l711t463r924b546],
13	determinant	NN	O	determinant	rcmod	6	SENT_878	[p27l954t463r1389b527],
14	of	IN	O	of	_	0	SENT_878	[p27l1419t463r1498b527],
15	repaglinide	NN	O	repaglinide	nn	16	SENT_878	[p27l1520t463r1931b546],
16	pharmacokinetics	NNS	O	pharmacokinetic	prep_of	13	SENT_878	[p27l1960t464r2147b546, p27l643t575r1143b639],
17	.	.	O	.	_	0	SENT_878	[p27l1960t464r2147b546, p27l643t575r1143b639],

1	Clin	NNP	O	Clin	_	0	SENT_879	[p27l1174t575r1339b640],
2	.	.	O	.	_	0	SENT_879	[p27l1174t575r1339b640],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_880	[p27l1368t575r1789b639],
2	.	.	O	.	_	0	SENT_880	[p27l1368t575r1789b639],

1	Ther	NNP	O	Ther	_	0	SENT_881	[p27l1824t575r2009b639],
2	.	.	O	.	_	0	SENT_881	[p27l1824t575r2009b639],

1	77	CD	NUMBER	77	_	0	SENT_882	[p27l2036t577r2144b639],
2	:	:	O	:	_	0	SENT_882	[p27l2036t577r2144b639],
3	468-78	CD	NUMBER	468-78	num	5	SENT_882	[p27l643t687r912b751],
4	Evans	NNP	O	Evans	nn	5	SENT_882	[p27l643t801r861b863],
5	WE	NNP	O	WE	dep	1	SENT_882	[p27l901t801r1062b875],
6	,	,	O	,	_	0	SENT_882	[p27l901t801r1062b875],
7	Johnson	NNP	PERSON	Johnson	nn	8	SENT_882	[p27l1104t799r1403b863],
8	JA	NNP	O	JA	appos	5	SENT_882	[p27l1442t800r1555b863],
9	.	.	O	.	_	0	SENT_882	[p27l1442t800r1555b863],

1	2001	CD	DATE	2001	_	0	SENT_883	[p27l1600t799r1798b863],
2	.	.	O	.	_	0	SENT_883	[p27l1600t799r1798b863],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_884	[p27l1843t799r2147b863, p27l644t911r1098b994],
2	:	:	O	:	_	0	SENT_884	[p27l1843t799r2147b863, p27l644t911r1098b994],
3	the	DT	O	the	det	5	SENT_884	[p27l1150t911r1259b975],
4	inherited	VBN	O	inherit	amod	5	SENT_884	[p27l1305t911r1630b975],
5	basis	NN	O	basis	dep	1	SENT_884	[p27l1673t911r1853b975],
6	for	IN	O	for	_	0	SENT_884	[p27l1901t911r2007b975],
7	interindividual	JJ	O	interindividual	amod	8	SENT_884	[p27l2051t911r2147b974, p27l643t1023r1107b1087],
8	differences	NNS	O	difference	prep_for	5	SENT_884	[p27l1124t1023r1523b1087],
9	in	IN	O	in	_	0	SENT_884	[p27l1542t1023r1611b1086],
10	drug	NN	O	drug	nn	11	SENT_884	[p27l1628t1023r1792b1106],
11	response	NN	O	response	prep_in	5	SENT_884	[p27l1808t1043r2146b1106],
12	.	.	O	.	_	0	SENT_884	[p27l1808t1043r2146b1106],

1	Annu	NNP	PERSON	Annu	_	0	SENT_885	[p27l637t1136r849b1199],
2	.	.	O	.	_	0	SENT_885	[p27l637t1136r849b1199],

1	Rev.	NNP	O	Rev.	nn	3	SENT_886	[p27l891t1138r1035b1199],
2	Genomics	NNP	O	Genomics	nn	3	SENT_886	[p27l1084t1136r1443b1199],
3	Hum	NNP	O	Hum	_	0	SENT_886	[p27l1479t1138r1670b1199],
4	.	.	O	.	_	0	SENT_886	[p27l1479t1138r1670b1199],

1	Genet	NNP	PERSON	Genet	_	0	SENT_887	[p27l1719t1136r1950b1199],
2	.	.	O	.	_	0	SENT_887	[p27l1719t1136r1950b1199],

1	2:939	CD	NUMBER	2:939	num	3	SENT_888	[p27l1991t1135r2152b1199, p27l646t1247r731b1312],
2	Israel	NNP	LOCATION	Israel	nn	3	SENT_888	[p27l643t1359r844b1423],
3	E	NNP	O	E	_	0	SENT_888	[p27l880t1361r954b1435],
4	,	,	O	,	_	0	SENT_888	[p27l880t1361r954b1435],
5	Chinchilli	NNP	PERSON	Chinchilli	nn	6	SENT_888	[p27l995t1359r1357b1423],
6	VM	NNP	O	VM	appos	3	SENT_888	[p27l1394t1361r1559b1435],
7	,	,	O	,	_	0	SENT_888	[p27l1394t1361r1559b1435],
8	Ford	NNP	ORGANIZATION	Ford	nn	9	SENT_888	[p27l1599t1359r1769b1423],
9	JG	NNP	O	JG	appos	3	SENT_888	[p27l1804t1359r1924b1435],
10	,	,	O	,	_	0	SENT_888	[p27l1804t1359r1924b1435],
11	et	FW	O	et	nn	12	SENT_888	[p27l1964t1368r2028b1423],
12	al.	FW	O	al.	appos	3	SENT_888	[p27l2066t1359r2146b1423],
13	2004	CD	DATE	2004	dep	12	SENT_888	[p27l645t1472r842b1536],
14	.	.	O	.	_	0	SENT_888	[p27l645t1472r842b1536],

1	Use	NN	O	use	nsubj	16	SENT_889	[p27l907t1473r1047b1536],
2	of	IN	O	of	prep	1	SENT_889	[p27l1110t1471r1189b1535],
3	regularly	RB	O	regularly	pcomp	2	SENT_889	[p27l1242t1471r1570b1554],
4	scheduled	VBN	O	schedule	dep	1	SENT_889	[p27l1634t1471r1996b1535],
5	albuterol	NN	O	albuterol	nn	6	SENT_889	[p27l2058t1471r2147b1535, p27l642t1583r898b1647],
6	treatment	NN	O	treatment	dobj	4	SENT_889	[p27l947t1592r1292b1647],
7	in	IN	O	in	_	0	SENT_889	[p27l1339t1583r1408b1646],
8	asthma	NN	O	asthma	prep_in	6	SENT_889	[p27l1458t1583r1732b1647],
9	:	:	O	:	_	0	SENT_889	[p27l1458t1583r1732b1647],
10	genotypestratiﬁed	VBN	O	genotypestratiﬁed	dep	4	SENT_889	[p27l1788t1592r2147b1665, p27l646t1694r981b1770],
11	,	,	O	,	_	0	SENT_889	[p27l1788t1592r2147b1665, p27l646t1694r981b1770],
12	randomised	VBN	O	randomise	dep	4	SENT_889	[p27l1000t1694r1446b1770],
13	,	,	O	,	_	0	SENT_889	[p27l1000t1694r1446b1770],
14	placebo	NN	O	placebo	nn	15	SENT_889	[p27l1465t1694r2151b1778],
15	—	NN	O	—	dobj	4	SENT_889	[p27l1465t1694r2151b1778],
16	controlled	VBN	O	control	_	0	SENT_889	[p27l1465t1694r2151b1778],
17	cross-over	JJ	O	cross-over	amod	18	SENT_889	[p27l644t1827r1021b1871],
18	trial	NN	O	trial	dobj	16	SENT_889	[p27l1045t1806r1208b1871],
19	.	.	O	.	_	0	SENT_889	[p27l1045t1806r1208b1871],

1	Lancet	NNP	O	Lancet	_	0	SENT_890	[p27l1237t1809r1489b1871],
2	9444	CD	NUMBER	9444	num	1	SENT_890	[p27l1512t1807r1711b1871],
3	:	:	O	:	_	0	SENT_890	[p27l1512t1807r1711b1871],
4	1505	CD	DATE	1505	number	5	SENT_890	[p27l1729t1806r2037b1871],
5	—	CD	NUMBER	—	dep	1	SENT_890	[p27l1729t1806r2037b1871],
6	l2	NN	O	l2	nn	8	SENT_890	[p27l1729t1806r2037b1871],
7	Liggett	NNP	ORGANIZATION	Liggett	nn	8	SENT_890	[p27l643t1919r907b2001],
8	SB	NN	O	sb	dep	5	SENT_890	[p27l938t1919r1063b1983],
9	.	.	O	.	_	0	SENT_890	[p27l938t1919r1063b1983],

1	2000	CD	DATE	2000	_	0	SENT_891	[p27l1100t1919r1297b1983],
2	.	.	O	.	_	0	SENT_891	[p27l1100t1919r1297b1983],

1	Beta	NN	O	beta	nn	2	SENT_892	[p27l1333t1918r2019b2001],
2	(	NN	O	(	_	0	SENT_892	[p27l1333t1918r2019b2001],
3	2	CD	NUMBER	2	num	4	SENT_892	[p27l1333t1918r2019b2001],
4	)	NN	O	)	dep	2	SENT_892	[p27l1333t1918r2019b2001],
5	.	.	O	.	_	0	SENT_892	[p27l1333t1918r2019b2001],

1	—	NN	O	—	_	0	SENT_893	[p27l1333t1918r2019b2001],
2	.	.	O	.	_	0	SENT_893	[p27l1333t1918r2019b2001],

1	adrenergic	JJ	O	adrenergic	amod	2	SENT_894	[p27l1333t1918r2019b2001],
2	receptor	NN	O	receptor	_	0	SENT_894	[p27l2050t1938r2147b1983, p27l644t2040r872b2114],
3	pharmacogenetics	NNS	O	pharmacogenetic	dep	2	SENT_894	[p27l905t2030r1583b2114],
4	.	.	O	.	_	0	SENT_894	[p27l905t2030r1583b2114],

1	Am	NNP	O	Am	_	0	SENT_895	[p27l1617t2032r1757b2094],
2	.	.	O	.	_	0	SENT_895	[p27l1617t2032r1757b2094],

1	J.	NNP	PERSON	J.	nn	2	SENT_896	[p27l1802t2033r1854b2095],
2	Respir	NNP	PERSON	Respir	_	0	SENT_896	[p27l1898t2033r2141b2113],
3	.	.	O	.	_	0	SENT_896	[p27l1898t2033r2141b2113],

1	Crit	NNP	O	Crit	_	0	SENT_897	[p27l648t2144r803b2207],
2	.	.	O	.	_	0	SENT_897	[p27l648t2144r803b2207],

1	Care	NNP	O	Care	nn	2	SENT_898	[p27l841t2143r1013b2207],
2	Med	NNP	O	Med	_	0	SENT_898	[p27l1037t2142r1218b2206],
3	.	.	O	.	_	0	SENT_898	[p27l1037t2142r1218b2206],

1	16l	NN	O	16l	_	0	SENT_899	[p27l1257t2142r1772b2207],
2	:	:	O	:	_	0	SENT_899	[p27l1257t2142r1772b2207],
3	Sl97	NN	O	sl97	nn	5	SENT_899	[p27l1257t2142r1772b2207],
4	—	CD	NUMBER	—	num	5	SENT_899	[p27l1257t2142r1772b2207],
5	20l	NN	O	20l	dep	1	SENT_899	[p27l1257t2142r1772b2207],
6	Dishy	JJ	O	dishy	amod	7	SENT_899	[p27l643t2255r859b2337],
7	V	NN	O	v	dep	1	SENT_899	[p27l943t2256r1026b2330],
8	,	,	O	,	_	0	SENT_899	[p27l943t2256r1026b2330],
9	Sofowora	NNP	O	Sofowora	nn	10	SENT_899	[p27l1116t2255r1465b2319],
10	GG	NNS	O	gg	appos	1	SENT_899	[p27l1549t2255r1697b2330],
11	,	,	O	,	_	0	SENT_899	[p27l1549t2255r1697b2330],
12	Xie	NNP	O	Xie	nn	13	SENT_899	[p27l1784t2255r1914b2319],
13	HG	NNP	O	HG	appos	1	SENT_899	[p27l1998t2255r2147b2330],
14	,	,	O	,	_	0	SENT_899	[p27l1998t2255r2147b2330],
15	et	FW	O	et	nn	16	SENT_899	[p27l644t2377r709b2431],
16	al.	FW	O	al.	appos	1	SENT_899	[p27l778t2367r858b2431],
17	2001	CD	DATE	2001	dep	16	SENT_899	[p27l934t2368r1132b2431],
18	.	.	O	.	_	0	SENT_899	[p27l934t2368r1132b2431],

1	The	DT	O	the	det	2	SENT_900	[p27l1206t2367r1345b2431],
2	effect	NN	O	effect	_	0	SENT_900	[p27l1416t2367r1621b2431],
3	of	IN	O	of	_	0	SENT_900	[p27l1690t2367r1768b2431],
4	common	JJ	O	common	amod	5	SENT_900	[p27l1833t2387r2151b2431],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_900	[p27l642t2478r1209b2562],
6	of	IN	O	of	_	0	SENT_900	[p27l1260t2478r1339b2542],
7	the	DT	O	the	det	9	SENT_900	[p27l1381t2478r1490b2542],
8	beta2-adrenergic	JJ	O	beta2-adrenergic	amod	9	SENT_900	[p27l1537t2478r2148b2562],
9	receptor	NN	O	receptor	prep_of	2	SENT_900	[p27l642t2600r943b2673],
10	on	IN	O	on	_	0	SENT_900	[p27l961t2611r1050b2655],
11	agonist-mediated	JJ	O	agonist-mediated	amod	13	SENT_900	[p27l1070t2591r1698b2673],
12	vascular	JJ	O	vascular	amod	13	SENT_900	[p27l1716t2591r2018b2655],
13	desensitization	NN	O	desensitization	prep_on	9	SENT_900	[p27l2037t2591r2147b2655, p27l646t2702r1117b2766],
14	.	.	O	.	_	0	SENT_900	[p27l2037t2591r2147b2655, p27l646t2702r1117b2766],

1	N.	NNP	O	N.	nn	2	SENT_901	[p27l1151t2704r1227b2766],
2	Engl	NNP	O	Engl	_	0	SENT_901	[p27l1269t2702r1455b2784],
3	.	.	O	.	_	0	SENT_901	[p27l1269t2702r1455b2784],

1	J.	NNP	O	J.	nn	2	SENT_902	[p27l1496t2704r1548b2767],
2	Med	NNP	O	Med	_	0	SENT_902	[p27l1588t2702r1769b2766],
3	.	.	O	.	_	0	SENT_902	[p27l1588t2702r1769b2766],

1	142103035	CD	NUMBER	142103035	num	3	SENT_903	[p27l1815t2702r2152b2766, p27l646t2813r728b2878],
2	Lima	NNP	LOCATION	Lima	nn	3	SENT_903	[p27l643t2926r836b2990],
3	JJ	NN	O	jj	_	0	SENT_903	[p27l864t2927r954b3001],
4	,	,	O	,	_	0	SENT_903	[p27l864t2927r954b3001],
5	Thomason	NNP	PERSON	Thomason	nn	6	SENT_903	[p27l988t2926r1372b2990],
6	DB	NNP	O	DB	appos	3	SENT_903	[p27l1404t2927r1548b3001],
7	,	,	O	,	_	0	SENT_903	[p27l1404t2927r1548b3001],
8	Mohamed	NNP	O	Mohamed	nn	9	SENT_903	[p27l1582t2926r1952b2990],
9	MH	NNP	O	MH	appos	3	SENT_903	[p27l1982t2927r2147b3001],
10	,	,	O	,	_	0	SENT_903	[p27l1982t2927r2147b3001],
11	et	FW	O	et	nn	12	SENT_903	[p27l644t3048r708b3102],
12	al.	FW	O	al.	appos	3	SENT_903	[p27l747t3038r827b3102],
13	1999	CD	DATE	1999	dep	12	SENT_903	[p27l879t3038r1068b3103],
14	.	.	O	.	_	0	SENT_903	[p27l879t3038r1068b3103],

1	Impact	NN	O	impact	_	0	SENT_904	[p27l1112t3039r1365b3121],
2	of	IN	O	of	_	0	SENT_904	[p27l1403t3038r1481b3102],
3	genetic	JJ	O	genetic	amod	4	SENT_904	[p27l1514t3038r1774b3121],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_904	[p27l1812t3038r2147b3121, p27l642t3150r899b3233],
5	of	IN	O	of	_	0	SENT_904	[p27l941t3150r1020b3214],
6	the	DT	O	the	det	8	SENT_904	[p27l1053t3150r1162b3214],
7	beta2-adrenergic	JJ	O	beta2-adrenergic	amod	8	SENT_904	[p27l1200t3150r1811b3233],
8	receptor	NN	O	receptor	prep_of	1	SENT_904	[p27l1851t3159r2152b3233],
9	on	IN	O	on	_	0	SENT_904	[p27l645t3282r733b3326],
10	albuterol	NN	O	albuterol	nn	12	SENT_904	[p27l760t3262r1080b3326],
11	bronchodilator	NN	O	bronchodilator	nn	12	SENT_904	[p27l1105t3262r1645b3326],
12	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	8	SENT_904	[p27l1668t3262r2147b3344, p27l643t3373r918b3437],
13	.	.	O	.	_	0	SENT_904	[p27l1668t3262r2147b3344, p27l643t3373r918b3437],

1	Clin	NNP	O	Clin	_	0	SENT_905	[p27l970t3373r1135b3438],
2	.	.	O	.	_	0	SENT_905	[p27l970t3373r1135b3438],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_906	[p27l1188t3373r1609b3437],
2	.	.	O	.	_	0	SENT_906	[p27l1188t3373r1609b3437],

1	Ther	NNP	O	Ther	_	0	SENT_907	[p27l1666t3373r1851b3437],
2	.	.	O	.	_	0	SENT_907	[p27l1666t3373r1851b3437],

1	5:51925	CD	NUMBER	5:51925	num	3	SENT_908	[p27l1900t3373r2152b3438, p27l645t3483r728b3548],
2	Israel	NNP	LOCATION	Israel	nn	3	SENT_908	[p27l643t3595r844b3658],
3	E	NNP	O	E	_	0	SENT_908	[p27l885t3596r958b3670],
4	,	,	O	,	_	0	SENT_908	[p27l885t3596r958b3670],
5	Drazen	NNP	PERSON	Drazen	nn	6	SENT_908	[p27l1002t3596r1264b3658],
6	JM	NN	PERSON	jm	appos	3	SENT_908	[p27l1304t3596r1439b3670],
7	,	,	O	,	_	0	SENT_908	[p27l1304t3596r1439b3670],
8	Liggett	NNP	ORGANIZATION	Liggett	nn	9	SENT_908	[p27l1482t3594r1747b3677],
9	SB	NN	O	sb	appos	3	SENT_908	[p27l1789t3595r1915b3670],
10	,	,	O	,	_	0	SENT_908	[p27l1789t3595r1915b3670],
11	et	FW	O	et	nn	12	SENT_908	[p27l1960t3605r2024b3658],
12	al.	FW	O	al.	appos	3	SENT_908	[p27l2066t3594r2146b3658],
13	2001	CD	DATE	2001	dep	12	SENT_908	[p27l645t3705r842b3769],
14	.	.	O	.	_	0	SENT_908	[p27l645t3705r842b3769],

1	Effect	NN	O	effect	_	0	SENT_909	[p27l906t3705r1127b3769],
2	of	IN	O	of	_	0	SENT_909	[p27l1185t3705r1264b3769],
3	polymorphism	NN	O	polymorphism	prep_of	1	SENT_909	[p27l1315t3705r1850b3787],
4	of	IN	O	of	_	0	SENT_909	[p27l1909t3705r1988b3769],
5	the	DT	O	the	det	9	SENT_909	[p27l2041t3705r2150b3769],
6	beta	NN	O	beta	nn	9	SENT_909	[p28l642t21r1315b104],
7	(	NN	O	(	nn	9	SENT_909	[p28l642t21r1315b104],
8	2	CD	NUMBER	2	num	9	SENT_909	[p28l642t21r1315b104],
9	)	NN	O	)	prep_of	1	SENT_909	[p28l642t21r1315b104],
10	.	.	O	.	_	0	SENT_909	[p28l642t21r1315b104],

1	—	NN	O	—	_	0	SENT_910	[p28l642t21r1315b104],
2	.	.	O	.	_	0	SENT_910	[p28l642t21r1315b104],

1	adrenergic	JJ	O	adrenergic	amod	2	SENT_911	[p28l642t21r1315b104],
2	receptor	NN	O	receptor	_	0	SENT_911	[p28l1358t31r1659b104],
3	on	IN	O	on	_	0	SENT_911	[p28l1701t42r1789b85],
4	response	NN	O	response	prep_on	2	SENT_911	[p28l1831t42r2150b104],
5	to	TO	O	to	_	0	SENT_911	[p28l643t141r711b195],
6	regular	JJ	O	regular	amod	7	SENT_911	[p28l764t132r1023b214],
7	use	NN	O	use	prep_to	2	SENT_911	[p28l1073t152r1193b195],
8	of	IN	O	of	_	0	SENT_911	[p28l1248t131r1327b195],
9	albuterol	NN	O	albuterol	prep_of	2	SENT_911	[p28l1376t131r1695b195],
10	in	IN	O	in	_	0	SENT_911	[p28l1748t131r1817b195],
11	asthma	NN	O	asthma	prep_in	9	SENT_911	[p28l1872t131r2146b195],
12	.	.	O	.	_	0	SENT_911	[p28l1872t131r2146b195],

1	Int	NN	O	int	_	0	SENT_912	[p28l246t449r393b527],
2	.	.	O	.	_	0	SENT_912	[p28l246t449r393b527],

1	Arch	NNP	O	Arch	_	0	SENT_913	[p28l472t446r714b527],
2	.	.	O	.	_	0	SENT_913	[p28l472t446r714b527],

1	Allergy	NNP	O	Allergy	nn	2	SENT_914	[p28l794t446r1135b550],
2	Immunol	NNP	O	Immunol	_	0	SENT_914	[p28l1209t446r1643b527],
3	.	.	O	.	_	0	SENT_914	[p28l1209t446r1643b527],

1	124118386	CD	NUMBER	124118386	num	3	SENT_915	[p28l1729t446r2154b527, p28l254t586r361b668],
2	Drysdale	NNP	PERSON	Drysdale	nn	3	SENT_915	[p28l249t727r663b832],
3	CM	NN	O	cm	_	0	SENT_915	[p28l711t728r911b823],
4	,	,	O	,	_	0	SENT_915	[p28l711t728r911b823],
5	McGraw	NNP	PERSON	McGraw	nn	6	SENT_915	[p28l960t728r1366b809],
6	DW	NNP	O	DW	appos	3	SENT_915	[p28l1412t730r1623b823],
7	,	,	O	,	_	0	SENT_915	[p28l1412t730r1623b823],
8	Stack	NNP	ORGANIZATION	Stack	nn	9	SENT_915	[p28l1676t727r1929b809],
9	CB	NNP	ORGANIZATION	CB	appos	3	SENT_915	[p28l1974t728r2148b823],
10	,	,	O	,	_	0	SENT_915	[p28l1974t728r2148b823],
11	et	FW	O	et	nn	12	SENT_915	[p28l251t882r331b950],
12	al.	FW	O	al.	appos	3	SENT_915	[p28l356t870r457b950],
13	2000	CD	DATE	2000	dep	12	SENT_915	[p28l487t870r737b951],
14	.	.	O	.	_	0	SENT_915	[p28l487t870r737b951],

1	Complex	NN	O	complex	nn	2	SENT_916	[p28l768t870r1185b974],
2	promoter	NN	O	promoter	dep	12	SENT_916	[p28l1208t882r1632b974],
3	and	CC	O	and	_	0	SENT_916	[p28l1655t870r1818b950],
4	coding	VBG	O	code	amod	6	SENT_916	[p28l1841t870r2151b975],
5	region	NN	O	region	nn	6	SENT_916	[p28l248t1009r540b1114],
6	beta	NN	O	beta	conj_and	2	SENT_916	[p28l582t1009r776b1090],
7	2	CD	NUMBER	2	number	8	SENT_916	[p28l819t1009r1395b1114],
8	—	CD	NUMBER	—	num	11	SENT_916	[p28l819t1009r1395b1114],
9	adrenergic	JJ	O	adrenergic	amod	11	SENT_916	[p28l819t1009r1395b1114],
10	receptor	NN	O	receptor	nn	11	SENT_916	[p28l1439t1021r1818b1114],
11	haplotypes	NNS	O	haplotype	nsubj	12	SENT_916	[p28l1859t1009r2149b1114, p28l249t1162r488b1255],
12	alter	VBP	O	alter	_	0	SENT_916	[p28l515t1150r717b1232],
13	receptor	NN	O	receptor	nn	14	SENT_916	[p28l737t1163r1116b1255],
14	expression	NN	O	expression	dobj	12	SENT_916	[p28l1137t1150r1626b1255],
15	and	CC	O	and	_	0	SENT_916	[p28l1651t1150r1813b1232],
16	predict	VB	O	predict	conj_and	12	SENT_916	[p28l1833t1150r2154b1255],
17	in	FW	O	in	nn	18	SENT_916	[p28l249t1292r336b1371],
18	vivo	FW	O	vivo	advmod	16	SENT_916	[p28l370t1292r565b1373],
19	responsiveness	NN	O	responsiveness	dobj	16	SENT_916	[p28l599t1292r1310b1396],
20	.	.	O	.	_	0	SENT_916	[p28l599t1292r1310b1396],

1	Proc	NNP	O	Proc	_	0	SENT_917	[p28l1348t1295r1584b1373],
2	.	.	O	.	_	0	SENT_917	[p28l1348t1295r1584b1373],

1	Natl.	NNP	O	Natl.	nn	2	SENT_918	[p28l1626t1292r1844b1373],
2	Acad	NNP	O	Acad	_	0	SENT_918	[p28l1881t1292r2142b1373],
3	.	.	O	.	_	0	SENT_918	[p28l1881t1292r2142b1373],

1	Sci	NNP	O	Sci	_	0	SENT_919	[p28l249t1433r406b1514],
2	.	.	O	.	_	0	SENT_919	[p28l249t1433r406b1514],

1	USA	NNP	LOCATION	USA	nn	6	SENT_920	[p28l458t1433r655b1514],
2	97:10483	CD	NUMBER	97:10483	num	6	SENT_920	[p28l692t1432r1293b1514],
3	—	CD	NUMBER	—	num	6	SENT_920	[p28l692t1432r1293b1514],
4	88	CD	NUMBER	88	num	6	SENT_920	[p28l692t1432r1293b1514],
5	Johnson	NNP	O	Johnson	nn	6	SENT_920	[p28l249t1574r626b1655],
6	JA	NNP	O	JA	_	0	SENT_920	[p28l661t1574r805b1669],
7	,	,	O	,	_	0	SENT_920	[p28l661t1574r805b1669],
8	Lima	NNP	LOCATION	Lima	nn	9	SENT_920	[p28l845t1573r1089b1655],
9	JL	NNP	O	JL	appos	6	SENT_920	[p28l1123t1576r1259b1655],
10	.	.	O	.	_	0	SENT_920	[p28l1123t1576r1259b1655],

1	2003	CD	DATE	2003	_	0	SENT_921	[p28l1304t1574r1553b1655],
2	.	.	O	.	_	0	SENT_921	[p28l1304t1574r1553b1655],

1	Drug	NN	O	drug	nn	3	SENT_922	[p28l1595t1576r1829b1678],
2	receptor/effector	JJ	O	receptor/effector	amod	3	SENT_922	[p28l1866t1599r2149b1678, p28l249t1715r766b1796],
3	polymorphisms	NNS	O	polymorphism	_	0	SENT_922	[p28l805t1715r1520b1819],
4	and	CC	O	and	_	0	SENT_922	[p28l1567t1715r1730b1796],
5	pharmacogenetics	NNS	O	pharmacogenetic	conj_and	3	SENT_922	[p28l1768t1715r2149b1819, p28l251t1857r759b1962],
6	:	:	O	:	_	0	SENT_922	[p28l1768t1715r2149b1819, p28l251t1857r759b1962],
7	current	JJ	DATE	current	amod	8	SENT_922	[p28l799t1869r1124b1937],
8	status	NN	O	status	dep	3	SENT_922	[p28l1157t1869r1411b1937],
9	and	CC	O	and	_	0	SENT_922	[p28l1446t1857r1609b1937],
10	challenges	NNS	O	challenge	dep	3	SENT_922	[p28l1640t1857r2146b1962],
11	.	.	O	.	_	0	SENT_922	[p28l1640t1857r2146b1962],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_923	[p28l247t1996r1104b2100],
2	13:525	CD	NUMBER	13:525	num	6	SENT_923	[p28l1149t1996r1628b2078],
3	—	CD	NUMBER	—	num	6	SENT_923	[p28l1149t1996r1628b2078],
4	34	CD	NUMBER	34	num	6	SENT_923	[p28l1149t1996r1628b2078],
5	Ahmadi	NNP	ORGANIZATION	Ahmadi	nn	6	SENT_923	[p28l249t2138r618b2218],
6	KR	NNP	ORGANIZATION	KR	dep	1	SENT_923	[p28l665t2140r845b2232],
7	,	,	O	,	_	0	SENT_923	[p28l665t2140r845b2232],
8	Weale	NNP	ORGANIZATION	Weale	nn	9	SENT_923	[p28l892t2138r1175b2218],
9	ME	NNP	ORGANIZATION	ME	appos	6	SENT_923	[p28l1219t2140r1414b2232],
10	,	,	O	,	_	0	SENT_923	[p28l1219t2140r1414b2232],
11	Xue	NNP	O	Xue	nn	12	SENT_923	[p28l1462t2140r1652b2218],
12	ZY	NNP	O	ZY	appos	6	SENT_923	[p28l1694t2140r1871b2232],
13	,	,	O	,	_	0	SENT_923	[p28l1694t2140r1871b2232],
14	et	FW	O	et	nn	15	SENT_923	[p28l1920t2150r2001b2218],
15	al.	FW	O	al.	appos	6	SENT_923	[p28l2045t2138r2146b2218],
16	2005	CD	DATE	2005	dep	15	SENT_923	[p28l251t2279r500b2360],
17	.	.	O	.	_	0	SENT_923	[p28l251t2279r500b2360],

1	A	DT	O	a	det	6	SENT_924	[p28l540t2280r621b2358],
2	single	JJ	O	single	amod	6	SENT_924	[p28l658t2279r1446b2384],
3	—	NN	O	—	nn	6	SENT_924	[p28l658t2279r1446b2384],
4	nucleotide	NN	O	nucleotide	nn	6	SENT_924	[p28l658t2279r1446b2384],
5	polymorphism	NN	O	polymorphism	nn	6	SENT_924	[p28l1479t2279r2154b2384],
6	tagging	NN	O	tagging	nsubj	7	SENT_924	[p28l249t2418r592b2523],
7	set	VBN	O	set	_	0	SENT_924	[p28l647t2430r770b2500],
8	for	IN	O	for	_	0	SENT_924	[p28l817t2418r951b2500],
9	human	JJ	O	human	amod	11	SENT_924	[p28l997t2418r1309b2500],
10	drug	NN	O	drug	nn	11	SENT_924	[p28l1359t2418r1566b2523],
11	metabolism	NN	O	metabolism	prep_for	7	SENT_924	[p28l1615t2418r2154b2500],
12	and	CC	O	and	_	0	SENT_924	[p28l252t2560r415b2641],
13	transport	NN	O	transport	prep_for	7	SENT_924	[p28l446t2572r877b2664],
14	.	.	O	.	_	0	SENT_924	[p28l446t2572r877b2664],

1	Nat	NN	PERSON	nat	_	0	SENT_925	[p28l910t2563r1097b2641],
2	.	.	O	.	_	0	SENT_925	[p28l910t2563r1097b2641],

1	Genet	NNP	PERSON	Genet	_	0	SENT_926	[p28l1144t2561r1436b2641],
2	.	.	O	.	_	0	SENT_926	[p28l1144t2561r1436b2641],

1	37:84	CD	NUMBER	37:84	num	4	SENT_927	[p28l1477t2560r1905b2642],
2	-89	CD	NUMBER	-89	num	4	SENT_927	[p28l1477t2560r1905b2642],
3	Tate	NNP	O	Tate	nn	4	SENT_927	[p28l249t2704r443b2782],
4	SK	NNP	O	SK	_	0	SENT_927	[p28l470t2702r636b2798],
5	,	,	O	,	_	0	SENT_927	[p28l470t2702r636b2798],
6	Depondt	NNP	O	Depondt	nn	7	SENT_927	[p28l664t2702r1062b2807],
7	C	NNP	O	C	appos	4	SENT_927	[p28l1085t2702r1183b2798],
8	,	,	O	,	_	0	SENT_927	[p28l1085t2702r1183b2798],
9	Sisodiyam	NNP	O	Sisodiyam	nn	10	SENT_927	[p28l1215t2702r1699b2807],
10	SM	NNP	O	SM	appos	4	SENT_927	[p28l1725t2702r1910b2797],
11	,	,	O	,	_	0	SENT_927	[p28l1725t2702r1910b2797],
12	et	FW	O	et	nn	13	SENT_927	[p28l1939t2714r2021b2782],
13	al.	FW	O	al.	appos	4	SENT_927	[p28l2045t2702r2146b2783],
14	2005	CD	DATE	2005	dep	13	SENT_927	[p28l251t2841r500b2923],
15	.	.	O	.	_	0	SENT_927	[p28l251t2841r500b2923],

1	Genetic	JJ	O	genetic	amod	2	SENT_928	[p28l535t2841r888b2923],
2	predictors	NNS	O	predictor	nsubj	8	SENT_928	[p28l915t2841r1373b2946],
3	of	IN	O	of	_	0	SENT_928	[p28l1403t2841r1503b2923],
4	the	DT	O	the	det	7	SENT_928	[p28l1522t2841r1659b2923],
5	maximum	NN	O	maximum	nn	7	SENT_928	[p28l1686t2841r2154b2923],
6	doses	NNS	O	dose	nn	7	SENT_928	[p28l251t2983r500b3064],
7	patients	NNS	O	patient	prep_of	2	SENT_928	[p28l537t2983r893b3087],
8	receive	VBP	O	receive	_	0	SENT_928	[p28l930t2983r1257b3064],
9	during	IN	O	during	_	0	SENT_928	[p28l1294t2983r1592b3087],
10	clinical	JJ	O	clinical	amod	11	SENT_928	[p28l1629t2983r1965b3064],
11	use	NN	O	use	prep_during	8	SENT_928	[p28l2001t3008r2152b3064],
12	of	IN	O	of	_	0	SENT_928	[p28l251t3124r350b3204],
13	the	DT	O	the	det	18	SENT_928	[p28l373t3124r510b3204],
14	anti	JJ	O	anti	amod	18	SENT_928	[p28l543t3124r1146b3229],
15	—	NN	O	—	nn	18	SENT_928	[p28l543t3124r1146b3229],
16	epileptic	JJ	O	epileptic	amod	18	SENT_928	[p28l543t3124r1146b3229],
17	drugs	NNS	O	drug	nn	18	SENT_928	[p28l1180t3124r1429b3229],
18	carbamazepine	NN	O	carbamazepine	prep_of	11	SENT_928	[p28l1463t3124r2151b3229],
19	and	CC	O	and	_	0	SENT_928	[p28l252t3263r415b3344],
20	phenytoin	NN	O	phenytoin	conj_and	18	SENT_928	[p28l435t3263r917b3368],
21	.	.	O	.	_	0	SENT_928	[p28l435t3263r917b3368],

1	Proc	NNP	O	Proc	_	0	SENT_929	[p28l944t3266r1181b3344],
2	.	.	O	.	_	0	SENT_929	[p28l944t3266r1181b3344],

1	Natl.	NNP	O	Natl.	nn	2	SENT_930	[p28l1212t3263r1430b3345],
2	Acad	NNP	O	Acad	_	0	SENT_930	[p28l1457t3263r1717b3345],
3	.	.	O	.	_	0	SENT_930	[p28l1457t3263r1717b3345],

1	Sci	NNP	O	Sci	_	0	SENT_931	[p28l1753t3265r1908b3345],
2	.	.	O	.	_	0	SENT_931	[p28l1753t3265r1908b3345],

1	USA	NNP	LOCATION	USA	_	0	SENT_932	[p28l1954t3265r2149b3345],
2	102:5507	CD	NUMBER	102:5507	number	3	SENT_932	[p28l260t3404r856b3486],
3	—	CD	NUMBER	—	dep	1	SENT_932	[p28l260t3404r856b3486],
4	l2	NN	O	l2	dep	3	SENT_932	[p28l260t3404r856b3486],

1	Holleman	NNP	PERSON	Holleman	nn	2	SENT_933	[p28l249t3547r703b3628],
2	A	NNP	O	A	_	0	SENT_933	[p28l791t3548r897b3643],
3	,	,	O	,	_	0	SENT_933	[p28l791t3548r897b3643],
4	Cheok	NNP	PERSON	Cheok	nn	5	SENT_933	[p28l991t3547r1291b3628],
5	MH	NNP	O	MH	appos	2	SENT_933	[p28l1376t3550r1585b3643],
6	,	,	O	,	_	0	SENT_933	[p28l1376t3550r1585b3643],
7	den	NN	O	den	nn	9	SENT_933	[p28l1679t3547r1843b3628],
8	Boer	NNP	O	Boer	nn	9	SENT_933	[p28l1931t3549r2154b3628],
9	ML	NNP	O	ML	appos	2	SENT_933	[p28l249t3689r444b3782],
10	,	,	O	,	_	0	SENT_933	[p28l249t3689r444b3782],
11	et	FW	O	et	nn	12	SENT_933	[p28l511t3698r593b3767],
12	al.	FW	O	al.	appos	2	SENT_933	[p28l655t3686r756b3767],
13	2004	CD	DATE	2004	dep	12	SENT_933	[p28l825t3687r1075b3768],
14	.	.	O	.	_	0	SENT_933	[p28l825t3687r1075b3768],

1	Gene	NNP	O	Gene	_	0	SENT_934	[p28l1143t3686r1914b3791],
2	—	NN	O	—	nn	4	SENT_934	[p28l1143t3686r1914b3791],
3	expression	NN	O	expression	nn	4	SENT_934	[p28l1143t3686r1914b3791],
4	patterns	NNS	O	pattern	dep	1	SENT_934	[p28l1974t3698r2149b3791, p29l249t36r469b106],

1	in	IN	O	in	_	0	SENT_935	[p29l508t25r595b104],
2	drug-resistant	JJ	O	drug-resistant	amod	6	SENT_935	[p29l632t25r1265b129],
3	acute	JJ	O	acute	amod	6	SENT_935	[p29l1302t37r1541b106],
4	lymphoblastic	JJ	O	lymphoblastic	amod	6	SENT_935	[p29l1577t25r2149b129, p29l249t167r361b247],
5	leukemia	NN	O	leukemia	nn	6	SENT_935	[p29l407t167r829b247],
6	cells	NNS	O	cell	pobj	1	SENT_935	[p29l873t167r1078b247],
7	and	CC	O	and	_	0	SENT_935	[p29l1127t167r1290b247],
8	response	NN	O	response	nn	10	SENT_935	[p29l1332t193r1734b272],
9	to	TO	O	to	dep	10	SENT_935	[p29l1779t179r1866b247],
10	treatment	NN	O	treatment	pobj	1	SENT_935	[p29l1911t179r2149b247, p29l249t319r500b387],
11	.	.	O	.	_	0	SENT_935	[p29l1911t179r2149b247, p29l249t319r500b387],

1	N.	NNP	O	N.	nn	2	SENT_936	[p29l534t309r631b388],
2	Engl	NNP	O	Engl	_	0	SENT_936	[p29l672t306r907b410],
3	.	.	O	.	_	0	SENT_936	[p29l672t306r907b410],

1	J.	NNP	O	J.	nn	2	SENT_937	[p29l948t309r1013b388],
2	Med	NNP	O	Med	_	0	SENT_937	[p29l1053t306r1282b387],
3	.	.	O	.	_	0	SENT_937	[p29l1053t306r1282b387],

1	35l	NN	O	35l	_	0	SENT_938	[p29l1324t306r1869b388],
2	:533	CD	NUMBER	:533	num	1	SENT_938	[p29l1324t306r1869b388],
3	—	CD	NUMBER	—	number	4	SENT_938	[p29l1324t306r1869b388],
4	42	CD	NUMBER	42	dep	1	SENT_938	[p29l1324t306r1869b388],
5	Lugthart	NNP	ORGANIZATION	Lugthart	dep	4	SENT_938	[p29l249t448r647b552],
6	S	NN	ORGANIZATION	s	dep	1	SENT_938	[p29l701t448r784b543],
7	,	,	O	,	_	0	SENT_938	[p29l701t448r784b543],
8	Cheok	NNP	PERSON	Cheok	nn	9	SENT_938	[p29l844t448r1144b529],
9	MH	NNP	O	MH	appos	6	SENT_938	[p29l1194t449r1403b543],
10	,	,	O	,	_	0	SENT_938	[p29l1194t449r1403b543],
11	den	NN	O	den	nn	13	SENT_938	[p29l1462t448r1625b529],
12	Boer	NNP	ORGANIZATION	Boer	nn	13	SENT_938	[p29l1678t449r1902b529],
13	ML	NNP	ORGANIZATION	ML	appos	1	SENT_938	[p29l1953t449r2148b543],
14	,	,	O	,	_	0	SENT_938	[p29l1953t449r2148b543],
15	et	FW	O	et	nn	16	SENT_938	[p29l251t602r331b670],
16	al.	FW	O	al.	appos	1	SENT_938	[p29l361t590r461b670],
17	2005	CD	DATE	2005	dep	16	SENT_938	[p29l497t590r747b671],
18	.	.	O	.	_	0	SENT_938	[p29l497t590r747b671],

1	Identiﬁcation	NN	O	identiﬁcation	nsubj	4	SENT_939	[p29l782t590r1396b670],
2	of	IN	O	of	_	0	SENT_939	[p29l1426t590r1525b670],
3	genes	NNS	O	gene	prep_of	1	SENT_939	[p29l1547t615r1803b695],
4	associated	VBN	O	associate	_	0	SENT_939	[p29l1836t590r2149b670, p29l252t729r440b810],
5	with	IN	O	with	_	0	SENT_939	[p29l483t729r686b811],
6	chemotherapy	NN	O	chemotherapy	nn	7	SENT_939	[p29l729t729r1378b834],
7	cross	NN	O	cross	prep_with	4	SENT_939	[p29l1424t729r2151b810],
8	—	CD	NUMBER	—	num	9	SENT_939	[p29l1424t729r2151b810],
9	resistance	NN	O	resistance	dep	7	SENT_939	[p29l1424t729r2151b810],
10	and	CC	O	and	_	0	SENT_939	[p29l252t871r415b952],
11	treatment	NN	O	treatment	nn	12	SENT_939	[p29l436t883r872b952],
12	response	NN	O	response	prep_with	4	SENT_939	[p29l892t896r1295b975],
13	in	IN	O	in	_	0	SENT_939	[p29l1319t871r1406b950],
14	childhood	NN	O	childhood	nn	17	SENT_939	[p29l1429t871r1889b952],
15	acute	JJ	O	acute	amod	17	SENT_939	[p29l1914t883r2152b952],
16	lymphoblastic	JJ	O	lymphoblastic	amod	17	SENT_939	[p29l249t1012r900b1116],
17	leukemia	NN	O	leukemia	prep_in	12	SENT_939	[p29l949t1012r1391b1093],
18	.	.	O	.	_	0	SENT_939	[p29l949t1012r1391b1093],

1	Cancer	NN	O	cancer	nn	2	SENT_940	[p29l1449t1013r1786b1094],
2	Cell	NN	O	cell	_	0	SENT_940	[p29l1835t1012r2021b1094],
3	7	CD	NUMBER	7	num	5	SENT_940	[p29l2066t1014r2145b1093],
4	:	:	O	:	_	0	SENT_940	[p29l2066t1014r2145b1093],
5	375-86	CD	NUMBER	375-86	dep	2	SENT_940	[p29l252t1152r592b1234],

1	Kager	NN	O	kager	nn	2	SENT_941	[p29l252t1296r531b1398],
2	L	NN	O	l	_	0	SENT_941	[p29l563t1296r657b1389],
3	,	,	O	,	_	0	SENT_941	[p29l563t1296r657b1389],
4	Cheok	NNP	PERSON	Cheok	nn	5	SENT_941	[p29l698t1293r997b1375],
5	M	NNP	PERSON	M	appos	2	SENT_941	[p29l1029t1296r1155b1389],
6	,	,	O	,	_	0	SENT_941	[p29l1029t1296r1155b1389],
7	Yang	NNP	PERSON	Yang	nn	8	SENT_941	[p29l1194t1296r1428b1398],
8	W	NNP	PERSON	W	appos	2	SENT_941	[p29l1463t1296r1595b1389],
9	,	,	O	,	_	0	SENT_941	[p29l1463t1296r1595b1389],
10	et	FW	O	et	nn	11	SENT_941	[p29l1636t1305r1717b1375],
11	al.	FW	O	al.	appos	2	SENT_941	[p29l1753t1293r1854b1375],
12	2005	CD	DATE	2005	dep	11	SENT_941	[p29l1897t1293r2118b1375],
13	.	.	O	.	_	0	SENT_941	[p29l2133t1361r2146b1375],

1	Folate	NNP	O	Folate	nn	4	SENT_942	[p29l249t1436r534b1516],
2	pathway	NN	O	pathway	nn	4	SENT_942	[p29l561t1436r949b1540],
3	gene	NN	O	gene	nn	4	SENT_942	[p29l980t1461r1194b1540],
4	expression	NN	O	expression	nsubj	5	SENT_942	[p29l1223t1436r1713b1540],
5	differs	VBZ	O	differ	_	0	SENT_942	[p29l1742t1436r2035b1516],
6	in	IN	O	in	_	0	SENT_942	[p29l2066t1436r2153b1515],
7	subtypes	NNS	O	subtype	prep_in	5	SENT_942	[p29l254t1575r649b1680],
8	of	IN	O	of	_	0	SENT_942	[p29l676t1575r776b1656],
9	acute	JJ	O	acute	amod	11	SENT_942	[p29l794t1587r1032b1656],
10	lymphoblastic	JJ	O	lymphoblastic	amod	11	SENT_942	[p29l1056t1575r1707b1680],
11	leukemia	NN	O	leukemia	prep_of	7	SENT_942	[p29l1733t1575r2154b1656],
12	and	CC	O	and	_	0	SENT_942	[p29l252t1717r415b1798],
13	inﬂuences	NNS	O	inﬂuences	prep_in	5	SENT_942	[p29l435t1716r899b1798],
14	methotrexate	NN	O	methotrexate	nn	17	SENT_942	[p29l924t1717r1522b1798],
15	pharmacody	NN	O	pharmacody	nn	17	SENT_942	[p29l1544t1716r2149b1821],
16	—	NN	O	—	nn	17	SENT_942	[p29l1544t1716r2149b1821],
17	namics	NNS	O	namic	dep	13	SENT_942	[p29l249t1859r598b1940],
18	.	.	O	.	_	0	SENT_942	[p29l249t1859r598b1940],

1	J.	NNP	PERSON	J.	nn	2	SENT_943	[p29l633t1862r698b1941],
2	Clin	NNP	PERSON	Clin	_	0	SENT_943	[p29l748t1859r956b1941],
3	.	.	O	.	_	0	SENT_943	[p29l748t1859r956b1941],

1	Invest	VB	O	invest	_	0	SENT_944	[p29l995t1862r1290b1940],
2	.	.	O	.	_	0	SENT_944	[p29l995t1862r1290b1940],

1	115:110	CD	NUMBER	115:110	_	0	SENT_945	[p29l1339t1859r1874b1940],
2	—	CD	NUMBER	—	num	3	SENT_945	[p29l1339t1859r1874b1940],
3	17	CD	NUMBER	17	dep	1	SENT_945	[p29l1339t1859r1874b1940],

1	Cheng	NNP	O	Cheng	nn	2	SENT_946	[p29l251t2000r547b2105],
2	Q	NNP	O	Q	_	0	SENT_946	[p29l596t2000r698b2100],
3	,	,	O	,	_	0	SENT_946	[p29l596t2000r698b2100],
4	Yang	NNP	PERSON	Yang	nn	5	SENT_946	[p29l748t2002r982b2105],
5	W	NNP	PERSON	W	appos	2	SENT_946	[p29l1026t2003r1159b2096],
6	,	,	O	,	_	0	SENT_946	[p29l1026t2003r1159b2096],
7	Raimondi	NNP	ORGANIZATION	Raimondi	nn	8	SENT_946	[p29l1208t2000r1660b2080],
8	SC	NNP	ORGANIZATION	SC	appos	2	SENT_946	[p29l1709t2000r1869b2096],
9	,	,	O	,	_	0	SENT_946	[p29l1709t2000r1869b2096],
10	et	FW	O	et	nn	11	SENT_946	[p29l1919t2012r2001b2080],
11	al.	FW	O	al.	appos	2	SENT_946	[p29l2045t2000r2146b2081],
12	2005	CD	DATE	2005	dep	11	SENT_946	[p29l251t2139r500b2221],
13	.	.	O	.	_	0	SENT_946	[p29l251t2139r500b2221],

1	Karyotypic	JJ	MISC	karyotypic	amod	2	SENT_947	[p29l585t2139r1098b2244],
2	abnormalities	NNS	O	abnormality	nsubj	3	SENT_947	[p29l1178t2139r1801b2221],
3	create	VBP	O	create	_	0	SENT_947	[p29l1880t2151r2151b2221],
4	discordance	NN	O	discordance	dobj	3	SENT_947	[p29l251t2282r799b2362],
5	of	IN	O	of	_	0	SENT_947	[p29l867t2282r966b2362],
6	germline	NN	O	germline	nn	7	SENT_947	[p29l1027t2282r1434b2387],
7	genotype	NN	O	genotype	prep_of	4	SENT_947	[p29l1502t2294r1922b2386],
8	and	CC	O	and	_	0	SENT_947	[p29l1991t2282r2154b2362],
9	cancer	NN	O	cancer	nn	11	SENT_947	[p29l250t2449r551b2503],
10	cell	NN	O	cell	nn	11	SENT_947	[p29l644t2423r807b2503],
11	phenotypes	NNS	O	phenotype	prep_of	4	SENT_947	[p29l901t2423r1449b2528],
12	.	.	O	.	_	0	SENT_947	[p29l901t2423r1449b2528],

1	Nat	NN	PERSON	nat	_	0	SENT_948	[p29l1545t2426r1732b2505],
2	.	.	O	.	_	0	SENT_948	[p29l1545t2426r1732b2505],

1	Genet	NNP	PERSON	Genet	_	0	SENT_949	[p29l1855t2425r2142b2505],
2	.	.	O	.	_	0	SENT_949	[p29l1855t2425r2142b2505],

1	371878-82	CD	NUMBER	371878-82	_	0	SENT_950	[p29l252t2564r740b2645],

1	PHARMACOGENOMICS	NN	O	pharmacogenomic	nn	2	SENT_951	[p29l1244t2720r1649b2746],
2	C-1	NN	O	c-1	_	0	SENT_951	[p29l1743t2720r1794b2746],

1	D	NN	O	d	_	0	SENT_952	[p30l6t2469r72b2565],
2	‘	CD	NUMBER	‘	num	1	SENT_952	[p30l6t2469r72b2565],
3	from	IN	O	from	_	0	SENT_952	[p30l6t2064r65b2226],
4	www.annua1reViews.org	NN	O	www.annua1reviews.org	prep_from	1	SENT_952	[p30l6t1221r82b2042],
5	5/14	CD	NUMBER	5/14	num	4	SENT_952	[p30l89t2081r149b2244],
6	.	.	O	.	_	0	SENT_952	[p30l89t2081r149b2244],

1	For	IN	O	for	_	0	SENT_953	[p30l92t1937r149b2054],
2	personal	JJ	O	personal	amod	3	SENT_953	[p30l90t1632r167b1916],
3	use	NN	O	use	pobj	1	SENT_953	[p30l109t1499r149b1609],
4	only	RB	O	only	advmod	3	SENT_953	[p30l90t1310r167b1474],
5	.	.	O	.	_	0	SENT_953	[p30l90t1310r167b1474],

1	CO	NNP	O	CO	nsubj	2	SENT_954	[p30l15t3021r68b3236],
2	|	VBD	O	|	_	0	SENT_954	[p30l15t3021r68b3236],
3	"	``	O	"	punct	2	SENT_954	[p30l15t3021r68b3236],
4	lC	NN	O	lc	dobj	2	SENT_954	[p30l15t3021r68b3236],
5	.	.	O	.	_	0	SENT_954	[p30l15t3021r68b3236],

1	time	NN	O	time	_	0	SENT_955	[p30l382t3403r552b3467],
2	[	CD	NUMBER	[	num	3	SENT_955	[p30l583t3403r681b3482],
3	h	NN	O	h	dep	1	SENT_955	[p30l583t3403r681b3482],
4	]	CD	NUMBER	]	dep	1	SENT_955	[p30l583t3403r681b3482],

1	COHC	NNP	O	COHC	_	0	SENT_956	[p30l1134t3021r1188b3236],
2	.	.	O	.	_	0	SENT_956	[p30l1134t3021r1188b3236],

1	Concentration	NN	O	concentration	nn	5	SENT_957	[p30l1461t1616r1509b2030],
2	Concentration	NN	O	concentration	nn	5	SENT_957	[p30l1461t947r1508b1361],
3	Concentration	NN	O	concentration	nn	5	SENT_957	[p30l1462t238r1509b653],
4	duplication	NN	O	duplication	nn	5	SENT_957	[p30l1674t483r1998b543],
5	time	NN	O	time	_	0	SENT_957	[p30l1682t683r1825b737],
6	[	CD	NUMBER	[	num	7	SENT_957	[p30l1852t683r1934b750],
7	h	NN	O	h	dep	5	SENT_957	[p30l1852t683r1934b750],
8	]	CD	NUMBER	]	dep	5	SENT_957	[p30l1852t683r1934b750],

1	H	NN	O	h	nn	3	SENT_958	[p30l1792t880r1884b1069],
2	normal	JJ	O	normal	amod	3	SENT_958	[p30l1751t1109r1950b1156],
3	time	NN	O	time	_	0	SENT_958	[p30l1694t1370r1838b1423],
4	[	CD	NUMBER	[	num	5	SENT_958	[p30l1864t1370r1946b1436],
5	h	NN	O	h	dep	3	SENT_958	[p30l1864t1370r1946b1436],
6	]	CD	NUMBER	]	dep	3	SENT_958	[p30l1864t1370r1946b1436],

1	H	NN	O	h	_	0	SENT_959	[p30l1796t1701r1889b1890],

1	mutations	NNS	O	mutation	_	0	SENT_960	[p30l1719t1926r2009b1973],
2	time	NN	O	time	dep	1	SENT_960	[p30l1697t2057r1841b2111],
3	[	CD	NUMBER	[	num	2	SENT_960	[p30l1868t2057r1949b2124],
4	h	NN	O	h	dep	1	SENT_960	[p30l1868t2057r1949b2124],
5	]	CD	NUMBER	]	num	4	SENT_960	[p30l1868t2057r1949b2124],

1	AI11	NN	O	ai11	_	0	SENT_961	[p31l267t2246r290b2312],
2	’11	CD	NUMBER	’11	number	3	SENT_961	[p31l267t2246r290b2312],
3	1	CD	NUMBER	1	num	1	SENT_961	[p31l275t2201r290b2215],
4	.	.	O	.	_	0	SENT_961	[p31l275t2201r290b2215],

1	Rev.	NNP	O	Rev.	nn	2	SENT_962	[p31l267t2130r290b2190],
2	Med	NNP	O	Med	_	0	SENT_962	[p31l267t2021r290b2088],
3	.	.	O	.	_	0	SENT_962	[p31l267t2021r290b2088],

1	2006.57	CD	NUMBER	2006.57	_	0	SENT_963	[p31l267t1776r291b2010],
2	:	:	O	:	_	0	SENT_963	[p31l267t1776r291b2010],
3	ll9-137	CD	NUMBER	ll9-137	dep	1	SENT_963	[p31l267t1776r291b2010],
4	.	.	O	.	_	0	SENT_963	[p31l267t1776r291b2010],

1	Downloaded	VBN	O	download	_	0	SENT_964	[p31l267t1596r290b1766],
2	by	IN	O	by	_	0	SENT_964	[p31l300t2246r331b2278],
3	Unive	JJ	O	unive	amod	4	SENT_964	[p31l300t2124r324b2205],
4	rsity	NN	O	rsity	prep_by	1	SENT_964	[p31l300t2034r331b2092],
5	of	IN	O	of	_	0	SENT_964	[p31l300t1995r324b2024],
6	Wisconsin	NNP	LOCATION	Wisconsin	prep_of	4	SENT_964	[p31l300t1849r324b1989],
7	-	:	O	-	_	0	SENT_964	[p31l314t1830r317b1839],
8	Madison	NNP	O	Madison	dep	4	SENT_964	[p31l300t1704r324b1820],
9	on	IN	O	on	_	0	SENT_964	[p31l308t1663r324b1695],
10	01/0	CD	NUMBER	01/0	prep_on	8	SENT_964	[p31l300t1595r324b1653],

1	C-2	NN	O	c-2	_	0	SENT_965	[p31l452t2419r506b2445],
2	HT3	NN	O	ht3	nn	3	SENT_965	[p31l489t1425r626b1510],
3	Receptor	NN	O	receptor	dep	1	SENT_965	[p31l657t1425r1014b1506],

1	Figure	NNP	O	Figure	nsubj	8	SENT_966	[p31l557t1596r667b1632],
2	1	CD	NUMBER	1	num	1	SENT_966	[p31l686t1596r702b1624],
3	Drug-response	JJ	O	drug-response	amod	4	SENT_966	[p31l753t1597r985b1632],
4	phenotype	NN	O	phenotype	dep	1	SENT_966	[p31l1002t1596r1167b1632],
5	is	VBZ	O	be	cop	8	SENT_966	[p31l1184t1596r1209b1624],
6	a	DT	O	a	det	8	SENT_966	[p31l1228t1605r1244b1624],
7	complex	JJ	O	complex	amod	8	SENT_966	[p31l1261t1596r1395b1632],
8	trait	NN	O	trait	_	0	SENT_966	[p31l1413t1596r1484b1624],
9	.	.	O	.	_	0	SENT_966	[p31l1413t1596r1484b1624],

1	(	NN	O	(	nsubj	11	SENT_967	[p31l1504t1596r1547b1630],
2	a	DT	O	a	det	3	SENT_967	[p31l1504t1596r1547b1630],
3	)	CD	NUMBER	)	dep	1	SENT_967	[p31l1504t1596r1547b1630],
4	The	DT	O	the	det	7	SENT_967	[p31l1565t1596r1625b1624],
5	HT3	NN	O	ht3	nn	7	SENT_967	[p31l1643t1597r1709b1634],
6	antagonist	NN	O	antagonist	nn	7	SENT_967	[p31l1729t1596r1890b1632],
7	tropisetrone	NN	O	tropisetrone	dep	1	SENT_967	[p31l557t1646r744b1682],
8	is	VBZ	O	be	cop	11	SENT_967	[p31l754t1646r779b1674],
9	a	DT	O	a	det	11	SENT_967	[p31l790t1655r806b1674],
10	CYPZD6	NN	O	cypzd6	nn	11	SENT_967	[p31l815t1646r958b1674],
11	substrate	NN	O	substrate	_	0	SENT_967	[p31l970t1646r1116b1674],
12	.	.	O	.	_	0	SENT_967	[p31l970t1646r1116b1674],

1	After	IN	O	after	_	0	SENT_968	[p31l1125t1646r1209b1674],
2	receiving	VBG	O	receive	prepc_after	18	SENT_968	[p31l1217t1646r1362b1682],
3	the	DT	O	the	det	5	SENT_968	[p31l1372t1646r1419b1674],
4	same	JJ	O	same	amod	5	SENT_968	[p31l1430t1655r1509b1674],
5	dose	NN	O	dose	dobj	2	SENT_968	[p31l1519t1646r1599b1679],
6	,	,	O	,	_	0	SENT_968	[p31l1519t1646r1599b1679],
7	patients	NNS	O	patient	nsubj	18	SENT_968	[p31l1609t1646r1731b1682],
8	with	IN	O	with	_	0	SENT_968	[p31l1742t1646r1811b1674],
9	high	JJ	O	high	amod	11	SENT_968	[p31l1820t1646r1889b1682],
10	enzyme	NN	O	enzyme	nn	11	SENT_968	[p31l557t1705r678b1732],
11	activity	NN	O	activity	prep_with	7	SENT_968	[p31l694t1696r809b1732],
12	due	JJ	O	due	_	0	SENT_968	[p31l824t1696r880b1724],
13	to	TO	O	to	_	0	SENT_968	[p31l894t1700r923b1724],
14	gene	NN	O	gene	nn	15	SENT_968	[p31l939t1705r1012b1732],
15	duplication	NN	O	duplication	prep_due_to	11	SENT_968	[p31l1027t1696r1203b1732],
16	will	MD	O	will	aux	18	SENT_968	[p31l1218t1696r1278b1724],
17	not	RB	O	not	neg	18	SENT_968	[p31l1292t1700r1342b1724],
18	achieve	VB	O	achieve	_	0	SENT_968	[p31l1357t1696r1474b1724],
19	effective	JJ	O	effective	amod	21	SENT_968	[p31l1489t1696r1623b1724],
20	drug	NN	O	drug	nn	21	SENT_968	[p31l1638t1696r1709b1732],
21	concentrations	NNS	O	concentration	dobj	18	SENT_968	[p31l1724t1700r1888b1724, p31l557t1746r640b1774],
22	.	.	O	.	_	0	SENT_968	[p31l1724t1700r1888b1724, p31l557t1746r640b1774],

1	(	NN	O	(	nsubjpass	21	SENT_969	[p31l655t1746r697b1780],
2	b	NN	O	b	dep	10	SENT_969	[p31l655t1746r697b1780],
3	)	CD	NUMBER	)	num	2	SENT_969	[p31l655t1746r697b1780],
4	Because	IN	O	because	dep	10	SENT_969	[p31l710t1747r840b1774],
5	the	DT	O	the	det	6	SENT_969	[p31l852t1746r899b1774],
6	drug	NN	O	drug	nsubj	10	SENT_969	[p31l910t1746r981b1782],
7	is	VBZ	O	be	cop	10	SENT_969	[p31l993t1746r1017b1774],
8	a	DT	O	a	det	10	SENT_969	[p31l1030t1755r1046b1774],
9	Pgp	NNP	ORGANIZATION	Pgp	nn	10	SENT_969	[p31l1057t1747r1117b1782],
10	substrate	NN	O	substrate	dep	21	SENT_969	[p31l1130t1746r1277b1779],
11	,	,	O	,	_	0	SENT_969	[p31l1130t1746r1277b1779],
12	transfer	NN	O	transfer	appos	10	SENT_969	[p31l1289t1746r1410b1774],
13	from	IN	O	from	_	0	SENT_969	[p31l1420t1746r1496b1774],
14	blood	NN	O	blood	prep_from	12	SENT_969	[p31l1507t1746r1597b1774],
15	to	TO	O	to	_	0	SENT_969	[p31l1607t1750r1637b1774],
16	central	JJ	O	central	amod	18	SENT_969	[p31l1649t1746r1755b1774],
17	nervous	JJ	O	nervous	amod	18	SENT_969	[p31l1766t1755r1889b1774],
18	system	NN	O	system	prep_to	14	SENT_969	[p31l558t1800r666b1832],
19	will	MD	O	will	aux	21	SENT_969	[p31l681t1796r741b1824],
20	be	VB	O	be	auxpass	21	SENT_969	[p31l757t1796r793b1824],
21	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_969	[p31l809t1796r976b1824],
22	by	IN	O	by	_	0	SENT_969	[p31l990t1796r1029b1832],
23	the	DT	O	the	det	24	SENT_969	[p31l1045t1796r1092b1824],
24	level	NN	O	level	agent	21	SENT_969	[p31l1108t1796r1182b1824],
25	of	IN	O	of	_	0	SENT_969	[p31l1198t1796r1233b1824],
26	Pgp	NN	ORGANIZATION	pgp	nn	27	SENT_969	[p31l1245t1797r1305b1832],
27	expression	NN	O	expression	prep_of	24	SENT_969	[p31l1322t1796r1498b1832],
28	,	,	O	,	_	0	SENT_969	[p31l1322t1796r1498b1832],
29	an	DT	O	a	det	31	SENT_969	[p31l1516t1805r1551b1824],
30	additional	JJ	O	additional	amod	31	SENT_969	[p31l1567t1796r1724b1824],
31	source	NN	O	source	appos	27	SENT_969	[p31l1741t1805r1842b1824],
32	of	IN	O	of	_	0	SENT_969	[p31l1858t1796r1892b1824],
33	variability	NN	O	variability	prep_of	31	SENT_969	[p31l557t1846r723b1882],
34	,	,	O	,	_	0	SENT_969	[p31l557t1846r723b1882],
35	at	IN	O	at	_	0	SENT_969	[p31l740t1851r767b1874],
36	the	DT	O	the	det	38	SENT_969	[p31l781t1846r828b1874],
37	blood-brain	JJ	O	blood-brain	amod	38	SENT_969	[p31l843t1846r1027b1874],
38	barrier	NN	O	barrier	prep_at	21	SENT_969	[p31l1041t1846r1146b1874],
39	(	CD	NUMBER	(	num	40	SENT_969	[p31l1161t1847r1273b1880],
40	BBB	NNP	O	BBB	dep	38	SENT_969	[p31l1161t1847r1273b1880],
41	)	CD	NUMBER	)	num	40	SENT_969	[p31l1161t1847r1273b1880],
42	.	.	O	.	_	0	SENT_969	[p31l1161t1847r1273b1880],

1	(	NN	O	(	nn	2	SENT_970	[p31l1290t1847r1331b1880],
2	c	NN	O	c	nsubjpass	13	SENT_970	[p31l1290t1847r1331b1880],
3	)	CD	NUMBER	)	dep	2	SENT_970	[p31l1290t1847r1331b1880],
4	The	DT	O	the	det	5	SENT_970	[p31l1346t1846r1406b1874],
5	magnitude	NN	O	magnitude	dep	2	SENT_970	[p31l1421t1846r1587b1882],
6	of	IN	O	of	_	0	SENT_970	[p31l1602t1846r1636b1874],
7	response	NN	O	response	prep_of	5	SENT_970	[p31l1648t1855r1785b1882],
8	at	IN	O	at	_	0	SENT_970	[p31l1801t1851r1828b1874],
9	the	DT	O	the	det	11	SENT_970	[p31l1842t1846r1889b1874],
10	HT3	NN	O	ht3	nn	11	SENT_970	[p31l557t1897r622b1934],
11	receptor	NN	O	receptor	prep_at	7	SENT_970	[p31l635t1901r765b1932],
12	is	VBZ	O	be	auxpass	13	SENT_970	[p31l777t1896r801b1924],
13	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_970	[p31l814t1896r980b1924],
14	not	RB	O	not	neg	15	SENT_970	[p31l992t1901r1042b1924],
15	only	RB	O	only	preconj	13	SENT_970	[p31l1054t1896r1123b1932],
16	by	IN	O	by	_	0	SENT_970	[p31l1134t1896r1173b1932],
17	drug	NN	O	drug	nn	18	SENT_970	[p31l1186t1896r1257b1932],
18	concentration	NN	O	concentration	agent	13	SENT_970	[p31l1269t1896r1483b1924],
19	but	CC	O	but	_	0	SENT_970	[p31l1495t1896r1545b1924],
20	also	RB	O	also	advmod	13	SENT_970	[p31l1557t1896r1618b1924],
21	by	IN	O	by	_	0	SENT_970	[p31l1630t1896r1669b1932],
22	genetic	JJ	O	genetic	amod	23	SENT_970	[p31l1682t1896r1794b1932],
23	polymorphisms	NNS	O	polymorphism	agent	13	SENT_970	[p31l1806t1896r1888b1932, p31l557t1946r731b1982],
24	in	IN	O	in	_	0	SENT_970	[p31l749t1946r778b1973],
25	the	DT	O	the	det	26	SENT_970	[p31l795t1946r842b1974],
26	receptor	NN	O	receptor	prep_in	23	SENT_970	[p31l859t1950r989b1982],
27	and	CC	O	and	_	0	SENT_970	[p31l1006t1946r1062b1974],
28	concentration	NN	O	concentration	prep_in	23	SENT_970	[p31l1079t1946r1293b1974],
29	of	IN	O	of	_	0	SENT_970	[p31l1310t1946r1344b1974],
30	neutrotransmitter	NN	O	neutrotransmitter	prep_of	26	SENT_970	[p31l1359t1946r1631b1974],
31	in	IN	O	in	_	0	SENT_970	[p31l1647t1946r1677b1973],
32	the	DT	O	the	det	34	SENT_970	[p31l1694t1946r1741b1974],
33	synaptic	JJ	O	synaptic	amod	34	SENT_970	[p31l1760t1946r1889b1982],
34	cleft	NN	O	cleft	prep_in	13	SENT_970	[p31l557t1996r634b2023],
35	.	.	O	.	_	0	SENT_970	[p31l557t1996r634b2023],

1	Serotonin	NN	O	serotonin	nn	2	SENT_971	[p31l656t1996r808b2024],
2	concentration	NN	O	concentration	nsubjpass	4	SENT_971	[p31l827t1996r1041b2023],
3	is	VBZ	O	be	auxpass	4	SENT_971	[p31l1060t1996r1084b2023],
4	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_971	[p31l1104t1996r1271b2023],
5	by	IN	O	by	_	0	SENT_971	[p31l1289t1996r1328b2032],
6	proteins	NNS	O	protein	agent	4	SENT_971	[p31l1347t1996r1473b2032],
7	involved	VBN	O	involve	partmod	6	SENT_971	[p31l1492t1996r1627b2023],
8	in	IN	O	in	_	0	SENT_971	[p31l1646t1996r1676b2023],
9	biosynthesis	NN	O	biosynthesis	prep_in	7	SENT_971	[p31l1694t1996r1888b2032],
10	(	CD	NUMBER	(	num	9	SENT_971	[p31l558t2046r672b2080],
11	TPH2	NN	O	tph2	nn	24	SENT_971	[p31l558t2046r672b2080],
12	,	,	O	,	_	0	SENT_971	[p31l558t2046r672b2080],
13	tryptophane	NN	O	tryptophane	dep	24	SENT_971	[p31l688t2046r875b2082],
14	hydroxylase	NN	O	hydroxylase	nn	24	SENT_971	[p31l890t2046r1082b2082],
15	2	CD	NUMBER	2	num	24	SENT_971	[p31l1097t2046r1137b2080],
16	)	NN	O	)	nn	24	SENT_971	[p31l1097t2046r1137b2080],
17	,	,	O	,	_	0	SENT_971	[p31l1097t2046r1137b2080],
18	transport	NN	O	transport	dep	24	SENT_971	[p31l1153t2050r1293b2082],
19	(	CD	NUMBER	(	num	24	SENT_971	[p31l1308t2046r1419b2080],
20	SERT	NNP	O	SERT	nn	24	SENT_971	[p31l1308t2046r1419b2080],
21	,	,	O	,	_	0	SENT_971	[p31l1308t2046r1419b2080],
22	high-afﬁnity	JJ	O	high-afﬁnity	amod	24	SENT_971	[p31l1435t2046r1632b2082],
23	serotonin	NN	O	serotonin	nn	24	SENT_971	[p31l1648t2046r1793b2073],
24	reuptake	NN	O	reuptake	dep	7	SENT_971	[p31l1807t2054r1889b2082, p31l557t2127r621b2155],

1	transporter	NN	O	transporter	_	0	SENT_972	[p31l639t2127r830b2163],
2	)	NN	O	)	dep	1	SENT_972	[p31l639t2127r830b2163],
3	,	,	O	,	_	0	SENT_972	[p31l639t2127r830b2163],
4	and	CC	O	and	_	0	SENT_972	[p31l850t2127r906b2155],
5	catabolism	NN	O	catabolism	nn	7	SENT_972	[p31l923t2127r1094b2155],
6	(	CD	NUMBER	(	num	7	SENT_972	[p31l1112t2127r1221b2161],
7	MAO	NNP	O	MAO	conj_and	2	SENT_972	[p31l1112t2127r1221b2161],
8	,	,	O	,	_	0	SENT_972	[p31l1112t2127r1221b2161],
9	monoamine	NN	O	monoamine	nn	11	SENT_972	[p31l1240t2127r1426b2155],
10	oxidase	NN	O	oxidase	nn	11	SENT_972	[p31l1444t2127r1584b2161],
11	)	NN	O	)	appos	7	SENT_972	[p31l1444t2127r1584b2161],
12	.	.	O	.	_	0	SENT_972	[p31l1444t2127r1584b2161],

1	Genetic	JJ	O	genetic	amod	2	SENT_973	[p31l1604t2127r1725b2155],
2	polymorphisms	NNS	O	polymorphism	nsubjpass	8	SENT_973	[p31l1743t2127r1888b2163, p31l556t2177r667b2213],
3	that	WDT	O	that	nsubj	4	SENT_973	[p31l681t2177r740b2205],
4	affect	VBP	O	affect	rcmod	2	SENT_973	[p31l753t2177r841b2205],
5	function	NN	O	function	dobj	4	SENT_973	[p31l854t2177r984b2205],
6	have	VBP	O	have	aux	8	SENT_973	[p31l998t2177r1070b2205],
7	been	VBN	O	be	auxpass	8	SENT_973	[p31l1083t2177r1157b2205],
8	described	VBN	O	describe	_	0	SENT_973	[p31l1170t2177r1321b2205],
9	for	IN	O	for	_	0	SENT_973	[p31l1334t2177r1380b2205],
10	all	DT	O	all	prep_for	8	SENT_973	[p31l1393t2177r1430b2205],
11	of	IN	O	of	_	0	SENT_973	[p31l1444t2177r1479b2205],
12	the	DT	O	the	det	13	SENT_973	[p31l1489t2177r1536b2205],
13	genes	NNS	O	gene	prep_of	10	SENT_973	[p31l1550t2186r1638b2213],
14	encoding	VBG	O	encode	xcomp	8	SENT_973	[p31l1652t2177r1795b2213],
15	these	DT	O	these	det	16	SENT_973	[p31l1809t2177r1889b2205],
16	proteins	NNS	O	protein	dobj	14	SENT_973	[p31l556t2258r691b2294],
17	.	.	O	.	_	0	SENT_973	[p31l556t2258r691b2294],

1	A	DT	O	a	det	3	SENT_974	[p31l703t2258r730b2286],
2	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	3	SENT_974	[p31l742t2258r1011b2294],
3	analysis	NN	O	analysis	nsubj	19	SENT_974	[p31l1025t2258r1150b2294],
4	of	IN	O	of	_	0	SENT_974	[p31l1163t2258r1197b2286],
5	nonresponse	JJ	O	nonresponse	amod	9	SENT_974	[p31l1207t2267r1403b2294],
6	or	CC	O	or	_	0	SENT_974	[p31l1416t2267r1448b2286],
7	poor	JJ	O	poor	conj_or	5	SENT_974	[p31l1459t2267r1532b2294],
8	response	NN	O	response	nn	9	SENT_974	[p31l1543t2267r1681b2294],
9	(	NN	O	(	prep_of	3	SENT_974	[p31l1694t2258r1848b2292],
10	observed	VBN	O	observe	partmod	9	SENT_974	[p31l1694t2258r1848b2292],
11	in	IN	O	in	_	0	SENT_974	[p31l1860t2258r1889b2286],
12	~	NN	O	~	prep_in	10	SENT_974	[p31l559t2308r659b2336],
13	30	CD	PERCENT	30	number	14	SENT_974	[p31l559t2308r659b2336],
14	%	NN	PERCENT	%	amod	12	SENT_974	[p31l559t2308r659b2336],
15	of	IN	O	of	_	0	SENT_974	[p31l673t2308r708b2336],
16	patients	NNS	O	patient	prep_of	12	SENT_974	[p31l716t2308r851b2344],
17	)	CD	NUMBER	)	dep	12	SENT_974	[p31l716t2308r851b2344],
18	should	MD	O	should	aux	19	SENT_974	[p31l865t2308r969b2336],
19	include	VB	O	include	_	0	SENT_974	[p31l980t2308r1096b2336],
20	all	DT	O	all	dobj	19	SENT_974	[p31l1109t2308r1146b2336],
21	of	IN	O	of	_	0	SENT_974	[p31l1159t2308r1193b2336],
22	these	DT	O	these	det	24	SENT_974	[p31l1202t2308r1282b2336],
23	candidate	NN	O	candidate	nn	24	SENT_974	[p31l1295t2308r1445b2336],
24	genes	NNS	O	gene	prep_of	20	SENT_974	[p31l1457t2317r1554b2344],
25	.	.	O	.	_	0	SENT_974	[p31l1457t2317r1554b2344],

1	EICHELBAUM	NNP	O	EICHELBAUM	nsubj	5	SENT_975	[p31l600t2419r842b2445],
2	I	PRP	O	I	dep	1	SENT_975	[p31l862t2426r876b2441],
3	INGELMAN-SUNDBERG	NN	O	ingelman-sundberg	dep	1	SENT_975	[p31l896t2419r1310b2445],
4	I	PRP	O	I	dep	3	SENT_975	[p31l1329t2426r1344b2441],
5	EVANS	VBP	O	evan	_	0	SENT_975	[p31l1364t2419r1481b2445],

1	33	CD	NUMBER	33	num	2	SENT_976	[p32l1851t2966r1888b2995],
2	49	CD	NUMBER	49	_	0	SENT_976	[p32l1850t3028r1890b3057],
3	65	CD	NUMBER	65	num	4	SENT_976	[p32l1851t3139r1889b3169],
4	83	CD	NUMBER	83	dep	2	SENT_976	[p32l1852t3252r1888b3281],
5	.	.	O	.	_	0	SENT_976	[p32l1762t338r1798b463],

1	b	NN	O	b	_	0	SENT_977	[p32l1762t338r1798b463],
2	§	CD	NUMBER	§	number	1	SENT_977	[p32l1762t338r1798b463],
3	§	CD	NUMBER	§	number	1	SENT_977	[p32l1762t338r1798b463],
4	3:8	CD	NUMBER	3:8	number	1	SENT_977	[p32l1766t475r1790b557],
5	505	CD	NUMBER	505	dep	1	SENT_977	[p32l1762t569r1790b689],
6	:	:	O	:	_	0	SENT_977	[p32l1762t569r1790b689],
7	»	CD	NUMBER	»	num	8	SENT_977	[p32l1762t569r1790b689],
8	woamob	NN	O	woamob	dep	1	SENT_977	[p32l1762t701r1790b808],
9	on	IN	O	on	_	0	SENT_977	[p32l1762t820r1790b857],
10	E8	NN	O	e8	nn	12	SENT_977	[p32l1771t868r1790b922],
11	momboaonm	NN	O	momboaonm	nn	12	SENT_977	[p32l1762t935r1798b1114],
12	BEE	NN	O	bee	prep_on	8	SENT_977	[p32l1763t1125r1790b1230],
13	.	.	O	.	_	0	SENT_977	[p32l1763t1125r1790b1230],

1	«	NN	O	«	_	0	SENT_978	[p32l1762t1241r1790b1319],
2	.85	CD	NUMBER	.85	num	1	SENT_978	[p32l1762t1241r1790b1319],
3	:	:	O	:	_	0	SENT_978	[p32l1762t1332r1790b1369],
4	m	NN	O	m	nn	5	SENT_978	[p32l1762t1332r1790b1369],
5	wan	NN	O	wan	dep	1	SENT_978	[p32l1762t1381r1790b1437],
6	.	.	O	.	_	0	SENT_978	[p32l1762t1451r1795b1597],

1	wo	MD	O	will	aux	3	SENT_979	[p32l1762t1451r1795b1597],
2	>	JJR	O	>	amod	3	SENT_979	[p32l1762t1451r1795b1597],
3	oEom	NN	O	oeom	_	0	SENT_979	[p32l1762t1451r1795b1597],
4	Sm	NN	O	sm	nn	6	SENT_979	[p32l1771t1610r1790b1656],
5	mcoumbaooaoo	NN	O	mcoumbaooaoo	nn	6	SENT_979	[p32l1762t1670r1790b1899],
6	ZOE	NN	O	zoe	dep	15	SENT_979	[p32l1762t1910r1790b1991],
7	33:8	CD	NUMBER	33:8	number	8	SENT_979	[p32l1762t2001r1790b2120],
8	3:86	CD	NUMBER	3:86	dep	6	SENT_979	[p32l1762t2131r1790b2240],
9	480	CD	NUMBER	480	num	11	SENT_979	[p32l1712t46r1746b131],
10	bﬁmxoa	NN	O	bﬁmxoa	nn	11	SENT_979	[p32l1712t142r1748b262],
11	ouowomoamﬁon	NN	O	ouowomoamﬁon	dep	8	SENT_979	[p32l1712t272r1748b495],
12	SHE	NN	O	she	dep	15	SENT_979	[p32l1712t504r1740b573],
13	»	CD	NUMBER	»	num	12	SENT_979	[p32l1712t504r1740b573],
14	woﬁowoﬁ	NN	O	woﬁowoﬁ	nn	15	SENT_979	[p32l1712t582r1748b734],
15	E3	NN	O	e3	dep	3	SENT_979	[p32l1712t744r1740b810],
16	ﬁaoumm	NN	O	ﬁaoumm	nn	17	SENT_979	[p32l1712t820r1748b942],
17	E	NN	O	e	dep	15	SENT_979	[p32l1712t951r1740b981],
18	@	IN	O	@	_	0	SENT_979	[p32l1712t990r1740b1128],
19	3828	CD	NUMBER	3828	number	20	SENT_979	[p32l1712t990r1740b1128],
20	295	CD	NUMBER	295	prep_@	3	SENT_979	[p32l1721t1138r1740b1213],
21	E5	NN	O	e5	nn	25	SENT_979	[p32l1712t1222r1740b1281],
22	mowow	NN	O	mowow	nn	25	SENT_979	[p32l1712t1291r1740b1377],
23	E28	NN	O	e28	nn	25	SENT_979	[p32l1712t1388r1746b1488],
24	ontsmoummouoﬁ	NN	O	ontsmoummouoﬁ	nn	25	SENT_979	[p32l1712t1499r1748b1746],
25	SE3	NN	O	se3	dep	20	SENT_979	[p32l1712t1755r1748b1851],
26	.	.	O	.	_	0	SENT_979	[p32l1712t1755r1748b1851],

1	E3	NN	O	e3	_	0	SENT_980	[p32l1712t1862r1740b1926],
2	@	SYM	O	@	dep	4	SENT_980	[p32l1712t1935r1746b2063],
3	8203	CD	NUMBER	8203	num	4	SENT_980	[p32l1712t1935r1746b2063],
4	wow	NN	O	wow	rcmod	1	SENT_980	[p32l1712t2075r1740b2147],
5	:	:	O	:	_	0	SENT_980	[p32l1712t2075r1740b2147],
6	E	NN	O	e	nn	7	SENT_980	[p32l1712t2157r1740b2182],
7	ma	NN	O	ma	dep	1	SENT_980	[p32l1712t2192r1748b2241],
8	-	:	O	-	_	0	SENT_980	[p32l1662t46r1690b111],
9	mow	VB	O	mow	dep	7	SENT_980	[p32l1662t46r1690b111],
10	o	NN	O	o	nn	11	SENT_980	[p32l1662t123r1698b402],
11	_	NN	O	_	dobj	9	SENT_980	[p32l1662t123r1698b402],
12	;	:	O	;	_	0	SENT_980	[p32l1662t123r1698b402],
13	:	:	O	:	_	0	SENT_980	[p32l1662t123r1698b402],
14	oo	CD	PERCENT	oo	num	15	SENT_980	[p32l1662t123r1698b402],
15	%	NN	PERCENT	%	dep	7	SENT_980	[p32l1662t123r1698b402],
16	-	:	O	-	_	0	SENT_980	[p32l1662t123r1698b402],
17	ombo	NN	O	ombo	dep	15	SENT_980	[p32l1662t123r1698b402],
18	:	:	O	:	_	0	SENT_980	[p32l1662t123r1698b402],
19	om	NN	O	om	dep	27	SENT_980	[p32l1662t123r1698b402],
20	5:3	CD	NUMBER	5:3	dep	19	SENT_980	[p32l1662t413r1690b497],
21	Eoamm	NNP	O	Eoamm	nn	25	SENT_980	[p32l1662t510r1698b619],
22	Raﬁ	NNP	O	Raﬁ	nn	25	SENT_980	[p32l1662t629r1690b708],
23	Eoﬁon	NNP	O	Eoﬁon	nn	25	SENT_980	[p32l1662t718r1690b830],
24	oﬁ	NN	O	oﬁ	nn	25	SENT_980	[p32l1662t840r1690b888],
25	E	NN	O	e	dep	27	SENT_980	[p32l1662t899r1690b928],
26	couommow	NN	O	couommow	nn	27	SENT_980	[p32l1662t939r1698b1072],
27	m	NN	O	m	dep	30	SENT_980	[p32l1662t1084r1690b1126],
28	<	JJR	O	<	amod	29	SENT_980	[p32l1662t1084r1690b1126],
29	.3	NN	NUMBER	.3	dep	27	SENT_980	[p32l1662t1137r1698b1264],
30	mE	NN	O	me	dep	33	SENT_980	[p32l1662t1137r1698b1264],
31	§	CD	NUMBER	§	num	30	SENT_980	[p32l1662t1137r1698b1264],
32	~	NN	O	~	nn	33	SENT_980	[p32l1662t1137r1698b1264],
33	EM	NN	O	em	dep	17	SENT_980	[p32l1662t1270r1698b1346],
34	:	:	O	:	_	0	SENT_980	[p32l1662t1270r1698b1346],
35	gab	NN	O	gab	dep	45	SENT_980	[p32l1662t1356r1698b1415],
36	\	CD	MONEY	\	num	35	SENT_980	[p32l1662t1427r1698b1547],
37	€	CD	MONEY	€	num	39	SENT_980	[p32l1662t1427r1698b1547],
38	o_x8	NN	O	o_x8	nn	39	SENT_980	[p32l1662t1427r1698b1547],
39	mo	NN	DURATION	mo	dep	35	SENT_980	[p32l1662t1555r1690b1589],
40	zonoswob	NN	O	zonoswob	dep	45	SENT_980	[p32l1662t1601r1698b1757],
41	.5	CD	MONEY	.5	num	40	SENT_980	[p32l1662t1767r1698b1868],
42	£	CD	MONEY	£	num	45	SENT_980	[p32l1662t1767r1698b1868],
43	mE	NN	O	me	nn	45	SENT_980	[p32l1662t1767r1698b1868],
44	basmowmqwa	NN	O	basmowmqwa	nn	45	SENT_980	[p32l1662t1879r1698b2074],
45	m	NN	O	m	dep	50	SENT_980	[p32l1671t2085r1690b2102],
46	95	CD	NUMBER	95	number	47	SENT_980	[p32l1662t2114r1690b2174],
47	82	CD	NUMBER	82	dep	45	SENT_980	[p32l1662t2185r1690b2241],
48	-935	CD	NUMBER	-935	num	49	SENT_980	[p32l1616t46r1640b134],
49	moonouonmmw	NN	O	moonouonmmw	dep	47	SENT_980	[p32l1612t146r1640b319],
50	822	CD	NUMBER	822	dep	33	SENT_980	[p32l1612t331r1640b424],
51	.	.	O	.	_	0	SENT_980	[p32l1612t331r1640b424],

1	aaouabaooaoo	NN	O	aaouabaooaoo	nn	7	SENT_981	[p32l1612t437r1640b675],
2	ZOE	NN	O	zoe	nn	7	SENT_981	[p32l1612t686r1640b767],
3	Bamﬂ	NN	O	bamﬂ	nn	7	SENT_981	[p32l1612t777r1648b878],
4	E895	NN	O	e895	nn	7	SENT_981	[p32l1612t889r1640b1011],
5	Eons	NNS	O	eon	nn	7	SENT_981	[p32l1612t1022r1640b1109],
6	Bﬁsﬁsoom	NN	O	bﬁsﬁsoom	nn	7	SENT_981	[p32l1612t1122r1640b1300],
7	ﬂsoumm	NN	O	ﬂsoumm	_	0	SENT_981	[p32l1612t1313r1648b1435],
8	msowmaouoaoa	NN	O	msowmaouoaoa	nsubj	10	SENT_981	[p32l1612t1447r1648b1657],
9	can	MD	O	can	aux	10	SENT_981	[p32l1612t1668r1640b1723],
10	AZUHV	VB	O	azuhv	rcmod	7	SENT_981	[p32l1612t1737r1646b1851],
11	mowuoﬂosa	NN	O	mowuoﬂosa	nn	12	SENT_981	[p32l1612t1865r1640b2043],
12	o	NN	O	o	dobj	10	SENT_981	[p32l1612t2055r1648b2241],
13	:	:	O	:	_	0	SENT_981	[p32l1612t2055r1648b2241],
14	Ea	NN	O	ea	nn	16	SENT_981	[p32l1612t2055r1648b2241],
15	=	JJ	O	=	amod	16	SENT_981	[p32l1612t2055r1648b2241],
16	moEH	NN	O	moeh	dep	7	SENT_981	[p32l1612t2055r1648b2241],
17	Pﬁom	NN	O	pﬁom	dep	16	SENT_981	[p32l1562t45r1590b136],
18	2	CD	NUMBER	2	num	17	SENT_981	[p32l1562t151r1590b198],
19	:	:	O	:	_	0	SENT_981	[p32l1562t151r1590b198],
20	mo	NN	DURATION	mo	nn	23	SENT_981	[p32l1562t210r1590b244],
21	waonmbcoocoo	NN	O	waonmbcoocoo	nn	23	SENT_981	[p32l1562t260r1590b488],
22	HESZOO	NN	O	heszoo	nn	23	SENT_981	[p32l1562t502r1590b620],
23	Bamﬁ	NN	O	bamﬁ	dep	7	SENT_981	[p32l1562t634r1598b735],
24	28:8	CD	NUMBER	28:8	num	25	SENT_981	[p32l1562t749r1590b860],
25	Bﬂsﬁsoom	NNP	O	Bﬂsﬁsoom	dep	23	SENT_981	[p32l1562t875r1590b1053],
26	3:053	CD	NUMBER	3:053	num	25	SENT_981	[p32l1562t1069r1598b1191],
27	.	.	O	.	_	0	SENT_981	[p32l1562t1204r1590b1456],

1	.	.	O	.	_	0	SENT_982	[p32l1562t1204r1590b1456],

1	:	:	O	:	_	0	SENT_983	[p32l1562t1204r1590b1456],
2	o_omow	NN	O	o_omow	_	0	SENT_983	[p32l1562t1204r1590b1456],
3	.	.	O	.	_	0	SENT_983	[p32l1562t1204r1590b1456],

1	.	.	O	.	_	0	SENT_984	[p32l1562t1204r1590b1456],

1	_	NN	O	_	nn	8	SENT_985	[p32l1562t1204r1590b1456],
2	.2	NN	NUMBER	.2	nn	8	SENT_985	[p32l1562t1204r1590b1456],
3	mH	NN	O	mh	nn	8	SENT_985	[p32l1562t1204r1590b1456],
4	écouwm	NN	O	écouwm	nn	8	SENT_985	[p32l1562t1471r1598b1603],
5	SN	NN	O	sn	nn	8	SENT_985	[p32l1562t1617r1590b1654],
6	8	CD	NUMBER	8	num	8	SENT_985	[p32l1566t1670r1590b1699],
7	coﬁw	NN	O	coﬁw	nn	8	SENT_985	[p32l1562t1713r1598b1798],
8	Em	NN	O	em	_	0	SENT_985	[p32l1571t1813r1590b1859],
9	msonmoéoﬁ	NN	O	msonmoéoﬁ	nn	10	SENT_985	[p32l1562t1875r1590b2065],
10	oaismout	NN	O	oaismout	dep	8	SENT_985	[p32l1562t2079r1598b2241],
11	yo	NN	O	yo	nn	14	SENT_985	[p32l1512t42r1540b76],
12	mommmow	NN	O	mommmow	nn	14	SENT_985	[p32l1512t94r1548b217],
13	Qmaownoéoov	NNP	O	Qmaownoéoov	nn	14	SENT_985	[p32l1512t236r1546b461],
14	Euoﬁaa	NNP	O	Euoﬁaa	dep	10	SENT_985	[p32l1512t480r1540b607],
15	:2	CD	NUMBER	:2	num	14	SENT_985	[p32l1512t624r1540b708],
16	?	.	O	?	_	0	SENT_985	[p32l1512t624r1540b708],

1	»	NN	O	»	nn	3	SENT_986	[p32l1512t624r1540b708],
2	.223	CD	NUMBER	.223	num	3	SENT_986	[p32l1512t727r1548b836],
3	ooh	NN	O	ooh	_	0	SENT_986	[p32l1512t853r1540b931],
4	:	:	O	:	_	0	SENT_986	[p32l1512t853r1540b931],
5	Q8	NN	O	q8	nn	7	SENT_986	[p32l1517t948r1548b997],
6	Eoommgm	NN	O	eoommgm	nn	7	SENT_986	[p32l1512t1014r1548b1144],
7	2t	NN	O	2t	dep	3	SENT_986	[p32l1512t1163r1540b1210],
8	5	CD	NUMBER	5	num	9	SENT_986	[p32l1512t1227r1540b1256],
9	woaoﬂow	NN	O	woaoﬂow	dep	7	SENT_986	[p32l1512t1273r1548b1406],
10	3	CD	NUMBER	3	dep	9	SENT_986	[p32l1512t1425r1540b1467],
11	.	.	O	.	_	0	SENT_986	[p32l1512t1425r1540b1467],

1	.9385	NN	NUMBER	.9385	_	0	SENT_987	[p32l1512t1484r1540b1614],
2	:	:	O	:	_	0	SENT_987	[p32l1512t1484r1540b1614],
3	E	NN	O	e	nn	8	SENT_987	[p32l1512t1631r1540b1661],
4	bwﬁoa	NN	O	bwﬁoa	nn	8	SENT_987	[p32l1512t1678r1548b1794],
5	H2n_H	NN	O	h2n_h	nn	8	SENT_987	[p32l1513t1812r1540b1916],
6	mo	NN	DURATION	mo	nn	8	SENT_987	[p32l1512t1930r1540b1964],
7	oosﬁioai	NN	O	oosﬁioai	nn	8	SENT_987	[p32l1512t1982r1540b2156],
8	Em	NN	O	em	dep	1	SENT_987	[p32l1516t2173r1540b2241],
9	:	:	O	:	_	0	SENT_987	[p32l1516t2173r1540b2241],
10	ﬁdowoo	NN	O	ﬁdowoo	nn	13	SENT_987	[p32l1462t46r1490b175],
11	Eﬁomoﬁa	NN	O	eﬁomoﬁa	nn	13	SENT_987	[p32l1462t189r1490b349],
12	mﬁmsno	NN	O	mﬁmsno	nn	13	SENT_987	[p32l1462t363r1498b482],
13	m2o	NN	O	m2o	dep	8	SENT_987	[p32l1462t496r1490b594],
14	=	JJ	O	=	amod	16	SENT_987	[p32l1462t496r1490b594],
15	m	NN	O	m	nn	16	SENT_987	[p32l1462t496r1490b594],
16	E838	NN	O	e838	nsubj	17	SENT_987	[p32l1466t607r1490b717],
17	HEAR	VBP	O	hear	rcmod	13	SENT_987	[p32l1463t730r1490b834],
18	Emﬁﬁowoi	JJ	O	emﬁﬁowoi	amod	20	SENT_987	[p32l1462t846r1498b1046],
19	Qt	NN	O	qt	nn	20	SENT_987	[p32l1462t1058r1490b1105],
20	SE3	NN	O	se3	dobj	17	SENT_987	[p32l1462t1117r1498b1213],
21	.	.	O	.	_	0	SENT_987	[p32l1462t1117r1498b1213],

1	£	NN	MONEY	£	nn	4	SENT_988	[p32l1462t1227r1498b1327],
2	289	CD	MONEY	289	num	4	SENT_988	[p32l1462t1227r1498b1327],
3	a2	NN	O	a2	nn	4	SENT_988	[p32l1462t1339r1490b1391],
4	Em	NN	O	em	_	0	SENT_988	[p32l1462t1403r1490b1446],
5	OJH	NN	O	ojh	dep	4	SENT_988	[p32l1462t1459r1490b1519],
6	.	.	O	.	_	0	SENT_988	[p32l1462t1459r1490b1519],

1	Aoﬁanswoﬁg	NNP	O	Aoﬁanswoﬁg	nn	4	SENT_989	[p32l1462t1533r1498b1740],
2	.2	NN	NUMBER	.2	nn	4	SENT_989	[p32l1462t1754r1498b2010],
3	_	NN	O	_	nn	4	SENT_989	[p32l1462t1754r1498b2010],
4	Eao	NN	O	eao	nsubj	18	SENT_989	[p32l1462t1754r1498b2010],
5	§	CD	NUMBER	§	num	6	SENT_989	[p32l1462t1754r1498b2010],
6	85E	NN	O	85e	dep	4	SENT_989	[p32l1462t1754r1498b2010],
7	daimoﬁﬁmmv	NN	O	daimoﬁﬁmmv	nn	13	SENT_989	[p32l1462t2025r1498b2240],
8	mnounomvoﬁ	NN	O	mnounomvoﬁ	nn	13	SENT_989	[p32l1412t45r1440b234],
9	onﬂsmoﬂﬁ	NN	O	onﬂsmoﬂﬁ	nn	13	SENT_989	[p32l1412t245r1448b407],
10	8	CD	NUMBER	8	num	13	SENT_989	[p32l1416t417r1440b447],
11	omaommou	NN	O	omaommou	nn	13	SENT_989	[p32l1421t457r1448b595],
12	mcuuﬁhﬁow	NN	O	mcuuﬁhﬁow	nn	13	SENT_989	[p32l1412t605r1448b795],
13	E	NN	O	e	dep	4	SENT_989	[p32l1412t805r1440b835],
14	28	CD	NUMBER	28	number	15	SENT_989	[p32l1412t845r1440b906],
15	wt	JJ	O	wt	amod	13	SENT_989	[p32l1412t917r1440b952],
16	was	VBD	O	be	cop	18	SENT_989	[p32l1412t962r1440b1018],
17	CE/ErC	NNP	O	CE/ErC	nn	18	SENT_989	[p32l1413t1030r1446b1159],
18	omSo	NNP	O	omSo	_	0	SENT_989	[p32l1412t1170r1448b1485],
19	.	.	O	.	_	0	SENT_989	[p32l1412t1170r1448b1485],

1	u.	NN	O	u.	nn	2	SENT_990	[p32l1412t1170r1448b1485],
2	m	NN	O	m	_	0	SENT_990	[p32l1412t1170r1448b1485],
3	:	:	O	:	_	0	SENT_990	[p32l1412t1170r1448b1485],
4	mb	NN	O	mb	dep	2	SENT_990	[p32l1412t1170r1448b1485],
5	<	JJR	O	<	amod	7	SENT_990	[p32l1412t1170r1448b1485],
6	EBE-m	NN	O	ebe-m	nn	7	SENT_990	[p32l1412t1170r1448b1485],
7	osismomﬁ	NN	O	osismomﬁ	dep	4	SENT_990	[p32l1412t1496r1448b1658],
8	.5	CD	NUMBER	.5	num	12	SENT_990	[p32l1412t1665r1440b1700],
9	Emﬁnﬁoqbﬁom	NNP	O	Emﬁnﬁoqbﬁom	nn	12	SENT_990	[p32l1412t1710r1448b1941],
10	33:00	CD	NUMBER	33:00	num	12	SENT_990	[p32l1412t1951r1440b2072],
11	N	NN	O	n	nn	12	SENT_990	[p32l1412t2102r1440b2120],
12	Piwmm	NN	O	piwmm	dep	7	SENT_990	[p32l1412t2131r1448b2241],

1	,	,	O	,	_	0	SENT_991	[p32l1660t2940r1666b2950],
2	m	NN	O	m	nn	3	SENT_991	[p32l1652t3212r1692b3231],
3	S	NN	O	s	nsubj	4	SENT_991	[p32l1645t2926r1660b2945],
4	W	NN	O	w	_	0	SENT_991	[p32l1585t2916r1643b2945],
5	N	NN	O	n	dep	4	SENT_991	[p32l1580t3094r1615b3125],
6	,	,	O	,	_	0	SENT_991	[p32l1580t3094r1615b3125],
7	W	NN	O	w	dep	5	SENT_991	[p32l1590t3202r1650b3231],

1	M	NN	O	m	nn	3	SENT_992	[p32l1498t2917r1545b2945],
2	m	NN	O	m	nn	3	SENT_992	[p32l1493t3093r1553b3119],
3	M	NN	O	m	_	0	SENT_992	[p32l1510t3202r1552b3231],
4	,	,	O	,	_	0	SENT_992	[p32l1488t2763r1494b2773],
5	a	DT	O	a	appos	3	SENT_992	[p32l1489t3212r1508b3231],

1	W	NNP	O	W	nn	2	SENT_993	[p32l1370t2739r1437b2768],
2	W	NNP	O	W	_	0	SENT_993	[p32l1379t2805r1428b2834],
3	mm	NN	O	mm	nn	5	SENT_993	[p32l1345t2870r1430b2945],
4	H	NN	O	h	nn	5	SENT_993	[p32l1388t3028r1427b3057],
5	W	NN	O	w	dep	2	SENT_993	[p32l1359t3093r1416b3119],
6	*	CD	NUMBER	*	num	7	SENT_993	[p32l1365t3205r1427b3237],
7	E	NN	O	e	dep	5	SENT_993	[p32l1335t212r1351b259],
8	?	.	O	?	_	0	SENT_993	[p32l1335t212r1351b259],

1	s.	NN	O	s.	_	0	SENT_994	[p32l1345t659r1365b799],
2	__	CD	MONEY	__	num	3	SENT_994	[p32l1345t659r1365b799],
3	€	NN	MONEY	€	dep	1	SENT_994	[p32l1345t659r1365b799],
4	.	.	O	.	_	0	SENT_994	[p32l1345t659r1365b799],

1	.	.	O	.	_	0	SENT_995	[p32l1345t659r1365b799],

1	§	NN	O	§	nn	2	SENT_996	[p32l1345t659r1365b799],
2	E.E	NN	O	e.e	_	0	SENT_996	[p32l1345t659r1365b799],
3	23.35	CD	PERCENT	23.35	num	4	SENT_996	[p32l1343t1885r1365b2016],
4	%	NN	PERCENT	%	dep	2	SENT_996	[p32l1343t1885r1365b2016],
5	E	NN	O	e	nn	14	SENT_996	[p32l1343t2740r1370b2768],
6	O	NN	O	o	nn	14	SENT_996	[p32l1325t2806r1378b2834],
7	*	NN	O	*	nn	14	SENT_996	[p32l1325t2806r1378b2834],
8	m	NN	O	m	nn	14	SENT_996	[p32l1337t2926r1372b2945],
9	A.	NN	O	a.	nn	14	SENT_996	[p32l1339t3028r1373b3057],
10	O	NN	O	o	nn	14	SENT_996	[p32l1333t3093r1358b3119],
11	O	NN	O	o	nn	14	SENT_996	[p32l1339t3205r1364b3231],
12	3	CD	NUMBER	3	num	14	SENT_996	[p32l1313t63r1327b86],
13	«	NN	O	«	nn	14	SENT_996	[p32l1313t133r1327b144],
14	E	NN	O	e	dep	4	SENT_996	[p32l1313t191r1327b212],
15	.	.	O	.	_	0	SENT_996	[p32l1313t264r1327b270],

1	as	RB	O	as	_	0	SENT_997	[p32l1313t319r1327b342],
2	.	.	O	.	_	0	SENT_997	[p32l1313t390r1327b400],

1	.	.	O	.	_	0	SENT_998	[p32l1313t390r1327b400],

1	a.E.	NNP	O	a.E.	nn	2	SENT_999	[p32l1317t596r1337b865],
2	__	NNP	O	__	_	0	SENT_999	[p32l1317t596r1337b865],
3	.	.	O	.	_	0	SENT_999	[p32l1317t596r1337b865],

1	.	.	O	.	_	0	SENT_1000	[p32l1317t596r1337b865],

1	!	.	O	!	_	0	SENT_1001	[p32l1317t596r1337b865],

1	sE	NN	O	se	_	0	SENT_1002	[p32l1317t596r1337b865],
2	.	.	O	.	_	0	SENT_1002	[p32l1317t596r1337b865],

1	§	NN	O	§	_	0	SENT_1003	[p32l1317t596r1337b865],
2	!	.	O	!	_	0	SENT_1003	[p32l1317t596r1337b865],

1	£	NN	MONEY	£	_	0	SENT_1004	[p32l1317t596r1337b865],
2	§	CD	MONEY	§	number	3	SENT_1004	[p32l1317t596r1337b865],
3	3	CD	MONEY	3	num	4	SENT_1004	[p32l1317t596r1337b865],
4	£	NN	MONEY	£	dep	1	SENT_1004	[p32l1317t596r1337b865],
5	:53	CD	MONEY	:53	number	6	SENT_1004	[p32l1317t1145r1333b1194],
6	:5	CD	MONEY	:5	num	4	SENT_1004	[p32l1317t1281r1333b1326],
7	:	:	O	:	_	0	SENT_1004	[p32l1317t1281r1333b1326],
8	:5	CD	NUMBER	:5	dep	1	SENT_1004	[p32l1317t1413r1333b1452],
9	:	:	O	:	_	0	SENT_1004	[p32l1317t1413r1333b1452],
10	d	NN	O	d	nn	14	SENT_1004	[p32l1312t2739r1334b2769],
11	E	NN	O	e	nn	14	SENT_1004	[p32l1317t2865r1344b2896],
12	o	NN	O	o	nn	14	SENT_1004	[p32l1317t2926r1335b2945],
13	C	NN	O	c	nn	14	SENT_1004	[p32l1314t3038r1331b3057],
14	L	NN	O	l	dep	8	SENT_1004	[p32l1316t3206r1338b3230],
15	.	.	O	.	_	0	SENT_1004	[p32l1306t2829r1311b2834],

1	.	.	O	.	_	0	SENT_1005	[p32l1308t3029r1312b3034],

1	N	NN	O	n	nn	2	SENT_1006	[p32l1306t3094r1332b3119],
2	r	NN	O	r	nsubj	3	SENT_1006	[p32l1275t403r1309b426],
3	M.	NN	O	m.	_	0	SENT_1006	[p32l1290t715r1291b730],
4	.	.	O	.	_	0	SENT_1006	[p32l1295t911r1309b922],

1	_	NN	O	_	_	0	SENT_1007	[p32l1295t911r1309b922],
2	m	NN	O	m	dep	1	SENT_1007	[p32l1263t963r1301b979],
3	.	.	O	.	_	0	SENT_1007	[p32l1293t1510r1309b1520],

1	.	.	O	.	_	0	SENT_1008	[p32l1293t1510r1309b1520],

1	m	NN	O	m	nn	4	SENT_1009	[p32l1264t2749r1311b2768],
2	S	NN	O	s	nn	4	SENT_1009	[p32l1285t2805r1306b2834],
3	NC	NN	O	nc	nn	4	SENT_1009	[p32l1279t2871r1317b2946],
4	n	NN	O	n	_	0	SENT_1009	[p32l1287t3038r1311b3057],
5	U	NNP	O	U	nn	7	SENT_1009	[p32l1280t3094r1305b3119],
6	m	NN	O	m	nn	7	SENT_1009	[p32l1266t3205r1315b3231],
7	N.	NNP	O	N.	dep	4	SENT_1009	[p32l1245t404r1267b426],
8	.	.	O	.	_	0	SENT_1009	[p32l1245t404r1267b426],

1	.	.	O	.	_	0	SENT_1010	[p32l1245t404r1267b426],

1	W	NN	O	w	nn	3	SENT_1011	[p32l1239t697r1291b772],
2	I	CD	NUMBER	i	num	3	SENT_1011	[p32l1241t797r1277b873],
3	.3	NN	NUMBER	.3	nsubj	16	SENT_1011	[p32l1253t911r1269b951],
4	,	,	O	,	_	0	SENT_1011	[p32l1253t911r1269b951],
5	m	NN	O	m	appos	3	SENT_1011	[p32l1251t1570r1279b1588],
6	a	DT	O	a	det	9	SENT_1011	[p32l1243t2749r1263b2768],
7	n	NN	O	n	nn	9	SENT_1011	[p32l1254t2815r1273b2834],
8	A	NN	O	a	nn	9	SENT_1011	[p32l1253t2871r1278b2896],
9	n	NN	O	n	dep	5	SENT_1011	[p32l1247t2926r1273b2950],
10	,	,	O	,	_	0	SENT_1011	[p32l1247t2926r1273b2950],
11	E	NN	O	e	nn	13	SENT_1011	[p32l1259t3029r1286b3057],
12	M	NN	O	m	nn	13	SENT_1011	[p32l1247t3094r1279b3119],
13	N	NN	O	n	appos	9	SENT_1011	[p32l1239t3206r1265b3231],
14	W	NN	O	w	dep	13	SENT_1011	[p32l1215t404r1249b426],
15	“	CD	NUMBER	“	num	14	SENT_1011	[p32l1215t404r1249b426],
16	saw	VBD	O	see	_	0	SENT_1011	[p32l1196t911r1257b979],
17	a	DT	O	a	det	22	SENT_1011	[p32l1235t1570r1249b1588],
18	h	NN	O	h	nn	22	SENT_1011	[p32l1223t2739r1242b2768],
19	M	NN	O	m	nn	22	SENT_1011	[p32l1213t2805r1252b2834],
20	S	NN	O	s	nn	22	SENT_1011	[p32l1222t2870r1239b2896],
21	o	NN	O	o	nn	22	SENT_1011	[p32l1226t2926r1245b2945],
22	R	NN	O	r	dobj	16	SENT_1011	[p32l1213t3032r1246b3063],
23	,	,	O	,	_	0	SENT_1011	[p32l1213t3032r1246b3063],
24	M	NN	O	m	nn	26	SENT_1011	[p32l1215t3094r1246b3119],
25	O	NN	O	o	nn	26	SENT_1011	[p32l1207t3199r1237b3231],
26	mw	NN	O	mw	appos	22	SENT_1011	[p32l1177t404r1223b538],
27	.	.	O	.	_	0	SENT_1011	[p32l1177t404r1223b538],

1	_	NN	O	_	_	0	SENT_1012	[p32l1177t404r1223b538],
2	.	.	O	.	_	0	SENT_1012	[p32l1177t404r1223b538],

1	.	.	O	.	_	0	SENT_1013	[p32l1177t404r1223b538],

1	|	NN	O	|	_	0	SENT_1014	[p32l1177t404r1223b538],
2	ss	NN	O	ss	dep	1	SENT_1014	[p32l1185t911r1211b1075],
3	.	.	O	.	_	0	SENT_1014	[p32l1185t911r1211b1075],

1	.	.	O	.	_	0	SENT_1015	[p32l1185t911r1211b1075],

1	|	NN	O	|	_	0	SENT_1016	[p32l1185t911r1211b1075],
2	cam	NN	O	cam	nn	3	SENT_1016	[p32l1174t1510r1229b1588],
3	mAA	NN	O	maa	dep	1	SENT_1016	[p32l1166t2740r1225b3119],
4	.	.	O	.	_	0	SENT_1016	[p32l1166t2740r1225b3119],

1	mnEI	NN	O	mneus	nn	2	SENT_1017	[p32l1166t2740r1225b3119],
2	C	NN	O	c	_	0	SENT_1017	[p32l1171t3205r1193b3231],
3	3	CD	NUMBER	3	num	4	SENT_1017	[p32l1155t404r1169b426],
4	89m	NN	O	89m	dep	2	SENT_1017	[p32l1151t911r1179b984],
5	.	.	O	.	_	0	SENT_1017	[p32l1151t911r1179b984],

1	d	NN	O	d	nn	2	SENT_1018	[p32l1156t2805r1177b2834],
2	N	NN	O	n	_	0	SENT_1018	[p32l1157t2871r1183b2896],
3	a	DT	O	a	det	6	SENT_1018	[p32l1154t2926r1173b2945],
4	o	NN	O	o	nn	6	SENT_1018	[p32l1164t2975r1183b2995],
5	C	NN	O	c	nn	6	SENT_1018	[p32l1166t3031r1189b3057],
6	H	NN	O	h	dep	2	SENT_1018	[p32l1162t3094r1187b3119],
7	3	CD	NUMBER	3	dep	6	SENT_1018	[p32l1137t404r1151b426],
8	M	NN	O	m	dep	2	SENT_1018	[p32l1132t1570r1173b1592],
9	,	,	O	,	_	0	SENT_1018	[p32l1146t2763r1153b2774],
10	n	NN	O	n	nn	17	SENT_1018	[p32l1135t2815r1154b2834],
11	O	NN	O	o	nn	17	SENT_1018	[p32l1131t2870r1155b2896],
12	h	NN	O	h	nn	17	SENT_1018	[p32l1133t2916r1153b2945],
13	m	NN	O	m	nn	17	SENT_1018	[p32l1133t2975r1162b2995],
14	N	NN	O	n	nn	17	SENT_1018	[p32l1139t3032r1165b3057],
15	G	NN	O	g	nn	17	SENT_1018	[p32l1136t3093r1161b3119],
16	M	NN	O	m	nn	17	SENT_1018	[p32l1134t3206r1170b3230],
17	.3	NN	NUMBER	.3	appos	8	SENT_1018	[p32l1117t404r1131b426],
18	Guam	NNP	O	Guam	nn	19	SENT_1018	[p32l1107t911r1147b979],
19	Y	NN	O	y	dep	2	SENT_1018	[p32l1118t2743r1143b2768],
20	a	DT	O	a	det	21	SENT_1018	[p32l1114t2815r1133b2834],
21	I	PRP	O	I	dep	19	SENT_1018	[p32l1118t2871r1130b2896],
22	.	.	O	.	_	0	SENT_1018	[p32l1105t2917r1133b2945],

1	w	NN	O	w	_	0	SENT_1019	[p32l1105t2917r1133b2945],
2	6	CD	NUMBER	6	num	1	SENT_1019	[p32l1114t2975r1130b2995],
3	A	DT	O	a	det	5	SENT_1019	[p32l1113t3032r1139b3057],
4	U	NN	O	u	nn	5	SENT_1019	[p32l1109t3094r1135b3119],
5	T	NN	O	t	dep	1	SENT_1019	[p32l1111t3206r1133b3230],
6	.	.	O	.	_	0	SENT_1019	[p32l1095t404r1109b410],

1	-	:	O	-	_	0	SENT_1020	[p32l1101t959r1107b979],
2	a	DT	O	a	det	4	SENT_1020	[p32l1095t1510r1111b1542],
3	m	NN	O	m	nn	4	SENT_1020	[p32l1066t2743r1117b2769],
4	n	NN	O	n	_	0	SENT_1020	[p32l1073t2815r1099b2838],
5	,	,	O	,	_	0	SENT_1020	[p32l1073t2815r1099b2838],
6	H	NN	O	h	nn	10	SENT_1020	[p32l1084t2871r1118b2896],
7	R	NN	O	r	nn	10	SENT_1020	[p32l1077t2917r1102b2945],
8	M	NN	O	m	nn	10	SENT_1020	[p32l1072t2965r1114b2995],
9	c	NN	O	c	nn	10	SENT_1020	[p32l1083t3025r1111b3057],
10	o	NN	O	o	appos	4	SENT_1020	[p32l1083t3093r1108b3119],
11	M	NN	O	m	prep	4	SENT_1020	[p32l1073t3205r1111b3230],
12	a	DT	O	a	det	13	SENT_1020	[p32l1049t1195r1073b1266],
13	_	NN	O	_	dep	11	SENT_1020	[p32l1049t1195r1073b1266],
14	.	.	O	.	_	0	SENT_1020	[p32l1049t1195r1073b1266],

1	.	.	O	.	_	0	SENT_1021	[p32l1049t1195r1073b1266],

1	_	NN	O	_	_	0	SENT_1022	[p32l1049t1195r1073b1266],
2	8n	NN	O	8n	dep	1	SENT_1022	[p32l1049t1195r1073b1266],
3	.	.	O	.	_	0	SENT_1022	[p32l1049t1273r1067b1410],

1	.	.	O	.	_	0	SENT_1023	[p32l1049t1273r1067b1410],

1	e	LS	O	e	dep	4	SENT_1024	[p32l1049t1273r1067b1410],
2	~	FW	O	~	dep	4	SENT_1024	[p32l1049t1273r1067b1410],
3	__	FW	O	__	nn	4	SENT_1024	[p32l1049t1273r1067b1410],
4	u.	FW	O	u.	_	0	SENT_1024	[p32l1049t1273r1067b1410],
5	_	NN	O	_	dobj	4	SENT_1024	[p32l1049t1273r1067b1410],
6	.	.	O	.	_	0	SENT_1024	[p32l1049t1273r1067b1410],

1	.	.	O	.	_	0	SENT_1025	[p32l1049t1273r1067b1410],

1	_	NN	O	_	_	0	SENT_1026	[p32l1049t1273r1067b1410],
2	>	JJR	O	>	dep	1	SENT_1026	[p32l1049t1273r1067b1410],
3	_	CD	NUMBER	_	num	5	SENT_1026	[p32l1049t1273r1067b1410],
4	E	NN	O	e	nn	5	SENT_1026	[p32l1049t1273r1067b1410],
5	__	NN	O	__	dep	2	SENT_1026	[p32l1049t1273r1067b1410],
6	L	NN	O	l	nn	8	SENT_1026	[p32l1042t2743r1064b2768],
7	W	NN	O	w	nn	8	SENT_1026	[p32l1036t2805r1071b2834],
8	B	NN	O	b	dep	1	SENT_1026	[p32l1047t2871r1081b2896],
9	G.	NNP	O	G.	nn	11	SENT_1026	[p32l1029t2917r1063b2946],
10	A	NNP	O	A	nn	11	SENT_1026	[p32l1043t2966r1070b2994],
11	E	NNP	PERCENT	E	dep	8	SENT_1026	[p32l1049t3032r1071b3057],
12	%	NN	PERCENT	%	nn	13	SENT_1026	[p32l1032t3094r1082b3119],
13	D	NN	O	d	dep	1	SENT_1026	[p32l1046t3206r1071b3230],
14	m	NN	O	m	dep	16	SENT_1026	[p32l992t2743r1041b2769],
15	m	NN	O	m	dep	16	SENT_1026	[p32l984t2806r1035b2834],
16	mic	JJ	O	mic	amod	13	SENT_1026	[p32l994t2871r1046b2995],
17	.	.	O	.	_	0	SENT_1026	[p32l994t2871r1046b2995],

1	M	NN	ORGANIZATION	m	nn	5	SENT_1027	[p32l1000t3032r1048b3057],
2	T	NN	ORGANIZATION	t	nn	5	SENT_1027	[p32l1004t3088r1031b3119],
3	E	NN	ORGANIZATION	e	nn	5	SENT_1027	[p32l999t3200r1046b3230],
4	n	NN	ORGANIZATION	n	nn	5	SENT_1027	[p32l977t2688r996b2707],
5	N	NN	ORGANIZATION	n	_	0	SENT_1027	[p32l965t2743r991b2768],
6	I	PRP	O	I	nsubj	7	SENT_1027	[p32l979t2865r994b2896],
7	Wk	VBP	DURATION	wk	rcmod	5	SENT_1027	[p32l964t2926r1004b2995],
8	T	NN	O	t	nn	18	SENT_1027	[p32l978t3032r1000b3057],
9	Y	NN	O	y	nn	18	SENT_1027	[p32l966t3094r992b3119],
10	N	NN	O	n	nn	18	SENT_1027	[p32l961t3206r987b3231],
11	L	NN	O	l	nn	18	SENT_1027	[p32l934t1991r997b2005],
12	W	NN	O	w	nn	18	SENT_1027	[p32l926t2688r975b2707],
13	o	NN	O	o	nn	18	SENT_1027	[p32l934t2737r964b2769],
14	M	NN	O	m	nn	18	SENT_1027	[p32l919t2806r974b2834],
15	mam	NN	O	mam	nn	18	SENT_1027	[p32l913t2871r967b2995],
16	m	NN	O	m	nn	18	SENT_1027	[p32l932t3031r975b3057],
17	M	NN	O	m	nn	18	SENT_1027	[p32l920t3093r966b3119],
18	m	NN	O	m	nn	24	SENT_1027	[p32l918t3205r960b3231],
19	23	CD	NUMBER	23	number	20	SENT_1027	[p32l898t211r914b259],
20	>	JJR	O	>	amod	18	SENT_1027	[p32l898t211r914b259],
21	9.2	CD	NUMBER	9.2	dep	23	SENT_1027	[p32l898t1887r912b1945],
22	e	LS	O	e	dep	21	SENT_1027	[p32l900t2370r915b2388],
23	M	NN	O	m	dep	24	SENT_1027	[p32l897t2677r926b2707],
24	N	NN	O	n	dobj	7	SENT_1027	[p32l894t2743r920b2768],
25	.	.	O	.	_	0	SENT_1027	[p32l896t2805r906b2834],

1	l	NN	O	l	nn	7	SENT_1028	[p32l896t2805r906b2834],
2	O	NN	O	o	nn	7	SENT_1028	[p32l887t2870r912b2896],
3	Y	NN	O	y	nn	7	SENT_1028	[p32l893t2920r918b2945],
4	n	NN	O	n	nn	7	SENT_1028	[p32l895t2975r914b2995],
5	R	NN	O	r	nn	7	SENT_1028	[p32l907t3032r931b3057],
6	R	NN	O	r	nn	7	SENT_1028	[p32l896t3094r919b3119],
7	E	NN	O	e	_	0	SENT_1028	[p32l895t3206r916b3230],
8	3	CD	NUMBER	3	num	9	SENT_1028	[p32l876t63r890b86],
9	u	NN	O	u	dep	7	SENT_1028	[p32l876t133r890b144],
10	3	CD	NUMBER	3	dep	9	SENT_1028	[p32l876t191r890b212],
11	.	.	O	.	_	0	SENT_1028	[p32l876t264r890b270],

1	2	LS	NUMBER	2	_	0	SENT_1029	[p32l876t319r890b342],
2	.	.	O	.	_	0	SENT_1029	[p32l876t319r890b342],

1	3	CD	NUMBER	3	_	0	SENT_1030	[p32l878t1147r896b1196],
2	...	:	O	...	_	0	SENT_1030	[p32l878t1147r896b1196],
3	:	:	O	:	_	0	SENT_1030	[p32l878t1147r896b1196],
4	:53	CD	NUMBER	:53	dep	9	SENT_1030	[p32l878t1283r896b1328],
5	5	CD	NUMBER	5	dep	4	SENT_1030	[p32l878t1414r896b1454],
6	...	:	O	...	_	0	SENT_1030	[p32l878t1414r896b1454],
7	:	:	O	:	_	0	SENT_1030	[p32l878t1414r896b1454],
8	a	DT	O	a	dep	4	SENT_1030	[p32l856t1514r872b1524],
9	g	NN	O	g	npadvmod	10	SENT_1030	[p32l848t1875r900b2148],
10	@	IN	O	@	dep	13	SENT_1030	[p32l854t2362r898b2388],
11	*	CD	NUMBER	*	pobj	10	SENT_1030	[p32l854t2362r898b2388],
12	Um	NN	O	um	nn	13	SENT_1030	[p32l854t2679r894b2707],
13	E	NN	O	e	dep	1	SENT_1030	[p32l856t2743r893b2769],
14	.	.	O	.	_	0	SENT_1030	[p32l862t2805r894b2834],

1	la.	NN	O	la.	_	0	SENT_1031	[p32l862t2805r894b2834],
2	.	.	O	.	_	0	SENT_1031	[p32l862t2805r894b2834],

1	S	NN	O	s	nn	5	SENT_1032	[p32l867t2871r884b2896],
2	PVPAV	NN	PERCENT	pvpav	nn	5	SENT_1032	[p32l850t2920r894b2995],
3	W	NN	PERCENT	w	nn	5	SENT_1032	[p32l849t3026r906b3057],
4	%	NN	PERCENT	%	nn	5	SENT_1032	[p32l847t3094r895b3119],
5	H	NN	O	h	_	0	SENT_1032	[p32l868t3206r894b3230],
6	i	FW	O	i	dep	5	SENT_1032	[p32l854t2149r866b2162],
7	.	.	O	.	_	0	SENT_1032	[p32l844t2362r853b2388],

1	l	NN	O	l	_	0	SENT_1033	[p32l844t2362r853b2388],
2	.....	CD	NUMBER	.....	dep	1	SENT_1033	[p32l828t95r844b160],
3	.	.	O	.	_	0	SENT_1033	[p32l828t95r844b160],

1	i.	NN	O	i.	_	0	SENT_1034	[p32l828t95r844b160],
2	.	.	O	.	_	0	SENT_1034	[p32l828t95r844b160],

1	8	CD	NUMBER	8	_	0	SENT_1035	[p32l822t1889r838b2012],
2	:	:	O	:	_	0	SENT_1035	[p32l822t1889r838b2012],
3	<<	CD	NUMBER	<<	num	4	SENT_1035	[p32l822t1889r838b2012],
4	S.	NNP	O	S.	dep	1	SENT_1035	[p32l822t1889r838b2012],
5	.	.	O	.	_	0	SENT_1035	[p32l822t1889r838b2012],

1	o	NN	O	o	nn	4	SENT_1036	[p32l822t1889r838b2012],
2	d	NN	O	d	nn	4	SENT_1036	[p32l824t2361r844b2388],
3	h	NN	O	h	nn	4	SENT_1036	[p32l823t2677r843b2707],
4	T	NN	O	t	nsubj	7	SENT_1036	[p32l834t2743r855b2768],
5	1	CD	PERCENT	1	number	6	SENT_1036	[p32l821t2805r863b2834],
6	%	NN	PERCENT	%	amod	4	SENT_1036	[p32l821t2805r863b2834],
7	Am	VBP	O	be	_	0	SENT_1036	[p32l795t2871r865b2896],
8	.	.	O	.	_	0	SENT_1036	[p32l795t2871r865b2896],

1	“	CD	PERCENT	“	num	2	SENT_1037	[p32l795t2871r865b2896],
2	%	NN	PERCENT	%	_	0	SENT_1037	[p32l822t2920r872b2945],
3	1a	CD	NUMBER	1a	num	5	SENT_1037	[p32l819t2965r841b2995],
4	O	NN	O	o	nn	5	SENT_1037	[p32l824t3031r848b3057],
5	T	NN	O	t	rcmod	2	SENT_1037	[p32l819t3088r846b3119],
6	W	NN	O	w	prep	5	SENT_1037	[p32l815t3149r855b3168],
7	My	PRP$	O	my	dep	6	SENT_1037	[p32l818t3205r867b3231],
8	3	CD	NUMBER	3	dep	5	SENT_1037	[p32l774t97r790b190],
9	:	:	O	:	_	0	SENT_1037	[p32l774t97r790b190],
10	:	:	O	:	_	0	SENT_1037	[p32l774t97r790b190],
11	_	CD	NUMBER	_	num	12	SENT_1037	[p32l790t1654r822b1804],
12	§	NN	O	§	dep	2	SENT_1037	[p32l790t1654r822b1804],
13	.	.	O	.	_	0	SENT_1037	[p32l790t1654r822b1804],

1	%	NN	O	%	nn	4	SENT_1038	[p32l790t1654r822b1804],
2	__	NN	O	__	nn	4	SENT_1038	[p32l790t1654r822b1804],
3	B	NN	O	b	nn	4	SENT_1038	[p32l790t1654r822b1804],
4	o	NN	O	o	_	0	SENT_1038	[p32l772t1875r822b2162],
5	*	CD	NUMBER	*	num	8	SENT_1038	[p32l772t1875r822b2162],
6	W.	NNP	O	W.	nn	8	SENT_1038	[p32l775t2362r823b2388],
7	,	,	O	,	_	0	SENT_1038	[p32l769t2677r833b3281],
8	mmRaommNRaon	NNP	O	mmRaommNRaon	dep	4	SENT_1038	[p32l769t2677r833b3281],
9	8	CD	NUMBER	8	number	10	SENT_1038	[p32l752t1514r768b1546],
10	«	CD	NUMBER	«	num	12	SENT_1038	[p32l752t1514r768b1546],
11	n.	NN	O	n.	nn	12	SENT_1038	[p32l756t1680r782b1780],
12	_	NN	O	_	dep	8	SENT_1038	[p32l756t1680r782b1780],
13	.	.	O	.	_	0	SENT_1038	[p32l756t1680r782b1780],

1	_	NN	O	_	_	0	SENT_1039	[p32l756t1680r782b1780],
2	2n	CD	NUMBER	2n	num	3	SENT_1039	[p32l756t1680r782b1780],
3	_	NN	O	_	dep	1	SENT_1039	[p32l756t1680r782b1780],
4	.	.	O	.	_	0	SENT_1039	[p32l756t1680r782b1780],

1	_	NN	O	_	_	0	SENT_1040	[p32l756t1680r782b1780],
2	.	.	O	.	_	0	SENT_1040	[p32l756t1680r782b1780],

1	ounNm	NN	O	ounnm	_	0	SENT_1041	[p32l734t1969r764b2072],
2	.	.	O	.	_	0	SENT_1041	[p32l734t1969r764b2072],

1	G.	NNP	O	G.	nn	2	SENT_1042	[p32l734t1969r764b2072],
2	_	NNP	O	_	_	0	SENT_1042	[p32l734t1969r764b2072],
3	.	.	O	.	_	0	SENT_1042	[p32l734t1969r764b2072],

1	<	JJR	O	<	_	0	SENT_1043	[p32l734t1969r764b2072],
2	:04	CD	NUMBER	:04	num	4	SENT_1043	[p32l739t2361r773b2395],
3	S	NN	O	s	nn	4	SENT_1043	[p32l734t2529r759b2570],
4	M	NN	O	m	dep	1	SENT_1043	[p32l743t2679r780b2707],
5	M	NN	O	m	nn	7	SENT_1043	[p32l712t2737r768b2768],
6	ﬂy	NN	O	ﬂy	nn	7	SENT_1043	[p32l733t2815r759b2838],
7	R	NN	O	r	dep	4	SENT_1043	[p32l745t2871r768b2896],
8	T	NN	O	t	dep	1	SENT_1043	[p32l746t2914r772b2945],
9	a	DT	O	a	dep	8	SENT_1043	[p32l736t2975r762b2999],
10	,	,	O	,	_	0	SENT_1043	[p32l736t2975r762b2999],
11	T	NN	O	t	appos	8	SENT_1043	[p32l725t3031r784b3057],
12	Q	NNP	O	Q	nn	14	SENT_1043	[p32l737t3093r782b3119],
13	N	NNP	O	N	nn	14	SENT_1043	[p32l733t3139r793b3169],
14	E	NNP	O	E	dep	1	SENT_1043	[p32l726t3206r791b3230],
15	m	NN	O	m	nn	16	SENT_1043	[p32l733t3261r783b3281],
16	~	NN	O	~	dep	14	SENT_1043	[p32l696t1875r742b2162],
17	.	.	O	.	_	0	SENT_1043	[p32l696t1875r742b2162],

1	w	NN	O	w	nn	3	SENT_1044	[p32l704t2370r728b2388],
2	T	NN	O	t	nn	3	SENT_1044	[p32l698t2529r731b2569],
3	s	NNS	O	s	_	0	SENT_1044	[p32l702t2681r730b2713],
4	,	,	O	,	_	0	SENT_1044	[p32l702t2681r730b2713],
5	aPR.	NN	DATE	apr.	nn	8	SENT_1044	[p32l693t2815r744b3281],
6	mNNaAd	NN	O	mnnaad	nn	8	SENT_1044	[p32l693t2815r744b3281],
7	M	NN	O	m	nn	8	SENT_1044	[p32l696t1979r697b1983],
8	M	NN	O	m	appos	3	SENT_1044	[p32l696t2025r697b2031],
9	.	.	O	.	_	0	SENT_1044	[p32l679t2362r703b2388],

1	w	NN	O	w	_	0	SENT_1045	[p32l679t2362r703b2388],
2	6	CD	NUMBER	6	num	1	SENT_1045	[p32l675t2407r694b2434],
3	I	PRP	O	I	dep	4	SENT_1045	[p32l688t2682r700b2707],
4	m	NN	O	m	dep	1	SENT_1045	[p32l682t2815r711b2834],
5	:	:	O	:	_	0	SENT_1045	[p32l693t2874r699b2896],
6	E	NN	O	e	nn	8	SENT_1045	[p32l687t2920r709b2945],
7	hz	NN	O	hz	nn	8	SENT_1045	[p32l674t2965r704b2995],
8	A	NN	O	a	dep	1	SENT_1045	[p32l684t3093r709b3119],
9	W	NN	O	w	prep	8	SENT_1045	[p32l682t3140r718b3169],
10	H	NN	O	h	dep	9	SENT_1045	[p32l672t3253r705b3280],
11	5	CD	NUMBER	5	num	10	SENT_1045	[p32l668t241r682b302],
12	...	:	O	...	_	0	SENT_1045	[p32l668t241r682b302],
13	as	RB	O	as	dep	1	SENT_1045	[p32l658t1498r672b1546],
14	.	.	O	.	_	0	SENT_1045	[p32l636t1875r684b2162],

1	.	.	O	.	_	0	SENT_1046	[p32l636t1875r684b2162],

1	Wm	NN	O	wm	nn	2	SENT_1047	[p32l638t2370r677b2434],
2	N	NN	O	n	_	0	SENT_1047	[p32l654t2530r696b2569],
3	$	$	MONEY	$	amod	5	SENT_1047	[p32l631t2681r700b3281],
4	m.	JJ	MONEY	m.	dep	3	SENT_1047	[p32l631t2681r700b3281],
5	mo.	NN	O	mo.	dep	2	SENT_1047	[p32l631t2681r700b3281],
6	nIo	NN	O	nio	dep	5	SENT_1047	[p32l631t2681r700b3281],
7	.	.	O	.	_	0	SENT_1047	[p32l631t2681r700b3281],

1	CmWCA	NN	O	cmwca	_	0	SENT_1048	[p32l631t2681r700b3281],
2	.	.	O	.	_	0	SENT_1048	[p32l631t2681r700b3281],

1	mnnJ	NN	O	mnnj	_	0	SENT_1049	[p32l631t2681r700b3281],
2	.	.	O	.	_	0	SENT_1049	[p32l631t2681r700b3281],

1	u	NN	O	u	nsubj	2	SENT_1050	[p32l614t1198r636b1408],
2	=	JJ	O	=	_	0	SENT_1050	[p32l614t1198r636b1408],
3	.	.	O	.	_	0	SENT_1050	[p32l614t1198r636b1408],

1	uan	NN	O	uan	nn	3	SENT_1051	[p32l614t1198r636b1408],
2	__	CD	NUMBER	__	num	3	SENT_1051	[p32l614t1198r636b1408],
3	E.	NNP	O	E.	_	0	SENT_1051	[p32l614t1198r636b1408],
4	o	NN	O	o	dep	3	SENT_1051	[p32l614t1198r636b1408],
5	_	CD	NUMBER	_	num	4	SENT_1051	[p32l614t1198r636b1408],
6	...	:	O	...	_	0	SENT_1051	[p32l614t1198r636b1408],
7	_	CD	NUMBER	_	num	8	SENT_1051	[p32l614t1198r636b1408],
8	2Eoo	NN	O	2eoo	dep	3	SENT_1051	[p32l614t1198r636b1408],
9	‘	CD	NUMBER	‘	dep	8	SENT_1051	[p32l634t1899r635b1904],
10	:	:	O	:	_	0	SENT_1051	[p32l634t1923r635b1934],
11	‘	CD	NUMBER	‘	num	12	SENT_1051	[p32l634t2055r635b2060],
12	R	NN	O	r	dep	3	SENT_1051	[p32l621t2362r644b2387],
13	2	CD	NUMBER	2	num	16	SENT_1051	[p32l619t2407r636b2433],
14	E	NN	O	e	nn	16	SENT_1051	[p32l623t2530r654b2569],
15	N	NN	PERCENT	n	nn	16	SENT_1051	[p32l619t2682r645b2707],
16	%	NN	PERCENT	%	dep	12	SENT_1051	[p32l608t2743r648b2769],
17	.	.	O	.	_	0	SENT_1051	[p32l615t2806r640b2834],

1	u	NN	O	u	nn	7	SENT_1052	[p32l615t2806r640b2834],
2	M	NN	PERCENT	m	nn	7	SENT_1052	[p32l621t2871r652b2896],
3	%	NN	PERCENT	%	nn	7	SENT_1052	[p32l610t2920r662b2945],
4	*	CD	NUMBER	*	num	7	SENT_1052	[p32l608t2965r640b2995],
5	E	NN	O	e	nn	7	SENT_1052	[p32l605t3032r651b3057],
6	S	NN	O	s	nn	7	SENT_1052	[p32l607t3149r622b3168],
7	L	NN	O	l	_	0	SENT_1052	[p32l609t3206r630b3230],
8	6	CD	NUMBER	6	dep	7	SENT_1052	[p32l607t3261r623b3281],
9	.	.	O	.	_	0	SENT_1052	[p32l596t1925r614b2058],

1	a_m	NN	O	a_m	nn	2	SENT_1053	[p32l596t1925r614b2058],
2	__	NN	O	__	dep	3	SENT_1053	[p32l596t1925r614b2058],
3	<	JJR	O	<	_	0	SENT_1053	[p32l596t1925r614b2058],
4	.	.	O	.	_	0	SENT_1053	[p32l596t1925r614b2058],

1	E.E.	NNP	PERSON	E.E.	nn	3	SENT_1054	[p32l596t1925r614b2058],
2	W	NNP	PERSON	W	nn	3	SENT_1054	[p32l566t2361r613b2388],
3	W	NNP	PERSON	W	_	0	SENT_1054	[p32l563t2407r605b2438],
4	,	,	O	,	_	0	SENT_1054	[p32l563t2407r605b2438],
5	T	NN	O	t	nn	6	SENT_1054	[p32l588t2529r621b2569],
6	arm	NN	O	arm	dep	3	SENT_1054	[p32l571t2681r619b2707],
7	C	NN	O	c	prep	6	SENT_1054	[p32l584t2743r607b2769],
8	Q	NNP	O	Q	nn	16	SENT_1054	[p32l585t2806r619b2842],
9	E	NNP	O	E	nn	16	SENT_1054	[p32l572t2870r620b2896],
10	E	NNP	O	E	nn	16	SENT_1054	[p32l574t2920r609b2945],
11	H	NNP	O	H	nn	16	SENT_1054	[p32l576t2967r609b2994],
12	W	NNP	O	W	nn	16	SENT_1054	[p32l559t3031r604b3057],
13	T	NN	O	t	nn	16	SENT_1054	[p32l560t3094r582b3119],
14	m	NN	O	m	nn	16	SENT_1054	[p32l557t3149r606b3168],
15	W	NN	O	w	nn	16	SENT_1054	[p32l558t3205r608b3231],
16	D	NN	O	d	dep	7	SENT_1054	[p32l564t3253r605b3281],
17	,	,	O	,	_	0	SENT_1054	[p32l564t3253r605b3281],
18	.	.	O	.	_	0	SENT_1054	[p32l532t207r562b312],

1	a_u_xo	NN	O	a_u_xo	_	0	SENT_1055	[p32l532t207r562b312],
2	.	.	O	.	_	0	SENT_1055	[p32l532t207r562b312],

1	_	NN	O	_	_	0	SENT_1056	[p32l532t207r562b312],
2	.	.	O	.	_	0	SENT_1056	[p32l532t207r562b312],

1	Ezmonxm	NN	O	ezmonxm	nn	4	SENT_1057	[p32l532t612r562b745],
2	u_E	NN	O	u_e	nn	4	SENT_1057	[p32l532t755r564b884],
3	£	NN	O	£	nn	4	SENT_1057	[p32l532t755r564b884],
4	m	NN	O	m	_	0	SENT_1057	[p32l532t755r564b884],
5	>	JJR	O	>	amod	7	SENT_1057	[p32l532t755r564b884],
6	w	NN	O	w	nn	7	SENT_1057	[p32l532t755r564b884],
7	anon	NN	O	anon	dep	4	SENT_1057	[p32l532t1237r556b1310],
8	.	.	O	.	_	0	SENT_1057	[p32l532t1237r556b1310],

1	m	NN	O	m	_	0	SENT_1058	[p32l532t1321r562b1388],
2	_	NN	O	_	dep	1	SENT_1058	[p32l532t1321r562b1388],
3	.	.	O	.	_	0	SENT_1058	[p32l532t1321r562b1388],

1	:	:	O	:	_	0	SENT_1059	[p32l532t1321r562b1388],
2	n	NN	O	n	_	0	SENT_1059	[p32l532t1321r562b1388],
3	_	VBG	O	_	partmod	2	SENT_1059	[p32l532t1321r562b1388],
4	un_bu	JJ	O	un_bu	amod	5	SENT_1059	[p32l532t1852r562b2152],
5	_	NN	O	_	dobj	3	SENT_1059	[p32l532t1852r562b2152],
6	.	.	O	.	_	0	SENT_1059	[p32l532t1852r562b2152],

1	_	NN	O	_	_	0	SENT_1060	[p32l532t1852r562b2152],
2	w	NN	O	w	dep	1	SENT_1060	[p32l532t1852r562b2152],
3	:	:	O	:	_	0	SENT_1060	[p32l532t1852r562b2152],
4	n	NN	O	n	nn	6	SENT_1060	[p32l532t1852r562b2152],
5	=	JJ	O	=	amod	6	SENT_1060	[p32l532t1852r562b2152],
6	wn_bo	NN	O	wn_bo	dep	2	SENT_1060	[p32l532t1852r562b2152],
7	:	:	O	:	_	0	SENT_1060	[p32l532t1852r562b2152],
8	mU	NN	O	mu	nn	11	SENT_1060	[p32l532t1852r562b2152],
9	m	NN	O	m	nn	11	SENT_1060	[p32l528t2370r564b2388],
10	W	NNP	O	W	nn	11	SENT_1060	[p32l510t2416r552b2434],
11	W	NNP	O	W	dep	35	SENT_1060	[p32l502t2529r586b2570],
12	M	NN	PERCENT	m	nn	13	SENT_1060	[p32l532t2681r569b2707],
13	%	NN	PERCENT	%	dep	11	SENT_1060	[p32l531t2743r583b2768],
14	‘	CD	NUMBER	‘	number	15	SENT_1060	[p32l527t2810r574b2834],
15	w	NN	O	w	amod	32	SENT_1060	[p32l527t2810r574b2834],
16	E	NN	O	e	nn	32	SENT_1060	[p32l528t2871r572b2896],
17	W	NN	O	w	nn	32	SENT_1060	[p32l525t2920r573b2945],
18	m	NN	O	m	nn	32	SENT_1060	[p32l512t2975r565b2995],
19	M	NN	O	m	nn	32	SENT_1060	[p32l525t3032r557b3057],
20	K	NN	O	k	nn	32	SENT_1060	[p32l514t3093r559b3119],
21	M	NN	O	m	nn	32	SENT_1060	[p32l515t3139r555b3168],
22	E	NN	O	e	nn	32	SENT_1060	[p32l513t3206r557b3230],
23	1m	NN	O	1m	nn	32	SENT_1060	[p32l513t3251r555b3281],
24	A	NN	O	a	nn	32	SENT_1060	[p32l502t2362r526b2387],
25	lu	NN	O	lu	nn	32	SENT_1060	[p32l482t2407r509b2434],
26	W	NN	O	w	nn	32	SENT_1060	[p32l479t2681r531b2707],
27	V	NN	O	v	nn	32	SENT_1060	[p32l506t2743r531b2768],
28	M	NN	PERCENT	m	nn	32	SENT_1060	[p32l491t2806r528b2833],
29	%	NN	PERCENT	%	nn	32	SENT_1060	[p32l477t2870r527b2896],
30	A	NN	O	a	nn	32	SENT_1060	[p32l492t2914r524b2945],
31	T	NN	O	t	nn	32	SENT_1060	[p32l494t2967r518b2994],
32	W.	NNP	O	W.	rcmod	13	SENT_1060	[p32l477t3032r525b3057],
33	mu	NN	O	mu	dep	35	SENT_1060	[p32l474t3094r513b3119],
34	T	NN	O	t	nn	35	SENT_1060	[p32l494t3140r518b3168],
35	O	NN	O	o	dep	44	SENT_1060	[p32l488t3205r512b3231],
36	a	DT	O	a	det	40	SENT_1060	[p32l492t3261r511b3281],
37	ﬁw	NN	O	ﬁw	nn	40	SENT_1060	[p32l446t2316r495b2434],
38	C	NN	O	c	nn	40	SENT_1060	[p32l449t2513r500b2570],
39	A	NN	O	a	nn	40	SENT_1060	[p32l447t2675r478b2707],
40	m	NN	O	m	dep	35	SENT_1060	[p32l446t2737r504b2768],
41	B	NN	O	b	nn	44	SENT_1060	[p32l446t2865r473b2896],
42	C	NN	O	c	nn	44	SENT_1060	[p32l447t3025r475b3057],
43	E	NN	O	e	nn	44	SENT_1060	[p32l446t3088r473b3119],
44	M	NN	O	m	dep	1	SENT_1060	[p32l446t3200r486b3230],

1	5:0	CD	NUMBER	5:0	num	2	SENT_1061	[p32l305t618r336b683],
2	em	NN	O	em	_	0	SENT_1061	[p32l313t693r329b736],
3	:	:	O	:	_	0	SENT_1061	[p32l313t693r329b736],
4	3822	CD	NUMBER	3822	dep	2	SENT_1061	[p32l305t745r336b858],
5	.	.	O	.	_	0	SENT_1061	[p32l305t745r336b858],

1	you	PRP	O	you	_	0	SENT_1062	[p32l306t866r329b912],
2	.	.	O	.	_	0	SENT_1062	[p32l305t923r329b1047],

1	E	NN	O	e	_	0	SENT_1063	[p32l305t923r329b1047],
2	\	CD	NUMBER	\	num	1	SENT_1063	[p32l305t923r329b1047],
3	mo	NN	DURATION	mo	dep	1	SENT_1063	[p32l305t923r329b1047],
4	>	JJR	O	>	amod	5	SENT_1063	[p32l305t923r329b1047],
5	o	NN	O	o	dobj	3	SENT_1063	[p32l305t923r329b1047],
6	no	DT	O	no	dep	5	SENT_1063	[p32l313t1056r329b1089],
7	:	:	O	:	_	0	SENT_1063	[p32l305t1098r329b1214],
8	om	CD	PERCENT	om	num	9	SENT_1063	[p32l305t1098r329b1214],
9	%	NN	PERCENT	%	dep	5	SENT_1063	[p32l305t1098r329b1214],
10	m	NN	O	m	dep	9	SENT_1063	[p32l305t1098r329b1214],
11	§	SYM	O	§	dep	5	SENT_1063	[p32l305t1098r329b1214],
12	-	:	O	-	_	0	SENT_1063	[p32l319t1224r322b1233],
13	Emaoomrﬁ	NNP	O	Emaoomrﬁ	nn	15	SENT_1063	[p32l305t1243r329b1383],
14	mo	NN	DURATION	mo	nn	15	SENT_1063	[p32l305t1389r329b1418],
15	bmm	NN	O	bmm	dep	1	SENT_1063	[p32l305t1428r336b1568],
16	.6	CD	NUMBER	.6	num	18	SENT_1063	[p32l305t1428r336b1568],
17	>	JJR	O	>	amod	18	SENT_1063	[p32l305t1428r336b1568],
18	_	NN	O	_	dep	15	SENT_1063	[p32l305t1428r336b1568],
19	:	:	O	:	_	0	SENT_1063	[p32l305t1428r336b1568],
20	D	NNP	O	D	dep	1	SENT_1063	[p32l305t1428r336b1568],
21	an	DT	O	a	det	23	SENT_1063	[p32l305t1577r336b1610],
22	Eco	NNP	LOCATION	Eco	nn	23	SENT_1063	[p32l302t2832r333b2897],
23	om	NN	O	om	dep	20	SENT_1063	[p32l310t2906r326b2950],
24	:	:	O	:	_	0	SENT_1063	[p32l310t2906r326b2950],
25	Enemies	NNS	O	enemy	dep	1	SENT_1063	[p32l302t2959r333b3071],
26	Sm	NN	O	sm	dep	25	SENT_1063	[p32l303t3078r326b3125],
27	.	.	O	.	_	0	SENT_1063	[p32l302t3135r326b3260],

1	E	NN	O	e	nn	3	SENT_1064	[p32l302t3135r326b3260],
2	\	CD	NUMBER	\	num	3	SENT_1064	[p32l302t3135r326b3260],
3	mo	NN	DURATION	mo	_	0	SENT_1064	[p32l302t3135r326b3260],
4	:	:	O	:	_	0	SENT_1064	[p32l302t3135r326b3260],
5	o	NN	O	o	dep	3	SENT_1064	[p32l302t3135r326b3260],
6	no	DT	O	no	det	7	SENT_1064	[p32l310t3269r326b3301],
7	wHO	NN	O	who	dep	5	SENT_1064	[p32l272t583r302b907],
8	.	.	O	.	_	0	SENT_1064	[p32l272t583r302b907],

1	m	NN	O	m	_	0	SENT_1065	[p32l272t583r302b907],
2	>>	CD	NUMBER	>>	number	3	SENT_1065	[p32l272t583r302b907],
3	3	CD	NUMBER	3	num	5	SENT_1065	[p32l272t583r302b907],
4	>	JJR	O	>	amod	5	SENT_1065	[p32l272t583r302b907],
5	®	NN	O	®	dep	1	SENT_1065	[p32l272t583r302b907],
6	H	NN	O	h	nn	8	SENT_1065	[p32l272t583r302b907],
7	—	CD	NUMBER	—	num	8	SENT_1065	[p32l272t583r302b907],
8	d5ﬁEd	NN	O	d5ﬁed	dep	5	SENT_1065	[p32l272t583r302b907],
9	.	.	O	.	_	0	SENT_1065	[p32l272t583r302b907],

1	>>	NN	O	>>	_	0	SENT_1066	[p32l272t583r302b907],
2	>>	CD	NUMBER	>>	number	3	SENT_1066	[p32l272t583r302b907],
3	>>	CD	NUMBER	>>	dep	1	SENT_1066	[p32l272t583r302b907],
4	Eoﬂ	NN	O	eoﬂ	nn	5	SENT_1066	[p32l272t916r295b981],
5	uowaoEBoD	NN	O	uowaoebod	dep	3	SENT_1066	[p32l272t990r295b1160],
6	.	.	O	.	_	0	SENT_1066	[p32l272t1170r296b1267],

1	.	.	O	.	_	0	SENT_1067	[p32l272t1170r296b1267],

1	\	RB	O	\	advmod	4	SENT_1068	[p32l272t1170r296b1267],
2	am	VBP	O	be	cop	4	SENT_1068	[p32l272t1170r296b1267],
3	_	CD	NUMBER	_	number	4	SENT_1068	[p32l272t1170r296b1267],
4	.9	CD	NUMBER	.9	_	0	SENT_1068	[p32l272t1170r296b1267],
5	_	NN	O	_	nn	6	SENT_1068	[p32l272t1274r295b1284],
6	ﬁméoom	NN	O	ﬁméoom	dep	4	SENT_1068	[p32l272t1290r296b1404],
7	.32	CD	NUMBER	.32	num	8	SENT_1068	[p32l272t1416r295b1483],
8	sum	NN	O	sum	nsubj	4	SENT_1068	[p32l272t1493r295b1553],
9	.	.	O	.	_	0	SENT_1068	[p32l272t1564r295b1644],

1	:	:	O	:	_	0	SENT_1069	[p32l272t1564r295b1644],
2	:	:	O	:	_	0	SENT_1069	[p32l272t1564r295b1644],
3	:	:	O	:	_	0	SENT_1069	[p32l272t1564r295b1644],
4	<	JJR	O	<	amod	5	SENT_1069	[p32l272t1564r295b1644],
5	mHo	NN	O	mho	dep	2	SENT_1069	[p32l269t2797r299b3120],
6	.	.	O	.	_	0	SENT_1069	[p32l269t2797r299b3120],

1	mB2	NN	O	mb2	dep	7	SENT_1070	[p32l269t2797r299b3120],
2	>	JJR	O	>	amod	3	SENT_1070	[p32l269t2797r299b3120],
3	oH_m	NN	O	oh_m	dep	1	SENT_1070	[p32l269t2797r299b3120],
4	:	:	O	:	_	0	SENT_1070	[p32l269t2797r299b3120],
5	:	:	O	:	_	0	SENT_1070	[p32l269t2797r299b3120],
6	:	:	O	:	_	0	SENT_1070	[p32l269t2797r299b3120],
7	d.	VB	O	d.	_	0	SENT_1070	[p32l269t2797r299b3120],
8	BBB	NNP	O	BBB	nn	9	SENT_1070	[p32l269t2797r299b3120],
9	Eob	NNP	O	Eob	nsubj	10	SENT_1070	[p32l269t3128r292b3193],
10	cause	VB	O	cause	ccomp	7	SENT_1070	[p32l269t3202r292b3307],
11	?	.	O	?	_	0	SENT_1070	[p32l269t3202r292b3307],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1071	[p33l269t505r292b585],
2	.	.	O	.	_	0	SENT_1071	[p33l269t505r292b585],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1072	[p33l269t434r292b494],
2	Med	NNP	O	Med	_	0	SENT_1072	[p33l269t357r292b424],
3	.	.	O	.	_	0	SENT_1072	[p33l269t357r292b424],

1	2006.57:119	CD	NUMBER	2006.57:119	num	2	SENT_1073	[p33l269t111r293b346],
2	-137	CD	NUMBER	-137	_	0	SENT_1073	[p33l269t111r293b346],
3	.	.	O	.	_	0	SENT_1073	[p33l269t111r293b346],

1	Dow	NNP	MISC	Dow	_	0	SENT_1074	[p33l269t36r292b100],
2	by	IN	O	by	_	0	SENT_1074	[p33l302t519r333b551],
3	University	NNP	ORGANIZATION	University	prep_by	1	SENT_1074	[p33l302t369r333b509],
4	of	IN	ORGANIZATION	of	_	0	SENT_1074	[p33l302t331r326b360],
5	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	1	SENT_1074	[p33l302t183r326b324],
6	-	:	O	-	_	0	SENT_1074	[p33l316t165r319b174],
7	Madison	NNP	PERSON	Madison	dep	1	SENT_1074	[p33l302t39r326b155],

1	Annu	NNP	PERSON	Annu	_	0	SENT_1075	[p33l278t2900r301b2980],
2	.	.	O	.	_	0	SENT_1075	[p33l278t2900r301b2980],

1	Rev.	NNP	O	Rev.	nn	2	SENT_1076	[p33l278t2830r301b2889],
2	Med	NNP	O	Med	_	0	SENT_1076	[p33l278t2754r301b2819],
3	2006.57	CD	NUMBER	2006.57	num	2	SENT_1076	[p33l278t2628r301b2743],
4	:	:	O	:	_	0	SENT_1076	[p33l278t2628r301b2743],
5	1	CD	NUMBER	1	number	6	SENT_1076	[p33l278t2612r301b2622],
6	19-137	CD	NUMBER	19-137	dep	2	SENT_1076	[p33l278t2507r302b2605],
7	.	.	O	.	_	0	SENT_1076	[p33l278t2507r302b2605],

1	Dow	NNP	MISC	Dow	nsubj	2	SENT_1077	[p33l278t2432r301b2496],
2	nloaded	VBD	O	nload	_	0	SENT_1077	[p33l278t2317r301b2422],
3	from	IN	O	from	_	0	SENT_1077	[p33l278t2243r301b2308],
4	wwW.annualrevieWs.org	NN	O	www.annualreviews.org	prep_from	2	SENT_1077	[p33l278t1911r308b2234],
5	by	IN	O	by	_	0	SENT_1077	[p33l311t2914r342b2946],
6	University	NNP	ORGANIZATION	University	prep_by	2	SENT_1077	[p33l311t2764r342b2904],
7	of	IN	ORGANIZATION	of	_	0	SENT_1077	[p33l311t2728r335b2757],
8	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	6	SENT_1077	[p33l311t2580r335b2721],
9	-	:	O	-	_	0	SENT_1077	[p33l325t2562r328b2570],
10	Madison	NNP	O	Madison	dep	6	SENT_1077	[p33l311t2435r335b2552],
11	on	IN	O	on	_	0	SENT_1077	[p33l319t2384r335b2416],
12	01/05/14	CD	DATE	01/05/14	prep_on	10	SENT_1077	[p33l311t2250r335b2374],
13	.	.	O	.	_	0	SENT_1077	[p33l311t2250r335b2374],

1	For	IN	O	for	_	0	SENT_1078	[p33l312t2193r335b2239],
2	personal	JJ	O	personal	amod	3	SENT_1078	[p33l311t2073r342b2185],
3	use	NN	O	use	pobj	1	SENT_1078	[p33l319t2020r335b2064],
4	only	RB	O	only	advmod	3	SENT_1078	[p33l311t1946r342b2011],
5	.	.	O	.	_	0	SENT_1078	[p33l311t1946r342b2011],

1	MOLECULAR	JJ	O	molecular	dep	160	SENT_1079	[p33l446t40r681b71],
2	IMAGING	NN	O	imaging	dep	160	SENT_1079	[p33l693t40r858b71],
3	IN	IN	O	in	dep	160	SENT_1079	[p33l870t46r908b71],
4	THE	DT	O	the	dep	160	SENT_1079	[p33l920t46r990b71],
5	DEVELOPMENT	NNP	O	DEVELOPMENT	dep	160	SENT_1079	[p33l1003t40r1276b71],
6	OF	IN	O	of	dep	160	SENT_1079	[p33l1289t45r1335b71],
7	CANCER	NNP	O	CANCER	dep	160	SENT_1079	[p33l1348t39r1500b71],
8	THERAPEUTICS	NNPS	O	THERAPEUTICS	dep	160	SENT_1079	[p33l492t90r776b127],
9	,	,	O	,	_	0	SENT_1079	[p33l492t90r776b127],
10	Johannes	NNP	PERSON	Johannes	dep	160	SENT_1079	[p33l790t92r945b121],
11	Czernin	NNP	PERSON	Czernin	dep	160	SENT_1079	[p33l959t92r1094b126],
12	,	,	O	,	_	0	SENT_1079	[p33l959t92r1094b126],
13	Wolfgang	NNP	PERSON	Wolfgang	dep	160	SENT_1079	[p33l1111t92r1265b129],
14	A.	NNP	PERSON	A.	dep	160	SENT_1079	[p33l1274t92r1308b121],
15	Weber	NNP	PERSON	Weber	dep	160	SENT_1079	[p33l1325t92r1428b126],
16	,	,	O	,	_	0	SENT_1079	[p33l1325t92r1428b126],
17	and	CC	O	and	dep	160	SENT_1079	[p33l492t142r555b171],
18	Harvey	NNP	PERSON	Harvey	dep	160	SENT_1079	[p33l564t143r685b179],
19	R.	NNP	PERSON	R.	dep	160	SENT_1079	[p33l695t143r727b171],
20	Herschman	NNP	PERSON	Herschman	dep	160	SENT_1079	[p33l741t142r931b171],
21	99	CD	NUMBER	99	dep	160	SENT_1079	[p33l1851t142r1890b171],
22	PHARMACOGENOMICS	NNPS	O	PHARMACOGENOMICS	dep	160	SENT_1079	[p33l447t202r847b233],
23	AND	CC	O	and	dep	160	SENT_1079	[p33l861t208r938b233],
24	INDIVIDUALIZED	NNPS	O	INDIVIDUALIZED	dep	160	SENT_1079	[p33l952t202r1252b233],
25	DRUG	NN	O	drug	dep	160	SENT_1079	[p33l1265t202r1374b233],
26	THERAPY	NN	O	therapy	dep	160	SENT_1079	[p33l1387t202r1569b239],
27	,	,	O	,	_	0	SENT_1079	[p33l1387t202r1569b239],
28	Michel	NNP	PERSON	Michel	dep	160	SENT_1079	[p33l491t254r607b283],
29	Eichelbaum	NNP	PERSON	Eichelbaum	dep	160	SENT_1079	[p33l617t254r820b288],
30	,	,	O	,	_	0	SENT_1079	[p33l617t254r820b288],
31	Magnus	NNP	PERSON	Magnus	dep	160	SENT_1079	[p33l834t255r968b291],
32	Ingelman-Sundberg	NNP	PERSON	Ingelman-Sundberg	dep	160	SENT_1079	[p33l979t254r1312b291],
33	,	,	O	,	_	0	SENT_1079	[p33l979t254r1312b291],
34	and	CC	O	and	dep	160	SENT_1079	[p33l492t304r555b333],
35	William	NNP	PERSON	William	dep	160	SENT_1079	[p33l567t304r693b334],
36	E.	NNP	PERSON	E.	dep	160	SENT_1079	[p33l704t305r735b333],
37	Evans	NNP	PERSON	Evans	dep	160	SENT_1079	[p33l750t305r851b333],
38	119	CD	NUMBER	119	dep	160	SENT_1079	[p33l1833t304r1890b334],
39	AVIAN	NNP	O	AVIAN	dep	160	SENT_1079	[p33l447t363r567b395],
40	FLU	NNP	O	FLU	dep	160	SENT_1079	[p33l579t364r652b395],
41	TO	TO	O	to	dep	160	SENT_1079	[p33l664t370r712b395],
42	HUMAN	NNP	O	HUMAN	dep	160	SENT_1079	[p33l725t364r868b395],
43	INFLUENZA	NNP	O	INFLUENZA	dep	160	SENT_1079	[p33l881t364r1097b401],
44	,	,	O	,	_	0	SENT_1079	[p33l881t364r1097b401],
45	David	NNP	PERSON	David	dep	160	SENT_1079	[p33l1110t366r1214b395],
46	B.	NNP	PERSON	B.	dep	160	SENT_1079	[p33l1222t367r1254b395],
47	Lewis	NNP	PERSON	Lewis	dep	160	SENT_1079	[p33l1268t367r1364b395],
48	139	CD	NUMBER	139	dep	160	SENT_1079	[p33l1833t366r1890b396],
49	EMERGING	NNP	O	EMERGING	dep	160	SENT_1079	[p33l446t426r643b458],
50	THERAPEUTICS	NNP	O	THERAPEUTICS	dep	160	SENT_1079	[p33l656t426r928b458],
51	FOR	IN	O	for	dep	160	SENT_1079	[p33l942t432r1013b458],
52	CHRONIC	NNP	O	CHRONIC	dep	160	SENT_1079	[p33l1026t426r1194b458],
53	HEPATITIS	NN	O	hepatitis	dep	160	SENT_1079	[p33l1207t426r1396b458],
54	B	NN	O	b	dep	160	SENT_1079	[p33l1410t426r1449b464],
55	,	,	O	,	_	0	SENT_1079	[p33l1410t426r1449b464],
56	Mark	NNP	PERSON	Mark	dep	160	SENT_1079	[p33l491t478r583b508],
57	E.	NNP	PERSON	E.	dep	160	SENT_1079	[p33l592t480r623b508],
58	Mailliard	NNP	PERSON	Mailliard	dep	160	SENT_1079	[p33l637t478r797b508],
59	and	CC	O	and	dep	160	SENT_1079	[p33l807t478r870b508],
60	John	NNP	PERSON	John	dep	160	SENT_1079	[p33l878t478r958b508],
61	L.	NNP	PERSON	L.	dep	160	SENT_1079	[p33l968t480r998b508],
62	Gollan	NNP	PERSON	Gollan	dep	160	SENT_1079	[p33l1015t478r1127b508],
63	155	CD	NUMBER	155	dep	160	SENT_1079	[p33l1833t478r1889b508],
64	THE	DT	O	the	dep	160	SENT_1079	[p33l447t539r522b570],
65	ROTAVIRUS	NN	O	rotavirus	dep	160	SENT_1079	[p33l535t539r746b570],
66	VACCINE	NN	O	vaccine	dep	160	SENT_1079	[p33l760t539r923b570],
67	SAGA	NN	O	saga	dep	160	SENT_1079	[p33l937t538r1048b576],
68	,	,	O	,	_	0	SENT_1079	[p33l937t538r1048b576],
69	Alan	NNP	PERSON	Alan	dep	160	SENT_1079	[p33l1060t541r1139b570],
70	R.	NNP	PERSON	R.	dep	160	SENT_1079	[p33l1151t542r1182b570],
71	Shaw	NNP	PERSON	Shaw	dep	160	SENT_1079	[p33l1198t541r1287b570],
72	167	CD	NUMBER	167	dep	160	SENT_1079	[p33l1833t541r1889b570],
73	WEST	NNP	O	WEST	dep	160	SENT_1079	[p33l446t601r550b632],
74	NILE	NNP	O	NILE	dep	160	SENT_1079	[p33l562t601r651b632],
75	VIRUS	NNP	O	VIRUS	dep	160	SENT_1079	[p33l664t601r785b632],
76	:	:	O	:	_	0	SENT_1079	[p33l664t601r785b632],
77	EPIDEMIOLOGY	NNP	O	EPIDEMIOLOGY	dep	160	SENT_1079	[p33l806t601r1087b632],
78	AND	CC	O	and	dep	160	SENT_1079	[p33l1099t606r1177b632],
79	CLINICAL	NNP	O	CLINICAL	dep	160	SENT_1079	[p33l1190t600r1366b632],
80	FEATURES	NNPS	O	FEATURES	dep	160	SENT_1079	[p33l1378t601r1565b632],
81	OF	IN	O	of	dep	160	SENT_1079	[p33l1580t606r1625b632],
82	AN	DT	O	a	dep	160	SENT_1079	[p33l1637t606r1689b632],
83	EMERGING	NNP	O	EMERGING	dep	160	SENT_1079	[p33l492t649r689b681],
84	EPIDEMIC	NNP	O	EPIDEMIC	dep	160	SENT_1079	[p33l701t649r878b681],
85	IN	IN	O	in	dep	160	SENT_1079	[p33l891t656r928b681],
86	THE	DT	O	the	dep	160	SENT_1079	[p33l941t656r1011b681],
87	UNITED	NNP	ORGANIZATION	UNITED	dep	160	SENT_1079	[p33l1023t649r1164b681],
88	STATES	NNS	ORGANIZATION	state	dep	160	SENT_1079	[p33l1178t649r1325b687],
89	,	,	O	,	_	0	SENT_1079	[p33l1178t649r1325b687],
90	Edward	NNP	PERSON	Edward	dep	160	SENT_1079	[p33l1338t651r1470b681],
91	B.	NNP	PERSON	B.	dep	160	SENT_1079	[p33l1479t653r1510b681],
92	Hayes	NNP	PERSON	Hayes	dep	160	SENT_1079	[p33l1525t653r1628b689],
93	and	CC	O	and	dep	160	SENT_1079	[p33l492t692r555b721],
94	Duane	NNP	PERSON	Duane	dep	160	SENT_1079	[p33l564t693r674b721],
95	J.	NNP	PERSON	J.	dep	160	SENT_1079	[p33l685t693r709b721],
96	Gubler	NNP	PERSON	Gubler	dep	160	SENT_1079	[p33l726t692r842b721],
97	181	CD	NUMBER	181	dep	160	SENT_1079	[p33l1833t692r1887b721],
98	PROSTATITIS/CHRONIC	NN	O	prostatitis/chronic	dep	160	SENT_1079	[p33l447t751r863b783],
99	PELVIC	NN	O	pelvic	dep	160	SENT_1079	[p33l876t752r1007b783],
100	PAIN	NN	O	pain	dep	160	SENT_1079	[p33l1020t752r1109b783],
101	SYNDROME	NN	O	syndrome	dep	160	SENT_1079	[p33l1122t751r1340b789],
102	,	,	O	,	_	0	SENT_1079	[p33l1122t751r1340b789],
103	Geoﬁrey	NNP	PERSON	Geoﬁrey	dep	160	SENT_1079	[p33l494t794r633b832],
104	M.	NNP	PERSON	M.	dep	160	SENT_1079	[p33l643t795r684b824],
105	Habermacher	NNP	PERSON	Habermacher	dep	160	SENT_1079	[p33l699t794r930b828],
106	,	,	O	,	_	0	SENT_1079	[p33l699t794r930b828],
107	Judd	NNP	PERSON	Judd	dep	160	SENT_1079	[p33l945t794r1026b824],
108	T.	NNP	PERSON	T.	dep	160	SENT_1079	[p33l1037t795r1061b824],
109	Chason	NNP	PERSON	Chason	dep	160	SENT_1079	[p33l1078t794r1208b829],
110	,	,	O	,	_	0	SENT_1079	[p33l1078t794r1208b829],
111	and	CC	O	and	dep	160	SENT_1079	[p33l1224t794r1287b824],
112	Anthony	NNP	PERSON	Anthony	dep	160	SENT_1079	[p33l1294t794r1434b832],
113	J.	NNP	PERSON	J.	dep	160	SENT_1079	[p33l1444t795r1468b824],
114	Schaeﬁer	NNP	PERSON	Schaeﬁer	dep	160	SENT_1079	[p33l1484t794r1640b832],
115	195	CD	NUMBER	195	dep	160	SENT_1079	[p33l1833t794r1889b824],
116	CELIAC	JJ	O	celiac	dep	160	SENT_1079	[p33l447t843r583b875],
117	DISEASE	NN	O	disease	dep	160	SENT_1079	[p33l596t844r761b881],
118	,	,	O	,	_	0	SENT_1079	[p33l596t844r761b881],
119	Peter	NNP	PERSON	Peter	dep	160	SENT_1079	[p33l775t847r863b875],
120	H.R.	NNP	PERSON	H.R.	dep	160	SENT_1079	[p33l872t847r944b875],
121	Green	NNP	PERSON	Green	dep	160	SENT_1079	[p33l961t846r1060b875],
122	and	CC	O	and	dep	160	SENT_1079	[p33l1072t846r1135b875],
123	Bana	NNP	PERSON	Bana	dep	160	SENT_1079	[p33l1143t847r1231b875],
124	Jabri	NNP	PERSON	Jabri	dep	160	SENT_1079	[p33l1241t846r1328b875],
125	207	CD	NUMBER	207	dep	160	SENT_1079	[p33l1830t846r1889b875],
126	AMYLOIDOSIS	NNP	O	AMYLOIDOSIS	dep	160	SENT_1079	[p33l447t906r713b944],
127	,	,	O	,	_	0	SENT_1079	[p33l447t906r713b944],
128	Mark	NNP	PERSON	Mark	dep	160	SENT_1079	[p33l726t908r818b938],
129	B.	NNP	PERSON	B.	dep	160	SENT_1079	[p33l827t909r859b938],
130	Pepys	NNP	PERSON	Pepys	dep	160	SENT_1079	[p33l873t909r969b946],
131	223	CD	NUMBER	223	dep	160	SENT_1079	[p33l1830t909r1888b938],
132	SURGICAL	JJ	O	surgical	dep	160	SENT_1079	[p33l448t968r633b1000],
133	TREATMENT	NN	O	treatment	dep	160	SENT_1079	[p33l645t969r869b1000],
134	OF	IN	O	of	dep	160	SENT_1079	[p33l882t974r928b1000],
135	MORBID	JJ	O	morbid	dep	160	SENT_1079	[p33l940t969r1092b1000],
136	OBESITY	NN	O	obesity	dep	160	SENT_1079	[p33l1106t968r1275b1006],
137	,	,	O	,	_	0	SENT_1079	[p33l1106t968r1275b1006],
138	Peter	NNP	PERSON	Peter	dep	160	SENT_1079	[p33l1289t972r1376b1000],
139	F	NN	PERSON	f	dep	160	SENT_1079	[p33l1386t972r1413b1000],
140	Crookes	NN	PERSON	crooke	dep	160	SENT_1079	[p33l1429t971r1561b1000],
141	243	CD	NUMBER	243	dep	160	SENT_1079	[p33l1830t971r1888b1000],
142	THERAPEUTIC	NNP	O	THERAPEUTIC	dep	160	SENT_1079	[p33l447t1031r700b1063],
143	APPROACHES	NNP	O	APPROACHES	dep	160	SENT_1079	[p33l713t1031r955b1063],
144	TO	TO	O	to	dep	160	SENT_1079	[p33l969t1037r1016b1063],
145	PRESERVE	VB	O	preserve	dep	160	SENT_1079	[p33l1029t1031r1215b1063],
146	ISLET	NN	O	islet	dep	160	SENT_1079	[p33l1228t1031r1329b1063],
147	MASS	NN	O	mass	dep	160	SENT_1079	[p33l1341t1031r1446b1063],
148	IN	IN	O	in	dep	160	SENT_1079	[p33l1460t1038r1498b1063],
149	TYPE	NN	O	type	dep	160	SENT_1079	[p33l1510t1031r1603b1063],
150	2	CD	NUMBER	2	dep	160	SENT_1079	[p33l1616t1031r1636b1063],
151	DIABETES	NN	O	diabetes	dep	160	SENT_1079	[p33l492t1072r684b1109],
152	,	,	O	,	_	0	SENT_1079	[p33l492t1072r684b1109],
153	Laurie	NNP	PERSON	Laurie	dep	160	SENT_1079	[p33l697t1075r807b1103],
154	L.	NNP	PERSON	L.	dep	160	SENT_1079	[p33l818t1075r848b1103],
155	Baggio	NNP	PERSON	Baggio	dep	160	SENT_1079	[p33l862t1075r981b1111],
156	and	CC	O	and	dep	160	SENT_1079	[p33l993t1074r1056b1103],
157	Daniel	NNP	PERSON	Daniel	dep	160	SENT_1079	[p33l1064t1074r1178b1103],
158	J.	NNP	PERSON	J.	dep	160	SENT_1079	[p33l1188t1075r1212b1103],
159	Drucker	NNP	PERSON	Drucker	dep	160	SENT_1079	[p33l1226t1074r1365b1103],
160	265	CD	NUMBER	265	_	0	SENT_1079	[p33l1830t1074r1889b1103],

1	v	LS	O	v	_	0	SENT_1080	[p33l1871t1166r1891b1186],

1	Vi	NNP	PERSON	Vi	nn	2	SENT_1081	[p33l436t1261r467b1291],
2	CONTENTS	NNP	O	CONTENTS	_	0	SENT_1081	[p33l587t1264r779b1291],

1	ENZYME	NN	O	enzyme	dep	196	SENT_1082	[p33l436t1386r593b1417],
2	REPLACEMENT	NN	O	replacement	dep	196	SENT_1082	[p33l605t1386r876b1417],
3	FOR	IN	O	for	dep	196	SENT_1082	[p33l888t1392r959b1417],
4	LYSOSOMAL	JJ	MISC	lysosomal	dep	196	SENT_1082	[p33l971t1386r1196b1417],
5	DISEASES	NNS	O	disease	dep	196	SENT_1082	[p33l1209t1386r1394b1423],
6	,	,	O	,	_	0	SENT_1082	[p33l1209t1386r1394b1423],
7	Roscoe	NNP	PERSON	Roscoe	dep	196	SENT_1082	[p33l480t1438r600b1466],
8	o.	NNP	PERSON	o.	dep	196	SENT_1082	[p33l614t1437r647b1466],
9	Brady	NNP	PERSON	Brady	dep	196	SENT_1082	[p33l662t1437r762b1474],
10	283	CD	NUMBER	283	dep	196	SENT_1082	[p33l1819t1437r1877b1466],
11	GENETIC	NNP	O	GENETIC	dep	196	SENT_1082	[p33l437t1496r597b1528],
12	BASIS	NNPS	O	BASIS	dep	196	SENT_1082	[p33l610t1497r717b1528],
13	OF	IN	O	of	dep	196	SENT_1082	[p33l732t1502r777b1528],
14	LIPODYSTROPHIES	NNPS	MISC	LIPODYSTROPHIES	dep	196	SENT_1082	[p33l789t1497r1121b1528],
15	AND	CC	O	and	dep	196	SENT_1082	[p33l1135t1502r1213b1528],
16	MANAGEMENT	NNPS	O	MANAGEMENT	dep	196	SENT_1082	[p33l1225t1497r1496b1528],
17	OF	IN	O	of	dep	196	SENT_1082	[p33l1509t1502r1555b1528],
18	METABOLIC	NN	MISC	metabolic	dep	196	SENT_1082	[p33l481t1545r701b1577],
19	COMPLICATIONS	NNS	O	complication	dep	196	SENT_1082	[p33l715t1545r1025b1583],
20	,	,	O	,	_	0	SENT_1082	[p33l715t1545r1025b1583],
21	Anil	NNP	PERSON	Anil	dep	196	SENT_1082	[p33l1037t1547r1108b1577],
22	K.	NNP	PERSON	K.	dep	196	SENT_1082	[p33l1119t1549r1152b1577],
23	Agarwal	NNP	PERSON	Agarwal	dep	196	SENT_1082	[p33l1165t1547r1310b1585],
24	and	CC	O	and	dep	196	SENT_1082	[p33l1321t1547r1384b1577],
25	Abhimanyu	NNP	PERSON	Abhimanyu	dep	196	SENT_1082	[p33l1391t1547r1581b1585],
26	Garg	NNP	PERSON	Garg	dep	196	SENT_1082	[p33l1594t1548r1678b1585],
27	297	CD	NUMBER	297	dep	196	SENT_1082	[p33l1819t1548r1878b1577],
28	NUCLEAR	NN	O	nuclear	dep	196	SENT_1082	[p33l436t1607r614b1638],
29	RECEPTORS	NNS	O	receptor	dep	196	SENT_1082	[p33l626t1607r837b1638],
30	IN	IN	O	in	dep	196	SENT_1082	[p33l851t1613r889b1638],
31	LIPID	NN	MISC	lipid	dep	196	SENT_1082	[p33l901t1607r998b1638],
32	METABOLISM	NN	O	metabolism	dep	196	SENT_1082	[p33l1011t1607r1269b1638],
33	:	:	O	:	_	0	SENT_1082	[p33l1011t1607r1269b1638],
34	TARGETING	VBG	O	target	dep	196	SENT_1082	[p33l1290t1607r1499b1638],
35	THE	DT	O	the	dep	196	SENT_1082	[p33l1511t1613r1582b1638],
36	HEART	NN	O	heart	dep	196	SENT_1082	[p33l1594t1607r1721b1638],
37	OF	IN	O	of	dep	196	SENT_1082	[p33l482t1662r528b1687],
38	DYSLIPIDEMIA	NNP	LOCATION	DYSLIPIDEMIA	dep	196	SENT_1082	[p33l540t1656r814b1693],
39	,	,	O	,	_	0	SENT_1082	[p33l540t1656r814b1693],
40	Simon	NNP	PERSON	Simon	dep	196	SENT_1082	[p33l829t1659r931b1687],
41	W	NNP	PERSON	W	dep	196	SENT_1082	[p33l945t1659r980b1687],
42	Beaven	NNP	PERSON	Beaven	dep	196	SENT_1082	[p33l994t1659r1115b1687],
43	and	CC	O	and	dep	196	SENT_1082	[p33l1127t1658r1190b1687],
44	Peter	NNP	PERSON	Peter	dep	196	SENT_1082	[p33l1199t1659r1287b1687],
45	Tontonoz	NNP	PERSON	Tontonoz	dep	196	SENT_1082	[p33l1298t1659r1446b1690],
46	313	CD	NUMBER	313	dep	196	SENT_1082	[p33l1819t1658r1877b1687],
47	HEMOCHROMATOSIS	NNS	O	hemochromatosis	dep	196	SENT_1082	[p33l436t1718r820b1749],
48	:	:	O	:	_	0	SENT_1082	[p33l436t1718r820b1749],
49	GENETICS	NNS	O	genetics	dep	196	SENT_1082	[p33l842t1717r1021b1749],
50	AND	CC	O	and	dep	196	SENT_1082	[p33l1035t1724r1113b1749],
51	PATHOPHYSIOLOGY	NN	O	pathophysiology	dep	196	SENT_1082	[p33l1126t1718r1494b1755],
52	,	,	O	,	_	0	SENT_1082	[p33l1126t1718r1494b1755],
53	Ernest	NNP	PERSON	Ernest	dep	196	SENT_1082	[p33l481t1761r590b1789],
54	Beutler	NNP	PERSON	Beutler	dep	196	SENT_1082	[p33l599t1760r723b1789],
55	331	CD	NUMBER	331	dep	196	SENT_1082	[p33l1819t1760r1876b1789],
56	THERAPEUTIC	NNP	O	THERAPEUTIC	dep	196	SENT_1082	[p33l436t1819r689b1851],
57	USE	NNP	O	USE	dep	196	SENT_1082	[p33l703t1819r777b1851],
58	OF	IN	O	of	dep	196	SENT_1082	[p33l790t1825r836b1850],
59	CALCIMIMETICS	NNP	LOCATION	CALCIMIMETICS	dep	196	SENT_1082	[p33l848t1819r1151b1856],
60	,	,	O	,	_	0	SENT_1082	[p33l848t1819r1151b1856],
61	Steven	NNP	PERSON	Steven	dep	196	SENT_1082	[p33l1165t1822r1271b1851],
62	C.	NNP	PERSON	C.	dep	196	SENT_1082	[p33l1285t1822r1316b1851],
63	Hebert	NNP	PERSON	Hebert	dep	196	SENT_1082	[p33l1330t1821r1447b1850],
64	349	CD	NUMBER	349	dep	196	SENT_1082	[p33l1819t1821r1878b1851],
65	TOWARD	IN	O	toward	dep	196	SENT_1082	[p33l436t1881r595b1913],
66	A	DT	O	a	dep	196	SENT_1082	[p33l608t1887r633b1912],
67	UNIFIED	JJ	O	unified	dep	196	SENT_1082	[p33l646t1881r797b1913],
68	THEORY	NN	O	theory	dep	196	SENT_1082	[p33l810t1881r962b1913],
69	OF	IN	O	of	dep	196	SENT_1082	[p33l975t1887r1021b1913],
70	RENAL	JJ	O	renal	dep	196	SENT_1082	[p33l1033t1881r1160b1913],
71	PROGRESSION	NN	O	progression	dep	196	SENT_1082	[p33l1172t1881r1436b1919],
72	,	,	O	,	_	0	SENT_1082	[p33l1172t1881r1436b1919],
73	Raymond	NNP	PERSON	Raymond	dep	196	SENT_1082	[p33l480t1933r639b1970],
74	C.	NNP	PERSON	C.	dep	196	SENT_1082	[p33l651t1934r682b1962],
75	Harris	NNP	PERSON	Harris	dep	196	SENT_1082	[p33l696t1934r807b1962],
76	and	CC	O	and	dep	196	SENT_1082	[p33l818t1933r881b1962],
77	Eric	NNP	PERSON	Eric	dep	196	SENT_1082	[p33l890t1934r961b1962],
78	G.	NNP	PERSON	G.	dep	196	SENT_1082	[p33l974t1934r1008b1962],
79	Neilson	NNP	PERSON	Neilson	dep	196	SENT_1082	[p33l1022t1933r1149b1962],
80	365	CD	NUMBER	365	dep	196	SENT_1082	[p33l1819t1933r1877b1962],
81	CD4	NN	O	cd4	dep	196	SENT_1082	[p33l436t1987r546b2024],
82	+	CC	O	+	dep	196	SENT_1082	[p33l436t1987r546b2024],
83	CD25	NN	O	cd25	dep	196	SENT_1082	[p33l551t1987r683b2024],
84	+	CC	O	+	dep	196	SENT_1082	[p33l551t1987r683b2024],
85	REGULATORY	NN	O	regulatory	dep	196	SENT_1082	[p33l699t1993r951b2024],
86	T	NN	O	t	dep	196	SENT_1082	[p33l963t1993r990b2024],
87	CELLS	NNS	O	cell	dep	196	SENT_1082	[p33l1003t1993r1117b2024],
88	AND	CC	O	and	dep	196	SENT_1082	[p33l1131t1999r1209b2024],
89	THEIR	NNS	O	their	dep	196	SENT_1082	[p33l1222t1993r1334b2024],
90	THERAPEUTIC	NNP	O	THERAPEUTIC	dep	196	SENT_1082	[p33l1347t1993r1600b2024],
91	POTENTIAL	NNP	O	POTENTIAL	dep	196	SENT_1082	[p33l482t2043r696b2080],
92	,	,	O	,	_	0	SENT_1082	[p33l482t2043r696b2080],
93	David	NNP	PERSON	David	dep	196	SENT_1082	[p33l709t2045r813b2074],
94	A.	NNP	PERSON	A.	dep	196	SENT_1082	[p33l819t2046r853b2074],
95	Randolph	NNP	PERSON	Randolph	dep	196	SENT_1082	[p33l867t2045r1028b2082],
96	and	CC	O	and	dep	196	SENT_1082	[p33l1040t2045r1103b2074],
97	C.	NNP	PERSON	C.	dep	196	SENT_1082	[p33l1115t2046r1146b2074],
98	Garrison	NNP	PERSON	Garrison	dep	196	SENT_1082	[p33l1163t2046r1312b2074],
99	Fathman	NNP	PERSON	Fathman	dep	196	SENT_1082	[p33l1324t2045r1469b2074],
100	381	CD	NUMBER	381	dep	196	SENT_1082	[p33l1819t2045r1876b2074],
101	UMBILICAL	JJ	O	umbilical	dep	196	SENT_1082	[p33l436t2105r645b2137],
102	CORD	NN	O	cord	dep	196	SENT_1082	[p33l657t2105r763b2137],
103	BLOOD	NN	O	blood	dep	196	SENT_1082	[p33l776t2105r906b2136],
104	TRANSPLANTATION	NN	O	transplantation	dep	196	SENT_1082	[p33l919t2105r1273b2136],
105	AND	CC	O	and	dep	196	SENT_1082	[p33l1285t2111r1363b2136],
106	BANKING	NN	O	banking	dep	196	SENT_1082	[p33l1376t2105r1559b2142],
107	,	,	O	,	_	0	SENT_1082	[p33l1376t2105r1559b2142],
108	Claudio	NNP	PERSON	Claudio	dep	196	SENT_1082	[p33l484t2156r614b2186],
109	G.	NNP	PERSON	G.	dep	196	SENT_1082	[p33l627t2157r661b2186],
110	Brunstein	NNP	PERSON	Brunstein	dep	196	SENT_1082	[p33l675t2158r836b2186],
111	and	CC	O	and	dep	196	SENT_1082	[p33l848t2156r911b2186],
112	John	NNP	PERSON	John	dep	196	SENT_1082	[p33l920t2156r999b2186],
113	E.	NNP	PERSON	E.	dep	196	SENT_1082	[p33l1010t2158r1042b2186],
114	Wagner	NNP	PERSON	Wagner	dep	196	SENT_1082	[p33l1059t2158r1185b2194],
115	403	CD	NUMBER	403	dep	196	SENT_1082	[p33l1818t2157r1877b2186],
116	CURRENT	JJ	O	current	dep	196	SENT_1082	[p33l436t2216r611b2248],
117	CONCEPTS	NNS	O	concept	dep	196	SENT_1082	[p33l624t2216r814b2248],
118	IN	IN	O	in	dep	196	SENT_1082	[p33l828t2223r866b2248],
119	THROMBOTIC	NN	O	thrombotic	dep	196	SENT_1082	[p33l878t2217r1123b2248],
120	THROMBOCYTOPENIC	NN	LOCATION	thrombocytopenic	dep	196	SENT_1082	[p33l1137t2217r1527b2248],
121	PURPURA	NN	LOCATION	purpura	dep	196	SENT_1082	[p33l481t2267r664b2304],
122	,	,	O	,	_	0	SENT_1082	[p33l481t2267r664b2304],
123	Han-Mou	NNP	PERSON	Han-Mou	dep	196	SENT_1082	[p33l677t2270r838b2298],
124	Tsai	NNP	PERSON	Tsai	dep	196	SENT_1082	[p33l852t2270r920b2298],
125	419	CD	NUMBER	419	dep	196	SENT_1082	[p33l1818t2269r1878b2298],
126	USE	NNP	O	USE	dep	196	SENT_1082	[p33l436t2329r511b2360],
127	OF	IN	O	of	dep	196	SENT_1082	[p33l523t2335r569b2360],
128	STENTS	NNP	O	STENTS	dep	196	SENT_1082	[p33l582t2328r717b2360],
129	TO	TO	O	to	dep	196	SENT_1082	[p33l731t2335r779b2360],
130	TREAT	VB	O	treat	dep	196	SENT_1082	[p33l792t2329r912b2360],
131	EXTRACRANIAL	JJ	O	extracranial	dep	196	SENT_1082	[p33l924t2329r1213b2360],
132	CEREBROVASCULAR	NN	O	cerebrovascular	dep	196	SENT_1082	[p33l1226t2328r1595b2360],
133	DISEASE	NN	O	disease	dep	196	SENT_1082	[p33l481t2379r647b2416],
134	,	,	O	,	_	0	SENT_1082	[p33l481t2379r647b2416],
135	Philip	NNP	PERSON	Philip	dep	196	SENT_1082	[p33l660t2381r761b2418],
136	M.	NNP	PERSON	M.	dep	196	SENT_1082	[p33l772t2382r813b2410],
137	Meyers	NNP	PERSON	Meyers	dep	196	SENT_1082	[p33l827t2382r954b2418],
138	,	,	O	,	_	0	SENT_1082	[p33l827t2382r954b2418],
139	H.	NNP	PERSON	H.	dep	196	SENT_1082	[p33l969t2382r1005b2410],
140	Christian	NNP	PERSON	Christian	dep	196	SENT_1082	[p33l1022t2381r1176b2411],
141	Schumacher	NNP	PERSON	Schumacher	dep	196	SENT_1082	[p33l1188t2381r1392b2415],
142	;	:	O	;	_	0	SENT_1082	[p33l1188t2381r1392b2415],
143	Randall	NNP	PERSON	Randall	dep	196	SENT_1082	[p33l480t2440r613b2470],
144	T.	NNP	PERSON	T.	dep	196	SENT_1082	[p33l625t2441r649b2470],
145	Higashida	NNP	PERSON	Higashida	dep	196	SENT_1082	[p33l663t2440r842b2478],
146	,	,	O	,	_	0	SENT_1082	[p33l663t2440r842b2478],
147	Megan	NNP	PERSON	Megan	dep	196	SENT_1082	[p33l856t2441r970b2478],
148	C.	NNP	PERSON	C.	dep	196	SENT_1082	[p33l984t2441r1015b2470],
149	Leary	NNP	PERSON	Leary	dep	196	SENT_1082	[p33l1029t2441r1130b2478],
150	,	,	O	,	_	0	SENT_1082	[p33l1029t2441r1130b2478],
151	and	CC	O	and	dep	196	SENT_1082	[p33l1146t2440r1209b2470],
152	Louis	NNP	PERSON	Louis	dep	196	SENT_1082	[p33l1217t2441r1309b2470],
153	R.	NNP	PERSON	R.	dep	196	SENT_1082	[p33l1320t2441r1352b2470],
154	Caplan	NNP	PERSON	Caplan	dep	196	SENT_1082	[p33l1369t2440r1488b2478],
155	437	CD	NUMBER	437	dep	196	SENT_1082	[p33l1818t2440r1878b2470],
156	NEW	NNP	O	NEW	dep	196	SENT_1082	[p33l436t2501r524b2532],
157	DIRECTIONS	NNPS	O	DIRECTIONS	dep	196	SENT_1082	[p33l536t2501r757b2532],
158	IN	IN	O	in	dep	196	SENT_1082	[p33l771t2507r809b2532],
159	CARDIAC	NNP	O	CARDIAC	dep	196	SENT_1082	[p33l822t2500r990b2533],
160	TRANSPLANTATION	NNP	O	TRANSPLANTATION	dep	196	SENT_1082	[p33l1003t2501r1366b2538],
161	,	,	O	,	_	0	SENT_1082	[p33l1003t2501r1366b2538],
162	Abdulaziz	NNP	PERSON	Abdulaziz	dep	196	SENT_1082	[p33l1378t2503r1544b2535],
163	Al-khaldi	NNP	PERSON	Al-khaldi	dep	196	SENT_1082	[p33l1552t2503r1709b2532],
164	and	CC	O	and	dep	196	SENT_1082	[p33l482t2553r544b2583],
165	Robert	NNP	PERSON	Robert	dep	196	SENT_1082	[p33l553t2553r668b2583],
166	C.	NNP	PERSON	C.	dep	196	SENT_1082	[p33l680t2554r711b2583],
167	Robbins	NNP	PERSON	Robbins	dep	196	SENT_1082	[p33l725t2553r861b2583],
168	455	CD	NUMBER	455	dep	196	SENT_1082	[p33l1818t2553r1877b2583],
169	EXERCISE-INDUCED	JJ	O	exercise-induced	dep	196	SENT_1082	[p33l436t2614r796b2646],
170	VENTRICULAR	NN	O	ventricular	dep	196	SENT_1082	[p33l809t2614r1068b2646],
171	ARRHYTHMIAS	NN	O	arrhythmia	dep	196	SENT_1082	[p33l1080t2614r1352b2646],
172	IN	IN	O	in	dep	196	SENT_1082	[p33l1366t2620r1403b2645],
173	PATIENTS	NNS	O	patient	dep	196	SENT_1082	[p33l1416t2614r1590b2646],
174	VVITH	JJ	O	vvith	dep	196	SENT_1082	[p33l1603t2620r1698b2645],
175	NO	NN	O	no	dep	196	SENT_1082	[p33l481t2664r539b2695],
176	STRUCTURAL	NNP	MISC	STRUCTURAL	dep	196	SENT_1082	[p33l554t2664r796b2696],
177	CARDIAC	NNP	O	CARDIAC	dep	196	SENT_1082	[p33l809t2664r977b2696],
178	DISEASE	NNP	O	DISEASE	dep	196	SENT_1082	[p33l990t2664r1156b2701],
179	,	,	O	,	_	0	SENT_1082	[p33l990t2664r1156b2701],
180	Melvin	NNP	PERSON	Melvin	dep	196	SENT_1082	[p33l1168t2666r1284b2695],
181	M.	NNP	PERSON	M.	dep	196	SENT_1082	[p33l1294t2667r1335b2695],
182	Scheinman	NNP	PERSON	Scheinman	dep	196	SENT_1082	[p33l1351t2666r1531b2696],
183	and	CC	O	and	dep	196	SENT_1082	[p33l482t2716r545b2745],
184	Jason	NNP	PERSON	Jason	dep	196	SENT_1082	[p33l553t2717r648b2745],
185	Lam	NNP	PERSON	Lam	dep	196	SENT_1082	[p33l659t2717r733b2745],
186	273	CD	NUMBER	273	dep	196	SENT_1082	[p33l1819t2716r1877b2745],
187	CARDIOTOXICITY	NNP	O	CARDIOTOXICITY	dep	196	SENT_1082	[p33l436t2773r753b2806],
188	INDUCED	VBD	O	induce	dep	196	SENT_1082	[p33l766t2774r932b2805],
189	BY	IN	O	by	dep	196	SENT_1082	[p33l945t2780r994b2805],
190	CHEMOTHERAPY	NN	O	chemotherapy	dep	196	SENT_1082	[p33l1007t2773r1312b2806],
191	AND	CC	O	and	dep	196	SENT_1082	[p33l1324t2780r1402b2805],
192	ANTIBODY	NN	O	antibody	dep	196	SENT_1082	[p33l1415t2773r1611b2805],
193	THERAPY	NN	O	therapy	dep	196	SENT_1082	[p33l482t2824r664b2861],
194	,	,	O	,	_	0	SENT_1082	[p33l482t2824r664b2861],
195	Edward	NNP	PERSON	Edward	dep	196	SENT_1082	[p33l677t2826r809b2855],
196	TH	NN	O	th	_	0	SENT_1082	[p33l820t2827r884b2855],
197	.	.	O	.	_	0	SENT_1082	[p33l820t2827r884b2855],

1	Yeh	NN	PERSON	yeh	nsubj	9	SENT_1083	[p33l902t2826r956b2855],
2	485	CD	NUMBER	485	number	3	SENT_1083	[p33l1818t2826r1878b2855],
3	“	CD	NUMBER	“	num	5	SENT_1083	[p33l437t2886r730b2918],
4	SUNDOWNING	NN	O	sundowning	nn	5	SENT_1083	[p33l437t2886r730b2918],
5	”	NN	O	”	dep	1	SENT_1083	[p33l437t2886r730b2918],
6	AND	CC	O	and	_	0	SENT_1083	[p33l743t2892r821b2917],
7	OTHER	NN	O	other	conj_and	5	SENT_1083	[p33l835t2886r962b2918],
8	TEMPORALLY	RB	O	temporally	advmod	9	SENT_1083	[p33l974t2886r1220b2917],
9	ASSOCIATED	VBD	O	associate	_	0	SENT_1083	[p33l1233t2886r1465b2918],
10	AGITATION	NNP	O	AGITATION	nn	11	SENT_1083	[p33l1478t2886r1685b2917],
11	STATES	NNS	O	state	dobj	9	SENT_1083	[p33l483t2936r618b2967],
12	IN	IN	O	in	_	0	SENT_1083	[p33l632t2942r670b2967],
13	DEMENTIA	NNP	MISC	DEMENTIA	nn	14	SENT_1083	[p33l682t2936r878b2967],
14	PATIENTS	NNS	O	patient	prep_in	9	SENT_1083	[p33l891t2936r1076b2973],
15	,	,	O	,	_	0	SENT_1083	[p33l891t2936r1076b2973],
16	David	NNP	PERSON	David	nn	17	SENT_1083	[p33l1089t2938r1193b2967],
17	Bachman	NNP	PERSON	Bachman	prep_in	9	SENT_1083	[p33l1201t2938r1357b2967],
18	and	CC	O	and	_	0	SENT_1083	[p33l1369t2938r1432b2967],
19	Peter	NNP	PERSON	Peter	nn	20	SENT_1083	[p33l1441t2939r1529b2967],
20	Rabins	NNP	PERSON	Rabins	prep_in	9	SENT_1083	[p33l1537t2938r1652b2967],
21	499	CD	NUMBER	499	num	23	SENT_1083	[p33l1818t2938r1878b2968],
22	CURRENT	JJ	DATE	current	amod	23	SENT_1083	[p33l436t2998r611b3030],
23	PHARMACOTHERAPY	NN	O	pharmacotherapy	dep	20	SENT_1083	[p33l624t2998r1003b3030],
24	FOR	IN	O	for	_	0	SENT_1083	[p33l1015t3004r1086b3030],
25	ALzHEIMER	NN	O	alzheimer	nn	27	SENT_1083	[p33l1098t2998r1346b3030],
26	’S	NN	O	’s	nn	27	SENT_1083	[p33l1098t2998r1346b3030],
27	DISEASE	NN	O	disease	prep_for	9	SENT_1083	[p33l1360t2998r1525b3036],
28	,	,	O	,	_	0	SENT_1083	[p33l1360t2998r1525b3036],
29	A.	NN	PERSON	a.	nn	30	SENT_1083	[p33l479t3051r512b3080],
30	Lleo	NNP	PERSON	Lleo	prep_for	9	SENT_1083	[p33l527t3050r607b3085],
31	,	,	O	,	_	0	SENT_1083	[p33l527t3050r607b3085],
32	S.M.	NNP	PERSON	S.M.	nn	33	SENT_1083	[p33l622t3051r693b3080],
33	Greenberg	NNP	PERSON	Greenberg	prep_for	9	SENT_1083	[p33l710t3050r890b3088],
34	,	,	O	,	_	0	SENT_1083	[p33l710t3050r890b3088],
35	and	CC	O	and	_	0	SENT_1083	[p33l906t3050r969b3080],
36	JH	NN	O	jh	prep_for	9	SENT_1083	[p33l977t3051r1042b3080],
37	.	.	O	.	_	0	SENT_1083	[p33l977t3051r1042b3080],

1	Growdon	NNP	PERSON	Growdon	dep	18	SENT_1084	[p33l1058t3050r1210b3080],
2	513	CD	NUMBER	513	num	4	SENT_1084	[p33l1819t3050r1877b3080],
3	NEW	NNP	O	NEW	nn	4	SENT_1084	[p33l436t3110r524b3141],
4	TREATMENTS	NNS	O	treatment	dep	1	SENT_1084	[p33l536t3110r779b3141],
5	FOR	IN	O	for	_	0	SENT_1084	[p33l793t3116r863b3141],
6	NEUROPATHIC	NN	MISC	neuropathic	nn	7	SENT_1084	[p33l875t3110r1138b3141],
7	PAIN	NN	O	pain	prep_for	4	SENT_1084	[p33l1151t3110r1249b3147],
8	,	,	O	,	_	0	SENT_1084	[p33l1151t3110r1249b3147],
9	Andrew	NNP	PERSON	Andrew	nn	12	SENT_1084	[p33l1261t3112r1389b3141],
10	S.	NNP	PERSON	S.	nn	12	SENT_1084	[p33l1401t3113r1427b3141],
11	C.	NNP	PERSON	C.	nn	12	SENT_1084	[p33l1434t3113r1465b3141],
12	Rice	NNP	PERSON	Rice	conj_and	7	SENT_1084	[p33l1479t3113r1552b3141],
13	and	CC	O	and	_	0	SENT_1084	[p33l482t3161r545b3190],
14	Raymond	NNP	PERSON	Raymond	nn	16	SENT_1084	[p33l553t3161r712b3198],
15	G.	NNP	PERSON	G.	nn	16	SENT_1084	[p33l723t3161r757b3190],
16	Hill	NNP	PERSON	Hill	prep_for	4	SENT_1084	[p33l771t3161r836b3190],
17	535	CD	NUMBER	535	dep	18	SENT_1084	[p33l1819t3161r1877b3190],
18	PLANT	NNP	O	PLANT	dep	30	SENT_1084	[p33l436t3221r567b3258],
19	,	,	O	,	_	0	SENT_1084	[p33l436t3221r567b3258],
20	SYNTHETIC	NNP	O	SYNTHETIC	appos	18	SENT_1084	[p33l583t3220r798b3258],
21	,	,	O	,	_	0	SENT_1084	[p33l583t3220r798b3258],
22	AND	NNP	O	AND	nn	24	SENT_1084	[p33l812t3226r890b3252],
23	ENDOGENOUS	NNP	O	ENDOGENOUS	nn	24	SENT_1084	[p33l903t3221r1155b3252],
24	CANNABINOIDS	NNPS	O	CANNABINOIDS	appos	18	SENT_1084	[p33l1170t3220r1451b3252],
25	IN	IN	O	in	_	0	SENT_1084	[p33l1465t3227r1503b3252],
26	MEDICINE	NNP	O	MEDICINE	prep_in	24	SENT_1084	[p33l1515t3221r1710b3258],
27	,	,	O	,	_	0	SENT_1084	[p33l1515t3221r1710b3258],
28	Vincenzo	NNP	PERSON	Vincenzo	appos	18	SENT_1084	[p33l484t3265r629b3296],
29	Di	NNP	PERSON	Di	nn	30	SENT_1084	[p33l640t3265r682b3293],
30	Marzo	NNP	PERSON	Marzo	dep	35	SENT_1084	[p33l692t3265r800b3296],
31	and	CC	O	and	_	0	SENT_1084	[p33l812t3264r875b3293],
32	Luciano	NNP	PERSON	Luciano	nn	34	SENT_1084	[p33l883t3265r1019b3293],
33	De	NNP	PERSON	De	nn	34	SENT_1084	[p33l1030t3265r1077b3293],
34	Petrocellis	NNPS	PERSON	Petrocellis	dep	35	SENT_1084	[p33l1089t3264r1263b3293],
35	553	CD	NUMBER	553	_	0	SENT_1084	[p33l1819t3264r1877b3293],
36	THE	DT	O	the	det	39	SENT_1084	[p33l436t3324r511b3355],
37	HEALTH	NN	O	health	nn	39	SENT_1084	[p33l523t3324r675b3355],
38	INSURANCE	NN	O	insurance	nn	39	SENT_1084	[p33l687t3324r898b3355],
39	PORTABILITY	NN	MISC	portability	nsubj	42	SENT_1084	[p33l909t3324r1153b3355],
40	AND	CC	O	and	_	0	SENT_1084	[p33l1164t3329r1242b3355],
41	ACCOUNTABILITY	NN	O	accountability	nsubj	42	SENT_1084	[p33l1254t3323r1582b3355],
42	ACT	VBP	O	act	rcmod	35	SENT_1084	[p33l1594t3323r1673b3355],
43	OF	IN	O	of	prep	42	SENT_1084	[p33l1685t3329r1730b3355],

1	1996	CD	DATE	1996	num	2	SENT_1085	[p33l486t3372r571b3405],
2	(	CD	NUMBER	(	_	0	SENT_1085	[p33l586t3372r748b3412],
3	HIPAA	NNP	ORGANIZATION	HIPAA	dep	2	SENT_1085	[p33l586t3372r748b3412],
4	)	CD	NUMBER	)	num	6	SENT_1085	[p33l586t3372r748b3412],
5	PRIVACY	NNP	O	PRIVACY	nn	6	SENT_1085	[p33l761t3373r923b3405],
6	RULE	NN	O	rule	dep	3	SENT_1085	[p33l935t3373r1045b3405],
7	:	:	O	:	_	0	SENT_1085	[p33l935t3373r1045b3405],
8	IMPLICATIONS	NNS	O	implication	dep	3	SENT_1085	[p33l1066t3373r1324b3405],
9	FOR	IN	O	for	_	0	SENT_1085	[p33l1338t3379r1409b3405],
10	CLINICAL	JJ	O	clinical	amod	11	SENT_1085	[p33l1421t3372r1596b3405],
11	RESEARCH	NN	O	research	prep_for	8	SENT_1085	[p33l481t3423r687b3460],
12	,	,	O	,	_	0	SENT_1085	[p33l481t3423r687b3460],
13	Rachel	NNP	PERSON	Rachel	nn	14	SENT_1085	[p33l700t3425r816b3454],
14	Nosowsky	NNP	PERSON	Nosowsky	prep_for	8	SENT_1085	[p33l825t3425r991b3462],
15	and	CC	O	and	_	0	SENT_1085	[p33l1002t3425r1065b3454],
16	Thomas	NNP	PERSON	Thomas	nn	18	SENT_1085	[p33l1077t3425r1205b3454],
17	J.	NNP	PERSON	J.	nn	18	SENT_1085	[p33l1216t3426r1240b3454],
18	Giordano	NNP	PERSON	Giordano	prep_for	8	SENT_1085	[p33l1256t3425r1413b3454],
19	575	CD	NUMBER	575	num	18	SENT_1085	[p33l1819t3425r1877b3454],

